[
{
  "model": "agmp_app.index",
  "pk": 1,
  "fields": {
    "recname": "11-Beta-Hydroxylase Deficiency",
    "keywords": "11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2,
  "fields": {
    "recname": "17-Hydroxysteroid Dehydrogenase Deficiency",
    "keywords": "17-Hydroxysteroid Dehydrogenase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3,
  "fields": {
    "recname": "21-Hydroxylase Deficiency",
    "keywords": "21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 4,
  "fields": {
    "recname": "46, Xy Disorders Of Sex Development",
    "keywords": "46, Xy Disorders Of Sex Development"
  }
},
{
  "model": "agmp_app.index",
  "pk": 5,
  "fields": {
    "recname": "Acquired Immunodeficiency Syndrome",
    "keywords": "Acquired Immunodeficiency Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 6,
  "fields": {
    "recname": "Acrodermatitis Continua Of Hallopeau",
    "keywords": "Acrodermatitis Continua Of Hallopeau"
  }
},
{
  "model": "agmp_app.index",
  "pk": 7,
  "fields": {
    "recname": "Acrodermatitis Enteropathica",
    "keywords": "Acrodermatitis Enteropathica"
  }
},
{
  "model": "agmp_app.index",
  "pk": 8,
  "fields": {
    "recname": "Active Tuberculosis",
    "keywords": "Active Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 9,
  "fields": {
    "recname": "Acute Hiv Infection",
    "keywords": "Acute Hiv Infection"
  }
},
{
  "model": "agmp_app.index",
  "pk": 10,
  "fields": {
    "recname": "Acute Intermittent Porphyria",
    "keywords": "Acute Intermittent Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 11,
  "fields": {
    "recname": "Acute Lymphocytic Leukemia",
    "keywords": "Acute Lymphocytic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 12,
  "fields": {
    "recname": "Acute Periodontitis",
    "keywords": "Acute Periodontitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 13,
  "fields": {
    "recname": "Adult Acute Lymphocytic Leukemia",
    "keywords": "Adult Acute Lymphocytic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 14,
  "fields": {
    "recname": "Agenesis Of Corpus Callosum",
    "keywords": "Agenesis Of Corpus Callosum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 15,
  "fields": {
    "recname": "Age Related Macular Degeneration",
    "keywords": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 16,
  "fields": {
    "recname": "Albinism, Oculocutaneous",
    "keywords": "Albinism, Oculocutaneous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 17,
  "fields": {
    "recname": "Albinism, Oculocutaneous, Type Ib (Disorder)",
    "keywords": "Albinism, Oculocutaneous, Type Ib (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 18,
  "fields": {
    "recname": "Albinism, Oculocutaneous, Type I, Temperature-Sensitive",
    "keywords": "Albinism, Oculocutaneous, Type I, Temperature-Sensitive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 19,
  "fields": {
    "recname": "Alkaptonuria",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 20,
  "fields": {
    "recname": "Alopecia",
    "keywords": "Alopecia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 21,
  "fields": {
    "recname": "Alpha 1-Antitrypsin Deficiency",
    "keywords": "Alpha 1-Antitrypsin Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 22,
  "fields": {
    "recname": "Alpha-Sarcoglycanopathies",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 23,
  "fields": {
    "recname": "Alpha-Thalassemia",
    "keywords": "Alpha-Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 24,
  "fields": {
    "recname": "Amyotrophic Lateral Sclerosis 2, Juvenile (Disorder)",
    "keywords": "Amyotrophic Lateral Sclerosis 2, Juvenile (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 25,
  "fields": {
    "recname": "Amyotrophic Lateral Sclerosis 5",
    "keywords": "Amyotrophic Lateral Sclerosis 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 26,
  "fields": {
    "recname": "Anemia",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 27,
  "fields": {
    "recname": "Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency",
    "keywords": "Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 28,
  "fields": {
    "recname": "Anemia, Sickle Cell",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 29,
  "fields": {
    "recname": "Anhaptoglobinemia",
    "keywords": "Anhaptoglobinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 30,
  "fields": {
    "recname": "Antiphospholipid Syndrome",
    "keywords": "Antiphospholipid Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 31,
  "fields": {
    "recname": "Antithrombin Iii Deficiency",
    "keywords": "Antithrombin Iii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 32,
  "fields": {
    "recname": "Arrhythmogenic Right Ventricular Dysplasia",
    "keywords": "Arrhythmogenic Right Ventricular Dysplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 33,
  "fields": {
    "recname": "Arterial Calcification, Generalized, Of Infancy, 2",
    "keywords": "Arterial Calcification, Generalized, Of Infancy, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 34,
  "fields": {
    "recname": "Arterial Tortuosity Syndrome",
    "keywords": "Arterial Tortuosity Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 35,
  "fields": {
    "recname": "Arthrogryposis, Distal, With Impaired Proprioception And Touch",
    "keywords": "Arthrogryposis, Distal, With Impaired Proprioception And Touch"
  }
},
{
  "model": "agmp_app.index",
  "pk": 36,
  "fields": {
    "recname": "Aspartylglucosaminuria",
    "keywords": "Aspartylglucosaminuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 37,
  "fields": {
    "recname": "Asymmetric Septal Hypertrophy",
    "keywords": "Asymmetric Septal Hypertrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 38,
  "fields": {
    "recname": "Ataxia, Spastic, 2, Autosomal Recessive (Disorder)",
    "keywords": "Ataxia, Spastic, 2, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 39,
  "fields": {
    "recname": "Ataxia Telangiectasia",
    "keywords": "Ataxia Telangiectasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 40,
  "fields": {
    "recname": "Ataxia With Vitamin E Deficiency",
    "keywords": "Ataxia With Vitamin E Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 41,
  "fields": {
    "recname": "Auditory Neuropathy",
    "keywords": "Auditory Neuropathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 42,
  "fields": {
    "recname": "Auditory Neuropathy Spectrum Disorder",
    "keywords": "Auditory Neuropathy Spectrum Disorder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 43,
  "fields": {
    "recname": "Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant",
    "keywords": "Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 44,
  "fields": {
    "recname": "Autosomal Recessive Polycystic Kidney Disease",
    "keywords": "Autosomal Recessive Polycystic Kidney Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 45,
  "fields": {
    "recname": "Avellino Corneal Dystrophy",
    "keywords": "Avellino Corneal Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 46,
  "fields": {
    "recname": "Bacteremia",
    "keywords": "Bacteremia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 47,
  "fields": {
    "recname": "Bacteremia, Susceptibility To, 2",
    "keywords": "Bacteremia, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 48,
  "fields": {
    "recname": "Bardet-Biedl Syndrome",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 49,
  "fields": {
    "recname": "Bardet-Biedl Syndrome 10",
    "keywords": "Bardet-Biedl Syndrome 10"
  }
},
{
  "model": "agmp_app.index",
  "pk": 50,
  "fields": {
    "recname": "Bardet-Biedl Syndrome 2 (Disorder)",
    "keywords": "Bardet-Biedl Syndrome 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 51,
  "fields": {
    "recname": "Basal Ganglia Disease, Biotin-Responsive",
    "keywords": "Basal Ganglia Disease, Biotin-Responsive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 52,
  "fields": {
    "recname": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)",
    "keywords": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 53,
  "fields": {
    "recname": "Beta^0^ Thalassemia",
    "keywords": "Beta^0^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 54,
  "fields": {
    "recname": "Beta-Knossos-Thalassemia",
    "keywords": "Beta-Knossos-Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 55,
  "fields": {
    "recname": "Beta^+^ Thalassemia",
    "keywords": "Beta^+^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 56,
  "fields": {
    "recname": "Beta Thalassemia",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 57,
  "fields": {
    "recname": "Bifid Nose With Or Without Anorectal And Renal Anomalies",
    "keywords": "Bifid Nose With Or Without Anorectal And Renal Anomalies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 58,
  "fields": {
    "recname": "Biotinidase Deficiency",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 59,
  "fields": {
    "recname": "Bipolar I Disorder",
    "keywords": "Bipolar I Disorder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 60,
  "fields": {
    "recname": "Bladder Neoplasm",
    "keywords": "Bladder Neoplasm"
  }
},
{
  "model": "agmp_app.index",
  "pk": 61,
  "fields": {
    "recname": "Blood Pressure",
    "keywords": "Blood Pressure"
  }
},
{
  "model": "agmp_app.index",
  "pk": 62,
  "fields": {
    "recname": "Blood Pressure Finding",
    "keywords": "Blood Pressure Finding"
  }
},
{
  "model": "agmp_app.index",
  "pk": 63,
  "fields": {
    "recname": "Body Height",
    "keywords": "Body Height"
  }
},
{
  "model": "agmp_app.index",
  "pk": 64,
  "fields": {
    "recname": "Body Mass Index",
    "keywords": "Body Mass Index"
  }
},
{
  "model": "agmp_app.index",
  "pk": 65,
  "fields": {
    "recname": "Breast Cancer, Familial",
    "keywords": "Breast Cancer, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 66,
  "fields": {
    "recname": "Breast Carcinoma",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 67,
  "fields": {
    "recname": "Breast Carcinoma, Sporadic",
    "keywords": "Breast Carcinoma, Sporadic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 68,
  "fields": {
    "recname": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 69,
  "fields": {
    "recname": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 70,
  "fields": {
    "recname": "Bronchiectasis With Or Without Elevated Sweat Chloride 1",
    "keywords": "Bronchiectasis With Or Without Elevated Sweat Chloride 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 71,
  "fields": {
    "recname": "Brown Oculocutaneous Albinism",
    "keywords": "Brown Oculocutaneous Albinism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 72,
  "fields": {
    "recname": "Buruli Ulcer, Susceptibility To",
    "keywords": "Buruli Ulcer, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 73,
  "fields": {
    "recname": "Candidiasis, Familial, 2",
    "keywords": "Candidiasis, Familial, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 74,
  "fields": {
    "recname": "Carcinoma Of Bladder",
    "keywords": "Carcinoma Of Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 75,
  "fields": {
    "recname": "Cardiomyopathies",
    "keywords": "Cardiomyopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 76,
  "fields": {
    "recname": "Cardiomyopathy, Dilated, 1D (Disorder)",
    "keywords": "Cardiomyopathy, Dilated, 1D (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 77,
  "fields": {
    "recname": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)",
    "keywords": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 78,
  "fields": {
    "recname": "Cardiomyopathy, Familial Hypertrophic, 2",
    "keywords": "Cardiomyopathy, Familial Hypertrophic, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 79,
  "fields": {
    "recname": "Cardiomyopathy, Familial Idiopathic",
    "keywords": "Cardiomyopathy, Familial Idiopathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 80,
  "fields": {
    "recname": "Cardiomyopathy, Familial Restrictive, 3 (Disorder)",
    "keywords": "Cardiomyopathy, Familial Restrictive, 3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 81,
  "fields": {
    "recname": "Cardiomyopathy, Hypertrophic, Familial",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 82,
  "fields": {
    "recname": "Cardiovascular Diseases",
    "keywords": "Cardiovascular Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 83,
  "fields": {
    "recname": "Cataract",
    "keywords": "Cataract"
  }
},
{
  "model": "agmp_app.index",
  "pk": 84,
  "fields": {
    "recname": "Cataract 4, Multiple Types",
    "keywords": "Cataract 4, Multiple Types"
  }
},
{
  "model": "agmp_app.index",
  "pk": 85,
  "fields": {
    "recname": "Cataract, Congenital, Cerulean Type, 3",
    "keywords": "Cataract, Congenital, Cerulean Type, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 86,
  "fields": {
    "recname": "Cataract, Crystalline Aculeiform",
    "keywords": "Cataract, Crystalline Aculeiform"
  }
},
{
  "model": "agmp_app.index",
  "pk": 87,
  "fields": {
    "recname": "Cataract, Punctate, Progressive Juvenile-Onset",
    "keywords": "Cataract, Punctate, Progressive Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 88,
  "fields": {
    "recname": "Central Core Disease, Autosomal Recessive",
    "keywords": "Central Core Disease, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 89,
  "fields": {
    "recname": "Central Core Myopathy (Disorder)",
    "keywords": "Central Core Myopathy (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 90,
  "fields": {
    "recname": "Ceroid Lipofuscinosis, Neuronal, 7",
    "keywords": "Ceroid Lipofuscinosis, Neuronal, 7"
  }
},
{
  "model": "agmp_app.index",
  "pk": 91,
  "fields": {
    "recname": "Cervical Cancer",
    "keywords": "Cervical Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 92,
  "fields": {
    "recname": "Cervix Carcinoma",
    "keywords": "Cervix Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 93,
  "fields": {
    "recname": "Charcot-Marie-Tooth Disease",
    "keywords": "Charcot-Marie-Tooth Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 94,
  "fields": {
    "recname": "Charcot-Marie-Tooth Disease, Axonal, Type 2K",
    "keywords": "Charcot-Marie-Tooth Disease, Axonal, Type 2K"
  }
},
{
  "model": "agmp_app.index",
  "pk": 95,
  "fields": {
    "recname": "Charcot-Marie-Tooth Disease, Axonal, Type 2X",
    "keywords": "Charcot-Marie-Tooth Disease, Axonal, Type 2X"
  }
},
{
  "model": "agmp_app.index",
  "pk": 96,
  "fields": {
    "recname": "Charcot-Marie-Tooth Disease, Type 2B1",
    "keywords": "Charcot-Marie-Tooth Disease, Type 2B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 97,
  "fields": {
    "recname": "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form"
  }
},
{
  "model": "agmp_app.index",
  "pk": 98,
  "fields": {
    "recname": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 99,
  "fields": {
    "recname": "Charcot-Marie-Tooth Disease, Type 4C",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 100,
  "fields": {
    "recname": "Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma",
    "keywords": "Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 101,
  "fields": {
    "recname": "Chester-Type Porphyria",
    "keywords": "Chester-Type Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 102,
  "fields": {
    "recname": "Childhood Acute Lymphoblastic Leukemia",
    "keywords": "Childhood Acute Lymphoblastic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 103,
  "fields": {
    "recname": "Chronic Active Hepatitis",
    "keywords": "Chronic Active Hepatitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 104,
  "fields": {
    "recname": "Chronic Obstructive Airway Disease",
    "keywords": "Chronic Obstructive Airway Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 105,
  "fields": {
    "recname": "Chylomicron Retention Disease",
    "keywords": "Chylomicron Retention Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 106,
  "fields": {
    "recname": "Citrullinemia",
    "keywords": "Citrullinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 107,
  "fields": {
    "recname": "Classical Galactosemia",
    "keywords": "Classical Galactosemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 108,
  "fields": {
    "recname": "Classical Phenylketonuria",
    "keywords": "Classical Phenylketonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 109,
  "fields": {
    "recname": "Colitis",
    "keywords": "Colitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 110,
  "fields": {
    "recname": "Colon Carcinoma",
    "keywords": "Colon Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 111,
  "fields": {
    "recname": "Colorectal Adenomatous Polyposis, Autosomal Recessive",
    "keywords": "Colorectal Adenomatous Polyposis, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 112,
  "fields": {
    "recname": "Colorectal Cancer",
    "keywords": "Colorectal Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 113,
  "fields": {
    "recname": "Colorectal Carcinoma",
    "keywords": "Colorectal Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 114,
  "fields": {
    "recname": "Colorectal Neoplasms",
    "keywords": "Colorectal Neoplasms"
  }
},
{
  "model": "agmp_app.index",
  "pk": 115,
  "fields": {
    "recname": "Complement Component 7 Deficiency",
    "keywords": "Complement Component 7 Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 116,
  "fields": {
    "recname": "Complete Hydatidiform Mole",
    "keywords": "Complete Hydatidiform Mole"
  }
},
{
  "model": "agmp_app.index",
  "pk": 117,
  "fields": {
    "recname": "Cone-Rod Dystrophy 18",
    "keywords": "Cone-Rod Dystrophy 18"
  }
},
{
  "model": "agmp_app.index",
  "pk": 118,
  "fields": {
    "recname": "Cone-Rod Dystrophy 3 (Disorder)",
    "keywords": "Cone-Rod Dystrophy 3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 119,
  "fields": {
    "recname": "Cone-Rod Dystrophy 9",
    "keywords": "Cone-Rod Dystrophy 9"
  }
},
{
  "model": "agmp_app.index",
  "pk": 120,
  "fields": {
    "recname": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 121,
  "fields": {
    "recname": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency",
    "keywords": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 122,
  "fields": {
    "recname": "Congenital Bilateral Aplasia Of Vas Deferens",
    "keywords": "Congenital Bilateral Aplasia Of Vas Deferens"
  }
},
{
  "model": "agmp_app.index",
  "pk": 123,
  "fields": {
    "recname": "Congenital Disorder Of Glycosylation, Type Iil",
    "keywords": "Congenital Disorder Of Glycosylation, Type Iil"
  }
},
{
  "model": "agmp_app.index",
  "pk": 124,
  "fields": {
    "recname": "Congenital Disorder Of Glycosylation, Type Iin",
    "keywords": "Congenital Disorder Of Glycosylation, Type Iin"
  }
},
{
  "model": "agmp_app.index",
  "pk": 125,
  "fields": {
    "recname": "Corneal Dystrophy, Lattice Type 3",
    "keywords": "Corneal Dystrophy, Lattice Type 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 126,
  "fields": {
    "recname": "Coronary Artery Disease",
    "keywords": "Coronary Artery Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 127,
  "fields": {
    "recname": "Cranioectodermal Dysplasia 3",
    "keywords": "Cranioectodermal Dysplasia 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 128,
  "fields": {
    "recname": "C-Reactive Protein Measurement",
    "keywords": "C-Reactive Protein Measurement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 129,
  "fields": {
    "recname": "Creutzfeldt-Jakob Disease",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 130,
  "fields": {
    "recname": "Creutzfeldt-Jakob Disease, Familial",
    "keywords": "Creutzfeldt-Jakob Disease, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 131,
  "fields": {
    "recname": "Creutzfeldt-Jakob Disease, Heidenhain Variant",
    "keywords": "Creutzfeldt-Jakob Disease, Heidenhain Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 132,
  "fields": {
    "recname": "Creutzfeldt-Jakob Disease, Sporadic",
    "keywords": "Creutzfeldt-Jakob Disease, Sporadic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 133,
  "fields": {
    "recname": "Crigler NAjjar Syndrome, Type 1",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 134,
  "fields": {
    "recname": "Crohn Disease",
    "keywords": "Crohn Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 135,
  "fields": {
    "recname": "Cryptorchidism",
    "keywords": "Cryptorchidism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 136,
  "fields": {
    "recname": "Cystic Fibrosis",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 137,
  "fields": {
    "recname": "Cystinosis, Benign, Nonnephropathic",
    "keywords": "Cystinosis, Benign, Nonnephropathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 138,
  "fields": {
    "recname": "Cystinuria",
    "keywords": "Cystinuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 139,
  "fields": {
    "recname": "Cystinuria, Type A",
    "keywords": "Cystinuria, Type A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 140,
  "fields": {
    "recname": "Cystinuria, Type A-B",
    "keywords": "Cystinuria, Type A-B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 141,
  "fields": {
    "recname": "Cystinuria, Type B",
    "keywords": "Cystinuria, Type B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 142,
  "fields": {
    "recname": "Deafness, Autosomal Dominant 23",
    "keywords": "Deafness, Autosomal Dominant 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 143,
  "fields": {
    "recname": "Deafness, Autosomal Dominant 3A (Disorder)",
    "keywords": "Deafness, Autosomal Dominant 3A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 144,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 10",
    "keywords": "Deafness, Autosomal Recessive 10"
  }
},
{
  "model": "agmp_app.index",
  "pk": 145,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 102",
    "keywords": "Deafness, Autosomal Recessive 102"
  }
},
{
  "model": "agmp_app.index",
  "pk": 146,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 105",
    "keywords": "Deafness, Autosomal Recessive 105"
  }
},
{
  "model": "agmp_app.index",
  "pk": 147,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 1A (Disorder)",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 148,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 31",
    "keywords": "Deafness, Autosomal Recessive 31"
  }
},
{
  "model": "agmp_app.index",
  "pk": 149,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 53",
    "keywords": "Deafness, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.index",
  "pk": 150,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 66",
    "keywords": "Deafness, Autosomal Recessive 66"
  }
},
{
  "model": "agmp_app.index",
  "pk": 151,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 79",
    "keywords": "Deafness, Autosomal Recessive 79"
  }
},
{
  "model": "agmp_app.index",
  "pk": 152,
  "fields": {
    "recname": "Deafness, Autosomal Recessive 84A",
    "keywords": "Deafness, Autosomal Recessive 84A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 153,
  "fields": {
    "recname": "Deafness, Autosomal Recessive (Disorder)",
    "keywords": "Deafness, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 154,
  "fields": {
    "recname": "Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8",
    "keywords": "Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 155,
  "fields": {
    "recname": "Deafness, Congenital, With Inner Ear Agenesis, Microtia, And Microdontia",
    "keywords": "Deafness, Congenital, With Inner Ear Agenesis, Microtia, And Microdontia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 156,
  "fields": {
    "recname": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)",
    "keywords": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 157,
  "fields": {
    "recname": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 158,
  "fields": {
    "recname": "Deficiency Of Glucose-6-Phosphate Dehydrogenase",
    "keywords": "Deficiency Of Glucose-6-Phosphate Dehydrogenase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 159,
  "fields": {
    "recname": "Deficiency Of Monooxygenase",
    "keywords": "Deficiency Of Monooxygenase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 160,
  "fields": {
    "recname": "Deficiency Of Pyruvate Kinase",
    "keywords": "Deficiency Of Pyruvate Kinase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 161,
  "fields": {
    "recname": "Diabetes",
    "keywords": "Diabetes"
  }
},
{
  "model": "agmp_app.index",
  "pk": 162,
  "fields": {
    "recname": "Diabetes Mellitus",
    "keywords": "Diabetes Mellitus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 163,
  "fields": {
    "recname": "Diabetes Mellitus, Insulin-Dependent",
    "keywords": "Diabetes Mellitus, Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 164,
  "fields": {
    "recname": "Diabetes Mellitus, Non-Insulin-Dependent",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 165,
  "fields": {
    "recname": "Diabetic Nephropathy",
    "keywords": "Diabetic Nephropathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 166,
  "fields": {
    "recname": "Disorder Of Achilles Tendon",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 167,
  "fields": {
    "recname": "Drug-Induced Liver Disease",
    "keywords": "Drug-Induced Liver Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 168,
  "fields": {
    "recname": "Dwarfism",
    "keywords": "Dwarfism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 169,
  "fields": {
    "recname": "Early Myoclonic Encephalopathy",
    "keywords": "Early Myoclonic Encephalopathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 170,
  "fields": {
    "recname": "Ectodermal Dysplasia 11A, Hypohidrotic/Hair/Tooth Type, Autosomal Dominant",
    "keywords": "Ectodermal Dysplasia 11A, Hypohidrotic/Hair/Tooth Type, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 171,
  "fields": {
    "recname": "Ectodermal Dysplasia 11B, Hypohidrotic/Hair/Tooth Type, Autosomal Recessive",
    "keywords": "Ectodermal Dysplasia 11B, Hypohidrotic/Hair/Tooth Type, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 172,
  "fields": {
    "recname": "Ectodermal Dysplasia 3, Anhidrotic",
    "keywords": "Ectodermal Dysplasia 3, Anhidrotic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 173,
  "fields": {
    "recname": "Ectodermal Dysplasia-Syndactyly Syndrome 1",
    "keywords": "Ectodermal Dysplasia-Syndactyly Syndrome 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 174,
  "fields": {
    "recname": "Elliptocytosis 2 (Disorder)",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 175,
  "fields": {
    "recname": "Encephalitis, St. Louis",
    "keywords": "Encephalitis, St. Louis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 176,
  "fields": {
    "recname": "Encephalopathy Adverse Event",
    "keywords": "Encephalopathy Adverse Event"
  }
},
{
  "model": "agmp_app.index",
  "pk": 177,
  "fields": {
    "recname": "Enlarged Vestibular Aqueduct",
    "keywords": "Enlarged Vestibular Aqueduct"
  }
},
{
  "model": "agmp_app.index",
  "pk": 178,
  "fields": {
    "recname": "Epilepsies, Partial",
    "keywords": "Epilepsies, Partial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 179,
  "fields": {
    "recname": "Epilepsy, Familial Adult Myoclonic, 5",
    "keywords": "Epilepsy, Familial Adult Myoclonic, 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 180,
  "fields": {
    "recname": "Epilepsy, Familial Temporal Lobe, 5",
    "keywords": "Epilepsy, Familial Temporal Lobe, 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 181,
  "fields": {
    "recname": "Epilepsy, Progressive Myoclonic 3",
    "keywords": "Epilepsy, Progressive Myoclonic 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 182,
  "fields": {
    "recname": "Epilepsy, Progressive Myoclonic, 8",
    "keywords": "Epilepsy, Progressive Myoclonic, 8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 183,
  "fields": {
    "recname": "Epilepsy, Temporal Lobe",
    "keywords": "Epilepsy, Temporal Lobe"
  }
},
{
  "model": "agmp_app.index",
  "pk": 184,
  "fields": {
    "recname": "Estren-Dameshek Variant Of Fanconi Anemia",
    "keywords": "Estren-Dameshek Variant Of Fanconi Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 185,
  "fields": {
    "recname": "Estren-Dameshek Variant Of Fanconi Pancytopenia",
    "keywords": "Estren-Dameshek Variant Of Fanconi Pancytopenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 186,
  "fields": {
    "recname": "Estrogen Resistance",
    "keywords": "Estrogen Resistance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 187,
  "fields": {
    "recname": "Exfoliation Syndrome",
    "keywords": "Exfoliation Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 188,
  "fields": {
    "recname": "Factor V And Factor Viii, Combined Deficiency Of, 2",
    "keywords": "Factor V And Factor Viii, Combined Deficiency Of, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 189,
  "fields": {
    "recname": "Factor Vii Deficiency",
    "keywords": "Factor Vii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 190,
  "fields": {
    "recname": "Familial Cold Urticaria",
    "keywords": "Familial Cold Urticaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 191,
  "fields": {
    "recname": "Familial (Fpah)",
    "keywords": "Familial (Fpah)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 192,
  "fields": {
    "recname": "Familial Mediterranean Fever",
    "keywords": "Familial Mediterranean Fever"
  }
},
{
  "model": "agmp_app.index",
  "pk": 193,
  "fields": {
    "recname": "Familial Medullary Thyroid Carcinoma",
    "keywords": "Familial Medullary Thyroid Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 194,
  "fields": {
    "recname": "Familial Porphyria Cutanea Tarda",
    "keywords": "Familial Porphyria Cutanea Tarda"
  }
},
{
  "model": "agmp_app.index",
  "pk": 195,
  "fields": {
    "recname": "Fanconi Anemia",
    "keywords": "Fanconi Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 196,
  "fields": {
    "recname": "Fanconi Anemia, Complementation Group A (Disorder)",
    "keywords": "Fanconi Anemia, Complementation Group A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 197,
  "fields": {
    "recname": "Fanconi Anemia, Complementation Group C",
    "keywords": "Fanconi Anemia, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 198,
  "fields": {
    "recname": "Fanconi Anemia Complementation Group G",
    "keywords": "Fanconi Anemia Complementation Group G"
  }
},
{
  "model": "agmp_app.index",
  "pk": 199,
  "fields": {
    "recname": "Fatal Familial Insomnia",
    "keywords": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 200,
  "fields": {
    "recname": "Febrile Convulsions",
    "keywords": "Febrile Convulsions"
  }
},
{
  "model": "agmp_app.index",
  "pk": 201,
  "fields": {
    "recname": "Febrile Seizures, Familial, 11",
    "keywords": "Febrile Seizures, Familial, 11"
  }
},
{
  "model": "agmp_app.index",
  "pk": 202,
  "fields": {
    "recname": "Fetal Hemoglobin Quantitative Trait Locus 1",
    "keywords": "Fetal Hemoglobin Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 203,
  "fields": {
    "recname": "Focal Glomerulosclerosis",
    "keywords": "Focal Glomerulosclerosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 204,
  "fields": {
    "recname": "Focal Segmental Glomerulosclerosis 4, Susceptibility To",
    "keywords": "Focal Segmental Glomerulosclerosis 4, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 205,
  "fields": {
    "recname": "Frontotemporal Dementia",
    "keywords": "Frontotemporal Dementia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 206,
  "fields": {
    "recname": "Fucosidase Deficiency Disease",
    "keywords": "Fucosidase Deficiency Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 207,
  "fields": {
    "recname": "Fundus Dystrophy, Pseudoinflammatory, Of Sorsby",
    "keywords": "Fundus Dystrophy, Pseudoinflammatory, Of Sorsby"
  }
},
{
  "model": "agmp_app.index",
  "pk": 208,
  "fields": {
    "recname": "Gaucher Disease",
    "keywords": "Gaucher Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 209,
  "fields": {
    "recname": "Gaucher Disease, Type 1",
    "keywords": "Gaucher Disease, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 210,
  "fields": {
    "recname": "Generalized Pustular Psoriasis",
    "keywords": "Generalized Pustular Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 211,
  "fields": {
    "recname": "Genetic Diseases, Inborn",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 212,
  "fields": {
    "recname": "Gestational Trophoblastic Disease",
    "keywords": "Gestational Trophoblastic Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 213,
  "fields": {
    "recname": "Ghosal Hematodiaphyseal Syndrome",
    "keywords": "Ghosal Hematodiaphyseal Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 214,
  "fields": {
    "recname": "Giant Axonal Neuropathy 1",
    "keywords": "Giant Axonal Neuropathy 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 215,
  "fields": {
    "recname": "Glaucoma 3, Primary Congenital, A",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 216,
  "fields": {
    "recname": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 217,
  "fields": {
    "recname": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 218,
  "fields": {
    "recname": "Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency",
    "keywords": "Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 219,
  "fields": {
    "recname": "Glutaric Aciduria, Type 1",
    "keywords": "Glutaric Aciduria, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 220,
  "fields": {
    "recname": "Glycogen Storage Disease Iiia",
    "keywords": "Glycogen Storage Disease Iiia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 221,
  "fields": {
    "recname": "Glycogen Storage Disease Type I",
    "keywords": "Glycogen Storage Disease Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 222,
  "fields": {
    "recname": "Glycogen Storage Disease Type Ii",
    "keywords": "Glycogen Storage Disease Type Ii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 223,
  "fields": {
    "recname": "Glycogen Storage Disease Type Iii",
    "keywords": "Glycogen Storage Disease Type Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 224,
  "fields": {
    "recname": "Glycogen Storage Disease Type V",
    "keywords": "Glycogen Storage Disease Type V"
  }
},
{
  "model": "agmp_app.index",
  "pk": 225,
  "fields": {
    "recname": "Gm2-Gangliosidosis, Adult Chronic Type",
    "keywords": "Gm2-Gangliosidosis, Adult Chronic Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 226,
  "fields": {
    "recname": "Gm2-Gangliosidosis, Variant B1",
    "keywords": "Gm2-Gangliosidosis, Variant B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 227,
  "fields": {
    "recname": "Gout",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 228,
  "fields": {
    "recname": "Gronblad-Strandberg Syndrome",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 229,
  "fields": {
    "recname": "Growth Retardation, Alopecia, Pseudoanodontia And Optic Atrophy",
    "keywords": "Growth Retardation, Alopecia, Pseudoanodontia And Optic Atrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 230,
  "fields": {
    "recname": "Heart Diseases",
    "keywords": "Heart Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 231,
  "fields": {
    "recname": "Hemochromatosis, Type 1",
    "keywords": "Hemochromatosis, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 232,
  "fields": {
    "recname": "Hemochromatosis, Type 4",
    "keywords": "Hemochromatosis, Type 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 233,
  "fields": {
    "recname": "Hemoglobin E/Beta Thalassemia Disease",
    "keywords": "Hemoglobin E/Beta Thalassemia Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 234,
  "fields": {
    "recname": "Henoch-Schoenlein Purpura",
    "keywords": "Henoch-Schoenlein Purpura"
  }
},
{
  "model": "agmp_app.index",
  "pk": 235,
  "fields": {
    "recname": "Hepatitis B Virus, Susceptibility To",
    "keywords": "Hepatitis B Virus, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 236,
  "fields": {
    "recname": "Hepatitis C",
    "keywords": "Hepatitis C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 237,
  "fields": {
    "recname": "Hepatitis C, Chronic",
    "keywords": "Hepatitis C, Chronic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 238,
  "fields": {
    "recname": "Hepatoerythropoietic Porphyria",
    "keywords": "Hepatoerythropoietic Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 239,
  "fields": {
    "recname": "Hepatolenticular Degeneration",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 240,
  "fields": {
    "recname": "Hereditary Breast And Ovarian Cancer Syndrome",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 241,
  "fields": {
    "recname": "Hereditary Hemochromatosis",
    "keywords": "Hereditary Hemochromatosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 242,
  "fields": {
    "recname": "Hereditary Motor And Sensory-Neuropathy Type Ii",
    "keywords": "Hereditary Motor And Sensory-Neuropathy Type Ii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 243,
  "fields": {
    "recname": "Hereditary Nonpolyposis Colorectal Cancer",
    "keywords": "Hereditary Nonpolyposis Colorectal Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 244,
  "fields": {
    "recname": "Hereditary Pyropoikilocytosis",
    "keywords": "Hereditary Pyropoikilocytosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 245,
  "fields": {
    "recname": "Hexosaminidase A Deficiency, Adult Type",
    "keywords": "Hexosaminidase A Deficiency, Adult Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 246,
  "fields": {
    "recname": "Hip Dysplasia, Beukes Type",
    "keywords": "Hip Dysplasia, Beukes Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 247,
  "fields": {
    "recname": "Hirschsprung Disease",
    "keywords": "Hirschsprung Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 248,
  "fields": {
    "recname": "Histiocytosis With Joint Contractures And Sensorineural Deafness",
    "keywords": "Histiocytosis With Joint Contractures And Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 249,
  "fields": {
    "recname": "Hiv Infections",
    "keywords": "Hiv Infections"
  }
},
{
  "model": "agmp_app.index",
  "pk": 250,
  "fields": {
    "recname": "Homocysteine Measurement",
    "keywords": "Homocysteine Measurement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 251,
  "fields": {
    "recname": "Hsan Type Iv",
    "keywords": "Hsan Type Iv"
  }
},
{
  "model": "agmp_app.index",
  "pk": 252,
  "fields": {
    "recname": "Huntington Disease-Like 1",
    "keywords": "Huntington Disease-Like 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 253,
  "fields": {
    "recname": "Hydrophthalmos",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 254,
  "fields": {
    "recname": "Hydroxymethylbilane Synthase Deficiency",
    "keywords": "Hydroxymethylbilane Synthase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 255,
  "fields": {
    "recname": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency",
    "keywords": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 256,
  "fields": {
    "recname": "Hypercholesterolemia, Familial",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 257,
  "fields": {
    "recname": "Hyperhomocysteinemia, Thrombotic, Cbs-Related",
    "keywords": "Hyperhomocysteinemia, Thrombotic, Cbs-Related"
  }
},
{
  "model": "agmp_app.index",
  "pk": 258,
  "fields": {
    "recname": "Hyperlipoproteinemia Type Iia",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 259,
  "fields": {
    "recname": "Hyperphenylalaninaemia",
    "keywords": "Hyperphenylalaninaemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 260,
  "fields": {
    "recname": "Hyperphenylalaninemia, Non-Pku Mild",
    "keywords": "Hyperphenylalaninemia, Non-Pku Mild"
  }
},
{
  "model": "agmp_app.index",
  "pk": 261,
  "fields": {
    "recname": "Hypertensive Disease",
    "keywords": "Hypertensive Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 262,
  "fields": {
    "recname": "Hypertrophic Cardiomyopathy",
    "keywords": "Hypertrophic Cardiomyopathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 263,
  "fields": {
    "recname": "Hypohaptoglobinemia (Disorder)",
    "keywords": "Hypohaptoglobinemia (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 264,
  "fields": {
    "recname": "Hypoparathyroidism-Retardation-Dysmorphism Syndrome",
    "keywords": "Hypoparathyroidism-Retardation-Dysmorphism Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 265,
  "fields": {
    "recname": "Hypothyroidism, Congenital, Nongoitrous, 4",
    "keywords": "Hypothyroidism, Congenital, Nongoitrous, 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 266,
  "fields": {
    "recname": "Hypotonia, Infantile, With Psychomotor Retardation",
    "keywords": "Hypotonia, Infantile, With Psychomotor Retardation"
  }
},
{
  "model": "agmp_app.index",
  "pk": 267,
  "fields": {
    "recname": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2",
    "keywords": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 268,
  "fields": {
    "recname": "Hypotrichosis 11",
    "keywords": "Hypotrichosis 11"
  }
},
{
  "model": "agmp_app.index",
  "pk": 269,
  "fields": {
    "recname": "Hypotrichosis 6",
    "keywords": "Hypotrichosis 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 270,
  "fields": {
    "recname": "Hypotrichosis Simplex",
    "keywords": "Hypotrichosis Simplex"
  }
},
{
  "model": "agmp_app.index",
  "pk": 271,
  "fields": {
    "recname": "Ichthyosiform Erythroderma, Congenital",
    "keywords": "Ichthyosiform Erythroderma, Congenital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 272,
  "fields": {
    "recname": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 273,
  "fields": {
    "recname": "Ichthyosis, Congenital, Autosomal Recessive 9",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 9"
  }
},
{
  "model": "agmp_app.index",
  "pk": 274,
  "fields": {
    "recname": "Ichthyosis, Hystrix-Like, With Deafness",
    "keywords": "Ichthyosis, Hystrix-Like, With Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 275,
  "fields": {
    "recname": "Ichthyosis, Lamellar, 3",
    "keywords": "Ichthyosis, Lamellar, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 276,
  "fields": {
    "recname": "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis",
    "keywords": "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 277,
  "fields": {
    "recname": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive",
    "keywords": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 278,
  "fields": {
    "recname": "Idiopathic Hypertrophic Subaortic Stenosis",
    "keywords": "Idiopathic Hypertrophic Subaortic Stenosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 279,
  "fields": {
    "recname": "Idiopathic Pulmonary Arterial Hypertension",
    "keywords": "Idiopathic Pulmonary Arterial Hypertension"
  }
},
{
  "model": "agmp_app.index",
  "pk": 280,
  "fields": {
    "recname": "Idiopathic Pulmonary Fibrosis",
    "keywords": "Idiopathic Pulmonary Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 281,
  "fields": {
    "recname": "Immunodeficiency 23",
    "keywords": "Immunodeficiency 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 282,
  "fields": {
    "recname": "Immunodeficiency 27A",
    "keywords": "Immunodeficiency 27A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 283,
  "fields": {
    "recname": "Immunodeficiency 29",
    "keywords": "Immunodeficiency 29"
  }
},
{
  "model": "agmp_app.index",
  "pk": 284,
  "fields": {
    "recname": "Inclusion Body Myopathy, Autosomal Recessive",
    "keywords": "Inclusion Body Myopathy, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 285,
  "fields": {
    "recname": "Infection Caused By Helicobacter Pylori",
    "keywords": "Infection Caused By Helicobacter Pylori"
  }
},
{
  "model": "agmp_app.index",
  "pk": 286,
  "fields": {
    "recname": "Inflammatory Bowel Diseases",
    "keywords": "Inflammatory Bowel Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 287,
  "fields": {
    "recname": "Iron Deficiency",
    "keywords": "Iron Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 288,
  "fields": {
    "recname": "Iron Overload",
    "keywords": "Iron Overload"
  }
},
{
  "model": "agmp_app.index",
  "pk": 289,
  "fields": {
    "recname": "Isolated Growth Hormone Deficiency, Type Ii",
    "keywords": "Isolated Growth Hormone Deficiency, Type Ii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 290,
  "fields": {
    "recname": "Isovaleryl-Coa Dehydrogenase Deficiency",
    "keywords": "Isovaleryl-Coa Dehydrogenase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 291,
  "fields": {
    "recname": "Jaundice, Chronic Idiopathic",
    "keywords": "Jaundice, Chronic Idiopathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 292,
  "fields": {
    "recname": "Job Syndrome",
    "keywords": "Job Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 293,
  "fields": {
    "recname": "Juvenile Nephropathic Cystinosis (Disorder)",
    "keywords": "Juvenile Nephropathic Cystinosis (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 294,
  "fields": {
    "recname": "Juvenile-Onset Vitelliform Macular Dystrophy",
    "keywords": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 295,
  "fields": {
    "recname": "Keloid",
    "keywords": "Keloid"
  }
},
{
  "model": "agmp_app.index",
  "pk": 296,
  "fields": {
    "recname": "Kenny-Caffey Syndrome, Type 1",
    "keywords": "Kenny-Caffey Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 297,
  "fields": {
    "recname": "Knuckle Pads, Leuconychia And Sensorineural Deafness",
    "keywords": "Knuckle Pads, Leuconychia And Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 298,
  "fields": {
    "recname": "Lactase Persistence",
    "keywords": "Lactase Persistence"
  }
},
{
  "model": "agmp_app.index",
  "pk": 299,
  "fields": {
    "recname": "Lactic Acidosis, Congenital Infantile, Due To Lad Deficiency",
    "keywords": "Lactic Acidosis, Congenital Infantile, Due To Lad Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 300,
  "fields": {
    "recname": "Lamellar Ichthyosis, Type 2",
    "keywords": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 301,
  "fields": {
    "recname": "Laron Syndrome",
    "keywords": "Laron Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 302,
  "fields": {
    "recname": "Leigh Disease",
    "keywords": "Leigh Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 303,
  "fields": {
    "recname": "Leigh Syndrome Due To Mitochondrial Complex I Deficiency",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex I Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 304,
  "fields": {
    "recname": "Leigh Syndrome Due To Mitochondrial Complex Ii Deficiency",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex Ii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 305,
  "fields": {
    "recname": "Leigh Syndrome Due To Mitochondrial Complex Iii Deficiency",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex Iii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 306,
  "fields": {
    "recname": "Leigh Syndrome Due To Mitochondrial Complex Iv Deficiency",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex Iv Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 307,
  "fields": {
    "recname": "Leigh Syndrome Due To Mitochondrial Complex V Deficiency",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex V Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 308,
  "fields": {
    "recname": "Leukemia",
    "keywords": "Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 309,
  "fields": {
    "recname": "Limb-Girdle Muscular Dystrophy Type 2A",
    "keywords": "Limb-Girdle Muscular Dystrophy Type 2A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 310,
  "fields": {
    "recname": "Limb-Girdle Muscular Dystrophy, Type 2E",
    "keywords": "Limb-Girdle Muscular Dystrophy, Type 2E"
  }
},
{
  "model": "agmp_app.index",
  "pk": 311,
  "fields": {
    "recname": "Lipoid Proteinosis Of Urbach And Wiethe",
    "keywords": "Lipoid Proteinosis Of Urbach And Wiethe"
  }
},
{
  "model": "agmp_app.index",
  "pk": 312,
  "fields": {
    "recname": "Liver And Intrahepatic Biliary Tract Carcinoma",
    "keywords": "Liver And Intrahepatic Biliary Tract Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 313,
  "fields": {
    "recname": "Liver Carcinoma",
    "keywords": "Liver Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 314,
  "fields": {
    "recname": "Liver Diseases",
    "keywords": "Liver Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 315,
  "fields": {
    "recname": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2",
    "keywords": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 316,
  "fields": {
    "recname": "Lupus Erythematosus",
    "keywords": "Lupus Erythematosus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 317,
  "fields": {
    "recname": "Lupus Erythematosus, Discoid",
    "keywords": "Lupus Erythematosus, Discoid"
  }
},
{
  "model": "agmp_app.index",
  "pk": 318,
  "fields": {
    "recname": "Lupus Erythematosus, Systemic",
    "keywords": "Lupus Erythematosus, Systemic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 319,
  "fields": {
    "recname": "Lupus Nephritis",
    "keywords": "Lupus Nephritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 320,
  "fields": {
    "recname": "Lupus Vulgaris",
    "keywords": "Lupus Vulgaris"
  }
},
{
  "model": "agmp_app.index",
  "pk": 321,
  "fields": {
    "recname": "Lymphoma, Non-Hodgkin",
    "keywords": "Lymphoma, Non-Hodgkin"
  }
},
{
  "model": "agmp_app.index",
  "pk": 322,
  "fields": {
    "recname": "Lysinuric Protein Intolerance",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 323,
  "fields": {
    "recname": "Macrocephaly, Dysmorphic Facies, And Psychomotor Retardation",
    "keywords": "Macrocephaly, Dysmorphic Facies, And Psychomotor Retardation"
  }
},
{
  "model": "agmp_app.index",
  "pk": 324,
  "fields": {
    "recname": "Macular Degeneration, Age-Related, 1",
    "keywords": "Macular Degeneration, Age-Related, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 325,
  "fields": {
    "recname": "Malaria",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 326,
  "fields": {
    "recname": "Malaria, Cerebral, Susceptibility To (Finding)",
    "keywords": "Malaria, Cerebral, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 327,
  "fields": {
    "recname": "Malaria, Susceptibility To (Finding)",
    "keywords": "Malaria, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 328,
  "fields": {
    "recname": "Malignant Neoplasm Of Breast",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 329,
  "fields": {
    "recname": "Malignant Neoplasm Of Liver",
    "keywords": "Malignant Neoplasm Of Liver"
  }
},
{
  "model": "agmp_app.index",
  "pk": 330,
  "fields": {
    "recname": "Malignant Neoplasm Of Pancreas",
    "keywords": "Malignant Neoplasm Of Pancreas"
  }
},
{
  "model": "agmp_app.index",
  "pk": 331,
  "fields": {
    "recname": "Malignant Neoplasm Of Urinary Bladder",
    "keywords": "Malignant Neoplasm Of Urinary Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 332,
  "fields": {
    "recname": "Malignant Neoplasms",
    "keywords": "Malignant Neoplasms"
  }
},
{
  "model": "agmp_app.index",
  "pk": 333,
  "fields": {
    "recname": "Malignant Tumor Of Cervix",
    "keywords": "Malignant Tumor Of Cervix"
  }
},
{
  "model": "agmp_app.index",
  "pk": 334,
  "fields": {
    "recname": "Malignant Tumor Of Colon",
    "keywords": "Malignant Tumor Of Colon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 335,
  "fields": {
    "recname": "Mannose-Binding Protein Deficiency",
    "keywords": "Mannose-Binding Protein Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 336,
  "fields": {
    "recname": "Masp2 Deficiency",
    "keywords": "Masp2 Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 337,
  "fields": {
    "recname": "Medullary Carcinoma Of Thyroid",
    "keywords": "Medullary Carcinoma Of Thyroid"
  }
},
{
  "model": "agmp_app.index",
  "pk": 338,
  "fields": {
    "recname": "Megalencephalic Leukoencephalopathy With Subcortical Cysts",
    "keywords": "Megalencephalic Leukoencephalopathy With Subcortical Cysts"
  }
},
{
  "model": "agmp_app.index",
  "pk": 339,
  "fields": {
    "recname": "Megaloblastic Anemia Due To Inborn Errors Of Metabolism",
    "keywords": "Megaloblastic Anemia Due To Inborn Errors Of Metabolism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 340,
  "fields": {
    "recname": "Melanoma",
    "keywords": "Melanoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 341,
  "fields": {
    "recname": "Melanoma, Cutaneous Malignant, Susceptibility To, 2",
    "keywords": "Melanoma, Cutaneous Malignant, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 342,
  "fields": {
    "recname": "Melanoma-Pancreatic Cancer Syndrome",
    "keywords": "Melanoma-Pancreatic Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 343,
  "fields": {
    "recname": "Meleda Disease",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 344,
  "fields": {
    "recname": "Meningoencephalitis",
    "keywords": "Meningoencephalitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 345,
  "fields": {
    "recname": "Mental Retardation, Autosomal Recessive 13",
    "keywords": "Mental Retardation, Autosomal Recessive 13"
  }
},
{
  "model": "agmp_app.index",
  "pk": 346,
  "fields": {
    "recname": "Mental Retardation, Autosomal Recessive 53",
    "keywords": "Mental Retardation, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.index",
  "pk": 347,
  "fields": {
    "recname": "Methylmalonic Acidemia",
    "keywords": "Methylmalonic Acidemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 348,
  "fields": {
    "recname": "Methylmalonic Aciduria Due To Methylmalonyl-Coa Mutase Deficiency",
    "keywords": "Methylmalonic Aciduria Due To Methylmalonyl-Coa Mutase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 349,
  "fields": {
    "recname": "Microcephaly 4, Primary, Autosomal Recessive",
    "keywords": "Microcephaly 4, Primary, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 350,
  "fields": {
    "recname": "Microcephaly, Epilepsy, And Diabetes Syndrome",
    "keywords": "Microcephaly, Epilepsy, And Diabetes Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 351,
  "fields": {
    "recname": "Microcephaly, Primary Autosomal Recessive, 3",
    "keywords": "Microcephaly, Primary Autosomal Recessive, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 352,
  "fields": {
    "recname": "Microcephaly, Primary Autosomal Recessive, 5",
    "keywords": "Microcephaly, Primary Autosomal Recessive, 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 353,
  "fields": {
    "recname": "Microphthalmia, Isolated 6",
    "keywords": "Microphthalmia, Isolated 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 354,
  "fields": {
    "recname": "Microphthalmia, Syndromic 11",
    "keywords": "Microphthalmia, Syndromic 11"
  }
},
{
  "model": "agmp_app.index",
  "pk": 355,
  "fields": {
    "recname": "Microphthalmos",
    "keywords": "Microphthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 356,
  "fields": {
    "recname": "Minicore Myopathy, Moderate, With Hand Involvement",
    "keywords": "Minicore Myopathy, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 357,
  "fields": {
    "recname": "Mitochondrial Complex I Deficiency",
    "keywords": "Mitochondrial Complex I Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 358,
  "fields": {
    "recname": "Mononeuropathy Of The Median Nerve, Mild",
    "keywords": "Mononeuropathy Of The Median Nerve, Mild"
  }
},
{
  "model": "agmp_app.index",
  "pk": 359,
  "fields": {
    "recname": "Mps Iii C",
    "keywords": "Mps Iii C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 360,
  "fields": {
    "recname": "Muckle-Wells Syndrome",
    "keywords": "Muckle-Wells Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 361,
  "fields": {
    "recname": "Mucopolysaccharidosis Iii",
    "keywords": "Mucopolysaccharidosis Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 362,
  "fields": {
    "recname": "Mucopolysaccharidosis Type Iiia",
    "keywords": "Mucopolysaccharidosis Type Iiia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 363,
  "fields": {
    "recname": "Multicore Myopathy, Moderate, With Hand Involvement",
    "keywords": "Multicore Myopathy, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 364,
  "fields": {
    "recname": "Multiminicore Disease, Moderate, With Hand Involvement",
    "keywords": "Multiminicore Disease, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 365,
  "fields": {
    "recname": "Multiple Sclerosis",
    "keywords": "Multiple Sclerosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 366,
  "fields": {
    "recname": "Muscular Dystrophy, Congenital, 1C",
    "keywords": "Muscular Dystrophy, Congenital, 1C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 367,
  "fields": {
    "recname": "Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 9",
    "keywords": "Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 9"
  }
},
{
  "model": "agmp_app.index",
  "pk": 368,
  "fields": {
    "recname": "Muscular Dystrophy, Limb-Girdle, Type 2I",
    "keywords": "Muscular Dystrophy, Limb-Girdle, Type 2I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 369,
  "fields": {
    "recname": "Mutilating Keratoderma",
    "keywords": "Mutilating Keratoderma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 370,
  "fields": {
    "recname": "Myasthenic Syndrome, Congenital, 12",
    "keywords": "Myasthenic Syndrome, Congenital, 12"
  }
},
{
  "model": "agmp_app.index",
  "pk": 371,
  "fields": {
    "recname": "Myasthenic Syndrome, Congenital, Associated With Acetylcholine Receptor Deficiency",
    "keywords": "Myasthenic Syndrome, Congenital, Associated With Acetylcholine Receptor Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 372,
  "fields": {
    "recname": "Myocardial Infarction",
    "keywords": "Myocardial Infarction"
  }
},
{
  "model": "agmp_app.index",
  "pk": 373,
  "fields": {
    "recname": "Myoclonic Epilepsies, Progressive",
    "keywords": "Myoclonic Epilepsies, Progressive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 374,
  "fields": {
    "recname": "NAdh Cytochrome B5 Reductase Deficiency",
    "keywords": "NAdh Cytochrome B5 Reductase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 375,
  "fields": {
    "recname": "NAdh:Q(1) Oxidoreductase Deficiency",
    "keywords": "NAdh:Q(1) Oxidoreductase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 376,
  "fields": {
    "recname": "Necrotizing Encephalopathy, Infantile Subacute, Of Leigh",
    "keywords": "Necrotizing Encephalopathy, Infantile Subacute, Of Leigh"
  }
},
{
  "model": "agmp_app.index",
  "pk": 377,
  "fields": {
    "recname": "Nemaline Myopathy 8",
    "keywords": "Nemaline Myopathy 8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 378,
  "fields": {
    "recname": "Neoplasm Metastasis",
    "keywords": "Neoplasm Metastasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 379,
  "fields": {
    "recname": "Neoplastic Syndromes, Hereditary",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 380,
  "fields": {
    "recname": "Nephritis",
    "keywords": "Nephritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 381,
  "fields": {
    "recname": "Neurodegeneration With Brain Iron Accumulation 4",
    "keywords": "Neurodegeneration With Brain Iron Accumulation 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 382,
  "fields": {
    "recname": "Neurodegeneration With Brain Iron Accumulation (Nbia)",
    "keywords": "Neurodegeneration With Brain Iron Accumulation (Nbia)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 383,
  "fields": {
    "recname": "Neurodegenerative Disorders",
    "keywords": "Neurodegenerative Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 384,
  "fields": {
    "recname": "Neuromuscular Disease, Congenital, With Uniform Type 1 Fiber (Disorder)",
    "keywords": "Neuromuscular Disease, Congenital, With Uniform Type 1 Fiber (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 385,
  "fields": {
    "recname": "Neuropathy, Hereditary Sensory, With Spastic Paraplegia, Autosomal Recessive",
    "keywords": "Neuropathy, Hereditary Sensory, With Spastic Paraplegia, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 386,
  "fields": {
    "recname": "Neutrophil Count (Procedure)",
    "keywords": "Neutrophil Count (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 387,
  "fields": {
    "recname": "New Variant Creutzfeldt-Jakob Disease",
    "keywords": "New Variant Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 388,
  "fields": {
    "recname": "Niemann-Pick Disease, Type A",
    "keywords": "Niemann-Pick Disease, Type A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 389,
  "fields": {
    "recname": "Niemann-Pick Disease, Type B",
    "keywords": "Niemann-Pick Disease, Type B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 390,
  "fields": {
    "recname": "Niemann-Pick Disease, Type C",
    "keywords": "Niemann-Pick Disease, Type C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 391,
  "fields": {
    "recname": "Niemann-Pick Disease, Type C2",
    "keywords": "Niemann-Pick Disease, Type C2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 392,
  "fields": {
    "recname": "Nijmegen Breakage Syndrome",
    "keywords": "Nijmegen Breakage Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 393,
  "fields": {
    "recname": "Nonnuclear Polymorphic Congenital Cataract",
    "keywords": "Nonnuclear Polymorphic Congenital Cataract"
  }
},
{
  "model": "agmp_app.index",
  "pk": 394,
  "fields": {
    "recname": "Nonsyndromic Deafness",
    "keywords": "Nonsyndromic Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 395,
  "fields": {
    "recname": "Noonan Syndrome",
    "keywords": "Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 396,
  "fields": {
    "recname": "Obesity",
    "keywords": "Obesity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 397,
  "fields": {
    "recname": "Oculocutaneous Albinism Type 1",
    "keywords": "Oculocutaneous Albinism Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 398,
  "fields": {
    "recname": "Oculocutaneous Albinism Type 2",
    "keywords": "Oculocutaneous Albinism Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 399,
  "fields": {
    "recname": "Optic Atrophy 7 (Disorder)",
    "keywords": "Optic Atrophy 7 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 400,
  "fields": {
    "recname": "Optic Atrophy, Hereditary, Leber",
    "keywords": "Optic Atrophy, Hereditary, Leber"
  }
},
{
  "model": "agmp_app.index",
  "pk": 401,
  "fields": {
    "recname": "Osteogenesis Imperfecta, Recessive Perinatal Lethal",
    "keywords": "Osteogenesis Imperfecta, Recessive Perinatal Lethal"
  }
},
{
  "model": "agmp_app.index",
  "pk": 402,
  "fields": {
    "recname": "Osteogenesis Imperfecta Type Iii (Disorder)",
    "keywords": "Osteogenesis Imperfecta Type Iii (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 403,
  "fields": {
    "recname": "Osteogenesis Imperfecta Type Vii",
    "keywords": "Osteogenesis Imperfecta Type Vii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 404,
  "fields": {
    "recname": "Osteogenesis Imperfecta, Type Viii",
    "keywords": "Osteogenesis Imperfecta, Type Viii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 405,
  "fields": {
    "recname": "Osteogenesis Imperfecta, Type Xiii",
    "keywords": "Osteogenesis Imperfecta, Type Xiii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 406,
  "fields": {
    "recname": "Other Creutzfeldt-Jakob Disease",
    "keywords": "Other Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 407,
  "fields": {
    "recname": "Overweight",
    "keywords": "Overweight"
  }
},
{
  "model": "agmp_app.index",
  "pk": 408,
  "fields": {
    "recname": "Palmoplantar Keratoderma With Deafness",
    "keywords": "Palmoplantar Keratoderma With Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 409,
  "fields": {
    "recname": "Palmoplantar Keratosis",
    "keywords": "Palmoplantar Keratosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 410,
  "fields": {
    "recname": "Pancreatic Carcinoma",
    "keywords": "Pancreatic Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 411,
  "fields": {
    "recname": "Pancreatic Ductal Adenocarcinoma",
    "keywords": "Pancreatic Ductal Adenocarcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 412,
  "fields": {
    "recname": "Pancreatitis",
    "keywords": "Pancreatitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 413,
  "fields": {
    "recname": "Pancreatitis, Chronic",
    "keywords": "Pancreatitis, Chronic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 414,
  "fields": {
    "recname": "Panhypopituitarism",
    "keywords": "Panhypopituitarism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 415,
  "fields": {
    "recname": "Papillon-Lefevre Disease",
    "keywords": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 416,
  "fields": {
    "recname": "Parkinson Disease",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 417,
  "fields": {
    "recname": "Parkinson Disease 11, Autosomal Dominant",
    "keywords": "Parkinson Disease 11, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 418,
  "fields": {
    "recname": "Parkinson Disease 6, Autosomal Recessive Early-Onset",
    "keywords": "Parkinson Disease 6, Autosomal Recessive Early-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 419,
  "fields": {
    "recname": "Parkinson Disease 6, Late-Onset, Susceptibility To",
    "keywords": "Parkinson Disease 6, Late-Onset, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 420,
  "fields": {
    "recname": "Parkinson Disease 8 (Disorder)",
    "keywords": "Parkinson Disease 8 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 421,
  "fields": {
    "recname": "Parkinson Disease, Familial, Type 1",
    "keywords": "Parkinson Disease, Familial, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 422,
  "fields": {
    "recname": "Parkinson Disease, Late-Onset",
    "keywords": "Parkinson Disease, Late-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 423,
  "fields": {
    "recname": "Parkinsonian Disorders",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 424,
  "fields": {
    "recname": "Peeling Skin Syndrome",
    "keywords": "Peeling Skin Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 425,
  "fields": {
    "recname": "Peeling Skin Syndrome 5",
    "keywords": "Peeling Skin Syndrome 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 426,
  "fields": {
    "recname": "Peeling Skin Syndrome, Acral Type",
    "keywords": "Peeling Skin Syndrome, Acral Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 427,
  "fields": {
    "recname": "Pendred'S Syndrome",
    "keywords": "Pendred'S Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 428,
  "fields": {
    "recname": "Periodontitis, Juvenile",
    "keywords": "Periodontitis, Juvenile"
  }
},
{
  "model": "agmp_app.index",
  "pk": 429,
  "fields": {
    "recname": "Pfaundler-Hurler Syndrome",
    "keywords": "Pfaundler-Hurler Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 430,
  "fields": {
    "recname": "Phenylketonuria, Maternal",
    "keywords": "Phenylketonuria, Maternal"
  }
},
{
  "model": "agmp_app.index",
  "pk": 431,
  "fields": {
    "recname": "Phenylketonurias",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 432,
  "fields": {
    "recname": "Pheochromocytoma",
    "keywords": "Pheochromocytoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 433,
  "fields": {
    "recname": "Piebaldism",
    "keywords": "Piebaldism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 434,
  "fields": {
    "recname": "Piebaldism With Sensorineural Deafness",
    "keywords": "Piebaldism With Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 435,
  "fields": {
    "recname": "Pituitary Dwarfism Type 3",
    "keywords": "Pituitary Dwarfism Type 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 436,
  "fields": {
    "recname": "Pneumococcal Bacteraemia",
    "keywords": "Pneumococcal Bacteraemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 437,
  "fields": {
    "recname": "Poikiloderma Of Kindler",
    "keywords": "Poikiloderma Of Kindler"
  }
},
{
  "model": "agmp_app.index",
  "pk": 438,
  "fields": {
    "recname": "Poikiloderma With Neutropenia",
    "keywords": "Poikiloderma With Neutropenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 439,
  "fields": {
    "recname": "Polycystic Ovarian Disease Due To 17-Ketosteroid Reductase Deficiency",
    "keywords": "Polycystic Ovarian Disease Due To 17-Ketosteroid Reductase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 440,
  "fields": {
    "recname": "Polycystic Ovary Syndrome",
    "keywords": "Polycystic Ovary Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 441,
  "fields": {
    "recname": "Polycythemia Vera",
    "keywords": "Polycythemia Vera"
  }
},
{
  "model": "agmp_app.index",
  "pk": 442,
  "fields": {
    "recname": "Polyendocrinopathies, Autoimmune",
    "keywords": "Polyendocrinopathies, Autoimmune"
  }
},
{
  "model": "agmp_app.index",
  "pk": 443,
  "fields": {
    "recname": "Polyglandular Deficiency Syndrome, Persian-Jewish Type",
    "keywords": "Polyglandular Deficiency Syndrome, Persian-Jewish Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 444,
  "fields": {
    "recname": "Polyglandular Type I Autoimmune Syndrome",
    "keywords": "Polyglandular Type I Autoimmune Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 445,
  "fields": {
    "recname": "Polymicrogyria, Bilateral Occipital",
    "keywords": "Polymicrogyria, Bilateral Occipital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 446,
  "fields": {
    "recname": "Polymicrogyria, Bilateral Temporooccipital",
    "keywords": "Polymicrogyria, Bilateral Temporooccipital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 447,
  "fields": {
    "recname": "Polyposis, Adenomatous Intestinal",
    "keywords": "Polyposis, Adenomatous Intestinal"
  }
},
{
  "model": "agmp_app.index",
  "pk": 448,
  "fields": {
    "recname": "Pontocerebellar Hypoplasia, Type 2D",
    "keywords": "Pontocerebellar Hypoplasia, Type 2D"
  }
},
{
  "model": "agmp_app.index",
  "pk": 449,
  "fields": {
    "recname": "Pontocerebellar Hypoplasia, Type 2E",
    "keywords": "Pontocerebellar Hypoplasia, Type 2E"
  }
},
{
  "model": "agmp_app.index",
  "pk": 450,
  "fields": {
    "recname": "Porphyria, Acute Intermittent, Nonerythroid Variant",
    "keywords": "Porphyria, Acute Intermittent, Nonerythroid Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 451,
  "fields": {
    "recname": "Porphyria Cutanea Tarda",
    "keywords": "Porphyria Cutanea Tarda"
  }
},
{
  "model": "agmp_app.index",
  "pk": 452,
  "fields": {
    "recname": "Porphyria, South African Type",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 453,
  "fields": {
    "recname": "Precursor Cell Lymphoblastic Leukemia Lymphoma",
    "keywords": "Precursor Cell Lymphoblastic Leukemia Lymphoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 454,
  "fields": {
    "recname": "Primary Congenital Glaucoma",
    "keywords": "Primary Congenital Glaucoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 455,
  "fields": {
    "recname": "Primary Hyperoxaluria, Type I",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 456,
  "fields": {
    "recname": "Primary Myelofibrosis",
    "keywords": "Primary Myelofibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 457,
  "fields": {
    "recname": "Prion Diseases",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 458,
  "fields": {
    "recname": "Progeria",
    "keywords": "Progeria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 459,
  "fields": {
    "recname": "Progressive Familial Heart Block, Type Ib",
    "keywords": "Progressive Familial Heart Block, Type Ib"
  }
},
{
  "model": "agmp_app.index",
  "pk": 460,
  "fields": {
    "recname": "Progressive Supranuclear Palsy",
    "keywords": "Progressive Supranuclear Palsy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 461,
  "fields": {
    "recname": "Prostate Carcinoma",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 462,
  "fields": {
    "recname": "Pseudoxanthoma Elasticum",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 463,
  "fields": {
    "recname": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 464,
  "fields": {
    "recname": "Psoriasis",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 465,
  "fields": {
    "recname": "Psoriasis 2",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 466,
  "fields": {
    "recname": "Psoriasis Vulgaris",
    "keywords": "Psoriasis Vulgaris"
  }
},
{
  "model": "agmp_app.index",
  "pk": 467,
  "fields": {
    "recname": "Pxe, Modifier Of Severity Of",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 468,
  "fields": {
    "recname": "Rabson-Mendenhall Syndrome",
    "keywords": "Rabson-Mendenhall Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 469,
  "fields": {
    "recname": "Rectal Carcinoma",
    "keywords": "Rectal Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 470,
  "fields": {
    "recname": "Respiratory Distress Syndrome, Newborn",
    "keywords": "Respiratory Distress Syndrome, Newborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 471,
  "fields": {
    "recname": "Retinitis Pigmentosa",
    "keywords": "Retinitis Pigmentosa"
  }
},
{
  "model": "agmp_app.index",
  "pk": 472,
  "fields": {
    "recname": "Retinitis Pigmentosa 14",
    "keywords": "Retinitis Pigmentosa 14"
  }
},
{
  "model": "agmp_app.index",
  "pk": 473,
  "fields": {
    "recname": "Retinitis Pigmentosa 2 (Disorder)",
    "keywords": "Retinitis Pigmentosa 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 474,
  "fields": {
    "recname": "Retinitis Pigmentosa 38 (Disorder)",
    "keywords": "Retinitis Pigmentosa 38 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 475,
  "fields": {
    "recname": "Retinitis Pigmentosa 40 (Disorder)",
    "keywords": "Retinitis Pigmentosa 40 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 476,
  "fields": {
    "recname": "Retinitis Pigmentosa 73",
    "keywords": "Retinitis Pigmentosa 73"
  }
},
{
  "model": "agmp_app.index",
  "pk": 477,
  "fields": {
    "recname": "Retinitis Pigmentosa 74",
    "keywords": "Retinitis Pigmentosa 74"
  }
},
{
  "model": "agmp_app.index",
  "pk": 478,
  "fields": {
    "recname": "Retinoblastoma",
    "keywords": "Retinoblastoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 479,
  "fields": {
    "recname": "Rett Syndrome",
    "keywords": "Rett Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 480,
  "fields": {
    "recname": "Rheumatoid Arthritis",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 481,
  "fields": {
    "recname": "Romano-Ward Syndrome",
    "keywords": "Romano-Ward Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 482,
  "fields": {
    "recname": "Saldino-Noonan Syndrome",
    "keywords": "Saldino-Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 483,
  "fields": {
    "recname": "Schizophrenia",
    "keywords": "Schizophrenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 484,
  "fields": {
    "recname": "Secondary Malignant Neoplasm Of Lymph Node",
    "keywords": "Secondary Malignant Neoplasm Of Lymph Node"
  }
},
{
  "model": "agmp_app.index",
  "pk": 485,
  "fields": {
    "recname": "Senile Cardiac Amyloidosis",
    "keywords": "Senile Cardiac Amyloidosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 486,
  "fields": {
    "recname": "Senter Syndrome",
    "keywords": "Senter Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 487,
  "fields": {
    "recname": "Severe Autosomal Recessive Muscular Dystrophy Of Childhood - North African Type (Disorder)",
    "keywords": "Severe Autosomal Recessive Muscular Dystrophy Of Childhood - North African Type (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 488,
  "fields": {
    "recname": "Severe Combined Immunodeficiency",
    "keywords": "Severe Combined Immunodeficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 489,
  "fields": {
    "recname": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type",
    "keywords": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 490,
  "fields": {
    "recname": "Shprintzen-Goldberg Syndrome",
    "keywords": "Shprintzen-Goldberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 491,
  "fields": {
    "recname": "Sickle Cell Trait",
    "keywords": "Sickle Cell Trait"
  }
},
{
  "model": "agmp_app.index",
  "pk": 492,
  "fields": {
    "recname": "Sickle Cell Trait/ Trachoma",
    "keywords": "Sickle Cell Trait/ Trachoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 493,
  "fields": {
    "recname": "Sitosterolemia",
    "keywords": "Sitosterolemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 494,
  "fields": {
    "recname": "Skin Creases, Congenital Symmetric Circumferential, 2",
    "keywords": "Skin Creases, Congenital Symmetric Circumferential, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 495,
  "fields": {
    "recname": "Skin-Hair-Eye Pigmentation, Variation In, 4",
    "keywords": "Skin-Hair-Eye Pigmentation, Variation In, 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 496,
  "fields": {
    "recname": "Spastic Ataxia, Charlevoix-Saguenay Type",
    "keywords": "Spastic Ataxia, Charlevoix-Saguenay Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 497,
  "fields": {
    "recname": "Spastic Paraplegia 11, Autosomal Recessive",
    "keywords": "Spastic Paraplegia 11, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 498,
  "fields": {
    "recname": "Spastic Paraplegia 15, Autosomal Recessive",
    "keywords": "Spastic Paraplegia 15, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 499,
  "fields": {
    "recname": "Spastic Paraplegia 30, Autosomal Recessive (Disorder)",
    "keywords": "Spastic Paraplegia 30, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 500,
  "fields": {
    "recname": "Spastic Paraplegia 43, Autosomal Recessive",
    "keywords": "Spastic Paraplegia 43, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 501,
  "fields": {
    "recname": "Spastic Paraplegia 46, Autosomal Recessive",
    "keywords": "Spastic Paraplegia 46, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 502,
  "fields": {
    "recname": "Spastic Paraplegia 4, Autosomal Dominant",
    "keywords": "Spastic Paraplegia 4, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 503,
  "fields": {
    "recname": "Spastic Paraplegia 5A, Autosomal Recessive (Disorder)",
    "keywords": "Spastic Paraplegia 5A, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 504,
  "fields": {
    "recname": "Spastic Paraplegia 7, Autosomal Recessive",
    "keywords": "Spastic Paraplegia 7, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 505,
  "fields": {
    "recname": "Spherocytosis, Type 5",
    "keywords": "Spherocytosis, Type 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 506,
  "fields": {
    "recname": "Spinal Muscular Atrophy, Distal, Autosomal Recessive, 5",
    "keywords": "Spinal Muscular Atrophy, Distal, Autosomal Recessive, 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 507,
  "fields": {
    "recname": "Spinocerebellar Ataxia 23",
    "keywords": "Spinocerebellar Ataxia 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 508,
  "fields": {
    "recname": "Sporadic Parkinson Disease",
    "keywords": "Sporadic Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 509,
  "fields": {
    "recname": "Stargardt Disease 1 (Disorder)",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 510,
  "fields": {
    "recname": "Stevens-Johnson Syndrome",
    "keywords": "Stevens-Johnson Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 511,
  "fields": {
    "recname": "Stickler Syndrome (Disorder)",
    "keywords": "Stickler Syndrome (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 512,
  "fields": {
    "recname": "Stickler Syndrome, Type 1",
    "keywords": "Stickler Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 513,
  "fields": {
    "recname": "Stickler Syndrome, Type Iv",
    "keywords": "Stickler Syndrome, Type Iv"
  }
},
{
  "model": "agmp_app.index",
  "pk": 514,
  "fields": {
    "recname": "Stomach Neoplasms",
    "keywords": "Stomach Neoplasms"
  }
},
{
  "model": "agmp_app.index",
  "pk": 515,
  "fields": {
    "recname": "Stuttering",
    "keywords": "Stuttering"
  }
},
{
  "model": "agmp_app.index",
  "pk": 516,
  "fields": {
    "recname": "Stuttering, Developmental",
    "keywords": "Stuttering, Developmental"
  }
},
{
  "model": "agmp_app.index",
  "pk": 517,
  "fields": {
    "recname": "Stuttering, Familial Persistent 1",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 518,
  "fields": {
    "recname": "Surfactant Metabolism Dysfunction, Pulmonary, 3",
    "keywords": "Surfactant Metabolism Dysfunction, Pulmonary, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 519,
  "fields": {
    "recname": "Systemic Arterial Pressure",
    "keywords": "Systemic Arterial Pressure"
  }
},
{
  "model": "agmp_app.index",
  "pk": 520,
  "fields": {
    "recname": "Systemic Onset Juvenile Chronic Arthritis",
    "keywords": "Systemic Onset Juvenile Chronic Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 521,
  "fields": {
    "recname": "Tay-Sachs Disease",
    "keywords": "Tay-Sachs Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 522,
  "fields": {
    "recname": "Tay-Sachs Disease, Juvenile",
    "keywords": "Tay-Sachs Disease, Juvenile"
  }
},
{
  "model": "agmp_app.index",
  "pk": 523,
  "fields": {
    "recname": "Tay-Sachs Disease, Pseudo-Ab Variant",
    "keywords": "Tay-Sachs Disease, Pseudo-Ab Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 524,
  "fields": {
    "recname": "Tay-Sachs Disease, Variant B1",
    "keywords": "Tay-Sachs Disease, Variant B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 525,
  "fields": {
    "recname": "Thrombocythemia, Essential",
    "keywords": "Thrombocythemia, Essential"
  }
},
{
  "model": "agmp_app.index",
  "pk": 526,
  "fields": {
    "recname": "Toxic Epidermal Necrolysis",
    "keywords": "Toxic Epidermal Necrolysis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 527,
  "fields": {
    "recname": "Transcolabamin Ii Deficiency",
    "keywords": "Transcolabamin Ii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 528,
  "fields": {
    "recname": "Tuberculosis",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 529,
  "fields": {
    "recname": "Tuberculosis, Pulmonary",
    "keywords": "Tuberculosis, Pulmonary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 530,
  "fields": {
    "recname": "Tuberculosis, Spinal",
    "keywords": "Tuberculosis, Spinal"
  }
},
{
  "model": "agmp_app.index",
  "pk": 531,
  "fields": {
    "recname": "Unverricht-Lundborg Syndrome",
    "keywords": "Unverricht-Lundborg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 532,
  "fields": {
    "recname": "Uric Acid Measurement (Procedure)",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 533,
  "fields": {
    "recname": "Usher Syndrome, Type 2C",
    "keywords": "Usher Syndrome, Type 2C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 534,
  "fields": {
    "recname": "Usher Syndrome, Type I",
    "keywords": "Usher Syndrome, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 535,
  "fields": {
    "recname": "Usher Syndrome, Type Ia, Formerly",
    "keywords": "Usher Syndrome, Type Ia, Formerly"
  }
},
{
  "model": "agmp_app.index",
  "pk": 536,
  "fields": {
    "recname": "Usher Syndrome, Type Ib (Disorder)",
    "keywords": "Usher Syndrome, Type Ib (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 537,
  "fields": {
    "recname": "Usher Syndrome, Type Ic",
    "keywords": "Usher Syndrome, Type Ic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 538,
  "fields": {
    "recname": "Usher Syndrome, Type If",
    "keywords": "Usher Syndrome, Type If"
  }
},
{
  "model": "agmp_app.index",
  "pk": 539,
  "fields": {
    "recname": "Usher Syndrome, Type I, French Variety, Formerly",
    "keywords": "Usher Syndrome, Type I, French Variety, Formerly"
  }
},
{
  "model": "agmp_app.index",
  "pk": 540,
  "fields": {
    "recname": "Usher Syndrome, Type Iia",
    "keywords": "Usher Syndrome, Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 541,
  "fields": {
    "recname": "Variegate Porphyria",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 542,
  "fields": {
    "recname": "Variegate Porphyria, Homozygous Variant",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 543,
  "fields": {
    "recname": "Vitamin D Hydroxylation-Deficient Rickets, Type 1B",
    "keywords": "Vitamin D Hydroxylation-Deficient Rickets, Type 1B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 544,
  "fields": {
    "recname": "Vitelliform Macular Dystrophy",
    "keywords": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 545,
  "fields": {
    "recname": "Walker-Warburg Congenital Muscular Dystrophy",
    "keywords": "Walker-Warburg Congenital Muscular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 546,
  "fields": {
    "recname": "Warburg Sjo Fledelius Syndrome",
    "keywords": "Warburg Sjo Fledelius Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 547,
  "fields": {
    "recname": "West Nile Virus, Susceptibility To (Finding)",
    "keywords": "West Nile Virus, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 548,
  "fields": {
    "recname": "White Blood Cell Count Quantitative Trait Locus 1",
    "keywords": "White Blood Cell Count Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 549,
  "fields": {
    "recname": "Xanthomatosis, Cerebrotendinous",
    "keywords": "Xanthomatosis, Cerebrotendinous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 550,
  "fields": {
    "recname": "Xeroderma Pigmentosum, Complementation Group C",
    "keywords": "Xeroderma Pigmentosum, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 551,
  "fields": {
    "recname": "Xeroderma Pigmentosum, Group A",
    "keywords": "Xeroderma Pigmentosum, Group A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 552,
  "fields": {
    "recname": "X-Linked Adrenal Hypoplasia",
    "keywords": "X-Linked Adrenal Hypoplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 553,
  "fields": {
    "recname": "SPATA3",
    "keywords": "SPATA3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 554,
  "fields": {
    "recname": "ENPP1",
    "keywords": "Nucleotide pyrophosphatase that generates diphosphate (PPi) and functions in bone mineralization and soft tissue calcification by regulating pyrophosphate levels (By similarity). PPi inhibits bone mineralization and soft tissue calcification by binding to nascent hydroxyapatite crystals, thereby preventing further growth of these crystals. Preferentially hydrolyzes ATP, but can also hydrolyze other nucleoside 5' triphosphates such as GTP, CTP, TTP and UTP to their corresponding monophosphates with release of pyrophosphate and diadenosine polyphosphates, and also 3',5'-cAMP to AMP. May also be involved in the regulation of the availability of nucleotide sugars in the endoplasmic reticulum and Golgi, and the regulation of purinergic signaling. Inhibits ectopic joint calcification and maintains articular chondrocytes by repressing hedgehog signaling; it is however unclear whether hedgehog inhibition is direct or indirect (By similarity). Appears to modulate insulin sensitivity and function. Also involved in melanogenesis. Also able to hydrolyze 2'-3'-cGAMP (cyclic GMP-AMP), a second messenger that activates TMEM173/STING and triggers type-I interferon production. 2'-3'-cGAMP degradation takes place in the lumen or extracellular space, and not in the cytosol where it is produced; the role of 2'-3'-cGAMP hydrolysis is therefore unclear. Not able to hydrolyze the 2'-3'-cGAMP linkage isomer 3'-3'-cGAMP ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 555,
  "fields": {
    "recname": "CTSC",
    "keywords": "Thiol protease. Has dipeptidylpeptidase activity. Active against a broad range of dipeptide substrates composed of both polar and hydrophobic amino acids. Proline cannot occupy the P1 position and arginine cannot occupy the P2 position of the substrate. Can act as both an exopeptidase and endopeptidase. Activates serine proteases such as elastase, cathepsin G and granzymes A and B. Can also activate neuraminidase and factor XIII."
  }
},
{
  "model": "agmp_app.index",
  "pk": 556,
  "fields": {
    "recname": "PRRC2A",
    "keywords": "May play a role in the regulation of pre-mRNA splicing."
  }
},
{
  "model": "agmp_app.index",
  "pk": 557,
  "fields": {
    "recname": "LOXL1-AS1",
    "keywords": "LOXL1-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 558,
  "fields": {
    "recname": "LOXL1",
    "keywords": "Active on elastin and collagen substrates."
  }
},
{
  "model": "agmp_app.index",
  "pk": 559,
  "fields": {
    "recname": "FANCC",
    "keywords": "DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Upon IFNG induction, may facilitate STAT1 activation by recruiting STAT1 to IFNGR1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 560,
  "fields": {
    "recname": "CYP1B1-AS1",
    "keywords": "CYP1B1-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 561,
  "fields": {
    "recname": "CYP1B1",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Exhibits catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2- and 4-hydroxy E1 and E2. Displays a predominant hydroxylase activity toward E2 at the C-4 position. Metabolizes testosterone and progesterone to B or D ring hydroxylated metabolites. May act as a major enzyme for all-trans retinoic acid biosynthesis in extrahepatic tissues. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid. Catalyzes the epoxidation of double bonds of certain PUFA. Converts arachidonic acid toward epoxyeicosatrienoic acid (EpETrE) regioisomers, 8,9-, 11,12-, and 14,15- EpETrE, that function as lipid mediators in the vascular system. Additionally, displays dehydratase activity toward oxygenated eicosanoids hydroperoxyeicosatetraenoates (HpETEs). This activity is independent of cytochrome P450 reductase, NADPH, and O2. Also involved in the oxidative metabolism of xenobiotics, particularly converting polycyclic aromatic hydrocarbons and heterocyclic aryl amines procarcinogens to DNA-damaging products. Plays an important role in retinal vascular development. Under hyperoxic O2 conditions, promotes retinal angiogenesis and capillary morphogenesis, likely by metabolizing the oxygenated products generated during the oxidative stress. Also, contributes to oxidative homeostasis and ultrastructural organization and function of trabecular meshwork tissue through modulation of POSTN expression (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 562,
  "fields": {
    "recname": "SGCB",
    "keywords": "Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix."
  }
},
{
  "model": "agmp_app.index",
  "pk": 563,
  "fields": {
    "recname": "GDAP1",
    "keywords": "Regulates the mitochondrial network by promoting mitochondrial fission."
  }
},
{
  "model": "agmp_app.index",
  "pk": 564,
  "fields": {
    "recname": "CDKN2A",
    "keywords": "Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein."
  }
},
{
  "model": "agmp_app.index",
  "pk": 565,
  "fields": {
    "recname": "CDKN2A",
    "keywords": "Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with COMMD1 and promotes its 'Lys63'-linked polyubiquitination. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development. Isoform smARF may be involved in regulation of autophagy and caspase-independent cell death; the short-lived mitochondrial isoform is stabilized by C1QBP."
  }
},
{
  "model": "agmp_app.index",
  "pk": 566,
  "fields": {
    "recname": "XPA",
    "keywords": "Involved in DNA excision repair. Initiates repair by binding to damaged sites with various affinities, depending on the photoproduct and the transcriptional state of the region. Required for UV-induced CHEK1 phosphorylation and the recruitment of CEP164 to cyclobutane pyrimidine dimmers (CPD), sites of DNA damage after UV irradiation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 567,
  "fields": {
    "recname": "TYR",
    "keywords": "This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds. Catalyzes the initial and rate limiting step in the cascade of reactions leading to melanin production from tyrosine. In addition to hydroxylating tyrosine to DOPA (3,4-dihydroxyphenylalanine), also catalyzes the oxidation of DOPA to DOPA-quinone, and possibly the oxidation of DHI (5,6-dihydroxyindole) to indole-5,6 quinone."
  }
},
{
  "model": "agmp_app.index",
  "pk": 568,
  "fields": {
    "recname": "GJB2",
    "keywords": "Structural component of gap junctions. Gap junctions are dodecameric channels that connect the cytoplasm of adjoining cells. They are formed by the docking of two hexameric hemichannels, one from each cell membrane. Small molecules and ions diffuse from one cell to a neighboring cell via the central pore ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 569,
  "fields": {
    "recname": "HP",
    "keywords": "As a result of hemolysis, hemoglobin is found to accumulate in the kidney and is secreted in the urine. Haptoglobin captures, and combines with free plasma hemoglobin to allow hepatic recycling of heme iron and to prevent kidney damage. Haptoglobin also acts as an antioxidant, has antibacterial activity, and plays a role in modulating many aspects of the acute phase response. Hemoglobin/haptoglobin complexes are rapidly cleared by the macrophage CD163 scavenger receptor expressed on the surface of liver Kupfer cells through an endocytic lysosomal degradation pathway."
  }
},
{
  "model": "agmp_app.index",
  "pk": 570,
  "fields": {
    "recname": "TXNL4B",
    "keywords": "Essential role in pre-mRNA splicing. Required in cell cycle progression for S/G(2) transition."
  }
},
{
  "model": "agmp_app.index",
  "pk": 571,
  "fields": {
    "recname": "CA4",
    "keywords": "Reversible hydration of carbon dioxide. May stimulate the sodium/bicarbonate transporter activity of SLC4A4 that acts in pH homeostasis. It is essential for acid overload removal from the retina and retina epithelium, and acid release in the choriocapillaris in the choroid."
  }
},
{
  "model": "agmp_app.index",
  "pk": 572,
  "fields": {
    "recname": "FKRP",
    "keywords": "Catalyzes the transfer of CDP-ribitol to ribitol 5-phosphate previously attached by FKTN/fukutin of to the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1). This constitutes the second step in the formation of the ribose 5-phosphate tandem repeat which links the phosphorylated O-mannosyl trisaccharide to the ligand binding moiety composed of repeats of 3-xylosyl-alpha-1,3-glucuronic acid-beta-1 ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 573,
  "fields": {
    "recname": "RP2",
    "keywords": "Acts as a GTPase-activating protein (GAP) involved in trafficking between the Golgi and the ciliary membrane. Involved in localization of proteins, such as NPHP3, to the cilium membrane by inducing hydrolysis of GTP ARL3, leading to the release of UNC119 (or UNC119B). Acts as a GTPase-activating protein (GAP) for tubulin in concert with tubulin-specific chaperone C, but does not enhance tubulin heterodimerization. Acts as guanine nucleotide dissociation inhibitor towards ADP-ribosylation factor-like proteins."
  }
},
{
  "model": "agmp_app.index",
  "pk": 574,
  "fields": {
    "recname": "MEFV",
    "keywords": "Involved in the regulation of innate immunity and the inflammatory response in response to IFNG/IFN-gamma. Organizes autophagic machinery by serving as a platform for the assembly of ULK1, Beclin 1/BECN1, ATG16L1, and ATG8 family members and recognizes specific autophagy targets, thus coordinating target recognition with assembly of the autophagic apparatus and initiation of autophagy. Acts as an autophagy receptor for the degradation of several inflammasome components, including CASP1, NLRP1 and NLRP3, hence preventing excessive IL1B- and IL18-mediated inflammation. However, it may also have a positive effect in the inflammatory pathway. In different experimental systems, it has been shown to activate IL1B production. It has also been shown to be required for PSTPIP1-induced PYCARD oligomerization and for formation of inflammasomes. Recruits PSTPIP1 to inflammasomes, and is required for PSTPIP1 oligomerization ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 575,
  "fields": {
    "recname": "NLRP7",
    "keywords": "Inhibits CASP1/caspase-1-dependent IL1B secretion."
  }
},
{
  "model": "agmp_app.index",
  "pk": 576,
  "fields": {
    "recname": "ARMS2",
    "keywords": "ARMS2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 577,
  "fields": {
    "recname": "HGD",
    "keywords": "HGD"
  }
},
{
  "model": "agmp_app.index",
  "pk": 578,
  "fields": {
    "recname": "IL15",
    "keywords": "Cytokine that stimulates the proliferation of T-lymphocytes. Stimulation by IL15 requires interaction of IL15 with components of the IL2 receptor, including IL2RB and probably IL2RG but not IL2RA. In neutrophils, stimulates phagocytosis probably by signaling through the IL15 receptor, composed of the subunits IL15RA, IL2RB and IL2RG, which results in kinase SYK activation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 579,
  "fields": {
    "recname": "SACS",
    "keywords": "Co-chaperone which acts as a regulator of the Hsp70 chaperone machinery and may be involved in the processing of other ataxia-linked proteins."
  }
},
{
  "model": "agmp_app.index",
  "pk": 580,
  "fields": {
    "recname": "MLC1",
    "keywords": "Regulates the response of astrocytes to hypo-osmosis by promoting calcium influx."
  }
},
{
  "model": "agmp_app.index",
  "pk": 581,
  "fields": {
    "recname": "ATP7B",
    "keywords": "Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload."
  }
},
{
  "model": "agmp_app.index",
  "pk": 582,
  "fields": {
    "recname": "PIEZO2",
    "keywords": "Component of a mechanosensitive channel required for rapidly adapting mechanically activated (MA) currents. Required for Merkel-cell mechanotransduction. Plays a major role in light-touch mechanosensation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 583,
  "fields": {
    "recname": "AP001180.4",
    "keywords": "AP001180.4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 584,
  "fields": {
    "recname": "CFH",
    "keywords": "Glycoprotein that plays an essential role in maintaining a well-balanced immune response by modulating complement activation. Acts as a soluble inhibitor of complement, where its binding to self markers such as glycan structures prevents complement activation and amplification on cell surfaces. Accelerates the decay of the complement alternative pathway (AP) C3 convertase C3bBb, thus preventing local formation of more C3b, the central player of the complement amplification loop. As a cofactor of the serine protease factor I, CFH also regulates proteolytic degradation of already-deposited C3b. In addition, mediates several cellular responses through interaction with specific receptors. For example, interacts with CR3/ITGAM receptor and thereby mediates the adhesion of human neutrophils to different pathogens. In turn, these pathogens are phagocytosed and destroyed ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 585,
  "fields": {
    "recname": "ADIPOQ",
    "keywords": "Important adipokine involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic and anti-inflammatory activities. Stimulates AMPK phosphorylation and activation in the liver and the skeletal muscle, enhancing glucose utilization and fatty-acid combustion. Antagonizes TNF-alpha by negatively regulating its expression in various tissues such as liver and macrophages, and also by counteracting its effects. Inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. May play a role in cell growth, angiogenesis and tissue remodeling by binding and sequestering various growth factors with distinct binding affinities, depending on the type of complex, LMW, MMW or HMW."
  }
},
{
  "model": "agmp_app.index",
  "pk": 586,
  "fields": {
    "recname": "ATP2B4",
    "keywords": "Calcium/calmodulin-regulated and magnesium-dependent enzyme that catalyzes the hydrolysis of ATP coupled with the transport of calcium out of the cell. By regulating sperm cell calcium homeostasis, may play a role in sperm motility (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 587,
  "fields": {
    "recname": "AC025946.1",
    "keywords": "AC025946.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 588,
  "fields": {
    "recname": "THEM7P",
    "keywords": "THEM7P"
  }
},
{
  "model": "agmp_app.index",
  "pk": 589,
  "fields": {
    "recname": "SLC26A4",
    "keywords": "Sodium-independent transporter of chloride and iodide."
  }
},
{
  "model": "agmp_app.index",
  "pk": 590,
  "fields": {
    "recname": "HFE",
    "keywords": "Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 591,
  "fields": {
    "recname": "CEP85L",
    "keywords": "CEP85L"
  }
},
{
  "model": "agmp_app.index",
  "pk": 592,
  "fields": {
    "recname": "PLN",
    "keywords": "Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. ATP2A2 inhibition is alleviated by PLN phosphorylation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 593,
  "fields": {
    "recname": "GALT",
    "keywords": "Plays an important role in galactose metabolism."
  }
},
{
  "model": "agmp_app.index",
  "pk": 594,
  "fields": {
    "recname": "PJVK",
    "keywords": "Essential in the activity of auditory pathway neurons."
  }
},
{
  "model": "agmp_app.index",
  "pk": 595,
  "fields": {
    "recname": "IL23R",
    "keywords": "Associates with IL12RB1 to form the interleukin-23 receptor. Binds IL23 and mediates T-cells, NK cells and possibly certain macrophage/myeloid cells stimulation probably through activation of the Jak-Stat signaling cascade. IL23 functions in innate and adaptive immunity and may participate in acute response to infection in peripheral tissues. IL23 may be responsible for autoimmune inflammatory diseases and be important for tumorigenesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 596,
  "fields": {
    "recname": "EIF4G1",
    "keywords": "Component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome."
  }
},
{
  "model": "agmp_app.index",
  "pk": 597,
  "fields": {
    "recname": "TGM5",
    "keywords": "Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. Contributes to the formation of the cornified cell envelope of keratinocytes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 598,
  "fields": {
    "recname": "ITPA",
    "keywords": "Pyrophosphatase that hydrolyzes the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP) as well as 2'-deoxy-N-6-hydroxylaminopurine triposphate (dHAPTP) and xanthosine 5'-triphosphate (XTP) to their respective monophosphate derivatives. The enzyme does not distinguish between the deoxy- and ribose forms. Probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal lesions."
  }
},
{
  "model": "agmp_app.index",
  "pk": 599,
  "fields": {
    "recname": "ESR1",
    "keywords": "Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full-length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 600,
  "fields": {
    "recname": "LINC00944",
    "keywords": "LINC00944"
  }
},
{
  "model": "agmp_app.index",
  "pk": 601,
  "fields": {
    "recname": "PCDHA1",
    "keywords": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 602,
  "fields": {
    "recname": "PCDHA3",
    "keywords": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 603,
  "fields": {
    "recname": "PCDHA2",
    "keywords": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 604,
  "fields": {
    "recname": "PCDHA4",
    "keywords": "Calcium-dependent cell-adhesion protein involved in cells self-recognition and non-self discrimination. Thereby, it is involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 605,
  "fields": {
    "recname": "BBS1",
    "keywords": "The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization. Plays a role in olfactory cilium biogenesis/maintenance and trafficking (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 606,
  "fields": {
    "recname": "ZDHHC24",
    "keywords": "ZDHHC24"
  }
},
{
  "model": "agmp_app.index",
  "pk": 607,
  "fields": {
    "recname": "CFTR",
    "keywords": "Epithelial ion channel that plays an important role in the regulation of epithelial ion and water transport and fluid homeostasis. Mediates the transport of chloride ions across the cell membrane. Channel activity is coupled to ATP hydrolysis. The ion channel is also permeable to HCO(3-); selectivity depends on the extracellular chloride concentration. Exerts its function also by modulating the activity of other ion channels and transporters. Plays an important role in airway fluid homeostasis. Contributes to the regulation of the pH and the ion content of the airway surface fluid layer and thereby plays an important role in defense against pathogens. Modulates the activity of the epithelial sodium channel (ENaC) complex, in part by regulating the cell surface expression of the ENaC complex. Inhibits the activity of the ENaC channel containing subunits SCNN1A, SCNN1B and SCNN1G. Inhibits the activity of the ENaC channel containing subunits SCNN1D, SCNN1B and SCNN1G, but not of the ENaC channel containing subunits SCNN1A, SCNN1B and SCNN1G. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the transporter SLC4A7. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 608,
  "fields": {
    "recname": "PYGM",
    "keywords": "Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties."
  }
},
{
  "model": "agmp_app.index",
  "pk": 609,
  "fields": {
    "recname": "FRG1-DT",
    "keywords": "FRG1-DT"
  }
},
{
  "model": "agmp_app.index",
  "pk": 610,
  "fields": {
    "recname": "GRM7",
    "keywords": "G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 611,
  "fields": {
    "recname": "GRM7-AS2",
    "keywords": "GRM7-AS2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 612,
  "fields": {
    "recname": "CPA6",
    "keywords": "May be involved in the proteolytic inactivation of enkephalins and neurotensin in some brain areas. May convert inactive angiotensin I into the biologically active angiotensin II. Releases a C-terminal amino acid, with preference for large hydrophobic C-terminal amino acids and shows only very weak activity toward small amino acids and histidine ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 613,
  "fields": {
    "recname": "IK",
    "keywords": "Involved in pre-mRNA splicing as a component of the spliceosome. Auxiliary spliceosomal protein that regulates selection of alternative splice sites in a small set of target pre-mRNA species (Probable). Required for normal mitotic cell cycle progression. Recruits MAD1L1 and MAD2L1 to kinetochores, and is required to trigger the spindle assembly checkpoint. Required for normal accumulation of SMU1 ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 614,
  "fields": {
    "recname": "PRNP",
    "keywords": "Its primary physiological function is unclear. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May promote myelin homeostasis through acting as an agonist for ADGRG6 receptor. May play a role in iron uptake and iron homeostasis. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (By similarity). Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also provides Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate side chains (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 615,
  "fields": {
    "recname": "TP53",
    "keywords": "Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2. However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 616,
  "fields": {
    "recname": "KRT8",
    "keywords": "Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle."
  }
},
{
  "model": "agmp_app.index",
  "pk": 617,
  "fields": {
    "recname": "SLC40A1",
    "keywords": "May be involved in iron export from duodenal epithelial cell and also in transfer of iron between maternal and fetal circulation. Mediates iron efflux in the presence of a ferroxidase (hephaestin and/or ceruloplasmin)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 618,
  "fields": {
    "recname": "BRCA2",
    "keywords": "Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 619,
  "fields": {
    "recname": "GIGYF2",
    "keywords": "Key component of the 4EHP-GYF2 complex, a multiprotein complex that acts as a repressor of translation initiation. In 4EHP-GYF2 the complex, acts as a factor that bridges EIF4E2 to ZFP36/TTP, linking translation repression with mRNA decay (By similarity). May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling, including IGF1 and insulin receptors ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 620,
  "fields": {
    "recname": "TOMM40",
    "keywords": "Channel-forming protein essential for import of protein precursors into mitochondria."
  }
},
{
  "model": "agmp_app.index",
  "pk": 621,
  "fields": {
    "recname": "PKLR",
    "keywords": "Plays a key role in glycolysis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 622,
  "fields": {
    "recname": "MIR196A2",
    "keywords": "MIR196A2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 623,
  "fields": {
    "recname": "HOXC6",
    "keywords": "Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 624,
  "fields": {
    "recname": "AC005906.2",
    "keywords": "AC005906.2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 625,
  "fields": {
    "recname": "NPC2",
    "keywords": "Intracellular cholesterol transporter which acts in concert with NPC1 and plays an important role in the egress of cholesterol from the lysosomal compartment. Unesterified cholesterol that has been released from LDLs in the lumen of the late endosomes/lysosomes is transferred by NPC2 to the cholesterol-binding pocket in the N-terminal domain of NPC1. May bind and mobilize cholesterol that is associated with membranes. NPC2 binds cholesterol with a 1:1 stoichiometry. Can bind a variety of sterols, including lathosterol, desmosterol and the plant sterols stigmasterol and beta-sitosterol. The secreted form of NCP2 regulates biliary cholesterol secretion via stimulation of ABCG5/ABCG8-mediated cholesterol transport (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 626,
  "fields": {
    "recname": "CYP4F22",
    "keywords": "CYP4F22"
  }
},
{
  "model": "agmp_app.index",
  "pk": 627,
  "fields": {
    "recname": "RYR1",
    "keywords": "Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering muscle contraction following depolarization of T-tubules. Repeated very high-level exercise increases the open probability of the channel and leads to Ca(2+) leaking into the cytoplasm. Can also mediate the release of Ca(2+) from intracellular stores in neurons, and may thereby promote prolonged Ca(2+) signaling in the brain. Required for normal embryonic development of muscle fibers and skeletal muscle. Required for normal heart morphogenesis, skin development and ossification during embryogenesis (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 628,
  "fields": {
    "recname": "NDUFAF5",
    "keywords": "Arginine hydroxylase involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1) at early stages. Acts by mediating hydroxylation of 'Arg-111' of NDUFS7. May also have methyltransferase activity (Probable)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 629,
  "fields": {
    "recname": "SPG11",
    "keywords": "May play a role in neurite plasticity by maintaining cytoskeleton stability and regulating synaptic vesicle transport."
  }
},
{
  "model": "agmp_app.index",
  "pk": 630,
  "fields": {
    "recname": "MFSD8",
    "keywords": "May be a carrier that transport small solutes by using chemiosmotic ion gradients."
  }
},
{
  "model": "agmp_app.index",
  "pk": 631,
  "fields": {
    "recname": "CCT5",
    "keywords": "Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. The TRiC complex plays a role in the folding of actin and tubulin (Probable)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 632,
  "fields": {
    "recname": "ZFYVE26",
    "keywords": "Phosphatidylinositol 3-phosphate-binding protein required for the abcission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abcission. May also be required for efficient homologous recombination DNA double-strand break repair."
  }
},
{
  "model": "agmp_app.index",
  "pk": 633,
  "fields": {
    "recname": "HMBS",
    "keywords": "Tetrapolymerization of the monopyrrole PBG into the hydroxymethylbilane pre-uroporphyrinogen in several discrete steps."
  }
},
{
  "model": "agmp_app.index",
  "pk": 634,
  "fields": {
    "recname": "GAN",
    "keywords": "Probable cytoskeletal component that directly or indirectly plays an important role in neurofilament architecture. May act as a substrate-specific adapter of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Controls degradation of TBCB. Controls degradation of MAP1B and MAP1S, and is critical for neuronal maintenance and survival."
  }
},
{
  "model": "agmp_app.index",
  "pk": 635,
  "fields": {
    "recname": "SMPD1",
    "keywords": "Converts sphingomyelin to ceramide. Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol."
  }
},
{
  "model": "agmp_app.index",
  "pk": 636,
  "fields": {
    "recname": "SBF2",
    "keywords": "Guanine nucleotide exchange factor (GEF) which activates RAB21 and possibly RAB28. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. In response to starvation-induced autophagy, activates RAB21 which in turn binds to and regulates SNARE protein VAMP8 endolysosomal transport required for SNARE-mediated autophagosome-lysosome fusion. Acts as an adapter for the phosphatase MTMR2 (By similarity). Increases MTMR2 catalytic activity towards phosphatidylinositol 3,5-bisphosphate and to a lesser extent towards phosphatidylinositol 3-phosphate (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 637,
  "fields": {
    "recname": "AIRE",
    "keywords": "Transcription factor playing an essential role to promote self-tolerance in the thymus by regulating the expression of a wide array of self-antigens that have the commonality of being tissue-restricted in their expression pattern in the periphery, called tissue restricted antigens (TRA). Binds to G-doublets in an A/T-rich environment; the preferred motif is a tandem repeat of 5'-ATTGGTTA-3' combined with a 5'-TTATTA-3' box. Binds to nucleosomes (By similarity). Binds to chromatin and interacts selectively with histone H3 that is not methylated at 'Lys-4', not phosphorylated at 'Thr-3' and not methylated at 'Arg-2'. Functions as a sensor of histone H3 modifications that are important for the epigenetic regulation of gene expression. Mainly expressed by medullary thymic epithelial cells (mTECs), induces the expression of thousands of tissue-restricted proteins, which are presented on major histocompatibility complex class I (MHC-I) and MHC-II molecules to developing T-cells percolating through the thymic medulla. Also induces self-tolerance through other mechanisms such as the regulation of the mTEC differentiation program. Controls the medullary accumulation of thymic dendritic cells and the development of regulatory T-cell through the regulation of XCL1 expression. Regulates the production of CCR4 and CCR7 ligands in medullary thymic epithelial cells and alters the coordinated maturation and migration of thymocytes. In thimic B-cells, allows the presentation of licensing-dependent endogenous self-anitgen for negative selection. In secondary lymphoid organs, induces functional inactivation of CD4(+) T-cells. Expressed by a distinct bone marrow-derived population, induces self-tolerance through a mechanism that does not require regulatory T-cells and is resitant to innate inflammatory stimuli (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 638,
  "fields": {
    "recname": "SLC39A4",
    "keywords": "Plays an important role in cellular zinc homeostasis as a zinc transporter. Regulated in response to zinc availability (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 639,
  "fields": {
    "recname": "GCDH",
    "keywords": "Catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. Isoform Short is inactive."
  }
},
{
  "model": "agmp_app.index",
  "pk": 640,
  "fields": {
    "recname": "TMEM126A",
    "keywords": "TMEM126A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 641,
  "fields": {
    "recname": "KIFBP",
    "keywords": "Required for organization of axonal microtubules, and axonal outgrowth and maintenance during peripheral and central nervous system development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 642,
  "fields": {
    "recname": "FANCA",
    "keywords": "DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be involved in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability."
  }
},
{
  "model": "agmp_app.index",
  "pk": 643,
  "fields": {
    "recname": "HEXA",
    "keywords": "Responsible for the degradation of GM2 gangliosides, and a variety of other molecules containing terminal N-acetyl hexosamines, in the brain and other tissues. The form B is active against certain oligosaccharides. The form S has no measurable activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 644,
  "fields": {
    "recname": "CYP27A1",
    "keywords": "Cytochrome P450 monooxygenase that catalyzes regio- and stereospecific hydroxylation of cholesterol and its derivatives. Hydroxylates (with R stereochemistry) the terminal methyl group of cholesterol side-chain in a three step reaction to yield at first a C26 alcohol, then a C26 aldehyde and finally a C26 acid. Regulates cholesterol homeostasis by catalyzing the conversion of excess cholesterol to bile acids via both the 'neutral' (classic) and the 'acid' (alternative) pathways. May also regulate cholesterol homeostasis via generation of active oxysterols, which act as ligands for NR1H2 and NR1H3 nuclear receptors, modulating the transcription of genes involved in lipid metabolism. Plays a role in cholestanol metabolism in the cerebellum. Similarly to cholesterol, hydroxylates cholestanol and may facilitate sterol diffusion through the blood-brain barrier to the systemic circulation for further degradation. Also hydroxylates retinal 7-ketocholesterol, a noxious oxysterol with pro-inflammatory and pro-apoptotic effects, and may play a role in its elimination from the retinal pigment epithelium. May play a redundant role in vitamin D biosynthesis. Catalyzes 25-hydroxylation of vitamin D3 that is required for its conversion to a functionally active form ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 645,
  "fields": {
    "recname": "EDARADD",
    "keywords": "Adapter protein that interacts with EDAR DEATH domain and couples the receptor to EDA signaling pathway during morphogenesis of ectodermal organs. Mediates the activation of NF-kappa-B."
  }
},
{
  "model": "agmp_app.index",
  "pk": 646,
  "fields": {
    "recname": "NLRP3",
    "keywords": "As the sensor component of the NLRP3 inflammasome, plays a crucial role in innate immunity and inflammation. In response to pathogens and other damage-associated signals, initiates the formation of the inflammasome polymeric complex, made of NLRP3, PYCARD and CASP1 (and possibly CASP4 and CASP5). Recruitment of proCASP1 to the inflammasome promotes its activation and CASP1-catalyzed IL1B and IL18 maturation and secretion in the extracellular milieu. Activation of NLRP3 inflammasome is also required for HMGB1 secretion. The active cytokines and HMGB1 stimulate inflammatory responses. Inflammasomes can also induce pyroptosis, an inflammatory form of programmed cell death. Under resting conditions, NLRP3 is autoinhibited. NLRP3 activation stimuli include extracellular ATP, reactive oxygen species, K(+) efflux, crystals of monosodium urate or cholesterol, amyloid-beta fibers, environmental or industrial particles and nanoparticles, cytosolic dsRNA, etc. However, it is unclear what constitutes the direct NLRP3 activator. Activation in presence of cytosolic dsRNA is mediated by DHX33. Independently of inflammasome activation, regulates the differentiation of T helper 2 (Th2) cells and has a role in Th2 cell-dependent asthma and tumor growth (By similarity). During Th2 differentiation, required for optimal IRF4 binding to IL4 promoter and for IRF4-dependent IL4 transcription. Binds to the consensus DNA sequence 5'-GRRGGNRGAG-3'. May also participate in the transcription of IL5, IL13, GATA3, CCR3, CCR4 and MAF (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 647,
  "fields": {
    "recname": "BBS2",
    "keywords": "The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization."
  }
},
{
  "model": "agmp_app.index",
  "pk": 648,
  "fields": {
    "recname": "GFER",
    "keywords": "FAD-dependent sulfhydryl oxidase that regenerates the redox-active disulfide bonds in CHCHD4/MIA40, a chaperone essential for disulfide bond formation and protein folding in the mitochondrial intermembrane space. The reduced form of CHCHD4/MIA40 forms a transient intermolecular disulfide bridge with GFER/ERV1, resulting in regeneration of the essential disulfide bonds in CHCHD4/MIA40, while GFER/ERV1 becomes re-oxidized by donating electrons to cytochrome c or molecular oxygen."
  }
},
{
  "model": "agmp_app.index",
  "pk": 649,
  "fields": {
    "recname": "HGSNAT",
    "keywords": "Lysosomal acetyltransferase that acetylates the non-reducing terminal alpha-glucosamine residue of intralysosomal heparin or heparan sulfate, converting it into a substrate for luminal alpha-N-acetyl glucosaminidase."
  }
},
{
  "model": "agmp_app.index",
  "pk": 650,
  "fields": {
    "recname": "SLURP1",
    "keywords": "Has an antitumor activity. Was found to be a marker of late differentiation of the skin. Implicated in maintaining the physiological and structural integrity of the keratinocyte layers of the skin. In vitro down-regulates keratinocyte proliferation; the function may involve the proposed role as modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits alpha-7-dependent nAChR currents in an allosteric manner. In T cells may be involved in regulation of intracellular Ca(2+) signaling. Seems to have an immunomodulatory function in the cornea (By similarity). The function may implicate a possible role as a scavenger receptor for PLAU thereby blocking PLAU-dependent functions of PLAUR such as in cell migration and proliferation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 651,
  "fields": {
    "recname": "SLC7A9",
    "keywords": "Involved in the high-affinity, sodium-independent transport of cystine and neutral and dibasic amino acids (system b(0,+)-like activity). Thought to be responsible for the high-affinity reabsorption of cystine in the kidney tubule."
  }
},
{
  "model": "agmp_app.index",
  "pk": 652,
  "fields": {
    "recname": "AGXT",
    "keywords": "AGXT"
  }
},
{
  "model": "agmp_app.index",
  "pk": 653,
  "fields": {
    "recname": "CYP7B1",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of endogenous oxysterols and steroid hormones, including neurosteroids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). Catalyzes the hydroxylation of carbon hydrogen bonds of steroids with a preference for 7-alpha position. Usually metabolizes steroids carrying a hydroxy group at position 3, functioning as a 3-hydroxy steroid 7-alpha hydroxylase. Hydroxylates oxysterols, including 25-hydroxycholesterol and (25R)-cholest-5-ene-3beta,26-diol toward 7-alpha hydroxy derivatives, which may be transported to the liver and converted to bile acids. Via its product 7-alpha,25-dihydroxycholesterol, a ligand for the chemotactic G protein-coupled receptor GPR183/EBI2, regulates B cell migration in germinal centers of lymphoid organs, thus guiding efficient maturation of plasma B cells and overall antigen-specific humoral immune response (By similarity). 7-alpha hydroxylates neurosteroids, including 3beta-hydroxyandrost-5-en-17-one (dehydroepiandrosterone) and pregnenolone, both involved in hippocampus-associated memory and learning. Metabolizes androstanoids toward 6- or 7-alpha hydroxy derivatives ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 654,
  "fields": {
    "recname": "ASS1",
    "keywords": "One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues."
  }
},
{
  "model": "agmp_app.index",
  "pk": 655,
  "fields": {
    "recname": "SLC7A7",
    "keywords": "Involved in the sodium-independent uptake of dibasic amino acids and sodium-dependent uptake of some neutral amino acids. Requires coexpression with SLC3A2/4F2hc to mediate the uptake of arginine, leucine and glutamine. Plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine. Involved in the transport of L-arginine in monocytes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 656,
  "fields": {
    "recname": "TGFBI",
    "keywords": "Plays a role in cell adhesion. May play a role in cell-collagen interactions (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 657,
  "fields": {
    "recname": "GHR",
    "keywords": "Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 658,
  "fields": {
    "recname": "SERPINC1",
    "keywords": "Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade. AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa. Its inhibitory activity is greatly enhanced in the presence of heparin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 659,
  "fields": {
    "recname": "ADGRV1",
    "keywords": "G-protein coupled receptor which has an essential role in the development of hearing and vision. Couples to G-alpha(i)-proteins, GNAI1/2/3, G-alpha(q)-proteins, GNAQ, as well as G-alpha(s)-proteins, GNAS, inhibiting adenylate cyclase (AC) activity and cAMP production. Required for the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells of the inner ear. In response to extracellular calcium, activates kinases PKA and PKC to regulate myelination by inhibiting the ubiquitination of MAG, thus enhancing the stability of this protein in myelin-forming cells of the auditory pathway. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport. Involved in the regulation of bone metabolism."
  }
},
{
  "model": "agmp_app.index",
  "pk": 660,
  "fields": {
    "recname": "SLC29A3",
    "keywords": "Mediates both influx and efflux of nucleosides across the membrane (equilibrative transporter). Mediates transport of adenine, adenosine and uridine, as well as several nucleoside analog drugs, such as anticancer and antiviral agents, including cladribine, cordycepin, tubercidin and AZT. Does not transport hypoxanthine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 661,
  "fields": {
    "recname": "FREM1",
    "keywords": "Extracellular matrix protein that plays a role in epidermal differentiation and is required for epidermal adhesion during embryonic development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 662,
  "fields": {
    "recname": "COL9A1",
    "keywords": "Structural component of hyaline cartilage and vitreous of the eye."
  }
},
{
  "model": "agmp_app.index",
  "pk": 663,
  "fields": {
    "recname": "RB1",
    "keywords": "Key regulator of entry into cell division that acts as a tumor suppressor. Promotes G0-G1 transition when phosphorylated by CDK3/cyclin-C. Acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 664,
  "fields": {
    "recname": "APC",
    "keywords": "Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization."
  }
},
{
  "model": "agmp_app.index",
  "pk": 665,
  "fields": {
    "recname": "KIT",
    "keywords": "Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Activated KIT also transmits signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3, STAT5A and STAT5B. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KIT signaling is modulated by protein phosphatases, and by rapid internalization and degradation of the receptor. Activated KIT promotes phosphorylation of the protein phosphatases PTPN6/SHP-1 and PTPRU, and of the transcription factors STAT1, STAT3, STAT5A and STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoform Crk-II), LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 666,
  "fields": {
    "recname": "EPB42",
    "keywords": "Probably plays an important role in the regulation of erythrocyte shape and mechanical properties."
  }
},
{
  "model": "agmp_app.index",
  "pk": 667,
  "fields": {
    "recname": "SFTPC",
    "keywords": "Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces."
  }
},
{
  "model": "agmp_app.index",
  "pk": 668,
  "fields": {
    "recname": "PROP1",
    "keywords": "Possibly involved in the ontogenesis of pituitary gonadotropes, as well as somatotropes, lactotropes and caudomedial thyrotropes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 669,
  "fields": {
    "recname": "TTPA",
    "keywords": "Binds alpha-tocopherol, enhances its transfer between separate membranes, and stimulates its release from liver cells. Binds both phosphatidylinol 3,4-bisphosphate and phosphatidylinol 4,5-bisphosphate; the resulting conformation change is important for the release of the bound alpha-tocopherol (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 670,
  "fields": {
    "recname": "UROD",
    "keywords": "Catalyzes the decarboxylation of four acetate groups of uroporphyrinogen-III to yield coproporphyrinogen-III."
  }
},
{
  "model": "agmp_app.index",
  "pk": 671,
  "fields": {
    "recname": "OCA2",
    "keywords": "Could be involved in the transport of tyrosine, the precursor to melanin synthesis, within the melanocyte. Regulates the pH of melanosome and the melanosome maturation. One of the components of the mammalian pigmentary system. Seems to regulate the post-translational processing of tyrosinase, which catalyzes the limiting reaction in melanin synthesis. May serve as a key control point at which ethnic skin color variation is determined. Major determinant of brown and/or blue eye color."
  }
},
{
  "model": "agmp_app.index",
  "pk": 672,
  "fields": {
    "recname": "MMUT",
    "keywords": "Involved in the degradation of several amino acids, odd-chain fatty acids and cholesterol via propionyl-CoA to the tricarboxylic acid cycle. MCM has different functions in other species."
  }
},
{
  "model": "agmp_app.index",
  "pk": 673,
  "fields": {
    "recname": "FERMT1",
    "keywords": "Involved in cell adhesion. Contributes to integrin activation. When coexpressed with talin, potentiates activation of ITGA2B. Required for normal keratinocyte proliferation. Required for normal polarization of basal keratinocytes in skin, and for normal cell shape. Required for normal adhesion of keratinocytes to fibronectin and laminin, and for normal keratinocyte migration to wound sites. May mediate TGF-beta 1 signaling in tumor progression."
  }
},
{
  "model": "agmp_app.index",
  "pk": 674,
  "fields": {
    "recname": "RXFP2",
    "keywords": "Receptor for relaxin. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. May also be a receptor for Leydig insulin-like peptide (INSL3)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 675,
  "fields": {
    "recname": "PPOX",
    "keywords": "Catalyzes the 6-electron oxidation of protoporphyrinogen-IX to form protoporphyrin-IX."
  }
},
{
  "model": "agmp_app.index",
  "pk": 676,
  "fields": {
    "recname": "SLC25A22",
    "keywords": "Involved in the transport of glutamate across the inner mitochondrial membrane. Glutamate is cotransported with H(+)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 677,
  "fields": {
    "recname": "CARD9",
    "keywords": "Adapter protein that plays a key role in innate immune response to a number of intracellular pathogens, such as C.albicans and L.monocytogenes. Is at the crossroads of ITAM-tyrosine kinase and the Toll-like receptors (TLR) and NOD2 signaling pathways. Probably controls various innate immune response pathways depending on the intracellular pathogen. In response to L.monocytogenes infection, acts by connecting NOD2 recognition of peptidoglycan to downstream activation of MAP kinases (MAPK) without activating NF-kappa-B. Also involved in activation of myeloid cells via classical ITAM-associated receptors and TLR: required for TLR-mediated activation of MAPK, while it is not required for TLR-induced activation of NF-kappa-B (By similarity). Controls CLEC7A (dectin-1)-mediated myeloid cell activation induced by the yeast cell wall component zymosan, leading to cytokine production and innate anti-fungal immunity: acts by regulating BCL10-MALT1-mediated NF-kappa-B activation pathway. Activates NF-kappa-B via BCL10. In response to the hyphal form of C.albicans, mediates CLEC6A (dectin-2)-induced I-kappa-B kinase ubiquitination, leading to NF-kappa-B activation via interaction with BCL10. In response to fungal infection, may be required for the development and subsequent differentiation of interleukin 17-producing T helper (TH-17) cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 678,
  "fields": {
    "recname": "PDE6B",
    "keywords": "This protein participates in processes of transmission and amplification of the visual signal. Necessary for the formation of a functional phosphodiesterase holoenzyme."
  }
},
{
  "model": "agmp_app.index",
  "pk": 679,
  "fields": {
    "recname": "SPTA1",
    "keywords": "Spectrin is the major constituent of the cytoskeletal network underlying the erythrocyte plasma membrane. It associates with band 4.1 and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane."
  }
},
{
  "model": "agmp_app.index",
  "pk": 680,
  "fields": {
    "recname": "TSHB",
    "keywords": "Indispensable for the control of thyroid structure and metabolism."
  }
},
{
  "model": "agmp_app.index",
  "pk": 681,
  "fields": {
    "recname": "FGFR2",
    "keywords": "Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 682,
  "fields": {
    "recname": "TNNT2",
    "keywords": "Troponin T is the tropomyosin-binding subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 683,
  "fields": {
    "recname": "C7",
    "keywords": "Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor."
  }
},
{
  "model": "agmp_app.index",
  "pk": 684,
  "fields": {
    "recname": "F7",
    "keywords": "Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium."
  }
},
{
  "model": "agmp_app.index",
  "pk": 685,
  "fields": {
    "recname": "DLD",
    "keywords": "Lipoamide dehydrogenase is a component of the glycine cleavage system as well as an E3 component of three alpha-ketoacid dehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, and branched-chain amino acid-dehydrogenase complex). The 2-oxoglutarate dehydrogenase complex is mainly active in the mitochondrion. A fraction of the 2-oxoglutarate dehydrogenase complex also localizes in the nucleus and is required for lysine succinylation of histones: associates with KAT2A on chromatin and provides succinyl-CoA to histone succinyltransferase KAT2A. In monomeric form may have additional moonlighting function as serine protease. Involved in the hyperactivation of spermatazoa during capacitation and in the spermatazoal acrosome reaction (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 686,
  "fields": {
    "recname": "IDUA",
    "keywords": "IDUA"
  }
},
{
  "model": "agmp_app.index",
  "pk": 687,
  "fields": {
    "recname": "SLC26A1",
    "keywords": "Mediates sulfate transport with high affinity. Mediates oxalate transport. Mediates bicarbonate transport (By similarity). Does not accept succinate as cosubstrate (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 688,
  "fields": {
    "recname": "TCF7L2",
    "keywords": "Participates in the Wnt signaling pathway and modulates MYC expression by binding to its promoter in a sequence-specific manner. Acts as repressor in the absence of CTNNB1, and as activator in its presence. Activates transcription from promoters with several copies of the Tcf motif 5'-CCTTTGATC-3' in the presence of CTNNB1. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7L2/TCF4 and CTNNB1. Expression of dominant-negative mutants results in cell-cycle arrest in G1. Necessary for the maintenance of the epithelial stem-cell compartment of the small intestine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 689,
  "fields": {
    "recname": "AC092813.1",
    "keywords": "AC092813.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 690,
  "fields": {
    "recname": "COL27A1",
    "keywords": "Plays a role during the calcification of cartilage and the transition of cartilage to bone."
  }
},
{
  "model": "agmp_app.index",
  "pk": 691,
  "fields": {
    "recname": "KCNQ1",
    "keywords": "Potassium channel that plays an important role in a number of tissues, including heart, inner ear, stomach and colon (By similarity). Associates with KCNE beta subunits that modulates current kinetics (By similarity). Induces a voltage-dependent by rapidly activating and slowly deactivating potassium-selective outward current (By similarity). Promotes also a delayed voltage activated potassium current showing outward rectification characteristic (By similarity). During beta-adrenergic receptor stimulation participates in cardiac repolarization by associating with KCNE1 to form the I(Ks) cardiac potassium current that increases the amplitude and slows down the activation kinetics of outward potassium current I(Ks) (By similarity). Muscarinic agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current. When associated with KCNE3, forms the potassium channel that is important for cyclic AMP-stimulated intestinal secretion of chloride ions. This interaction with KCNE3 is reduced by 17beta-estradiol, resulting in the reduction of currents (By similarity). During conditions of increased substrate load, maintains the driving force for proximal tubular and intestinal sodium ions absorption, gastric acid secretion, and cAMP-induced jejunal chloride ions secretion (By similarity). Allows the provision of potassium ions to the luminal membrane of the secretory canaliculus in the resting state as well as during stimulated acid secretion (By similarity). When associated with KCNE2, forms a heterooligomer complex leading to currents with an apparently instantaneous activation, a rapid deactivation process and a linear current-voltage relationship and decreases the amplitude of the outward current. When associated with KCNE4, inhibits voltage-gated potassium channel activity. When associated with KCNE5, this complex only conducts current upon strong and continued depolarization. Also forms a heterotetramer with KCNQ5; has a voltage-gated potassium channel activity. Binds with phosphatidylinositol 4,5-bisphosphate ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 692,
  "fields": {
    "recname": "MMP26",
    "keywords": "May hydrolyze collagen type IV, fibronectin, fibrinogen, beta-casein, type I gelatin and alpha-1 proteinase inhibitor. Is also able to activate progelatinase B."
  }
},
{
  "model": "agmp_app.index",
  "pk": 693,
  "fields": {
    "recname": "OR51F1",
    "keywords": "Odorant receptor."
  }
},
{
  "model": "agmp_app.index",
  "pk": 694,
  "fields": {
    "recname": "SLC39A8",
    "keywords": "Acts as a manganese and zinc influx transporter. Plays a role in manganese reabsorption in the proximal tubule of the kidney and in manganese uptake into the brain ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 695,
  "fields": {
    "recname": "ERCC2",
    "keywords": "ATP-dependent 5'-3' DNA helicase, component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. The ATP-dependent helicase activity of XPD/ERCC2 is required for DNA opening. In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. XPD/ERCC2 acts by forming a bridge between CAK and the core-TFIIH complex. Involved in the regulation of vitamin-D receptor activity. As part of the mitotic spindle-associated MMXD complex it plays a role in chromosome segregation. Might have a role in aging process and could play a causative role in the generation of skin cancers."
  }
},
{
  "model": "agmp_app.index",
  "pk": 696,
  "fields": {
    "recname": "SLC30A8",
    "keywords": "Facilitates the accumulation of zinc from the cytoplasm into intracellular vesicles, being a zinc-efflux transporter. May be a major component for providing zinc to insulin maturation and/or storage processes in insulin-secreting pancreatic beta-cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 697,
  "fields": {
    "recname": "PCAT1",
    "keywords": "PCAT1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 698,
  "fields": {
    "recname": "POU5F1B",
    "keywords": "Shows weak transcriptional activator activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 699,
  "fields": {
    "recname": "CASC8",
    "keywords": "CASC8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 700,
  "fields": {
    "recname": "Dec1",
    "keywords": "Dec1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 701,
  "fields": {
    "recname": "TNC",
    "keywords": "Extracellular matrix protein implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity as well as neuronal regeneration. Promotes neurite outgrowth from cortical neurons grown on a monolayer of astrocytes. Ligand for integrins alpha-8/beta-1, alpha-9/beta-1, alpha-V/beta-3 and alpha-V/beta-6. In tumors, stimulates angiogenesis by elongation, migration and sprouting of endothelial cells ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 702,
  "fields": {
    "recname": "SGCA",
    "keywords": "Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix."
  }
},
{
  "model": "agmp_app.index",
  "pk": 703,
  "fields": {
    "recname": "TMPRSS3",
    "keywords": "Probable serine protease that plays a role in hearing. Acts as a permissive factor for cochlear hair cell survival and activation at the onset of hearing and is required for saccular hair cell survival (By similarity). Activates ENaC (in vitro)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 704,
  "fields": {
    "recname": "PCDH15",
    "keywords": "Calcium-dependent cell-adhesion protein. Essential for maintenance of normal retinal and cochlear function."
  }
},
{
  "model": "agmp_app.index",
  "pk": 705,
  "fields": {
    "recname": "DYNC2H1",
    "keywords": "May function as a motor for intraflagellar retrograde transport. Functions in cilia biogenesis. May play a role in transport between endoplasmic reticulum and Golgi or organization of the Golgi in cells (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 706,
  "fields": {
    "recname": "ZRANB3",
    "keywords": "DNA annealing helicase and endonuclease required to maintain genome stability at stalled or collapsed replication forks by facilitating fork restart and limiting inappropriate recombination that could occur during template switching events. Recruited to the sites of stalled DNA replication by polyubiquitinated PCNA and acts as a structure-specific endonuclease that cleaves the replication fork D-loop intermediate, generating an accessible 3'-OH group in the template of the leading strand, which is amenable to extension by DNA polymerase. In addition to endonuclease activity, also catalyzes the fork regression via annealing helicase activity in order to prevent disintegration of the replication fork and the formation of double-strand breaks ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 707,
  "fields": {
    "recname": "RAB3GAP1",
    "keywords": "Probable catalytic subunit of a GTPase activating protein that has specificity for Rab3 subfamily (RAB3A, RAB3B, RAB3C and RAB3D). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones. Specifically converts active Rab3-GTP to the inactive form Rab3-GDP. Required for normal eye and brain development. May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non-synaptic vesicular release of neurotransmitters."
  }
},
{
  "model": "agmp_app.index",
  "pk": 708,
  "fields": {
    "recname": "SAR1B",
    "keywords": "Involved in transport from the endoplasmic reticulum to the Golgi apparatus. Activated by the guanine nucleotide exchange factor PREB. Involved in the selection of the protein cargo and the assembly of the COPII coat complex."
  }
},
{
  "model": "agmp_app.index",
  "pk": 709,
  "fields": {
    "recname": "TIMP3",
    "keywords": "Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. May form part of a tissue-specific acute response to remodeling stimuli. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, MMP-14 and MMP-15."
  }
},
{
  "model": "agmp_app.index",
  "pk": 710,
  "fields": {
    "recname": "SYN3",
    "keywords": "May be involved in the regulation of neurotransmitter release and synaptogenesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 711,
  "fields": {
    "recname": "AP4E1",
    "keywords": "Component of the adaptor protein complex 4 (AP-4). Adaptor protein complexes are vesicle coat components involved both in vesicle formation and cargo selection. They control the vesicular transport of proteins in different trafficking pathways. AP-4 forms a non clathrin-associated coat on vesicles departing the trans-Golgi network (TGN) and may be involved in the targeting of proteins from the trans-Golgi network (TGN) to the endosomal-lysosomal system. It is also involved in protein sorting to the basolateral membrane in epithelial cells and the proper asymmetric localization of somatodendritic proteins in neurons. AP-4 is involved in the recognition and binding of tyrosine-based sorting signals found in the cytoplasmic part of cargos, but may also recognize other types of sorting signal (Probable)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 712,
  "fields": {
    "recname": "BAIAP2",
    "keywords": "Adapter protein that links membrane-bound small G-proteins to cytoplasmic effector proteins. Necessary for CDC42-mediated reorganization of the actin cytoskeleton and for RAC1-mediated membrane ruffling. Involved in the regulation of the actin cytoskeleton by WASF family members and the Arp2/3 complex. Plays a role in neurite growth. Acts syngeristically with ENAH to promote filipodia formation. Plays a role in the reorganization of the actin cytoskeleton in response to bacterial infection. Participates in actin bundling when associated with EPS8, promoting filopodial protrusions."
  }
},
{
  "model": "agmp_app.index",
  "pk": 713,
  "fields": {
    "recname": "AC011287.1",
    "keywords": "AC011287.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 714,
  "fields": {
    "recname": "STX6",
    "keywords": "Involved in intracellular vesicle trafficking."
  }
},
{
  "model": "agmp_app.index",
  "pk": 715,
  "fields": {
    "recname": "TULP1",
    "keywords": "Required for normal development of photoreceptor synapses. Required for normal photoreceptor function and for long-term survival of photoreceptor cells. Interacts with cytoskeleton proteins and may play a role in protein transport in photoreceptor cells (By similarity). Binds lipids, especially phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 3,4,5-bisphosphate, phosphatidylserine and phosphatidic acid (in vitro). Contribute to stimulation of phagocytosis of apoptotic retinal pigment epithelium (RPE) cells and macrophages."
  }
},
{
  "model": "agmp_app.index",
  "pk": 716,
  "fields": {
    "recname": "SLC24A5",
    "keywords": "Cation exchanger involved in pigmentation, possibly by participating in ion transport in melanosomes. Predominant sodium-Calcium exchanger in melanocytes. Probably transports 1 Ca(2+) and 1 K(+) to the melanosome in exchange for 4 cytoplasmic Na(+)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 717,
  "fields": {
    "recname": "BCL11A",
    "keywords": "Transcription factor associated with the BAF SWI/SNF chromatin remodeling complex (By similarity). Repressor of fetal hemoglobin (HbF) level. Involved in brain development. May play a role in hematopoiesis. Essential factor in lymphopoiesis required for B-cell formation in fetal liver. May function as a modulator of the transcriptional repression activity of ARP1 (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 718,
  "fields": {
    "recname": "IVD",
    "keywords": "IVD"
  }
},
{
  "model": "agmp_app.index",
  "pk": 719,
  "fields": {
    "recname": "FAM155A",
    "keywords": "FAM155A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 720,
  "fields": {
    "recname": "SERPINB8",
    "keywords": "Has an important role in epithelial desmosome-mediated cell-cell adhesion."
  }
},
{
  "model": "agmp_app.index",
  "pk": 721,
  "fields": {
    "recname": "ASPM",
    "keywords": "Involved in mitotic spindle regulation and coordination of mitotic processes. The function in regulating microtubule dynamics at spindle poles including spindle orientation, astral microtubule density and poleward microtubule flux seems to depend on the association with the katanin complex formed by KATNA1 and KATNB1. Enhances the microtubule lattice severing activity of KATNA1 by recruiting the katanin complex to microtubules. Can block microtubule minus-end growth and reversely this function can be enhanced by the katanin complex. May have a preferential role in regulating neurogenesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 722,
  "fields": {
    "recname": "MCM6",
    "keywords": "Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 723,
  "fields": {
    "recname": "CARD14",
    "keywords": "Acts as a scaffolding protein that can activate the inflammatory transcription factor NF-kappa-B and p38/JNK MAP kinase signaling pathways. Forms a signaling complex with BCL10 and MALT1, and activates MALT1 proteolytic activity and inflammatory gene expression. MALT1 is indispensable for CARD14-induced activation of NF-kappa-B and p38/JNK MAP kinases. May play a role in signaling mediated by TRAF2, TRAF3 and TRAF6 and protects cells against apoptosis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 724,
  "fields": {
    "recname": "PAEP",
    "keywords": "Glycoprotein that regulates critical steps during fertilization and also has immunomonomodulatory effects. Four glycoforms, namely glycodelin-S, -A, -F and -C have been identified in reproductive tissues that differ in glycosylation and biological activity. Glycodelin-A has contraceptive and immunosuppressive activities. Glycodelin-C stimulates binding of spermatozoa to the zona pellucida. Glycodelin-F inhibits spermatozoa-zona pellucida binding and significantly suppresses progesterone-induced acrosome reaction of spermatozoa. Glycodelin-S in seminal plasma maintains the uncapacitated state of human spermatozoa ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 725,
  "fields": {
    "recname": "IGF2BP2",
    "keywords": "RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation (By similarity). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binding is isoform-specific. Binds to beta-actin/ACTB and MYC transcripts."
  }
},
{
  "model": "agmp_app.index",
  "pk": 726,
  "fields": {
    "recname": "CSTB",
    "keywords": "This is an intracellular thiol proteinase inhibitor. Tightly binding reversible inhibitor of cathepsins L, H and B."
  }
},
{
  "model": "agmp_app.index",
  "pk": 727,
  "fields": {
    "recname": "CSMD1",
    "keywords": "Potential suppressor of squamous cell carcinomas."
  }
},
{
  "model": "agmp_app.index",
  "pk": 728,
  "fields": {
    "recname": "PKHD1",
    "keywords": "May be required for correct bipolar cell division through the regulation of centrosome duplication and mitotic spindle assembly. May be a receptor protein that acts in collecting-duct and biliary differentiation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 729,
  "fields": {
    "recname": "ABCA3",
    "keywords": "Plays an important role in the formation of pulmonary surfactant, probably by transporting lipids such as cholesterol."
  }
},
{
  "model": "agmp_app.index",
  "pk": 730,
  "fields": {
    "recname": "GLT6D1",
    "keywords": "GLT6D1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 731,
  "fields": {
    "recname": "OR51N1P",
    "keywords": "OR51N1P"
  }
},
{
  "model": "agmp_app.index",
  "pk": 732,
  "fields": {
    "recname": "SLC11A1",
    "keywords": "Divalent transition metal (iron and manganese) transporter involved in iron metabolism and host resistance to certain pathogens. Macrophage-specific membrane transport function. Controls natural resistance to infection with intracellular parasites. Pathogen resistance involves sequestration of Fe(2+) and Mn(2+), cofactors of both prokaryotic and eukaryotic catalases and superoxide dismutases, not only to protect the macrophage against its own generation of reactive oxygen species, but to deny the cations to the pathogen for synthesis of its protective enzymes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 733,
  "fields": {
    "recname": "NOD2",
    "keywords": "Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3, INAVA and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages. Component of an autophagy-mediated antibacterial pathway together with ATG16L1. Plays also a role in sensing single-stranded RNA (ssRNA) from viruses. Interacts with mitochondrial antiviral signaling/MAVS, leading to activation of interferon regulatory factor-3/IRF3 and expression of type I interferon ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 734,
  "fields": {
    "recname": "NALCN",
    "keywords": "Voltage-independent, cation-nonselective channel which is permeable to sodium, potassium and calcium ions. Regulates the resting membrane potential and controls neuronal excitability. Neuropeptides such as neurotensin and substance P (SP) stimulate the firing of action potentials by activating NALCN through a SRC family kinases-dependent pathway. In addition to its baseline activity, NALCN activity is enhanced/modulated by several GPCRs. Required for normal respiratory rhythm and neonatal survival. Involved in systemic osmoregulation by controlling the serum sodium concentration. NALCN is partly responsible for the substance P-induced depolarization and regulation of the intestinal pace-making activity in the interstitial cells of Cajal. Plays a critical role in both maintenance of spontaneous firing of substantia nigra pars reticulata (SNr) neurons and physiological modulation of SNr neuron excitability (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 735,
  "fields": {
    "recname": "ERCC5",
    "keywords": "Single-stranded structure-specific DNA endonuclease involved in DNA excision repair. Makes the 3'incision in DNA nucleotide excision repair (NER). Acts as a cofactor for a DNA glycosylase that removes oxidized pyrimidines from DNA. May also be involved in transcription-coupled repair of this kind of damage, in transcription by RNA polymerase II, and perhaps in other processes too."
  }
},
{
  "model": "agmp_app.index",
  "pk": 736,
  "fields": {
    "recname": "BIVM-ERCC5",
    "keywords": "BIVM-ERCC5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 737,
  "fields": {
    "recname": "LINC00871",
    "keywords": "LINC00871"
  }
},
{
  "model": "agmp_app.index",
  "pk": 738,
  "fields": {
    "recname": "CCR2",
    "keywords": "Key functional receptor for CCL2 but can also bind CCL7 and CCL12. Its binding with CCL2 on monocytes and macrophages mediates chemotaxis and migration induction through the activation of the PI3K cascade, the small G protein Rac and lamellipodium protrusion (Probable). Also acts as a receptor for the beta-defensin DEFB106A/DEFB106B. Regulates the expression of T-cell inflammatory cytokines and T-cell differentiation, promoting the differentiation of T-cells into T-helper 17 cells (Th17) during inflammation (By similarity). Facilitates the export of mature thymocytes by enhancing directional movement of thymocytes to sphingosine-1-phosphate stimulation and up-regulation of S1P1R expression; signals through the JAK-STAT pathway to regulate FOXO1 activity leading to an increased expression of S1P1R (By similarity). Plays an important role in mediating peripheral nerve injury-induced neuropathic pain (By similarity). Increases NMDA-mediated synaptic transmission in both dopamine D1 and D2 receptor-containing neurons, which may be caused by MAPK/ERK-dependent phosphorylation of GRIN2B/NMDAR2B (By similarity). Mediates the recruitment of macrophages and monocytes to the injury site following brain injury (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 739,
  "fields": {
    "recname": "NOS3",
    "keywords": "Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets."
  }
},
{
  "model": "agmp_app.index",
  "pk": 740,
  "fields": {
    "recname": "MBL2",
    "keywords": "Calcium-dependent lectin involved in innate immune defense. Binds mannose, fucose and N-acetylglucosamine on different microorganisms and activates the lectin complement pathway. Binds to late apoptotic cells, as well as to apoptotic blebs and to necrotic cells, but not to early apoptotic cells, facilitating their uptake by macrophages. May bind DNA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 741,
  "fields": {
    "recname": "ABCA4",
    "keywords": "Catalyzes the translocation of specific phospholipids from the extracellular/lumenal to the cytoplasmic leaflet of membrane coupled to the hydrolysis of ATP. Transports preferentially phosphatidylethanolamine. In the visual cycle, acts as an inward-directed retinoid flipase, retinoid substrates imported by ABCA4 from the extracellular or intradiscal (rod) membrane surfaces to the cytoplasmic membrane surface are all-trans-retinaldehyde (ATR) and N-retinyl-phosphatidyl-ethanolamine (NR-PE). Once transported to the cytoplasmic surface, ATR is reduced to vitamin A by trans-retinol dehydrogenase (tRDH) and then transferred to the retinal pigment epithelium (RPE) where it is converted to 11-cis-retinal. May play a role in photoresponse, removing ATR/NR-PE from the extracellular photoreceptor surfaces during bleach recovery."
  }
},
{
  "model": "agmp_app.index",
  "pk": 742,
  "fields": {
    "recname": "IL19",
    "keywords": "May play some important roles in inflammatory responses. Up-regulates IL-6 and TNF-alpha and induces apoptosis (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 743,
  "fields": {
    "recname": "IL10",
    "keywords": "Major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation. Mechanistically, IL10 binds to its heterotetrameric receptor comprising IL10RA and IL10RB leading to JAK1 and STAT2-mediated phosphorylation of STAT3. In turn, STAT3 translocates to the nucleus where it drives expression of anti-inflammatory mediators. Targets antigen-presenting cells (APCs) such as macrophages and monocytes and inhibits their release of pro-inflammatory cytokines including granulocyte-macrophage colony-stimulating factor /GM-CSF, granulocyte colony-stimulating factor/G-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8 and TNF-alpha. Interferes also with antigen presentation by reducing the expression of MHC-class II and co-stimulatory molecules, thereby inhibiting their ability to induce T cell activation. In addition, controls the inflammatory response of macrophages by reprogramming essential metabolic pathways including mTOR signaling (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 744,
  "fields": {
    "recname": "G6PC",
    "keywords": "Hydrolyzes glucose-6-phosphate to glucose in the endoplasmic reticulum. Forms with the glucose-6-phosphate transporter (SLC37A4/G6PT) the complex responsible for glucose production through glycogenolysis and gluconeogenesis. Hence, it is the key enzyme in homeostatic regulation of blood glucose levels."
  }
},
{
  "model": "agmp_app.index",
  "pk": 745,
  "fields": {
    "recname": "IL4R",
    "keywords": "Receptor for both interleukin 4 and interleukin 13. Couples to the JAK1/2/3-STAT6 pathway. The IL4 response is involved in promoting Th2 differentiation. The IL4/IL13 responses are involved in regulating IgE production and, chemokine and mucus production at sites of allergic inflammation. In certain cell types, can signal through activation of insulin receptor substrates, IRS1/IRS2."
  }
},
{
  "model": "agmp_app.index",
  "pk": 746,
  "fields": {
    "recname": "PPARG",
    "keywords": "Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of ARNTL/BMAL1 in the blood vessels (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 747,
  "fields": {
    "recname": "PALB2",
    "keywords": "Plays a critical role in homologous recombination repair (HRR) through its ability to recruit BRCA2 and RAD51 to DNA breaks. Strongly stimulates the DNA strand-invasion activity of RAD51, stabilizes the nucleoprotein filament against a disruptive BRC3-BRC4 polypeptide and helps RAD51 to overcome the suppressive effect of replication protein A (RPA). Functionally cooperates with RAD51AP1 in promoting of D-loop formation by RAD51. Serves as the molecular scaffold in the formation of the BRCA1-PALB2-BRCA2 complex which is essential for homologous recombination. Via its WD repeats is proposed to scaffold a HR complex containing RAD51C and BRCA2 which is thought to play a role in HR-mediated DNA repair. Essential partner of BRCA2 that promotes the localization and stability of BRCA2. Also enables its recombinational repair and checkpoint functions of BRCA2. May act by promoting stable association of BRCA2 with nuclear structures, allowing BRCA2 to escape the effects of proteasome-mediated degradation. Binds DNA with high affinity for D loop, which comprises single-stranded, double-stranded and branched DNA structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with BRCA2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 748,
  "fields": {
    "recname": "LEPR",
    "keywords": "Receptor for hormone LEP/leptin (Probable). On ligand binding, mediates LEP central and peripheral effects through the activation of different signaling pathways such as JAK2/STAT3 and MAPK cascade/FOS. In the hypothalamus, LEP acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones (By similarity). In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic and affects innate and adaptive immunity. Control of energy homeostasis and melanocortin production (stimulation of POMC and full repression of AgRP transcription) is mediated by STAT3 signaling, whereas distinct signals regulate NPY and the control of fertility, growth and glucose homeostasis. Involved in the regulation of counter-regulatory response to hypoglycemia by inhibiting neurons of the parabrachial nucleus. Has a specific effect on T lymphocyte responses, differentially regulating the proliferation of naive and memory T -ells. Leptin increases Th1 and suppresses Th2 cytokine production (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 749,
  "fields": {
    "recname": "BTD",
    "keywords": "Catalytic release of biotin from biocytin, the product of biotin-dependent carboxylases degradation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 750,
  "fields": {
    "recname": "PTPRQ",
    "keywords": "PTPRQ"
  }
},
{
  "model": "agmp_app.index",
  "pk": 751,
  "fields": {
    "recname": "AC107223.1",
    "keywords": "AC107223.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 752,
  "fields": {
    "recname": "TENM3-AS1",
    "keywords": "TENM3-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 753,
  "fields": {
    "recname": "VPS35",
    "keywords": "Acts as component of the retromer cargo-selective complex (CSC). The CSC is believed to be the core functional component of retromer or respective retromer complex variants acting to prevent missorting of selected transmembrane cargo proteins into the lysosomal degradation pathway. The recruitment of the CSC to the endosomal membrane involves RAB7A and SNX3. The CSC seems to associate with the cytoplasmic domain of cargo proteins predominantly via VPS35; however, these interactions seem to be of low affinity and retromer SNX proteins may also contribute to cargo selectivity thus questioning the classical function of the CSC. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX3-retromer mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway. The SNX27-retromer is believed to be involved in endosome-to-plasma membrane trafficking and recycling of a broad spectrum of cargo proteins. The CSC seems to act as recruitment hub for other proteins, such as the WASH complex and TBC1D5 (Probable). Required for retrograde transport of lysosomal enzyme receptor IGF2R and SLC11A2. Required to regulate transcytosis of the polymeric immunoglobulin receptor (pIgR-pIgA). Required for endosomal localization of WASHC2C. Mediates the association of the CSC with the WASH complex via WASHC2. Required for the endosomal localization of TBC1D5 ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 754,
  "fields": {
    "recname": "AP002989.1",
    "keywords": "AP002989.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 755,
  "fields": {
    "recname": "PKP2",
    "keywords": "May play a role in junctional plaques."
  }
},
{
  "model": "agmp_app.index",
  "pk": 756,
  "fields": {
    "recname": "TBXAS1",
    "keywords": "TBXAS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 757,
  "fields": {
    "recname": "NIPAL4",
    "keywords": "Acts as a Mg(2+) transporter. Can also transport other divalent cations such as Ba(2+), Mn(2+), Sr(2+) and Co(2+) but to a much less extent than Mg(2+) (By similarity). May be a receptor for ligands (trioxilins A3 and B3) from the hepoxilin pathway."
  }
},
{
  "model": "agmp_app.index",
  "pk": 758,
  "fields": {
    "recname": "ADAM19",
    "keywords": "Participates in the proteolytic processing of beta-type neuregulin isoforms which are involved in neurogenesis and synaptogenesis, suggesting a regulatory role in glial cell. Also cleaves alpha-2 macroglobulin. May be involved in osteoblast differentiation and/or osteoblast activity in bone (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 759,
  "fields": {
    "recname": "PAH",
    "keywords": "Catalyzes the hydroxylation of L-phenylalanine to L-tyrosine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 760,
  "fields": {
    "recname": "MT-ND6",
    "keywords": "Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 761,
  "fields": {
    "recname": "MT-ATP6",
    "keywords": "Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Key component of the proton channel; it may play a direct role in the translocation of protons across the membrane."
  }
},
{
  "model": "agmp_app.index",
  "pk": 762,
  "fields": {
    "recname": "GDF1",
    "keywords": "May mediate cell differentiation events during embryonic development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 763,
  "fields": {
    "recname": "CERS1",
    "keywords": "Ceramide synthase that catalyzes formation of ceramide from sphinganine and acyl-CoA substrates, with high selectivity toward stearoyl-CoA (octadecanoyl-CoA; C18:0-CoA)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 764,
  "fields": {
    "recname": "IRF5",
    "keywords": "Transcription factor involved in the induction of interferons IFNA and INFB and inflammatory cytokines upon virus infection. Activated by TLR7 or TLR8 signaling."
  }
},
{
  "model": "agmp_app.index",
  "pk": 765,
  "fields": {
    "recname": "KCTD7",
    "keywords": "May be involved in the control of excitability of cortical neurons."
  }
},
{
  "model": "agmp_app.index",
  "pk": 766,
  "fields": {
    "recname": "UNC80",
    "keywords": "Component of the NALCN sodium channel complex, required for channel regulation. This complex is a cation channel activated by neuropeptides substance P, neurotensin, and extracellular calcium that regulates neuronal excitability by controlling the sizes of NALCN-dependent sodium-leak current. UNC80 is essential for NALCN sensitivity to extracellular calcium."
  }
},
{
  "model": "agmp_app.index",
  "pk": 767,
  "fields": {
    "recname": "GFPT1",
    "keywords": "Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins. Regulates the circadian expression of clock genes ARNTL/BMAL1 and CRY1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 768,
  "fields": {
    "recname": "SLC26A4-AS1",
    "keywords": "SLC26A4-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 769,
  "fields": {
    "recname": "CA2",
    "keywords": "Essential for bone resorption and osteoclast differentiation (By similarity). Reversible hydration of carbon dioxide. Can hydrate cyanamide to urea. Involved in the regulation of fluid secretion into the anterior chamber of the eye. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption. Stimulates the chloride-bicarbonate exchange activity of SLC26A6."
  }
},
{
  "model": "agmp_app.index",
  "pk": 770,
  "fields": {
    "recname": "IL13",
    "keywords": "Cytokine. Inhibits inflammatory cytokine production. Synergizes with IL2 in regulating interferon-gamma synthesis. May be critical in regulating inflammatory and immune responses. Positively regulates IL31RA expression in macrophages (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 771,
  "fields": {
    "recname": "TH2LCRR",
    "keywords": "TH2LCRR"
  }
},
{
  "model": "agmp_app.index",
  "pk": 772,
  "fields": {
    "recname": "ABCA1",
    "keywords": "Catalyzes the translocation of specific phospholipids from the cytoplasmic to the extracellular/lumenal leaflet of membrane coupled to the hydrolysis of ATP. Thereby, participates to phospholipids transfer to apoliproteins to form nascent high density lipoproteins/HDLs. Transports preferentially phosphatidylcholine over phosphatidylserine. May play a similar role in the efflux of intracellular cholesterol to apoliproteins and the formation of nascent high density lipoproteins/HDLs ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 773,
  "fields": {
    "recname": "AL360015.1",
    "keywords": "AL360015.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 774,
  "fields": {
    "recname": "AC093495.1",
    "keywords": "AC093495.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 775,
  "fields": {
    "recname": "XPC",
    "keywords": "Involved in global genome nucleotide excision repair (GG-NER) by acting as damage sensing and DNA-binding factor component of the XPC complex. Has only a low DNA repair activity by itself which is stimulated by RAD23B and RAD23A. Has a preference to bind DNA containing a short single-stranded segment but not to damaged oligonucleotides. This feature is proposed to be related to a dynamic sensor function: XPC can rapidly screen duplex DNA for non-hydrogen-bonded bases by forming a transient nucleoprotein intermediate complex which matures into a stable recognition complex through an intrinsic single-stranded DNA-binding activity. The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, XPA, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex. The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs. The orientation of XPC complex binding appears to be crucial for inducing a productive NER. XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery. Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair. In vitro, the XPC:RAD23B dimer is sufficient to initiate NER; it preferentially binds to cisplatin and UV-damaged double-stranded DNA and also binds to a variety of chemically and structurally diverse DNA adducts. XPC:RAD23B contacts DNA both 5' and 3' of a cisplatin lesion with a preference for the 5' side. XPC:RAD23B induces a bend in DNA upon binding. XPC:RAD23B stimulates the activity of DNA glycosylases TDG and SMUG1 ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 776,
  "fields": {
    "recname": "IFNAR2",
    "keywords": "Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 3 is a potent inhibitor of type I IFN receptor activity ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 777,
  "fields": {
    "recname": "KCNQ1",
    "keywords": "Potassium channel that plays an important role in a number of tissues, including heart, inner ear, stomach and colon (By similarity). Associates with KCNE beta subunits that modulates current kinetics (By similarity). Induces a voltage-dependent by rapidly activating and slowly deactivating potassium-selective outward current (By similarity). Promotes also a delayed voltage activated potassium current showing outward rectification characteristic (By similarity). During beta-adrenergic receptor stimulation participates in cardiac repolarization by associating with KCNE1 to form the I(Ks) cardiac potassium current that increases the amplitude and slows down the activation kinetics of outward potassium current I(Ks) (By similarity). Muscarinic agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current. When associated with KCNE3, forms the potassium channel that is important for cyclic AMP-stimulated intestinal secretion of chloride ions. This interaction with KCNE3 is reduced by 17beta-estradiol, resulting in the reduction of currents (By similarity). During conditions of increased substrate load, maintains the driving force for proximal tubular and intestinal sodium ions absorption, gastric acid secretion, and cAMP-induced jejunal chloride ions secretion (By similarity). Allows the provision of potassium ions to the luminal membrane of the secretory canaliculus in the resting state as well as during stimulated acid secretion (By similarity). When associated with KCNE2, forms a heterooligomer complex leading to currents with an apparently instantaneous activation, a rapid deactivation process and a linear current-voltage relationship and decreases the amplitude of the outward current. When associated with KCNE4, inhibits voltage-gated potassium channel activity. When associated with KCNE5, this complex only conducts current upon strong and continued depolarization. Also forms a heterotetramer with KCNQ5; has a voltage-gated potassium channel activity. Binds with phosphatidylinositol 4,5-bisphosphate ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 778,
  "fields": {
    "recname": "APOL1",
    "keywords": "May play a role in lipid exchange and transport throughout the body. May participate in reverse cholesterol transport from peripheral cells to the liver."
  }
},
{
  "model": "agmp_app.index",
  "pk": 779,
  "fields": {
    "recname": "ADIPOQ-AS1",
    "keywords": "ADIPOQ-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 780,
  "fields": {
    "recname": "HNF1A",
    "keywords": "Transcriptional activator that regulates the tissue specific expression of multiple genes, especially in pancreatic islet cells and in liver (By similarity). Binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Activates the transcription of CYP1A2, CYP2E1 and CYP3A11 (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 781,
  "fields": {
    "recname": "CTLA4",
    "keywords": "Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28."
  }
},
{
  "model": "agmp_app.index",
  "pk": 782,
  "fields": {
    "recname": "IL17F",
    "keywords": "Ligand for IL17RA and IL17RC. The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC. Involved in stimulating the production of other cytokines such as IL6, IL8 and CSF2, and in regulation of cartilage matrix turnover. Also involved in stimulating the proliferation of peripheral blood mononuclear cells and T-cells and in inhibition of angiogenesis. Plays a role in the induction of neutrophilia in the lungs and in the exacerbation of antigen-induced pulmonary allergic inflammation (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 783,
  "fields": {
    "recname": "METTL25",
    "keywords": "Putative methyltransferase."
  }
},
{
  "model": "agmp_app.index",
  "pk": 784,
  "fields": {
    "recname": "AL137856.1",
    "keywords": "AL137856.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 785,
  "fields": {
    "recname": "PTPN22",
    "keywords": "Acts as negative regulator of T-cell receptor (TCR) signaling by direct dephosphorylation of the Src family kinases LCK and FYN, ITAMs of the TCRz/CD3 complex, as well as ZAP70, VAV, VCP and other key signaling molecules. Associates with and probably dephosphorylates CBL. Dephosphorylates LCK at its activating 'Tyr-394' residue. Dephosphorylates ZAP70 at its activating 'Tyr-493' residue. Dephosphorylates the immune system activator SKAP2. Positively regulates toll-like receptor (TLR)-induced type 1 interferon production. Promotes host antiviral responses mediated by type 1 interferon (By similarity). Regulates NOD2-induced pro-inflammatory cytokine secretion and autophagy ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 786,
  "fields": {
    "recname": "SLC14A2-AS1",
    "keywords": "SLC14A2-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 787,
  "fields": {
    "recname": "SLC14A2",
    "keywords": "Specialized low-affinity vasopressin-regulated urea transporter. Mediates rapid transepithelial urea transport across the inner medullary collecting duct and plays a major role in the urinary concentrating mechanism."
  }
},
{
  "model": "agmp_app.index",
  "pk": 788,
  "fields": {
    "recname": "AGL",
    "keywords": "Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 789,
  "fields": {
    "recname": "DSG1-AS1",
    "keywords": "DSG1-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 790,
  "fields": {
    "recname": "DSG4",
    "keywords": "Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion. Coordinates the transition from proliferation to differentiation in hair follicle keratinocytes (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 791,
  "fields": {
    "recname": "PTPN11",
    "keywords": "Acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus. Positively regulates MAPK signal transduction pathway. Dephosphorylates GAB1, ARHGAP35 and EGFR. Dephosphorylates ROCK2 at 'Tyr-722' resulting in stimulatation of its RhoA binding activity. Dephosphorylates CDC73 ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 792,
  "fields": {
    "recname": "NECTIN4",
    "keywords": "Seems to be involved in cell adhesion through trans-homophilic and -heterophilic interactions, the latter including specifically interactions with NECTIN1. Does not act as receptor for alpha-herpesvirus entry into cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 793,
  "fields": {
    "recname": "SEPSECS",
    "keywords": "Converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) required for selenoprotein biosynthesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 794,
  "fields": {
    "recname": "TRAPPC9",
    "keywords": "Functions as an activator of NF-kappa-B through increased phosphorylation of the IKK complex. May function in neuronal cells differentiation. May play a role in vesicular transport from endoplasmic reticulum to Golgi."
  }
},
{
  "model": "agmp_app.index",
  "pk": 795,
  "fields": {
    "recname": "TRPM4",
    "keywords": "Calcium-activated non selective (CAN) cation channel that mediates membrane depolarization. While it is activated by increase in intracellular Ca(2+), it is impermeable to it. Mediates transport of monovalent cations (Na(+) > K(+) > Cs(+) > Li(+)), leading to depolarize the membrane. It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, endocrine pancreas cells, kidney epithelial cells, cochlea hair cells etc. Participates in T-cell activation by modulating Ca(2+) oscillations after T lymphocyte activation, which is required for NFAT-dependent IL2 production. Involved in myogenic constriction of cerebral arteries. Controls insulin secretion in pancreatic beta-cells. May also be involved in pacemaking or could cause irregular electrical activity under conditions of Ca(2+) overload. Affects T-helper 1 (Th1) and T-helper 2 (Th2) cell motility and cytokine production through differential regulation of calcium signaling and NFATC1 localization. Enhances cell proliferation through up-regulation of the beta-catenin signaling pathway."
  }
},
{
  "model": "agmp_app.index",
  "pk": 796,
  "fields": {
    "recname": "PEX6",
    "keywords": "Involved in peroxisome biosynthesis. Required for stability of the PTS1 receptor. Anchored by PEX26 to peroxisome membranes, possibly to form heteromeric AAA ATPase complexes required for the import of proteins into peroxisomes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 797,
  "fields": {
    "recname": "PGM3",
    "keywords": "Catalyzes the conversion of GlcNAc-6-P into GlcNAc-1-P during the synthesis of uridine diphosphate/UDP-GlcNAc, a sugar nucleotide critical to multiple glycosylation pathways including protein N- and O-glycosylation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 798,
  "fields": {
    "recname": "DOP1A",
    "keywords": "May be involved in protein traffic between late Golgi and early endosomes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 799,
  "fields": {
    "recname": "MYH7",
    "keywords": "Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle."
  }
},
{
  "model": "agmp_app.index",
  "pk": 800,
  "fields": {
    "recname": "ACKR1",
    "keywords": "Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Has a promiscuous chemokine-binding profile, interacting with inflammatory chemokines of both the CXC and the CC subfamilies but not with homeostatic chemokines. Acts as a receptor for chemokines including CCL2, CCL5, CCL7, CCL11, CCL13, CCL14, CCL17, CXCL5, CXCL6, IL8/CXCL8, CXCL11, GRO, RANTES, MCP-1, TARC and also for the malaria parasites P.vivax and P.knowlesi. May regulate chemokine bioavailability and, consequently, leukocyte recruitment through two distinct mechanisms: when expressed in endothelial cells, it sustains the abluminal to luminal transcytosis of tissue-derived chemokines and their subsequent presentation to circulating leukocytes; when expressed in erythrocytes, serves as blood reservoir of cognate chemokines but also as a chemokine sink, buffering potential surges in plasma chemokine levels."
  }
},
{
  "model": "agmp_app.index",
  "pk": 801,
  "fields": {
    "recname": "CADM3-AS1",
    "keywords": "CADM3-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 802,
  "fields": {
    "recname": "FGF3",
    "keywords": "Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal ear development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 803,
  "fields": {
    "recname": "HBB",
    "keywords": "Involved in oxygen transport from the lung to the various peripheral tissues."
  }
},
{
  "model": "agmp_app.index",
  "pk": 804,
  "fields": {
    "recname": "HBA2",
    "keywords": "Involved in oxygen transport from the lung to the various peripheral tissues."
  }
},
{
  "model": "agmp_app.index",
  "pk": 805,
  "fields": {
    "recname": "BEST1",
    "keywords": "Forms calcium-sensitive chloride channels. Highly permeable to bicarbonate."
  }
},
{
  "model": "agmp_app.index",
  "pk": 806,
  "fields": {
    "recname": "ABCC6",
    "keywords": "May participate directly in the active transport of drugs into subcellular organelles or influence drug distribution indirectly. Transports glutathione conjugates as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 807,
  "fields": {
    "recname": "BRCA1",
    "keywords": "E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 808,
  "fields": {
    "recname": "CRYGD",
    "keywords": "Crystallins are the dominant structural components of the vertebrate eye lens."
  }
},
{
  "model": "agmp_app.index",
  "pk": 809,
  "fields": {
    "recname": "CYP11B1",
    "keywords": "A cytochrome P450 monooxygenase involved in the biosynthesis of adrenal corticoids. Catalyzes the hydroxylation of carbon hydrogen bond at 11-beta position of 11-deoxycortisol and 11-deoxycorticosterone/21-hydroxyprogesterone yielding cortisol or corticosterone, respectively. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate and reducing the second into a water molecule. Two electrons are provided by NADPH via a two-protein mitochondrial transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin) ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 810,
  "fields": {
    "recname": "GML",
    "keywords": "May play a role in the apoptotic pathway or cell-cycle regulation induced by p53/TP53 after DNA damage."
  }
},
{
  "model": "agmp_app.index",
  "pk": 811,
  "fields": {
    "recname": "MECP2",
    "keywords": "Chromosomal protein that binds to methylated DNA. It can bind specifically to a single methyl-CpG pair. It is not influenced by sequences flanking the methyl-CpGs. Mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A. Binds both 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)-containing DNA, with a preference for 5-methylcytosine (5mC)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 812,
  "fields": {
    "recname": "ABCA12",
    "keywords": "Probable transporter involved in lipid homeostasis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 813,
  "fields": {
    "recname": "KLHL3",
    "keywords": "Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that acts as a regulator of ion transport in the distal nephron. The BCR(KLHL3) complex acts by mediating ubiquitination of WNK4, an inhibitor of potassium channel KCNJ1, leading to WNK4 degradation. The BCR(KLHL3) complex also mediates ubiquitination and degradation of CLDN8, a tight-junction protein required for paracellular chloride transport in the kidney (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 814,
  "fields": {
    "recname": "MYT1",
    "keywords": "Binds to the promoter region of genes encoding proteolipid proteins of the central nervous system. May play a role in the development of neurons and oligodendroglia in the CNS. May regulate a critical transition point in oligodendrocyte lineage development by modulating oligodendrocyte progenitor proliferation relative to terminal differentiation and up-regulation of myelin gene transcription."
  }
},
{
  "model": "agmp_app.index",
  "pk": 815,
  "fields": {
    "recname": "MYT1",
    "keywords": "Binds to the promoter region of genes encoding proteolipid proteins of the central nervous system. May play a role in the development of neurons and oligodendroglia in the CNS. May regulate a critical transition point in oligodendrocyte lineage development by modulating oligodendrocyte progenitor proliferation relative to terminal differentiation and up-regulation of myelin gene transcription."
  }
},
{
  "model": "agmp_app.index",
  "pk": 816,
  "fields": {
    "recname": "CCR5AS",
    "keywords": "CCR5AS"
  }
},
{
  "model": "agmp_app.index",
  "pk": 817,
  "fields": {
    "recname": "CCR5",
    "keywords": "Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 818,
  "fields": {
    "recname": "LRRK2",
    "keywords": "Serine/threonine-protein kinase which phosphorylates a broad range of proteins involved in multiple processes such as neuronal plasticity, autophagy, and vesicle trafficking. Is a key regulator of RAB GTPases by regulating the GTP/GDP exchange and interaction partners of RABs through phosphorylation. Phosphorylates RAB3A, RAB3B, RAB3C, RAB3D, RAB5A, RAB5B, RAB5C, RAB8A, RAB8B, RAB10, RAB12, RAB35, and RAB43. Regulates the RAB3IP-catalyzed GDP/GTP exchange for RAB8A through the phosphorylation of 'Thr-72' on RAB8A. Inhibits the interaction between RAB8A and GDI1 and/or GDI2 by phosphorylating 'Thr-72' on RAB8A. Regulates primary ciliogenesis through phosphorylation of RAB8A and RAB10, which promotes SHH signaling in the brain. Together with RAB29, plays a role in the retrograde trafficking pathway for recycling proteins, such as mannose-6-phosphate receptor (M6PR), between lysosomes and the Golgi apparatus in a retromer-dependent manner. Regulates neuronal process morphology in the intact central nervous system (CNS). Plays a role in synaptic vesicle trafficking. Plays an important role in recruiting SEC16A to endoplasmic reticulum exit sites (ERES) and in regulating ER to Golgi vesicle-mediated transport and ERES organization. Positively regulates autophagy through a calcium-dependent activation of the CaMKK/AMPK signaling pathway. The process involves activation of nicotinic acid adenine dinucleotide phosphate (NAADP) receptors, increase in lysosomal pH, and calcium release from lysosomes. Phosphorylates PRDX3. By phosphorylating APP on 'Thr-743', which promotes the production and the nuclear translocation of the APP intracellular domain (AICD), regulates dopaminergic neuron apoptosis. Independent of its kinase activity, inhibits the proteosomal degradation of MAPT, thus promoting MAPT oligomerization and secretion. In addition, has GTPase activity via its Roc domain which regulates LRRK2 kinase activity ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 819,
  "fields": {
    "recname": "MUTYH",
    "keywords": "Involved in oxidative DNA damage repair. Initiates repair of A*oxoG to C*G by removing the inappropriately paired adenine base from the DNA backbone. Possesses both adenine and 2-OH-A DNA glycosylase activities."
  }
},
{
  "model": "agmp_app.index",
  "pk": 820,
  "fields": {
    "recname": "HBG2",
    "keywords": "Gamma chains make up the fetal hemoglobin F, in combination with alpha chains."
  }
},
{
  "model": "agmp_app.index",
  "pk": 821,
  "fields": {
    "recname": "GBA",
    "keywords": "Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose. Thereby, plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides, participates to the PKC-activated salvage pathway of ceramide formation. Also plays a role in cholesterol metabolism. May either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol. The short chain saturated C8:0-GlcCer and the mono-unsaturated C18:0-GlcCer being the most effective glucose donors for that transglucosylation reaction. Under specific conditions, may alternatively catalyze the reverse reaction, transferring glucose from cholesteryl-beta-D-glucoside to ceramide. Finally, may also hydrolyze cholesteryl-beta-D-glucoside to produce D-glucose and cholesterol ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 822,
  "fields": {
    "recname": "MYBPC3",
    "keywords": "Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role."
  }
},
{
  "model": "agmp_app.index",
  "pk": 823,
  "fields": {
    "recname": "ASAH1",
    "keywords": "Lysosomal ceramidase that hydrolyzes sphingolipid ceramides into sphingosine and free fatty acids at acidic pH. Ceramides, sphingosine, and its phosphorylated form sphingosine-1-phosphate are bioactive lipids that mediate cellular signaling pathways regulating several biological processes including cell proliferation, apoptosis and differentiation. Has a higher catalytic efficiency towards C12-ceramides versus other ceramides. Also catalyzes the reverse reaction allowing the synthesis of ceramides from fatty acids and sphingosine. For the reverse synthetic reaction, the natural sphingosine D-erythro isomer is more efficiently utilized as a substrate compared to D-erythro-dihydrosphingosine and D-erythro-phytosphingosine, while the fatty acids with chain lengths of 12 or 14 carbons are the most efficiently used. Has also an N-acylethanolamine hydrolase activity. By regulating the levels of ceramides, sphingosine and sphingosine-1-phosphate in the epidermis, mediates the calcium-induced differentiation of epidermal keratinocytes. Also indirectly regulates tumor necrosis factor/TNF-induced apoptosis (By similarity). By regulating the intracellular balance between ceramides and sphingosine, in adrenocortical cells, probably also acts as a regulator of steroidogenesis ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 824,
  "fields": {
    "recname": "MT-TW",
    "keywords": "MT-TW"
  }
},
{
  "model": "agmp_app.index",
  "pk": 825,
  "fields": {
    "recname": "MERTK",
    "keywords": "Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with GRB2 or PLCG2 and induces phosphorylation of MAPK1, MAPK2, FAK/PTK2 or RAC1. MERTK signaling plays a role in various processes such as macrophage clearance of apoptotic cells, platelet aggregation, cytoskeleton reorganization and engulfment. Functions in the retinal pigment epithelium (RPE) as a regulator of rod outer segments fragments phagocytosis. Plays also an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3."
  }
},
{
  "model": "agmp_app.index",
  "pk": 826,
  "fields": {
    "recname": "HBE1",
    "keywords": "The epsilon chain is a beta-type chain of early mammalian embryonic hemoglobin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 827,
  "fields": {
    "recname": "OR51B5",
    "keywords": "Odorant receptor."
  }
},
{
  "model": "agmp_app.index",
  "pk": 828,
  "fields": {
    "recname": "PIGG",
    "keywords": "Ethanolamine phosphate transferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers ethanolamine phosphate to the GPI second mannose."
  }
},
{
  "model": "agmp_app.index",
  "pk": 829,
  "fields": {
    "recname": "ADGRE1",
    "keywords": "Orphan receptor involved in cell adhesion and probably in cell-cell interactions specifically involving cells of the immune system. May play a role in regulatory T-cells (Treg) development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 830,
  "fields": {
    "recname": "USH2A",
    "keywords": "Involved in hearing and vision as member of the USH2 complex. In the inner ear, required for the maintenance of the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport."
  }
},
{
  "model": "agmp_app.index",
  "pk": 831,
  "fields": {
    "recname": "HMSD",
    "keywords": "Putative serine protease inhibitor."
  }
},
{
  "model": "agmp_app.index",
  "pk": 832,
  "fields": {
    "recname": "HMSD",
    "keywords": "This allelic splice variant of HMSD is the precursor of the histocompatibility antigen ACC-6. More generally, minor histocompatibility antigens (mHags) refer to immunogenic peptide which, when complexed with MHC, can generate an immune response after recognition by specific T-cells. The peptides are derived from polymorphic intracellular proteins, which are cleaved by normal pathways of antigen processing. The binding of these peptides to MHC class I or class II molecules and its expression on the cell surface can stimulate T-cell responses and thereby trigger graft rejection or graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation from HLA-identical sibling donor. GVHD is a frequent complication after bone marrow transplantation (BMT), due to mismatch of minor histocompatibility antigen in HLA-matched sibling marrow transplants. However, associated with GVHD, a favorable graft-versus-leukemia (GVL) can be induced by donor-recipient disparities in mHags. ACC-6 is presented to the cell surface by MHC HLA-B*4403. This complex specifically elicits donor-cytotoxic T-lymphocyte (CTL) reactivity against hematologic malignancies after treatment by HLA-identical allogenic BMT. It induces cell recognition and lysis by CTL. Immunogenicity of most autosomal mHags results from single-nucleotide polymorphisms that cause amino-acid substitutions within epitopes, leading to the differential recognition of peptides between donor and recipient."
  }
},
{
  "model": "agmp_app.index",
  "pk": 833,
  "fields": {
    "recname": "CAPN3",
    "keywords": "Calcium-regulated non-lysosomal thiol-protease."
  }
},
{
  "model": "agmp_app.index",
  "pk": 834,
  "fields": {
    "recname": "CTNS",
    "keywords": "Cystine/H(+) symporter thought to transport cystine out of lysosomes. Plays an important role in melanin synthesis, possibly by preventing melanosome acidification and subsequent degradation of tyrosinase TYR."
  }
},
{
  "model": "agmp_app.index",
  "pk": 835,
  "fields": {
    "recname": "C19orf12",
    "keywords": "C19orf12"
  }
},
{
  "model": "agmp_app.index",
  "pk": 836,
  "fields": {
    "recname": "AC119427.2",
    "keywords": "AC119427.2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 837,
  "fields": {
    "recname": "MYO7A",
    "keywords": "Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. In the retina, plays an important role in the renewal of the outer photoreceptor disks. Plays an important role in the distribution and migration of retinal pigment epithelial (RPE) melanosomes and phagosomes, and in the regulation of opsin transport in retinal photoreceptors. In the inner ear, plays an important role in differentiation, morphogenesis and organization of cochlear hair cell bundles. Involved in hair-cell vesicle trafficking of aminoglycosides, which are known to induce ototoxicity (By similarity). Motor protein that is a part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for normal hearing."
  }
},
{
  "model": "agmp_app.index",
  "pk": 838,
  "fields": {
    "recname": "FIG4",
    "keywords": "The PI(3,5)P2 regulatory complex regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). In vitro, hydrolyzes all three D5-phosphorylated polyphosphoinositide substrates in the order PtdIns(4,5)P2 > PtdIns(3,5)P2 > PtdIns(3,4,5)P3. Plays a role in the biogenesis of endosome carrier vesicles (ECV) / multivesicular bodies (MVB) transport intermediates from early endosomes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 839,
  "fields": {
    "recname": "CAPN10",
    "keywords": "Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. May play a role in insulin-stimulated glucose uptake."
  }
},
{
  "model": "agmp_app.index",
  "pk": 840,
  "fields": {
    "recname": "LPA",
    "keywords": "Apo(a) is the main constituent of lipoprotein(a) (Lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1. Lp(a) may be a ligand for megalin/Gp 330."
  }
},
{
  "model": "agmp_app.index",
  "pk": 841,
  "fields": {
    "recname": "GATA3",
    "keywords": "Transcriptional activator which binds to the enhancer of the T-cell receptor alpha and delta genes. Binds to the consensus sequence 5'-AGATAG-3'. Required for the T-helper 2 (Th2) differentiation process following immune and inflammatory responses."
  }
},
{
  "model": "agmp_app.index",
  "pk": 842,
  "fields": {
    "recname": "ALS2",
    "keywords": "May act as a GTPase regulator. Controls survival and growth of spinal motoneurons (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 843,
  "fields": {
    "recname": "AGA",
    "keywords": "Cleaves the GlcNAc-Asn bond which joins oligosaccharides to the peptide of asparagine-linked glycoproteins."
  }
},
{
  "model": "agmp_app.index",
  "pk": 844,
  "fields": {
    "recname": "AMN",
    "keywords": "Membrane-bound component of the endocytic receptor formed by AMN and CUBN. Required for normal CUBN glycosylation and trafficking to the cell surface. The complex formed by AMN and CUBN is required for efficient absorption of vitamin B12. Required for normal CUBN-mediated protein transport in the kidney (Probable)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 845,
  "fields": {
    "recname": "TPRN",
    "keywords": "TPRN"
  }
},
{
  "model": "agmp_app.index",
  "pk": 846,
  "fields": {
    "recname": "IL36RN",
    "keywords": "Inhibits the activity of interleukin-36 (IL36A,IL36B and IL36G) by binding to receptor IL1RL2 and preventing its association with the coreceptor IL1RAP for signaling. Part of the IL-36 signaling system that is thought to be present in epithelial barriers and to take part in local inflammatory response; similar to the IL-1 system with which it shares the coreceptor. Proposed to play a role in skin inflammation. May be involved in the innate immune response to fungal pathogens, such as Aspergillus fumigatus. May activate an anti-inflammatory signaling pathway by recruiting SIGIRR."
  }
},
{
  "model": "agmp_app.index",
  "pk": 847,
  "fields": {
    "recname": "COG6",
    "keywords": "Required for normal Golgi function."
  }
},
{
  "model": "agmp_app.index",
  "pk": 848,
  "fields": {
    "recname": "IER3IP1",
    "keywords": "May be implicated in the regulation of apoptosis. May be involved in protein transport between endoplasmic reticulum and Golgi apparatus (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 849,
  "fields": {
    "recname": "IFT43",
    "keywords": "As a component of IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs), it is involved in ciliogenesis. Involved in retrograde ciliary transport along microtubules from the ciliary tip to the base ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 850,
  "fields": {
    "recname": "VAX1",
    "keywords": "Transcription factor that may function in dorsoventral specification of the forebrain. Required for axon guidance and major tract formation in the developing forebrain. May contribute to the differentiation of the neuroretina, pigmented epithelium and optic stalk (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 851,
  "fields": {
    "recname": "KIF1A",
    "keywords": "Motor for anterograde axonal transport of synaptic vesicle precursors. Also required for neuronal dense core vesicles (DCVs) transport to the dendritic spines. The interaction calcium-dependent with CALM1 increases vesicle motility and interaction with the scaffolding proteins PPFIA2 and TANC2 recruits DCVs to synaptic sites."
  }
},
{
  "model": "agmp_app.index",
  "pk": 852,
  "fields": {
    "recname": "CRTAP",
    "keywords": "Necessary for efficient 3-hydroxylation of fibrillar collagen prolyl residues."
  }
},
{
  "model": "agmp_app.index",
  "pk": 853,
  "fields": {
    "recname": "NR0B1",
    "keywords": "Orphan nuclear receptor. Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis. Acts as a coregulatory protein that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions. May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 854,
  "fields": {
    "recname": "DNAJC13",
    "keywords": "Involved in membrane trafficking through early endosomes, such as the early endosome to recycling endosome transport implicated in the recycling of transferrin and the early endosome to late endosome transport implicated in degradation of EGF and EGFR. Involved in the regulation of endosomal membrane tubulation and regulates th dynamics of SNX1 on the endosomal membrane; via association with WASHC2 may link the WASH complex to the retromer SNX-BAR subcomplex ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 855,
  "fields": {
    "recname": "CCL2",
    "keywords": "Acts as a ligand for C-C chemokine receptor CCR2. Signals through binding and activation of CCR2 and induces a strong chemotactic response and mobilization of intracellular calcium ions. Exhibits a chemotactic activity for monocytes and basophils but not neutrophils or eosinophils. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 856,
  "fields": {
    "recname": "ANTXR1",
    "keywords": "Plays a role in cell attachment and migration. Interacts with extracellular matrix proteins and with the actin cytoskeleton. Mediates adhesion of cells to type 1 collagen and gelatin, reorganization of the actin cytoskeleton and promotes cell spreading. Plays a role in the angiogenic response of cultured umbilical vein endothelial cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 857,
  "fields": {
    "recname": "CNTN2",
    "keywords": "In conjunction with another transmembrane protein, CNTNAP2, contributes to the organization of axonal domains at nodes of Ranvier by maintaining voltage-gated potassium channels at the juxtaparanodal region. May be involved in cell adhesion."
  }
},
{
  "model": "agmp_app.index",
  "pk": 858,
  "fields": {
    "recname": "NTRK1",
    "keywords": "Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand. Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival (By similarity). Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors."
  }
},
{
  "model": "agmp_app.index",
  "pk": 859,
  "fields": {
    "recname": "BMP1",
    "keywords": "Cleaves the C-terminal propeptides of procollagen I, II and III. Induces cartilage and bone formation. May participate in dorsoventral patterning during early development by cleaving chordin (CHRD). Responsible for the proteolytic activation of lysyl oxidase LOX."
  }
},
{
  "model": "agmp_app.index",
  "pk": 860,
  "fields": {
    "recname": "TGM1",
    "keywords": "Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. Responsible for cross-linking epidermal proteins during formation of the stratum corneum. Involved in cell proliferation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 861,
  "fields": {
    "recname": "CDK5RAP2",
    "keywords": "Potential regulator of CDK5 activity via its interaction with CDK5R1. Negative regulator of centriole disengagement (licensing) which maintains centriole engagement and cohesion. Involved in regulation of mitotic spindle orientation (By similarity). Plays a role in the spindle checkpoint activation by acting as a transcriptional regulator of both BUBR1 and MAD2 promoter. Together with EB1/MAPRE1, may promote microtubule polymerization, bundle formation, growth and dynamics at the plus ends. Regulates centrosomal maturation by recruitment of the gamma-tubulin ring complex (gamma-TuRC) onto centrosomes. In complex with PDE4DIP isoform 13/MMG8/SMYLE, MAPRE1 and AKAP9, contributes to microtubules nucleation and extension from the centrosome to the cell periphery. Required for the recruitment of AKAP9 to centrosomes. Plays a role in neurogenesis (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 862,
  "fields": {
    "recname": "GBA2",
    "keywords": "Non-lysosomal glucosylceramidase that catalyzes the hydrolysis of glucosylceramide (GlcCer) to free glucose and ceramide. Glucosylceramides are membrane glycosphingolipids that have a wide intracellular distribution (By similarity). They are the main precursors of more complex glycosphingolipids that play a role in cellular growth, differentiation, adhesion, signaling, cytoskeletal dynamics and membrane properties (By similarity). Also involved in the transglucosylation of cholesterol, transferring glucose from glucosylceramides, thereby modifying its water solubility and biological properties (By similarity). Under specific conditions, may catalyze the reverse reaction, transferring glucose from cholesteryl-beta-D-glucoside to ceramide (By similarity). Finally, may also play a role in the metabolism of bile acids. It is able to hydrolyze bile acid 3-O-glucosides but also to produce bile acid-glucose conjugates thanks to a bile acid glucosyl transferase activity. However, the relevance of both activities is unclear in vivo (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 863,
  "fields": {
    "recname": "RAB28",
    "keywords": "RAB28"
  }
},
{
  "model": "agmp_app.index",
  "pk": 864,
  "fields": {
    "recname": "CBS",
    "keywords": "Hydro-lyase catalyzing the first step of the transsulfuration pathway, where the hydroxyl group of L-serine is displaced by L-homocysteine in a beta-replacement reaction to form L-cystathionine, the precursor of L-cysteine. This catabolic route allows the elimination of L-methionine and the toxic metabolite L-homocysteine. Also involved in the production of hydrogen sulfide, a gasotransmitter with signaling and cytoprotective effects on neurons (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 865,
  "fields": {
    "recname": "MAPKAPK3",
    "keywords": "Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression."
  }
},
{
  "model": "agmp_app.index",
  "pk": 866,
  "fields": {
    "recname": "PINK1-AS",
    "keywords": "PINK1-AS"
  }
},
{
  "model": "agmp_app.index",
  "pk": 867,
  "fields": {
    "recname": "PINK1",
    "keywords": "Protects against mitochondrial dysfunction during cellular stress by phosphorylating mitochondrial proteins. Involved in the clearance of damaged mitochondria via selective autophagy (mitophagy) by mediating activation and translocation of PRKN. Targets PRKN to dysfunctional depolarized mitochondria through the phosphorylation of MFN2. Activates PRKN in 2 steps: (1) by mediating phosphorylation at 'Ser-65' of PRKN and (2) mediating phosphorylation of ubiquitin, converting PRKN to its fully-active form. Required for ubiquinone reduction by mitochondrial complex I by mediating phosphorylation of complex I subunit NDUFA10 (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 868,
  "fields": {
    "recname": "TLR1",
    "keywords": "Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides. Cooperates with TLR2 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Forms the activation cluster TLR2:TLR1:CD14 in response to triacylated lipopeptides, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response."
  }
},
{
  "model": "agmp_app.index",
  "pk": 869,
  "fields": {
    "recname": "AC068993.2",
    "keywords": "AC068993.2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 870,
  "fields": {
    "recname": "POMGNT2",
    "keywords": "O-linked mannose beta-1,4-N-acetylglucosaminyltransferase that transfers UDP-N-acetyl-D-glucosamine to the 4-position of the mannose to generate N-acetyl-D-glucosamine-beta-1,4-O-D-mannosylprotein. Involved in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 871,
  "fields": {
    "recname": "SMAD7",
    "keywords": "Antagonist of signaling by TGF-beta (transforming growth factor) type 1 receptor superfamily members; has been shown to inhibit TGF-beta (Transforming growth factor) and activin signaling by associating with their receptors thus preventing SMAD2 access. Functions as an adapter to recruit SMURF2 to the TGF-beta receptor complex. Also acts by recruiting the PPP1R15A-PP1 complex to TGFBR1, which promotes its dephosphorylation. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator."
  }
},
{
  "model": "agmp_app.index",
  "pk": 872,
  "fields": {
    "recname": "TLR4",
    "keywords": "Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni(2+). Responses triggered by Ni(2+) require non-conserved histidines and are, therefore, species-specific. Both M.tuberculosis HSP70 (dnaK) and HSP65 (groEL-2) act via this protein to stimulate NF-kappa-B expression. In complex with TLR6, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion. Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-). Stimulation of monocytes in vitro with M.tuberculosis PstS1 induces p38 MAPK and ERK1/2 activation primarily via TLR2, but also partially via this receptor ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 873,
  "fields": {
    "recname": "FCGR3B",
    "keywords": "Receptor for the Fc region of immunoglobulins gamma. Low affinity receptor. Binds complexed or aggregated IgG and also monomeric IgG. Contrary to III-A, is not capable to mediate antibody-dependent cytotoxicity and phagocytosis. May serve as a trap for immune complexes in the peripheral circulation which does not activate neutrophils."
  }
},
{
  "model": "agmp_app.index",
  "pk": 874,
  "fields": {
    "recname": "ABO",
    "keywords": "ABO"
  }
},
{
  "model": "agmp_app.index",
  "pk": 875,
  "fields": {
    "recname": "KCNJ11",
    "keywords": "This receptor is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium (By similarity). Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with ABCC9. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 876,
  "fields": {
    "recname": "H6PD",
    "keywords": "Oxidizes glucose-6-phosphate and glucose, as well as other hexose-6-phosphates."
  }
},
{
  "model": "agmp_app.index",
  "pk": 877,
  "fields": {
    "recname": "RTN3",
    "keywords": "May be involved in membrane trafficking in the early secretory pathway. Inhibits BACE1 activity and amyloid precursor protein processing. May induce caspase-8 cascade and apoptosis. May favor BCL2 translocation to the mitochondria upon endoplasmic reticulum stress. In case of enteroviruses infection, RTN3 may be involved in the viral replication or pathogenesis. Induces the formation of endoplasmic reticulum tubules ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 878,
  "fields": {
    "recname": "ICAM1",
    "keywords": "ICAM proteins are ligands for the leukocyte adhesion protein LFA-1 (integrin alpha-L/beta-2). During leukocyte trans-endothelial migration, ICAM1 engagement promotes the assembly of endothelial apical cups through ARHGEF26/SGEF and RHOG activation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 879,
  "fields": {
    "recname": "AC011511.2",
    "keywords": "AC011511.2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 880,
  "fields": {
    "recname": "BBS10",
    "keywords": "Probable molecular chaperone that assists the folding of proteins upon ATP hydrolysis. Plays a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Involved in adipogenic differentiation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 881,
  "fields": {
    "recname": "LRRK1",
    "keywords": "LRRK1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 882,
  "fields": {
    "recname": "ATM",
    "keywords": "Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FANCD2, NFKBIA, BRCA1, CTIP, nibrin (NBN), TERF1, RAD9, UBQLN4 and DCLRE1C. May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Plays a role in replication-dependent histone mRNA degradation. Binds DNA ends. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation. Phosphorylates ATF2 which stimulates its function in DNA damage response. Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 883,
  "fields": {
    "recname": "MASP2",
    "keywords": "Serum protease that plays an important role in the activation of the complement system via mannose-binding lectin. After activation by auto-catalytic cleavage it cleaves C2 and C4, leading to their activation and to the formation of C3 convertase."
  }
},
{
  "model": "agmp_app.index",
  "pk": 884,
  "fields": {
    "recname": "LMNA",
    "keywords": "Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation. Required for osteoblastogenesis and bone formation. Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone. Required for cardiac homeostasis ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 885,
  "fields": {
    "recname": "MT-CO3",
    "keywords": "Subunits I, II and III form the functional core of the enzyme complex."
  }
},
{
  "model": "agmp_app.index",
  "pk": 886,
  "fields": {
    "recname": "SLC2A10",
    "keywords": "Facilitative glucose transporter required for the development of the cardiovascular system."
  }
},
{
  "model": "agmp_app.index",
  "pk": 887,
  "fields": {
    "recname": "FANCG",
    "keywords": "DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Candidate tumor suppressor gene."
  }
},
{
  "model": "agmp_app.index",
  "pk": 888,
  "fields": {
    "recname": "NBN",
    "keywords": "Component of the MRE11-RAD50-NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11. RAD50 may be required to bind DNA ends and hold them in close proximity. NBN modulate the DNA damage signal sensing by recruiting PI3/PI4-kinase family members ATM, ATR, and probably DNA-PKcs to the DNA damage sites and activating their functions. It can also recruit MRE11 and RAD50 to the proximity of DSBs by an interaction with the histone H2AX. NBN also functions in telomere length maintenance by generating the 3' overhang which serves as a primer for telomerase dependent telomere elongation. NBN is a major player in the control of intra-S-phase checkpoint and there is some evidence that NBN is involved in G1 and G2 checkpoints. The roles of NBS1/MRN encompass DNA damage sensor, signal transducer, and effector, which enable cells to maintain DNA integrity and genomic stability. Forms a complex with RBBP8 to link DNA double-strand break sensing to resection. Enhances AKT1 phosphorylation possibly by association with the mTORC2 complex."
  }
},
{
  "model": "agmp_app.index",
  "pk": 889,
  "fields": {
    "recname": "SNRPE",
    "keywords": "Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome. As part of the U7 snRNP it is involved in histone 3'-end processing. May indirectly play a role in hair development ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 890,
  "fields": {
    "recname": "CERS3",
    "keywords": "Ceramide synthase that catalyzes formation of ceramide from sphinganine and acyl-CoA substrates, with high selectivity toward very-long (C22:0-C24:0) and ultra long chain (more than C26:0) as acyl donor. It is crucial for the synthesis of ultra long-chain ceramides in the epidermis, to maintain epidermal lipid homeostasis and terminal. differentiation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 891,
  "fields": {
    "recname": "KIF1C",
    "keywords": "Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end-directed motility."
  }
},
{
  "model": "agmp_app.index",
  "pk": 892,
  "fields": {
    "recname": "VPS53",
    "keywords": "Acts as component of the GARP complex that is involved in retrograde transport from early and late endosomes to the trans-Golgi network (TGN). The GARP complex is required for the maintenance of the cycling of mannose 6-phosphate receptors between the TGN and endosomes, this cycling is necessary for proper lysosomal sorting of acid hydrolases such as CTSD. Acts as component of the EARP complex that is involved in endocytic recycling. The EARP complex associates with Rab4-positive endosomes and promotes recycling of internalized transferrin receptor (TFRC) to the plasma membrane ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 893,
  "fields": {
    "recname": "EPS8",
    "keywords": "Signaling adapter that controls various cellular protrusions by regulating actin cytoskeleton dynamics and architecture. Depending on its association with other signal transducers, can regulate different processes. Together with SOS1 and ABI1, forms a trimeric complex that participates in transduction of signals from Ras to Rac by activating the Rac-specific guanine nucleotide exchange factor (GEF) activity. Acts as a direct regulator of actin dynamics by binding actin filaments and has both barbed-end actin filament capping and actin bundling activities depending on the context. Displays barbed-end actin capping activity when associated with ABI1, thereby regulating actin-based motility process: capping activity is auto-inhibited and inhibition is relieved upon ABI1 interaction. Also shows actin bundling activity when associated with BAIAP2, enhancing BAIAP2-dependent membrane extensions and promoting filopodial protrusions. Involved in the regulation of processes such as axonal filopodia growth, stereocilia length, dendritic cell migration and cancer cell migration and invasion. Acts as a regulator of axonal filopodia formation in neurons: in the absence of neurotrophic factors, negatively regulates axonal filopodia formation via actin-capping activity. In contrast, it is phosphorylated in the presence of BDNF leading to inhibition of its actin-capping activity and stimulation of filopodia formation. Component of a complex with WHRN and MYO15A that localizes at stereocilia tips and is required for elongation of the stereocilia actin core. Indirectly involved in cell cycle progression; its degradation following ubiquitination being required during G2 phase to promote cell shape changes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 894,
  "fields": {
    "recname": "SASH1",
    "keywords": "Is a positive regulator of NF-kappa-B signaling downstream of TLR4 activation. It acts as a scaffold molecule to assemble a molecular complex that includes TRAF6, MAP3K7, CHUK and IKBKB, thereby facilitating NF-kappa-B signaling activation. Regulates TRAF6 and MAP3K7 ubiquitination. Involved in the regulation of cell mobility. Regulates lipolysaccharide (LPS)-induced endothelial cell migration. Is involved in the regulation of skin pigmentation through the control of melanocyte migration in the epidermis ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 895,
  "fields": {
    "recname": "CELSR1",
    "keywords": "Receptor that may have an important role in cell/cell signaling during nervous system formation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 896,
  "fields": {
    "recname": "FUT2",
    "keywords": "Mediates the transfer of fucose to the terminal galactose on glycan chains of cell surface glycoproteins and glycolipids. The resulting epitope plays a role in cell-cell interaction including host-microbe interaction. Mediates interaction with intestinal microbiota influencing its composition. Creates a soluble precursor oligosaccharide FuC-alpha ((1,2)Galbeta-) called the H antigen which is an essential substrate for the final step in the soluble ABO blood group antigen synthesis pathway ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 897,
  "fields": {
    "recname": "NFATC2",
    "keywords": "Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2, IL-3, IL-4, TNF-alpha or GM-CSF. Promotes invasive migration through the activation of GPC6 expression and WNT5A signaling pathway."
  }
},
{
  "model": "agmp_app.index",
  "pk": 898,
  "fields": {
    "recname": "TCN2",
    "keywords": "Primary vitamin B12-binding and transport protein. Delivers cobalamin to cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 899,
  "fields": {
    "recname": "KHDC3L",
    "keywords": "KHDC3L"
  }
},
{
  "model": "agmp_app.index",
  "pk": 900,
  "fields": {
    "recname": "COL11A2",
    "keywords": "May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils."
  }
},
{
  "model": "agmp_app.index",
  "pk": 901,
  "fields": {
    "recname": "TNFAIP3",
    "keywords": "Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages."
  }
},
{
  "model": "agmp_app.index",
  "pk": 902,
  "fields": {
    "recname": "RNF24",
    "keywords": "May play a role in TRPCs intracellular trafficking."
  }
},
{
  "model": "agmp_app.index",
  "pk": 903,
  "fields": {
    "recname": "CYP2R1",
    "keywords": "Has a D-25-hydroxylase activity on both forms of vitamin D, vitamin D(2) and D(3)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 904,
  "fields": {
    "recname": "ADA",
    "keywords": "Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine. Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4. Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion. Enhances dendritic cell immunogenicity by affecting dendritic cell costimulatory molecule expression and cytokines and chemokines secretion (By similarity). Enhances CD4+ T-cell differentiation and proliferation. Acts as a positive modulator of adenosine receptors ADORA1 and ADORA2A, by enhancing their ligand affinity via conformational change. Stimulates plasminogen activation. Plays a role in male fertility. Plays a protective role in early postimplantation embryonic development (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 905,
  "fields": {
    "recname": "PCDHGA1",
    "keywords": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 906,
  "fields": {
    "recname": "PCDHGA2",
    "keywords": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 907,
  "fields": {
    "recname": "SPG7",
    "keywords": "ATP-dependent zinc metalloprotease. Plays a role in the formation and regulation of the mitochondrial permeability transition pore (mPTP) and its proteolytic activity is dispensable for this function ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 908,
  "fields": {
    "recname": "SCNN1B",
    "keywords": "Sodium permeable non-voltage-sensitive ion channel inhibited by the diuretic amiloride. Mediates the electrodiffusion of the luminal sodium (and water, which follows osmotically) through the apical membrane of epithelial cells. Plays an essential role in electrolyte and blood pressure homeostasis, but also in airway surface liquid homeostasis, which is important for proper clearance of mucus. Controls the reabsorption of sodium in kidney, colon, lung and sweat glands. Also plays a role in taste perception."
  }
},
{
  "model": "agmp_app.index",
  "pk": 909,
  "fields": {
    "recname": "SERPINA1",
    "keywords": "Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 910,
  "fields": {
    "recname": "MAPK6",
    "keywords": "Atypical MAPK protein. Phosphorylates microtubule-associated protein 2 (MAP2) and MAPKAPK5. The precise role of the complex formed with MAPKAPK5 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPKAPK5, ERK3/MAPK6 is phosphorylated at Ser-189 and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6. May promote entry in the cell cycle (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 911,
  "fields": {
    "recname": "POT1-AS1",
    "keywords": "POT1-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 912,
  "fields": {
    "recname": "RS1",
    "keywords": "Binds negatively charged membrane lipids, such as phosphatidylserine and phosphoinositides (By similarity). May play a role in cell-cell adhesion processes in the retina, via homomeric interaction between octamers present on the surface of two neighboring cells. Required for normal structure and function of the retina ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 913,
  "fields": {
    "recname": "UGT1A3",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 914,
  "fields": {
    "recname": "UGT1A9",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 915,
  "fields": {
    "recname": "UGT1A4",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1 (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 916,
  "fields": {
    "recname": "UGT1A6",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols. Isoform 3 lacks transferase activity but acts as a negative regulator of isoform 1 (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 917,
  "fields": {
    "recname": "UGT1A7",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 918,
  "fields": {
    "recname": "UGT1A8",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 919,
  "fields": {
    "recname": "UGT1A10",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 920,
  "fields": {
    "recname": "UGT1A5",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1 (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 921,
  "fields": {
    "recname": "BDNF",
    "keywords": "Important signaling molecule that activates signaling cascades downstream of NTRK2. During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribution to a range of adaptive neuronal responses including long-term potentiation (LTP), long-term depression (LTD), certain forms of short-term synaptic plasticity, as well as homeostatic regulation of intrinsic neuronal excitability."
  }
},
{
  "model": "agmp_app.index",
  "pk": 922,
  "fields": {
    "recname": "BDNF-AS",
    "keywords": "BDNF-AS"
  }
},
{
  "model": "agmp_app.index",
  "pk": 923,
  "fields": {
    "recname": "MSH2",
    "keywords": "Component of the post-replicative DNA mismatch repair system (MMR). Forms two different heterodimers: MutS alpha (MSH2-MSH6 heterodimer) and MutS beta (MSH2-MSH3 heterodimer) which binds to DNA mismatches thereby initiating DNA repair. When bound, heterodimers bend the DNA helix and shields approximately 20 base pairs. MutS alpha recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. MutS beta recognizes larger insertion-deletion loops up to 13 nucleotides long. After mismatch binding, MutS alpha or beta forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. Recruits DNA helicase MCM9 to chromatin which unwinds the mismatch containing DNA strand. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. In melanocytes may modulate both UV-B-induced cell cycle regulation and apoptosis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 924,
  "fields": {
    "recname": "MAPT",
    "keywords": "Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization."
  }
},
{
  "model": "agmp_app.index",
  "pk": 925,
  "fields": {
    "recname": "KIAA1257",
    "keywords": "KIAA1257"
  }
},
{
  "model": "agmp_app.index",
  "pk": 926,
  "fields": {
    "recname": "CYP21A2",
    "keywords": "Specifically catalyzes the 21-hydroxylation of steroids. Required for the adrenal synthesis of mineralocorticoids and glucocorticoids ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 927,
  "fields": {
    "recname": "PON1",
    "keywords": "Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 928,
  "fields": {
    "recname": "CPNE4",
    "keywords": "Probable calcium-dependent phospholipid-binding protein that may play a role in calcium-mediated intracellular processes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 929,
  "fields": {
    "recname": "IL17RD",
    "keywords": "Feedback inhibitor of fibroblast growth factor mediated Ras-MAPK signaling and ERK activation. May inhibit FGF-induced FGFR1 tyrosine phosphorylation. Regulates the nuclear ERK signaling pathway by spatially blocking nuclear translocation of activated ERK without inhibiting cytoplasmic phosphorylation of ERK. Mediates JNK activation and may be involved in apoptosis. Might have a role in the early stages of fate specification of GnRH-secreting neurons (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 930,
  "fields": {
    "recname": "PCDHA6",
    "keywords": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 931,
  "fields": {
    "recname": "PCDHA5",
    "keywords": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 932,
  "fields": {
    "recname": "PCDHA7",
    "keywords": "Calcium-dependent cell-adhesion protein involved in cells self-recognition and non-self discrimination. Thereby, it is involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 933,
  "fields": {
    "recname": "SRA1",
    "keywords": "Functional RNA which acts as a transcriptional coactivator that selectively enhances steroid receptor-mediated transactivation ligand-independently through a mechanism involving the modulating N-terminal domain (AF-1) of steroid receptors. Also mediates transcriptional coactivation of steroid receptors ligand-dependently through the steroid-binding domain (AF-2). Enhances cellular proliferation and differentiation and promotes apoptosis in vivo. May play a role in tumorigenesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 934,
  "fields": {
    "recname": "INS-IGF2",
    "keywords": "INS-IGF2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 935,
  "fields": {
    "recname": "INS",
    "keywords": "Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver."
  }
},
{
  "model": "agmp_app.index",
  "pk": 936,
  "fields": {
    "recname": "AL356234.2",
    "keywords": "AL356234.2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 937,
  "fields": {
    "recname": "CD2AP",
    "keywords": "Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton. In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity). May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By similarity). May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis. Plays a role in epithelial cell junctions formation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 938,
  "fields": {
    "recname": "ELMO1",
    "keywords": "Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Acts in association with DOCK1 and CRK. Was initially proposed to be required in complex with DOCK1 to activate Rac Rho small GTPases. May enhance the guanine nucleotide exchange factor (GEF) activity of DOCK1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 939,
  "fields": {
    "recname": "IL17RC",
    "keywords": "Receptor for IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RA. Receptor for the heterodimer formed by IL17A and IL17B as part of a heterodimeric complex with IL17RA. Has also been shown to be the cognate receptor for IL17F and to bind IL17A with high affinity without the need for IL17RA. Activation of IL17RC leads to induction of expression of inflammatory chemokines and cytokines such as CXCL1 ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 940,
  "fields": {
    "recname": "SLC19A3",
    "keywords": "Mediates high affinity thiamine uptake, probably via a proton anti-port mechanism. Has no folate transport activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 941,
  "fields": {
    "recname": "GH1",
    "keywords": "Plays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF-1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues."
  }
},
{
  "model": "agmp_app.index",
  "pk": 942,
  "fields": {
    "recname": "CSHL1",
    "keywords": "May be a novel gestational hormone required to compensate for absence of other members of the GH/CS cluster during gestation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 943,
  "fields": {
    "recname": "COL1A1",
    "keywords": "Type I collagen is a member of group I collagen (fibrillar forming collagen)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 944,
  "fields": {
    "recname": "COL1A2",
    "keywords": "Type I collagen is a member of group I collagen (fibrillar forming collagen)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 945,
  "fields": {
    "recname": "P3H1",
    "keywords": "Basement membrane-associated chondroitin sulfate proteoglycan (CSPG). Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens, especially types IV and V. May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts."
  }
},
{
  "model": "agmp_app.index",
  "pk": 946,
  "fields": {
    "recname": "GLB1",
    "keywords": "Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans."
  }
},
{
  "model": "agmp_app.index",
  "pk": 947,
  "fields": {
    "recname": "PRSS56",
    "keywords": "Serine protease required during eye development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 948,
  "fields": {
    "recname": "PNPLA3",
    "keywords": "Specifically catalyzes coenzyme A (CoA)-dependent acylation of 1-acyl-sn-glycerol 3-phosphate (2-lysophosphatidic acid/LPA) to generate phosphatidic acid (PA), an important metabolic intermediate and precursor for both triglycerides and glycerophospholipids. Does not esterify other lysophospholipids. Acyl donors are long chain (at least C16) fatty acyl-CoAs: arachidonoyl-CoA, linoleoyl-CoA, oleoyl-CoA and at a lesser extent palmitoyl-CoA. Additionally possesses low triacylglycerol lipase and CoA-independent acylglycerol transacylase activities and thus may play a role in acyl-chain remodeling of triglycerides ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 949,
  "fields": {
    "recname": "MC4R",
    "keywords": "Receptor specific to the heptapeptide core common to adrenocorticotropic hormone and alpha-, beta-, and gamma-MSH. Plays a central role in energy homeostasis and somatic growth. This receptor is mediated by G proteins that stimulate adenylate cyclase (cAMP)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 950,
  "fields": {
    "recname": "AL160269.1",
    "keywords": "AL160269.1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 951,
  "fields": {
    "recname": "HSD17B3",
    "keywords": "Favors the reduction of androstenedione to testosterone. Uses NADPH while the two other EDH17B enzymes use NADH."
  }
},
{
  "model": "agmp_app.index",
  "pk": 952,
  "fields": {
    "recname": "GNE",
    "keywords": "Regulates and initiates biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. Plays an essential role in early development (By similarity). Required for normal sialylation in hematopoietic cells. Sialylation is implicated in cell adhesion, signal transduction, tumorigenicity and metastatic behavior of malignant cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 953,
  "fields": {
    "recname": "CLTA",
    "keywords": "Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Acts as component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 954,
  "fields": {
    "recname": "C1orf141",
    "keywords": "C1orf141"
  }
},
{
  "model": "agmp_app.index",
  "pk": 955,
  "fields": {
    "recname": "IFNGR1",
    "keywords": "Associates with IFNGR2 to form a receptor for the cytokine interferon gamma (IFNG). Ligand binding stimulates activation of the JAK/STAT signaling pathway. Plays an essential role in the IFN-gamma pathway that is required for the cellular response to infectious agents ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 956,
  "fields": {
    "recname": "BBS12",
    "keywords": "Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Involved in adipogenic differentiation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 957,
  "fields": {
    "recname": "HERC1",
    "keywords": "Involved in membrane trafficking via some guanine nucleotide exchange factor (GEF) activity and its ability to bind clathrin. Acts as a GEF for Arf and Rab, by exchanging bound GDP for free GTP. Binds phosphatidylinositol 4,5-bisphosphate, which is required for GEF activity. May also act as a E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates."
  }
},
{
  "model": "agmp_app.index",
  "pk": 958,
  "fields": {
    "recname": "OTOF",
    "keywords": "Key calcium ion sensor involved in the Ca(2+)-triggered synaptic vesicle-plasma membrane fusion and in the control of neurotransmitter release at these output synapses. Interacts in a calcium-dependent manner to the presynaptic SNARE proteins at ribbon synapses of cochlear inner hair cells (IHCs) to trigger exocytosis of neurotransmitter. Also essential to synaptic exocytosis in immature outer hair cells (OHCs). May also play a role within the recycling of endosomes (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 959,
  "fields": {
    "recname": "ZMYM6",
    "keywords": "Plays a role in the regulation of cell morphology and cytoskeletal organization."
  }
},
{
  "model": "agmp_app.index",
  "pk": 960,
  "fields": {
    "recname": "DNAJB2",
    "keywords": "Functions as a co-chaperone, regulating the substrate binding and activating the ATPase activity of chaperones of the HSP70/heat shock protein 70 family. In parallel, also contributes to the ubiquitin-dependent proteasomal degradation of misfolded proteins. Thereby, may regulate the aggregation and promote the functional recovery of misfolded proteins like HTT, MC4R, PRKN, RHO and SOD1 and be crucial for many biological processes. Isoform 1 which is localized to the endoplasmic reticulum membranes may specifically function in ER-associated protein degradation of misfolded proteins ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 961,
  "fields": {
    "recname": "STAT4",
    "keywords": "Carries out a dual function: signal transduction and activation of transcription. Involved in IL12 signaling."
  }
},
{
  "model": "agmp_app.index",
  "pk": 962,
  "fields": {
    "recname": "KLHL40",
    "keywords": "Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that acts as a key regulator of skeletal muscle development. The BCR(KLHL40) complex acts by mediating ubiquitination and degradation of TFDP1, thereby regulating the activity of the E2F:DP transcription factor complex (By similarity). Promotes stabilization of LMOD3 by acting as a negative regulator of LMOD3 ubiquitination; the molecular process by which it negatively regulates ubiquitination of LMOD3 is however unclear (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 963,
  "fields": {
    "recname": "KIDINS220",
    "keywords": "Promotes a prolonged MAP-kinase signaling by neurotrophins through activation of a Rap1-dependent mechanism. Provides a docking site for the CRKL-C3G complex, resulting in Rap1-dependent sustained ERK activation. May play an important role in regulating postsynaptic signal transduction through the syntrophin-mediated localization of receptor tyrosine kinases such as EPHA4. In cooperation with SNTA1 can enhance EPHA4-induced JAK/STAT activation. Plays a role in nerve growth factor (NGF)-induced recruitment of RAPGEF2 to late endosomes and neurite outgrowth. May play a role in neurotrophin- and ephrin-mediated neuronal outgrowth and in axon guidance during neural development and in neuronal regeneration (By similarity). Modulates stress-induced apoptosis of melanoma cells via regulation of the MEK/ERK signaling pathway."
  }
},
{
  "model": "agmp_app.index",
  "pk": 964,
  "fields": {
    "recname": "RET",
    "keywords": "Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis; involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Acts as a dependence receptor; in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers; these diseases are characterized by aberrant integrins-regulated cell migration. Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which induces inhibition of food-intake. Activates MAPK- and AKT-signaling pathways. Isoform 1 in complex with GFRAL induces higher activation of MAPK-signaling pathway than isoform 2 in complex with GFRAL ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 965,
  "fields": {
    "recname": "CXCR4",
    "keywords": "Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ion levels and enhancing MAPK1/MAPK3 activation. Involved in the AKT signaling cascade. Plays a role in regulation of cell migration, e.g. during wound healing. Acts as a receptor for extracellular ubiquitin; leading to enhanced intracellular calcium ions and reduced cellular cAMP levels. Binds bacterial lipopolysaccharide (LPS) et mediates LPS-induced inflammatory response, including TNF secretion by monocytes. Involved in hematopoiesis and in cardiac ventricular septum formation. Also plays an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. Involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 966,
  "fields": {
    "recname": "PTPRG",
    "keywords": "Possesses tyrosine phosphatase activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 967,
  "fields": {
    "recname": "KNL1",
    "keywords": "Performs two crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Required for attachment of the kinetochores to the spindle microtubules. Directly links BUB1 and BUB1B to kinetochores. Part of the MIS12 complex, which may be fundamental for kinetochore formation and proper chromosome segregation during mitosis. Acts in coordination with CENPK to recruit the NDC80 complex to the outer kinetochore."
  }
},
{
  "model": "agmp_app.index",
  "pk": 968,
  "fields": {
    "recname": "SRY",
    "keywords": "Transcriptional regulator that controls a genetic switch in male development. It is necessary and sufficient for initiating male sex determination by directing the development of supporting cell precursors (pre-Sertoli cells) as Sertoli rather than granulosa cells (By similarity). In male adult brain involved in the maintenance of motor functions of dopaminergic neurons (By similarity). Involved in different aspects of gene regulation including promoter activation or repression (By similarity). Promotes DNA bending. SRY HMG box recognizes DNA by partial intercalation in the minor groove. Also involved in pre-mRNA splicing. Binds to the DNA consensus sequence 5'-[AT]AACAA[AT]-3'."
  }
},
{
  "model": "agmp_app.index",
  "pk": 969,
  "fields": {
    "recname": "TBCE",
    "keywords": "Tubulin-folding protein; involved in the second step of the tubulin folding pathway and in the regulation of tubulin heterodimer dissociation. Required for correct organization of microtubule cytoskeleton and mitotic splindle, and maintenance of the neuronal microtubule network."
  }
},
{
  "model": "agmp_app.index",
  "pk": 970,
  "fields": {
    "recname": "TTR",
    "keywords": "Thyroid hormone-binding protein. Probably transports thyroxine from the bloodstream to the brain."
  }
},
{
  "model": "agmp_app.index",
  "pk": 971,
  "fields": {
    "recname": "SPTBN2",
    "keywords": "Probably plays an important role in neuronal membrane skeleton."
  }
},
{
  "model": "agmp_app.index",
  "pk": 972,
  "fields": {
    "recname": "C11orf65",
    "keywords": "C11orf65"
  }
},
{
  "model": "agmp_app.index",
  "pk": 973,
  "fields": {
    "recname": "HARS1",
    "keywords": "Cytoplasmic histidine--tRNA ligase (Probable). Plays a role in axon guidance."
  }
},
{
  "model": "agmp_app.index",
  "pk": 974,
  "fields": {
    "recname": "SGSH",
    "keywords": "Catalyzes a step in lysosomal heparan sulfate degradation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 975,
  "fields": {
    "recname": "SUB1",
    "keywords": "General coactivator that functions cooperatively with TAFs and mediates functional interactions between upstream activators and the general transcriptional machinery. May be involved in stabilizing the multiprotein transcription complex. Binds single-stranded DNA. Also binds, in vitro, non-specifically to double-stranded DNA (ds DNA)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 976,
  "fields": {
    "recname": "CHRNE",
    "keywords": "After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane."
  }
},
{
  "model": "agmp_app.index",
  "pk": 977,
  "fields": {
    "recname": "JAK2",
    "keywords": "Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins. Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, cell stimulation with erythropoietin (EPO) during erythropoiesis leads to JAK2 autophosphorylation, activation, and its association with erythropoietin receptor (EPOR) that becomes phosphorylated in its cytoplasmic domain. Then, STAT5 (STAT5A or STAT5B) is recruited, phosphorylated and activated by JAK2. Once activated, dimerized STAT5 translocates into the nucleus and promotes the transcription of several essential genes involved in the modulation of erythropoiesis. Part of a signaling cascade that is activated by increased cellular retinol and that leads to the activation of STAT5 (STAT5A or STAT5B). In addition, JAK2 mediates angiotensin-2-induced ARHGEF1 phosphorylation. Plays a role in cell cycle by phosphorylating CDKN1B. Cooperates with TEC through reciprocal phosphorylation to mediate cytokine-driven activation of FOS transcription. In the nucleus, plays a key role in chromatin by specifically mediating phosphorylation of 'Tyr-41' of histone H3 (H3Y41ph), a specific tag that promotes exclusion of CBX5 (HP1 alpha) from chromatin ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 978,
  "fields": {
    "recname": "PDYN-AS1",
    "keywords": "PDYN-AS1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 979,
  "fields": {
    "recname": "PDYN",
    "keywords": "Leu-enkephalins compete with and mimic the effects of opiate drugs. They play a role in a number of physiologic functions, including pain perception and responses to stress (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 980,
  "fields": {
    "recname": "TREM2",
    "keywords": "Forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding. Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia. Binding to amyloid-beta 42 mediates microglial activation, proliferation, migration, apoptosis and expression of pro-inflammatory cytokines, such as IL6R and CCL3, and the anti-inflammatory cytokine ARG1 (By similarity). Acts as a receptor for lipoprotein particles such as LDL, VLDL, and HDL and for apolipoproteins such as APOA1, APOA2, APOB, APOE, APOE2, APOE3, APOE4, and CLU and enhances their uptake in microglia. Binds phospholipids (preferably anionic lipids) such as phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol and sphingomyelin. Regulates microglial proliferation by acting as an upstream regulator of the Wnt/beta-catenin signaling cascade (By similarity). Required for microglial phagocytosis of apoptotic neurons. Also required for microglial activation and phagocytosis of myelin debris after neuronal injury and of neuronal synapses during synapse elimination in the developing brain (By similarity). Regulates microglial chemotaxis and process outgrowth, and also the microglial response to oxidative stress and lipopolysaccharide (By similarity). It suppresses PI3K and NF-kappa-B signaling in response to lipopolysaccharide; thus promoting phagocytosis, suppressing pro-inflammatory cytokine and nitric oxide production, inhibiting apoptosis and increasing expression of IL10 and TGFB (By similarity). During oxidative stress, it promotes anti-apoptotic NF-kappa-B signaling and ERK signaling (By similarity). Plays a role in microglial MTOR activation and metabolism (By similarity). Regulates age-related changes in microglial numbers. Triggers activation of the immune responses in macrophages and dendritic cells. Mediates cytokine-induced formation of multinucleated giant cells which are formed by the fusion of macrophages (By similarity). In dendritic cells, it mediates up-regulation of chemokine receptor CCR7 and dendritic cell maturation and survival. Involved in the positive regulation of osteoclast differentiation ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 981,
  "fields": {
    "recname": "CDKAL1",
    "keywords": "Catalyzes the methylthiolation of N6-threonylcarbamoyladenosine (t(6)A), leading to the formation of 2-methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 982,
  "fields": {
    "recname": "CDC14A",
    "keywords": "Dual-specificity phosphatase. Required for centrosome separation and productive cytokinesis during cell division. Dephosphorylates SIRT2 around early anaphase. May dephosphorylate the APC subunit FZR1/CDH1, thereby promoting APC-FZR1 dependent degradation of mitotic cyclins and subsequent exit from mitosis. Required for normal hearing ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 983,
  "fields": {
    "recname": "MLXIPL",
    "keywords": "Transcriptional repressor. Binds to the canonical and non-canonical E box sequences 5'-CACGTG-3' (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 984,
  "fields": {
    "recname": "KIF7",
    "keywords": "Essential for hedgehog signaling regulation: acts as both a negative and positive regulator of sonic hedgehog (Shh) and Indian hedgehog (Ihh) pathways, acting downstream of SMO, through both SUFU-dependent and -independent mechanisms. Involved in the regulation of microtubular dynamics. Required for proper organization of the ciliary tip and control of ciliary localization of SUFU-GLI2 complexes (By similarity). Required for localization of GLI3 to cilia in response to Shh. Negatively regulates Shh signaling by preventing inappropriate activation of the transcriptional activator GLI2 in the absence of ligand. Positively regulates Shh signaling by preventing the processing of the transcription factor GLI3 into its repressor form. In keratinocytes, promotes the dissociation of SUFU-GLI2 complexes, GLI2 nuclear translocation and Shh signaling activation (By similarity). Involved in the regulation of epidermal differentiation and chondrocyte development (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 985,
  "fields": {
    "recname": "SLC35A2",
    "keywords": "Transports nucleotide sugars from the cytosol into Golgi vesicles where glycosyltransferases function."
  }
},
{
  "model": "agmp_app.index",
  "pk": 986,
  "fields": {
    "recname": "MCFD2",
    "keywords": "The MCFD2-LMAN1 complex forms a specific cargo receptor for the ER-to-Golgi transport of selected proteins. Plays a role in the secretion of coagulation factors."
  }
},
{
  "model": "agmp_app.index",
  "pk": 987,
  "fields": {
    "recname": "IL12B",
    "keywords": "Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 988,
  "fields": {
    "recname": "SDHB",
    "keywords": "Iron-sulfur protein (IP) subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 989,
  "fields": {
    "recname": "SGCG",
    "keywords": "Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix."
  }
},
{
  "model": "agmp_app.index",
  "pk": 990,
  "fields": {
    "recname": "CDKL5",
    "keywords": "Mediates phosphorylation of MECP2. May regulate ciliogenesis ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 991,
  "fields": {
    "recname": "USB1",
    "keywords": "Phosphodiesterase responsible for the U6 snRNA 3' end processing. Acts as an exoribonuclease (RNase) responsible for trimming the poly(U) tract of the last nucleotides in the pre-U6 snRNA molecule, leading to the formation of mature U6 snRNA 3' end-terminated with a 2',3'-cyclic phosphate."
  }
},
{
  "model": "agmp_app.index",
  "pk": 992,
  "fields": {
    "recname": "ADAM9",
    "keywords": "Cleaves and releases a number of molecules with important roles in tumorigenesis and angiogenesis, such as TEK, KDR, EPHB4, CD40, VCAM1 and CDH5. May mediate cell-cell, cell-matrix interactions and regulate the motility of cells via interactions with integrins."
  }
},
{
  "model": "agmp_app.index",
  "pk": 993,
  "fields": {
    "recname": "DCDC2",
    "keywords": "Protein that plays a role in the inhibition of canonical Wnt signaling pathway. May be involved in neuronal migration during development of the cerebral neocortex (By similarity). Involved in the control of ciliogenesis and ciliary length ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 994,
  "fields": {
    "recname": "UFSP2",
    "keywords": "Thiol protease which recognizes and hydrolyzes the peptide bond at the C-terminal Gly of UFM1, a ubiquitin-like modifier protein bound to a number of target proteins. Does not hydrolyze SUMO1 or ISG15 ubiquitin-like proteins. Through TRIP4 deufmylation may regulate intracellular nuclear receptors transactivation and thereby regulate cell proliferation and differentiation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 995,
  "fields": {
    "recname": "GRHL3",
    "keywords": "Transcription factor playing important roles in primary neurulation and in the differentiation of stratified epithelia of both ectodermal and endodermal origin (By similarity). Binds directly to the consensus DNA sequence 5'-AACCGGTT-3' acting as an activator and repressor on distinct target genes. xhibits functional redundancy with GRHL2 in epidermal morphogenetic events and epidermal wound repair (By similarity). Exhibits functional redundancy with GRHL2 in epidermal morphogenetic events and epidermal wound repair but is essential to form the epidermal barrier with TGM3 as critical direct target gene among others. Despite being dispensable during normal epidermal homeostasis in the adulthood, is again required for barrier repair after immune-mediated epidermal damage, regulates distinct gene batteries in embryonic epidermal differentiation and adult epidermal barrier reformation after injury. Plays unique and cooperative roles with GRHL2 in establishing distinct zones of primary neurulation. Essential for spinal closure, functions cooperatively with GRHL2 in closure 2 (forebrain/midbrain boundary) and posterior neuropore closure (By similarity). Also required for proper development of the oral periderm. No genetic interaction with GRHL3, no functional cooperativity due to diverse target gene selectivity ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 996,
  "fields": {
    "recname": "SIX1",
    "keywords": "Transcription factor that is involved in the regulation of cell proliferation, apoptosis and embryonic development. Plays an important role in the development of several organs, including kidney, muscle and inner ear. Depending on context, functions as transcriptional repressor or activator. Lacks an activation domain, and requires interaction with EYA family members for transcription activation. Mediates nuclear translocation of EYA1 and EYA2. Binds the 5'-TCA[AG][AG]TTNC-3' motif present in the MEF3 element in the MYOG promoter. Regulates the expression of numerous genes, including MYC, CCND1 and EZR. Acts as activator of the IGFBP5 promoter, probably coactivated by EYA2. Repression of precursor cell proliferation in myoblasts is switched to activation through recruitment of EYA3 to the SIX1-DACH1 complex. During myogenesis, seems to act together with EYA2 and DACH2 (By similarity). Regulates the expression of CCNA1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 997,
  "fields": {
    "recname": "DAG1",
    "keywords": "The dystroglycan complex is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization."
  }
},
{
  "model": "agmp_app.index",
  "pk": 998,
  "fields": {
    "recname": "SH3TC2",
    "keywords": "SH3TC2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 999,
  "fields": {
    "recname": "FUCA1",
    "keywords": "Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-linked fucose joined to the reducing-end N-acetylglucosamine of the carbohydrate moieties of glycoproteins."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1000,
  "fields": {
    "recname": "TACSTD2",
    "keywords": "May function as a growth factor receptor."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1001,
  "fields": {
    "recname": "TOX3",
    "keywords": "Transcriptional coactivator of the p300/CBP-mediated transcription complex. Activates transactivation through cAMP response element (CRE) sites. Protects against cell death by inducing antiapoptotic and repressing pro-apoptotic transcripts. Stimulates transcription from the estrogen-responsive or BCL-2 promoters. Required for depolarization-induced transcription activation of the C-FOS promoter in neurons. Associates with chromatin to the estrogen-responsive C3 promoter region."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1002,
  "fields": {
    "recname": "FTO",
    "keywords": "RNA demethylase that mediates oxidative demethylation of different RNA species, such as mRNAs, tRNAs and snRNAs, and acts as a regulator of fat mass, adipogenesis and energy homeostasis. Specifically demethylates N(6)-methyladenosine (m6A) RNA, the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes. M6A demethylation by FTO affects mRNA expression and stability. Also able to demethylate m6A in U6 small nuclear RNA (snRNA). Mediates demethylation of N(6),2'-O-dimethyladenosine cap (m6A(m)), by demethylating the N(6)-methyladenosine at the second transcribed position of mRNAs and U6 snRNA. Demethylation of m6A(m) in the 5'-cap by FTO affects mRNA stability by promoting susceptibility to decapping. Also acts as a tRNA demethylase by removing N(1)-methyladenine from various tRNAs. Has no activity towards 1-methylguanine. Has no detectable activity towards double-stranded DNA. Also able to repair alkylated DNA and RNA by oxidative demethylation: demethylates single-stranded RNA containing 3-methyluracil, single-stranded DNA containing 3-methylthymine and has low demethylase activity towards single-stranded DNA containing 1-methyladenine or 3-methylcytosine. Ability to repair alkylated DNA and RNA is however unsure in vivo. Involved in the regulation of fat mass, adipogenesis and body weight, thereby contributing to the regulation of body size and body fat accumulation. Involved in the regulation of thermogenesis and the control of adipocyte differentiation into brown or white fat cells. Regulates activity of the dopaminergic midbrain circuitry via its ability to demethylate m6A in mRNAs (By similarity). Plays an oncogenic role in a number of acute myeloid leukemias by enhancing leukemic oncogene-mediated cell transformation: acts by mediating m6A demethylation of target transcripts such as MYC, CEBPA, ASB2 and RARA, leading to promote their expression ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1003,
  "fields": {
    "recname": "ABO",
    "keywords": "ABO"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1004,
  "fields": {
    "recname": "TMPRSS6",
    "keywords": "Serine protease which hydrolyzes a range of proteins including type I collagen, fibronectin and fibrinogen. Can also activate urokinase-type plasminogen activator with low efficiency. May play a specialized role in matrix remodeling processes in liver. Through the cleavage of HJV, a regulator of the expression of the iron absorption-regulating hormone hepicidin/HAMP, plays a role in iron homeostasis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1005,
  "fields": {
    "recname": "CLDN1",
    "keywords": "Claudins function as major constituents of the tight junction complexes that regulate the permeability of epithelia. While some claudin family members play essential roles in the formation of impermeable barriers, others mediate the permeability to ions and small molecules. Often, several claudin family members are coexpressed and interact with each other, and this determines the overall permeability. CLDN1 is required to prevent the paracellular diffusion of small molecules through tight junctions in the epidermis and is required for the normal barrier function of the skin. Required for normal water homeostasis and to prevent excessive water loss through the skin, probably via an indirect effect on the expression levels of other proteins, since CLDN1 itself seems to be dispensable for water barrier formation in keratinocyte tight junctions ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1006,
  "fields": {
    "recname": "MAPRE2",
    "keywords": "May be involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. May play a role in cell migration (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1007,
  "fields": {
    "recname": "SPAST",
    "keywords": "ATP-dependent microtubule severing protein that specifically recognizes and cuts microtubules that are polyglutamylated. Preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold. Severing activity is not dependent on tubulin acetylation or detyrosination. Microtubule severing promotes reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. It is critical for the biogenesis and maintenance of complex microtubule arrays in axons, spindles and cilia. SPAST is involved in abscission step of cytokinesis and nuclear envelope reassembly during anaphase in cooperation with the ESCRT-III complex. Recruited at the midbody, probably by IST1, and participates in membrane fission during abscission together with the ESCRT-III complex. Recruited to the nuclear membrane by IST1 and mediates microtubule severing, promoting nuclear envelope sealing and mitotic spindle disassembly during late anaphase. Required for membrane traffic from the endoplasmic reticulum (ER) to the Golgi and endosome recycling. Recruited by IST1 to endosomes and regulates early endosomal tubulation and recycling by mediating microtubule severing. Probably plays a role in axon growth and the formation of axonal branches ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1008,
  "fields": {
    "recname": "CCDC174",
    "keywords": "Probably involved in neuronal development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1009,
  "fields": {
    "recname": "ECM1",
    "keywords": "Involved in endochondral bone formation as negative regulator of bone mineralization. Stimulates the proliferation of endothelial cells and promotes angiogenesis. Inhibits MMP9 proteolytic activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1010,
  "fields": {
    "recname": "WHRN",
    "keywords": "Involved in hearing and vision as member of the USH2 complex. Necessary for elongation and maintenance of inner and outer hair cell stereocilia in the organ of Corti in the inner ear. Involved in the maintenance of the hair bundle ankle region, which connects stereocilia in cochlear hair cells of the inner ear. In retina photoreceptors, required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1011,
  "fields": {
    "recname": "USH1C",
    "keywords": "Anchoring/scaffolding protein that is a part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for normal development and maintenance of cochlear hair cell bundles (By similarity). As part of the intermicrovillar adhesion complex/IMAC plays a role in brush border differentiation, controlling microvilli organization and length. Probably plays a central regulatory role in the assembly of the complex, recruiting CDHR2, CDHR5 and MYO7B to the microvilli tips ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1012,
  "fields": {
    "recname": "RP1",
    "keywords": "Microtubule-associated protein regulating the stability and length of the microtubule-based axoneme of photoreceptors. Required for the differentiation of photoreceptor cells, it plays a role in the organization of the outer segment of rod and cone photoreceptors ensuring the correct orientation and higher-order stacking of outer segment disks along the photoreceptor axoneme (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1013,
  "fields": {
    "recname": "HMCN1",
    "keywords": "Promotes cleavage furrow maturation during cytokinesis in preimplantation embryos. May play a role in the architecture of adhesive and flexible epithelial cell junctions. May play a role during myocardial remodeling by imparting an effect on cardiac fibroblast migration."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1014,
  "fields": {
    "recname": "INSR",
    "keywords": "Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. In adipocytes, inhibits lipolysis (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1015,
  "fields": {
    "recname": "NNT",
    "keywords": "The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane (By similarity). May play a role in reactive oxygen species (ROS) detoxification in the adrenal gland ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1016,
  "fields": {
    "recname": "TREML4",
    "keywords": "Positively regulates Toll-like receptor TLR7 signaling in macrophages."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1017,
  "fields": {
    "recname": "ABCG8",
    "keywords": "ABCG5 and ABCG8 form an obligate heterodimer that mediates Mg(2+)- and ATP-dependent sterol transport across the cell membrane. Plays an essential role in the selective transport of the dietary cholesterol in and out of the enterocytes and in the selective sterol excretion by the liver into bile. Required for normal sterol homeostasis. The heterodimer with ABCG5 has ATPase activity ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1018,
  "fields": {
    "recname": "CDH13",
    "keywords": "Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. May act as a negative regulator of neural cell growth."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1019,
  "fields": {
    "recname": "ABCB1",
    "keywords": "Translocates drugs and phospholipids across the membrane. Catalyzes the flop of phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane. Participates mainly to the flop of phosphatidylcholine, phosphatidylethanolamine, beta-D-glucosylceramides and sphingomyelins. Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1020,
  "fields": {
    "recname": "ABCB11",
    "keywords": "Catalyzes the secretion of conjugated bile salts across the canalicular membrane of hepatocytes in an ATP-dependent manner. Transports taurine-conjugated bile salts more rapidly than glycine-conjugated bile salts."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1021,
  "fields": {
    "recname": "ABCC2",
    "keywords": "Mediates hepatobiliary excretion of numerous organic anions and conjugated organic anions such as methotrexate, 17beta-estradiol 17-glucosiduronic acid and leukotriene C4. Also transports sulfated bile salt such as taurolithocholate sulfate. May function as a cellular cisplatin transporter."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1022,
  "fields": {
    "recname": "ABCG2",
    "keywords": "High-capacity urate exporter functioning in both renal and extrarenal urate excretion. Plays a role in porphyrin homeostasis as it is able to mediates the export of protoporhyrin IX (PPIX) both from mitochondria to cytosol and from cytosol to extracellular space, and cellular export of hemin, and heme. Xenobiotic transporter that may play an important role in the exclusion of xenobiotics from the brain. Appears to play a major role in the multidrug resistance phenotype of several cancer cell lines. Implicated in the efflux of numerous drugs and xenobiotics: mitoxantrone, the photosensitizer pheophorbide, camptothecin, methotrexate, azidothymidine (AZT), and the anthracyclines daunorubicin and doxorubicin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1023,
  "fields": {
    "recname": "ACE",
    "keywords": "Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. Inhibitors of ACE are commonly used to treat hypertension and some types of renal and cardiac dysfunction. The glycosidase activity probably uses different active site residues than the metalloprotease activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1024,
  "fields": {
    "recname": "ADRB1",
    "keywords": "Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1025,
  "fields": {
    "recname": "ADRB2",
    "keywords": "Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1026,
  "fields": {
    "recname": "ANGPT1",
    "keywords": "Binds and activates TEK/TIE2 receptor by inducing its dimerization and tyrosine phosphorylation. Plays an important role in the regulation of angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Required for normal angiogenesis and heart development during embryogenesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts. In quiescent vessels, ANGPT1 oligomers recruit TEK to cell-cell contacts, forming complexes with TEK molecules from adjoining cells, and this leads to preferential activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascades. In migrating endothelial cells that lack cell-cell adhesions, ANGT1 recruits TEK to contacts with the extracellular matrix, leading to the formation of focal adhesion complexes, activation of PTK2/FAK and of the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, and ultimately to the stimulation of sprouting angiogenesis. Mediates blood vessel maturation/stability. Implicated in endothelial developmental processes later and distinct from that of VEGF. Appears to play a crucial role in mediating reciprocal interactions between the endothelium and surrounding matrix and mesenchyme. It may have a potential therapeutic utility since it can be used for specifically targeting tumor vasculature or for promoting angiogenic processes in certain organs such as an ischemic heart."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1027,
  "fields": {
    "recname": "ANGPT2",
    "keywords": "Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling. Can induce tyrosine phosphorylation of TEK/TIE2 in the absence of ANGPT1. In the absence of angiogenic inducers, such as VEGF, ANGPT2-mediated loosening of cell-matrix contacts may induce endothelial cell apoptosis with consequent vascular regression. In concert with VEGF, it may facilitate endothelial cell migration and proliferation, thus serving as a permissive angiogenic signal."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1028,
  "fields": {
    "recname": "AOX1",
    "keywords": "Oxidase with broad substrate specificity, oxidizing aromatic azaheterocycles, such as N1-methylnicotinamide, N-methylphthalazinium and phthalazine, as well as aldehydes, such as benzaldehyde, retinal, pyridoxal, and vanillin. Plays a key role in the metabolism of xenobiotics and drugs containing aromatic azaheterocyclic substituents. Participates in the bioactivation of prodrugs such as famciclovir, catalyzing the oxidation step from 6-deoxypenciclovir to penciclovir, which is a potent antiviral agent. Is probably involved in the regulation of reactive oxygen species homeostasis. May be a prominent source of superoxide generation via the one-electron reduction of molecular oxygen. Also may catalyze nitric oxide (NO) production via the reduction of nitrite to NO with NADH or aldehyde as electron donor. May play a role in adipogenesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1029,
  "fields": {
    "recname": "APOC1",
    "keywords": "Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10% of the protein of the VLDL and 2% of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1030,
  "fields": {
    "recname": "APOE",
    "keywords": "APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but shows a preferential binding to high-density lipoproteins (HDL). It also binds a wide range of cellular receptors including the LDL receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8 and the very low-density lipoprotein receptor/VLDLR that mediate the cellular uptake of the APOE-containing lipoprotein particles. Finally, APOE has also a heparin-binding activity and binds heparan-sulfate proteoglycans on the surface of cells, a property that supports the capture and the receptor-mediated uptake of APOE-containing lipoproteins by cells. A main function of APOE is to mediate lipoprotein clearance through the uptake of chylomicrons, VLDLs, and HDLs by hepatocytes. APOE is also involved in the biosynthesis by the liver of VLDLs as well as their uptake by peripheral tissues ensuring the delivery of triglycerides and energy storage in muscle, heart and adipose tissues. By participating to the lipoprotein-mediated distribution of lipids among tissues, APOE plays a critical role in plasma and tissues lipid homeostasis. APOE is also involved in two steps of reverse cholesterol transport, the HDLs-mediated transport of cholesterol from peripheral tissues to the liver, and thereby plays an important role in cholesterol homeostasis. First, it is functionally associated with ABCA1 in the biogenesis of HDLs in tissues. Second, it is enriched in circulating HDLs and mediates their uptake by hepatocytes. APOE also plays an important role in lipid transport in the central nervous system, regulating neuron survival and sprouting. APOE in also involved in innate and adaptive immune responses, controlling for instance the survival of myeloid-derived suppressor cells (By similarity). APOE, may also play a role in transcription regulation through a receptor-dependent and cholesterol-independent mechanism, that activates MAP3K12 and a non-canonical MAPK signal transduction pathway that results in enhanced AP-1-mediated transcription of APP."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1031,
  "fields": {
    "recname": "BRINP3",
    "keywords": "Inhibits neuronal cell proliferation by negative regulation of the cell cycle transition. Promotes pituitary gonadotrope cell proliferation, migration and invasion, when overexpressed. May play a role in cell pituitary tumor development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1032,
  "fields": {
    "recname": "CALU",
    "keywords": "Involved in regulation of vitamin K-dependent carboxylation of multiple N-terminal glutamate residues. Seems to inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low affinity (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1033,
  "fields": {
    "recname": "CAPZA1",
    "keywords": "F-actin-capping proteins bind in a Ca2+-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. May play a role in the formation of epithelial cell junctions."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1034,
  "fields": {
    "recname": "CES1P1",
    "keywords": "Has no esterase activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1035,
  "fields": {
    "recname": "CHIC2",
    "keywords": "CHIC2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1036,
  "fields": {
    "recname": "COMT",
    "keywords": "Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1037,
  "fields": {
    "recname": "CYP1A2",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2. Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis. May act as a major enzyme for all-trans retinoic acid biosynthesis in the liver. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid. Primarily catalyzes stereoselective epoxidation of the last double bond of polyunsaturated fatty acids (PUFA), displaying a strong preference for the (R,S) stereoisomer. Catalyzes bisallylic hydroxylation and omega-1 hydroxylation of PUFA. May also participate in eicosanoids metabolism by converting hydroperoxide species into oxo metabolites (lipoxygenase-like reaction, NADPH-independent). Plays a role in the oxidative metabolism of xenobiotics. Catalyzes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin. Metabolizes caffeine via N3-demethylation (Probable)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1038,
  "fields": {
    "recname": "CYP2A6",
    "keywords": "Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1,4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1039,
  "fields": {
    "recname": "CYP2B6",
    "keywords": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,4-cineole 2-exo-monooxygenase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1040,
  "fields": {
    "recname": "CYP2C18",
    "keywords": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1041,
  "fields": {
    "recname": "CYP2C19",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of polyunsaturated fatty acids (PUFA). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Hydroxylates PUFA specifically at the omega-1 position. Catalyzes the epoxidation of double bonds of PUFA . Also metabolizes plant monoterpenes such as limonene. Oxygenates (R)- and (S)-limonene to produce carveol and perillyl alcohol. Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine. Hydroxylates fenbendazole at the 4' position."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1042,
  "fields": {
    "recname": "CYP2C8",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Primarily catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFA) with a preference for the last double bond. Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes all trans-retinoic acid toward its 4-hydroxylated form. Displays 16-alpha hydroxylase activity toward estrogen steroid hormones, 17beta-estradiol (E2) and estrone (E1). Plays a role in the oxidative metabolism of xenobiotics. It is the principal enzyme responsible for the metabolism of the anti-cancer drug paclitaxel (taxol)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1043,
  "fields": {
    "recname": "CYP2C9",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids and steroids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFA). Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis. Exhibits low catalytic activity for the formation of catechol estrogens from 17beta-estradiol (E2) and estrone (E1), namely 2-hydroxy E1 and E2. Catalyzes bisallylic hydroxylation and hydroxylation with double-bond migration of polyunsaturated fatty acids (PUFA). Also metabolizes plant monoterpenes such as limonene. Oxygenates (R)- and (S)-limonene to produce carveol and perillyl alcohol. Contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1044,
  "fields": {
    "recname": "CYP2D6",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of fatty acids, steroids and retinoids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFA). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 20-hydroxyeicosatetraenoic acid ethanolamide (20-HETE-EA) and 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling. Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis. Catalyzes the oxidative transformations of all-trans retinol to all-trans retinal, a precursor for the active form all-trans-retinoic acid. Also involved in the oxidative metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1045,
  "fields": {
    "recname": "CYP3A4",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position. Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone. Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones. Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis. Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond. Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling. Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance. Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole. Hydroxylates antimalarial drug quinine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1046,
  "fields": {
    "recname": "CYP3A5",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of catechol estrogens from 17beta-estradiol (E2) and estrone (E1), namely 2-hydroxy E1 and E2. Catalyzes 6beta-hydroxylation of the steroid hormones testosterone, progesterone, and androstenedione. Catalyzes the oxidative conversion of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA). Further metabolizes all trans-retinoic acid (atRA) to 4-hydroxyretinoate and may play a role in hepatic atRA clearance. Also involved in the oxidative metabolism of xenobiotics, including calcium channel blocking drug nifedipine and immunosuppressive drug cyclosporine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1047,
  "fields": {
    "recname": "CYP3A7",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of steroid hormones and vitamins during embryogenesis. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes 3beta-hydroxyandrost-5-en-17-one (dehydroepiandrosterone, DHEA), a precursor in the biosynthesis of androgen and estrogen steroid hormones. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1), particularly D-ring hydroxylated estrone at the C16-alpha position. Mainly hydroxylates all trans-retinoic acid (atRA) to 4-hydroxyretinoate and may play a role in atRA clearance during fetal development. Also involved in the oxidative metabolism of xenobiotics including anticonvulsants."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1048,
  "fields": {
    "recname": "CYP4F2",
    "keywords": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, eicosanoids and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). Catalyzes predominantly the oxidation of the terminal carbon (omega-oxidation) of long- and very long-chain fatty acids. Displays high omega-hydroxylase activity toward polyunsaturated fatty acids (PUFAs). Participates in the conversion of arachidonic acid to omega-hydroxyeicosatetraenoic acid (20-HETE), a signaling molecule acting both as vasoconstrictive and natriuretic with overall effect on arterial blood pressure. Plays a role in the oxidative inactivation of eicosanoids, including both proinflammatory and anti-inflammatory mediators such as leukotriene B4 (LTB4), lipoxin A4 (LXA4), and several HETEs. Catalyzes omega-hydroxylation of 3-hydroxy fatty acids. Converts monoepoxides of linoleic acid leukotoxin and isoleukotoxin to omega-hydroxylated metabolites. Contributes to the degradation of very long-chain fatty acids (VLCFAs) by catalyzing successive omega-oxidations and chain shortening. Plays an important role in vitamin metabolism by chain shortening. Catalyzes omega-hydroxylation of the phytyl chain of tocopherols (forms of vitamin E), with preference for gamma-tocopherols over alpha-tocopherols, thus promoting retention of alpha-tocopherols in tissues . Omega-hydroxylates and inactivates phylloquinone (vitamin K1), and menaquinone-4 (MK-4, a form of vitamin K2), both acting as cofactors in blood coagulation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1049,
  "fields": {
    "recname": "DOT1L",
    "keywords": "Histone methyltransferase. Methylates 'Lys-79' of histone H3. Nucleosomes are preferred as substrate compared to free histones. Binds to DNA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1050,
  "fields": {
    "recname": "DRD1",
    "keywords": "Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1051,
  "fields": {
    "recname": "DRD2",
    "keywords": "Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1052,
  "fields": {
    "recname": "DTNBP1",
    "keywords": "Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex to facilitate the transport of TYRP1 independent of AP-3 function. Plays a role in synaptic vesicle trafficking and in neurotransmitter release. Plays a role in the regulation of cell surface exposure of DRD2. May play a role in actin cytoskeleton reorganization and neurite outgrowth. May modulate MAPK8 phosphorylation. Appears to promote neuronal transmission and viability through regulating the expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signaling and influencing glutamatergic release. Regulates the expression of SYN1 through binding to its promoter. Modulates prefrontal cortical activity via the dopamine/D2 pathway."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1053,
  "fields": {
    "recname": "DUSP1",
    "keywords": "Dual specificity phosphatase that dephosphorylates MAP kinase MAPK1/ERK2 on both 'Thr-183' and 'Tyr-185', regulating its activity during the meiotic cell cycle."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1054,
  "fields": {
    "recname": "EDNRA",
    "keywords": "Receptor for endothelin-1. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of binding affinities for ET-A is: ET1 > ET2 >> ET3."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1055,
  "fields": {
    "recname": "EPHX1",
    "keywords": "Biotransformation enzyme that catalyzes the hydrolysis of arene and aliphatic epoxides to less reactive and more water soluble dihydrodiols by the trans addition of water (By similarity). May play a role in the metabolism of endogenous lipids such as epoxide-containing fatty acids"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1056,
  "fields": {
    "recname": "FGF2",
    "keywords": "Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4. Also acts as an integrin ligand which is required for FGF2 signaling. Binds to integrin ITGAV:ITGB3. Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Can induce angiogenesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1057,
  "fields": {
    "recname": "FMO3",
    "keywords": "Essential hepatic enzyme that catalyzes the oxygenation of a wide variety of nitrogen- and sulfur-containing compounds including drugs as well as dietary compounds. Plays an important role in the metabolism of trimethylamine (TMA), via the production of trimethylamine N-oxide (TMAO) metabolite. TMA is generated by the action of gut microbiota using dietary precursors such as choline, choline containing compounds, betaine or L-carnitine. By regulating TMAO concentration, FMO3 directly impacts both platelet responsiveness and rate of thrombus formation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1058,
  "fields": {
    "recname": "FOXA3",
    "keywords": "Transcription factor that is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites (By similarity). Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis; binds to and activates transcription from the G6PC promoter. Binds to the CYP3A4 promoter and activates its transcription in cooperation with CEBPA. Binds to the CYP3A7 promoter together with members of the CTF/NF-I family. Involved in regulation of neuronal-specific transcription. May be involved in regulation of spermatogenesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1059,
  "fields": {
    "recname": "FPGS",
    "keywords": "Catalyzes conversion of folates to polyglutamate derivatives allowing concentration of folate compounds in the cell and the intracellular retention of these cofactors, which are important substrates for most of the folate-dependent enzymes that are involved in one-carbon transfer reactions involved in purine, pyrimidine and amino acid synthesis. Unsubstituted reduced folates are the preferred substrates. Metabolizes methotrexate (MTX) to polyglutamates."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1060,
  "fields": {
    "recname": "G6PD",
    "keywords": "Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. The main function of this enzyme is to provide reducing power (NADPH) and pentose phosphates for fatty acid and nucleic acid synthesis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1061,
  "fields": {
    "recname": "GGCX",
    "keywords": "Mediates the vitamin K-dependent carboxylation of glutamate residues to calcium-binding gamma-carboxyglutamate (Gla) residues with the concomitant conversion of the reduced hydroquinone form of vitamin K to vitamin K epoxide."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1062,
  "fields": {
    "recname": "GNB3",
    "keywords": "Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1063,
  "fields": {
    "recname": "GRIN1",
    "keywords": "Component of NMDA receptor complexes that function as heterotetrameric, ligand-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Channel activation requires binding of the neurotransmitter glutamate to the epsilon subunit, glycine binding to the zeta subunit, plus membrane depolarization to eliminate channel inhibition by Mg2+. Sensitivity to glutamate and channel kinetics depend on the subunit composition."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1064,
  "fields": {
    "recname": "GRK4",
    "keywords": "Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1065,
  "fields": {
    "recname": "GRK5",
    "keywords": "Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein-coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors, muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70-interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2-mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor. Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1066,
  "fields": {
    "recname": "HLA-A",
    "keywords": "HLA-A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1067,
  "fields": {
    "recname": "HLA-B",
    "keywords": "HLA-B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1068,
  "fields": {
    "recname": "HMGCR",
    "keywords": "Transmembrane glycoprotein that is the rate-limiting enzyme in cholesterol biosynthesis as well as in the biosynthesis of nonsterol isoprenoids that are essential for normal cell function including ubiquinone and geranylgeranyl proteins."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1069,
  "fields": {
    "recname": "HNF4A",
    "keywords": "Transcriptional regulator which controls the expression of hepatic genes during the transition of endodermal cells to hepatic progenitor cells, facilitating the recruitment of RNA pol II to the promoters of target genes. Activates the transcription of CYP2C38 (By similarity). Represses the CLOCK-ARNTL/BMAL1 transcriptional activity and is essential for circadian rhythm maintenance and period regulation in the liver and colon cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1070,
  "fields": {
    "recname": "IFNL3",
    "keywords": "Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1071,
  "fields": {
    "recname": "IFNL4",
    "keywords": "Cytokine that may trigger an antiviral response activating the JAK-STAT pathway and up-regulating specifically some interferon-stimulated genes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1072,
  "fields": {
    "recname": "LDLR",
    "keywords": "Binds LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. (Microbial infection) Acts as a receptor for hepatitis C virus in hepatocytes, but not through a direct interaction with viral proteins. (Microbial infection) Acts as a receptor for Vesicular stomatitis virus. (Microbial infection) In case of HIV-1 infection, may function as a receptor for extracellular Tat in neurons, mediating its internalization in uninfected cells."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1073,
  "fields": {
    "recname": "LRRC15",
    "keywords": "LRRC15"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1074,
  "fields": {
    "recname": "MMP9",
    "keywords": "May play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption. Cleaves KiSS1 at a Gly-|-Leu bond. Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments. Degrades fibronectin but not laminin or Pz-peptide."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1075,
  "fields": {
    "recname": "MOV10",
    "keywords": "5' to 3' RNA helicase contributing to UPF1 mRNA target degradation by translocation along 3' UTRs. Required for microRNA (miRNA)-mediated gene silencing by the RNA-induced silencing complex (RISC). Required for both miRNA-mediated translational repression and miRNA-mediated cleavage of complementary mRNAs by RISC. In cooperation with FMR1, regulates miRNA-mediated translational repression by AGO2. Restricts retrotransposition of long interspersed element-1 (LINE-1) in cooperation with TUT4 and TUT7 counteracting the RNA chaperonne activity of L1RE1. Facilitates LINE-1 uridylation by TUT4 and TUT7. Required for embryonic viability and for normal central nervous system development and function. Plays two critical roles in early brain development: suppresses retroelements in the nucleus by directly inhibiting cDNA synthesis, while regulates cytoskeletal mRNAs to influence neurite outgrowth in the cytosol (By similarity). May function as a messenger ribonucleoprotein (mRNP) clearance factor."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1076,
  "fields": {
    "recname": "MTHFR",
    "keywords": "Catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1077,
  "fields": {
    "recname": "NEDD4L",
    "keywords": "E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Inhibits TGF-beta signaling by triggering SMAD2 and TGFBR1 ubiquitination and proteasome-dependent degradation. Promotes ubiquitination and internalization of various plasma membrane channels such as ENaC, SCN2A/Nav1.2, SCN3A/Nav1.3, SCN5A/Nav1.5, SCN9A/Nav1.7, SCN10A/Nav1.8, KCNA3/Kv1.3, KCNH2, EAAT1, KCNQ2/Kv7.2, KCNQ3/Kv7.3 or CLC5. Promotes ubiquitination and degradation of SGK1 and TNK2. Ubiquitinates BRAT1 and this ubiquitination is enhanced in the presence of NDFIP1. Plays a role in dendrite formation by melanocytes. Involved in the regulation of TOR signaling. Ubiquitinates and regulates protein levels of NTRK1 once this one is activated by NGF."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1078,
  "fields": {
    "recname": "NR1I2",
    "keywords": "Nuclear receptor that binds and is activated by variety of endogenous and xenobiotic compounds. Transcription factor that activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs and endogenous compounds. Activated by the antibiotic rifampicin and various plant metabolites, such as hyperforin, guggulipid, colupulone, and isoflavones. Response to specific ligands is species-specific. Activated by naturally occurring steroids, such as pregnenolone and progesterone. Binds to a response element in the promoters of the CYP3A4 and ABCB1/MDR1 genes."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1079,
  "fields": {
    "recname": "NR1I3",
    "keywords": "Binds and transactivates the retinoic acid response elements that control expression of the retinoic acid receptor beta 2 and alcohol dehydrogenase 3 genes. Transactivates both the phenobarbital responsive element module of the human CYP2B6 gene and the CYP3A4 xenobiotic response element."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1080,
  "fields": {
    "recname": "OPRD1",
    "keywords": "G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1081,
  "fields": {
    "recname": "OPRK1",
    "keywords": "G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain. Plays a role in mediating reduced physical activity upon treatment with synthetic opioids. Plays a role in the regulation of salivation in response to synthetic opioids. May play a role in arousal and regulation of autonomic and neuroendocrine functions."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1082,
  "fields": {
    "recname": "OPRM1",
    "keywords": "Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effector. The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extent to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15. They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B. Also couples to adenylate cyclase stimulatory G alpha proteins. The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4. Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization. Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction. The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins. The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation. Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling. Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling. Endogenous ligands induce rapid desensitization, endocytosis and recycling whereas morphine induces only low desensitization and endocytosis. Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties. Involved in neurogenesis. Isoform 12 couples to GNAS and is proposed to be involved in excitatory effects. Isoform 16 and isoform 17 do not bind agonists but may act through oligomerization with binding-competent OPRM1 isoforms and reduce their ligand binding activity."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1083,
  "fields": {
    "recname": "P2RY12",
    "keywords": "Receptor for ADP and ATP coupled to G-proteins that inhibit the adenylyl cyclase second messenger system. Not activated by UDP and UTP. Required for normal platelet aggregation and blood coagulation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1084,
  "fields": {
    "recname": "PADI4",
    "keywords": "Catalyzes the citrullination/deimination of arginine residues of proteins such as histones, thereby playing a key role in histone code and regulation of stem cell maintenance. Citrullinates histone H1 at 'Arg-54' (to form H1R54ci), histone H3 at 'Arg-2', 'Arg-8', 'Arg-17' and/or 'Arg-26' (to form H3R2ci, H3R8ci, H3R17ci, H3R26ci, respectively) and histone H4 at 'Arg-3' (to form H4R3ci). Acts as a key regulator of stem cell maintenance by mediating citrullination of histone H1: citrullination of 'Arg-54' of histone H1 (H1R54ci) results in H1 displacement from chromatin and global chromatin decondensation, thereby promoting pluripotency and stem cell maintenance. Promotes profound chromatin decondensation during the innate immune response to infection in neutrophils by mediating formation of H1R54ci. Citrullination of histone H3 prevents their methylation by CARM1 and HRMT1L2/PRMT1 and represses transcription. Citrullinates EP300/P300 at 'Arg-2142', which favors its interaction with NCOA2/GRIP1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1085,
  "fields": {
    "recname": "PCSK9",
    "keywords": "Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation. Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway. Inhibits epithelial Na+ channel (ENaC)-mediated Na+ absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1086,
  "fields": {
    "recname": "POR",
    "keywords": "This enzyme is required for electron transfer from NADP to cytochrome P450 in microsomes. It can also provide electron transfer to heme oxygenase and cytochrome B5."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1087,
  "fields": {
    "recname": "PRSS53",
    "keywords": "In vitro can degrade the fibrinogen alpha chain of as well as pro-urokinase-type plasminogen activator."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1088,
  "fields": {
    "recname": "PTPRD",
    "keywords": "Can bidirectionally induce pre- and post-synaptic differentiation of neurons by mediating interaction with IL1RAP and IL1RAPL1 trans-synaptically. Involved in pre-synaptic differentiation through interaction with SLITRK2."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1089,
  "fields": {
    "recname": "RGS4",
    "keywords": "Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Activity on G(z)-alpha is inhibited by phosphorylation of the G-protein. Activity on G(z)-alpha and G(i)-alpha-1 is inhibited by palmitoylation of the G-protein."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1090,
  "fields": {
    "recname": "RRM1",
    "keywords": "Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1091,
  "fields": {
    "recname": "RRM2",
    "keywords": "Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. Inhibits Wnt signaling."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1092,
  "fields": {
    "recname": "RRM2B",
    "keywords": "Plays a pivotal role in cell survival by repairing damaged DNA in a p53/TP53-dependent manner. Supplies deoxyribonucleotides for DNA repair in cells arrested at G1 or G2. Contains an iron-tyrosyl free radical center required for catalysis. Forms an active ribonucleotide reductase (RNR) complex with RRM1 which is expressed both in resting and proliferating cells in response to DNA damage."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1093,
  "fields": {
    "recname": "RXRA",
    "keywords": "Receptor for retinoic acid that acts as a transcription factor. Forms homo- or heterodimers with retinoic acid receptors (RARs) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5 to regulate transcription. The high affinity ligand for retinoid X receptors (RXRs) is 9-cis retinoic acid. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone deacetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and coactivators are recruited leading to transcriptional activation. Serves as a common heterodimeric partner for a number of nuclear receptors, such as RARA, RARB and PPARA. The RXRA/RARB heterodimer can act as a transcriptional repressor or transcriptional activator, depending on the RARE DNA element context. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes. Together with RARA, positively regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1 signaling response to pulsatile shear stress in vascular endothelial cells. Acts as an enhancer of RARA binding to RARE DNA element. May facilitate the nuclear import of heterodimerization partners such as VDR and NR4A1. Promotes myelin debris phagocytosis and remyelination by macrophages. Plays a role in the attenuation of the innate immune system in response to viral infections, possibly by negatively regulating the transcription of antiviral genes such as type I IFN genes. Involved in the regulation of calcium signaling by repressing ITPR2 gene expression, thereby controlling cellular senescence."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1094,
  "fields": {
    "recname": "SH2B3",
    "keywords": "Links T-cell receptor activation signal to phospholipase C-gamma-1, GRB2 and phosphatidylinositol 3-kinase."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1095,
  "fields": {
    "recname": "SLC10A1",
    "keywords": "The hepatic sodium/bile acid uptake system exhibits broad substrate specificity and transports various non-bile acid organic compounds as well. It is strictly dependent on the extracellular presence of sodium."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1096,
  "fields": {
    "recname": "SLC18A2",
    "keywords": "Involved in the ATP-dependent vesicular transport of biogenic amine neurotransmitters. Pumps cytosolic monoamines including dopamine, norepinephrine, serotonin, and histamine into synaptic vesicles. Requisite for vesicular amine storage prior to secretion via exocytosis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1097,
  "fields": {
    "recname": "SLC22A12",
    "keywords": "Required for efficient urate re-absorption in the kidney. Regulates blood urate levels. Mediates saturable urate uptake by facilitating the exchange of urate against organic anions."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1098,
  "fields": {
    "recname": "SLC25A31",
    "keywords": "Catalyzes the exchange of cytoplasmic ADP with mitochondrial ATP across the mitochondrial inner membrane. May serve to mediate energy generating and energy consuming processes in the distal flagellum, possibly as a nucleotide shuttle between flagellar glycolysis, protein phosphorylation and mechanisms of motility."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1099,
  "fields": {
    "recname": "SLC6A4",
    "keywords": "Serotonin transporter whose primary function in the central nervous system involves the regulation of serotonergic signaling via transport of serotonin molecules from the synaptic cleft back into the pre-synaptic terminal for re-utilization. Plays a key role in mediating regulation of the availability of serotonin to other receptors of serotonergic systems. Terminates the action of serotonin and recycles it in a sodium-dependent manner."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1100,
  "fields": {
    "recname": "SLCO1B1",
    "keywords": "Mediates the Na+-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. Involved in the clearance of bile acids and organic anions from the liver."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1101,
  "fields": {
    "recname": "SORCS2",
    "keywords": "The heterodimer formed by NGFR and SORCS2 functions as receptor for the precursor forms of NGF (proNGF) and BDNF (proBDNF). ProNGF and proBDNF binding both promote axon growth cone collapse (in vitro). Plays a role in the regulation of dendritic spine density in hippocampus neurons (By similarity). Required for normal neurite branching and extension in response to BDNF. Plays a role in BDNF-dependent hippocampal synaptic plasticity. Together with NGFR and NTRK2, is required both for BDNF-mediated synaptic long-term depression and long-term potentiation. ProNGF binding promotes dissociation of TRIO from the heterodimer, which leads to inactivation of RAC1 and/or RAC2 and subsequent reorganization of the actin cytoskeleton. Together with the retromer complex subunit VPS35, required for normal expression of GRIN2A at synapses and dendritic cell membranes. Required for normal expression of the amino acid transporter SLC1A1 at the cell membrane, and thereby contributes to protect cells against oxidative stress (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1102,
  "fields": {
    "recname": "STX1B",
    "keywords": "Potentially involved in docking of synaptic vesicles at presynaptic active zones. May mediate Ca2+-regulation of exocytosis acrosomal reaction in sperm (By similarity)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1103,
  "fields": {
    "recname": "SULT1A1",
    "keywords": "Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of catecholamines, phenolic drugs and neurotransmitters. Has also estrogen sulfotransferase activity. responsible for the sulfonation and activation of minoxidil. Is Mediates the metabolic activation of carcinogenic N-hydroxyarylamines to DNA binding products and could so participate as modulating factor of cancer risk."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1104,
  "fields": {
    "recname": "UGT1A1",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1105,
  "fields": {
    "recname": "UGT2B10",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1106,
  "fields": {
    "recname": "UGT2B15",
    "keywords": "UDPGTs are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isozyme displays activity toward several classes of xenobiotic substrates, including simple phenolic compounds, 7-hydroxylated coumarins, flavonoids, anthraquinones, and certain drugs and their hydroxylated metabolites. It also catalyzes the glucuronidation of endogenous estrogens and androgens."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1107,
  "fields": {
    "recname": "UGT2B7",
    "keywords": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Its unique specificity for 3,4-catechol estrogens and estriol suggests it may play an important role in regulating the level and activity of these potent and active estrogen metabolites. Is also active with androsterone, hyodeoxycholic acid and tetrachlorocatechol (in vitro)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1108,
  "fields": {
    "recname": "VEGFA",
    "keywords": "Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth. Binding to NRP1 receptor initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (By similarity)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1109,
  "fields": {
    "recname": "VEGFC",
    "keywords": "Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates KDR/VEGFR2 and FLT4/VEGFR3 receptors."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1110,
  "fields": {
    "recname": "VKORC1",
    "keywords": "Involved in vitamin K metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K. Vitamin K is required for the gamma-carboxylation of various proteins, including clotting factors, and is required for normal blood coagulation, but also for normal bone development."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1111,
  "fields": {
    "recname": "XDH",
    "keywords": "Key enzyme in purine degradation. Catalyzes the oxidation of hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric acid. Contributes to the generation of reactive oxygen species. Has also low oxidase activity towards aldehydes (in vitro)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1112,
  "fields": {
    "recname": "ZMAT4",
    "keywords": "ZMAT4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1113,
  "fields": {
    "recname": "ZNF536",
    "keywords": "ZNF536"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1114,
  "fields": {
    "recname": "warfarin",
    "keywords": "Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1115,
  "fields": {
    "recname": "haloperidol",
    "keywords": "Haloperidol is indicated for a number of conditions including for the treatment of schizophrenia, for the manifestations of psychotic disorders, for the control of tics and vocal utterances of Tourette\u2019s Disorder in children and adults, for treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). Haloperidol is also indicated in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. Haloperidol should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1116,
  "fields": {
    "recname": "clozapine",
    "keywords": "For use in patients with treatment-resistant schizophrenia."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1117,
  "fields": {
    "recname": "mephenytoin",
    "keywords": "For the treatment of refractory partial epilepsy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1118,
  "fields": {
    "recname": "efavirenz",
    "keywords": "(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1119,
  "fields": {
    "recname": "amlodipine",
    "keywords": "Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetal\u2019s or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1120,
  "fields": {
    "recname": "salbutamol",
    "keywords": "Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known to induce bronchospasm."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1121,
  "fields": {
    "recname": "phenytoin",
    "keywords": "For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1122,
  "fields": {
    "recname": "zidovudine",
    "keywords": "Used in combination with other antiretroviral agents for the treatment of human immunovirus (HIV) infections."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1123,
  "fields": {
    "recname": "caffeine",
    "keywords": "For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1124,
  "fields": {
    "recname": "tacrolimus",
    "keywords": "For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1125,
  "fields": {
    "recname": "simvastatin",
    "keywords": "Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL\u2011C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1126,
  "fields": {
    "recname": "nelfinavir",
    "keywords": "Used in combination with other antiviral drugs in the treatment of HIV in both adults and children."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1127,
  "fields": {
    "recname": "nevirapine",
    "keywords": "For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1128,
  "fields": {
    "recname": "artesunate",
    "keywords": "For the treatment of severe malaria caused by Plasmodium falciparum in adults and children"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1129,
  "fields": {
    "recname": "Amodiaquine",
    "keywords": "For treatment of acute malarial attacks in non-immune subjects."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1130,
  "fields": {
    "recname": "hydrochlorothiazide",
    "keywords": "Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1131,
  "fields": {
    "recname": "nicotine",
    "keywords": "For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1132,
  "fields": {
    "recname": "metoprolol",
    "keywords": "Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1133,
  "fields": {
    "recname": "Beta Blocking Agents",
    "keywords": "ambiguous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1134,
  "fields": {
    "recname": "carbamazepine",
    "keywords": "Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. "
  }
},
{
  "model": "agmp_app.index",
  "pk": 1135,
  "fields": {
    "recname": "bupropion",
    "keywords": "Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1136,
  "fields": {
    "recname": "peginterferon alfa-2a",
    "keywords": "Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease Label. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies. Peginterferon alfa-2a is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1137,
  "fields": {
    "recname": "ribavirin",
    "keywords": "Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates. The addition of ribavirin in Technivie therapy indicated for treating HCV genotype 1a and 4 infections is recommended in patients with or without cirrhosis.Resistance: viral genetic determinants resulting in variable response to ribavirin therapy has not been yet determined."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1138,
  "fields": {
    "recname": "peginterferon alfa-2b",
    "keywords": "Peginterferon alfa-2b is indicated for the treatment of HCV in combination with Ribavirin and a NS3/4A protease inhibitor for genotype 1 or without a NS3/4A protease inhibitor for genotypes 2-6. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1139,
  "fields": {
    "recname": "citalopram",
    "keywords": "For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1140,
  "fields": {
    "recname": "acenocoumarol",
    "keywords": "For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1141,
  "fields": {
    "recname": "losartan",
    "keywords": "Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1142,
  "fields": {
    "recname": "atorvastatin",
    "keywords": "Atorvastatin is approved for the treatment of several types of dyslipidemias including: Primary hyperlipidemia and mixed dyslipidemia in adults, Hypertriglyceridemia, Primary dysbetalipoproteinemia, Homozygous familial hypercholesterolemia, Heterozygous familial hypercholesterolemia in adolescent patients with failed dietary modifications. Dyslipidemia is defined as an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis. Atorvastatin is indicated, in combination with dietary modifications, to prevent cardiovascular events in patients with cardiac risk factors and/or abnormal lipid profiles. Atorvastatin can be used as a preventive agent for myocardial infarction, stroke, revascularization, and angina, in patients without coronary heart disease but with multiple risk factors, and in patients with type 2 diabetes without coronary heart disease but multiple risk factors. Atorvastatin can also be used as a preventive agent for non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure and angina in patients with coronary heart disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1143,
  "fields": {
    "recname": "ramipril",
    "keywords": "For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1144,
  "fields": {
    "recname": "codeine",
    "keywords": "Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1145,
  "fields": {
    "recname": "atenolol",
    "keywords": "1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis.3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1146,
  "fields": {
    "recname": "Cladribine",
    "keywords": "For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1147,
  "fields": {
    "recname": "cytarabine",
    "keywords": "For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1148,
  "fields": {
    "recname": "artemisinin and derivatives",
    "keywords": "Not available"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1149,
  "fields": {
    "recname": "dextromethorphan",
    "keywords": "For treatment and relief of dry cough."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1150,
  "fields": {
    "recname": "Debrisoquine",
    "keywords": "For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1151,
  "fields": {
    "recname": "metoprolol",
    "keywords": "Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1152,
  "fields": {
    "recname": "atazanavir",
    "keywords": "Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1153,
  "fields": {
    "recname": "voriconazole",
    "keywords": "For the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1154,
  "fields": {
    "recname": "hydralazine",
    "keywords": "For the treatment of essential hypertension, alone or as an adjunct. Also for the management of severe hypertension when the drug cannot be given orally or when blood pressure must be lowered immediately, congestive heart failure (in combination with cardiac glycosides and diuretics and/or with isosorbide dinitrate), and hypertension secondary to pre-eclampsia/eclampsia."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1155,
  "fields": {
    "recname": "isosorbide dinitrate",
    "keywords": "For the prevention of angina pectoris due to coronary artery disease."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1156,
  "fields": {
    "recname": "atenolol",
    "keywords": "Indicated for: 1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis. 3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1157,
  "fields": {
    "recname": "hydrochlorothiazide",
    "keywords": "Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1158,
  "fields": {
    "recname": "trandolapril",
    "keywords": "For the treatment of mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure (CHF), to improve survival following myocardial infarction (MI) in individuals who are hemodynamically stable and demonstrate symptoms of left ventricular systolic dysfunction or signs of CHF within a few days following acute MI, and to slow progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1159,
  "fields": {
    "recname": "verapamil",
    "keywords": "For the treatment of hypertension, angina, and cluster headache prophylaxis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1160,
  "fields": {
    "recname": "hmg coa reductase inhibitors",
    "keywords": "This is a class of dugs That reduce illness and mortality in those who are at high risk of cardiovascular disease. There are various forms of statins, some of which include atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1161,
  "fields": {
    "recname": "lopinavir",
    "keywords": "Indicated in combination with other antiretroviral agents for the treatment of HIV-infection."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1162,
  "fields": {
    "recname": "imatinib",
    "keywords": "For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST)."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1163,
  "fields": {
    "recname": "lumefantrine",
    "keywords": "Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1164,
  "fields": {
    "recname": "bevacizumab",
    "keywords": "As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1165,
  "fields": {
    "recname": "cotinine",
    "keywords": "Cotinine is an alkaloid found in tobacco and is also the predominant metabolite of nicotine."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1166,
  "fields": {
    "recname": "levonorgestrel",
    "keywords": "Emergency contraception: Levonorgestrel, in the single-agent emergency contraceptive form, is indicated for the prevention of pregnancy after the confirmed or suspected failure of contraception methods or following unprotected intercourse. It is distributed by prescription for patients under 17, and over the counter for those above this age. This levonorgestrel-only form of contraception is not indicated for regular contraception and must be taken as soon as possible within 72 hours after intercourse. It has shown a lower efficacy when it is used off label within 96 hours. Long-term contraception or nonemergency contraception: In addition to the above indication in emergency contraception, levonorgestrel is combined with other contraceptives in contraceptive formulations designed for regular use, for example with ethinyl estradiol. It is used in various hormone-releasing intrauterine devices for long-term contraception ranging for a duration of 3-5 years. Product labeling for Mirena specifically mentions that it is recommended in women who have had at least 1 child. A subdermal implant is also available for the prevention of pregnancy for up to 5 years. Hormone therapy and off-label uses: Levonorgestrel is prescribed in combination with estradiol as hormone therapy during menopause to manage vasomotor symptoms and to prevent osteoporosis.24Off-label, levonorgestrel may be used to treat menorrhagia, endometrial hyperplasia, and endometriosis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1167,
  "fields": {
    "recname": "aripiprazole",
    "keywords": "Aripiprazole is indicated for manic and mixed episodes associated with bipolar I disorder, irritability associated with autism spectrum disorder, treatment of schizophrenia, treatment of Tourette's disorder, and as an adjunctive treatment of major depressive disorder. An injectable formulation of aripiprazole is indicated for agitation associated with schizophrenia or bipolar mania."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1168,
  "fields": {
    "recname": "buprenorphine",
    "keywords": "For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1169,
  "fields": {
    "recname": "rosuvastatin",
    "keywords": "The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1170,
  "fields": {
    "recname": "hydrocodone",
    "keywords": "Hydrocodone is indicated for the management of acute pain, sometimes in combination with acetaminophen or ibuprofen, as well as the symptomatic treatment of the common cold and allergic rhinitis in combination with decongestants, antihistamines, and expectorants."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1171,
  "fields": {
    "recname": "methadone",
    "keywords": "Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Methadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1172,
  "fields": {
    "recname": "acenocoumarol",
    "keywords": "For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1173,
  "fields": {
    "recname": "warfarin",
    "keywords": "Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1174,
  "fields": {
    "recname": "cyclosporine",
    "keywords": "Cyclosporine is officially approved for different conditions listed below: Prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. For this indication, it can be used concomitantly with azathioprine and corticosteroids. Treatment of patients with severe active, rheumatoid arthritis when the patient no longer responds to methotrexate. Concomitantly with methotrexate for the treatment of patients with severe active rheumatoid arthritis when patients do not respond to methotrexate treatment alone. Treatment of adult nonimmunocompromised patients with severe, recalcitrant, plaque psoriasis that have failed to respond to at least one systemic therapy or when systemic therapies are not tolerated or contraindicated. Its ophthalmic solution is indicated to increase tear production in patients with keratoconjunctivitis sicca in patients from 4 years old. Prevention of graft rejection following bone marrow transplantation and in the treatment of graft-versus-host disease (GVHD). Treatment of steroid dependent and steroid-resistant nephrotic syndrome due to glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis or membranous glomerulonephritis in adults and children. Away from all this approved and reviewed indications, cyclosporine is commonly used on dermatology for the treatment of various inflammatory skin conditions such as atopic dermatitis, blistering disorders, and connective tissue diseases."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1175,
  "fields": {
    "recname": "interferon alfa-2a recombinant",
    "keywords": "For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatment of oral warts arising from HIV infection."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1176,
  "fields": {
    "recname": "Interferon alfa-2b recombinant",
    "keywords": "For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1177,
  "fields": {
    "recname": "methotrexate",
    "keywords": "Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis. Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis. Other formulations are indicated to treat gestational choriocarcinoma, chorioadenoma destruens, hydatiform mole, breast cancer, epidermoid cancer of the head and neck, advanced mycosis fungoides, lung cancer, and advanced non-Hodgkin's lymphoma. It is also used in the maintenance of acute lymphocytic leukemia. Methotrexate is also given before treatment with leucovorin to prolong relapse-free survival following surgical removal of a tumour in non-metastatic osteosarcoma."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1178,
  "fields": {
    "recname": "clopidogrel",
    "keywords": "Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1179,
  "fields": {
    "recname": "morphine",
    "keywords": "Morphine is used for the management of chronic moderate-to-severe pain. Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder and drug abuse."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1180,
  "fields": {
    "recname": "o-desmethyltramadol",
    "keywords": "o-desmethyltramadol is an opioid analgesic and the main active metabolite of tramadol"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1181,
  "fields": {
    "recname": "omeprazole",
    "keywords": "Omeprazole, according to the FDA label Label is a proton pump inhibitor (PPI) used for the following purposes: Treatment of active duodenal ulcer in adults. Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults. Treatment of active benign gastric ulcer in adults. Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 1 year of age and older Treatment of erosive esophagitis (EE) due to acid-mediated GERD in patients 1 month of age and older. Maintenance of healing of EE due to acid-mediated GERD in patients 1 year of age and older. Pathologic hypersecretory conditions in adults."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1182,
  "fields": {
    "recname": "olanzapine",
    "keywords": "Olanzapine was initially used orally and intramuscularly for the chronic treatment of schizophrenia in patients over 13 years old and other psychiatric disorders such as bipolar I disorder including mixed or manic episodes. Olanzapine is also indicated, in combination with lithium or valproate for the short-term treatment of acute manic or mixed episodes associated with bipolar I disorder in adults. As well, olanzapine is indicated, in combination with fluoxetine for the treatment of episodes of depression associated with bipolar disorder type 1 and treatment-resistant depression in patients over 10 years old. Olanzapine is also approved for the management of psychomotor agitation associated with schizophrenia and bipolar I mania. Schizophrenia is a complex biochemical brain disorder that affects the person's ability to differentiate reality. It is usually observed as the presence of delusions, hallucinations, social withdrawal and disturbed thinking. Bipolar disorder is a mental health condition defined by periods of extreme mood disturbances. It is categorized in different types from which type 1 is known to involve episodes of severe mania and often depression while type 2 presents less severe forms of mania."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1183,
  "fields": {
    "recname": "perphenazine",
    "keywords": "For use in the management of the manifestations of psychotic disorders and for the control of severe nausea and vomiting in adults."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1184,
  "fields": {
    "recname": "risperidone",
    "keywords": "Risperidone is indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with Bipolar I Disorder, and irritability associated with autistic disorder. Risperidone has additional indications through Health Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches. Risperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1185,
  "fields": {
    "recname": "quetiapine",
    "keywords": "Quetiapine is used in the symptomatic treatment of schizophrenia. It may be used for the management of acute manic or mixed episodes in patients bipolar I disorder as a monotherapy or with other agents. It is also used in the management of depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression. Some off-label uses for this drug include post-traumatic stress disorder (PTSD), generalized anxiety, and psychosis associated with Parkinson's disease."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1186,
  "fields": {
    "recname": "ziprasidone",
    "keywords": "In it's oral form, ziprasidone is approved for the treatment of Schizophrenia, as monotherapy for acute treatment of manic or mixed episodes related to bipolar I disorder, and as adjunctive therapy to lithium or valproate for maintenance treatment of bipolar I disorder. The injectable formulation is approved only for treatment of acute agitation in schizophrenia."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1187,
  "fields": {
    "recname": "telaprevir",
    "keywords": "Telaprevir, when used in combination with Ribavirin, Peginterferon alfa-2a, and Peginterferon alfa-2b is indicated for use in the treatment of chronic HCV genotype 1 infection in adults"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1188,
  "fields": {
    "recname": "allopurinol",
    "keywords": "Allopurinol is indicated in: 1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present. 3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1189,
  "fields": {
    "recname": "febuxostat",
    "keywords": "For the treatment of hyperuricemia in patients with gout."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1190,
  "fields": {
    "recname": "acetaminophen",
    "keywords": "In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being oral forms. Acetaminophen injection is indicated for: Management of mild to moderate pain, Management of moderate to severe pain with adjunctive opioid analgesics, Reduction of fever. Because of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics. Specific dosing guidelines should be followed when administering acetaminophen to children."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1191,
  "fields": {
    "recname": "uric acid",
    "keywords": "There is no approved indication for uric acid. The potential therapeutic use for uric acid is as an adjunct in acute ischemic stroke."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1192,
  "fields": {
    "recname": "prednisone",
    "keywords": "For the treatment of drug-induced allergic reactions, perennial or seasonal allergic rhinitis, serum sickness, giant cell arteritis acute rheumatic or nonrheumatic carditis, systemic dermatomyositis, systemic lupus erythematosus, atopic dermatitis, contact dermatitis, exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe (Stevens-Johnson syndrome) erythema multiforme, mycosis fungoides, pemphigus, severe psoriasis, acute adrenocortical insufficiency, Addison's disease, secondary adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with neoplasms, nonsuppurative thyroiditis, ulceratice colitis, Crohn's disease, acquired hemolytic anemia, congenital hypoplastic anemia, erythroblastopenia, adult secondary thrombocytopenia, adult idiopathic thrombocytopenia purpura, acute or subacute bursitis, epicondylitis, acute nonspecific tenosynovitis, acute or chronic lymphocytic leukemia, Hodgkin's or non-Hodgkin's lynphomas, Waldenstrom's macroglobulinemia, primary brain tumors (adjunct), nephrotic syndrome, tuberculous meningitis, multiple sclerosis, myasthenia gravis. cerebral edema, chorioretinitis, diffuse posterior choroiditis, aleergic conjunctivitis, Herpes zoster ophthalmicus, anterior segment inflammation, iridocyclitis, iritis, keratitis, optoc neuritis, sympathetic ophthalmia, corneal marginal allergic ulcers, symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy and aspiration pneumonitis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1193,
  "fields": {
    "recname": "emtricitabine",
    "keywords": "Indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and for postexposure prophylaxis of HIV infection in health care workers and others exposed occupationally or nonoccupationally via percutaneous injury or mucous membrane or nonintact skin contact with blood, tissues, or other body fluids associated with risk for transmission of the virus."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1194,
  "fields": {
    "recname": "rs28371685",
    "keywords": "Allele T is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1195,
  "fields": {
    "recname": "rs28371685",
    "keywords": "Allele T is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1196,
  "fields": {
    "recname": "rs28371686",
    "keywords": "Allele G is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1197,
  "fields": {
    "recname": "rs28371686",
    "keywords": "Allele G is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1198,
  "fields": {
    "recname": "rs7900194",
    "keywords": "Allele A is associated with decreased dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1199,
  "fields": {
    "recname": "rs7900194",
    "keywords": "Allele A is associated with decreased dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1200,
  "fields": {
    "recname": "rs9332131",
    "keywords": "Genotype DEL is associated with decreased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1201,
  "fields": {
    "recname": "rs9332131",
    "keywords": "Genotype DEL is associated with decreased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1202,
  "fields": {
    "recname": "rs1057910",
    "keywords": "Allele C is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1203,
  "fields": {
    "recname": "rs1057910",
    "keywords": "Allele C is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1204,
  "fields": {
    "recname": "rs1799853",
    "keywords": "Allele T is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1205,
  "fields": {
    "recname": "rs1799853",
    "keywords": "Allele T is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1206,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Allele T is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1207,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Allele T is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1208,
  "fields": {
    "recname": "rs2884737",
    "keywords": "Allele C is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1209,
  "fields": {
    "recname": "rs2884737",
    "keywords": "Allele C is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1210,
  "fields": {
    "recname": "rs17880887",
    "keywords": "Allele T is not associated with decreased dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1211,
  "fields": {
    "recname": "rs17880887",
    "keywords": "Allele T is not associated with decreased dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1212,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Allele T is not associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1213,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Allele T is not associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1214,
  "fields": {
    "recname": "rs7089580",
    "keywords": "Allele T is associated with increased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1215,
  "fields": {
    "recname": "rs7089580",
    "keywords": "Allele T is associated with increased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1216,
  "fields": {
    "recname": "rs61162043",
    "keywords": "Allele G is associated with increased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1217,
  "fields": {
    "recname": "rs61162043",
    "keywords": "Allele G is associated with increased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1218,
  "fields": {
    "recname": "rs7089580",
    "keywords": "Genotype AT is associated with increased dose of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1219,
  "fields": {
    "recname": "rs7089580",
    "keywords": "Genotype AT is associated with increased dose of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1220,
  "fields": {
    "recname": "rs7089580",
    "keywords": "Genotype AT is associated with increased clearance of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1221,
  "fields": {
    "recname": "rs7089580",
    "keywords": "Genotype AT is associated with increased clearance of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1222,
  "fields": {
    "recname": "rs28371686",
    "keywords": "Allele G is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1223,
  "fields": {
    "recname": "rs28371686",
    "keywords": "Allele G is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1224,
  "fields": {
    "recname": "rs9332131",
    "keywords": "Allele del is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1225,
  "fields": {
    "recname": "rs9332131",
    "keywords": "Allele del is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1226,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotype GG is not associated with dose of warfarin in Pulmonary Embolism as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1227,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotype GG is not associated with dose of warfarin in Pulmonary Embolism as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1228,
  "fields": {
    "recname": "rs202201137",
    "keywords": "Allele G is associated with decreased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1229,
  "fields": {
    "recname": "rs202201137",
    "keywords": "Allele G is associated with decreased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1230,
  "fields": {
    "recname": "rs28371686",
    "keywords": "Allele G is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1231,
  "fields": {
    "recname": "rs28371686",
    "keywords": "Allele G is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1232,
  "fields": {
    "recname": "rs1799853",
    "keywords": "Allele T is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1233,
  "fields": {
    "recname": "rs1799853",
    "keywords": "Allele T is associated with decreased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1234,
  "fields": {
    "recname": "rs7900194",
    "keywords": "Allele A is associated with decreased dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1235,
  "fields": {
    "recname": "rs7900194",
    "keywords": "Allele A is associated with decreased dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1236,
  "fields": {
    "recname": "rs1057910",
    "keywords": "Allele C is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1237,
  "fields": {
    "recname": "rs1057910",
    "keywords": "Allele C is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1238,
  "fields": {
    "recname": "rs56165452",
    "keywords": "Genotype CT is associated with decreased dose of warfarin as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1239,
  "fields": {
    "recname": "rs56165452",
    "keywords": "Genotype CT is associated with decreased dose of warfarin as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1240,
  "fields": {
    "recname": "rs339097",
    "keywords": "Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1241,
  "fields": {
    "recname": "rs339097",
    "keywords": "Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1242,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1243,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1244,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Allele C is not associated with decreased dose of warfarin as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1245,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Allele C is not associated with decreased dose of warfarin as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1246,
  "fields": {
    "recname": "rs339097",
    "keywords": "Allele G is associated with increased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1247,
  "fields": {
    "recname": "rs339097",
    "keywords": "Allele G is associated with increased dose of warfarin."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1248,
  "fields": {
    "recname": "rs7294",
    "keywords": "Allele T is associated with increased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1249,
  "fields": {
    "recname": "rs7294",
    "keywords": "Allele T is associated with increased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1250,
  "fields": {
    "recname": "rs7200749",
    "keywords": "Allele A is associated with increased dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1251,
  "fields": {
    "recname": "rs7200749",
    "keywords": "Allele A is associated with increased dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1252,
  "fields": {
    "recname": "rs72547529",
    "keywords": "Allele T is associated with increased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1253,
  "fields": {
    "recname": "rs72547529",
    "keywords": "Allele T is associated with increased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1254,
  "fields": {
    "recname": "rs72547529",
    "keywords": "Allele T is associated with increased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1255,
  "fields": {
    "recname": "rs72547529",
    "keywords": "Allele T is associated with increased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1256,
  "fields": {
    "recname": "rs72547529",
    "keywords": "Allele T is associated with increased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1257,
  "fields": {
    "recname": "rs72547529",
    "keywords": "Allele T is associated with increased dose of warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1258,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1259,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1260,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1261,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1262,
  "fields": {
    "recname": "rs7294",
    "keywords": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1263,
  "fields": {
    "recname": "rs7294",
    "keywords": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1264,
  "fields": {
    "recname": "rs2359612",
    "keywords": "Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1265,
  "fields": {
    "recname": "rs2359612",
    "keywords": "Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1266,
  "fields": {
    "recname": "rs8050894",
    "keywords": "Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1267,
  "fields": {
    "recname": "rs8050894",
    "keywords": "Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1268,
  "fields": {
    "recname": "rs72547529",
    "keywords": "Allele T is associated with decreased response to warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1269,
  "fields": {
    "recname": "rs72547529",
    "keywords": "Allele T is associated with decreased response to warfarin as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1270,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1271,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1272,
  "fields": {
    "recname": "rs4889606",
    "keywords": "Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1273,
  "fields": {
    "recname": "rs4889606",
    "keywords": "Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1274,
  "fields": {
    "recname": "rs61742245",
    "keywords": "Genotypes AA + AC are associated with increased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1275,
  "fields": {
    "recname": "rs61742245",
    "keywords": "Genotypes AA + AC are associated with increased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1276,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1277,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1278,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotypes CT + TT is not associated with increased dose of warfarin in people with Atrial Fibrillation, Cardiomyopathies, heart valve replacement, Peripheral Vascular Diseases, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1279,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotypes CT + TT is not associated with increased dose of warfarin in people with Atrial Fibrillation, Cardiomyopathies, heart valve replacement, Peripheral Vascular Diseases, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1280,
  "fields": {
    "recname": "rs7856096",
    "keywords": "Allele G is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1281,
  "fields": {
    "recname": "rs7856096",
    "keywords": "Allele G is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1282,
  "fields": {
    "recname": "rs7856096",
    "keywords": "Allele G is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1283,
  "fields": {
    "recname": "rs7856096",
    "keywords": "Allele G is associated with decreased dose of warfarin as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1284,
  "fields": {
    "recname": "rs7856096",
    "keywords": "Genotype AA is not associated with dose of warfarin as compared to genotypes AG + GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1285,
  "fields": {
    "recname": "rs7856096",
    "keywords": "Genotype AA is not associated with dose of warfarin as compared to genotypes AG + GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1286,
  "fields": {
    "recname": "rs4889606",
    "keywords": "Genotypes AG + GG are associated with decreased dose of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1287,
  "fields": {
    "recname": "rs4889606",
    "keywords": "Genotypes AG + GG are associated with decreased dose of warfarin as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1288,
  "fields": {
    "recname": "rs12714145",
    "keywords": "Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1289,
  "fields": {
    "recname": "rs12714145",
    "keywords": "Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1290,
  "fields": {
    "recname": "rs12777823",
    "keywords": "Allele A is associated with dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1291,
  "fields": {
    "recname": "rs12777823",
    "keywords": "Allele A is associated with dose of warfarin as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1292,
  "fields": {
    "recname": "rs28371686",
    "keywords": "Allele G is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1293,
  "fields": {
    "recname": "rs7900194",
    "keywords": "Allele A is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1294,
  "fields": {
    "recname": "rs28371685",
    "keywords": "Allele T is associated with increased metabolism of phenytoin in people with no disease as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1295,
  "fields": {
    "recname": "rs9332131",
    "keywords": "Genotype DEL is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1296,
  "fields": {
    "recname": "rs1043550",
    "keywords": "Allele G is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1297,
  "fields": {
    "recname": "rs1043550",
    "keywords": "Allele G is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1298,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Allele T is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1299,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Allele T is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1300,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotype TT is not associated with dose of acenocoumarol as compared to genotype CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1301,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotype TT is not associated with dose of acenocoumarol as compared to genotype CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1302,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotype TT is associated with decreased dose of acenocoumarol as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1303,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotype TT is associated with decreased dose of acenocoumarol as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1304,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotype CC is associated with increased dose of acenocoumarol as compared to genotype CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1305,
  "fields": {
    "recname": "rs9923231",
    "keywords": "Genotype CC is associated with increased dose of acenocoumarol as compared to genotype CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1306,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotype TT is not associated with dose of acenocoumarol as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1307,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotype TT is not associated with dose of acenocoumarol as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1308,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotype CT is not associated with dose of acenocoumarol as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1309,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotype CT is not associated with dose of acenocoumarol as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1310,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotype TT is associated with increased dose of acenocoumarol as compared to genotype CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1311,
  "fields": {
    "recname": "rs2108622",
    "keywords": "Genotype TT is associated with increased dose of acenocoumarol as compared to genotype CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1312,
  "fields": {
    "recname": "rs909706",
    "keywords": "Genotype TC is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1313,
  "fields": {
    "recname": "rs742105",
    "keywords": "Genotypes TT + CT are associated with increased response to clozapine in people with Schizophrenia as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1314,
  "fields": {
    "recname": "rs1799732",
    "keywords": "Genotype DEL is not associated with increased response to clozapine in people with Schizophrenia as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1315,
  "fields": {
    "recname": "rs11146020",
    "keywords": "Genotypes CC + CG are not associated with increased response to clozapine in people with Schizophrenia as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1316,
  "fields": {
    "recname": "rs686",
    "keywords": "Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1317,
  "fields": {
    "recname": "rs265976",
    "keywords": "Genotype GT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes GG + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1318,
  "fields": {
    "recname": "rs265981",
    "keywords": "Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1319,
  "fields": {
    "recname": "rs4532",
    "keywords": "Allele C is not associated with response to clozapine in people with Schizophrenia as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1320,
  "fields": {
    "recname": "rs11188072",
    "keywords": "Genotype TT is associated with increased metabolism of mephenytoin in people with no disease as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1321,
  "fields": {
    "recname": "rs12248560",
    "keywords": "Genotype TT is associated with increased metabolism of mephenytoin in people with no disease as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1322,
  "fields": {
    "recname": "rs12248560",
    "keywords": "Genotype TT is associated with increased metabolism of omeprazole in people with no disease as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1323,
  "fields": {
    "recname": "rs4244285",
    "keywords": "Genotype AA is associated with decreased metabolism of nelfinavir in people with HIV Infections as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1324,
  "fields": {
    "recname": "rs1799732",
    "keywords": "Genotype G/del is associated with decreased response to aripiprazole in people with schizoaffective disorder."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1325,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Allele C is associated with decreased metabolism of efavirenz in people with HIV."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1326,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Allele T (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele G (assigned as extensive metabolizer phenotype) ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1327,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Allele C (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele T (assigned as extensive metabolizer phenotype) ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1328,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotype TT (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype GG (assigned as extensive metabolizer phenotype) ."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1329,
  "fields": {
    "recname": "rs36118214",
    "keywords": "Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1330,
  "fields": {
    "recname": "rs28399433",
    "keywords": "Genotype AC is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1331,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotype TT is associated with decreased clearance of efavirenz in children with HIV Infections as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1332,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Allele T is associated with decreased metabolism of efavirenz in people with HIV."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1333,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Allele C is associated with decreased metabolism of efavirenz in people with HIV."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1334,
  "fields": {
    "recname": "rs35303484",
    "keywords": "Allele G is associated with concentrations of efavirenz in people with HIV as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1335,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT is associated with concentrations of efavirenz in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1336,
  "fields": {
    "recname": "rs3842",
    "keywords": "Allele C is associated with concentrations of efavirenz in people with HIV as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1337,
  "fields": {
    "recname": "rs4803419",
    "keywords": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1338,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1339,
  "fields": {
    "recname": "rs35303484",
    "keywords": "Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AG + GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1340,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Genotype CC is associated with increased concentrations of efavirenz in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1341,
  "fields": {
    "recname": "rs707265",
    "keywords": "Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AG + GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1342,
  "fields": {
    "recname": "rs1042389",
    "keywords": "Genotype TT is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CC + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1343,
  "fields": {
    "recname": "rs2279343",
    "keywords": "Allele G is associated with increased concentrations of efavirenz in people with HIV as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1344,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1345,
  "fields": {
    "recname": "rs7668258",
    "keywords": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1346,
  "fields": {
    "recname": "rs28399454",
    "keywords": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1347,
  "fields": {
    "recname": "rs3732360",
    "keywords": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1348,
  "fields": {
    "recname": "rs1054190",
    "keywords": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1349,
  "fields": {
    "recname": "rs1054191",
    "keywords": "Genotype GG is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AA + AG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1350,
  "fields": {
    "recname": "rs3814057",
    "keywords": "Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AC + CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1351,
  "fields": {
    "recname": "rs762551",
    "keywords": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AA + AC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1352,
  "fields": {
    "recname": "rs45564134",
    "keywords": "Allele G is not associated with concentrations of efavirenz in people with HIV as compared to genotypes G/del + del/del."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1353,
  "fields": {
    "recname": "rs4803419",
    "keywords": "Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1354,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1355,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Allele C is associated with increased concentrations of efavirenz in people with HIV as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1356,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1357,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Genotype CT is associated with increased concentrations of efavirenz in children with HIV as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1358,
  "fields": {
    "recname": "rs2279343",
    "keywords": "Genotypes AG + GG are associated with increased concentrations of efavirenz in children with HIV as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1359,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotype TT is associated with increased concentrations of efavirenz in people with HIV as compared to genotypes GG + GT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1360,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1361,
  "fields": {
    "recname": "rs2279343",
    "keywords": "Allele G is not associated with increased concentrations of efavirenz in children with HIV as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1362,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Genotype CT is associated with increased concentrations of efavirenz in children with HIV as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1363,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT is associated with decreased clearance of efavirenz in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1364,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Genotypes CC + CT is associated with decreased clearance of efavirenz in people with HIV as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1365,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with increased concentrations of efavirenz in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1366,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1367,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with increased concentrations of efavirenz in women with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1368,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with decreased concentrations of levonorgestrel in women with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1369,
  "fields": {
    "recname": "rs4803419",
    "keywords": "Genotype CT is associated with decreased concentrations of levonorgestrel in women with HIV as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1370,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT is associated with increased concentrations of efavirenz in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1371,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with decreased resistance to efavirenz in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1372,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with increased concentrations of efavirenz as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1373,
  "fields": {
    "recname": "rs28365062",
    "keywords": "Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotypes AA + AG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1374,
  "fields": {
    "recname": "rs28399433",
    "keywords": "Allele C is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1375,
  "fields": {
    "recname": "rs3842",
    "keywords": "Allele C is associated with metabolism of efavirenz in people with HIV as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1376,
  "fields": {
    "recname": "rs3842",
    "keywords": "Genotypes CC + CT is associated with increased trough concentration of efavirenz in people with HIV and Tuberculosis as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1377,
  "fields": {
    "recname": "rs2307424",
    "keywords": "Genotype GG is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype AG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1378,
  "fields": {
    "recname": "rs3003596",
    "keywords": "Genotype GG is associated with increased metabolism of efavirenz in people with HIV Infections as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1379,
  "fields": {
    "recname": "rs2502815",
    "keywords": "Genotype AA is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1380,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT are associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1381,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Genotype CC is not associated with decreased clearance of nevirapine in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1382,
  "fields": {
    "recname": "rs28371706",
    "keywords": "Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1383,
  "fields": {
    "recname": "rs2472677",
    "keywords": "Genotypes CT + TT are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1384,
  "fields": {
    "recname": "rs1523130",
    "keywords": "Genotypes CC + CT are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1385,
  "fields": {
    "recname": "rs3842689",
    "keywords": "Genotypes GAGAAG/DEL + DEL/DEL are associated with increased clearance of nevirapine in people with HIV as compared to genotype GAGAAG/GAGAAG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1386,
  "fields": {
    "recname": "rs1045642",
    "keywords": "Genotypes AA + AG are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1387,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotypes GT + TT is associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1388,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Genotype CT is associated with decreased clearance of nevirapine in people with HIV as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1389,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Allele T is associated with increased concentrations of nevirapine in women as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1390,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Allele C is associated with increased concentrations of nevirapine in women as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1391,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Genotype TT is associated with increased concentrations of nevirapine in people with HIV as compared to genotypes GG + GT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1392,
  "fields": {
    "recname": "rs762551",
    "keywords": "Genotype CC is associated with increased response to nevirapine in people with HIV as compared to genotypes AA + AC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1393,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Allele C is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1394,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Allele T is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1395,
  "fields": {
    "recname": "rs3745274",
    "keywords": "Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1396,
  "fields": {
    "recname": "rs28399499",
    "keywords": "Allele C is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1397,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Allele C is associated with increased concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1398,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Allele T is associated with decreased response to lumefantrine in women with Malaria and Pregnancy as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1399,
  "fields": {
    "recname": "rs3842",
    "keywords": "Allele C is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1400,
  "fields": {
    "recname": "rs3842",
    "keywords": "Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1401,
  "fields": {
    "recname": "rs2246709",
    "keywords": "Genotypes AG + GG are associated with increased response to amlodipine in people with Hypertension as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1402,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Genotypes CT + TT are associated with increased response to amlodipine in women with Hypertension as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1403,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Genotypes CT + TT are not associated with response to amlodipine in women with Hypertension as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1404,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Genotypes CT + TT are not associated with response to amlodipine in people with Hypertension as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1405,
  "fields": {
    "recname": "rs2246709",
    "keywords": "Genotypes AG + GG are not associated with response to amlodipine in men with Hypertension as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1406,
  "fields": {
    "recname": "rs2246709",
    "keywords": "Genotypes AG + GG are not associated with response to amlodipine in women with Hypertension as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1407,
  "fields": {
    "recname": "rs2246709",
    "keywords": "Genotypes AG + GG are not associated with response to amlodipine in people with Hypertension as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1408,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Genotypes CT + TT are not associated with response to amlodipine in men with Hypertension as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1409,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Genotype TT is associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotypes CC + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1410,
  "fields": {
    "recname": "rs28365063",
    "keywords": "Genotype AA is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to genotypes AG + GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1411,
  "fields": {
    "recname": "rs3814055",
    "keywords": "Allele T is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1412,
  "fields": {
    "recname": "rs4148740",
    "keywords": "Genotype AG is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1413,
  "fields": {
    "recname": "rs1128503",
    "keywords": "Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1414,
  "fields": {
    "recname": "rs4148739",
    "keywords": "Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotype CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1415,
  "fields": {
    "recname": "rs2234922",
    "keywords": "Genotype GG is not associated with clearance of carbamazepine in people with Epilepsy as compared to genotypes AA + AG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1416,
  "fields": {
    "recname": "rs1051740",
    "keywords": "Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotypes CC + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1417,
  "fields": {
    "recname": "rs2273697",
    "keywords": "Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1418,
  "fields": {
    "recname": "rs4148386",
    "keywords": "Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1419,
  "fields": {
    "recname": "rs35599367",
    "keywords": "Allele A is not associated with concentrations of lopinavir in people with HIV."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1420,
  "fields": {
    "recname": "rs2740574",
    "keywords": "Genotypes CT + TT is not associated with concentrations of lopinavir in people with HIV as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1421,
  "fields": {
    "recname": "rs7910642",
    "keywords": "Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1422,
  "fields": {
    "recname": "rs2306283",
    "keywords": "Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1423,
  "fields": {
    "recname": "rs4149056",
    "keywords": "Allele C is not associated with concentrations of lopinavir in people with HIV."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1424,
  "fields": {
    "recname": "rs4149044",
    "keywords": "Genotypes AA + AT is not associated with concentrations of lopinavir in people with HIV as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1425,
  "fields": {
    "recname": "rs4149045",
    "keywords": "Genotypes AG + GG is not associated with concentrations of lopinavir in people with HIV as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1426,
  "fields": {
    "recname": "rs4149057",
    "keywords": "Genotypes CC + CT is not associated with concentrations of lopinavir in people with HIV as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1427,
  "fields": {
    "recname": "rs2242480",
    "keywords": "Allele T is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1428,
  "fields": {
    "recname": "rs4646437",
    "keywords": "Allele A is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1429,
  "fields": {
    "recname": "rs4646450",
    "keywords": "Allele A is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1430,
  "fields": {
    "recname": "rs2257401",
    "keywords": "Allele C is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1431,
  "fields": {
    "recname": "rs1045642",
    "keywords": "Genotype AG is not associated with concentrations of tacrolimus in people with Kidney Transplantation as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1432,
  "fields": {
    "recname": "rs4646437",
    "keywords": "Genotypes AG + GG is associated with increased dose-adjusted trough concentrations of cyclosporine in people with Kidney Transplantation as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1433,
  "fields": {
    "recname": "rs4646437",
    "keywords": "Genotypes AG + GG is associated with increased response to cyclosporine in people with Kidney Transplantation as compared to genotype AA."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1434,
  "fields": {
    "recname": "rs2032582",
    "keywords": "Genotypes AC + CC is associated with increased dose of cyclosporine in people with Kidney Transplantation as compared to genotypes AA + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1435,
  "fields": {
    "recname": "rs2032582",
    "keywords": "Genotypes AC + CC is associated with decreased dose-adjusted trough concentrations of cyclosporine in people with Kidney Transplantation as compared to genotypes AA + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1436,
  "fields": {
    "recname": "rs881152",
    "keywords": "Allele G is associated with increased response to salbutamol in people with Asthma as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1437,
  "fields": {
    "recname": "rs881152",
    "keywords": "Allele G is not associated with increased response to salbutamol in people with Asthma as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1438,
  "fields": {
    "recname": "rs28365062",
    "keywords": "Allele G is associated with increased metabolism of zidovudine as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1439,
  "fields": {
    "recname": "rs140471703",
    "keywords": "Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1440,
  "fields": {
    "recname": "rs376817657",
    "keywords": "Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1441,
  "fields": {
    "recname": "rs143690364",
    "keywords": "Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1442,
  "fields": {
    "recname": "rs2266782",
    "keywords": "Genotypes AA + AG is associated with decreased metabolism of nicotine in CYP2A6 reduced, but not normal, metabolizers as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1443,
  "fields": {
    "recname": "rs1057868",
    "keywords": "Genotypes CT + TT is associated with increased metabolism of nicotine in CYP2A6 normal, but not reduced, metabolizers as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1444,
  "fields": {
    "recname": "rs2266782",
    "keywords": "Allele G is not associated with metabolism of nicotine in people with Tobacco Use Disorder as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1445,
  "fields": {
    "recname": "rs61750900",
    "keywords": "Genotype GG is not associated with metabolism of nicotine in people with Tobacco Use Disorder as compared to genotype GT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1446,
  "fields": {
    "recname": "rs2942857",
    "keywords": "Genotype CC is not associated with increased exposure to nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1447,
  "fields": {
    "recname": "rs2942857",
    "keywords": "Genotype CC is not associated with increased clearance of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1448,
  "fields": {
    "recname": "rs2266782",
    "keywords": "Allele G is not associated with metabolism of cotinine in people with Tobacco Use Disorder as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1449,
  "fields": {
    "recname": "rs61750900",
    "keywords": "Genotype GG is not associated with metabolism of cotinine in people with Tobacco Use Disorder as compared to genotype GT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1450,
  "fields": {
    "recname": "rs2942857",
    "keywords": "Genotype CC is associated with increased exposure to cotinine in people with Tobacco Use Disorder as compared to genotypes AA + AC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1451,
  "fields": {
    "recname": "rs2942857",
    "keywords": "Genotype CC is associated with decreased clearance of cotinine in people with Tobacco Use Disorder as compared to genotypes AA + AC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1452,
  "fields": {
    "recname": "rs185430475",
    "keywords": "Allele G is not associated with metabolism of nicotine as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1453,
  "fields": {
    "recname": "rs2269879",
    "keywords": "Genotypes CT + TT are not associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1454,
  "fields": {
    "recname": "rs2269879",
    "keywords": "Genotypes CT + TT are not associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1455,
  "fields": {
    "recname": "rs4149601",
    "keywords": "Allele G is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1456,
  "fields": {
    "recname": "rs4149601",
    "keywords": "Allele G is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1457,
  "fields": {
    "recname": "rs1008899",
    "keywords": "Allele A is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1458,
  "fields": {
    "recname": "rs1008899",
    "keywords": "Allele A is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1459,
  "fields": {
    "recname": "rs292449",
    "keywords": "Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1460,
  "fields": {
    "recname": "rs292449",
    "keywords": "Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1461,
  "fields": {
    "recname": "rs3184504",
    "keywords": "Allele T is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1462,
  "fields": {
    "recname": "rs3184504",
    "keywords": "Allele T is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1463,
  "fields": {
    "recname": "rs871606",
    "keywords": "Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1464,
  "fields": {
    "recname": "rs871606",
    "keywords": "Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1465,
  "fields": {
    "recname": "rs12076902",
    "keywords": "Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1466,
  "fields": {
    "recname": "rs12076902",
    "keywords": "Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1467,
  "fields": {
    "recname": "rs12069113",
    "keywords": "Allele C is not associated with response to atenolol in people with Hypertension as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1468,
  "fields": {
    "recname": "rs12069113",
    "keywords": "Allele C is not associated with response to atenolol in people with Hypertension as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1469,
  "fields": {
    "recname": "rs12721616",
    "keywords": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1470,
  "fields": {
    "recname": "rs8187692",
    "keywords": "Allele A is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1471,
  "fields": {
    "recname": "rs17216198",
    "keywords": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1472,
  "fields": {
    "recname": "rs17216177",
    "keywords": "Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1473,
  "fields": {
    "recname": "rs3740066",
    "keywords": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1474,
  "fields": {
    "recname": "rs7899457",
    "keywords": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1475,
  "fields": {
    "recname": "rs8187706",
    "keywords": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1476,
  "fields": {
    "recname": "rs8187710",
    "keywords": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1477,
  "fields": {
    "recname": "rs11045854",
    "keywords": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1478,
  "fields": {
    "recname": "rs12305884",
    "keywords": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1479,
  "fields": {
    "recname": "rs11045873",
    "keywords": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1480,
  "fields": {
    "recname": "rs11045874",
    "keywords": "Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1481,
  "fields": {
    "recname": "rs34671512",
    "keywords": "Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1482,
  "fields": {
    "recname": "rs3212207",
    "keywords": "Allele C is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1483,
  "fields": {
    "recname": "rs1805343",
    "keywords": "Allele A is associated with increased exposure to rosuvastatin in healthy individuals."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1484,
  "fields": {
    "recname": "rs7579275",
    "keywords": "Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1485,
  "fields": {
    "recname": "rs2287622",
    "keywords": "Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1486,
  "fields": {
    "recname": "rs16980091",
    "keywords": "Allele T is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1487,
  "fields": {
    "recname": "rs56903885",
    "keywords": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1488,
  "fields": {
    "recname": "rs1523130",
    "keywords": "Genotype CC (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1489,
  "fields": {
    "recname": "rs2472677",
    "keywords": "Genotype CT (assigned as deficiency phenotype) is associated with decreased concentrations of atazanavir in people with HIV as compared to genotypes CC + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1490,
  "fields": {
    "recname": "rs2306283",
    "keywords": "Genotype GG (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotypes AA + AG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1491,
  "fields": {
    "recname": "rs4149056",
    "keywords": "Genotype CT (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1492,
  "fields": {
    "recname": "rs887829",
    "keywords": "Genotype TT is associated with increased discontinuation of atazanavir in people with HIV as compared to genotypes CC + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1493,
  "fields": {
    "recname": "rs887829",
    "keywords": "Genotype TT is not associated with increased discontinuation of atazanavir as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1494,
  "fields": {
    "recname": "rs887829",
    "keywords": "Genotype CT is not associated with increased discontinuation of atazanavir as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1495,
  "fields": {
    "recname": "rs73208473",
    "keywords": "Allele A is associated with decreased exposure to atazanavir in women with HIV as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1496,
  "fields": {
    "recname": "rs2960306",
    "keywords": "Genotypes GT + TT are associated with decreased response to metoprolol in men with hypertensive nephrosclerosis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1497,
  "fields": {
    "recname": "rs2960306",
    "keywords": "Genotypes GT + TT are associated with decreased response to metoprolol in men with hypertensive nephrosclerosis."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1498,
  "fields": {
    "recname": "rs1024323",
    "keywords": "Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1499,
  "fields": {
    "recname": "rs1024323",
    "keywords": "Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1500,
  "fields": {
    "recname": "rs1024323",
    "keywords": "Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1501,
  "fields": {
    "recname": "rs1024323",
    "keywords": "Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1502,
  "fields": {
    "recname": "rs1801058",
    "keywords": "Genotype CT is associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1503,
  "fields": {
    "recname": "rs1801058",
    "keywords": "Genotype CT is associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1504,
  "fields": {
    "recname": "rs2960306",
    "keywords": "Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1505,
  "fields": {
    "recname": "rs2960306",
    "keywords": "Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1506,
  "fields": {
    "recname": "rs1801058",
    "keywords": "Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1507,
  "fields": {
    "recname": "rs1801058",
    "keywords": "Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1508,
  "fields": {
    "recname": "rs1045642",
    "keywords": "Genotypes AA + AG is associated with decreased trough concentration of imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1509,
  "fields": {
    "recname": "rs1128503",
    "keywords": "Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1510,
  "fields": {
    "recname": "rs2032582",
    "keywords": "Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1511,
  "fields": {
    "recname": "rs1045642",
    "keywords": "Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1512,
  "fields": {
    "recname": "rs2273897",
    "keywords": "Genotype TT is associated with increased concentrations of emtricitabine in people with HIV and Pregnancy as compared to genotypes CC + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1513,
  "fields": {
    "recname": "rs25531",
    "keywords": "Allele C is not associated with response to citalopram in people with Depression as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1514,
  "fields": {
    "recname": "rs1801252",
    "keywords": "Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1515,
  "fields": {
    "recname": "rs1801253",
    "keywords": "Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1516,
  "fields": {
    "recname": "rs363371",
    "keywords": "Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1517,
  "fields": {
    "recname": "rs363390",
    "keywords": "Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1518,
  "fields": {
    "recname": "rs363343",
    "keywords": "Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1519,
  "fields": {
    "recname": "rs929493",
    "keywords": "Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1520,
  "fields": {
    "recname": "rs737865",
    "keywords": "Genotype AA is associated with decreased response to bupropion in smokers as compared to genotypes AG + GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1521,
  "fields": {
    "recname": "rs4680",
    "keywords": "Allele G is not associated with dose of morphine in people with Pain as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1522,
  "fields": {
    "recname": "rs17174629",
    "keywords": "Allele G is not associated with dose of morphine in people with Pain as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1523,
  "fields": {
    "recname": "rs1799972",
    "keywords": "Allele T is not associated with dose of morphine in people with Pain as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1524,
  "fields": {
    "recname": "rs1799971",
    "keywords": "Allele G is not associated with dose of morphine in people with Pain as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1525,
  "fields": {
    "recname": "rs1051660",
    "keywords": "Allele A is associated with decreased dose of morphine in people with Pain as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1526,
  "fields": {
    "recname": "rs17161788",
    "keywords": "Genotype TT is associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to genotypes CC + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1527,
  "fields": {
    "recname": "rs4359",
    "keywords": "Genotypes CC + TT are associated with increased response to ramipril in people with Hypertension as compared to genotype CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1528,
  "fields": {
    "recname": "rs4344",
    "keywords": "Genotypes AA + GG are associated with increased response to ramipril in people with Hypertension as compared to genotype AG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1529,
  "fields": {
    "recname": "rs4363",
    "keywords": "Genotypes AA + AG are not associated with increased response to ramipril in people with Hypertension as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1530,
  "fields": {
    "recname": "rs2053044",
    "keywords": "Genotypes AA + AG is associated with increased response to ramipril in people with Hypertension as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1531,
  "fields": {
    "recname": "rs3785161",
    "keywords": "Allele C is not associated with response to trandolapril in people with Hypertension as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1532,
  "fields": {
    "recname": "rs2515462",
    "keywords": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1533,
  "fields": {
    "recname": "rs13269021",
    "keywords": "Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1534,
  "fields": {
    "recname": "rs1375668",
    "keywords": "Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1535,
  "fields": {
    "recname": "rs2515409",
    "keywords": "Allele C is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1536,
  "fields": {
    "recname": "rs10102851",
    "keywords": "Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1537,
  "fields": {
    "recname": "rs2445365",
    "keywords": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1538,
  "fields": {
    "recname": "rs2274755",
    "keywords": "Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1539,
  "fields": {
    "recname": "rs2236416",
    "keywords": "Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1540,
  "fields": {
    "recname": "rs17577",
    "keywords": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1541,
  "fields": {
    "recname": "rs1960669",
    "keywords": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1542,
  "fields": {
    "recname": "rs833068",
    "keywords": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1543,
  "fields": {
    "recname": "rs833069",
    "keywords": "Allele C is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele T."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1544,
  "fields": {
    "recname": "rs678849",
    "keywords": "Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1545,
  "fields": {
    "recname": "rs678849",
    "keywords": "Genotype CC is not associated with response to methadone in people with Opioid-Related Disorders as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1546,
  "fields": {
    "recname": "rs678849",
    "keywords": "Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1547,
  "fields": {
    "recname": "rs529520",
    "keywords": "Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1548,
  "fields": {
    "recname": "rs581111",
    "keywords": "Allele G is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1549,
  "fields": {
    "recname": "rs2234918",
    "keywords": "Allele T is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1550,
  "fields": {
    "recname": "rs678849",
    "keywords": "Genotype CC is associated with increased response to methadone in people with Opioid-Related Disorders as compared to genotypes CT + TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1551,
  "fields": {
    "recname": "rs529520",
    "keywords": "Allele C is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1552,
  "fields": {
    "recname": "rs581111",
    "keywords": "Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1553,
  "fields": {
    "recname": "rs2234918",
    "keywords": "Allele T is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele C."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1554,
  "fields": {
    "recname": "rs1801133",
    "keywords": "Genotypes AA + AG is associated with increased exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1555,
  "fields": {
    "recname": "rs2046934",
    "keywords": "Allele G is associated with resistance to clopidogrel in people with Acute coronary syndrome as compared to allele A."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1556,
  "fields": {
    "recname": "rs2842030",
    "keywords": "Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes TT + GT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1557,
  "fields": {
    "recname": "rs2231142",
    "keywords": "Allele T is associated with decreased response to allopurinol in people with Gout as compared to allele G."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1558,
  "fields": {
    "recname": "rs9282861",
    "keywords": "Genotype TT is not associated with decreased metabolism of acetaminophen in healthy individuals as compared to genotypes CC + CT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1559,
  "fields": {
    "recname": "rs1902023",
    "keywords": "Genotype AA is associated with increased metabolism of acetaminophen in healthy individuals as compared to genotypes AC + CC."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1560,
  "fields": {
    "recname": "rs5333",
    "keywords": "Genotypes CC + CT is associated with increased resistance to prednisone in children with Nephrotic Syndrome as compared to genotype TT."
  }
},
{
  "model": "agmp_app.index",
  "pk": 1561,
  "fields": {
    "recname": "rs10011796",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1562,
  "fields": {
    "recname": "rs10011796",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1563,
  "fields": {
    "recname": "rs10192428",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1564,
  "fields": {
    "recname": "rs1044498",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1565,
  "fields": {
    "recname": "rs1044703733",
    "keywords": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1566,
  "fields": {
    "recname": "rs1046089",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1567,
  "fields": {
    "recname": "rs1048661",
    "keywords": "Exfoliation Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1568,
  "fields": {
    "recname": "rs1048661",
    "keywords": "Exfoliation Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1569,
  "fields": {
    "recname": "rs104886457",
    "keywords": "Fanconi Anemia, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1570,
  "fields": {
    "recname": "rs104886457",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1571,
  "fields": {
    "recname": "rs104893628",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1572,
  "fields": {
    "recname": "rs104893628",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1573,
  "fields": {
    "recname": "rs104893628",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1574,
  "fields": {
    "recname": "rs104893628",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1575,
  "fields": {
    "recname": "rs104893628",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1576,
  "fields": {
    "recname": "rs104893628",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1577,
  "fields": {
    "recname": "rs104893628",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1578,
  "fields": {
    "recname": "rs104893628",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1579,
  "fields": {
    "recname": "rs104893629",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1580,
  "fields": {
    "recname": "rs104893629",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1581,
  "fields": {
    "recname": "rs104893629",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1582,
  "fields": {
    "recname": "rs104893629",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1583,
  "fields": {
    "recname": "rs104893869",
    "keywords": "Limb-Girdle Muscular Dystrophy, Type 2E"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1584,
  "fields": {
    "recname": "rs104894075",
    "keywords": "Charcot-Marie-Tooth Disease, Axonal, Type 2K"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1585,
  "fields": {
    "recname": "rs104894075",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1586,
  "fields": {
    "recname": "rs104894075",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1587,
  "fields": {
    "recname": "rs104894075",
    "keywords": "Charcot-Marie-Tooth Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1588,
  "fields": {
    "recname": "rs104894075",
    "keywords": "Charcot-Marie-Tooth Disease, Axonal, Type 2K"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1589,
  "fields": {
    "recname": "rs104894075",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1590,
  "fields": {
    "recname": "rs104894075",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1591,
  "fields": {
    "recname": "rs104894076",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1592,
  "fields": {
    "recname": "rs104894099",
    "keywords": "Melanoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1593,
  "fields": {
    "recname": "rs104894099",
    "keywords": "Melanoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1594,
  "fields": {
    "recname": "rs104894099",
    "keywords": "Melanoma-Pancreatic Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1595,
  "fields": {
    "recname": "rs104894099",
    "keywords": "Melanoma-Pancreatic Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1596,
  "fields": {
    "recname": "rs104894099",
    "keywords": "Melanoma, Cutaneous Malignant, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1597,
  "fields": {
    "recname": "rs104894099",
    "keywords": "Melanoma, Cutaneous Malignant, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1598,
  "fields": {
    "recname": "rs104894099",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1599,
  "fields": {
    "recname": "rs104894099",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1600,
  "fields": {
    "recname": "rs104894132",
    "keywords": "Xeroderma Pigmentosum, Group A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1601,
  "fields": {
    "recname": "rs104894132",
    "keywords": "Xeroderma Pigmentosum, Group A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1602,
  "fields": {
    "recname": "rs104894215",
    "keywords": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1603,
  "fields": {
    "recname": "rs104894216",
    "keywords": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1604,
  "fields": {
    "recname": "rs104894313",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1605,
  "fields": {
    "recname": "rs104894397",
    "keywords": "Deafness, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1606,
  "fields": {
    "recname": "rs104894398",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1607,
  "fields": {
    "recname": "rs104894398",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1608,
  "fields": {
    "recname": "rs104894398",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1609,
  "fields": {
    "recname": "rs104894401",
    "keywords": "Deafness, Autosomal Dominant 3A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1610,
  "fields": {
    "recname": "rs104894401",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1611,
  "fields": {
    "recname": "rs104894402",
    "keywords": "Deafness, Autosomal Dominant 3A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1612,
  "fields": {
    "recname": "rs104894517",
    "keywords": "Anhaptoglobinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1613,
  "fields": {
    "recname": "rs104894517",
    "keywords": "Anhaptoglobinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1614,
  "fields": {
    "recname": "rs104894517",
    "keywords": "Anhaptoglobinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1615,
  "fields": {
    "recname": "rs104894517",
    "keywords": "Anhaptoglobinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1616,
  "fields": {
    "recname": "rs104894517",
    "keywords": "Hypohaptoglobinemia (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1617,
  "fields": {
    "recname": "rs104894517",
    "keywords": "Hypohaptoglobinemia (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1618,
  "fields": {
    "recname": "rs104894559",
    "keywords": "Retinitis Pigmentosa"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1619,
  "fields": {
    "recname": "rs104894682",
    "keywords": "Muscular Dystrophy, Limb-Girdle, Type 2I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1620,
  "fields": {
    "recname": "rs104894927",
    "keywords": "Retinitis Pigmentosa 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1621,
  "fields": {
    "recname": "rs104895091",
    "keywords": "Familial Mediterranean Fever"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1622,
  "fields": {
    "recname": "rs104895506",
    "keywords": "Gestational Trophoblastic Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1623,
  "fields": {
    "recname": "rs10490924",
    "keywords": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1624,
  "fields": {
    "recname": "rs1049246177",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1625,
  "fields": {
    "recname": "rs1050828",
    "keywords": "Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1626,
  "fields": {
    "recname": "rs1050828",
    "keywords": "Deficiency Of Glucose-6-Phosphate Dehydrogenase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1627,
  "fields": {
    "recname": "rs1050828",
    "keywords": "Cataract"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1628,
  "fields": {
    "recname": "rs1050828",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1629,
  "fields": {
    "recname": "rs1050829",
    "keywords": "Cataract"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1630,
  "fields": {
    "recname": "rs1050829",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1631,
  "fields": {
    "recname": "rs10519612",
    "keywords": "Acute Lymphocytic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1632,
  "fields": {
    "recname": "rs1057516362",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1633,
  "fields": {
    "recname": "rs1057516467",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1634,
  "fields": {
    "recname": "rs1057516689",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1635,
  "fields": {
    "recname": "rs1057516766",
    "keywords": "Megalencephalic Leukoencephalopathy With Subcortical Cysts"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1636,
  "fields": {
    "recname": "rs1057517233",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1637,
  "fields": {
    "recname": "rs1057519425",
    "keywords": "Arthrogryposis, Distal, With Impaired Proprioception And Touch"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1638,
  "fields": {
    "recname": "rs1057519425",
    "keywords": "Arthrogryposis, Distal, With Impaired Proprioception And Touch"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1639,
  "fields": {
    "recname": "rs1057519626",
    "keywords": "Arthrogryposis, Distal, With Impaired Proprioception And Touch"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1640,
  "fields": {
    "recname": "rs1061170",
    "keywords": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1641,
  "fields": {
    "recname": "rs1061170",
    "keywords": "Glycogen Storage Disease Type Ii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1642,
  "fields": {
    "recname": "rs1061170",
    "keywords": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1643,
  "fields": {
    "recname": "rs1061170",
    "keywords": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1644,
  "fields": {
    "recname": "rs1061170",
    "keywords": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1645,
  "fields": {
    "recname": "rs1063538",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1646,
  "fields": {
    "recname": "rs10900585",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1647,
  "fields": {
    "recname": "rs10900585",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1648,
  "fields": {
    "recname": "rs10905371",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1649,
  "fields": {
    "recname": "rs10905374",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1650,
  "fields": {
    "recname": "rs11031728",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1651,
  "fields": {
    "recname": "rs111033307",
    "keywords": "Enlarged Vestibular Aqueduct"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1652,
  "fields": {
    "recname": "rs111033307",
    "keywords": "Pendred'S Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1653,
  "fields": {
    "recname": "rs111033307",
    "keywords": "Enlarged Vestibular Aqueduct"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1654,
  "fields": {
    "recname": "rs111033307",
    "keywords": "Pendred'S Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1655,
  "fields": {
    "recname": "rs111033558",
    "keywords": "Hemochromatosis, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1656,
  "fields": {
    "recname": "rs111033558",
    "keywords": "Hereditary Hemochromatosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1657,
  "fields": {
    "recname": "rs111033559",
    "keywords": "Cardiomyopathy, Familial Idiopathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1658,
  "fields": {
    "recname": "rs111033559",
    "keywords": "Cardiomyopathy, Familial Idiopathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1659,
  "fields": {
    "recname": "rs111033690",
    "keywords": "Classical Galactosemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1660,
  "fields": {
    "recname": "rs111033690",
    "keywords": "Classical Galactosemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1661,
  "fields": {
    "recname": "rs111033690",
    "keywords": "Classical Galactosemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1662,
  "fields": {
    "recname": "rs111706634",
    "keywords": "Auditory Neuropathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1663,
  "fields": {
    "recname": "rs111706634",
    "keywords": "Auditory Neuropathy Spectrum Disorder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1664,
  "fields": {
    "recname": "rs11209026",
    "keywords": "Crohn Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1665,
  "fields": {
    "recname": "rs11209026",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1666,
  "fields": {
    "recname": "rs11209026",
    "keywords": "Inflammatory Bowel Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1667,
  "fields": {
    "recname": "rs112176450",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1668,
  "fields": {
    "recname": "rs112292549",
    "keywords": "Peeling Skin Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1669,
  "fields": {
    "recname": "rs1127354",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1670,
  "fields": {
    "recname": "rs1127354",
    "keywords": "Hepatitis C, Chronic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1671,
  "fields": {
    "recname": "rs1127354",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1672,
  "fields": {
    "recname": "rs1131692059",
    "keywords": "Estrogen Resistance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1673,
  "fields": {
    "recname": "rs11335470",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1674,
  "fields": {
    "recname": "rs113425597",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1675,
  "fields": {
    "recname": "rs113425597",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1676,
  "fields": {
    "recname": "rs113425597",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1677,
  "fields": {
    "recname": "rs113425597",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1678,
  "fields": {
    "recname": "rs113624356",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1679,
  "fields": {
    "recname": "rs113624356",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1680,
  "fields": {
    "recname": "rs113993959",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1681,
  "fields": {
    "recname": "rs114073621",
    "keywords": "Glycogen Storage Disease Type V"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1682,
  "fields": {
    "recname": "rs114169033",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1683,
  "fields": {
    "recname": "rs114246623",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1684,
  "fields": {
    "recname": "rs114246623",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1685,
  "fields": {
    "recname": "rs114402678",
    "keywords": "Febrile Seizures, Familial, 11"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1686,
  "fields": {
    "recname": "rs115338764",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1687,
  "fields": {
    "recname": "rs11538758",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1688,
  "fields": {
    "recname": "rs11540654",
    "keywords": "Breast Cancer, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1689,
  "fields": {
    "recname": "rs11540654",
    "keywords": "Breast Carcinoma, Sporadic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1690,
  "fields": {
    "recname": "rs11540654",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1691,
  "fields": {
    "recname": "rs11540654",
    "keywords": "Liver Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1692,
  "fields": {
    "recname": "rs11554495",
    "keywords": "Malignant Neoplasm Of Pancreas"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1693,
  "fields": {
    "recname": "rs11554495",
    "keywords": "Pancreatic Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1694,
  "fields": {
    "recname": "rs11554495",
    "keywords": "Pancreatitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1695,
  "fields": {
    "recname": "rs11568350",
    "keywords": "Iron Overload"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1696,
  "fields": {
    "recname": "rs11571658",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1697,
  "fields": {
    "recname": "rs11571658",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1698,
  "fields": {
    "recname": "rs116074753",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1699,
  "fields": {
    "recname": "rs1160985",
    "keywords": "C-Reactive Protein Measurement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1700,
  "fields": {
    "recname": "rs116100695",
    "keywords": "Deficiency Of Pyruvate Kinase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1701,
  "fields": {
    "recname": "rs11614913",
    "keywords": "Chronic Obstructive Airway Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1702,
  "fields": {
    "recname": "rs11614913",
    "keywords": "Chronic Obstructive Airway Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1703,
  "fields": {
    "recname": "rs116568708",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1704,
  "fields": {
    "recname": "rs116568708",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1705,
  "fields": {
    "recname": "rs11694",
    "keywords": "Niemann-Pick Disease, Type C2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1706,
  "fields": {
    "recname": "rs116987552",
    "keywords": "Glycogen Storage Disease Type V"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1707,
  "fields": {
    "recname": "rs118091316",
    "keywords": "Ichthyosis, Lamellar, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1708,
  "fields": {
    "recname": "rs118091316",
    "keywords": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1709,
  "fields": {
    "recname": "rs118192164",
    "keywords": "Central Core Disease, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1710,
  "fields": {
    "recname": "rs118192164",
    "keywords": "Central Core Myopathy (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1711,
  "fields": {
    "recname": "rs118192164",
    "keywords": "Minicore Myopathy, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1712,
  "fields": {
    "recname": "rs118192164",
    "keywords": "Multicore Myopathy, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1713,
  "fields": {
    "recname": "rs118192164",
    "keywords": "Multiminicore Disease, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1714,
  "fields": {
    "recname": "rs118192164",
    "keywords": "Neuromuscular Disease, Congenital, With Uniform Type 1 Fiber (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1715,
  "fields": {
    "recname": "rs118192172",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1716,
  "fields": {
    "recname": "rs118192178",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1717,
  "fields": {
    "recname": "rs118203929",
    "keywords": "Mitochondrial Complex I Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1718,
  "fields": {
    "recname": "rs118203929",
    "keywords": "NAdh:Q(1) Oxidoreductase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1719,
  "fields": {
    "recname": "rs118203935",
    "keywords": "Ichthyosis, Lamellar, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1720,
  "fields": {
    "recname": "rs118203935",
    "keywords": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1721,
  "fields": {
    "recname": "rs118203936",
    "keywords": "Ichthyosis, Lamellar, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1722,
  "fields": {
    "recname": "rs118203936",
    "keywords": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1723,
  "fields": {
    "recname": "rs118203937",
    "keywords": "Ichthyosis, Lamellar, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1724,
  "fields": {
    "recname": "rs118203937",
    "keywords": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1725,
  "fields": {
    "recname": "rs118203963",
    "keywords": "Charcot-Marie-Tooth Disease, Axonal, Type 2X"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1726,
  "fields": {
    "recname": "rs118203963",
    "keywords": "Spastic Paraplegia 11, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1727,
  "fields": {
    "recname": "rs118203978",
    "keywords": "Ceroid Lipofuscinosis, Neuronal, 7"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1728,
  "fields": {
    "recname": "rs118203986",
    "keywords": "Neuropathy, Hereditary Sensory, With Spastic Paraplegia, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1729,
  "fields": {
    "recname": "rs118203988",
    "keywords": "Auditory Neuropathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1730,
  "fields": {
    "recname": "rs118203988",
    "keywords": "Auditory Neuropathy Spectrum Disorder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1731,
  "fields": {
    "recname": "rs118204050",
    "keywords": "Spastic Paraplegia 15, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1732,
  "fields": {
    "recname": "rs118204089",
    "keywords": "Deficiency Of Pyruvate Kinase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1733,
  "fields": {
    "recname": "rs118204094",
    "keywords": "Acute Intermittent Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1734,
  "fields": {
    "recname": "rs118204094",
    "keywords": "Chester-Type Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1735,
  "fields": {
    "recname": "rs118204094",
    "keywords": "Hydroxymethylbilane Synthase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1736,
  "fields": {
    "recname": "rs118204094",
    "keywords": "Porphyria, Acute Intermittent, Nonerythroid Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1737,
  "fields": {
    "recname": "rs119103259",
    "keywords": "Glycogen Storage Disease Type V"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1738,
  "fields": {
    "recname": "rs119485092",
    "keywords": "Giant Axonal Neuropathy 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1739,
  "fields": {
    "recname": "rs119485093",
    "keywords": "Giant Axonal Neuropathy 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1740,
  "fields": {
    "recname": "rs120074118",
    "keywords": "Niemann-Pick Disease, Type A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1741,
  "fields": {
    "recname": "rs120074118",
    "keywords": "Niemann-Pick Disease, Type B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1742,
  "fields": {
    "recname": "rs120074137",
    "keywords": "Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1743,
  "fields": {
    "recname": "rs120074138",
    "keywords": "Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1744,
  "fields": {
    "recname": "rs120074173",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1745,
  "fields": {
    "recname": "rs121434254",
    "keywords": "Polyglandular Type I Autoimmune Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1746,
  "fields": {
    "recname": "rs121434256",
    "keywords": "Polyglandular Type I Autoimmune Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1747,
  "fields": {
    "recname": "rs121434291",
    "keywords": "Acrodermatitis Enteropathica"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1748,
  "fields": {
    "recname": "rs121434371",
    "keywords": "Glutaric Aciduria, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1749,
  "fields": {
    "recname": "rs121434508",
    "keywords": "Optic Atrophy 7 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1750,
  "fields": {
    "recname": "rs121434508",
    "keywords": "Optic Atrophy 7 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1751,
  "fields": {
    "recname": "rs121434514",
    "keywords": "Shprintzen-Goldberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1752,
  "fields": {
    "recname": "rs121434515",
    "keywords": "Shprintzen-Goldberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1753,
  "fields": {
    "recname": "rs1217691063",
    "keywords": "Cardiovascular Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1754,
  "fields": {
    "recname": "rs1217691063",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1755,
  "fields": {
    "recname": "rs121907930",
    "keywords": "Fanconi Anemia, Complementation Group A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1756,
  "fields": {
    "recname": "rs121907952",
    "keywords": "Gm2-Gangliosidosis, Adult Chronic Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1757,
  "fields": {
    "recname": "rs121907952",
    "keywords": "Gm2-Gangliosidosis, Variant B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1758,
  "fields": {
    "recname": "rs121907952",
    "keywords": "Hexosaminidase A Deficiency, Adult Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1759,
  "fields": {
    "recname": "rs121907952",
    "keywords": "Tay-Sachs Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1760,
  "fields": {
    "recname": "rs121907952",
    "keywords": "Tay-Sachs Disease, Juvenile"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1761,
  "fields": {
    "recname": "rs121907952",
    "keywords": "Tay-Sachs Disease, Pseudo-Ab Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1762,
  "fields": {
    "recname": "rs121907952",
    "keywords": "Tay-Sachs Disease, Variant B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1763,
  "fields": {
    "recname": "rs121907957",
    "keywords": "Gm2-Gangliosidosis, Adult Chronic Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1764,
  "fields": {
    "recname": "rs121907957",
    "keywords": "Gm2-Gangliosidosis, Variant B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1765,
  "fields": {
    "recname": "rs121907957",
    "keywords": "Hexosaminidase A Deficiency, Adult Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1766,
  "fields": {
    "recname": "rs121907957",
    "keywords": "Tay-Sachs Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1767,
  "fields": {
    "recname": "rs121907957",
    "keywords": "Tay-Sachs Disease, Juvenile"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1768,
  "fields": {
    "recname": "rs121907957",
    "keywords": "Tay-Sachs Disease, Pseudo-Ab Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1769,
  "fields": {
    "recname": "rs121907957",
    "keywords": "Tay-Sachs Disease, Variant B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1770,
  "fields": {
    "recname": "rs121907960",
    "keywords": "Tay-Sachs Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1771,
  "fields": {
    "recname": "rs121907960",
    "keywords": "Tay-Sachs Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1772,
  "fields": {
    "recname": "rs121907969",
    "keywords": "Tay-Sachs Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1773,
  "fields": {
    "recname": "rs121908024",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1774,
  "fields": {
    "recname": "rs121908027",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1775,
  "fields": {
    "recname": "rs121908028",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1776,
  "fields": {
    "recname": "rs121908028",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1777,
  "fields": {
    "recname": "rs121908028",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1778,
  "fields": {
    "recname": "rs121908028",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1779,
  "fields": {
    "recname": "rs121908028",
    "keywords": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1780,
  "fields": {
    "recname": "rs121908028",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1781,
  "fields": {
    "recname": "rs121908028",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1782,
  "fields": {
    "recname": "rs121908029",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1783,
  "fields": {
    "recname": "rs121908030",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1784,
  "fields": {
    "recname": "rs121908030",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1785,
  "fields": {
    "recname": "rs121908033",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1786,
  "fields": {
    "recname": "rs121908033",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1787,
  "fields": {
    "recname": "rs121908033",
    "keywords": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1788,
  "fields": {
    "recname": "rs121908102",
    "keywords": "Xanthomatosis, Cerebrotendinous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1789,
  "fields": {
    "recname": "rs121908112",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1790,
  "fields": {
    "recname": "rs121908116",
    "keywords": "Ectodermal Dysplasia 11A, Hypohidrotic/Hair/Tooth Type, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1791,
  "fields": {
    "recname": "rs121908116",
    "keywords": "Ectodermal Dysplasia 3, Anhidrotic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1792,
  "fields": {
    "recname": "rs121908150",
    "keywords": "Familial Cold Urticaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1793,
  "fields": {
    "recname": "rs121908150",
    "keywords": "Muckle-Wells Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1794,
  "fields": {
    "recname": "rs121908151",
    "keywords": "Muckle-Wells Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1795,
  "fields": {
    "recname": "rs121908177",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1796,
  "fields": {
    "recname": "rs121908179",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1797,
  "fields": {
    "recname": "rs121908192",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1798,
  "fields": {
    "recname": "rs121908192",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1799,
  "fields": {
    "recname": "rs121908285",
    "keywords": "Mps Iii C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1800,
  "fields": {
    "recname": "rs121908286",
    "keywords": "Mps Iii C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1801,
  "fields": {
    "recname": "rs121908317",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1802,
  "fields": {
    "recname": "rs121908319",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1803,
  "fields": {
    "recname": "rs121908320",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1804,
  "fields": {
    "recname": "rs121908320",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1805,
  "fields": {
    "recname": "rs121908345",
    "keywords": "Megalencephalic Leukoencephalopathy With Subcortical Cysts"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1806,
  "fields": {
    "recname": "rs121908479",
    "keywords": "Cystinuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1807,
  "fields": {
    "recname": "rs121908479",
    "keywords": "Cystinuria, Type A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1808,
  "fields": {
    "recname": "rs121908479",
    "keywords": "Cystinuria, Type A-B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1809,
  "fields": {
    "recname": "rs121908479",
    "keywords": "Cystinuria, Type B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1810,
  "fields": {
    "recname": "rs121908479",
    "keywords": "Cystinuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1811,
  "fields": {
    "recname": "rs121908480",
    "keywords": "Cystinuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1812,
  "fields": {
    "recname": "rs121908480",
    "keywords": "Cystinuria, Type A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1813,
  "fields": {
    "recname": "rs121908480",
    "keywords": "Cystinuria, Type A-B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1814,
  "fields": {
    "recname": "rs121908480",
    "keywords": "Cystinuria, Type B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1815,
  "fields": {
    "recname": "rs121908482",
    "keywords": "Cystinuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1816,
  "fields": {
    "recname": "rs121908482",
    "keywords": "Cystinuria, Type A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1817,
  "fields": {
    "recname": "rs121908482",
    "keywords": "Cystinuria, Type A-B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1818,
  "fields": {
    "recname": "rs121908482",
    "keywords": "Cystinuria, Type B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1819,
  "fields": {
    "recname": "rs121908483",
    "keywords": "Cystinuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1820,
  "fields": {
    "recname": "rs121908483",
    "keywords": "Cystinuria, Type A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1821,
  "fields": {
    "recname": "rs121908483",
    "keywords": "Cystinuria, Type A-B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1822,
  "fields": {
    "recname": "rs121908483",
    "keywords": "Cystinuria, Type B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1823,
  "fields": {
    "recname": "rs121908524",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1824,
  "fields": {
    "recname": "rs121908525",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1825,
  "fields": {
    "recname": "rs121908525",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1826,
  "fields": {
    "recname": "rs121908525",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1827,
  "fields": {
    "recname": "rs121908530",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1828,
  "fields": {
    "recname": "rs121908611",
    "keywords": "Spastic Paraplegia 5A, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1829,
  "fields": {
    "recname": "rs121908614",
    "keywords": "Spastic Paraplegia 5A, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1830,
  "fields": {
    "recname": "rs121908641",
    "keywords": "Citrullinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1831,
  "fields": {
    "recname": "rs121908676",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1832,
  "fields": {
    "recname": "rs121908679",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1833,
  "fields": {
    "recname": "rs121909211",
    "keywords": "Avellino Corneal Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1834,
  "fields": {
    "recname": "rs121909358",
    "keywords": "Laron Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1835,
  "fields": {
    "recname": "rs121909363",
    "keywords": "Laron Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1836,
  "fields": {
    "recname": "rs121909547",
    "keywords": "Antithrombin Iii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1837,
  "fields": {
    "recname": "rs121909763",
    "keywords": "Usher Syndrome, Type 2C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1838,
  "fields": {
    "recname": "rs121909763",
    "keywords": "Usher Syndrome, Type 2C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1839,
  "fields": {
    "recname": "rs121912583",
    "keywords": "Histiocytosis With Joint Contractures And Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1840,
  "fields": {
    "recname": "rs121912609",
    "keywords": "Bifid Nose With Or Without Anorectal And Renal Anomalies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1841,
  "fields": {
    "recname": "rs121912610",
    "keywords": "Bifid Nose With Or Without Anorectal And Renal Anomalies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1842,
  "fields": {
    "recname": "rs121912654",
    "keywords": "Liver Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1843,
  "fields": {
    "recname": "rs121912931",
    "keywords": "Stickler Syndrome (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1844,
  "fields": {
    "recname": "rs121912931",
    "keywords": "Stickler Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1845,
  "fields": {
    "recname": "rs121912931",
    "keywords": "Stickler Syndrome, Type Iv"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1846,
  "fields": {
    "recname": "rs121913301",
    "keywords": "Retinoblastoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1847,
  "fields": {
    "recname": "rs121913302",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1848,
  "fields": {
    "recname": "rs121913329",
    "keywords": "Colorectal Neoplasms"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1849,
  "fields": {
    "recname": "rs121913332",
    "keywords": "Colorectal Neoplasms"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1850,
  "fields": {
    "recname": "rs121913684",
    "keywords": "Piebaldism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1851,
  "fields": {
    "recname": "rs121913684",
    "keywords": "Piebaldism With Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1852,
  "fields": {
    "recname": "rs121917734",
    "keywords": "Spherocytosis, Type 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1853,
  "fields": {
    "recname": "rs121917734",
    "keywords": "Spherocytosis, Type 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1854,
  "fields": {
    "recname": "rs121917777",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1855,
  "fields": {
    "recname": "rs121917777",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1856,
  "fields": {
    "recname": "rs121917784",
    "keywords": "Fanconi Anemia, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1857,
  "fields": {
    "recname": "rs121917785",
    "keywords": "Fanconi Anemia, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1858,
  "fields": {
    "recname": "rs121917834",
    "keywords": "Respiratory Distress Syndrome, Newborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1859,
  "fields": {
    "recname": "rs121917839",
    "keywords": "Pituitary Dwarfism Type 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1860,
  "fields": {
    "recname": "rs121917843",
    "keywords": "Dwarfism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1861,
  "fields": {
    "recname": "rs121917843",
    "keywords": "Panhypopituitarism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1862,
  "fields": {
    "recname": "rs121917843",
    "keywords": "Pituitary Dwarfism Type 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1863,
  "fields": {
    "recname": "rs121917851",
    "keywords": "Ataxia With Vitamin E Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1864,
  "fields": {
    "recname": "rs121918057",
    "keywords": "Hepatoerythropoietic Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1865,
  "fields": {
    "recname": "rs121918057",
    "keywords": "Familial Porphyria Cutanea Tarda"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1866,
  "fields": {
    "recname": "rs121918057",
    "keywords": "Hepatoerythropoietic Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1867,
  "fields": {
    "recname": "rs121918057",
    "keywords": "Porphyria Cutanea Tarda"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1868,
  "fields": {
    "recname": "rs121918057",
    "keywords": "Porphyria Cutanea Tarda"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1869,
  "fields": {
    "recname": "rs121918167",
    "keywords": "Albinism, Oculocutaneous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1870,
  "fields": {
    "recname": "rs121918168",
    "keywords": "Brown Oculocutaneous Albinism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1871,
  "fields": {
    "recname": "rs121918168",
    "keywords": "Oculocutaneous Albinism Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1872,
  "fields": {
    "recname": "rs121918257",
    "keywords": "Methylmalonic Aciduria Due To Methylmalonyl-Coa Mutase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1873,
  "fields": {
    "recname": "rs121918292",
    "keywords": "Poikiloderma Of Kindler"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1874,
  "fields": {
    "recname": "rs121918303",
    "keywords": "Cryptorchidism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1875,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1876,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1877,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1878,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1879,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1880,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1881,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1882,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1883,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1884,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1885,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1886,
  "fields": {
    "recname": "rs121918324",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1887,
  "fields": {
    "recname": "rs121918325",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1888,
  "fields": {
    "recname": "rs121918325",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1889,
  "fields": {
    "recname": "rs121918325",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1890,
  "fields": {
    "recname": "rs121918325",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1891,
  "fields": {
    "recname": "rs121918325",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1892,
  "fields": {
    "recname": "rs121918325",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1893,
  "fields": {
    "recname": "rs121918326",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1894,
  "fields": {
    "recname": "rs121918326",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1895,
  "fields": {
    "recname": "rs121918326",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1896,
  "fields": {
    "recname": "rs121918335",
    "keywords": "Early Myoclonic Encephalopathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1897,
  "fields": {
    "recname": "rs121918338",
    "keywords": "Colitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1898,
  "fields": {
    "recname": "rs121918583",
    "keywords": "Retinitis Pigmentosa 40 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1899,
  "fields": {
    "recname": "rs121918583",
    "keywords": "Retinitis Pigmentosa 40 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1900,
  "fields": {
    "recname": "rs121918641",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1901,
  "fields": {
    "recname": "rs121918641",
    "keywords": "Hereditary Pyropoikilocytosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1902,
  "fields": {
    "recname": "rs121918641",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1903,
  "fields": {
    "recname": "rs121918641",
    "keywords": "Hereditary Pyropoikilocytosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1904,
  "fields": {
    "recname": "rs121918642",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1905,
  "fields": {
    "recname": "rs121918642",
    "keywords": "Hereditary Pyropoikilocytosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1906,
  "fields": {
    "recname": "rs121918643",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1907,
  "fields": {
    "recname": "rs121918643",
    "keywords": "Hereditary Pyropoikilocytosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1908,
  "fields": {
    "recname": "rs121918670",
    "keywords": "Hypothyroidism, Congenital, Nongoitrous, 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1909,
  "fields": {
    "recname": "rs1219648",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1910,
  "fields": {
    "recname": "rs1219648",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1911,
  "fields": {
    "recname": "rs121964856",
    "keywords": "Cardiomyopathy, Dilated, 1D (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1912,
  "fields": {
    "recname": "rs121964856",
    "keywords": "Cardiomyopathy, Familial Hypertrophic, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1913,
  "fields": {
    "recname": "rs121964856",
    "keywords": "Cardiomyopathy, Familial Restrictive, 3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1914,
  "fields": {
    "recname": "rs121964921",
    "keywords": "Complement Component 7 Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1915,
  "fields": {
    "recname": "rs121964931",
    "keywords": "Factor Vii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1916,
  "fields": {
    "recname": "rs121964990",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1917,
  "fields": {
    "recname": "rs121964990",
    "keywords": "Lactic Acidosis, Congenital Infantile, Due To Lad Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1918,
  "fields": {
    "recname": "rs121964990",
    "keywords": "NAdh Cytochrome B5 Reductase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1919,
  "fields": {
    "recname": "rs121965021",
    "keywords": "Pfaundler-Hurler Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1920,
  "fields": {
    "recname": "rs121965021",
    "keywords": "Pfaundler-Hurler Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1921,
  "fields": {
    "recname": "rs121965022",
    "keywords": "Pfaundler-Hurler Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1922,
  "fields": {
    "recname": "rs121965022",
    "keywords": "Pfaundler-Hurler Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1923,
  "fields": {
    "recname": "rs12255372",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1924,
  "fields": {
    "recname": "rs12255372",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1925,
  "fields": {
    "recname": "rs12255372",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1926,
  "fields": {
    "recname": "rs12255372",
    "keywords": "Polycystic Ovary Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1927,
  "fields": {
    "recname": "rs12405994",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1928,
  "fields": {
    "recname": "rs1249744",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1929,
  "fields": {
    "recname": "rs12720459",
    "keywords": "Romano-Ward Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1930,
  "fields": {
    "recname": "rs12720459",
    "keywords": "Romano-Ward Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1931,
  "fields": {
    "recname": "rs12788102",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1932,
  "fields": {
    "recname": "rs12788102",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1933,
  "fields": {
    "recname": "rs12789492",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1934,
  "fields": {
    "recname": "rs12801757",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1935,
  "fields": {
    "recname": "rs12806476",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1936,
  "fields": {
    "recname": "rs12808215",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1937,
  "fields": {
    "recname": "rs12979860",
    "keywords": "Liver Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1938,
  "fields": {
    "recname": "rs12979860",
    "keywords": "Hepatitis C, Chronic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1939,
  "fields": {
    "recname": "rs12979860",
    "keywords": "Liver Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1940,
  "fields": {
    "recname": "rs13107325",
    "keywords": "Schizophrenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1941,
  "fields": {
    "recname": "rs13181",
    "keywords": "Bladder Neoplasm"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1942,
  "fields": {
    "recname": "rs13181",
    "keywords": "Carcinoma Of Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1943,
  "fields": {
    "recname": "rs13181",
    "keywords": "Malignant Neoplasm Of Urinary Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1944,
  "fields": {
    "recname": "rs13181",
    "keywords": "Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1945,
  "fields": {
    "recname": "rs13266634",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1946,
  "fields": {
    "recname": "rs13281615",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1947,
  "fields": {
    "recname": "rs13281615",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1948,
  "fields": {
    "recname": "rs13281615",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1949,
  "fields": {
    "recname": "rs13281615",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1950,
  "fields": {
    "recname": "rs13281615",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1951,
  "fields": {
    "recname": "rs13281615",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1952,
  "fields": {
    "recname": "rs1330363",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1953,
  "fields": {
    "recname": "rs1330363",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1954,
  "fields": {
    "recname": "rs13321",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1955,
  "fields": {
    "recname": "rs13321",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1956,
  "fields": {
    "recname": "rs137852347",
    "keywords": "Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1957,
  "fields": {
    "recname": "rs137852621",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1958,
  "fields": {
    "recname": "rs137852621",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1959,
  "fields": {
    "recname": "rs137852999",
    "keywords": "Deafness, Autosomal Recessive 10"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1960,
  "fields": {
    "recname": "rs137852999",
    "keywords": "Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1961,
  "fields": {
    "recname": "rs137853003",
    "keywords": "Usher Syndrome, Type If"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1962,
  "fields": {
    "recname": "rs137853016",
    "keywords": "Spastic Ataxia, Charlevoix-Saguenay Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1963,
  "fields": {
    "recname": "rs137853017",
    "keywords": "Spastic Ataxia, Charlevoix-Saguenay Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1964,
  "fields": {
    "recname": "rs137853025",
    "keywords": "Saldino-Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1965,
  "fields": {
    "recname": "rs137853025",
    "keywords": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1966,
  "fields": {
    "recname": "rs137853027",
    "keywords": "Saldino-Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1967,
  "fields": {
    "recname": "rs137853027",
    "keywords": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1968,
  "fields": {
    "recname": "rs137853028",
    "keywords": "Saldino-Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1969,
  "fields": {
    "recname": "rs137853028",
    "keywords": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1970,
  "fields": {
    "recname": "rs137853034",
    "keywords": "Saldino-Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1971,
  "fields": {
    "recname": "rs137853034",
    "keywords": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1972,
  "fields": {
    "recname": "rs137853035",
    "keywords": "Saldino-Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1973,
  "fields": {
    "recname": "rs137853035",
    "keywords": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1974,
  "fields": {
    "recname": "rs137853052",
    "keywords": "Warburg Sjo Fledelius Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1975,
  "fields": {
    "recname": "rs137853052",
    "keywords": "Warburg Sjo Fledelius Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1976,
  "fields": {
    "recname": "rs137853125",
    "keywords": "Chylomicron Retention Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1977,
  "fields": {
    "recname": "rs137853126",
    "keywords": "Chylomicron Retention Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1978,
  "fields": {
    "recname": "rs137853284",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1979,
  "fields": {
    "recname": "rs137853293",
    "keywords": "Retinoblastoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1980,
  "fields": {
    "recname": "rs137853300",
    "keywords": "Fundus Dystrophy, Pseudoinflammatory, Of Sorsby"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1981,
  "fields": {
    "recname": "rs137853300",
    "keywords": "Fundus Dystrophy, Pseudoinflammatory, Of Sorsby"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1982,
  "fields": {
    "recname": "rs137854575",
    "keywords": "Polyposis, Adenomatous Intestinal"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1983,
  "fields": {
    "recname": "rs137943601",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1984,
  "fields": {
    "recname": "rs137943601",
    "keywords": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1985,
  "fields": {
    "recname": "rs138043021",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1986,
  "fields": {
    "recname": "rs139361635",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1987,
  "fields": {
    "recname": "rs139361635",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1988,
  "fields": {
    "recname": "rs139640763",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1989,
  "fields": {
    "recname": "rs140721383",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1990,
  "fields": {
    "recname": "rs140721383",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1991,
  "fields": {
    "recname": "rs140817150",
    "keywords": "Pneumococcal Bacteraemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1992,
  "fields": {
    "recname": "rs1411478",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1993,
  "fields": {
    "recname": "rs1411478",
    "keywords": "Progressive Supranuclear Palsy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1994,
  "fields": {
    "recname": "rs141278078",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1995,
  "fields": {
    "recname": "rs1417402",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1996,
  "fields": {
    "recname": "rs141980901",
    "keywords": "Retinitis Pigmentosa 14"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1997,
  "fields": {
    "recname": "rs1426654",
    "keywords": "Skin-Hair-Eye Pigmentation, Variation In, 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1998,
  "fields": {
    "recname": "rs1427407",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 1999,
  "fields": {
    "recname": "rs142761835",
    "keywords": "Isovaleryl-Coa Dehydrogenase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2000,
  "fields": {
    "recname": "rs143570936",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2001,
  "fields": {
    "recname": "rs143570936",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2002,
  "fields": {
    "recname": "rs143570936",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2003,
  "fields": {
    "recname": "rs144312179",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2004,
  "fields": {
    "recname": "rs144666367",
    "keywords": "Peeling Skin Syndrome 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2005,
  "fields": {
    "recname": "rs145489194",
    "keywords": "Microcephaly, Primary Autosomal Recessive, 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2006,
  "fields": {
    "recname": "rs145513733",
    "keywords": "Albinism, Oculocutaneous, Type I, Temperature-Sensitive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2007,
  "fields": {
    "recname": "rs145513733",
    "keywords": "Albinism, Oculocutaneous, Type Ib (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2008,
  "fields": {
    "recname": "rs145946881",
    "keywords": "Lactase Persistence"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2009,
  "fields": {
    "recname": "rs146214639",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2010,
  "fields": {
    "recname": "rs147030232",
    "keywords": "Bardet-Biedl Syndrome 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2011,
  "fields": {
    "recname": "rs1470452230",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2012,
  "fields": {
    "recname": "rs1470452230",
    "keywords": "Hepatitis C, Chronic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2013,
  "fields": {
    "recname": "rs1470579",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2014,
  "fields": {
    "recname": "rs1470579",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2015,
  "fields": {
    "recname": "rs147484110",
    "keywords": "Myoclonic Epilepsies, Progressive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2016,
  "fields": {
    "recname": "rs147739031",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2017,
  "fields": {
    "recname": "rs148499164",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2018,
  "fields": {
    "recname": "rs148542782",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2019,
  "fields": {
    "recname": "rs148542782",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2020,
  "fields": {
    "recname": "rs148542782",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2021,
  "fields": {
    "recname": "rs148542782",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2022,
  "fields": {
    "recname": "rs148617572",
    "keywords": "Autosomal Recessive Polycystic Kidney Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2023,
  "fields": {
    "recname": "rs149277003",
    "keywords": "Estren-Dameshek Variant Of Fanconi Pancytopenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2024,
  "fields": {
    "recname": "rs149330893",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2025,
  "fields": {
    "recname": "rs149989682",
    "keywords": "Idiopathic Pulmonary Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2026,
  "fields": {
    "recname": "rs149989682",
    "keywords": "Respiratory Distress Syndrome, Newborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2027,
  "fields": {
    "recname": "rs149989682",
    "keywords": "Surfactant Metabolism Dysfunction, Pulmonary, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2028,
  "fields": {
    "recname": "rs1537415",
    "keywords": "Acute Periodontitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2029,
  "fields": {
    "recname": "rs1537415",
    "keywords": "Periodontitis, Juvenile"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2030,
  "fields": {
    "recname": "rs1543061",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2031,
  "fields": {
    "recname": "rs1594812",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2032,
  "fields": {
    "recname": "rs17227978",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2033,
  "fields": {
    "recname": "rs17227978",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2034,
  "fields": {
    "recname": "rs17228092",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2035,
  "fields": {
    "recname": "rs17228176",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2036,
  "fields": {
    "recname": "rs17228183",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2037,
  "fields": {
    "recname": "rs17233141",
    "keywords": "Estren-Dameshek Variant Of Fanconi Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2038,
  "fields": {
    "recname": "rs17233141",
    "keywords": "Estren-Dameshek Variant Of Fanconi Pancytopenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2039,
  "fields": {
    "recname": "rs17233141",
    "keywords": "Fanconi Anemia, Complementation Group A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2040,
  "fields": {
    "recname": "rs17235409",
    "keywords": "Buruli Ulcer, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2041,
  "fields": {
    "recname": "rs17313265",
    "keywords": "Crohn Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2042,
  "fields": {
    "recname": "rs17325567",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2043,
  "fields": {
    "recname": "rs17325567",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2044,
  "fields": {
    "recname": "rs17621578",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2045,
  "fields": {
    "recname": "rs17621578",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2046,
  "fields": {
    "recname": "rs17655",
    "keywords": "Bladder Neoplasm"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2047,
  "fields": {
    "recname": "rs17655",
    "keywords": "Bladder Neoplasm"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2048,
  "fields": {
    "recname": "rs17655",
    "keywords": "Carcinoma Of Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2049,
  "fields": {
    "recname": "rs17655",
    "keywords": "Carcinoma Of Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2050,
  "fields": {
    "recname": "rs17655",
    "keywords": "Malignant Neoplasm Of Urinary Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2051,
  "fields": {
    "recname": "rs17655",
    "keywords": "Malignant Neoplasm Of Urinary Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2052,
  "fields": {
    "recname": "rs17655",
    "keywords": "Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2053,
  "fields": {
    "recname": "rs17655",
    "keywords": "Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2054,
  "fields": {
    "recname": "rs17728971",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2055,
  "fields": {
    "recname": "rs179363877",
    "keywords": "Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2056,
  "fields": {
    "recname": "rs179363877",
    "keywords": "Polyglandular Deficiency Syndrome, Persian-Jewish Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2057,
  "fields": {
    "recname": "rs179363877",
    "keywords": "Polyglandular Type I Autoimmune Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2058,
  "fields": {
    "recname": "rs179363880",
    "keywords": "Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2059,
  "fields": {
    "recname": "rs179363880",
    "keywords": "Polyglandular Deficiency Syndrome, Persian-Jewish Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2060,
  "fields": {
    "recname": "rs179363880",
    "keywords": "Polyglandular Type I Autoimmune Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2061,
  "fields": {
    "recname": "rs1799864",
    "keywords": "Acquired Immunodeficiency Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2062,
  "fields": {
    "recname": "rs1799945",
    "keywords": "Hereditary Hemochromatosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2063,
  "fields": {
    "recname": "rs1799945",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2064,
  "fields": {
    "recname": "rs1799983",
    "keywords": "Myocardial Infarction"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2065,
  "fields": {
    "recname": "rs1799990",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2066,
  "fields": {
    "recname": "rs1799990",
    "keywords": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2067,
  "fields": {
    "recname": "rs1800014",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2068,
  "fields": {
    "recname": "rs1800014",
    "keywords": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2069,
  "fields": {
    "recname": "rs1800450",
    "keywords": "Mannose-Binding Protein Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2070,
  "fields": {
    "recname": "rs1800553",
    "keywords": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2071,
  "fields": {
    "recname": "rs1800555",
    "keywords": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2072,
  "fields": {
    "recname": "rs1800562",
    "keywords": "Hereditary Hemochromatosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2073,
  "fields": {
    "recname": "rs1800562",
    "keywords": "Hemochromatosis, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2074,
  "fields": {
    "recname": "rs1800562",
    "keywords": "Iron Overload"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2075,
  "fields": {
    "recname": "rs1800728",
    "keywords": "Cone-Rod Dystrophy 3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2076,
  "fields": {
    "recname": "rs1800728",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2077,
  "fields": {
    "recname": "rs1800728",
    "keywords": "Cone-Rod Dystrophy 3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2078,
  "fields": {
    "recname": "rs1800728",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2079,
  "fields": {
    "recname": "rs1800871",
    "keywords": "Cervical Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2080,
  "fields": {
    "recname": "rs1800871",
    "keywords": "Cervical Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2081,
  "fields": {
    "recname": "rs1800871",
    "keywords": "Cervix Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2082,
  "fields": {
    "recname": "rs1800871",
    "keywords": "Cervix Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2083,
  "fields": {
    "recname": "rs1800871",
    "keywords": "Malignant Tumor Of Cervix"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2084,
  "fields": {
    "recname": "rs1800871",
    "keywords": "Malignant Tumor Of Cervix"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2085,
  "fields": {
    "recname": "rs1800872",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2086,
  "fields": {
    "recname": "rs1800872",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2087,
  "fields": {
    "recname": "rs1800872",
    "keywords": "Cervical Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2088,
  "fields": {
    "recname": "rs1800872",
    "keywords": "Cervical Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2089,
  "fields": {
    "recname": "rs1800872",
    "keywords": "Cervix Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2090,
  "fields": {
    "recname": "rs1800872",
    "keywords": "Cervix Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2091,
  "fields": {
    "recname": "rs1800872",
    "keywords": "Malignant Tumor Of Cervix"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2092,
  "fields": {
    "recname": "rs1800872",
    "keywords": "Malignant Tumor Of Cervix"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2093,
  "fields": {
    "recname": "rs1801002",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2094,
  "fields": {
    "recname": "rs1801133",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2095,
  "fields": {
    "recname": "rs1801175",
    "keywords": "Glycogen Storage Disease Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2096,
  "fields": {
    "recname": "rs1801275",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2097,
  "fields": {
    "recname": "rs1801282",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2098,
  "fields": {
    "recname": "rs1801282",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2099,
  "fields": {
    "recname": "rs1801282",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2100,
  "fields": {
    "recname": "rs1801282",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2101,
  "fields": {
    "recname": "rs1801282",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2102,
  "fields": {
    "recname": "rs180177097",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2103,
  "fields": {
    "recname": "rs180177239",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2104,
  "fields": {
    "recname": "rs180177430",
    "keywords": "Muckle-Wells Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2105,
  "fields": {
    "recname": "rs180177478",
    "keywords": "Familial Cold Urticaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2106,
  "fields": {
    "recname": "rs1805096",
    "keywords": "Obesity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2107,
  "fields": {
    "recname": "rs1805096",
    "keywords": "C-Reactive Protein Measurement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2108,
  "fields": {
    "recname": "rs1805192",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2109,
  "fields": {
    "recname": "rs1805192",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2110,
  "fields": {
    "recname": "rs181396238",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2111,
  "fields": {
    "recname": "rs183258549",
    "keywords": "Deafness, Autosomal Recessive 84A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2112,
  "fields": {
    "recname": "rs186873296",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2113,
  "fields": {
    "recname": "rs1878468",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2114,
  "fields": {
    "recname": "rs188286943",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2115,
  "fields": {
    "recname": "rs189159450",
    "keywords": "Acute Intermittent Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2116,
  "fields": {
    "recname": "rs189159450",
    "keywords": "Chester-Type Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2117,
  "fields": {
    "recname": "rs189159450",
    "keywords": "Hydroxymethylbilane Synthase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2118,
  "fields": {
    "recname": "rs189159450",
    "keywords": "Porphyria, Acute Intermittent, Nonerythroid Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2119,
  "fields": {
    "recname": "rs1917445",
    "keywords": "Neutrophil Count (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2120,
  "fields": {
    "recname": "rs193922107",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2121,
  "fields": {
    "recname": "rs193922109",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2122,
  "fields": {
    "recname": "rs193922109",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2123,
  "fields": {
    "recname": "rs193922674",
    "keywords": "Arrhythmogenic Right Ventricular Dysplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2124,
  "fields": {
    "recname": "rs193922837",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2125,
  "fields": {
    "recname": "rs199422114",
    "keywords": "Ghosal Hematodiaphyseal Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2126,
  "fields": {
    "recname": "rs199422216",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2127,
  "fields": {
    "recname": "rs199422216",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2128,
  "fields": {
    "recname": "rs199422217",
    "keywords": "Ichthyosiform Erythroderma, Congenital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2129,
  "fields": {
    "recname": "rs199422217",
    "keywords": "Ichthyosiform Erythroderma, Congenital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2130,
  "fields": {
    "recname": "rs199422217",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2131,
  "fields": {
    "recname": "rs199422217",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2132,
  "fields": {
    "recname": "rs199475575",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2133,
  "fields": {
    "recname": "rs199475579",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2134,
  "fields": {
    "recname": "rs199476104",
    "keywords": "Optic Atrophy, Hereditary, Leber"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2135,
  "fields": {
    "recname": "rs199476134",
    "keywords": "Optic Atrophy, Hereditary, Leber"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2136,
  "fields": {
    "recname": "rs200024180",
    "keywords": "Epilepsy, Progressive Myoclonic, 8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2137,
  "fields": {
    "recname": "rs200024180",
    "keywords": "Epilepsy, Progressive Myoclonic, 8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2138,
  "fields": {
    "recname": "rs2004640",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2139,
  "fields": {
    "recname": "rs200652879",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2140,
  "fields": {
    "recname": "rs200659479",
    "keywords": "Encephalopathy Adverse Event"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2141,
  "fields": {
    "recname": "rs200659479",
    "keywords": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2142,
  "fields": {
    "recname": "rs200678853",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2143,
  "fields": {
    "recname": "rs200731780",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2144,
  "fields": {
    "recname": "rs200790561",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2145,
  "fields": {
    "recname": "rs200790561",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2146,
  "fields": {
    "recname": "rs201124247",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2147,
  "fields": {
    "recname": "rs201129618",
    "keywords": "Ichthyosis, Lamellar, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2148,
  "fields": {
    "recname": "rs201129618",
    "keywords": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2149,
  "fields": {
    "recname": "rs201285077",
    "keywords": "Generalized Pustular Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2150,
  "fields": {
    "recname": "rs201285077",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2151,
  "fields": {
    "recname": "rs201285077",
    "keywords": "Psoriasis Vulgaris"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2152,
  "fields": {
    "recname": "rs201322234",
    "keywords": "Myasthenic Syndrome, Congenital, 12"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2153,
  "fields": {
    "recname": "rs201573863",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2154,
  "fields": {
    "recname": "rs201573863",
    "keywords": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2155,
  "fields": {
    "recname": "rs201636911",
    "keywords": "Pendred'S Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2156,
  "fields": {
    "recname": "rs201636911",
    "keywords": "Pendred'S Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2157,
  "fields": {
    "recname": "rs201928238",
    "keywords": "Avellino Corneal Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2158,
  "fields": {
    "recname": "rs202033121",
    "keywords": "Usher Syndrome, Type If"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2159,
  "fields": {
    "recname": "rs202179988",
    "keywords": "Congenital Bilateral Aplasia Of Vas Deferens"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2160,
  "fields": {
    "recname": "rs202179988",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2161,
  "fields": {
    "recname": "rs20541",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2162,
  "fields": {
    "recname": "rs20541",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2163,
  "fields": {
    "recname": "rs2057178",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2164,
  "fields": {
    "recname": "rs2057178",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2165,
  "fields": {
    "recname": "rs2066714",
    "keywords": "Obesity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2166,
  "fields": {
    "recname": "rs2066714",
    "keywords": "Overweight"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2167,
  "fields": {
    "recname": "rs2066844",
    "keywords": "Crohn Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2168,
  "fields": {
    "recname": "rs2066845",
    "keywords": "Crohn Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2169,
  "fields": {
    "recname": "rs2070744",
    "keywords": "Myocardial Infarction"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2170,
  "fields": {
    "recname": "rs2104772",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2171,
  "fields": {
    "recname": "rs2104772",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2172,
  "fields": {
    "recname": "rs217086",
    "keywords": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2173,
  "fields": {
    "recname": "rs2185710",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2174,
  "fields": {
    "recname": "rs2199936",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2175,
  "fields": {
    "recname": "rs2199936",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2176,
  "fields": {
    "recname": "rs2228001",
    "keywords": "Bladder Neoplasm"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2177,
  "fields": {
    "recname": "rs2228001",
    "keywords": "Bladder Neoplasm"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2178,
  "fields": {
    "recname": "rs2228001",
    "keywords": "Carcinoma Of Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2179,
  "fields": {
    "recname": "rs2228001",
    "keywords": "Carcinoma Of Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2180,
  "fields": {
    "recname": "rs2228001",
    "keywords": "Malignant Neoplasm Of Urinary Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2181,
  "fields": {
    "recname": "rs2228001",
    "keywords": "Malignant Neoplasm Of Urinary Bladder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2182,
  "fields": {
    "recname": "rs2228001",
    "keywords": "Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2183,
  "fields": {
    "recname": "rs2228001",
    "keywords": "Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2184,
  "fields": {
    "recname": "rs2229207",
    "keywords": "Hepatitis B Virus, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2185,
  "fields": {
    "recname": "rs2230806",
    "keywords": "Obesity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2186,
  "fields": {
    "recname": "rs2230806",
    "keywords": "Overweight"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2187,
  "fields": {
    "recname": "rs2231142",
    "keywords": "Childhood Acute Lymphoblastic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2188,
  "fields": {
    "recname": "rs2231142",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2189,
  "fields": {
    "recname": "rs2231142",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2190,
  "fields": {
    "recname": "rs2237892",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2191,
  "fields": {
    "recname": "rs2237892",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2192,
  "fields": {
    "recname": "rs2237896",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2193,
  "fields": {
    "recname": "rs2237896",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2194,
  "fields": {
    "recname": "rs2239785",
    "keywords": "Focal Glomerulosclerosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2195,
  "fields": {
    "recname": "rs2241766",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2196,
  "fields": {
    "recname": "rs2241766",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2197,
  "fields": {
    "recname": "rs2241767",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2198,
  "fields": {
    "recname": "rs2241767",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2199,
  "fields": {
    "recname": "rs2259816",
    "keywords": "C-Reactive Protein Measurement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2200,
  "fields": {
    "recname": "rs231775",
    "keywords": "Hepatitis C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2201,
  "fields": {
    "recname": "rs231775",
    "keywords": "Lymphoma, Non-Hodgkin"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2202,
  "fields": {
    "recname": "rs2397084",
    "keywords": "Encephalitis, St. Louis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2203,
  "fields": {
    "recname": "rs2397084",
    "keywords": "Lupus Erythematosus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2204,
  "fields": {
    "recname": "rs2397084",
    "keywords": "Lupus Erythematosus, Discoid"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2205,
  "fields": {
    "recname": "rs2397084",
    "keywords": "Lupus Erythematosus, Systemic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2206,
  "fields": {
    "recname": "rs2397084",
    "keywords": "Lupus Nephritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2207,
  "fields": {
    "recname": "rs2397084",
    "keywords": "Lupus Vulgaris"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2208,
  "fields": {
    "recname": "rs2397084",
    "keywords": "Nephritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2209,
  "fields": {
    "recname": "rs2401027",
    "keywords": "Body Mass Index"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2210,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2211,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2212,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Inflammatory Bowel Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2213,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Inflammatory Bowel Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2214,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Diabetes"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2215,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Diabetes"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2216,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Diabetes Mellitus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2217,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Diabetes Mellitus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2218,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Diabetes Mellitus, Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2219,
  "fields": {
    "recname": "rs2476601",
    "keywords": "Diabetes Mellitus, Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2220,
  "fields": {
    "recname": "rs2543007",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2221,
  "fields": {
    "recname": "rs2543007",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2222,
  "fields": {
    "recname": "rs267606640",
    "keywords": "Glycogen Storage Disease Type Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2223,
  "fields": {
    "recname": "rs267606640",
    "keywords": "Glycogen Storage Disease Type Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2224,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Mitochondrial Complex I Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2225,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Leigh Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2226,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex I Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2227,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex Ii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2228,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex Iii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2229,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex Iv Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2230,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Leigh Syndrome Due To Mitochondrial Complex V Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2231,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Mitochondrial Complex I Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2232,
  "fields": {
    "recname": "rs267606689",
    "keywords": "Necrotizing Encephalopathy, Infantile Subacute, Of Leigh"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2233,
  "fields": {
    "recname": "rs267606776",
    "keywords": "Hypotrichosis 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2234,
  "fields": {
    "recname": "rs267606776",
    "keywords": "Hypotrichosis 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2235,
  "fields": {
    "recname": "rs267606777",
    "keywords": "Hypotrichosis 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2236,
  "fields": {
    "recname": "rs267606777",
    "keywords": "Hypotrichosis 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2237,
  "fields": {
    "recname": "rs267606990",
    "keywords": "Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2238,
  "fields": {
    "recname": "rs267606991",
    "keywords": "Ectodermal Dysplasia-Syndactyly Syndrome 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2239,
  "fields": {
    "recname": "rs267606992",
    "keywords": "Ectodermal Dysplasia-Syndactyly Syndrome 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2240,
  "fields": {
    "recname": "rs267607035",
    "keywords": "Pontocerebellar Hypoplasia, Type 2D"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2241,
  "fields": {
    "recname": "rs267607036",
    "keywords": "Pontocerebellar Hypoplasia, Type 2D"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2242,
  "fields": {
    "recname": "rs267607137",
    "keywords": "Mental Retardation, Autosomal Recessive 13"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2243,
  "fields": {
    "recname": "rs267607142",
    "keywords": "Progressive Familial Heart Block, Type Ib"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2244,
  "fields": {
    "recname": "rs267607199",
    "keywords": "Epilepsy, Progressive Myoclonic 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2245,
  "fields": {
    "recname": "rs267608247",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2246,
  "fields": {
    "recname": "rs267608259",
    "keywords": "Job Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2247,
  "fields": {
    "recname": "rs267608260",
    "keywords": "Immunodeficiency 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2248,
  "fields": {
    "recname": "rs267608260",
    "keywords": "Job Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2249,
  "fields": {
    "recname": "rs267608261",
    "keywords": "Immunodeficiency 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2250,
  "fields": {
    "recname": "rs267608261",
    "keywords": "Immunodeficiency 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2251,
  "fields": {
    "recname": "rs267608261",
    "keywords": "Job Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2252,
  "fields": {
    "recname": "rs267608261",
    "keywords": "Job Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2253,
  "fields": {
    "recname": "rs2725271",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2254,
  "fields": {
    "recname": "rs2725271",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2255,
  "fields": {
    "recname": "rs2754158",
    "keywords": "Asymmetric Septal Hypertrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2256,
  "fields": {
    "recname": "rs2754158",
    "keywords": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2257,
  "fields": {
    "recname": "rs2754158",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2258,
  "fields": {
    "recname": "rs2754158",
    "keywords": "Idiopathic Hypertrophic Subaortic Stenosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2259,
  "fields": {
    "recname": "rs2814778",
    "keywords": "White Blood Cell Count Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2260,
  "fields": {
    "recname": "rs2814778",
    "keywords": "White Blood Cell Count Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2261,
  "fields": {
    "recname": "rs2814778",
    "keywords": "White Blood Cell Count Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2262,
  "fields": {
    "recname": "rs2814778",
    "keywords": "White Blood Cell Count Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2263,
  "fields": {
    "recname": "rs2814778",
    "keywords": "Neutrophil Count (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2264,
  "fields": {
    "recname": "rs2814778",
    "keywords": "Neutrophil Count (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2265,
  "fields": {
    "recname": "rs281860303",
    "keywords": "Deafness, Congenital, With Inner Ear Agenesis, Microtia, And Microdontia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2266,
  "fields": {
    "recname": "rs281864519",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2267,
  "fields": {
    "recname": "rs281864819",
    "keywords": "Alpha-Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2268,
  "fields": {
    "recname": "rs281865207",
    "keywords": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2269,
  "fields": {
    "recname": "rs281865207",
    "keywords": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2270,
  "fields": {
    "recname": "rs281865207",
    "keywords": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2271,
  "fields": {
    "recname": "rs281865224",
    "keywords": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2272,
  "fields": {
    "recname": "rs281865224",
    "keywords": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2273,
  "fields": {
    "recname": "rs281865224",
    "keywords": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2274,
  "fields": {
    "recname": "rs281865226",
    "keywords": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2275,
  "fields": {
    "recname": "rs281865226",
    "keywords": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2276,
  "fields": {
    "recname": "rs281865226",
    "keywords": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2277,
  "fields": {
    "recname": "rs281865234",
    "keywords": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2278,
  "fields": {
    "recname": "rs281865234",
    "keywords": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2279,
  "fields": {
    "recname": "rs281865234",
    "keywords": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2280,
  "fields": {
    "recname": "rs281865238",
    "keywords": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2281,
  "fields": {
    "recname": "rs281865238",
    "keywords": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2282,
  "fields": {
    "recname": "rs281865238",
    "keywords": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2283,
  "fields": {
    "recname": "rs281865250",
    "keywords": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2284,
  "fields": {
    "recname": "rs281865250",
    "keywords": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2285,
  "fields": {
    "recname": "rs281865250",
    "keywords": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2286,
  "fields": {
    "recname": "rs281865414",
    "keywords": "Deafness, Autosomal Recessive 84A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2287,
  "fields": {
    "recname": "rs281865527",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2288,
  "fields": {
    "recname": "rs281865530",
    "keywords": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2289,
  "fields": {
    "recname": "rs281865530",
    "keywords": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2290,
  "fields": {
    "recname": "rs281865530",
    "keywords": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2291,
  "fields": {
    "recname": "rs281875215",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2292,
  "fields": {
    "recname": "rs281875215",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2293,
  "fields": {
    "recname": "rs2856597",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2294,
  "fields": {
    "recname": "rs2856597",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2295,
  "fields": {
    "recname": "rs2856597",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2296,
  "fields": {
    "recname": "rs2856597",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2297,
  "fields": {
    "recname": "rs28897672",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2298,
  "fields": {
    "recname": "rs28931594",
    "keywords": "Senter Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2299,
  "fields": {
    "recname": "rs28931605",
    "keywords": "Cataract 4, Multiple Types"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2300,
  "fields": {
    "recname": "rs28931605",
    "keywords": "Cataract, Congenital, Cerulean Type, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2301,
  "fields": {
    "recname": "rs28931605",
    "keywords": "Cataract, Crystalline Aculeiform"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2302,
  "fields": {
    "recname": "rs28931605",
    "keywords": "Cataract, Punctate, Progressive Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2303,
  "fields": {
    "recname": "rs28931605",
    "keywords": "Nonnuclear Polymorphic Congenital Cataract"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2304,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2305,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2306,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2307,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2308,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2309,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Huntington Disease-Like 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2310,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2311,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2312,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2313,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2314,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2315,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2316,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2317,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2318,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2319,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2320,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease, Heidenhain Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2321,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease, Sporadic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2322,
  "fields": {
    "recname": "rs28933385",
    "keywords": "New Variant Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2323,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2324,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2325,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2326,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2327,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2328,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2329,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2330,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Other Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2331,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2332,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2333,
  "fields": {
    "recname": "rs28933385",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2334,
  "fields": {
    "recname": "rs28933386",
    "keywords": "Noonan Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2335,
  "fields": {
    "recname": "rs28933693",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2336,
  "fields": {
    "recname": "rs28933693",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2337,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2338,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2339,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Deficiency Of Monooxygenase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2340,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Deficiency Of Monooxygenase"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2341,
  "fields": {
    "recname": "rs28934586",
    "keywords": "11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2342,
  "fields": {
    "recname": "rs28934586",
    "keywords": "11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2343,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2344,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2345,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2346,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2347,
  "fields": {
    "recname": "rs28934586",
    "keywords": "11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2348,
  "fields": {
    "recname": "rs28934586",
    "keywords": "11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2349,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2350,
  "fields": {
    "recname": "rs28934586",
    "keywords": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2351,
  "fields": {
    "recname": "rs28934595",
    "keywords": "Hemochromatosis, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2352,
  "fields": {
    "recname": "rs28934595",
    "keywords": "Hereditary Hemochromatosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2353,
  "fields": {
    "recname": "rs28934595",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2354,
  "fields": {
    "recname": "rs28934906",
    "keywords": "Rett Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2355,
  "fields": {
    "recname": "rs28936700",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2356,
  "fields": {
    "recname": "rs28936700",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2357,
  "fields": {
    "recname": "rs28936700",
    "keywords": "Primary Congenital Glaucoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2358,
  "fields": {
    "recname": "rs28936700",
    "keywords": "Primary Congenital Glaucoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2359,
  "fields": {
    "recname": "rs28937888",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2360,
  "fields": {
    "recname": "rs28937888",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2361,
  "fields": {
    "recname": "rs28937903",
    "keywords": "Muscular Dystrophy, Congenital, 1C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2362,
  "fields": {
    "recname": "rs28937903",
    "keywords": "Muscular Dystrophy, Limb-Girdle, Type 2I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2363,
  "fields": {
    "recname": "rs28937903",
    "keywords": "Walker-Warburg Congenital Muscular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2364,
  "fields": {
    "recname": "rs28937903",
    "keywords": "Muscular Dystrophy, Congenital, 1C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2365,
  "fields": {
    "recname": "rs28937903",
    "keywords": "Walker-Warburg Congenital Muscular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2366,
  "fields": {
    "recname": "rs28937903",
    "keywords": "Muscular Dystrophy, Limb-Girdle, Type 2I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2367,
  "fields": {
    "recname": "rs28937903",
    "keywords": "Walker-Warburg Congenital Muscular Dystrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2368,
  "fields": {
    "recname": "rs28937904",
    "keywords": "Muscular Dystrophy, Congenital, 1C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2369,
  "fields": {
    "recname": "rs28939084",
    "keywords": "Deafness, Autosomal Recessive 10"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2370,
  "fields": {
    "recname": "rs28939084",
    "keywords": "Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2371,
  "fields": {
    "recname": "rs28939702",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2372,
  "fields": {
    "recname": "rs28939702",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2373,
  "fields": {
    "recname": "rs28939702",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2374,
  "fields": {
    "recname": "rs28939702",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2375,
  "fields": {
    "recname": "rs28939702",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2376,
  "fields": {
    "recname": "rs28939702",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2377,
  "fields": {
    "recname": "rs28939702",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2378,
  "fields": {
    "recname": "rs28939702",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2379,
  "fields": {
    "recname": "rs28940268",
    "keywords": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2380,
  "fields": {
    "recname": "rs28940268",
    "keywords": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2381,
  "fields": {
    "recname": "rs28940269",
    "keywords": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2382,
  "fields": {
    "recname": "rs28940269",
    "keywords": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2383,
  "fields": {
    "recname": "rs28940270",
    "keywords": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2384,
  "fields": {
    "recname": "rs28940271",
    "keywords": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2385,
  "fields": {
    "recname": "rs28940568",
    "keywords": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2386,
  "fields": {
    "recname": "rs28940578",
    "keywords": "Familial Mediterranean Fever"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2387,
  "fields": {
    "recname": "rs28940579",
    "keywords": "Familial Mediterranean Fever"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2388,
  "fields": {
    "recname": "rs28940579",
    "keywords": "Systemic Onset Juvenile Chronic Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2389,
  "fields": {
    "recname": "rs28940876",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2390,
  "fields": {
    "recname": "rs28941776",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2391,
  "fields": {
    "recname": "rs28942075",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2392,
  "fields": {
    "recname": "rs28942078",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2393,
  "fields": {
    "recname": "rs28942078",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2394,
  "fields": {
    "recname": "rs28942078",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2395,
  "fields": {
    "recname": "rs28942078",
    "keywords": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2396,
  "fields": {
    "recname": "rs28942078",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2397,
  "fields": {
    "recname": "rs28942081",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2398,
  "fields": {
    "recname": "rs28942084",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2399,
  "fields": {
    "recname": "rs28942084",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2400,
  "fields": {
    "recname": "rs28942084",
    "keywords": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2401,
  "fields": {
    "recname": "rs28942100",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2402,
  "fields": {
    "recname": "rs28942109",
    "keywords": "Chylomicron Retention Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2403,
  "fields": {
    "recname": "rs28942110",
    "keywords": "Chylomicron Retention Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2404,
  "fields": {
    "recname": "rs28942111",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2405,
  "fields": {
    "recname": "rs2967790",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2406,
  "fields": {
    "recname": "rs2981582",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2407,
  "fields": {
    "recname": "rs2981582",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2408,
  "fields": {
    "recname": "rs2981582",
    "keywords": "Neoplasm Metastasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2409,
  "fields": {
    "recname": "rs3003172",
    "keywords": "Body Mass Index"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2410,
  "fields": {
    "recname": "rs3003172",
    "keywords": "Body Mass Index"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2411,
  "fields": {
    "recname": "rs312262720",
    "keywords": "Amyotrophic Lateral Sclerosis 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2412,
  "fields": {
    "recname": "rs312262720",
    "keywords": "Spastic Paraplegia 11, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2413,
  "fields": {
    "recname": "rs312262728",
    "keywords": "Spastic Paraplegia 11, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2414,
  "fields": {
    "recname": "rs3218713",
    "keywords": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2415,
  "fields": {
    "recname": "rs3218713",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2416,
  "fields": {
    "recname": "rs3218716",
    "keywords": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2417,
  "fields": {
    "recname": "rs3218716",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2418,
  "fields": {
    "recname": "rs3218716",
    "keywords": "Hypertrophic Cardiomyopathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2419,
  "fields": {
    "recname": "rs333",
    "keywords": "West Nile Virus, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2420,
  "fields": {
    "recname": "rs333",
    "keywords": "West Nile Virus, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2421,
  "fields": {
    "recname": "rs333",
    "keywords": "West Nile Virus, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2422,
  "fields": {
    "recname": "rs333",
    "keywords": "West Nile Virus, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2423,
  "fields": {
    "recname": "rs334",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2424,
  "fields": {
    "recname": "rs334",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2425,
  "fields": {
    "recname": "rs334",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2426,
  "fields": {
    "recname": "rs334",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2427,
  "fields": {
    "recname": "rs334",
    "keywords": "Sickle Cell Trait/ Trachoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2428,
  "fields": {
    "recname": "rs334",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2429,
  "fields": {
    "recname": "rs334",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2430,
  "fields": {
    "recname": "rs334",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2431,
  "fields": {
    "recname": "rs334",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2432,
  "fields": {
    "recname": "rs334",
    "keywords": "Sickle Cell Trait"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2433,
  "fields": {
    "recname": "rs334",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2434,
  "fields": {
    "recname": "rs334",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2435,
  "fields": {
    "recname": "rs334",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2436,
  "fields": {
    "recname": "rs334",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2437,
  "fields": {
    "recname": "rs334",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2438,
  "fields": {
    "recname": "rs334",
    "keywords": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2439,
  "fields": {
    "recname": "rs33915217",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2440,
  "fields": {
    "recname": "rs33915217",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2441,
  "fields": {
    "recname": "rs33915217",
    "keywords": "Beta^+^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2442,
  "fields": {
    "recname": "rs33930165",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2443,
  "fields": {
    "recname": "rs33930165",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2444,
  "fields": {
    "recname": "rs33931746",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2445,
  "fields": {
    "recname": "rs33931746",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2446,
  "fields": {
    "recname": "rs33943001",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2447,
  "fields": {
    "recname": "rs33945777",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2448,
  "fields": {
    "recname": "rs33945777",
    "keywords": "Beta^0^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2449,
  "fields": {
    "recname": "rs33949390",
    "keywords": "Parkinson Disease, Familial, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2450,
  "fields": {
    "recname": "rs33950507",
    "keywords": "Beta^+^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2451,
  "fields": {
    "recname": "rs33950507",
    "keywords": "Hemoglobin E/Beta Thalassemia Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2452,
  "fields": {
    "recname": "rs33956879",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2453,
  "fields": {
    "recname": "rs33971440",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2454,
  "fields": {
    "recname": "rs33980857",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2455,
  "fields": {
    "recname": "rs34116584",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2456,
  "fields": {
    "recname": "rs34213790",
    "keywords": "Hiv Infections"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2457,
  "fields": {
    "recname": "rs34218908",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2458,
  "fields": {
    "recname": "rs34612342",
    "keywords": "Colorectal Adenomatous Polyposis, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2459,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2460,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease 8 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2461,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease, Familial, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2462,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2463,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease 8 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2464,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2465,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2466,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2467,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2468,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2469,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2470,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease, Familial, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2471,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2472,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2473,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2474,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2475,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2476,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2477,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2478,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2479,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2480,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Neurodegenerative Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2481,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2482,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2483,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2484,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2485,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Familial (Fpah)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2486,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Sporadic Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2487,
  "fields": {
    "recname": "rs34637584",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2488,
  "fields": {
    "recname": "rs34731820",
    "keywords": "Albinism, Oculocutaneous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2489,
  "fields": {
    "recname": "rs34778348",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2490,
  "fields": {
    "recname": "rs34778348",
    "keywords": "Parkinson Disease, Familial, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2491,
  "fields": {
    "recname": "rs34809449",
    "keywords": "Fetal Hemoglobin Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2492,
  "fields": {
    "recname": "rs34889882",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2493,
  "fields": {
    "recname": "rs35269064",
    "keywords": "Citrullinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2494,
  "fields": {
    "recname": "rs35424040",
    "keywords": "Beta-Knossos-Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2495,
  "fields": {
    "recname": "rs35424040",
    "keywords": "Beta^+^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2496,
  "fields": {
    "recname": "rs35424040",
    "keywords": "Beta-Knossos-Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2497,
  "fields": {
    "recname": "rs35424040",
    "keywords": "Beta^+^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2498,
  "fields": {
    "recname": "rs35424040",
    "keywords": "Beta-Knossos-Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2499,
  "fields": {
    "recname": "rs35424040",
    "keywords": "Beta^+^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2500,
  "fields": {
    "recname": "rs35870237",
    "keywords": "Parkinson Disease, Familial, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2501,
  "fields": {
    "recname": "rs35894115",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2502,
  "fields": {
    "recname": "rs35894115",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2503,
  "fields": {
    "recname": "rs35894115",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2504,
  "fields": {
    "recname": "rs36015961",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2505,
  "fields": {
    "recname": "rs36053993",
    "keywords": "Colorectal Adenomatous Polyposis, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2506,
  "fields": {
    "recname": "rs36053993",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2507,
  "fields": {
    "recname": "rs36053993",
    "keywords": "Stomach Neoplasms"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2508,
  "fields": {
    "recname": "rs364897",
    "keywords": "Gaucher Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2509,
  "fields": {
    "recname": "rs367947846",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2510,
  "fields": {
    "recname": "rs368345612",
    "keywords": "Keloid"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2511,
  "fields": {
    "recname": "rs368420430",
    "keywords": "Hemochromatosis, Type 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2512,
  "fields": {
    "recname": "rs369973784",
    "keywords": "Glycogen Storage Disease Type Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2513,
  "fields": {
    "recname": "rs370471013",
    "keywords": "Leigh Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2514,
  "fields": {
    "recname": "rs370792293",
    "keywords": "Glycogen Storage Disease Iiia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2515,
  "fields": {
    "recname": "rs370792293",
    "keywords": "Glycogen Storage Disease Type Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2516,
  "fields": {
    "recname": "rs370860696",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2517,
  "fields": {
    "recname": "rs371482223",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2518,
  "fields": {
    "recname": "rs371482223",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2519,
  "fields": {
    "recname": "rs371675217",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2520,
  "fields": {
    "recname": "rs371675217",
    "keywords": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2521,
  "fields": {
    "recname": "rs371898076",
    "keywords": "Hypertrophic Cardiomyopathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2522,
  "fields": {
    "recname": "rs371956016",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2523,
  "fields": {
    "recname": "rs371956016",
    "keywords": "Retinitis Pigmentosa 38 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2524,
  "fields": {
    "recname": "rs372091",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2525,
  "fields": {
    "recname": "rs372091",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2526,
  "fields": {
    "recname": "rs372091",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2527,
  "fields": {
    "recname": "rs372091",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2528,
  "fields": {
    "recname": "rs372091",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2529,
  "fields": {
    "recname": "rs372091",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2530,
  "fields": {
    "recname": "rs372392424",
    "keywords": "Mental Retardation, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2531,
  "fields": {
    "recname": "rs372479885",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2532,
  "fields": {
    "recname": "rs373135339",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2533,
  "fields": {
    "recname": "rs373135339",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2534,
  "fields": {
    "recname": "rs373533",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2535,
  "fields": {
    "recname": "rs373599651",
    "keywords": "Usher Syndrome, Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2536,
  "fields": {
    "recname": "rs373921680",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2537,
  "fields": {
    "recname": "rs3743930",
    "keywords": "Familial Mediterranean Fever"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2538,
  "fields": {
    "recname": "rs374473331",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2539,
  "fields": {
    "recname": "rs374612640",
    "keywords": "Peeling Skin Syndrome 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2540,
  "fields": {
    "recname": "rs374612640",
    "keywords": "Peeling Skin Syndrome 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2541,
  "fields": {
    "recname": "rs374612640",
    "keywords": "Peeling Skin Syndrome 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2542,
  "fields": {
    "recname": "rs374665929",
    "keywords": "Limb-Girdle Muscular Dystrophy Type 2A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2543,
  "fields": {
    "recname": "rs374946172",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2544,
  "fields": {
    "recname": "rs375495026",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2545,
  "fields": {
    "recname": "rs375624435",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2546,
  "fields": {
    "recname": "rs375624435",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2547,
  "fields": {
    "recname": "rs375688767",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2548,
  "fields": {
    "recname": "rs375688767",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2549,
  "fields": {
    "recname": "rs375952052",
    "keywords": "Cystinosis, Benign, Nonnephropathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2550,
  "fields": {
    "recname": "rs375952052",
    "keywords": "Juvenile Nephropathic Cystinosis (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2551,
  "fields": {
    "recname": "rs376103979",
    "keywords": "Neurodegeneration With Brain Iron Accumulation 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2552,
  "fields": {
    "recname": "rs376103979",
    "keywords": "Spastic Paraplegia 43, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2553,
  "fields": {
    "recname": "rs376103979",
    "keywords": "Neurodegeneration With Brain Iron Accumulation (Nbia)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2554,
  "fields": {
    "recname": "rs376103979",
    "keywords": "Neurodegeneration With Brain Iron Accumulation 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2555,
  "fields": {
    "recname": "rs376103979",
    "keywords": "Spastic Paraplegia 43, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2556,
  "fields": {
    "recname": "rs376306240",
    "keywords": "Retinitis Pigmentosa 74"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2557,
  "fields": {
    "recname": "rs376923877",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2558,
  "fields": {
    "recname": "rs376923877",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2559,
  "fields": {
    "recname": "rs377267777",
    "keywords": "Usher Syndrome, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2560,
  "fields": {
    "recname": "rs377267777",
    "keywords": "Usher Syndrome, Type I, French Variety, Formerly"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2561,
  "fields": {
    "recname": "rs377267777",
    "keywords": "Usher Syndrome, Type Ia, Formerly"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2562,
  "fields": {
    "recname": "rs377267777",
    "keywords": "Usher Syndrome, Type Ib (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2563,
  "fields": {
    "recname": "rs377294947",
    "keywords": "Fanconi Anemia, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2564,
  "fields": {
    "recname": "rs377357931",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2565,
  "fields": {
    "recname": "rs3792267",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2566,
  "fields": {
    "recname": "rs3798220",
    "keywords": "Coronary Artery Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2567,
  "fields": {
    "recname": "rs3824662",
    "keywords": "Acute Lymphocytic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2568,
  "fields": {
    "recname": "rs3824662",
    "keywords": "Adult Acute Lymphocytic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2569,
  "fields": {
    "recname": "rs3824662",
    "keywords": "Childhood Acute Lymphoblastic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2570,
  "fields": {
    "recname": "rs3825942",
    "keywords": "Exfoliation Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2571,
  "fields": {
    "recname": "rs3825942",
    "keywords": "Exfoliation Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2572,
  "fields": {
    "recname": "rs3825942",
    "keywords": "Exfoliation Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2573,
  "fields": {
    "recname": "rs3825942",
    "keywords": "Exfoliation Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2574,
  "fields": {
    "recname": "rs386134173",
    "keywords": "Amyotrophic Lateral Sclerosis 2, Juvenile (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2575,
  "fields": {
    "recname": "rs386833435",
    "keywords": "Aspartylglucosaminuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2576,
  "fields": {
    "recname": "rs386833437",
    "keywords": "Aspartylglucosaminuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2577,
  "fields": {
    "recname": "rs386833441",
    "keywords": "Unverricht-Lundborg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2578,
  "fields": {
    "recname": "rs386833799",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2579,
  "fields": {
    "recname": "rs386833800",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2580,
  "fields": {
    "recname": "rs386833805",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2581,
  "fields": {
    "recname": "rs386833812",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2582,
  "fields": {
    "recname": "rs386833817",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2583,
  "fields": {
    "recname": "rs386833818",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2584,
  "fields": {
    "recname": "rs386833827",
    "keywords": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2585,
  "fields": {
    "recname": "rs386834170",
    "keywords": "Megaloblastic Anemia Due To Inborn Errors Of Metabolism"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2586,
  "fields": {
    "recname": "rs387906220",
    "keywords": "Deafness, Autosomal Recessive 79"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2587,
  "fields": {
    "recname": "rs387906221",
    "keywords": "Deafness, Autosomal Recessive 79"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2588,
  "fields": {
    "recname": "rs387906222",
    "keywords": "Deafness, Autosomal Recessive 79"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2589,
  "fields": {
    "recname": "rs387906301",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2590,
  "fields": {
    "recname": "rs387906301",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2591,
  "fields": {
    "recname": "rs387906563",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2592,
  "fields": {
    "recname": "rs387906563",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2593,
  "fields": {
    "recname": "rs387906563",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2594,
  "fields": {
    "recname": "rs387906563",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2595,
  "fields": {
    "recname": "rs387906563",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2596,
  "fields": {
    "recname": "rs387906914",
    "keywords": "Acrodermatitis Continua Of Hallopeau"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2597,
  "fields": {
    "recname": "rs387906914",
    "keywords": "Generalized Pustular Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2598,
  "fields": {
    "recname": "rs387906959",
    "keywords": "Congenital Disorder Of Glycosylation, Type Iil"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2599,
  "fields": {
    "recname": "rs387907012",
    "keywords": "Microcephaly, Epilepsy, And Diabetes Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2600,
  "fields": {
    "recname": "rs387907107",
    "keywords": "Cranioectodermal Dysplasia 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2601,
  "fields": {
    "recname": "rs387907252",
    "keywords": "Agenesis Of Corpus Callosum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2602,
  "fields": {
    "recname": "rs387907252",
    "keywords": "Microphthalmia, Syndromic 11"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2603,
  "fields": {
    "recname": "rs387907252",
    "keywords": "Microphthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2604,
  "fields": {
    "recname": "rs387907259",
    "keywords": "Spastic Paraplegia 30, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2605,
  "fields": {
    "recname": "rs387907267",
    "keywords": "Hypertrophic Cardiomyopathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2606,
  "fields": {
    "recname": "rs387907314",
    "keywords": "Retinitis Pigmentosa 38 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2607,
  "fields": {
    "recname": "rs387907333",
    "keywords": "Osteogenesis Imperfecta Type Vii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2608,
  "fields": {
    "recname": "rs387907373",
    "keywords": "X-Linked Adrenal Hypoplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2609,
  "fields": {
    "recname": "rs387907571",
    "keywords": "Parkinson Disease, Late-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2610,
  "fields": {
    "recname": "rs3917887",
    "keywords": "Tuberculosis, Spinal"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2611,
  "fields": {
    "recname": "rs397507173",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2612,
  "fields": {
    "recname": "rs397507858",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2613,
  "fields": {
    "recname": "rs397508538",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2614,
  "fields": {
    "recname": "rs397508604",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2615,
  "fields": {
    "recname": "rs397508700",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2616,
  "fields": {
    "recname": "rs397508988",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2617,
  "fields": {
    "recname": "rs397508988",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2618,
  "fields": {
    "recname": "rs397508988",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2619,
  "fields": {
    "recname": "rs397509050",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2620,
  "fields": {
    "recname": "rs397509050",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2621,
  "fields": {
    "recname": "rs397509050",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2622,
  "fields": {
    "recname": "rs397509050",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2623,
  "fields": {
    "recname": "rs397509050",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2624,
  "fields": {
    "recname": "rs397514341",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2625,
  "fields": {
    "recname": "rs397514357",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2626,
  "fields": {
    "recname": "rs397514386",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2627,
  "fields": {
    "recname": "rs397514398",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2628,
  "fields": {
    "recname": "rs397514409",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2629,
  "fields": {
    "recname": "rs397514411",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2630,
  "fields": {
    "recname": "rs397514414",
    "keywords": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2631,
  "fields": {
    "recname": "rs397514701",
    "keywords": "Growth Retardation, Alopecia, Pseudoanodontia And Optic Atrophy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2632,
  "fields": {
    "recname": "rs397515353",
    "keywords": "Xanthomatosis, Cerebrotendinous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2633,
  "fields": {
    "recname": "rs397515354",
    "keywords": "Xanthomatosis, Cerebrotendinous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2634,
  "fields": {
    "recname": "rs397515377",
    "keywords": "Ataxia With Vitamin E Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2635,
  "fields": {
    "recname": "rs397515377",
    "keywords": "Ataxia With Vitamin E Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2636,
  "fields": {
    "recname": "rs397515518",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2637,
  "fields": {
    "recname": "rs397516074",
    "keywords": "Hypertrophic Cardiomyopathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2638,
  "fields": {
    "recname": "rs397516127",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2639,
  "fields": {
    "recname": "rs397516127",
    "keywords": "Hypertrophic Cardiomyopathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2640,
  "fields": {
    "recname": "rs397516986",
    "keywords": "Arrhythmogenic Right Ventricular Dysplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2641,
  "fields": {
    "recname": "rs397517021",
    "keywords": "Arrhythmogenic Right Ventricular Dysplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2642,
  "fields": {
    "recname": "rs397517963",
    "keywords": "Usher Syndrome, Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2643,
  "fields": {
    "recname": "rs398122363",
    "keywords": "Candidiasis, Familial, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2644,
  "fields": {
    "recname": "rs398122363",
    "keywords": "Meningoencephalitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2645,
  "fields": {
    "recname": "rs398122363",
    "keywords": "Candidiasis, Familial, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2646,
  "fields": {
    "recname": "rs398122364",
    "keywords": "Candidiasis, Familial, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2647,
  "fields": {
    "recname": "rs398122387",
    "keywords": "Epilepsy, Familial Adult Myoclonic, 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2648,
  "fields": {
    "recname": "rs398122409",
    "keywords": "Neurodegeneration With Brain Iron Accumulation 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2649,
  "fields": {
    "recname": "rs398122810",
    "keywords": "Hsan Type Iv"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2650,
  "fields": {
    "recname": "rs398122891",
    "keywords": "Osteogenesis Imperfecta, Type Xiii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2651,
  "fields": {
    "recname": "rs398122905",
    "keywords": "Ichthyosiform Erythroderma, Congenital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2652,
  "fields": {
    "recname": "rs398122971",
    "keywords": "Microcephaly, Primary Autosomal Recessive, 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2653,
  "fields": {
    "recname": "rs398123012",
    "keywords": "Spastic Paraplegia 46, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2654,
  "fields": {
    "recname": "rs398123014",
    "keywords": "Spastic Paraplegia 46, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2655,
  "fields": {
    "recname": "rs398123015",
    "keywords": "Spastic Paraplegia 46, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2656,
  "fields": {
    "recname": "rs398123044",
    "keywords": "Cone-Rod Dystrophy 18"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2657,
  "fields": {
    "recname": "rs398123044",
    "keywords": "Retinitis Pigmentosa"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2658,
  "fields": {
    "recname": "rs398123151",
    "keywords": "Hyperhomocysteinemia, Thrombotic, Cbs-Related"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2659,
  "fields": {
    "recname": "rs398124208",
    "keywords": "Glycogen Storage Disease Type V"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2660,
  "fields": {
    "recname": "rs398124484",
    "keywords": "Autosomal Recessive Polycystic Kidney Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2661,
  "fields": {
    "recname": "rs41293463",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2662,
  "fields": {
    "recname": "rs41380347",
    "keywords": "Lactase Persistence"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2663,
  "fields": {
    "recname": "rs414171",
    "keywords": "Bacteremia, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2664,
  "fields": {
    "recname": "rs414171",
    "keywords": "Malaria, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2665,
  "fields": {
    "recname": "rs4143245",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2666,
  "fields": {
    "recname": "rs41525747",
    "keywords": "Lactase Persistence"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2667,
  "fields": {
    "recname": "rs4402960",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2668,
  "fields": {
    "recname": "rs4402960",
    "keywords": "Hypertensive Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2669,
  "fields": {
    "recname": "rs4402960",
    "keywords": "Obesity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2670,
  "fields": {
    "recname": "rs4402960",
    "keywords": "Overweight"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2671,
  "fields": {
    "recname": "rs4402960",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2672,
  "fields": {
    "recname": "rs4506565",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2673,
  "fields": {
    "recname": "rs4506565",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2674,
  "fields": {
    "recname": "rs45467995",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2675,
  "fields": {
    "recname": "rs45467995",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2676,
  "fields": {
    "recname": "rs45539432",
    "keywords": "Parkinson Disease 6, Autosomal Recessive Early-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2677,
  "fields": {
    "recname": "rs45539432",
    "keywords": "Parkinson Disease 6, Autosomal Recessive Early-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2678,
  "fields": {
    "recname": "rs45539432",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2679,
  "fields": {
    "recname": "rs45539432",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2680,
  "fields": {
    "recname": "rs461645",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2681,
  "fields": {
    "recname": "rs4833095",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2682,
  "fields": {
    "recname": "rs4833095",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2683,
  "fields": {
    "recname": "rs483352896",
    "keywords": "Mps Iii C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2684,
  "fields": {
    "recname": "rs483352896",
    "keywords": "Mucopolysaccharidosis Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2685,
  "fields": {
    "recname": "rs483352908",
    "keywords": "Mps Iii C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2686,
  "fields": {
    "recname": "rs483352908",
    "keywords": "Retinitis Pigmentosa 73"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2687,
  "fields": {
    "recname": "rs4842407",
    "keywords": "Drug-Induced Liver Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2688,
  "fields": {
    "recname": "rs4842407",
    "keywords": "Hiv Infections"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2689,
  "fields": {
    "recname": "rs4842407",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2690,
  "fields": {
    "recname": "rs488069",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2691,
  "fields": {
    "recname": "rs4939827",
    "keywords": "Colon Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2692,
  "fields": {
    "recname": "rs4939827",
    "keywords": "Colorectal Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2693,
  "fields": {
    "recname": "rs4939827",
    "keywords": "Colorectal Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2694,
  "fields": {
    "recname": "rs4939827",
    "keywords": "Malignant Tumor Of Colon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2695,
  "fields": {
    "recname": "rs4939827",
    "keywords": "Rectal Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2696,
  "fields": {
    "recname": "rs4951074",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2697,
  "fields": {
    "recname": "rs4951074",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2698,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2699,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Tuberculosis, Pulmonary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2700,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2701,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Active Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2702,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Tuberculosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2703,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Colorectal Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2704,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Colorectal Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2705,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Neoplasm Metastasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2706,
  "fields": {
    "recname": "rs4986790",
    "keywords": "Secondary Malignant Neoplasm Of Lymph Node"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2707,
  "fields": {
    "recname": "rs4986791",
    "keywords": "Colorectal Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2708,
  "fields": {
    "recname": "rs4986791",
    "keywords": "Colorectal Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2709,
  "fields": {
    "recname": "rs4986791",
    "keywords": "Neoplasm Metastasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2710,
  "fields": {
    "recname": "rs4986791",
    "keywords": "Secondary Malignant Neoplasm Of Lymph Node"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2711,
  "fields": {
    "recname": "rs4986888",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2712,
  "fields": {
    "recname": "rs4986888",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2713,
  "fields": {
    "recname": "rs4986888",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2714,
  "fields": {
    "recname": "rs4986888",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2715,
  "fields": {
    "recname": "rs4988235",
    "keywords": "Lactase Persistence"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2716,
  "fields": {
    "recname": "rs5010528",
    "keywords": "Hiv Infections"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2717,
  "fields": {
    "recname": "rs5010528",
    "keywords": "Stevens-Johnson Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2718,
  "fields": {
    "recname": "rs5010528",
    "keywords": "Toxic Epidermal Necrolysis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2719,
  "fields": {
    "recname": "rs5030738",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2720,
  "fields": {
    "recname": "rs5030845",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2721,
  "fields": {
    "recname": "rs5030847",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2722,
  "fields": {
    "recname": "rs5030851",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2723,
  "fields": {
    "recname": "rs5030853",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2724,
  "fields": {
    "recname": "rs5030857",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2725,
  "fields": {
    "recname": "rs505151",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2726,
  "fields": {
    "recname": "rs505922",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2727,
  "fields": {
    "recname": "rs505922",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2728,
  "fields": {
    "recname": "rs515726205",
    "keywords": "Neurodegeneration With Brain Iron Accumulation 4"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2729,
  "fields": {
    "recname": "rs5219",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2730,
  "fields": {
    "recname": "rs5219",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2731,
  "fields": {
    "recname": "rs5219",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2732,
  "fields": {
    "recname": "rs5219",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2733,
  "fields": {
    "recname": "rs532063800",
    "keywords": "Cataract"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2734,
  "fields": {
    "recname": "rs533478642",
    "keywords": "Albinism, Oculocutaneous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2735,
  "fields": {
    "recname": "rs533896621",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2736,
  "fields": {
    "recname": "rs536656846",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2737,
  "fields": {
    "recname": "rs542940704",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2738,
  "fields": {
    "recname": "rs542998",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2739,
  "fields": {
    "recname": "rs543287988",
    "keywords": "Cataract"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2740,
  "fields": {
    "recname": "rs544956641",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2741,
  "fields": {
    "recname": "rs544956641",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2742,
  "fields": {
    "recname": "rs5470",
    "keywords": "Sickle Cell Trait/ Trachoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2743,
  "fields": {
    "recname": "rs5470",
    "keywords": "Sickle Cell Trait/ Trachoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2744,
  "fields": {
    "recname": "rs5471",
    "keywords": "Sickle Cell Trait/ Trachoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2745,
  "fields": {
    "recname": "rs5471",
    "keywords": "Sickle Cell Trait/ Trachoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2746,
  "fields": {
    "recname": "rs5491",
    "keywords": "Malaria, Cerebral, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2747,
  "fields": {
    "recname": "rs5491",
    "keywords": "Malaria, Cerebral, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2748,
  "fields": {
    "recname": "rs5491",
    "keywords": "Malaria, Cerebral, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2749,
  "fields": {
    "recname": "rs5491",
    "keywords": "Malaria, Cerebral, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2750,
  "fields": {
    "recname": "rs549625604",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2751,
  "fields": {
    "recname": "rs550237440",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2752,
  "fields": {
    "recname": "rs556450190",
    "keywords": "Stuttering"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2753,
  "fields": {
    "recname": "rs556450190",
    "keywords": "Stuttering, Developmental"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2754,
  "fields": {
    "recname": "rs556450190",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2755,
  "fields": {
    "recname": "rs55739947",
    "keywords": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2756,
  "fields": {
    "recname": "rs55851803",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2757,
  "fields": {
    "recname": "rs55851803",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2758,
  "fields": {
    "recname": "rs55861249",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2759,
  "fields": {
    "recname": "rs55861249",
    "keywords": "Ataxia Telangiectasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2760,
  "fields": {
    "recname": "rs55861249",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2761,
  "fields": {
    "recname": "rs55989760",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2762,
  "fields": {
    "recname": "rs55989760",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2763,
  "fields": {
    "recname": "rs55989760",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2764,
  "fields": {
    "recname": "rs55989760",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2765,
  "fields": {
    "recname": "rs562853291",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2766,
  "fields": {
    "recname": "rs563235254",
    "keywords": "Albinism, Oculocutaneous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2767,
  "fields": {
    "recname": "rs56392418",
    "keywords": "Masp2 Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2768,
  "fields": {
    "recname": "rs565203731",
    "keywords": "Spastic Ataxia, Charlevoix-Saguenay Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2769,
  "fields": {
    "recname": "rs565203731",
    "keywords": "Spastic Ataxia, Charlevoix-Saguenay Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2770,
  "fields": {
    "recname": "rs566579877",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2771,
  "fields": {
    "recname": "rs568612627",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2772,
  "fields": {
    "recname": "rs568612627",
    "keywords": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2773,
  "fields": {
    "recname": "rs568612627",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2774,
  "fields": {
    "recname": "rs569846003",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2775,
  "fields": {
    "recname": "rs57077886",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2776,
  "fields": {
    "recname": "rs57077886",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2777,
  "fields": {
    "recname": "rs573931674",
    "keywords": "Parkinson Disease 6, Autosomal Recessive Early-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2778,
  "fields": {
    "recname": "rs573931674",
    "keywords": "Parkinson Disease 6, Late-Onset, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2779,
  "fields": {
    "recname": "rs574982768",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2780,
  "fields": {
    "recname": "rs57749775",
    "keywords": "Pancreatitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2781,
  "fields": {
    "recname": "rs57749775",
    "keywords": "Pancreatitis, Chronic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2782,
  "fields": {
    "recname": "rs577826548",
    "keywords": "Albinism, Oculocutaneous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2783,
  "fields": {
    "recname": "rs57865060",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2784,
  "fields": {
    "recname": "rs57865060",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2785,
  "fields": {
    "recname": "rs57865060",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2786,
  "fields": {
    "recname": "rs57865060",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2787,
  "fields": {
    "recname": "rs57865060",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2788,
  "fields": {
    "recname": "rs57865060",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2789,
  "fields": {
    "recname": "rs57865060",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2790,
  "fields": {
    "recname": "rs57865060",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2791,
  "fields": {
    "recname": "rs58596362",
    "keywords": "Progeria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2792,
  "fields": {
    "recname": "rs587776416",
    "keywords": "Breast Cancer, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2793,
  "fields": {
    "recname": "rs587776435",
    "keywords": "Leigh Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2794,
  "fields": {
    "recname": "rs587776437",
    "keywords": "Leigh Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2795,
  "fields": {
    "recname": "rs587776570",
    "keywords": "Fanconi Anemia, Complementation Group A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2796,
  "fields": {
    "recname": "rs587776600",
    "keywords": "Arterial Tortuosity Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2797,
  "fields": {
    "recname": "rs587776601",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2798,
  "fields": {
    "recname": "rs587776601",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2799,
  "fields": {
    "recname": "rs587776601",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2800,
  "fields": {
    "recname": "rs587776602",
    "keywords": "Meleda Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2801,
  "fields": {
    "recname": "rs587776640",
    "keywords": "Fanconi Anemia Complementation Group G"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2802,
  "fields": {
    "recname": "rs587776640",
    "keywords": "Fanconi Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2803,
  "fields": {
    "recname": "rs587776640",
    "keywords": "Fanconi Anemia Complementation Group G"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2804,
  "fields": {
    "recname": "rs587776640",
    "keywords": "Fanconi Anemia, Complementation Group A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2805,
  "fields": {
    "recname": "rs587776650",
    "keywords": "Nijmegen Breakage Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2806,
  "fields": {
    "recname": "rs587776783",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2807,
  "fields": {
    "recname": "rs587776924",
    "keywords": "Hypotrichosis 11"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2808,
  "fields": {
    "recname": "rs587776925",
    "keywords": "Hypotrichosis 11"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2809,
  "fields": {
    "recname": "rs587776925",
    "keywords": "Hypotrichosis Simplex"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2810,
  "fields": {
    "recname": "rs587776996",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 9"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2811,
  "fields": {
    "recname": "rs587777197",
    "keywords": "Ataxia, Spastic, 2, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2812,
  "fields": {
    "recname": "rs587777198",
    "keywords": "Ataxia, Spastic, 2, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2813,
  "fields": {
    "recname": "rs587777416",
    "keywords": "Immunodeficiency 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2814,
  "fields": {
    "recname": "rs587777465",
    "keywords": "Pontocerebellar Hypoplasia, Type 2E"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2815,
  "fields": {
    "recname": "rs587777466",
    "keywords": "Pontocerebellar Hypoplasia, Type 2E"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2816,
  "fields": {
    "recname": "rs587777532",
    "keywords": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2817,
  "fields": {
    "recname": "rs587777533",
    "keywords": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2818,
  "fields": {
    "recname": "rs587777534",
    "keywords": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2819,
  "fields": {
    "recname": "rs587777691",
    "keywords": "Deafness, Autosomal Recessive 102"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2820,
  "fields": {
    "recname": "rs587777716",
    "keywords": "Polymicrogyria, Bilateral Occipital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2821,
  "fields": {
    "recname": "rs587777716",
    "keywords": "Polymicrogyria, Bilateral Occipital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2822,
  "fields": {
    "recname": "rs587777716",
    "keywords": "Polymicrogyria, Bilateral Temporooccipital"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2823,
  "fields": {
    "recname": "rs587778812",
    "keywords": "Xanthomatosis, Cerebrotendinous"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2824,
  "fields": {
    "recname": "rs587780078",
    "keywords": "Colon Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2825,
  "fields": {
    "recname": "rs587780078",
    "keywords": "Colon Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2826,
  "fields": {
    "recname": "rs587780078",
    "keywords": "Colorectal Adenomatous Polyposis, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2827,
  "fields": {
    "recname": "rs587780078",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2828,
  "fields": {
    "recname": "rs587781245",
    "keywords": "Alopecia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2829,
  "fields": {
    "recname": "rs587781245",
    "keywords": "Palmoplantar Keratosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2830,
  "fields": {
    "recname": "rs587781347",
    "keywords": "Ataxia Telangiectasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2831,
  "fields": {
    "recname": "rs587781558",
    "keywords": "Ataxia Telangiectasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2832,
  "fields": {
    "recname": "rs587781558",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2833,
  "fields": {
    "recname": "rs587783211",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2834,
  "fields": {
    "recname": "rs587783309",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2835,
  "fields": {
    "recname": "rs5928",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2836,
  "fields": {
    "recname": "rs5928",
    "keywords": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2837,
  "fields": {
    "recname": "rs59885338",
    "keywords": "Charcot-Marie-Tooth Disease, Type 2B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2838,
  "fields": {
    "recname": "rs59885338",
    "keywords": "Charcot-Marie-Tooth Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2839,
  "fields": {
    "recname": "rs59885338",
    "keywords": "Charcot-Marie-Tooth Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2840,
  "fields": {
    "recname": "rs59885338",
    "keywords": "Charcot-Marie-Tooth Disease, Type 2B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2841,
  "fields": {
    "recname": "rs59885338",
    "keywords": "Hereditary Motor And Sensory-Neuropathy Type Ii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2842,
  "fields": {
    "recname": "rs59885338",
    "keywords": "Charcot-Marie-Tooth Disease, Type 2B1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2843,
  "fields": {
    "recname": "rs59885338",
    "keywords": "Hereditary Motor And Sensory-Neuropathy Type Ii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2844,
  "fields": {
    "recname": "rs6008813",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2845,
  "fields": {
    "recname": "rs601338",
    "keywords": "Infection Caused By Helicobacter Pylori"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2846,
  "fields": {
    "recname": "rs6021191",
    "keywords": "Acute Lymphocytic Leukemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2847,
  "fields": {
    "recname": "rs6021191",
    "keywords": "Precursor Cell Lymphoblastic Leukemia Lymphoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2848,
  "fields": {
    "recname": "rs60431989",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2849,
  "fields": {
    "recname": "rs606231119",
    "keywords": "Transcolabamin Ii Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2850,
  "fields": {
    "recname": "rs606231234",
    "keywords": "Complete Hydatidiform Mole"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2851,
  "fields": {
    "recname": "rs606231276",
    "keywords": "Peeling Skin Syndrome, Acral Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2852,
  "fields": {
    "recname": "rs606231410",
    "keywords": "Deafness, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2853,
  "fields": {
    "recname": "rs606231410",
    "keywords": "Nonsyndromic Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2854,
  "fields": {
    "recname": "rs60791294",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2855,
  "fields": {
    "recname": "rs60791294",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2856,
  "fields": {
    "recname": "rs60791294",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2857,
  "fields": {
    "recname": "rs60791294",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2858,
  "fields": {
    "recname": "rs60910145",
    "keywords": "Focal Segmental Glomerulosclerosis 4, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2859,
  "fields": {
    "recname": "rs610604",
    "keywords": "Psoriasis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2860,
  "fields": {
    "recname": "rs6139258",
    "keywords": "Drug-Induced Liver Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2861,
  "fields": {
    "recname": "rs6139258",
    "keywords": "Hiv Infections"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2862,
  "fields": {
    "recname": "rs61495246",
    "keywords": "Vitamin D Hydroxylation-Deficient Rickets, Type 1B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2863,
  "fields": {
    "recname": "rs61495246",
    "keywords": "Vitamin D Hydroxylation-Deficient Rickets, Type 1B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2864,
  "fields": {
    "recname": "rs61732239",
    "keywords": "Pancreatic Ductal Adenocarcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2865,
  "fields": {
    "recname": "rs61738009",
    "keywords": "Epilepsies, Partial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2866,
  "fields": {
    "recname": "rs61738009",
    "keywords": "Epilepsy, Familial Temporal Lobe, 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2867,
  "fields": {
    "recname": "rs61738009",
    "keywords": "Epilepsy, Temporal Lobe"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2868,
  "fields": {
    "recname": "rs61738009",
    "keywords": "Febrile Convulsions"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2869,
  "fields": {
    "recname": "rs61749035",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2870,
  "fields": {
    "recname": "rs61749035",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2871,
  "fields": {
    "recname": "rs61749409",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2872,
  "fields": {
    "recname": "rs61749423",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2873,
  "fields": {
    "recname": "rs61751402",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2874,
  "fields": {
    "recname": "rs61751408",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2875,
  "fields": {
    "recname": "rs61752361",
    "keywords": "Rett Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2876,
  "fields": {
    "recname": "rs61752717",
    "keywords": "Familial Mediterranean Fever"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2877,
  "fields": {
    "recname": "rs61752717",
    "keywords": "Familial Mediterranean Fever"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2878,
  "fields": {
    "recname": "rs61753180",
    "keywords": "Oculocutaneous Albinism Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2879,
  "fields": {
    "recname": "rs61753219",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2880,
  "fields": {
    "recname": "rs61754375",
    "keywords": "Oculocutaneous Albinism Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2881,
  "fields": {
    "recname": "rs61754388",
    "keywords": "Oculocutaneous Albinism Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2882,
  "fields": {
    "recname": "rs61755320",
    "keywords": "Henoch-Schoenlein Purpura"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2883,
  "fields": {
    "recname": "rs61755320",
    "keywords": "Spastic Paraplegia 7, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2884,
  "fields": {
    "recname": "rs61759921",
    "keywords": "Bronchiectasis With Or Without Elevated Sweat Chloride 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2885,
  "fields": {
    "recname": "rs61761869",
    "keywords": "Alpha 1-Antitrypsin Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2886,
  "fields": {
    "recname": "rs61761869",
    "keywords": "Alpha 1-Antitrypsin Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2887,
  "fields": {
    "recname": "rs62015197",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2888,
  "fields": {
    "recname": "rs62015197",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2889,
  "fields": {
    "recname": "rs62477096",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2890,
  "fields": {
    "recname": "rs62508646",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2891,
  "fields": {
    "recname": "rs62508646",
    "keywords": "Classical Phenylketonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2892,
  "fields": {
    "recname": "rs62508646",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2893,
  "fields": {
    "recname": "rs62508698",
    "keywords": "Classical Phenylketonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2894,
  "fields": {
    "recname": "rs62508698",
    "keywords": "Hyperphenylalaninemia, Non-Pku Mild"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2895,
  "fields": {
    "recname": "rs62508698",
    "keywords": "Phenylketonuria, Maternal"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2896,
  "fields": {
    "recname": "rs62508698",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2897,
  "fields": {
    "recname": "rs62508730",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2898,
  "fields": {
    "recname": "rs62508734",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2899,
  "fields": {
    "recname": "rs62516094",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2900,
  "fields": {
    "recname": "rs62516146",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2901,
  "fields": {
    "recname": "rs62589000",
    "keywords": "Obesity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2902,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2903,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2904,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2905,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2906,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2907,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2908,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2909,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2910,
  "fields": {
    "recname": "rs62625011",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2911,
  "fields": {
    "recname": "rs62642937",
    "keywords": "Hyperphenylalaninaemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2912,
  "fields": {
    "recname": "rs62642937",
    "keywords": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2913,
  "fields": {
    "recname": "rs62645944",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2914,
  "fields": {
    "recname": "rs62646861",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2915,
  "fields": {
    "recname": "rs62646861",
    "keywords": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2916,
  "fields": {
    "recname": "rs6265",
    "keywords": "Schizophrenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2917,
  "fields": {
    "recname": "rs6265",
    "keywords": "Schizophrenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2918,
  "fields": {
    "recname": "rs63749819",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2919,
  "fields": {
    "recname": "rs63749819",
    "keywords": "Beta^0^ Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2920,
  "fields": {
    "recname": "rs63749823",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2921,
  "fields": {
    "recname": "rs63749856",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2922,
  "fields": {
    "recname": "rs63749856",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2923,
  "fields": {
    "recname": "rs63749856",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2924,
  "fields": {
    "recname": "rs63749856",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2925,
  "fields": {
    "recname": "rs63749856",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2926,
  "fields": {
    "recname": "rs63749991",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2927,
  "fields": {
    "recname": "rs63750414",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2928,
  "fields": {
    "recname": "rs63750414",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2929,
  "fields": {
    "recname": "rs63750414",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2930,
  "fields": {
    "recname": "rs63750414",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2931,
  "fields": {
    "recname": "rs63751208",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2932,
  "fields": {
    "recname": "rs63751208",
    "keywords": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2933,
  "fields": {
    "recname": "rs63751325",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2934,
  "fields": {
    "recname": "rs63751438",
    "keywords": "Frontotemporal Dementia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2935,
  "fields": {
    "recname": "rs63751453",
    "keywords": "Hereditary Nonpolyposis Colorectal Cancer"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2936,
  "fields": {
    "recname": "rs6439153",
    "keywords": "Pneumococcal Bacteraemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2937,
  "fields": {
    "recname": "rs6475",
    "keywords": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2938,
  "fields": {
    "recname": "rs6475",
    "keywords": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2939,
  "fields": {
    "recname": "rs6475",
    "keywords": "Chronic Active Hepatitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2940,
  "fields": {
    "recname": "rs6572335",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2941,
  "fields": {
    "recname": "rs662",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2942,
  "fields": {
    "recname": "rs662",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2943,
  "fields": {
    "recname": "rs662",
    "keywords": "Bipolar I Disorder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2944,
  "fields": {
    "recname": "rs662",
    "keywords": "Antiphospholipid Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2945,
  "fields": {
    "recname": "rs662",
    "keywords": "Lupus Erythematosus, Systemic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2946,
  "fields": {
    "recname": "rs662",
    "keywords": "Polyendocrinopathies, Autoimmune"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2947,
  "fields": {
    "recname": "rs67561842",
    "keywords": "Arterial Calcification, Generalized, Of Infancy, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2948,
  "fields": {
    "recname": "rs67561842",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2949,
  "fields": {
    "recname": "rs6775745",
    "keywords": "Neutrophil Count (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2950,
  "fields": {
    "recname": "rs6780995",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2951,
  "fields": {
    "recname": "rs6780995",
    "keywords": "Sickle Cell Trait"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2952,
  "fields": {
    "recname": "rs6880234",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2953,
  "fields": {
    "recname": "rs6880234",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2954,
  "fields": {
    "recname": "rs6880234",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2955,
  "fields": {
    "recname": "rs6880234",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2956,
  "fields": {
    "recname": "rs6880234",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2957,
  "fields": {
    "recname": "rs6880234",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2958,
  "fields": {
    "recname": "rs6880234",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2959,
  "fields": {
    "recname": "rs6889768",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2960,
  "fields": {
    "recname": "rs689",
    "keywords": "Diabetes"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2961,
  "fields": {
    "recname": "rs689",
    "keywords": "Diabetes"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2962,
  "fields": {
    "recname": "rs689",
    "keywords": "Diabetes Mellitus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2963,
  "fields": {
    "recname": "rs689",
    "keywords": "Diabetes Mellitus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2964,
  "fields": {
    "recname": "rs6920220",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2965,
  "fields": {
    "recname": "rs6940729",
    "keywords": "Homocysteine Measurement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2966,
  "fields": {
    "recname": "rs6942726",
    "keywords": "Body Height"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2967,
  "fields": {
    "recname": "rs6965492",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2968,
  "fields": {
    "recname": "rs708567",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2969,
  "fields": {
    "recname": "rs708567",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2970,
  "fields": {
    "recname": "rs708567",
    "keywords": "Sickle Cell Trait"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2971,
  "fields": {
    "recname": "rs7096374",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2972,
  "fields": {
    "recname": "rs713993048",
    "keywords": "Basal Ganglia Disease, Biotin-Responsive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2973,
  "fields": {
    "recname": "rs713993048",
    "keywords": "Leigh Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2974,
  "fields": {
    "recname": "rs71640277",
    "keywords": "Isolated Growth Hormone Deficiency, Type Ii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2975,
  "fields": {
    "recname": "rs71640277",
    "keywords": "Isolated Growth Hormone Deficiency, Type Ii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2976,
  "fields": {
    "recname": "rs71785313",
    "keywords": "Focal Segmental Glomerulosclerosis 4, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2977,
  "fields": {
    "recname": "rs71785313",
    "keywords": "Focal Segmental Glomerulosclerosis 4, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2978,
  "fields": {
    "recname": "rs72474224",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2979,
  "fields": {
    "recname": "rs72474224",
    "keywords": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2980,
  "fields": {
    "recname": "rs72474224",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2981,
  "fields": {
    "recname": "rs72474224",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2982,
  "fields": {
    "recname": "rs72474224",
    "keywords": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2983,
  "fields": {
    "recname": "rs72474224",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2984,
  "fields": {
    "recname": "rs72549378",
    "keywords": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2985,
  "fields": {
    "recname": "rs72549378",
    "keywords": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2986,
  "fields": {
    "recname": "rs72549378",
    "keywords": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2987,
  "fields": {
    "recname": "rs72549378",
    "keywords": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2988,
  "fields": {
    "recname": "rs72550870",
    "keywords": "Masp2 Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2989,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2990,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2991,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2992,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2993,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2994,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2995,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2996,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2997,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2998,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 2999,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3000,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3001,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3002,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3003,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3004,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3005,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3006,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3007,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3008,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3009,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3010,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3011,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3012,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3013,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3014,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3015,
  "fields": {
    "recname": "rs72551351",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3016,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3017,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3018,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3019,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3020,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3021,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3022,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3023,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3024,
  "fields": {
    "recname": "rs72551352",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3025,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3026,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3027,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3028,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3029,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3030,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3031,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3032,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3033,
  "fields": {
    "recname": "rs72551354",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3034,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3035,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3036,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3037,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3038,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3039,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3040,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3041,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3042,
  "fields": {
    "recname": "rs72551355",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3043,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3044,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3045,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3046,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3047,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3048,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3049,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3050,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3051,
  "fields": {
    "recname": "rs72551356",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3052,
  "fields": {
    "recname": "rs72552255",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3053,
  "fields": {
    "recname": "rs72552285",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3054,
  "fields": {
    "recname": "rs72552285",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3055,
  "fields": {
    "recname": "rs72554080",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3056,
  "fields": {
    "recname": "rs72554080",
    "keywords": "Parkinson Disease 11, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3057,
  "fields": {
    "recname": "rs72558200",
    "keywords": "Jaundice, Chronic Idiopathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3058,
  "fields": {
    "recname": "rs72558200",
    "keywords": "Jaundice, Chronic Idiopathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3059,
  "fields": {
    "recname": "rs72558201",
    "keywords": "Jaundice, Chronic Idiopathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3060,
  "fields": {
    "recname": "rs72558201",
    "keywords": "Jaundice, Chronic Idiopathic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3061,
  "fields": {
    "recname": "rs72653744",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3062,
  "fields": {
    "recname": "rs72653772",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3063,
  "fields": {
    "recname": "rs72653772",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3064,
  "fields": {
    "recname": "rs72653772",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3065,
  "fields": {
    "recname": "rs72653772",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3066,
  "fields": {
    "recname": "rs72653785",
    "keywords": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3067,
  "fields": {
    "recname": "rs72653785",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3068,
  "fields": {
    "recname": "rs72653785",
    "keywords": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3069,
  "fields": {
    "recname": "rs72653785",
    "keywords": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3070,
  "fields": {
    "recname": "rs72656330",
    "keywords": "Osteogenesis Imperfecta, Recessive Perinatal Lethal"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3071,
  "fields": {
    "recname": "rs72658200",
    "keywords": "Osteogenesis Imperfecta Type Iii (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3072,
  "fields": {
    "recname": "rs72659348",
    "keywords": "Osteogenesis Imperfecta, Type Viii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3073,
  "fields": {
    "recname": "rs72659351",
    "keywords": "Osteogenesis Imperfecta, Type Viii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3074,
  "fields": {
    "recname": "rs72659351",
    "keywords": "Osteogenesis Imperfecta, Type Viii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3075,
  "fields": {
    "recname": "rs72659354",
    "keywords": "Osteogenesis Imperfecta, Type Viii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3076,
  "fields": {
    "recname": "rs72659355",
    "keywords": "Osteogenesis Imperfecta, Type Viii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3077,
  "fields": {
    "recname": "rs72664288",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3078,
  "fields": {
    "recname": "rs72664297",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3079,
  "fields": {
    "recname": "rs727503818",
    "keywords": "Bardet-Biedl Syndrome 10"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3080,
  "fields": {
    "recname": "rs727504409",
    "keywords": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3081,
  "fields": {
    "recname": "rs727504432",
    "keywords": "Arrhythmogenic Right Ventricular Dysplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3082,
  "fields": {
    "recname": "rs727504786",
    "keywords": "Arrhythmogenic Right Ventricular Dysplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3083,
  "fields": {
    "recname": "rs73043340",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3084,
  "fields": {
    "recname": "rs730880131",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3085,
  "fields": {
    "recname": "rs730880260",
    "keywords": "Ectodermal Dysplasia-Syndactyly Syndrome 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3086,
  "fields": {
    "recname": "rs730880281",
    "keywords": "Laron Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3087,
  "fields": {
    "recname": "rs730882064",
    "keywords": "Microphthalmia, Isolated 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3088,
  "fields": {
    "recname": "rs730882096",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3089,
  "fields": {
    "recname": "rs73505850",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3090,
  "fields": {
    "recname": "rs738409",
    "keywords": "Hepatitis C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3091,
  "fields": {
    "recname": "rs738409",
    "keywords": "Hepatitis C, Chronic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3092,
  "fields": {
    "recname": "rs738409",
    "keywords": "Liver And Intrahepatic Biliary Tract Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3093,
  "fields": {
    "recname": "rs738409",
    "keywords": "Liver Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3094,
  "fields": {
    "recname": "rs738409",
    "keywords": "Malignant Neoplasm Of Liver"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3095,
  "fields": {
    "recname": "rs73885319",
    "keywords": "Focal Segmental Glomerulosclerosis 4, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3096,
  "fields": {
    "recname": "rs7418956",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3097,
  "fields": {
    "recname": "rs74315139",
    "keywords": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3098,
  "fields": {
    "recname": "rs74315309",
    "keywords": "Ectodermal Dysplasia 11B, Hypohidrotic/Hair/Tooth Type, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3099,
  "fields": {
    "recname": "rs74315360",
    "keywords": "Parkinson Disease 6, Autosomal Recessive Early-Onset"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3100,
  "fields": {
    "recname": "rs74315360",
    "keywords": "Parkinson Disease 6, Late-Onset, Susceptibility To"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3101,
  "fields": {
    "recname": "rs74315407",
    "keywords": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3102,
  "fields": {
    "recname": "rs74315407",
    "keywords": "Prion Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3103,
  "fields": {
    "recname": "rs74315443",
    "keywords": "Unverricht-Lundborg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3104,
  "fields": {
    "recname": "rs746091400",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3105,
  "fields": {
    "recname": "rs747681609",
    "keywords": "Obesity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3106,
  "fields": {
    "recname": "rs747724352",
    "keywords": "17-Hydroxysteroid Dehydrogenase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3107,
  "fields": {
    "recname": "rs747724352",
    "keywords": "17-Hydroxysteroid Dehydrogenase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3108,
  "fields": {
    "recname": "rs747724352",
    "keywords": "46, Xy Disorders Of Sex Development"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3109,
  "fields": {
    "recname": "rs747724352",
    "keywords": "46, Xy Disorders Of Sex Development"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3110,
  "fields": {
    "recname": "rs747724352",
    "keywords": "Polycystic Ovarian Disease Due To 17-Ketosteroid Reductase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3111,
  "fields": {
    "recname": "rs747724352",
    "keywords": "Polycystic Ovarian Disease Due To 17-Ketosteroid Reductase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3112,
  "fields": {
    "recname": "rs747768373",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3113,
  "fields": {
    "recname": "rs748949603",
    "keywords": "Inclusion Body Myopathy, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3114,
  "fields": {
    "recname": "rs748949603",
    "keywords": "Inclusion Body Myopathy, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3115,
  "fields": {
    "recname": "rs749785672",
    "keywords": "Neurodegeneration With Brain Iron Accumulation (Nbia)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3116,
  "fields": {
    "recname": "rs749808170",
    "keywords": "Cataract"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3117,
  "fields": {
    "recname": "rs749980674",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3118,
  "fields": {
    "recname": "rs750470654",
    "keywords": "Glycogen Storage Disease Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3119,
  "fields": {
    "recname": "rs751163782",
    "keywords": "Cone-Rod Dystrophy 18"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3120,
  "fields": {
    "recname": "rs7517847",
    "keywords": "Liver Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3121,
  "fields": {
    "recname": "rs7517847",
    "keywords": "Liver Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3122,
  "fields": {
    "recname": "rs7517847",
    "keywords": "Malignant Neoplasms"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3123,
  "fields": {
    "recname": "rs7517847",
    "keywords": "Malignant Neoplasms"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3124,
  "fields": {
    "recname": "rs752113778",
    "keywords": "Immunodeficiency 27A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3125,
  "fields": {
    "recname": "rs752202089",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3126,
  "fields": {
    "recname": "rs752942769",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3127,
  "fields": {
    "recname": "rs753085",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3128,
  "fields": {
    "recname": "rs753288303",
    "keywords": "Methylmalonic Acidemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3129,
  "fields": {
    "recname": "rs753780877",
    "keywords": "Macrocephaly, Dysmorphic Facies, And Psychomotor Retardation"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3130,
  "fields": {
    "recname": "rs75391579",
    "keywords": "Classical Galactosemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3131,
  "fields": {
    "recname": "rs754508360",
    "keywords": "Auditory Neuropathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3132,
  "fields": {
    "recname": "rs754508360",
    "keywords": "Auditory Neuropathy Spectrum Disorder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3133,
  "fields": {
    "recname": "rs754532049",
    "keywords": "Xeroderma Pigmentosum, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3134,
  "fields": {
    "recname": "rs754532049",
    "keywords": "Xeroderma Pigmentosum, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3135,
  "fields": {
    "recname": "rs754532049",
    "keywords": "Xeroderma Pigmentosum, Complementation Group C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3136,
  "fields": {
    "recname": "rs754676104",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3137,
  "fields": {
    "recname": "rs75549581",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3138,
  "fields": {
    "recname": "rs75549581",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3139,
  "fields": {
    "recname": "rs7555340",
    "keywords": "Gout"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3140,
  "fields": {
    "recname": "rs7555340",
    "keywords": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3141,
  "fields": {
    "recname": "rs755667663",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3142,
  "fields": {
    "recname": "rs755709270",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3143,
  "fields": {
    "recname": "rs755709270",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3144,
  "fields": {
    "recname": "rs755734596",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3145,
  "fields": {
    "recname": "rs756134838",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3146,
  "fields": {
    "recname": "rs756138074",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3147,
  "fields": {
    "recname": "rs756572099",
    "keywords": "Pfaundler-Hurler Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3148,
  "fields": {
    "recname": "rs756614404",
    "keywords": "Spinal Muscular Atrophy, Distal, Autosomal Recessive, 5"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3149,
  "fields": {
    "recname": "rs757147440",
    "keywords": "Hereditary Pyropoikilocytosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3150,
  "fields": {
    "recname": "rs757366142",
    "keywords": "Acquired Immunodeficiency Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3151,
  "fields": {
    "recname": "rs7574865",
    "keywords": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3152,
  "fields": {
    "recname": "rs757679761",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3153,
  "fields": {
    "recname": "rs757679761",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3154,
  "fields": {
    "recname": "rs757988130",
    "keywords": "Acute Intermittent Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3155,
  "fields": {
    "recname": "rs758188096",
    "keywords": "Nemaline Myopathy 8"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3156,
  "fields": {
    "recname": "rs758236584",
    "keywords": "Hyperhomocysteinemia, Thrombotic, Cbs-Related"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3157,
  "fields": {
    "recname": "rs758355520",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3158,
  "fields": {
    "recname": "rs758355520",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3159,
  "fields": {
    "recname": "rs7587928",
    "keywords": "Neutrophil Count (Procedure)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3160,
  "fields": {
    "recname": "rs759581558",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3161,
  "fields": {
    "recname": "rs759581558",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3162,
  "fields": {
    "recname": "rs759736443",
    "keywords": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3163,
  "fields": {
    "recname": "rs759736443",
    "keywords": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3164,
  "fields": {
    "recname": "rs759834365",
    "keywords": "Schizophrenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3165,
  "fields": {
    "recname": "rs759834365",
    "keywords": "Schizophrenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3166,
  "fields": {
    "recname": "rs760021635",
    "keywords": "Stuttering"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3167,
  "fields": {
    "recname": "rs760021635",
    "keywords": "Stuttering, Developmental"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3168,
  "fields": {
    "recname": "rs760021635",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3169,
  "fields": {
    "recname": "rs760318047",
    "keywords": "Neurodegeneration With Brain Iron Accumulation (Nbia)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3170,
  "fields": {
    "recname": "rs76151636",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3171,
  "fields": {
    "recname": "rs762364495",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3172,
  "fields": {
    "recname": "rs762588484",
    "keywords": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3173,
  "fields": {
    "recname": "rs76262710",
    "keywords": "Familial Medullary Thyroid Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3174,
  "fields": {
    "recname": "rs76262710",
    "keywords": "Hirschsprung Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3175,
  "fields": {
    "recname": "rs76262710",
    "keywords": "Medullary Carcinoma Of Thyroid"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3176,
  "fields": {
    "recname": "rs76262710",
    "keywords": "Pheochromocytoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3177,
  "fields": {
    "recname": "rs763059810",
    "keywords": "Acquired Immunodeficiency Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3178,
  "fields": {
    "recname": "rs763222239",
    "keywords": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3179,
  "fields": {
    "recname": "rs7633054",
    "keywords": "Bacteremia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3180,
  "fields": {
    "recname": "rs763780",
    "keywords": "Lupus Erythematosus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3181,
  "fields": {
    "recname": "rs763780",
    "keywords": "Lupus Erythematosus, Discoid"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3182,
  "fields": {
    "recname": "rs763780",
    "keywords": "Lupus Erythematosus, Systemic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3183,
  "fields": {
    "recname": "rs763780",
    "keywords": "Lupus Nephritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3184,
  "fields": {
    "recname": "rs763780",
    "keywords": "Lupus Vulgaris"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3185,
  "fields": {
    "recname": "rs763780",
    "keywords": "Nephritis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3186,
  "fields": {
    "recname": "rs763915472",
    "keywords": "Microcephaly 4, Primary, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3187,
  "fields": {
    "recname": "rs763915472",
    "keywords": "Microcephaly 4, Primary, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3188,
  "fields": {
    "recname": "rs764249635",
    "keywords": "Acute Hiv Infection"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3189,
  "fields": {
    "recname": "rs765219004",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3190,
  "fields": {
    "recname": "rs765530357",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3191,
  "fields": {
    "recname": "rs766209297",
    "keywords": "Arrhythmogenic Right Ventricular Dysplasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3192,
  "fields": {
    "recname": "rs766696884",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3193,
  "fields": {
    "recname": "rs767004810",
    "keywords": "Hypoparathyroidism-Retardation-Dysmorphism Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3194,
  "fields": {
    "recname": "rs767004810",
    "keywords": "Kenny-Caffey Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3195,
  "fields": {
    "recname": "rs767201131",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3196,
  "fields": {
    "recname": "rs767218895",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3197,
  "fields": {
    "recname": "rs767350733",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3198,
  "fields": {
    "recname": "rs767419411",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3199,
  "fields": {
    "recname": "rs767419411",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3200,
  "fields": {
    "recname": "rs767419411",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3201,
  "fields": {
    "recname": "rs767423538",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3202,
  "fields": {
    "recname": "rs767522068",
    "keywords": "Meningoencephalitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3203,
  "fields": {
    "recname": "rs767633598",
    "keywords": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3204,
  "fields": {
    "recname": "rs76763715",
    "keywords": "Gaucher Disease, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3205,
  "fields": {
    "recname": "rs768933093",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3206,
  "fields": {
    "recname": "rs768933093",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3207,
  "fields": {
    "recname": "rs769452432",
    "keywords": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3208,
  "fields": {
    "recname": "rs769452432",
    "keywords": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3209,
  "fields": {
    "recname": "rs769452432",
    "keywords": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3210,
  "fields": {
    "recname": "rs76992529",
    "keywords": "Cardiomyopathies"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3211,
  "fields": {
    "recname": "rs76992529",
    "keywords": "Heart Diseases"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3212,
  "fields": {
    "recname": "rs76992529",
    "keywords": "Senile Cardiac Amyloidosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3213,
  "fields": {
    "recname": "rs769987150",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3214,
  "fields": {
    "recname": "rs77010898",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3215,
  "fields": {
    "recname": "rs770556842",
    "keywords": "Bardet-Biedl Syndrome 10"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3216,
  "fields": {
    "recname": "rs770641163",
    "keywords": "Ataxia Telangiectasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3217,
  "fields": {
    "recname": "rs770641163",
    "keywords": "Ataxia Telangiectasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3218,
  "fields": {
    "recname": "rs770641163",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3219,
  "fields": {
    "recname": "rs770641163",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3220,
  "fields": {
    "recname": "rs7706544",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3221,
  "fields": {
    "recname": "rs770947426",
    "keywords": "Mucopolysaccharidosis Type Iiia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3222,
  "fields": {
    "recname": "rs771069887",
    "keywords": "Glycogen Storage Disease Iiia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3223,
  "fields": {
    "recname": "rs771594651",
    "keywords": "Citrullinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3224,
  "fields": {
    "recname": "rs7726475",
    "keywords": "Blood Pressure"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3225,
  "fields": {
    "recname": "rs7726475",
    "keywords": "Blood Pressure Finding"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3226,
  "fields": {
    "recname": "rs7726475",
    "keywords": "Systemic Arterial Pressure"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3227,
  "fields": {
    "recname": "rs773429181",
    "keywords": "Auditory Neuropathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3228,
  "fields": {
    "recname": "rs773429181",
    "keywords": "Auditory Neuropathy Spectrum Disorder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3229,
  "fields": {
    "recname": "rs773526895",
    "keywords": "Myasthenic Syndrome, Congenital, Associated With Acetylcholine Receptor Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3230,
  "fields": {
    "recname": "rs77375493",
    "keywords": "Polycythemia Vera"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3231,
  "fields": {
    "recname": "rs77375493",
    "keywords": "Polycythemia Vera"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3232,
  "fields": {
    "recname": "rs77375493",
    "keywords": "Primary Myelofibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3233,
  "fields": {
    "recname": "rs77375493",
    "keywords": "Idiopathic Pulmonary Arterial Hypertension"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3234,
  "fields": {
    "recname": "rs77375493",
    "keywords": "Polycythemia Vera"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3235,
  "fields": {
    "recname": "rs77375493",
    "keywords": "Primary Myelofibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3236,
  "fields": {
    "recname": "rs77375493",
    "keywords": "Thrombocythemia, Essential"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3237,
  "fields": {
    "recname": "rs773876922",
    "keywords": "Spinocerebellar Ataxia 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3238,
  "fields": {
    "recname": "rs773876922",
    "keywords": "Spinocerebellar Ataxia 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3239,
  "fields": {
    "recname": "rs7748513",
    "keywords": "C-Reactive Protein Measurement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3240,
  "fields": {
    "recname": "rs774906736",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3241,
  "fields": {
    "recname": "rs775036118",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3242,
  "fields": {
    "recname": "rs775163147",
    "keywords": "Citrullinemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3243,
  "fields": {
    "recname": "rs775274569",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3244,
  "fields": {
    "recname": "rs7755898",
    "keywords": "21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3245,
  "fields": {
    "recname": "rs7755898",
    "keywords": "Chronic Active Hepatitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3246,
  "fields": {
    "recname": "rs7755898",
    "keywords": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3247,
  "fields": {
    "recname": "rs7755898",
    "keywords": "21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3248,
  "fields": {
    "recname": "rs7755898",
    "keywords": "Chronic Active Hepatitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3249,
  "fields": {
    "recname": "rs7755898",
    "keywords": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3250,
  "fields": {
    "recname": "rs7755898",
    "keywords": "21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3251,
  "fields": {
    "recname": "rs7756992",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3252,
  "fields": {
    "recname": "rs7756992",
    "keywords": "Diabetes"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3253,
  "fields": {
    "recname": "rs7756992",
    "keywords": "Diabetes Mellitus"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3254,
  "fields": {
    "recname": "rs7756992",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3255,
  "fields": {
    "recname": "rs7756992",
    "keywords": "Diabetic Nephropathy"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3256,
  "fields": {
    "recname": "rs7756992",
    "keywords": "Hypertensive Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3257,
  "fields": {
    "recname": "rs7756992",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3258,
  "fields": {
    "recname": "rs775903553",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3259,
  "fields": {
    "recname": "rs775903553",
    "keywords": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3260,
  "fields": {
    "recname": "rs775910328",
    "keywords": "Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3261,
  "fields": {
    "recname": "rs775910328",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3262,
  "fields": {
    "recname": "rs7769409",
    "keywords": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3263,
  "fields": {
    "recname": "rs7769409",
    "keywords": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3264,
  "fields": {
    "recname": "rs776977863",
    "keywords": "Glycogen Storage Disease Type Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3265,
  "fields": {
    "recname": "rs777112652",
    "keywords": "Deafness, Autosomal Recessive 105"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3266,
  "fields": {
    "recname": "rs777305616",
    "keywords": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3267,
  "fields": {
    "recname": "rs777640882",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3268,
  "fields": {
    "recname": "rs778210210",
    "keywords": "Congenital Disorder Of Glycosylation, Type Iin"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3269,
  "fields": {
    "recname": "rs778431173",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3270,
  "fields": {
    "recname": "rs779018464",
    "keywords": "Deafness, Autosomal Dominant 3A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3271,
  "fields": {
    "recname": "rs779018464",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3272,
  "fields": {
    "recname": "rs779018464",
    "keywords": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3273,
  "fields": {
    "recname": "rs779018464",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3274,
  "fields": {
    "recname": "rs779494870",
    "keywords": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3275,
  "fields": {
    "recname": "rs780014431",
    "keywords": "Severe Combined Immunodeficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3276,
  "fields": {
    "recname": "rs7800944",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3277,
  "fields": {
    "recname": "rs780520338",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3278,
  "fields": {
    "recname": "rs781752990",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3279,
  "fields": {
    "recname": "rs781897678",
    "keywords": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3280,
  "fields": {
    "recname": "rs78289603",
    "keywords": "Factor V And Factor Viii, Combined Deficiency Of, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3281,
  "fields": {
    "recname": "rs786200944",
    "keywords": "Cone-Rod Dystrophy 18"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3282,
  "fields": {
    "recname": "rs786200944",
    "keywords": "Retinitis Pigmentosa"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3283,
  "fields": {
    "recname": "rs786201006",
    "keywords": "Immunodeficiency 29"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3284,
  "fields": {
    "recname": "rs786203251",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3285,
  "fields": {
    "recname": "rs786204422",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3286,
  "fields": {
    "recname": "rs786204433",
    "keywords": "Ataxia Telangiectasia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3287,
  "fields": {
    "recname": "rs786204433",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3288,
  "fields": {
    "recname": "rs786204444",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3289,
  "fields": {
    "recname": "rs786204616",
    "keywords": "Glycogen Storage Disease Type Iii"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3290,
  "fields": {
    "recname": "rs786204628",
    "keywords": "Spastic Ataxia, Charlevoix-Saguenay Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3291,
  "fields": {
    "recname": "rs786204662",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3292,
  "fields": {
    "recname": "rs786204671",
    "keywords": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3293,
  "fields": {
    "recname": "rs786204786",
    "keywords": "Severe Autosomal Recessive Muscular Dystrophy Of Childhood - North African Type (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3294,
  "fields": {
    "recname": "rs786204963",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3295,
  "fields": {
    "recname": "rs786204967",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3296,
  "fields": {
    "recname": "rs786205051",
    "keywords": "Poikiloderma With Neutropenia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3297,
  "fields": {
    "recname": "rs786205151",
    "keywords": "Cone-Rod Dystrophy 9"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3298,
  "fields": {
    "recname": "rs78655421",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3299,
  "fields": {
    "recname": "rs7896254",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3300,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3301,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3302,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3303,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3304,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3305,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3306,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3307,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3308,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3309,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Polycystic Ovary Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3310,
  "fields": {
    "recname": "rs7903146",
    "keywords": "Obesity"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3311,
  "fields": {
    "recname": "rs7918885",
    "keywords": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3312,
  "fields": {
    "recname": "rs79389353",
    "keywords": "Cystinuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3313,
  "fields": {
    "recname": "rs79389353",
    "keywords": "Cystinuria, Type A"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3314,
  "fields": {
    "recname": "rs79389353",
    "keywords": "Cystinuria, Type A-B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3315,
  "fields": {
    "recname": "rs79389353",
    "keywords": "Cystinuria, Type B"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3316,
  "fields": {
    "recname": "rs794729665",
    "keywords": "Deafness, Autosomal Recessive 66"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3317,
  "fields": {
    "recname": "rs794729665",
    "keywords": "Deafness, Autosomal Recessive 66"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3318,
  "fields": {
    "recname": "rs794729665",
    "keywords": "Nonsyndromic Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3319,
  "fields": {
    "recname": "rs796052061",
    "keywords": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3320,
  "fields": {
    "recname": "rs796052130",
    "keywords": "Hip Dysplasia, Beukes Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3321,
  "fields": {
    "recname": "rs796943858",
    "keywords": "Unverricht-Lundborg Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3322,
  "fields": {
    "recname": "rs797044857",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3323,
  "fields": {
    "recname": "rs797044915",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3324,
  "fields": {
    "recname": "rs797044960",
    "keywords": "Deafness, Autosomal Dominant 23"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3325,
  "fields": {
    "recname": "rs797045023",
    "keywords": "Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 9"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3326,
  "fields": {
    "recname": "rs797045155",
    "keywords": "Retinitis Pigmentosa 74"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3327,
  "fields": {
    "recname": "rs7979473",
    "keywords": "C-Reactive Protein Measurement"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3328,
  "fields": {
    "recname": "rs79850223",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3329,
  "fields": {
    "recname": "rs80034486",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3330,
  "fields": {
    "recname": "rs80034486",
    "keywords": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3331,
  "fields": {
    "recname": "rs80338903",
    "keywords": "Usher Syndrome, Type Iia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3332,
  "fields": {
    "recname": "rs80338933",
    "keywords": "Charcot-Marie-Tooth Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3333,
  "fields": {
    "recname": "rs80338933",
    "keywords": "Charcot-Marie-Tooth Disease, Type 4C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3334,
  "fields": {
    "recname": "rs80338933",
    "keywords": "Mononeuropathy Of The Median Nerve, Mild"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3335,
  "fields": {
    "recname": "rs80338939",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3336,
  "fields": {
    "recname": "rs80338939",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3337,
  "fields": {
    "recname": "rs80338939",
    "keywords": "Deafness, Autosomal Dominant 3A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3338,
  "fields": {
    "recname": "rs80338939",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3339,
  "fields": {
    "recname": "rs80338939",
    "keywords": "Ichthyosis, Hystrix-Like, With Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3340,
  "fields": {
    "recname": "rs80338939",
    "keywords": "Knuckle Pads, Leuconychia And Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3341,
  "fields": {
    "recname": "rs80338939",
    "keywords": "Mutilating Keratoderma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3342,
  "fields": {
    "recname": "rs80338939",
    "keywords": "Palmoplantar Keratoderma With Deafness"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3343,
  "fields": {
    "recname": "rs80338948",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3344,
  "fields": {
    "recname": "rs80338948",
    "keywords": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3345,
  "fields": {
    "recname": "rs80338948",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3346,
  "fields": {
    "recname": "rs80338948",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3347,
  "fields": {
    "recname": "rs80338948",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3348,
  "fields": {
    "recname": "rs80338948",
    "keywords": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3349,
  "fields": {
    "recname": "rs80338948",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3350,
  "fields": {
    "recname": "rs80338950",
    "keywords": "Deafness, Autosomal Dominant 3A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3351,
  "fields": {
    "recname": "rs80338950",
    "keywords": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3352,
  "fields": {
    "recname": "rs80338950",
    "keywords": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3353,
  "fields": {
    "recname": "rs80338950",
    "keywords": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3354,
  "fields": {
    "recname": "rs80356769",
    "keywords": "Gaucher Disease, Type 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3355,
  "fields": {
    "recname": "rs80356936",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3356,
  "fields": {
    "recname": "rs80356936",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3357,
  "fields": {
    "recname": "rs80356936",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3358,
  "fields": {
    "recname": "rs80356936",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3359,
  "fields": {
    "recname": "rs80356936",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3360,
  "fields": {
    "recname": "rs80356936",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3361,
  "fields": {
    "recname": "rs80356936",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3362,
  "fields": {
    "recname": "rs80356997",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3363,
  "fields": {
    "recname": "rs80356997",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3364,
  "fields": {
    "recname": "rs80357064",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3365,
  "fields": {
    "recname": "rs80357254",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3366,
  "fields": {
    "recname": "rs80357391",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3367,
  "fields": {
    "recname": "rs80357446",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3368,
  "fields": {
    "recname": "rs80357569",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3369,
  "fields": {
    "recname": "rs80357569",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3370,
  "fields": {
    "recname": "rs80357590",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3371,
  "fields": {
    "recname": "rs80357640",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3372,
  "fields": {
    "recname": "rs80357701",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3373,
  "fields": {
    "recname": "rs80357701",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3374,
  "fields": {
    "recname": "rs80357701",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3375,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3376,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3377,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3378,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3379,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3380,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3381,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3382,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3383,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3384,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3385,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3386,
  "fields": {
    "recname": "rs80357724",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3387,
  "fields": {
    "recname": "rs80357727",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3388,
  "fields": {
    "recname": "rs80357727",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3389,
  "fields": {
    "recname": "rs80357727",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3390,
  "fields": {
    "recname": "rs80357727",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3391,
  "fields": {
    "recname": "rs80357728",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3392,
  "fields": {
    "recname": "rs80357728",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3393,
  "fields": {
    "recname": "rs80357728",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3394,
  "fields": {
    "recname": "rs80357728",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3395,
  "fields": {
    "recname": "rs80357783",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3396,
  "fields": {
    "recname": "rs80357783",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3397,
  "fields": {
    "recname": "rs80357786",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3398,
  "fields": {
    "recname": "rs80357786",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3399,
  "fields": {
    "recname": "rs80357888",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3400,
  "fields": {
    "recname": "rs80357888",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3401,
  "fields": {
    "recname": "rs80357888",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3402,
  "fields": {
    "recname": "rs80357915",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3403,
  "fields": {
    "recname": "rs80357915",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3404,
  "fields": {
    "recname": "rs80357919",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3405,
  "fields": {
    "recname": "rs80358041",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3406,
  "fields": {
    "recname": "rs80358086",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3407,
  "fields": {
    "recname": "rs80358195",
    "keywords": "Fucosidase Deficiency Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3408,
  "fields": {
    "recname": "rs80358226",
    "keywords": "Corneal Dystrophy, Lattice Type 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3409,
  "fields": {
    "recname": "rs80358227",
    "keywords": "Corneal Dystrophy, Lattice Type 3"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3410,
  "fields": {
    "recname": "rs80358241",
    "keywords": "Megalencephalic Leukoencephalopathy With Subcortical Cysts"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3411,
  "fields": {
    "recname": "rs80358242",
    "keywords": "Megalencephalic Leukoencephalopathy With Subcortical Cysts"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3412,
  "fields": {
    "recname": "rs80358260",
    "keywords": "Niemann-Pick Disease, Type C"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3413,
  "fields": {
    "recname": "rs80358260",
    "keywords": "Niemann-Pick Disease, Type C2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3414,
  "fields": {
    "recname": "rs80358266",
    "keywords": "Niemann-Pick Disease, Type C2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3415,
  "fields": {
    "recname": "rs80358268",
    "keywords": "Niemann-Pick Disease, Type C2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3416,
  "fields": {
    "recname": "rs80358344",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3417,
  "fields": {
    "recname": "rs80358344",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3418,
  "fields": {
    "recname": "rs80358928",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3419,
  "fields": {
    "recname": "rs80358928",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3420,
  "fields": {
    "recname": "rs80359180",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3421,
  "fields": {
    "recname": "rs80359180",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3422,
  "fields": {
    "recname": "rs80359277",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3423,
  "fields": {
    "recname": "rs80359277",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3424,
  "fields": {
    "recname": "rs80359277",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3425,
  "fields": {
    "recname": "rs80359297",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3426,
  "fields": {
    "recname": "rs80359375",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3427,
  "fields": {
    "recname": "rs80359473",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3428,
  "fields": {
    "recname": "rs80359473",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3429,
  "fields": {
    "recname": "rs80359473",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3430,
  "fields": {
    "recname": "rs80359527",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3431,
  "fields": {
    "recname": "rs80359530",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3432,
  "fields": {
    "recname": "rs80359535",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3433,
  "fields": {
    "recname": "rs80359535",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3434,
  "fields": {
    "recname": "rs80359624",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3435,
  "fields": {
    "recname": "rs80359644",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3436,
  "fields": {
    "recname": "rs80359688",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3437,
  "fields": {
    "recname": "rs80359688",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3438,
  "fields": {
    "recname": "rs80359688",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3439,
  "fields": {
    "recname": "rs80359688",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3440,
  "fields": {
    "recname": "rs80359688",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3441,
  "fields": {
    "recname": "rs80359688",
    "keywords": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3442,
  "fields": {
    "recname": "rs8051542",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3443,
  "fields": {
    "recname": "rs8051542",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3444,
  "fields": {
    "recname": "rs8057044",
    "keywords": "Hypertensive Disease"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3445,
  "fields": {
    "recname": "rs81002823",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3446,
  "fields": {
    "recname": "rs81002849",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3447,
  "fields": {
    "recname": "rs81002849",
    "keywords": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3448,
  "fields": {
    "recname": "rs8109875",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3449,
  "fields": {
    "recname": "rs8176672",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3450,
  "fields": {
    "recname": "rs8176672",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3451,
  "fields": {
    "recname": "rs8176693",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3452,
  "fields": {
    "recname": "rs8176693",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3453,
  "fields": {
    "recname": "rs8176703",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3454,
  "fields": {
    "recname": "rs8176703",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3455,
  "fields": {
    "recname": "rs8176719",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3456,
  "fields": {
    "recname": "rs8176719",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3457,
  "fields": {
    "recname": "rs8176722",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3458,
  "fields": {
    "recname": "rs8176722",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3459,
  "fields": {
    "recname": "rs8176743",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3460,
  "fields": {
    "recname": "rs8176743",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3461,
  "fields": {
    "recname": "rs8176746",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3462,
  "fields": {
    "recname": "rs8176746",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3463,
  "fields": {
    "recname": "rs8176749",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3464,
  "fields": {
    "recname": "rs8176749",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3465,
  "fields": {
    "recname": "rs8176751",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3466,
  "fields": {
    "recname": "rs8176751",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3467,
  "fields": {
    "recname": "rs822396",
    "keywords": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3468,
  "fields": {
    "recname": "rs854560",
    "keywords": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3469,
  "fields": {
    "recname": "rs854560",
    "keywords": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3470,
  "fields": {
    "recname": "rs854560",
    "keywords": "Bipolar I Disorder"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3471,
  "fields": {
    "recname": "rs854560",
    "keywords": "Antiphospholipid Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3472,
  "fields": {
    "recname": "rs854560",
    "keywords": "Lupus Erythematosus, Systemic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3473,
  "fields": {
    "recname": "rs854560",
    "keywords": "Polyendocrinopathies, Autoimmune"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3477,
  "fields": {
    "recname": "rs855791",
    "keywords": "Multiple Sclerosis, Malaria, Iron Deficiency, Anemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3478,
  "fields": {
    "recname": "rs863223305",
    "keywords": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3479,
  "fields": {
    "recname": "rs864309516",
    "keywords": "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3481,
  "fields": {
    "recname": "rs864309523",
    "keywords": "Deafness, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3482,
  "fields": {
    "recname": "rs864309717",
    "keywords": "Skin Creases, Congenital Symmetric Circumferential, 2"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3484,
  "fields": {
    "recname": "rs864321622",
    "keywords": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2, Encephalopathy Adverse Event"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3486,
  "fields": {
    "recname": "rs864321623",
    "keywords": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2, Encephalopathy Adverse Event"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3487,
  "fields": {
    "recname": "rs864622179",
    "keywords": "Spastic Paraplegia 4, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3489,
  "fields": {
    "recname": "rs866266998",
    "keywords": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3490,
  "fields": {
    "recname": "rs869025342",
    "keywords": "Hypotonia, Infantile, With Psychomotor Retardation"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3491,
  "fields": {
    "recname": "rs869025563",
    "keywords": "Lipoid Proteinosis Of Urbach And Wiethe"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3492,
  "fields": {
    "recname": "rs869320674",
    "keywords": "Deafness, Autosomal Recessive 31"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3493,
  "fields": {
    "recname": "rs869320772",
    "keywords": "Mental Retardation, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3494,
  "fields": {
    "recname": "rs869320773",
    "keywords": "Mental Retardation, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3495,
  "fields": {
    "recname": "rs875989778",
    "keywords": "Cone-Rod Dystrophy 18"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3496,
  "fields": {
    "recname": "rs875989900",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3497,
  "fields": {
    "recname": "rs875989907",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3498,
  "fields": {
    "recname": "rs876657624",
    "keywords": "Usher Syndrome, Type Ic"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3499,
  "fields": {
    "recname": "rs876661408",
    "keywords": "Deafness, Autosomal Recessive 105"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3500,
  "fields": {
    "recname": "rs878853326",
    "keywords": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3501,
  "fields": {
    "recname": "rs879254467",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3502,
  "fields": {
    "recname": "rs879254496",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3503,
  "fields": {
    "recname": "rs879254526",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3504,
  "fields": {
    "recname": "rs879254554",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3507,
  "fields": {
    "recname": "rs879254630",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3508,
  "fields": {
    "recname": "rs879254809",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3509,
  "fields": {
    "recname": "rs879254867",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3510,
  "fields": {
    "recname": "rs879254919",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3511,
  "fields": {
    "recname": "rs879255003",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3512,
  "fields": {
    "recname": "rs879255135",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3513,
  "fields": {
    "recname": "rs879255174",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3514,
  "fields": {
    "recname": "rs879255213",
    "keywords": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3515,
  "fields": {
    "recname": "rs879255281",
    "keywords": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3516,
  "fields": {
    "recname": "rs879255520",
    "keywords": "Macular Degeneration, Age-Related, 1"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3517,
  "fields": {
    "recname": "rs886037750",
    "keywords": "Rabson-Mendenhall Syndrome"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3518,
  "fields": {
    "recname": "rs886037762",
    "keywords": "Usher Syndrome, Type I"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3519,
  "fields": {
    "recname": "rs886037849",
    "keywords": "Mutilating Keratoderma"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3520,
  "fields": {
    "recname": "rs886039789",
    "keywords": "Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3521,
  "fields": {
    "recname": "rs886039790",
    "keywords": "Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3522,
  "fields": {
    "recname": "rs886040963",
    "keywords": "Ataxia With Vitamin E Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3523,
  "fields": {
    "recname": "rs886040964",
    "keywords": "Ataxia With Vitamin E Deficiency"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3526,
  "fields": {
    "recname": "rs900431442",
    "keywords": "Variegate Porphyria, Homozygous Variant, Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3527,
  "fields": {
    "recname": "rs9296359",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3528,
  "fields": {
    "recname": "rs946053",
    "keywords": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3529,
  "fields": {
    "recname": "rs957176669",
    "keywords": "Sitosterolemia"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3530,
  "fields": {
    "recname": "rs981454067",
    "keywords": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.index",
  "pk": 3531,
  "fields": {
    "recname": "rs9940464",
    "keywords": "Malaria"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG1",
  "fields": {
    "drug_name": "warfarin",
    "drug_bank_id": "DB00682",
    "state": "Approved",
    "indication": "Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",
    "iupac_name": "4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG10",
  "fields": {
    "drug_name": "caffeine",
    "drug_bank_id": "DB00201",
    "state": "Approved, Investigational",
    "indication": "For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.",
    "iupac_name": "1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG11",
  "fields": {
    "drug_name": "tacrolimus",
    "drug_bank_id": "DB00864",
    "state": "Approved, Investigational",
    "indication": "For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.",
    "iupac_name": "(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.04,?]octacos-18-ene-2,3,10,16-tetrone"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG12",
  "fields": {
    "drug_name": "simvastatin",
    "drug_bank_id": "DB00641",
    "state": "Approved",
    "indication": "Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.",
    "iupac_name": "(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG13",
  "fields": {
    "drug_name": "nelfinavir",
    "drug_bank_id": "DB00220",
    "state": "Approved",
    "indication": "Used in combination with other antiviral drugs in the treatment of HIV in both adults and children.",
    "iupac_name": "(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG14",
  "fields": {
    "drug_name": "nevirapine",
    "drug_bank_id": "DB00238",
    "state": "Approved",
    "indication": "For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.",
    "iupac_name": "11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG15",
  "fields": {
    "drug_name": "artesunate",
    "drug_bank_id": "DB09274",
    "state": "Approved, Investigational",
    "indication": "For the treatment of severe malaria caused by Plasmodium falciparum in adults and children",
    "iupac_name": "Butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG16",
  "fields": {
    "drug_name": "Amodiaquine",
    "drug_bank_id": "DB00613",
    "state": "Approved, Investigational",
    "indication": "For treatment of acute malarial attacks in non-immune subjects.",
    "iupac_name": "4-[(7-chloroquinolin-4-yl)amino]-2-[(diethylamino)methyl]phenol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG17",
  "fields": {
    "drug_name": "hydrochlorothiazide",
    "drug_bank_id": "DB00999",
    "state": "Approved",
    "indication": "Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.",
    "iupac_name": "6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG18",
  "fields": {
    "drug_name": "nicotine",
    "drug_bank_id": "DB00184",
    "state": "Approved",
    "indication": "For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.",
    "iupac_name": "(S)-3-(1-methylpyrrolidin-2-yl)pyridine"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG19",
  "fields": {
    "drug_name": "metoprolol",
    "drug_bank_id": "DB00264",
    "state": "Approved, Investigational",
    "indication": "Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",
    "iupac_name": "1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG2",
  "fields": {
    "drug_name": "haloperidol",
    "drug_bank_id": "DB00502",
    "state": "Approved",
    "indication": "Haloperidol is indicated for a number of conditions including for the treatment of schizophrenia, for the manifestations of psychotic disorders, for the control of tics and vocal utterances of Tourette's Disorder in children and adults, for treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). Haloperidol is also indicated in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. Haloperidol should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics",
    "iupac_name": "4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG20",
  "fields": {
    "drug_name": "Beta Blocking Agents",
    "drug_bank_id": "",
    "state": "ambiguous",
    "indication": "ambiguous",
    "iupac_name": "ambiguous"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG21",
  "fields": {
    "drug_name": "carbamazepine",
    "drug_bank_id": "DB00564",
    "state": "Approved, Investigational",
    "indication": "Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ",
    "iupac_name": "5-Carbamoyl-5H-dibenz(b,f)azepine"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG22",
  "fields": {
    "drug_name": "bupropion",
    "drug_bank_id": "DB01156",
    "state": "Approved",
    "indication": "Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",
    "iupac_name": "2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG23",
  "fields": {
    "drug_name": "peginterferon alfa-2a",
    "drug_bank_id": "DB00008",
    "state": "Approved, Investigational",
    "indication": "Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease Label. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies. Peginterferon alfa-2a is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation. ",
    "iupac_name": "CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG24",
  "fields": {
    "drug_name": "ribavirin",
    "drug_bank_id": "DB00811",
    "state": "Approved",
    "indication": "Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates. The addition of ribavirin in Technivie therapy indicated for treating HCV genotype 1a and 4 infections is recommended in patients with or without cirrhosis.Resistance: viral genetic determinants resulting in variable response to ribavirin therapy has not been yet determined.",
    "iupac_name": "1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG25",
  "fields": {
    "drug_name": "peginterferon alfa-2b",
    "drug_bank_id": "DB00022",
    "state": "Approved",
    "indication": "Peginterferon alfa-2b is indicated for the treatment of HCV in combination with Ribavirin and a NS3/4A protease inhibitor for genotype 1 or without a NS3/4A protease inhibitor for genotypes 2-6. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.",
    "iupac_name": "CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG26",
  "fields": {
    "drug_name": "citalopram",
    "drug_bank_id": "DB00215",
    "state": "Approved",
    "indication": "For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.",
    "iupac_name": "1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG27",
  "fields": {
    "drug_name": "acenocoumarol",
    "drug_bank_id": "DB01418",
    "state": "Approved, Investigational",
    "indication": "For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",
    "iupac_name": "4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG28",
  "fields": {
    "drug_name": "losartan",
    "drug_bank_id": "DB00678",
    "state": "Approved",
    "indication": "Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).",
    "iupac_name": "[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG29",
  "fields": {
    "drug_name": "atorvastatin",
    "drug_bank_id": "DB01076",
    "state": "Approved",
    "indication": "Atorvastatin is approved for the treatment of several types of dyslipidemias including: Primary hyperlipidemia and mixed dyslipidemia in adults, Hypertriglyceridemia, Primary dysbetalipoproteinemia, Homozygous familial hypercholesterolemia, Heterozygous familial hypercholesterolemia in adolescent patients with failed dietary modifications. Dyslipidemia is defined as an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis. Atorvastatin is indicated, in combination with dietary modifications, to prevent cardiovascular events in patients with cardiac risk factors and/or abnormal lipid profiles. Atorvastatin can be used as a preventive agent for myocardial infarction, stroke, revascularization, and angina, in patients without coronary heart disease but with multiple risk factors, and in patients with type 2 diabetes without coronary heart disease but multiple risk factors. Atorvastatin can also be used as a preventive agent for non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure and angina in patients with coronary heart disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.",
    "iupac_name": "(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG3",
  "fields": {
    "drug_name": "clozapine",
    "drug_bank_id": "DB00363",
    "state": "Approved",
    "indication": "For use in patients with treatment-resistant schizophrenia.",
    "iupac_name": "8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG30",
  "fields": {
    "drug_name": "ramipril",
    "drug_bank_id": "DB00178",
    "state": "Approved",
    "indication": "For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.",
    "iupac_name": "(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG31",
  "fields": {
    "drug_name": "codeine",
    "drug_bank_id": "DB00318",
    "state": "Approved,Illicit",
    "indication": "Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.",
    "iupac_name": "(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG32",
  "fields": {
    "drug_name": "atenolol",
    "drug_bank_id": "DB00335",
    "state": "Approved",
    "indication": "1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis.3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.",
    "iupac_name": "2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG33",
  "fields": {
    "drug_name": "Cladribine",
    "drug_bank_id": "DB00242",
    "state": "Approved, Investigational",
    "indication": "For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma.",
    "iupac_name": "(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG34",
  "fields": {
    "drug_name": "cytarabine",
    "drug_bank_id": "DB00987",
    "state": "Approved, Investigational",
    "indication": "For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.",
    "iupac_name": "4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG35",
  "fields": {
    "drug_name": "artemisinin and derivatives",
    "drug_bank_id": "DB13132",
    "state": "Investigational",
    "indication": "Not available",
    "iupac_name": "(3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG36",
  "fields": {
    "drug_name": "dextromethorphan",
    "drug_bank_id": "DB00514",
    "state": "Approved",
    "indication": "For treatment and relief of dry cough.",
    "iupac_name": "(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG37",
  "fields": {
    "drug_name": "Debrisoquine",
    "drug_bank_id": "DB04840",
    "state": "Approved, Investigational",
    "indication": "For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.",
    "iupac_name": "1,2,3,4-tetrahydroisoquinoline-2-carboximidamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG38",
  "fields": {
    "drug_name": "metoprolol",
    "drug_bank_id": "DB00264",
    "state": "Approved, Investigational",
    "indication": "Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",
    "iupac_name": "1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG39",
  "fields": {
    "drug_name": "atazanavir",
    "drug_bank_id": "DB01072",
    "state": "Approved, Investigational",
    "indication": "Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.",
    "iupac_name": "methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG4",
  "fields": {
    "drug_name": "mephenytoin",
    "drug_bank_id": "DB00532",
    "state": "Approved, Investigational, Withdrawn",
    "indication": "For the treatment of refractory partial epilepsy",
    "iupac_name": "5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG40",
  "fields": {
    "drug_name": "voriconazole",
    "drug_bank_id": "DB00582",
    "state": "Approved, Investigational",
    "indication": "For the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp.",
    "iupac_name": "(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG41",
  "fields": {
    "drug_name": "hydralazine",
    "drug_bank_id": "DB01275",
    "state": "Approved",
    "indication": "For the treatment of essential hypertension, alone or as an adjunct. Also for the management of severe hypertension when the drug cannot be given orally or when blood pressure must be lowered immediately, congestive heart failure (in combination with cardiac glycosides and diuretics and/or with isosorbide dinitrate), and hypertension secondary to pre-eclampsia/eclampsia.",
    "iupac_name": "1-hydrazinylphthalazine"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG42",
  "fields": {
    "drug_name": "isosorbide dinitrate",
    "drug_bank_id": "DB00883",
    "state": "Approved, Investigational",
    "indication": "For the prevention of angina pectoris due to coronary artery disease.",
    "iupac_name": "(3R,3aS,6S,6aS)-6-(nitrooxy)-hexahydrofuro[3,2-b]furan-3-yl nitrate"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG43",
  "fields": {
    "drug_name": "atenolol",
    "drug_bank_id": "DB00335",
    "state": "Approved",
    "indication": "Indicated for: 1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis. 3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.",
    "iupac_name": "2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG44",
  "fields": {
    "drug_name": "hydrochlorothiazide",
    "drug_bank_id": "DB00999",
    "state": "Approved",
    "indication": "Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.",
    "iupac_name": "6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG45",
  "fields": {
    "drug_name": "trandolapril",
    "drug_bank_id": "DB00519",
    "state": "Approved",
    "indication": "For the treatment of mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure (CHF), to improve survival following myocardial infarction (MI) in individuals who are hemodynamically stable and demonstrate symptoms of left ventricular systolic dysfunction or signs of CHF within a few days following acute MI, and to slow progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.",
    "iupac_name": "(2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG46",
  "fields": {
    "drug_name": "verapamil",
    "drug_bank_id": "DB00661",
    "state": "Approved",
    "indication": "For the treatment of hypertension, angina, and cluster headache prophylaxis.",
    "iupac_name": "2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG47",
  "fields": {
    "drug_name": "hmg coa reductase inhibitors",
    "drug_bank_id": "",
    "state": "",
    "indication": "This is a class of dugs That reduce illness and mortality in those who are at high risk of cardiovascular disease. There are various forms of statins, some of which include atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin.",
    "iupac_name": ""
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG48",
  "fields": {
    "drug_name": "lopinavir",
    "drug_bank_id": "DB01601",
    "state": "Approved",
    "indication": "Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.",
    "iupac_name": "(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG49",
  "fields": {
    "drug_name": "imatinib",
    "drug_bank_id": "DB00619",
    "state": "Approved",
    "indication": "For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).",
    "iupac_name": "N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG5",
  "fields": {
    "drug_name": "efavirenz",
    "drug_bank_id": "DB00625",
    "state": "Approved, Investigational",
    "indication": "(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one",
    "iupac_name": "(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG50",
  "fields": {
    "drug_name": "lumefantrine",
    "drug_bank_id": "DB06708",
    "state": "Approved",
    "indication": "Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.",
    "iupac_name": "2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG51",
  "fields": {
    "drug_name": "bevacizumab",
    "drug_bank_id": "DB00112",
    "state": "Approved, Investigational",
    "indication": "As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.",
    "iupac_name": "DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC/EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG52",
  "fields": {
    "drug_name": "cotinine",
    "drug_bank_id": "",
    "state": "",
    "indication": "Cotinine is an alkaloid found in tobacco and is also the predominant metabolite of nicotine.",
    "iupac_name": "(5S)-1-methyl-5-(3-pyridyl)pyrrolidin-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG53",
  "fields": {
    "drug_name": "levonorgestrel",
    "drug_bank_id": "DB00367",
    "state": "Approved, Investigational",
    "indication": "Emergency contraception: Levonorgestrel, in the single-agent emergency contraceptive form, is indicated for the prevention of pregnancy after the confirmed or suspected failure of contraception methods or following unprotected intercourse. It is distributed by prescription for patients under 17, and over the counter for those above this age. This levonorgestrel-only form of contraception is not indicated for regular contraception and must be taken as soon as possible within 72 hours after intercourse. It has shown a lower efficacy when it is used off label within 96 hours. Long-term contraception or nonemergency contraception: In addition to the above indication in emergency contraception, levonorgestrel is combined with other contraceptives in contraceptive formulations designed for regular use, for example with ethinyl estradiol. It is used in various hormone-releasing intrauterine devices for long-term contraception ranging for a duration of 3-5 years. Product labeling for Mirena specifically mentions that it is recommended in women who have had at least 1 child. A subdermal implant is also available for the prevention of pregnancy for up to 5 years. Hormone therapy and off-label uses: Levonorgestrel is prescribed in combination with estradiol as hormone therapy during menopause to manage vasomotor symptoms and to prevent osteoporosis.24Off-label, levonorgestrel may be used to treat menorrhagia, endometrial hyperplasia, and endometriosis.",
    "iupac_name": "(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG54",
  "fields": {
    "drug_name": "aripiprazole",
    "drug_bank_id": "DB01238",
    "state": "Approved, Investigational",
    "indication": "Aripiprazole is indicated for manic and mixed episodes associated with bipolar I disorder, irritability associated with autism spectrum disorder, treatment of schizophrenia, treatment of Tourette's disorder, and as an adjunctive treatment of major depressive disorder. An injectable formulation of aripiprazole is indicated for agitation associated with schizophrenia or bipolar mania.",
    "iupac_name": "7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG55",
  "fields": {
    "drug_name": "buprenorphine",
    "drug_bank_id": "DB00921",
    "state": "Approved, Illicit, Investigational",
    "indication": "For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.",
    "iupac_name": "(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG56",
  "fields": {
    "drug_name": "rosuvastatin",
    "drug_bank_id": "DB01098",
    "state": "Approved",
    "indication": "The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.",
    "iupac_name": "(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG57",
  "fields": {
    "drug_name": "hydrocodone",
    "drug_bank_id": "DB00956",
    "state": "Approved, Illicit, Investigational",
    "indication": "Hydrocodone is indicated for the management of acute pain, sometimes in combination with acetaminophen or ibuprofen, as well as the symptomatic treatment of the common cold and allergic rhinitis in combination with decongestants, antihistamines, and expectorants.",
    "iupac_name": "4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG58",
  "fields": {
    "drug_name": "methadone",
    "drug_bank_id": "DB00333",
    "state": "Approved",
    "indication": "Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Methadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services.",
    "iupac_name": "6-(dimethylamino)-4,4-diphenylheptan-3-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG6",
  "fields": {
    "drug_name": "amlodipine",
    "drug_bank_id": "DB00381",
    "state": "Approved",
    "indication": "Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetal's or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%.",
    "iupac_name": "3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG60",
  "fields": {
    "drug_name": "warfarin",
    "drug_bank_id": "DB00682",
    "state": "Approved",
    "indication": "Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",
    "iupac_name": "4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG61",
  "fields": {
    "drug_name": "cyclosporine",
    "drug_bank_id": "DB00091",
    "state": "Approved, Investigational",
    "indication": "Cyclosporine is officially approved for different conditions listed below: Prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. For this indication, it can be used concomitantly with azathioprine and corticosteroids. Treatment of patients with severe active, rheumatoid arthritis when the patient no longer responds to methotrexate. Concomitantly with methotrexate for the treatment of patients with severe active rheumatoid arthritis when patients do not respond to methotrexate treatment alone. Treatment of adult nonimmunocompromised patients with severe, recalcitrant, plaque psoriasis that have failed to respond to at least one systemic therapy or when systemic therapies are not tolerated or contraindicated. Its ophthalmic solution is indicated to increase tear production in patients with keratoconjunctivitis sicca in patients from 4 years old. Prevention of graft rejection following bone marrow transplantation and in the treatment of graft-versus-host disease (GVHD). Treatment of steroid dependent and steroid-resistant nephrotic syndrome due to glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis or membranous glomerulonephritis in adults and children. Away from all this approved and reviewed indications, cyclosporine is commonly used on dermatology for the treatment of various inflammatory skin conditions such as atopic dermatitis, blistering disorders, and connective tissue diseases.",
    "iupac_name": "(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG62",
  "fields": {
    "drug_name": "interferon alfa-2a recombinant",
    "drug_bank_id": "DB00034",
    "state": "Approved, Investigational",
    "indication": "For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatment of oral warts arising from HIV infection.",
    "iupac_name": "CDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG63",
  "fields": {
    "drug_name": "Interferon alfa-2b recombinant",
    "drug_bank_id": "DB00105",
    "state": "Approved",
    "indication": "For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma.",
    "iupac_name": "CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMNEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG64",
  "fields": {
    "drug_name": "methotrexate",
    "drug_bank_id": "DB00563",
    "state": "Approved",
    "indication": "Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis. Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis. Other formulations are indicated to treat gestational choriocarcinoma, chorioadenoma destruens, hydatiform mole, breast cancer, epidermoid cancer of the head and neck, advanced mycosis fungoides, lung cancer, and advanced non-Hodgkin's lymphoma. It is also used in the maintenance of acute lymphocytic leukemia. Methotrexate is also given before treatment with leucovorin to prolong relapse-free survival following surgical removal of a tumour in non-metastatic osteosarcoma.",
    "iupac_name": "(2S)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG65",
  "fields": {
    "drug_name": "clopidogrel",
    "drug_bank_id": "DB00758",
    "state": "Approved",
    "indication": "Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease.",
    "iupac_name": "methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG66",
  "fields": {
    "drug_name": "morphine",
    "drug_bank_id": "DB00295",
    "state": "Approved, Investigational",
    "indication": "Morphine is used for the management of chronic moderate-to-severe pain. Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder and drug abuse.",
    "iupac_name": "(4R,4aR,7S,7aR,12bS)-3-Methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG67",
  "fields": {
    "drug_name": "o-desmethyltramadol",
    "drug_bank_id": "",
    "state": "",
    "indication": "o-desmethyltramadol is an opioid analgesic and the main active metabolite of tramadol",
    "iupac_name": "3-(2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG68",
  "fields": {
    "drug_name": "omeprazole",
    "drug_bank_id": "DB00338",
    "state": "Approved, Investigational",
    "indication": "Omeprazole, according to the FDA label Label is a proton pump inhibitor (PPI) used for the following purposes: Treatment of active duodenal ulcer in adults. Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults. Treatment of active benign gastric ulcer in adults. Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 1 year of age and older Treatment of erosive esophagitis (EE) due to acid-mediated GERD in patients 1 month of age and older. Maintenance of healing of EE due to acid-mediated GERD in patients 1 year of age and older. Pathologic hypersecretory conditions in adults.",
    "iupac_name": "6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG69",
  "fields": {
    "drug_name": "olanzapine",
    "drug_bank_id": "DB00334",
    "state": "Approved, Investigational",
    "indication": "Olanzapine was initially used orally and intramuscularly for the chronic treatment of schizophrenia in patients over 13 years old and other psychiatric disorders such as bipolar I disorder including mixed or manic episodes. Olanzapine is also indicated, in combination with lithium or valproate for the short-term treatment of acute manic or mixed episodes associated with bipolar I disorder in adults. As well, olanzapine is indicated, in combination with fluoxetine for the treatment of episodes of depression associated with bipolar disorder type 1 and treatment-resistant depression in patients over 10 years old. Olanzapine is also approved for the management of psychomotor agitation associated with schizophrenia and bipolar I mania. Schizophrenia is a complex biochemical brain disorder that affects the person's ability to differentiate reality. It is usually observed as the presence of delusions, hallucinations, social withdrawal and disturbed thinking. Bipolar disorder is a mental health condition defined by periods of extreme mood disturbances. It is categorized in different types from which type 1 is known to involve episodes of severe mania and often depression while type 2 presents less severe forms of mania.",
    "iupac_name": "2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG7",
  "fields": {
    "drug_name": "salbutamol",
    "drug_bank_id": "DB01001",
    "state": "Approved",
    "indication": "Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known to induce bronchospasm.",
    "iupac_name": "4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG70",
  "fields": {
    "drug_name": "perphenazine",
    "drug_bank_id": "DB00850",
    "state": "Approved",
    "indication": "For use in the management of the manifestations of psychotic disorders and for the control of severe nausea and vomiting in adults.",
    "iupac_name": "2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethan-1-ol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG71",
  "fields": {
    "drug_name": "risperidone",
    "drug_bank_id": "DB00734",
    "state": "Approved, Investigational",
    "indication": "Risperidone is indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with Bipolar I Disorder, and irritability associated with autistic disorder. Risperidone has additional indications through Health Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches. Risperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression.",
    "iupac_name": "3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG72",
  "fields": {
    "drug_name": "quetiapine",
    "drug_bank_id": "DB01224",
    "state": "Approved",
    "indication": "Quetiapine is used in the symptomatic treatment of schizophrenia. It may be used for the management of acute manic or mixed episodes in patients bipolar I disorder as a monotherapy or with other agents. It is also used in the management of depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression. Some off-label uses for this drug include post-traumatic stress disorder (PTSD), generalized anxiety, and psychosis associated with Parkinson's disease.",
    "iupac_name": "2-(2-(4-Dibenzo[b,f][1,4]thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG73",
  "fields": {
    "drug_name": "ziprasidone",
    "drug_bank_id": "DB00246",
    "state": "Approved",
    "indication": "In it's oral form, ziprasidone is approved for the treatment of Schizophrenia, as monotherapy for acute treatment of manic or mixed episodes related to bipolar I disorder, and as adjunctive therapy to lithium or valproate for maintenance treatment of bipolar I disorder. The injectable formulation is approved only for treatment of acute agitation in schizophrenia.",
    "iupac_name": "5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG74",
  "fields": {
    "drug_name": "telaprevir",
    "drug_bank_id": "DB05521",
    "state": "Approved, Withdrawn",
    "indication": "Telaprevir, when used in combination with Ribavirin, Peginterferon alfa-2a, and Peginterferon alfa-2b is indicated for use in the treatment of chronic HCV genotype 1 infection in adults",
    "iupac_name": "(3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-(pyrazin-2-ylformamido)acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG75",
  "fields": {
    "drug_name": "allopurinol",
    "drug_bank_id": "DB00437",
    "state": "Approved",
    "indication": "Allopurinol is indicated in: 1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present. 3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.",
    "iupac_name": "1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG76",
  "fields": {
    "drug_name": "febuxostat",
    "drug_bank_id": "DB04854",
    "state": "Approved",
    "indication": "For the treatment of hyperuricemia in patients with gout.",
    "iupac_name": "2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG77",
  "fields": {
    "drug_name": "acetaminophen",
    "drug_bank_id": "DB00316",
    "state": "Approved",
    "indication": "In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being oral forms. Acetaminophen injection is indicated for: Management of mild to moderate pain, Management of moderate to severe pain with adjunctive opioid analgesics, Reduction of fever. Because of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics. Specific dosing guidelines should be followed when administering acetaminophen to children.",
    "iupac_name": "N-(4-hydroxyphenyl)acetamide"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG78",
  "fields": {
    "drug_name": "uric acid",
    "drug_bank_id": "DB08844",
    "state": "Investigational",
    "indication": "There is no approved indication for uric acid. The potential therapeutic use for uric acid is as an adjunct in acute ischemic stroke.",
    "iupac_name": "2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG79",
  "fields": {
    "drug_name": "prednisone",
    "drug_bank_id": "DB00635",
    "state": "Approved",
    "indication": "For the treatment of drug-induced allergic reactions, perennial or seasonal allergic rhinitis, serum sickness, giant cell arteritis acute rheumatic or nonrheumatic carditis, systemic dermatomyositis, systemic lupus erythematosus, atopic dermatitis, contact dermatitis, exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe (Stevens-Johnson syndrome) erythema multiforme, mycosis fungoides, pemphigus, severe psoriasis, acute adrenocortical insufficiency, Addison's disease, secondary adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with neoplasms, nonsuppurative thyroiditis, ulceratice colitis, Crohn's disease, acquired hemolytic anemia, congenital hypoplastic anemia, erythroblastopenia, adult secondary thrombocytopenia, adult idiopathic thrombocytopenia purpura, acute or subacute bursitis, epicondylitis, acute nonspecific tenosynovitis, acute or chronic lymphocytic leukemia, Hodgkin's or non-Hodgkin's lynphomas, Waldenstrom's macroglobulinemia, primary brain tumors (adjunct), nephrotic syndrome, tuberculous meningitis, multiple sclerosis, myasthenia gravis. cerebral edema, chorioretinitis, diffuse posterior choroiditis, aleergic conjunctivitis, Herpes zoster ophthalmicus, anterior segment inflammation, iridocyclitis, iritis, keratitis, optoc neuritis, sympathetic ophthalmia, corneal marginal allergic ulcers, symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy and aspiration pneumonitis.",
    "iupac_name": "17,21-dihydroxypregna-1,4-diene-3,11,20-trione"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG8",
  "fields": {
    "drug_name": "phenytoin",
    "drug_bank_id": "DB00252",
    "state": "Approved",
    "indication": "For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.",
    "iupac_name": "5,5-diphenylimidazolidine-2,4-dione"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG80",
  "fields": {
    "drug_name": "emtricitabine",
    "drug_bank_id": "DB00879",
    "state": "Approved, Investigational",
    "indication": "Indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and for postexposure prophylaxis of HIV infection in health care workers and others exposed occupationally or nonoccupationally via percutaneous injury or mucous membrane or nonintact skin contact with blood, tissues, or other body fluids associated with risk for transmission of the virus.",
    "iupac_name": "4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one"
  }
},
{
  "model": "agmp_app.drug",
  "pk": "DRUG9",
  "fields": {
    "drug_name": "zidovudine",
    "drug_bank_id": "DB00495",
    "state": "Approved",
    "indication": "Used in combination with other antiretroviral agents for the treatment of human immunovirus (HIV) infections.",
    "iupac_name": "3' Azido 2',3' Dideoxythymidine"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS1",
  "fields": {
    "disease_name": "11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS10",
  "fields": {
    "disease_name": "Acute Intermittent Porphyria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS100",
  "fields": {
    "disease_name": "Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS101",
  "fields": {
    "disease_name": "Chester-Type Porphyria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS102",
  "fields": {
    "disease_name": "Childhood Acute Lymphoblastic Leukemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS103",
  "fields": {
    "disease_name": "Chronic Active Hepatitis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS104",
  "fields": {
    "disease_name": "Chronic Obstructive Airway Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS105",
  "fields": {
    "disease_name": "Chylomicron Retention Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS106",
  "fields": {
    "disease_name": "Citrullinemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS107",
  "fields": {
    "disease_name": "Classical Galactosemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS108",
  "fields": {
    "disease_name": "Classical Phenylketonuria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS109",
  "fields": {
    "disease_name": "Colitis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS11",
  "fields": {
    "disease_name": "Acute Lymphocytic Leukemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS110",
  "fields": {
    "disease_name": "Colon Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS111",
  "fields": {
    "disease_name": "Colorectal Adenomatous Polyposis, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS112",
  "fields": {
    "disease_name": "Colorectal Cancer"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS113",
  "fields": {
    "disease_name": "Colorectal Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS114",
  "fields": {
    "disease_name": "Colorectal Neoplasms"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS115",
  "fields": {
    "disease_name": "Complement Component 7 Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS116",
  "fields": {
    "disease_name": "Complete Hydatidiform Mole"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS117",
  "fields": {
    "disease_name": "Cone-Rod Dystrophy 18"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS118",
  "fields": {
    "disease_name": "Cone-Rod Dystrophy 3 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS119",
  "fields": {
    "disease_name": "Cone-Rod Dystrophy 9"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS12",
  "fields": {
    "disease_name": "Acute Periodontitis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS120",
  "fields": {
    "disease_name": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS121",
  "fields": {
    "disease_name": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS122",
  "fields": {
    "disease_name": "Congenital Bilateral Aplasia Of Vas Deferens"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS123",
  "fields": {
    "disease_name": "Congenital Disorder Of Glycosylation, Type Iil"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS124",
  "fields": {
    "disease_name": "Congenital Disorder Of Glycosylation, Type Iin"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS125",
  "fields": {
    "disease_name": "Corneal Dystrophy, Lattice Type 3"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS126",
  "fields": {
    "disease_name": "Coronary Artery Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS127",
  "fields": {
    "disease_name": "Cranioectodermal Dysplasia 3"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS128",
  "fields": {
    "disease_name": "C-Reactive Protein Measurement"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS129",
  "fields": {
    "disease_name": "Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS13",
  "fields": {
    "disease_name": "Adult Acute Lymphocytic Leukemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS130",
  "fields": {
    "disease_name": "Creutzfeldt-Jakob Disease, Familial"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS131",
  "fields": {
    "disease_name": "Creutzfeldt-Jakob Disease, Heidenhain Variant"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS132",
  "fields": {
    "disease_name": "Creutzfeldt-Jakob Disease, Sporadic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS133",
  "fields": {
    "disease_name": "Crigler NAjjar Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS134",
  "fields": {
    "disease_name": "Crohn Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS135",
  "fields": {
    "disease_name": "Cryptorchidism"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS136",
  "fields": {
    "disease_name": "Cystic Fibrosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS137",
  "fields": {
    "disease_name": "Cystinosis, Benign, Nonnephropathic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS138",
  "fields": {
    "disease_name": "Cystinuria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS139",
  "fields": {
    "disease_name": "Cystinuria, Type A"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS14",
  "fields": {
    "disease_name": "Agenesis Of Corpus Callosum"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS140",
  "fields": {
    "disease_name": "Cystinuria, Type A-B"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS141",
  "fields": {
    "disease_name": "Cystinuria, Type B"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS142",
  "fields": {
    "disease_name": "Deafness, Autosomal Dominant 23"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS143",
  "fields": {
    "disease_name": "Deafness, Autosomal Dominant 3A (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS144",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 10"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS145",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 102"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS146",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 105"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS147",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 1A (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS148",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 31"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS149",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS15",
  "fields": {
    "disease_name": "Age Related Macular Degeneration"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS150",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 66"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS151",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 79"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS152",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive 84A"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS153",
  "fields": {
    "disease_name": "Deafness, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS154",
  "fields": {
    "disease_name": "Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS155",
  "fields": {
    "disease_name": "Deafness, Congenital, With Inner Ear Agenesis, Microtia, And Microdontia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS156",
  "fields": {
    "disease_name": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS157",
  "fields": {
    "disease_name": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS158",
  "fields": {
    "disease_name": "Deficiency Of Glucose-6-Phosphate Dehydrogenase"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS159",
  "fields": {
    "disease_name": "Deficiency Of Monooxygenase"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS16",
  "fields": {
    "disease_name": "Albinism, Oculocutaneous"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS160",
  "fields": {
    "disease_name": "Deficiency Of Pyruvate Kinase"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS161",
  "fields": {
    "disease_name": "Diabetes"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS162",
  "fields": {
    "disease_name": "Diabetes Mellitus"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS163",
  "fields": {
    "disease_name": "Diabetes Mellitus, Insulin-Dependent"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS164",
  "fields": {
    "disease_name": "Diabetes Mellitus, Non-Insulin-Dependent"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS165",
  "fields": {
    "disease_name": "Diabetic Nephropathy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS166",
  "fields": {
    "disease_name": "Disorder Of Achilles Tendon"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS167",
  "fields": {
    "disease_name": "Drug-Induced Liver Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS168",
  "fields": {
    "disease_name": "Dwarfism"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS169",
  "fields": {
    "disease_name": "Early Myoclonic Encephalopathy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS17",
  "fields": {
    "disease_name": "Albinism, Oculocutaneous, Type Ib (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS170",
  "fields": {
    "disease_name": "Ectodermal Dysplasia 11A, Hypohidrotic/Hair/Tooth Type, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS171",
  "fields": {
    "disease_name": "Ectodermal Dysplasia 11B, Hypohidrotic/Hair/Tooth Type, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS172",
  "fields": {
    "disease_name": "Ectodermal Dysplasia 3, Anhidrotic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS173",
  "fields": {
    "disease_name": "Ectodermal Dysplasia-Syndactyly Syndrome 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS174",
  "fields": {
    "disease_name": "Elliptocytosis 2 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS175",
  "fields": {
    "disease_name": "Encephalitis, St. Louis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS176",
  "fields": {
    "disease_name": "Encephalopathy Adverse Event"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS177",
  "fields": {
    "disease_name": "Enlarged Vestibular Aqueduct"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS178",
  "fields": {
    "disease_name": "Epilepsies, Partial"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS179",
  "fields": {
    "disease_name": "Epilepsy, Familial Adult Myoclonic, 5"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS18",
  "fields": {
    "disease_name": "Albinism, Oculocutaneous, Type I, Temperature-Sensitive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS180",
  "fields": {
    "disease_name": "Epilepsy, Familial Temporal Lobe, 5"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS181",
  "fields": {
    "disease_name": "Epilepsy, Progressive Myoclonic 3"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS182",
  "fields": {
    "disease_name": "Epilepsy, Progressive Myoclonic, 8"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS183",
  "fields": {
    "disease_name": "Epilepsy, Temporal Lobe"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS184",
  "fields": {
    "disease_name": "Estren-Dameshek Variant Of Fanconi Anemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS185",
  "fields": {
    "disease_name": "Estren-Dameshek Variant Of Fanconi Pancytopenia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS186",
  "fields": {
    "disease_name": "Estrogen Resistance"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS187",
  "fields": {
    "disease_name": "Exfoliation Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS188",
  "fields": {
    "disease_name": "Factor V And Factor Viii, Combined Deficiency Of, 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS189",
  "fields": {
    "disease_name": "Factor Vii Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS19",
  "fields": {
    "disease_name": "Alkaptonuria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS190",
  "fields": {
    "disease_name": "Familial Cold Urticaria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS191",
  "fields": {
    "disease_name": "Familial (Fpah)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS192",
  "fields": {
    "disease_name": "Familial Mediterranean Fever"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS193",
  "fields": {
    "disease_name": "Familial Medullary Thyroid Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS194",
  "fields": {
    "disease_name": "Familial Porphyria Cutanea Tarda"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS195",
  "fields": {
    "disease_name": "Fanconi Anemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS196",
  "fields": {
    "disease_name": "Fanconi Anemia, Complementation Group A (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS197",
  "fields": {
    "disease_name": "Fanconi Anemia, Complementation Group C"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS198",
  "fields": {
    "disease_name": "Fanconi Anemia Complementation Group G"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS199",
  "fields": {
    "disease_name": "Fatal Familial Insomnia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS2",
  "fields": {
    "disease_name": "17-Hydroxysteroid Dehydrogenase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS20",
  "fields": {
    "disease_name": "Alopecia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS200",
  "fields": {
    "disease_name": "Febrile Convulsions"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS201",
  "fields": {
    "disease_name": "Febrile Seizures, Familial, 11"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS202",
  "fields": {
    "disease_name": "Fetal Hemoglobin Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS203",
  "fields": {
    "disease_name": "Focal Glomerulosclerosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS204",
  "fields": {
    "disease_name": "Focal Segmental Glomerulosclerosis 4, Susceptibility To"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS205",
  "fields": {
    "disease_name": "Frontotemporal Dementia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS206",
  "fields": {
    "disease_name": "Fucosidase Deficiency Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS207",
  "fields": {
    "disease_name": "Fundus Dystrophy, Pseudoinflammatory, Of Sorsby"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS208",
  "fields": {
    "disease_name": "Gaucher Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS209",
  "fields": {
    "disease_name": "Gaucher Disease, Type 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS21",
  "fields": {
    "disease_name": "Alpha 1-Antitrypsin Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS210",
  "fields": {
    "disease_name": "Generalized Pustular Psoriasis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS211",
  "fields": {
    "disease_name": "Genetic Diseases, Inborn"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS212",
  "fields": {
    "disease_name": "Gestational Trophoblastic Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS213",
  "fields": {
    "disease_name": "Ghosal Hematodiaphyseal Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS214",
  "fields": {
    "disease_name": "Giant Axonal Neuropathy 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS215",
  "fields": {
    "disease_name": "Glaucoma 3, Primary Congenital, A"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS216",
  "fields": {
    "disease_name": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS217",
  "fields": {
    "disease_name": "Glaucoma, Primary Open Angle, Juvenile-Onset"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS218",
  "fields": {
    "disease_name": "Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS219",
  "fields": {
    "disease_name": "Glutaric Aciduria, Type 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS22",
  "fields": {
    "disease_name": "Alpha-Sarcoglycanopathies"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS220",
  "fields": {
    "disease_name": "Glycogen Storage Disease Iiia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS221",
  "fields": {
    "disease_name": "Glycogen Storage Disease Type I"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS222",
  "fields": {
    "disease_name": "Glycogen Storage Disease Type Ii"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS223",
  "fields": {
    "disease_name": "Glycogen Storage Disease Type Iii"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS224",
  "fields": {
    "disease_name": "Glycogen Storage Disease Type V"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS225",
  "fields": {
    "disease_name": "Gm2-Gangliosidosis, Adult Chronic Type"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS226",
  "fields": {
    "disease_name": "Gm2-Gangliosidosis, Variant B1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS227",
  "fields": {
    "disease_name": "Gout"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS228",
  "fields": {
    "disease_name": "Gronblad-Strandberg Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS229",
  "fields": {
    "disease_name": "Growth Retardation, Alopecia, Pseudoanodontia And Optic Atrophy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS23",
  "fields": {
    "disease_name": "Alpha-Thalassemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS230",
  "fields": {
    "disease_name": "Heart Diseases"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS231",
  "fields": {
    "disease_name": "Hemochromatosis, Type 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS232",
  "fields": {
    "disease_name": "Hemochromatosis, Type 4"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS233",
  "fields": {
    "disease_name": "Hemoglobin E/Beta Thalassemia Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS234",
  "fields": {
    "disease_name": "Henoch-Schoenlein Purpura"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS235",
  "fields": {
    "disease_name": "Hepatitis B Virus, Susceptibility To"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS236",
  "fields": {
    "disease_name": "Hepatitis C"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS237",
  "fields": {
    "disease_name": "Hepatitis C, Chronic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS238",
  "fields": {
    "disease_name": "Hepatoerythropoietic Porphyria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS239",
  "fields": {
    "disease_name": "Hepatolenticular Degeneration"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS24",
  "fields": {
    "disease_name": "Amyotrophic Lateral Sclerosis 2, Juvenile (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS240",
  "fields": {
    "disease_name": "Hereditary Breast And Ovarian Cancer Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS241",
  "fields": {
    "disease_name": "Hereditary Hemochromatosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS242",
  "fields": {
    "disease_name": "Hereditary Motor And Sensory-Neuropathy Type Ii"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS243",
  "fields": {
    "disease_name": "Hereditary Nonpolyposis Colorectal Cancer"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS244",
  "fields": {
    "disease_name": "Hereditary Pyropoikilocytosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS245",
  "fields": {
    "disease_name": "Hexosaminidase A Deficiency, Adult Type"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS246",
  "fields": {
    "disease_name": "Hip Dysplasia, Beukes Type"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS247",
  "fields": {
    "disease_name": "Hirschsprung Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS248",
  "fields": {
    "disease_name": "Histiocytosis With Joint Contractures And Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS249",
  "fields": {
    "disease_name": "Hiv Infections"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS25",
  "fields": {
    "disease_name": "Amyotrophic Lateral Sclerosis 5"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS250",
  "fields": {
    "disease_name": "Homocysteine Measurement"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS251",
  "fields": {
    "disease_name": "Hsan Type Iv"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS252",
  "fields": {
    "disease_name": "Huntington Disease-Like 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS253",
  "fields": {
    "disease_name": "Hydrophthalmos"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS254",
  "fields": {
    "disease_name": "Hydroxymethylbilane Synthase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS255",
  "fields": {
    "disease_name": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS256",
  "fields": {
    "disease_name": "Hypercholesterolemia, Familial"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS257",
  "fields": {
    "disease_name": "Hyperhomocysteinemia, Thrombotic, Cbs-Related"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS258",
  "fields": {
    "disease_name": "Hyperlipoproteinemia Type Iia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS259",
  "fields": {
    "disease_name": "Hyperphenylalaninaemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS26",
  "fields": {
    "disease_name": "Anemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS260",
  "fields": {
    "disease_name": "Hyperphenylalaninemia, Non-Pku Mild"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS261",
  "fields": {
    "disease_name": "Hypertensive Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS262",
  "fields": {
    "disease_name": "Hypertrophic Cardiomyopathy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS263",
  "fields": {
    "disease_name": "Hypohaptoglobinemia (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS264",
  "fields": {
    "disease_name": "Hypoparathyroidism-Retardation-Dysmorphism Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS265",
  "fields": {
    "disease_name": "Hypothyroidism, Congenital, Nongoitrous, 4"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS266",
  "fields": {
    "disease_name": "Hypotonia, Infantile, With Psychomotor Retardation"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS267",
  "fields": {
    "disease_name": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS268",
  "fields": {
    "disease_name": "Hypotrichosis 11"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS269",
  "fields": {
    "disease_name": "Hypotrichosis 6"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS27",
  "fields": {
    "disease_name": "Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS270",
  "fields": {
    "disease_name": "Hypotrichosis Simplex"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS271",
  "fields": {
    "disease_name": "Ichthyosiform Erythroderma, Congenital"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS272",
  "fields": {
    "disease_name": "Ichthyosis, Congenital, Autosomal Recessive 6"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS273",
  "fields": {
    "disease_name": "Ichthyosis, Congenital, Autosomal Recessive 9"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS274",
  "fields": {
    "disease_name": "Ichthyosis, Hystrix-Like, With Deafness"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS275",
  "fields": {
    "disease_name": "Ichthyosis, Lamellar, 3"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS276",
  "fields": {
    "disease_name": "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS277",
  "fields": {
    "disease_name": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS278",
  "fields": {
    "disease_name": "Idiopathic Hypertrophic Subaortic Stenosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS279",
  "fields": {
    "disease_name": "Idiopathic Pulmonary Arterial Hypertension"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS28",
  "fields": {
    "disease_name": "Anemia, Sickle Cell"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS280",
  "fields": {
    "disease_name": "Idiopathic Pulmonary Fibrosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS281",
  "fields": {
    "disease_name": "Immunodeficiency 23"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS282",
  "fields": {
    "disease_name": "Immunodeficiency 27A"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS283",
  "fields": {
    "disease_name": "Immunodeficiency 29"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS284",
  "fields": {
    "disease_name": "Inclusion Body Myopathy, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS285",
  "fields": {
    "disease_name": "Infection Caused By Helicobacter Pylori"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS286",
  "fields": {
    "disease_name": "Inflammatory Bowel Diseases"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS287",
  "fields": {
    "disease_name": "Iron Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS288",
  "fields": {
    "disease_name": "Iron Overload"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS289",
  "fields": {
    "disease_name": "Isolated Growth Hormone Deficiency, Type Ii"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS29",
  "fields": {
    "disease_name": "Anhaptoglobinemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS290",
  "fields": {
    "disease_name": "Isovaleryl-Coa Dehydrogenase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS291",
  "fields": {
    "disease_name": "Jaundice, Chronic Idiopathic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS292",
  "fields": {
    "disease_name": "Job Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS293",
  "fields": {
    "disease_name": "Juvenile Nephropathic Cystinosis (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS294",
  "fields": {
    "disease_name": "Juvenile-Onset Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS295",
  "fields": {
    "disease_name": "Keloid"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS296",
  "fields": {
    "disease_name": "Kenny-Caffey Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS297",
  "fields": {
    "disease_name": "Knuckle Pads, Leuconychia And Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS298",
  "fields": {
    "disease_name": "Lactase Persistence"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS299",
  "fields": {
    "disease_name": "Lactic Acidosis, Congenital Infantile, Due To Lad Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS3",
  "fields": {
    "disease_name": "21-Hydroxylase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS30",
  "fields": {
    "disease_name": "Antiphospholipid Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS300",
  "fields": {
    "disease_name": "Lamellar Ichthyosis, Type 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS301",
  "fields": {
    "disease_name": "Laron Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS302",
  "fields": {
    "disease_name": "Leigh Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS303",
  "fields": {
    "disease_name": "Leigh Syndrome Due To Mitochondrial Complex I Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS304",
  "fields": {
    "disease_name": "Leigh Syndrome Due To Mitochondrial Complex Ii Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS305",
  "fields": {
    "disease_name": "Leigh Syndrome Due To Mitochondrial Complex Iii Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS306",
  "fields": {
    "disease_name": "Leigh Syndrome Due To Mitochondrial Complex Iv Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS307",
  "fields": {
    "disease_name": "Leigh Syndrome Due To Mitochondrial Complex V Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS308",
  "fields": {
    "disease_name": "Leukemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS309",
  "fields": {
    "disease_name": "Limb-Girdle Muscular Dystrophy Type 2A"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS31",
  "fields": {
    "disease_name": "Antithrombin Iii Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS310",
  "fields": {
    "disease_name": "Limb-Girdle Muscular Dystrophy, Type 2E"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS311",
  "fields": {
    "disease_name": "Lipoid Proteinosis Of Urbach And Wiethe"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS312",
  "fields": {
    "disease_name": "Liver And Intrahepatic Biliary Tract Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS313",
  "fields": {
    "disease_name": "Liver Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS314",
  "fields": {
    "disease_name": "Liver Diseases"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS315",
  "fields": {
    "disease_name": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS316",
  "fields": {
    "disease_name": "Lupus Erythematosus"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS317",
  "fields": {
    "disease_name": "Lupus Erythematosus, Discoid"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS318",
  "fields": {
    "disease_name": "Lupus Erythematosus, Systemic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS319",
  "fields": {
    "disease_name": "Lupus Nephritis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS32",
  "fields": {
    "disease_name": "Arrhythmogenic Right Ventricular Dysplasia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS320",
  "fields": {
    "disease_name": "Lupus Vulgaris"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS321",
  "fields": {
    "disease_name": "Lymphoma, Non-Hodgkin"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS322",
  "fields": {
    "disease_name": "Lysinuric Protein Intolerance"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS323",
  "fields": {
    "disease_name": "Macrocephaly, Dysmorphic Facies, And Psychomotor Retardation"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS324",
  "fields": {
    "disease_name": "Macular Degeneration, Age-Related, 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS325",
  "fields": {
    "disease_name": "Malaria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS326",
  "fields": {
    "disease_name": "Malaria, Cerebral, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS327",
  "fields": {
    "disease_name": "Malaria, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS328",
  "fields": {
    "disease_name": "Malignant Neoplasm Of Breast"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS329",
  "fields": {
    "disease_name": "Malignant Neoplasm Of Liver"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS33",
  "fields": {
    "disease_name": "Arterial Calcification, Generalized, Of Infancy, 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS330",
  "fields": {
    "disease_name": "Malignant Neoplasm Of Pancreas"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS331",
  "fields": {
    "disease_name": "Malignant Neoplasm Of Urinary Bladder"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS332",
  "fields": {
    "disease_name": "Malignant Neoplasms"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS333",
  "fields": {
    "disease_name": "Malignant Tumor Of Cervix"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS334",
  "fields": {
    "disease_name": "Malignant Tumor Of Colon"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS335",
  "fields": {
    "disease_name": "Mannose-Binding Protein Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS336",
  "fields": {
    "disease_name": "Masp2 Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS337",
  "fields": {
    "disease_name": "Medullary Carcinoma Of Thyroid"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS338",
  "fields": {
    "disease_name": "Megalencephalic Leukoencephalopathy With Subcortical Cysts"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS339",
  "fields": {
    "disease_name": "Megaloblastic Anemia Due To Inborn Errors Of Metabolism"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS34",
  "fields": {
    "disease_name": "Arterial Tortuosity Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS340",
  "fields": {
    "disease_name": "Melanoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS341",
  "fields": {
    "disease_name": "Melanoma, Cutaneous Malignant, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS342",
  "fields": {
    "disease_name": "Melanoma-Pancreatic Cancer Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS343",
  "fields": {
    "disease_name": "Meleda Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS344",
  "fields": {
    "disease_name": "Meningoencephalitis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS345",
  "fields": {
    "disease_name": "Mental Retardation, Autosomal Recessive 13"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS346",
  "fields": {
    "disease_name": "Mental Retardation, Autosomal Recessive 53"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS347",
  "fields": {
    "disease_name": "Methylmalonic Acidemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS348",
  "fields": {
    "disease_name": "Methylmalonic Aciduria Due To Methylmalonyl-Coa Mutase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS349",
  "fields": {
    "disease_name": "Microcephaly 4, Primary, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS35",
  "fields": {
    "disease_name": "Arthrogryposis, Distal, With Impaired Proprioception And Touch"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS350",
  "fields": {
    "disease_name": "Microcephaly, Epilepsy, And Diabetes Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS351",
  "fields": {
    "disease_name": "Microcephaly, Primary Autosomal Recessive, 3"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS352",
  "fields": {
    "disease_name": "Microcephaly, Primary Autosomal Recessive, 5"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS353",
  "fields": {
    "disease_name": "Microphthalmia, Isolated 6"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS354",
  "fields": {
    "disease_name": "Microphthalmia, Syndromic 11"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS355",
  "fields": {
    "disease_name": "Microphthalmos"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS356",
  "fields": {
    "disease_name": "Minicore Myopathy, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS357",
  "fields": {
    "disease_name": "Mitochondrial Complex I Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS358",
  "fields": {
    "disease_name": "Mononeuropathy Of The Median Nerve, Mild"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS359",
  "fields": {
    "disease_name": "Mps Iii C"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS36",
  "fields": {
    "disease_name": "Aspartylglucosaminuria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS360",
  "fields": {
    "disease_name": "Muckle-Wells Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS361",
  "fields": {
    "disease_name": "Mucopolysaccharidosis Iii"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS362",
  "fields": {
    "disease_name": "Mucopolysaccharidosis Type Iiia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS363",
  "fields": {
    "disease_name": "Multicore Myopathy, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS364",
  "fields": {
    "disease_name": "Multiminicore Disease, Moderate, With Hand Involvement"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS365",
  "fields": {
    "disease_name": "Multiple Sclerosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS366",
  "fields": {
    "disease_name": "Muscular Dystrophy, Congenital, 1C"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS367",
  "fields": {
    "disease_name": "Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 9"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS368",
  "fields": {
    "disease_name": "Muscular Dystrophy, Limb-Girdle, Type 2I"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS369",
  "fields": {
    "disease_name": "Mutilating Keratoderma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS37",
  "fields": {
    "disease_name": "Asymmetric Septal Hypertrophy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS370",
  "fields": {
    "disease_name": "Myasthenic Syndrome, Congenital, 12"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS371",
  "fields": {
    "disease_name": "Myasthenic Syndrome, Congenital, Associated With Acetylcholine Receptor Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS372",
  "fields": {
    "disease_name": "Myocardial Infarction"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS373",
  "fields": {
    "disease_name": "Myoclonic Epilepsies, Progressive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS374",
  "fields": {
    "disease_name": "NAdh Cytochrome B5 Reductase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS375",
  "fields": {
    "disease_name": "NAdh:Q(1) Oxidoreductase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS376",
  "fields": {
    "disease_name": "Necrotizing Encephalopathy, Infantile Subacute, Of Leigh"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS377",
  "fields": {
    "disease_name": "Nemaline Myopathy 8"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS378",
  "fields": {
    "disease_name": "Neoplasm Metastasis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS379",
  "fields": {
    "disease_name": "Neoplastic Syndromes, Hereditary"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS38",
  "fields": {
    "disease_name": "Ataxia, Spastic, 2, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS380",
  "fields": {
    "disease_name": "Nephritis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS381",
  "fields": {
    "disease_name": "Neurodegeneration With Brain Iron Accumulation 4"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS382",
  "fields": {
    "disease_name": "Neurodegeneration With Brain Iron Accumulation (Nbia)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS383",
  "fields": {
    "disease_name": "Neurodegenerative Disorders"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS384",
  "fields": {
    "disease_name": "Neuromuscular Disease, Congenital, With Uniform Type 1 Fiber (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS385",
  "fields": {
    "disease_name": "Neuropathy, Hereditary Sensory, With Spastic Paraplegia, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS386",
  "fields": {
    "disease_name": "Neutrophil Count (Procedure)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS387",
  "fields": {
    "disease_name": "New Variant Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS388",
  "fields": {
    "disease_name": "Niemann-Pick Disease, Type A"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS389",
  "fields": {
    "disease_name": "Niemann-Pick Disease, Type B"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS39",
  "fields": {
    "disease_name": "Ataxia Telangiectasia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS390",
  "fields": {
    "disease_name": "Niemann-Pick Disease, Type C"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS391",
  "fields": {
    "disease_name": "Niemann-Pick Disease, Type C2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS392",
  "fields": {
    "disease_name": "Nijmegen Breakage Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS393",
  "fields": {
    "disease_name": "Nonnuclear Polymorphic Congenital Cataract"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS394",
  "fields": {
    "disease_name": "Nonsyndromic Deafness"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS395",
  "fields": {
    "disease_name": "Noonan Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS396",
  "fields": {
    "disease_name": "Obesity"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS397",
  "fields": {
    "disease_name": "Oculocutaneous Albinism Type 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS398",
  "fields": {
    "disease_name": "Oculocutaneous Albinism Type 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS399",
  "fields": {
    "disease_name": "Optic Atrophy 7 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS4",
  "fields": {
    "disease_name": "46, Xy Disorders Of Sex Development"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS40",
  "fields": {
    "disease_name": "Ataxia With Vitamin E Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS400",
  "fields": {
    "disease_name": "Optic Atrophy, Hereditary, Leber"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS401",
  "fields": {
    "disease_name": "Osteogenesis Imperfecta, Recessive Perinatal Lethal"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS402",
  "fields": {
    "disease_name": "Osteogenesis Imperfecta Type Iii (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS403",
  "fields": {
    "disease_name": "Osteogenesis Imperfecta Type Vii"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS404",
  "fields": {
    "disease_name": "Osteogenesis Imperfecta, Type Viii"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS405",
  "fields": {
    "disease_name": "Osteogenesis Imperfecta, Type Xiii"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS406",
  "fields": {
    "disease_name": "Other Creutzfeldt-Jakob Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS407",
  "fields": {
    "disease_name": "Overweight"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS408",
  "fields": {
    "disease_name": "Palmoplantar Keratoderma With Deafness"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS409",
  "fields": {
    "disease_name": "Palmoplantar Keratosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS41",
  "fields": {
    "disease_name": "Auditory Neuropathy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS410",
  "fields": {
    "disease_name": "Pancreatic Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS411",
  "fields": {
    "disease_name": "Pancreatic Ductal Adenocarcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS412",
  "fields": {
    "disease_name": "Pancreatitis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS413",
  "fields": {
    "disease_name": "Pancreatitis, Chronic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS414",
  "fields": {
    "disease_name": "Panhypopituitarism"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS415",
  "fields": {
    "disease_name": "Papillon-Lefevre Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS416",
  "fields": {
    "disease_name": "Parkinson Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS417",
  "fields": {
    "disease_name": "Parkinson Disease 11, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS418",
  "fields": {
    "disease_name": "Parkinson Disease 6, Autosomal Recessive Early-Onset"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS419",
  "fields": {
    "disease_name": "Parkinson Disease 6, Late-Onset, Susceptibility To"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS42",
  "fields": {
    "disease_name": "Auditory Neuropathy Spectrum Disorder"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS420",
  "fields": {
    "disease_name": "Parkinson Disease 8 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS421",
  "fields": {
    "disease_name": "Parkinson Disease, Familial, Type 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS422",
  "fields": {
    "disease_name": "Parkinson Disease, Late-Onset"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS423",
  "fields": {
    "disease_name": "Parkinsonian Disorders"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS424",
  "fields": {
    "disease_name": "Peeling Skin Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS425",
  "fields": {
    "disease_name": "Peeling Skin Syndrome 5"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS426",
  "fields": {
    "disease_name": "Peeling Skin Syndrome, Acral Type"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS427",
  "fields": {
    "disease_name": "Pendred'S Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS428",
  "fields": {
    "disease_name": "Periodontitis, Juvenile"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS429",
  "fields": {
    "disease_name": "Pfaundler-Hurler Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS43",
  "fields": {
    "disease_name": "Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS430",
  "fields": {
    "disease_name": "Phenylketonuria, Maternal"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS431",
  "fields": {
    "disease_name": "Phenylketonurias"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS432",
  "fields": {
    "disease_name": "Pheochromocytoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS433",
  "fields": {
    "disease_name": "Piebaldism"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS434",
  "fields": {
    "disease_name": "Piebaldism With Sensorineural Deafness"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS435",
  "fields": {
    "disease_name": "Pituitary Dwarfism Type 3"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS436",
  "fields": {
    "disease_name": "Pneumococcal Bacteraemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS437",
  "fields": {
    "disease_name": "Poikiloderma Of Kindler"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS438",
  "fields": {
    "disease_name": "Poikiloderma With Neutropenia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS439",
  "fields": {
    "disease_name": "Polycystic Ovarian Disease Due To 17-Ketosteroid Reductase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS44",
  "fields": {
    "disease_name": "Autosomal Recessive Polycystic Kidney Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS440",
  "fields": {
    "disease_name": "Polycystic Ovary Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS441",
  "fields": {
    "disease_name": "Polycythemia Vera"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS442",
  "fields": {
    "disease_name": "Polyendocrinopathies, Autoimmune"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS443",
  "fields": {
    "disease_name": "Polyglandular Deficiency Syndrome, Persian-Jewish Type"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS444",
  "fields": {
    "disease_name": "Polyglandular Type I Autoimmune Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS445",
  "fields": {
    "disease_name": "Polymicrogyria, Bilateral Occipital"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS446",
  "fields": {
    "disease_name": "Polymicrogyria, Bilateral Temporooccipital"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS447",
  "fields": {
    "disease_name": "Polyposis, Adenomatous Intestinal"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS448",
  "fields": {
    "disease_name": "Pontocerebellar Hypoplasia, Type 2D"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS449",
  "fields": {
    "disease_name": "Pontocerebellar Hypoplasia, Type 2E"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS45",
  "fields": {
    "disease_name": "Avellino Corneal Dystrophy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS450",
  "fields": {
    "disease_name": "Porphyria, Acute Intermittent, Nonerythroid Variant"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS451",
  "fields": {
    "disease_name": "Porphyria Cutanea Tarda"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS452",
  "fields": {
    "disease_name": "Porphyria, South African Type"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS453",
  "fields": {
    "disease_name": "Precursor Cell Lymphoblastic Leukemia Lymphoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS454",
  "fields": {
    "disease_name": "Primary Congenital Glaucoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS455",
  "fields": {
    "disease_name": "Primary Hyperoxaluria, Type I"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS456",
  "fields": {
    "disease_name": "Primary Myelofibrosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS457",
  "fields": {
    "disease_name": "Prion Diseases"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS458",
  "fields": {
    "disease_name": "Progeria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS459",
  "fields": {
    "disease_name": "Progressive Familial Heart Block, Type Ib"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS46",
  "fields": {
    "disease_name": "Bacteremia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS460",
  "fields": {
    "disease_name": "Progressive Supranuclear Palsy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS461",
  "fields": {
    "disease_name": "Prostate Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS462",
  "fields": {
    "disease_name": "Pseudoxanthoma Elasticum"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS463",
  "fields": {
    "disease_name": "Pseudoxanthoma Elasticum, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS464",
  "fields": {
    "disease_name": "Psoriasis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS465",
  "fields": {
    "disease_name": "Psoriasis 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS466",
  "fields": {
    "disease_name": "Psoriasis Vulgaris"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS467",
  "fields": {
    "disease_name": "Pxe, Modifier Of Severity Of"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS468",
  "fields": {
    "disease_name": "Rabson-Mendenhall Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS469",
  "fields": {
    "disease_name": "Rectal Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS47",
  "fields": {
    "disease_name": "Bacteremia, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS470",
  "fields": {
    "disease_name": "Respiratory Distress Syndrome, Newborn"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS471",
  "fields": {
    "disease_name": "Retinitis Pigmentosa"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS472",
  "fields": {
    "disease_name": "Retinitis Pigmentosa 14"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS473",
  "fields": {
    "disease_name": "Retinitis Pigmentosa 2 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS474",
  "fields": {
    "disease_name": "Retinitis Pigmentosa 38 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS475",
  "fields": {
    "disease_name": "Retinitis Pigmentosa 40 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS476",
  "fields": {
    "disease_name": "Retinitis Pigmentosa 73"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS477",
  "fields": {
    "disease_name": "Retinitis Pigmentosa 74"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS478",
  "fields": {
    "disease_name": "Retinoblastoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS479",
  "fields": {
    "disease_name": "Rett Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS48",
  "fields": {
    "disease_name": "Bardet-Biedl Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS480",
  "fields": {
    "disease_name": "Rheumatoid Arthritis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS481",
  "fields": {
    "disease_name": "Romano-Ward Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS482",
  "fields": {
    "disease_name": "Saldino-Noonan Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS483",
  "fields": {
    "disease_name": "Schizophrenia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS484",
  "fields": {
    "disease_name": "Secondary Malignant Neoplasm Of Lymph Node"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS485",
  "fields": {
    "disease_name": "Senile Cardiac Amyloidosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS486",
  "fields": {
    "disease_name": "Senter Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS487",
  "fields": {
    "disease_name": "Severe Autosomal Recessive Muscular Dystrophy Of Childhood - North African Type (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS488",
  "fields": {
    "disease_name": "Severe Combined Immunodeficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS489",
  "fields": {
    "disease_name": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS49",
  "fields": {
    "disease_name": "Bardet-Biedl Syndrome 10"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS490",
  "fields": {
    "disease_name": "Shprintzen-Goldberg Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS491",
  "fields": {
    "disease_name": "Sickle Cell Trait"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS492",
  "fields": {
    "disease_name": "Sickle Cell Trait/ Trachoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS493",
  "fields": {
    "disease_name": "Sitosterolemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS494",
  "fields": {
    "disease_name": "Skin Creases, Congenital Symmetric Circumferential, 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS495",
  "fields": {
    "disease_name": "Skin-Hair-Eye Pigmentation, Variation In, 4"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS496",
  "fields": {
    "disease_name": "Spastic Ataxia, Charlevoix-Saguenay Type"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS497",
  "fields": {
    "disease_name": "Spastic Paraplegia 11, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS498",
  "fields": {
    "disease_name": "Spastic Paraplegia 15, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS499",
  "fields": {
    "disease_name": "Spastic Paraplegia 30, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS5",
  "fields": {
    "disease_name": "Acquired Immunodeficiency Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS50",
  "fields": {
    "disease_name": "Bardet-Biedl Syndrome 2 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS500",
  "fields": {
    "disease_name": "Spastic Paraplegia 43, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS501",
  "fields": {
    "disease_name": "Spastic Paraplegia 46, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS502",
  "fields": {
    "disease_name": "Spastic Paraplegia 4, Autosomal Dominant"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS503",
  "fields": {
    "disease_name": "Spastic Paraplegia 5A, Autosomal Recessive (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS504",
  "fields": {
    "disease_name": "Spastic Paraplegia 7, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS505",
  "fields": {
    "disease_name": "Spherocytosis, Type 5"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS506",
  "fields": {
    "disease_name": "Spinal Muscular Atrophy, Distal, Autosomal Recessive, 5"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS507",
  "fields": {
    "disease_name": "Spinocerebellar Ataxia 23"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS508",
  "fields": {
    "disease_name": "Sporadic Parkinson Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS509",
  "fields": {
    "disease_name": "Stargardt Disease 1 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS51",
  "fields": {
    "disease_name": "Basal Ganglia Disease, Biotin-Responsive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS510",
  "fields": {
    "disease_name": "Stevens-Johnson Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS511",
  "fields": {
    "disease_name": "Stickler Syndrome (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS512",
  "fields": {
    "disease_name": "Stickler Syndrome, Type 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS513",
  "fields": {
    "disease_name": "Stickler Syndrome, Type Iv"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS514",
  "fields": {
    "disease_name": "Stomach Neoplasms"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS515",
  "fields": {
    "disease_name": "Stuttering"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS516",
  "fields": {
    "disease_name": "Stuttering, Developmental"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS517",
  "fields": {
    "disease_name": "Stuttering, Familial Persistent 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS518",
  "fields": {
    "disease_name": "Surfactant Metabolism Dysfunction, Pulmonary, 3"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS519",
  "fields": {
    "disease_name": "Systemic Arterial Pressure"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS52",
  "fields": {
    "disease_name": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS520",
  "fields": {
    "disease_name": "Systemic Onset Juvenile Chronic Arthritis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS521",
  "fields": {
    "disease_name": "Tay-Sachs Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS522",
  "fields": {
    "disease_name": "Tay-Sachs Disease, Juvenile"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS523",
  "fields": {
    "disease_name": "Tay-Sachs Disease, Pseudo-Ab Variant"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS524",
  "fields": {
    "disease_name": "Tay-Sachs Disease, Variant B1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS525",
  "fields": {
    "disease_name": "Thrombocythemia, Essential"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS526",
  "fields": {
    "disease_name": "Toxic Epidermal Necrolysis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS527",
  "fields": {
    "disease_name": "Transcolabamin Ii Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS528",
  "fields": {
    "disease_name": "Tuberculosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS529",
  "fields": {
    "disease_name": "Tuberculosis, Pulmonary"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS53",
  "fields": {
    "disease_name": "Beta^0^ Thalassemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS530",
  "fields": {
    "disease_name": "Tuberculosis, Spinal"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS531",
  "fields": {
    "disease_name": "Unverricht-Lundborg Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS532",
  "fields": {
    "disease_name": "Uric Acid Measurement (Procedure)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS533",
  "fields": {
    "disease_name": "Usher Syndrome, Type 2C"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS534",
  "fields": {
    "disease_name": "Usher Syndrome, Type I"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS535",
  "fields": {
    "disease_name": "Usher Syndrome, Type Ia, Formerly"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS536",
  "fields": {
    "disease_name": "Usher Syndrome, Type Ib (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS537",
  "fields": {
    "disease_name": "Usher Syndrome, Type Ic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS538",
  "fields": {
    "disease_name": "Usher Syndrome, Type If"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS539",
  "fields": {
    "disease_name": "Usher Syndrome, Type I, French Variety, Formerly"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS54",
  "fields": {
    "disease_name": "Beta-Knossos-Thalassemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS540",
  "fields": {
    "disease_name": "Usher Syndrome, Type Iia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS541",
  "fields": {
    "disease_name": "Variegate Porphyria"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS542",
  "fields": {
    "disease_name": "Variegate Porphyria, Homozygous Variant"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS543",
  "fields": {
    "disease_name": "Vitamin D Hydroxylation-Deficient Rickets, Type 1B"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS544",
  "fields": {
    "disease_name": "Vitelliform Macular Dystrophy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS545",
  "fields": {
    "disease_name": "Walker-Warburg Congenital Muscular Dystrophy"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS546",
  "fields": {
    "disease_name": "Warburg Sjo Fledelius Syndrome"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS547",
  "fields": {
    "disease_name": "West Nile Virus, Susceptibility To (Finding)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS548",
  "fields": {
    "disease_name": "White Blood Cell Count Quantitative Trait Locus 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS549",
  "fields": {
    "disease_name": "Xanthomatosis, Cerebrotendinous"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS55",
  "fields": {
    "disease_name": "Beta^+^ Thalassemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS550",
  "fields": {
    "disease_name": "Xeroderma Pigmentosum, Complementation Group C"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS551",
  "fields": {
    "disease_name": "Xeroderma Pigmentosum, Group A"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS552",
  "fields": {
    "disease_name": "X-Linked Adrenal Hypoplasia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS56",
  "fields": {
    "disease_name": "Beta Thalassemia"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS57",
  "fields": {
    "disease_name": "Bifid Nose With Or Without Anorectal And Renal Anomalies"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS58",
  "fields": {
    "disease_name": "Biotinidase Deficiency"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS59",
  "fields": {
    "disease_name": "Bipolar I Disorder"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS6",
  "fields": {
    "disease_name": "Acrodermatitis Continua Of Hallopeau"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS60",
  "fields": {
    "disease_name": "Bladder Neoplasm"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS61",
  "fields": {
    "disease_name": "Blood Pressure"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS62",
  "fields": {
    "disease_name": "Blood Pressure Finding"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS63",
  "fields": {
    "disease_name": "Body Height"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS64",
  "fields": {
    "disease_name": "Body Mass Index"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS65",
  "fields": {
    "disease_name": "Breast Cancer, Familial"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS66",
  "fields": {
    "disease_name": "Breast Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS67",
  "fields": {
    "disease_name": "Breast Carcinoma, Sporadic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS68",
  "fields": {
    "disease_name": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS69",
  "fields": {
    "disease_name": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS7",
  "fields": {
    "disease_name": "Acrodermatitis Enteropathica"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS70",
  "fields": {
    "disease_name": "Bronchiectasis With Or Without Elevated Sweat Chloride 1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS71",
  "fields": {
    "disease_name": "Brown Oculocutaneous Albinism"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS72",
  "fields": {
    "disease_name": "Buruli Ulcer, Susceptibility To"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS73",
  "fields": {
    "disease_name": "Candidiasis, Familial, 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS74",
  "fields": {
    "disease_name": "Carcinoma Of Bladder"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS75",
  "fields": {
    "disease_name": "Cardiomyopathies"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS76",
  "fields": {
    "disease_name": "Cardiomyopathy, Dilated, 1D (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS77",
  "fields": {
    "disease_name": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS78",
  "fields": {
    "disease_name": "Cardiomyopathy, Familial Hypertrophic, 2"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS79",
  "fields": {
    "disease_name": "Cardiomyopathy, Familial Idiopathic"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS8",
  "fields": {
    "disease_name": "Active Tuberculosis"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS80",
  "fields": {
    "disease_name": "Cardiomyopathy, Familial Restrictive, 3 (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS81",
  "fields": {
    "disease_name": "Cardiomyopathy, Hypertrophic, Familial"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS82",
  "fields": {
    "disease_name": "Cardiovascular Diseases"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS83",
  "fields": {
    "disease_name": "Cataract"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS84",
  "fields": {
    "disease_name": "Cataract 4, Multiple Types"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS85",
  "fields": {
    "disease_name": "Cataract, Congenital, Cerulean Type, 3"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS86",
  "fields": {
    "disease_name": "Cataract, Crystalline Aculeiform"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS87",
  "fields": {
    "disease_name": "Cataract, Punctate, Progressive Juvenile-Onset"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS88",
  "fields": {
    "disease_name": "Central Core Disease, Autosomal Recessive"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS89",
  "fields": {
    "disease_name": "Central Core Myopathy (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS9",
  "fields": {
    "disease_name": "Acute Hiv Infection"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS90",
  "fields": {
    "disease_name": "Ceroid Lipofuscinosis, Neuronal, 7"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS91",
  "fields": {
    "disease_name": "Cervical Cancer"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS92",
  "fields": {
    "disease_name": "Cervix Carcinoma"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS93",
  "fields": {
    "disease_name": "Charcot-Marie-Tooth Disease"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS94",
  "fields": {
    "disease_name": "Charcot-Marie-Tooth Disease, Axonal, Type 2K"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS95",
  "fields": {
    "disease_name": "Charcot-Marie-Tooth Disease, Axonal, Type 2X"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS96",
  "fields": {
    "disease_name": "Charcot-Marie-Tooth Disease, Type 2B1"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS97",
  "fields": {
    "disease_name": "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS98",
  "fields": {
    "disease_name": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)"
  }
},
{
  "model": "agmp_app.disease",
  "pk": "DIS99",
  "fields": {
    "disease_name": "Charcot-Marie-Tooth Disease, Type 4C"
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF1",
  "fields": {
    "reference_id": "24024897",
    "type": "PMID",
    "year": "2013",
    "title": "RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF10",
  "fields": {
    "reference_id": "28178031",
    "type": "PMID",
    "year": "2017",
    "title": "Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF100",
  "fields": {
    "reference_id": "25958342",
    "type": "PMID",
    "year": "2015",
    "title": "The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF101",
  "fields": {
    "reference_id": "22057858",
    "type": "PMID",
    "year": "2012",
    "title": "Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF102",
  "fields": {
    "reference_id": "27938396",
    "type": "PMID",
    "year": "2016",
    "title": "Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF103",
  "fields": {
    "reference_id": "18727922",
    "type": "PMID",
    "year": "2008",
    "title": "CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF104",
  "fields": {
    "reference_id": "25611810",
    "type": "PMID",
    "year": "2015",
    "title": "Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF105",
  "fields": {
    "reference_id": "21644011",
    "type": "PMID",
    "year": "2012",
    "title": "Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF106",
  "fields": {
    "reference_id": "20200517",
    "type": "PMID",
    "year": "2010",
    "title": "A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF107",
  "fields": {
    "reference_id": "28261502",
    "type": "PMID",
    "year": "2017",
    "title": "Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?"
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF108",
  "fields": {
    "reference_id": "19802360",
    "type": "PMID",
    "year": "2007",
    "title": "Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF109",
  "fields": {
    "reference_id": "29162334",
    "type": "PMID",
    "year": "2018",
    "title": "Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF11",
  "fields": {
    "reference_id": "17092969",
    "type": "PMID",
    "year": "2007",
    "title": "Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF110",
  "fields": {
    "reference_id": "23734829",
    "type": "PMID",
    "year": "2013",
    "title": "Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF111",
  "fields": {
    "reference_id": "19907160",
    "type": "PMID",
    "year": "2010",
    "title": "CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF112",
  "fields": {
    "reference_id": "23087401",
    "type": "PMID",
    "year": "2012",
    "title": "Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF113",
  "fields": {
    "reference_id": "21590310",
    "type": "PMID",
    "year": "2011",
    "title": "Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF114",
  "fields": {
    "reference_id": "26180834",
    "type": "PMID",
    "year": "2015",
    "title": "Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF115",
  "fields": {
    "reference_id": "28673279",
    "type": "PMID",
    "year": "2017",
    "title": "Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF116",
  "fields": {
    "reference_id": "28663312",
    "type": "PMID",
    "year": "2017",
    "title": "Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF117",
  "fields": {
    "reference_id": "23252947",
    "type": "PMID",
    "year": "2013",
    "title": "Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF118",
  "fields": {
    "reference_id": "27195527",
    "type": "PMID",
    "year": "2016",
    "title": "Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF119",
  "fields": {
    "reference_id": "23394389",
    "type": "PMID",
    "year": "2013",
    "title": "Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF12",
  "fields": {
    "reference_id": "25303294",
    "type": "PMID",
    "year": "2014",
    "title": "CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF120",
  "fields": {
    "reference_id": "29318894",
    "type": "PMID",
    "year": "2018",
    "title": "Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF121",
  "fields": {
    "reference_id": "20413733",
    "type": "PMID",
    "year": "2010",
    "title": "Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF122",
  "fields": {
    "reference_id": "19628728",
    "type": "PMID",
    "year": "2009",
    "title": "Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF123",
  "fields": {
    "reference_id": "8971426",
    "type": "PMID",
    "year": "1996",
    "title": "A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF124",
  "fields": {
    "reference_id": "25187485",
    "type": "PMID",
    "year": "2014",
    "title": "Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF125",
  "fields": {
    "reference_id": "28685643",
    "type": "PMID",
    "year": "2017",
    "title": "Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF126",
  "fields": {
    "reference_id": "30518301",
    "type": "PMID",
    "year": "2019",
    "title": "CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF127",
  "fields": {
    "reference_id": "29117017",
    "type": "PMID",
    "year": "2018",
    "title": "Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF128",
  "fields": {
    "reference_id": "26024874",
    "type": "PMID",
    "year": "2015",
    "title": "Race influences warfarin dose changes associated with genetic factors."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF129",
  "fields": {
    "reference_id": "15993850",
    "type": "PMID",
    "year": "2005",
    "title": "A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF13",
  "fields": {
    "reference_id": "29479633",
    "type": "PMID",
    "year": "2018",
    "title": "Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF130",
  "fields": {
    "reference_id": "20716240",
    "type": "PMID",
    "year": "2010",
    "title": "New genetic variant that might improve warfarin dose prediction in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF131",
  "fields": {
    "reference_id": "16876132",
    "type": "PMID",
    "year": "2007",
    "title": "Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF132",
  "fields": {
    "reference_id": "28921760",
    "type": "PMID",
    "year": "2018",
    "title": "Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF133",
  "fields": {
    "reference_id": "22940027",
    "type": "PMID",
    "year": "2012",
    "title": "Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF134",
  "fields": {
    "reference_id": "25306451",
    "type": "PMID",
    "year": "2014",
    "title": "G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF135",
  "fields": {
    "reference_id": "20176026",
    "type": "PMID",
    "year": "2010",
    "title": "Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF136",
  "fields": {
    "reference_id": "18618621",
    "type": "PMID",
    "year": "2009",
    "title": "SLC6A4 variation and citalopram response."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF137",
  "fields": {
    "reference_id": "29555325",
    "type": "PMID",
    "year": "2018",
    "title": "Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF138",
  "fields": {
    "reference_id": "23571513",
    "type": "PMID",
    "year": "2013",
    "title": "VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF139",
  "fields": {
    "reference_id": "20615525",
    "type": "PMID",
    "year": "2010",
    "title": "VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF14",
  "fields": {
    "reference_id": "17110455",
    "type": "PMID",
    "year": "2007",
    "title": "A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF141",
  "fields": {
    "reference_id": "25079360",
    "type": "PMID",
    "year": "2014",
    "title": "Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF142",
  "fields": {
    "reference_id": "26902034",
    "type": "PMID",
    "year": "2015",
    "title": "Interleukin 28B Polymorphism Predicts Treatment Outcome Among Egyptian Patients Infected With HCV Genotype 4."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF143",
  "fields": {
    "reference_id": "17329985",
    "type": "PMID",
    "year": "2007",
    "title": "Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF144",
  "fields": {
    "reference_id": "15289788",
    "type": "PMID",
    "year": "2004",
    "title": "Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF145",
  "fields": {
    "reference_id": "30672385",
    "type": "PMID",
    "year": "2019",
    "title": "Association of endothelin receptor type A rs5333 gene polymorphism with steroid response in Egyptian children with idiopathic nephrotic syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF146",
  "fields": {
    "reference_id": "16495778",
    "type": "PMID",
    "year": "2006",
    "title": "Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF147",
  "fields": {
    "reference_id": "26186989",
    "type": "PMID",
    "year": "2015",
    "title": "Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF148",
  "fields": {
    "reference_id": "16413245",
    "type": "PMID",
    "year": "2006",
    "title": "A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF149",
  "fields": {
    "reference_id": "28135054",
    "type": "PMID",
    "year": "2017",
    "title": "Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF15",
  "fields": {
    "reference_id": "24102823",
    "type": "PMID",
    "year": "2014",
    "title": "Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF150",
  "fields": {
    "reference_id": "25461246",
    "type": "PMID",
    "year": "2015",
    "title": "Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF151",
  "fields": {
    "reference_id": "24448396",
    "type": "PMID",
    "year": "2014",
    "title": "Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF152",
  "fields": {
    "reference_id": "25051018",
    "type": "PMID",
    "year": "2014",
    "title": "CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF153",
  "fields": {
    "reference_id": "26003758",
    "type": "PMID",
    "year": "2015",
    "title": "Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF154",
  "fields": {
    "reference_id": "28836054",
    "type": "PMID",
    "year": "2017",
    "title": "Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF155",
  "fields": {
    "reference_id": "21811894",
    "type": "PMID",
    "year": "2012",
    "title": "Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF156",
  "fields": {
    "reference_id": "24305170",
    "type": "PMID",
    "year": "2014",
    "title": "Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF157",
  "fields": {
    "reference_id": "22440088",
    "type": "PMID",
    "year": "2012",
    "title": "Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF158",
  "fields": {
    "reference_id": "11470994",
    "type": "PMID",
    "year": "2001",
    "title": "Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF159",
  "fields": {
    "reference_id": "20952418",
    "type": "PMID",
    "year": "2010",
    "title": "Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF16",
  "fields": {
    "reference_id": "26915813",
    "type": "PMID",
    "year": "2016",
    "title": "CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF160",
  "fields": {
    "reference_id": "29450233",
    "type": "PMID",
    "year": "2017",
    "title": "Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF161",
  "fields": {
    "reference_id": "25120580",
    "type": "PMID",
    "year": "2014",
    "title": "Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF162",
  "fields": {
    "reference_id": "12920202",
    "type": "PMID",
    "year": "2003",
    "title": "Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF163",
  "fields": {
    "reference_id": "25393304",
    "type": "PMID",
    "year": "2014",
    "title": "Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF164",
  "fields": {
    "reference_id": "29161757",
    "type": "PMID",
    "year": "2018",
    "title": "Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF165",
  "fields": {
    "reference_id": "26348712",
    "type": "PMID",
    "year": "2015",
    "title": "Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF166",
  "fields": {
    "reference_id": "25311495",
    "type": "PMID",
    "year": "2015",
    "title": "Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF167",
  "fields": {
    "reference_id": "18294361",
    "type": "PMID",
    "year": "2008",
    "title": "A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF168",
  "fields": {
    "reference_id": "26416757",
    "type": "PMID",
    "year": "2015",
    "title": "A novel locus of resistance to severe malaria in a region of ancient balancing selection."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF169",
  "fields": {
    "reference_id": "16757563",
    "type": "PMID",
    "year": "2006",
    "title": "Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF17",
  "fields": {
    "reference_id": "27035242",
    "type": "PMID",
    "year": "2016",
    "title": "Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF170",
  "fields": {
    "reference_id": "12815603",
    "type": "PMID",
    "year": "2003",
    "title": "Prion susceptibility and protective alleles exhibit marked geographic differences."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF171",
  "fields": {
    "reference_id": "18758830",
    "type": "PMID",
    "year": "2009",
    "title": "A locus for bilateral occipital polymicrogyria maps to chromosome 6q16-q22."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF172",
  "fields": {
    "reference_id": "24218364",
    "type": "PMID",
    "year": "2014",
    "title": "DNAJC13 mutations in Parkinson disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF173",
  "fields": {
    "reference_id": "16244493",
    "type": "PMID",
    "year": "2005",
    "title": "A novel autosomal recessive non-syndromic deafness locus, DFNB66, maps to chromosome 6p21.2-22.3 in a large Tunisian consanguineous family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF174",
  "fields": {
    "reference_id": "21306635",
    "type": "PMID",
    "year": "2011",
    "title": "Variable expressivity of FGF3 mutations associated with deafness and LAMM syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF175",
  "fields": {
    "reference_id": "22429511",
    "type": "PMID",
    "year": "2012",
    "title": "Segregation of a new mutation in SLC26A4 and p.E47X mutation in GJB2 within a consanguineous Tunisian family affected with Pendred syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF176",
  "fields": {
    "reference_id": "25814778",
    "type": "PMID",
    "year": "2015",
    "title": "BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF177",
  "fields": {
    "reference_id": "21642631",
    "type": "PMID",
    "year": "2011",
    "title": "Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF178",
  "fields": {
    "reference_id": "8664562",
    "type": "PMID",
    "year": "1996",
    "title": "An autosomal-recessive congenital myasthenic syndrome with tubular aggregates in a Libyan family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF179",
  "fields": {
    "reference_id": "19205970",
    "type": "PMID",
    "year": "2009",
    "title": "Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF18",
  "fields": {
    "reference_id": "19357842",
    "type": "PMID",
    "year": "2009",
    "title": "The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF180",
  "fields": {
    "reference_id": "11257256",
    "type": "PMID",
    "year": "2001",
    "title": "Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF181",
  "fields": {
    "reference_id": "21951981",
    "type": "PMID",
    "year": "2012",
    "title": "IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF182",
  "fields": {
    "reference_id": "20825431",
    "type": "PMID",
    "year": "2011",
    "title": "Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF183",
  "fields": {
    "reference_id": "21922598",
    "type": "PMID",
    "year": "2012",
    "title": "Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF184",
  "fields": {
    "reference_id": "22638694",
    "type": "PMID",
    "year": "2012",
    "title": "CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF185",
  "fields": {
    "reference_id": "22625666",
    "type": "PMID",
    "year": "2012",
    "title": "Hb S [\u00df6(A3)Glu\u001aVal, GAG>GTG] and \u00df-globin gene cluster haplotype distribution in Mauritania."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF186",
  "fields": {
    "reference_id": "16779724",
    "type": "PMID",
    "year": "2006",
    "title": "Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF187",
  "fields": {
    "reference_id": "17545720",
    "type": "PMID",
    "year": "2007",
    "title": "The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF188",
  "fields": {
    "reference_id": "21418779",
    "type": "PMID",
    "year": "2017",
    "title": "Signal transducer and activator of transcription and the risk of rheumatoid arthritis and thyroid autoimmune disorders."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF189",
  "fields": {
    "reference_id": "19732862",
    "type": "PMID",
    "year": "2009",
    "title": "FREM1 mutations cause bifid nose, renal agenesis, and anorectal malformations syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF19",
  "fields": {
    "reference_id": "26425837",
    "type": "PMID",
    "year": "2015",
    "title": "PTPRD gene associated with blood pressure response to atenolol and resistant hypertension."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF190",
  "fields": {
    "reference_id": "21612638",
    "type": "PMID",
    "year": "2011",
    "title": "Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF191",
  "fields": {
    "reference_id": "2386772",
    "type": "PMID",
    "year": "1990",
    "title": "A haemolytic syndrome associated with the complete absence of red cell membrane protein 4.2 in two Tunisian siblings."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF192",
  "fields": {
    "reference_id": "1304173",
    "type": "PMID",
    "year": "1992",
    "title": "High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF193",
  "fields": {
    "reference_id": "27129361",
    "type": "PMID",
    "year": "2016",
    "title": "NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF194",
  "fields": {
    "reference_id": "10954200",
    "type": "PMID",
    "year": "2000",
    "title": "Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF195",
  "fields": {
    "reference_id": "24729269",
    "type": "PMID",
    "year": "2014",
    "title": "BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF196",
  "fields": {
    "reference_id": "1684755",
    "type": "PMID",
    "year": "1991",
    "title": "Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF197",
  "fields": {
    "reference_id": "2352257",
    "type": "PMID",
    "year": "1990",
    "title": "An exon 4 mutation identified in the majority of South African familial hypercholesterolaemics."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF198",
  "fields": {
    "reference_id": "28723952",
    "type": "PMID",
    "year": "2017",
    "title": "Evidence for prehistoric origins of the G2019S mutation in the North African Berber population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF199",
  "fields": {
    "reference_id": "10335983",
    "type": "PMID",
    "year": "1999",
    "title": "A novel C-->A transversion within the distal CCAAT motif of the Ggamma-globin gene in the Algerian Ggammabeta+-hereditary persistence of fetal hemoglobin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF2",
  "fields": {
    "reference_id": "23173844",
    "type": "PMID",
    "year": "2012",
    "title": "PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF20",
  "fields": {
    "reference_id": "19238117",
    "type": "PMID",
    "year": "2009",
    "title": "In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF200",
  "fields": {
    "reference_id": "23680645",
    "type": "PMID",
    "year": "2013",
    "title": "Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF201",
  "fields": {
    "reference_id": "10889050",
    "type": "PMID",
    "year": "2000",
    "title": "Age and origin of the PRNP E200K mutation causing familial Creutzfeldt-Jacob disease in Libyan Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF202",
  "fields": {
    "reference_id": "18048408",
    "type": "PMID",
    "year": "2008",
    "title": "Haemoglobin S and haemoglobin C: 'quick but costly' versus 'slow but gratis' genetic adaptations to Plasmodium falciparum malaria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF203",
  "fields": {
    "reference_id": "20054342",
    "type": "PMID",
    "year": "2010",
    "title": "A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF204",
  "fields": {
    "reference_id": "19478817",
    "type": "PMID",
    "year": "2009",
    "title": "High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF205",
  "fields": {
    "reference_id": "18752149",
    "type": "PMID",
    "year": "2008",
    "title": "Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF206",
  "fields": {
    "reference_id": "20400458",
    "type": "PMID",
    "year": "2010",
    "title": "Genome-wide association of anthropometric traits in African- and African-derived populations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF207",
  "fields": {
    "reference_id": "21699405",
    "type": "PMID",
    "year": "2011",
    "title": "G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF208",
  "fields": {
    "reference_id": "24095258",
    "type": "PMID",
    "year": "2013",
    "title": "Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF209",
  "fields": {
    "reference_id": "1322637",
    "type": "PMID",
    "year": "1992",
    "title": "Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF21",
  "fields": {
    "reference_id": "27798726",
    "type": "PMID",
    "year": "2017",
    "title": "Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF210",
  "fields": {
    "reference_id": "25885115",
    "type": "PMID",
    "year": "2015",
    "title": "Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF211",
  "fields": {
    "reference_id": "22584997",
    "type": "PMID",
    "year": "2012",
    "title": "Mild iron overload in an African American man with SLC40A1 D270V."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF212",
  "fields": {
    "reference_id": "19529988",
    "type": "PMID",
    "year": "2009",
    "title": "A novel SACS gene mutation in a Tunisian family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF213",
  "fields": {
    "reference_id": "16865697",
    "type": "PMID",
    "year": "2006",
    "title": "Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF214",
  "fields": {
    "reference_id": "2895677",
    "type": "PMID",
    "year": "1988",
    "title": "Spectrin Oran (alpha II/21), a new spectrin variant concerning the alpha II domain and causing severe elliptocytosis in the homozygous state."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF215",
  "fields": {
    "reference_id": "16434418",
    "type": "PMID",
    "year": "2006",
    "title": "Autosomal recessive spastic paraplegia (SPG30) with mild ataxia and sensory neuropathy maps to chromosome 2q37.3."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF216",
  "fields": {
    "reference_id": "8095248",
    "type": "PMID",
    "year": "1993",
    "title": "A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF217",
  "fields": {
    "reference_id": "21700001",
    "type": "PMID",
    "year": "2011",
    "title": "A novel dominant mutation in SIX1, affecting a highly conserved residue, result in only auditory defects in humans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF218",
  "fields": {
    "reference_id": "14715874",
    "type": "PMID",
    "year": "2004",
    "title": "Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF219",
  "fields": {
    "reference_id": "8673113",
    "type": "PMID",
    "year": "1996",
    "title": "A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF22",
  "fields": {
    "reference_id": "23149928",
    "type": "PMID",
    "year": "2012",
    "title": "CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF220",
  "fields": {
    "reference_id": "26358359",
    "type": "PMID",
    "year": "2016",
    "title": "CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF221",
  "fields": {
    "reference_id": "16987798",
    "type": "PMID",
    "year": "2006",
    "title": "Detection of two rare beta-thalassemia alleles found in the Tunisian population: codon 47 (+A) and codons 106/107 (+G)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF222",
  "fields": {
    "reference_id": "22749234",
    "type": "PMID",
    "year": "2012",
    "title": "Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPAR?, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF223",
  "fields": {
    "reference_id": "25418591",
    "type": "PMID",
    "year": "2014",
    "title": "Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF224",
  "fields": {
    "reference_id": "20144646",
    "type": "PMID",
    "year": "2010",
    "title": "Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF225",
  "fields": {
    "reference_id": "2043465",
    "type": "PMID",
    "year": "1991",
    "title": "Occurrence of the alpha I 22 Arg----His (CGT----CAT) spectrin mutation in Tunisia: potential association with severe elliptopoikilocytosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF226",
  "fields": {
    "reference_id": "11013083",
    "type": "PMID",
    "year": "2000",
    "title": "Dating the origin of the V170M mutation causing non-type I cystinuria in Libyan Jews by linkage disequilibrium and physical mapping of the SLC7A9 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF227",
  "fields": {
    "reference_id": "8830180",
    "type": "PMID",
    "year": "1996",
    "title": "Single base deletion in exon 7 of the glycosylasparaginase gene causes a mild form of aspartylglycosaminuria in a patient of Mauritian origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF228",
  "fields": {
    "reference_id": "22983954",
    "type": "PMID",
    "year": "2012",
    "title": "Kinetochore KMN network gene CASC5 mutated in primary microcephaly."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF229",
  "fields": {
    "reference_id": "16395392",
    "type": "PMID",
    "year": "2006",
    "title": "Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF23",
  "fields": {
    "reference_id": "17392730",
    "type": "PMID",
    "year": "2007",
    "title": "Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF230",
  "fields": {
    "reference_id": "9664576",
    "type": "PMID",
    "year": "1998",
    "title": "Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF231",
  "fields": {
    "reference_id": "23415606",
    "type": "PMID",
    "year": "2013",
    "title": "STX6 rs1411478 is not associated with increased risk of Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF232",
  "fields": {
    "reference_id": "24175968",
    "type": "PMID",
    "year": "2014",
    "title": "Anaemia, iron deficiency and a common polymorphism of iron-regulation, TMPRSS6 rs855791, in Rwandan children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF233",
  "fields": {
    "reference_id": "16966502",
    "type": "PMID",
    "year": "2006",
    "title": "Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF234",
  "fields": {
    "reference_id": "3263645",
    "type": "PMID",
    "year": "1988",
    "title": "Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF235",
  "fields": {
    "reference_id": "20979190",
    "type": "PMID",
    "year": "2010",
    "title": "Germinal mosaicism in Noonan syndrome: A family with two affected siblings of normal parents."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF236",
  "fields": {
    "reference_id": "8488849",
    "type": "PMID",
    "year": "1993",
    "title": "Diverse growth hormone receptor gene mutations in Laron syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF237",
  "fields": {
    "reference_id": "23924173",
    "type": "PMID",
    "year": "2013",
    "title": "Heterozygous p.Asp50Asn mutation in the GJB2 gene in two Cameroonian patients with keratitis-ichthyosis-deafness (KID) syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF238",
  "fields": {
    "reference_id": "16806138",
    "type": "PMID",
    "year": "2006",
    "title": "Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF239",
  "fields": {
    "reference_id": "16030166",
    "type": "PMID",
    "year": "2005",
    "title": "Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF24",
  "fields": {
    "reference_id": "26111150",
    "type": "PMID",
    "year": "2015",
    "title": "Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF240",
  "fields": {
    "reference_id": "26708753",
    "type": "PMID",
    "year": "2016",
    "title": "Mutations in UNC80, Encoding Part of the UNC79-UNC80-NALCN Channel Complex, Cause Autosomal-Recessive Severe Infantile Encephalopathy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF241",
  "fields": {
    "reference_id": "22910930",
    "type": "PMID",
    "year": "2012",
    "title": "Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF242",
  "fields": {
    "reference_id": "11799477",
    "type": "PMID",
    "year": "2002",
    "title": "Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF243",
  "fields": {
    "reference_id": "9066878",
    "type": "PMID",
    "year": "1997",
    "title": "Acrocallosal syndrome in an Algerian boy born to consanguineous parents: review of the literature and further delineation of the syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF244",
  "fields": {
    "reference_id": "9631401",
    "type": "PMID",
    "year": "1998",
    "title": "LGMD 2E in Tunisia is caused by a homozygous missense mutation in beta-sarcoglycan exon 3."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF245",
  "fields": {
    "reference_id": "27684731",
    "type": "PMID",
    "year": "2017",
    "title": "GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF246",
  "fields": {
    "reference_id": "23478190",
    "type": "PMID",
    "year": "2013",
    "title": "Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF247",
  "fields": {
    "reference_id": "25987655",
    "type": "PMID",
    "year": "2015",
    "title": "Genome-wide analysis links NFATC2 with asparaginase hypersensitivity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF248",
  "fields": {
    "reference_id": "18992635",
    "type": "PMID",
    "year": "2008",
    "title": "Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF249",
  "fields": {
    "reference_id": "23810941",
    "type": "PMID",
    "year": "2013",
    "title": "Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF25",
  "fields": {
    "reference_id": "24217698",
    "type": "PMID",
    "year": "2014",
    "title": "Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF250",
  "fields": {
    "reference_id": "22095910",
    "type": "PMID",
    "year": "2012",
    "title": "VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF251",
  "fields": {
    "reference_id": "17285242",
    "type": "PMID",
    "year": "2007",
    "title": "Genetic heterogeneity of megaloblastic anaemia type 1 in Tunisian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF252",
  "fields": {
    "reference_id": "11285253",
    "type": "PMID",
    "year": "2001",
    "title": "Mutations in the gene encoding SLURP-1 in Mal de Meleda."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF253",
  "fields": {
    "reference_id": "12414836",
    "type": "PMID",
    "year": "2002",
    "title": "CYS127S (FH-Kairouan) and D245N (FH-Tozeur) mutations in the LDL receptor gene in Tunisian families with familial hypercholesterolaemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF254",
  "fields": {
    "reference_id": "16966503",
    "type": "PMID",
    "year": "2006",
    "title": "Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF255",
  "fields": {
    "reference_id": "16246960",
    "type": "PMID",
    "year": "2005",
    "title": "Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF256",
  "fields": {
    "reference_id": "8477267",
    "type": "PMID",
    "year": "1993",
    "title": "A deletion/insertion mutation in the IDUA gene in a Libyan Jewish patient with Hurler syndrome (mucopolysaccharidosis IH)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF257",
  "fields": {
    "reference_id": "22991235",
    "type": "PMID",
    "year": "2012",
    "title": "A homozygous IER3IP1 mutation causes microcephaly with simplified gyral pattern, epilepsy, and permanent neonatal diabetes syndrome (MEDS)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF258",
  "fields": {
    "reference_id": "17039343",
    "type": "PMID",
    "year": "2006",
    "title": "Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF259",
  "fields": {
    "reference_id": "27476651",
    "type": "PMID",
    "year": "2016",
    "title": "Loss-of-Function Mutations in SERPINB8 Linked to Exfoliative Ichthyosis with Impaired Mechanical Stability of Intercellular Adhesions."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF26",
  "fields": {
    "reference_id": "19916993",
    "type": "PMID",
    "year": "2009",
    "title": "A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF260",
  "fields": {
    "reference_id": "9887370",
    "type": "PMID",
    "year": "2010",
    "title": "Genetic linkage of Meleda disease to chromosome 8qter."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF261",
  "fields": {
    "reference_id": "11886537",
    "type": "PMID",
    "year": "2001",
    "title": "Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lef\u00e8vre syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF262",
  "fields": {
    "reference_id": "6584911",
    "type": "PMID",
    "year": "1984",
    "title": "Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF263",
  "fields": {
    "reference_id": "16292097",
    "type": "PMID",
    "year": "2005",
    "title": "An unexpected Cowden syndrome case found among members of a large familial adenomatous polyposis kindred."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF264",
  "fields": {
    "reference_id": "24577744",
    "type": "PMID",
    "year": "2014",
    "title": "VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF265",
  "fields": {
    "reference_id": "11126723",
    "type": "PMID",
    "year": "2000",
    "title": "Phylogenetic relationships of human populations in sub-Saharan Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF266",
  "fields": {
    "reference_id": "17347251",
    "type": "PMID",
    "year": "2007",
    "title": "Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF267",
  "fields": {
    "reference_id": "14674887",
    "type": "PMID",
    "year": "2003",
    "title": "A novel missense mutation in the gene encoding SLURP-1 in patients with Mal de Meleda from northern Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF268",
  "fields": {
    "reference_id": "8100856",
    "type": "PMID",
    "year": "1993",
    "title": "Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF269",
  "fields": {
    "reference_id": "8564843",
    "type": "PMID",
    "year": "1996",
    "title": "Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF27",
  "fields": {
    "reference_id": "19659438",
    "type": "PMID",
    "year": "2009",
    "title": "CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF270",
  "fields": {
    "reference_id": "12568299",
    "type": "PMID",
    "year": "2003",
    "title": "Frequencies of the hereditary hemochromatosis allele in different populations. Comparison of previous phenotypic methods and novel genotypic methods."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF271",
  "fields": {
    "reference_id": "10738517",
    "type": "PMID",
    "year": "1999",
    "title": "Mucopolysaccharidosis type I: characterization of a common mutation that causes Hurler syndrome in Moroccan subjects."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF272",
  "fields": {
    "reference_id": "22306650",
    "type": "PMID",
    "year": "2012",
    "title": "Common variants at 11p13 are associated with susceptibility to tuberculosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF273",
  "fields": {
    "reference_id": "20170898",
    "type": "PMID",
    "year": "2010",
    "title": "Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing loss."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF274",
  "fields": {
    "reference_id": "11346402",
    "type": "PMID",
    "year": "2001",
    "title": "Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF275",
  "fields": {
    "reference_id": "12350230",
    "type": "PMID",
    "year": "2002",
    "title": "The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF276",
  "fields": {
    "reference_id": "11524733",
    "type": "PMID",
    "year": "2001",
    "title": "Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF277",
  "fields": {
    "reference_id": "10649493",
    "type": "PMID",
    "year": "2000",
    "title": "Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF278",
  "fields": {
    "reference_id": "28905881",
    "type": "PMID",
    "year": "2017",
    "title": "Identification of ASAH1 as a susceptibility gene for familial keloids."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF279",
  "fields": {
    "reference_id": "23695285",
    "type": "PMID",
    "year": "2013",
    "title": "Stargardt disease: towards developing a model to predict phenotype."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF28",
  "fields": {
    "reference_id": "23360626",
    "type": "PMID",
    "year": "2013",
    "title": "Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF280",
  "fields": {
    "reference_id": "26010040",
    "type": "PMID",
    "year": "2016",
    "title": "Comorbidity in the Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF281",
  "fields": {
    "reference_id": "26515887",
    "type": "PMID",
    "year": "2016",
    "title": "Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF282",
  "fields": {
    "reference_id": "20552021",
    "type": "PMID",
    "year": "2010",
    "title": "Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF283",
  "fields": {
    "reference_id": "8128955",
    "type": "PMID",
    "year": "1994",
    "title": "Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF284",
  "fields": {
    "reference_id": "12372064",
    "type": "PMID",
    "year": "2002",
    "title": "A novel frameshift founder mutation in the cytochrome P450 1B1 (CYP1B1) gene is associated with primary congenital glaucoma in Morocco."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF285",
  "fields": {
    "reference_id": "2008182",
    "type": "PMID",
    "year": "1991",
    "title": "Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF286",
  "fields": {
    "reference_id": "10070616",
    "type": "PMID",
    "year": "1999",
    "title": "The molecular basis of transferase galactosaemia in South African negroids."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF287",
  "fields": {
    "reference_id": "19064877",
    "type": "PMID",
    "year": "2008",
    "title": "The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF288",
  "fields": {
    "reference_id": "23885733",
    "type": "PMID",
    "year": "2013",
    "title": "Implementation of a breast cancer genetic service in South Africa - lessons learned."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF289",
  "fields": {
    "reference_id": "25702837",
    "type": "PMID",
    "year": "2015",
    "title": "Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF29",
  "fields": {
    "reference_id": "21228733",
    "type": "PMID",
    "year": "2011",
    "title": "Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF290",
  "fields": {
    "reference_id": "12189496",
    "type": "PMID",
    "year": "2002",
    "title": "Megalencephalic leukoencephalopathy with subcortical cysts, a founder effect in Israeli patients and a higher than expected carrier rate among Libyan Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF291",
  "fields": {
    "reference_id": "23306536",
    "type": "PMID",
    "year": "2013",
    "title": "Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF292",
  "fields": {
    "reference_id": "25601850",
    "type": "PMID",
    "year": "2015",
    "title": "A missense mutation in DCDC2 causes human recessive deafness DFNB66, likely by interfering with sensory hair cell and supporting cell cilia length regulation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF293",
  "fields": {
    "reference_id": "25320599",
    "type": "PMID",
    "year": "2014",
    "title": "Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancer."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF294",
  "fields": {
    "reference_id": "11087788",
    "type": "PMID",
    "year": "2000",
    "title": "Novel mutations in spastin gene and absence of correlation with age at onset of symptoms."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF295",
  "fields": {
    "reference_id": "11001883",
    "type": "PMID",
    "year": "2000",
    "title": "Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF296",
  "fields": {
    "reference_id": "24080171",
    "type": "PMID",
    "year": "2014",
    "title": "EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF297",
  "fields": {
    "reference_id": "9950364",
    "type": "PMID",
    "year": "1999",
    "title": "Cystic fibrosis carrier frequencies in populations of African origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF298",
  "fields": {
    "reference_id": "15357568",
    "type": "PMID",
    "year": "2004",
    "title": "Pseudo-Bartter's syndrome in an Egyptian infant with cystic fibrosis mutation N1303K."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF299",
  "fields": {
    "reference_id": "11091222",
    "type": "PMID",
    "year": "2000",
    "title": "Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF3",
  "fields": {
    "reference_id": "27045425",
    "type": "PMID",
    "year": "2016",
    "title": "CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF30",
  "fields": {
    "reference_id": "22854539",
    "type": "PMID",
    "year": "2012",
    "title": "Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF300",
  "fields": {
    "reference_id": "25326109",
    "type": "PMID",
    "year": "2015",
    "title": "Common mutation causes cystinosis in the majority of black South African patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF301",
  "fields": {
    "reference_id": "16166780",
    "type": "PMID",
    "year": "2005",
    "title": "Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy presenting with severe keratopathy in an Egyptian patient with a homozygous R139X mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF302",
  "fields": {
    "reference_id": "27446417",
    "type": "PMID",
    "year": "2016",
    "title": "First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF303",
  "fields": {
    "reference_id": "10882754",
    "type": "PMID",
    "year": "2000",
    "title": "Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF304",
  "fields": {
    "reference_id": "9259197",
    "type": "PMID",
    "year": "1997",
    "title": "Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF305",
  "fields": {
    "reference_id": "23430897",
    "type": "PMID",
    "year": "2012",
    "title": "Identification of 11 Novel Homogentisate 1,2 Dioxygenase Variants in Alkaptonuria Patients and Establishment of a Novel LOVD-Based HGD Mutation Database."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF306",
  "fields": {
    "reference_id": "21603858",
    "type": "PMID",
    "year": "2012",
    "title": "Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF307",
  "fields": {
    "reference_id": "21422096",
    "type": "PMID",
    "year": "2011",
    "title": "Combined admixture mapping and association analysis identifies a novel blood pressure genetic locus on 5p13: contributions from the CARe consortium."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF308",
  "fields": {
    "reference_id": "11214903",
    "type": "PMID",
    "year": "2001",
    "title": "Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF309",
  "fields": {
    "reference_id": "18645608",
    "type": "PMID",
    "year": "2008",
    "title": "BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF31",
  "fields": {
    "reference_id": "18425130",
    "type": "PMID",
    "year": "2008",
    "title": "A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF310",
  "fields": {
    "reference_id": "18973462",
    "type": "PMID",
    "year": "2008",
    "title": "CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF311",
  "fields": {
    "reference_id": "8845852",
    "type": "PMID",
    "year": "1996",
    "title": "Mapping of a second locus for lamellar ichthyosis to chromosome 2q33-35."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF312",
  "fields": {
    "reference_id": "14607793",
    "type": "PMID",
    "year": "2004",
    "title": "Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF313",
  "fields": {
    "reference_id": "1825014",
    "type": "PMID",
    "year": "1991",
    "title": "Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF314",
  "fields": {
    "reference_id": "26545797",
    "type": "PMID",
    "year": "2016",
    "title": "Biochemical analyses and molecular modeling explain the functional loss of 17\u00df-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF315",
  "fields": {
    "reference_id": "22815638",
    "type": "PMID",
    "year": "2012",
    "title": "TMEM126A mutation in a Moroccan family with autosomal recessive optic atrophy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF316",
  "fields": {
    "reference_id": "15032968",
    "type": "PMID",
    "year": "2004",
    "title": "Arg120stop nonsense mutation in the RP2 gene: mutational hotspot and germ line mosaicism?"
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF317",
  "fields": {
    "reference_id": "20920667",
    "type": "PMID",
    "year": "2010",
    "title": "Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF318",
  "fields": {
    "reference_id": "7920663",
    "type": "PMID",
    "year": "1994",
    "title": "Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF319",
  "fields": {
    "reference_id": "22895189",
    "type": "PMID",
    "year": "2012",
    "title": "Genome-wide association study indicates two novel resistance loci for severe malaria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF32",
  "fields": {
    "reference_id": "21270790",
    "type": "PMID",
    "year": "2011",
    "title": "The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF320",
  "fields": {
    "reference_id": "27468853",
    "type": "PMID",
    "year": "2016",
    "title": "Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF321",
  "fields": {
    "reference_id": "25315659",
    "type": "PMID",
    "year": "2015",
    "title": "Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF322",
  "fields": {
    "reference_id": "9463797",
    "type": "PMID",
    "year": "2018",
    "title": "Identification of two novel mutations in the hydroxymethylbilane synthase gene in three patients from two unrelated families with acute intermittent porphyria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF323",
  "fields": {
    "reference_id": "17115391",
    "type": "PMID",
    "year": "2007",
    "title": "Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF324",
  "fields": {
    "reference_id": "25666505",
    "type": "PMID",
    "year": "2015",
    "title": "Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF325",
  "fields": {
    "reference_id": "25256132",
    "type": "PMID",
    "year": "2015",
    "title": "Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF326",
  "fields": {
    "reference_id": "10090891",
    "type": "PMID",
    "year": "1999",
    "title": "Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF327",
  "fields": {
    "reference_id": "25491720",
    "type": "PMID",
    "year": "2014",
    "title": "The TCF7L2 rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF328",
  "fields": {
    "reference_id": "28102864",
    "type": "PMID",
    "year": "2017",
    "title": "Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF329",
  "fields": {
    "reference_id": "23142382",
    "type": "PMID",
    "year": "2013",
    "title": "Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF33",
  "fields": {
    "reference_id": "19704172",
    "type": "PMID",
    "year": "2009",
    "title": "Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF330",
  "fields": {
    "reference_id": "28420445",
    "type": "PMID",
    "year": "2017",
    "title": "Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF331",
  "fields": {
    "reference_id": "19349200",
    "type": "PMID",
    "year": "2009",
    "title": "Two new mutations in the MT-TW gene leading to the disruption of the secondary structure of the tRNA(Trp) in patients with Leigh syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF332",
  "fields": {
    "reference_id": "16568030",
    "type": "PMID",
    "year": "2006",
    "title": "Novel variants in the hotspot region of RP1 in South African patients with retinitis pigmentosa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF333",
  "fields": {
    "reference_id": "22281939",
    "type": "PMID",
    "year": "2012",
    "title": "A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF334",
  "fields": {
    "reference_id": "22784038",
    "type": "PMID",
    "year": "2012",
    "title": "Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF335",
  "fields": {
    "reference_id": "22219649",
    "type": "PMID",
    "year": "2011",
    "title": "Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF336",
  "fields": {
    "reference_id": "20971220",
    "type": "PMID",
    "year": "2018",
    "title": "Expanding the clinical spectrum of SPG11 gene mutations in recessive hereditary spastic paraplegia with thin corpus callosum."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF337",
  "fields": {
    "reference_id": "21682854",
    "type": "PMID",
    "year": "2011",
    "title": "Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF338",
  "fields": {
    "reference_id": "23233322",
    "type": "PMID",
    "year": "2013",
    "title": "Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF339",
  "fields": {
    "reference_id": "7989045",
    "type": "PMID",
    "year": "1994",
    "title": "Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF34",
  "fields": {
    "reference_id": "25499099",
    "type": "PMID",
    "year": "2015",
    "title": "Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF340",
  "fields": {
    "reference_id": "28452232",
    "type": "PMID",
    "year": "2017",
    "title": "Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF341",
  "fields": {
    "reference_id": "23717212",
    "type": "PMID",
    "year": "2013",
    "title": "Imputation-based meta-analysis of severe malaria in three African populations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF342",
  "fields": {
    "reference_id": "20300792",
    "type": "PMID",
    "year": "2010",
    "title": "The spectrum of GNE mutations: allelic heterogeneity for a common phenotype."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF343",
  "fields": {
    "reference_id": "19286335",
    "type": "PMID",
    "year": "2010",
    "title": "TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF344",
  "fields": {
    "reference_id": "23297836",
    "type": "PMID",
    "year": "2013",
    "title": "The clinical and laboratory spectrum of Hb C [\u00df6(A3)Glu\u001aLys, GAG>AAG] disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF345",
  "fields": {
    "reference_id": "17301963",
    "type": "PMID",
    "year": "2007",
    "title": "Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF346",
  "fields": {
    "reference_id": "18008183",
    "type": "PMID",
    "year": "2007",
    "title": "Mutation spectrum of glycogen storage disease type Ia in Tunisia: implication for molecular diagnosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF347",
  "fields": {
    "reference_id": "26302166",
    "type": "PMID",
    "year": "2015",
    "title": "Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF348",
  "fields": {
    "reference_id": "20491958",
    "type": "PMID",
    "year": "2010",
    "title": "Molecular analysis in two Tunisian families with combined factor V and factor VIII deficiency."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF349",
  "fields": {
    "reference_id": "25541840",
    "type": "PMID",
    "year": "2015",
    "title": "Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF35",
  "fields": {
    "reference_id": "22486182",
    "type": "PMID",
    "year": "2012",
    "title": "Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF350",
  "fields": {
    "reference_id": "23697973",
    "type": "PMID",
    "year": "2012",
    "title": "BRCA1 and BRCA2 germline mutation spectrum in hereditary breast/ovarian cancer families from Maghrebian countries."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF351",
  "fields": {
    "reference_id": "25942481",
    "type": "PMID",
    "year": "2015",
    "title": "CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF352",
  "fields": {
    "reference_id": "26637978",
    "type": "PMID",
    "year": "2015",
    "title": "Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF353",
  "fields": {
    "reference_id": "12700603",
    "type": "PMID",
    "year": "2003",
    "title": "A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF354",
  "fields": {
    "reference_id": "12873855",
    "type": "PMID",
    "year": "2003",
    "title": "Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF355",
  "fields": {
    "reference_id": "22708048",
    "type": "PMID",
    "year": "2012",
    "title": "Mendelian susceptibility to mycobacterial disease in egyptian children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF356",
  "fields": {
    "reference_id": "15776430",
    "type": "PMID",
    "year": "2005",
    "title": "Conservation of the RB1 gene in human and primates."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF357",
  "fields": {
    "reference_id": "11350188",
    "type": "PMID",
    "year": "2001",
    "title": "Identification of the first variegate porphyria mutation in an indigenous black South African and further evidence for heterogeneity in variegate porphyria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF358",
  "fields": {
    "reference_id": "18685134",
    "type": "PMID",
    "year": "2008",
    "title": "PINK1 mutations and parkinsonism."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF359",
  "fields": {
    "reference_id": "20478407",
    "type": "PMID",
    "year": "2010",
    "title": "The toll-like receptor 1 variant S248N influences placental malaria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF36",
  "fields": {
    "reference_id": "17885551",
    "type": "PMID",
    "year": "2007",
    "title": "Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF360",
  "fields": {
    "reference_id": "11708871",
    "type": "PMID",
    "year": "2001",
    "title": "Phenotype and genotype heterogeneity in Mediterranean citrullinemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF361",
  "fields": {
    "reference_id": "27624329",
    "type": "PMID",
    "year": "2016",
    "title": "Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF362",
  "fields": {
    "reference_id": "16637051",
    "type": "PMID",
    "year": "2006",
    "title": "Oto-spondylo-megaepiphyseal dysplasia (OSMED): clinical and radiological findings in sibs homozygous for premature stop codon mutation in the COL11A2 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF363",
  "fields": {
    "reference_id": "18854872",
    "type": "PMID",
    "year": "2009",
    "title": "Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF364",
  "fields": {
    "reference_id": "10441578",
    "type": "PMID",
    "year": "1999",
    "title": "A locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21.2-q21.3."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF365",
  "fields": {
    "reference_id": "22034289",
    "type": "PMID",
    "year": "2012",
    "title": "High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF366",
  "fields": {
    "reference_id": "14635112",
    "type": "PMID",
    "year": "2003",
    "title": "Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF367",
  "fields": {
    "reference_id": "21668429",
    "type": "PMID",
    "year": "2011",
    "title": "Hepatoerythropoietic porphyria due to a novel mutation in the uroporphyrinogen decarboxylase gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF368",
  "fields": {
    "reference_id": "24934404",
    "type": "PMID",
    "year": "2014",
    "title": "Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF369",
  "fields": {
    "reference_id": "25487881",
    "type": "PMID",
    "year": "2015",
    "title": "Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF37",
  "fields": {
    "reference_id": "28045923",
    "type": "PMID",
    "year": "2017",
    "title": "Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF370",
  "fields": {
    "reference_id": "17159977",
    "type": "PMID",
    "year": "2007",
    "title": "Convergent adaptation of human lactase persistence in Africa and Europe."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF371",
  "fields": {
    "reference_id": "22521161",
    "type": "PMID",
    "year": "2012",
    "title": "Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF372",
  "fields": {
    "reference_id": "1757095",
    "type": "PMID",
    "year": "1991",
    "title": "Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areas."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF373",
  "fields": {
    "reference_id": "19780765",
    "type": "PMID",
    "year": "2009",
    "title": "Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF374",
  "fields": {
    "reference_id": "17203301",
    "type": "PMID",
    "year": "2007",
    "title": "A gene responsible for Ghosal hemato-diaphyseal dysplasia maps to chromosome 7q33-34."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF375",
  "fields": {
    "reference_id": "28185016",
    "type": "PMID",
    "year": "2017",
    "title": "Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF376",
  "fields": {
    "reference_id": "8937765",
    "type": "PMID",
    "year": "1996",
    "title": "The molecular characterization of Gaucher disease in South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF377",
  "fields": {
    "reference_id": "17333343",
    "type": "PMID",
    "year": "2007",
    "title": "BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF378",
  "fields": {
    "reference_id": "24131138",
    "type": "PMID",
    "year": "2013",
    "title": "Deep dermatophytosis and inherited CARD9 deficiency."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF379",
  "fields": {
    "reference_id": "24741995",
    "type": "PMID",
    "year": "2014",
    "title": "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF38",
  "fields": {
    "reference_id": "20673984",
    "type": "PMID",
    "year": "2010",
    "title": "Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF380",
  "fields": {
    "reference_id": "12707075",
    "type": "PMID",
    "year": "2003",
    "title": "Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF381",
  "fields": {
    "reference_id": "8682503",
    "type": "PMID",
    "year": "1996",
    "title": "Preliminary studies on the molecular basis of hyperphenylalaninemia in Egypt."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF382",
  "fields": {
    "reference_id": "25522698",
    "type": "PMID",
    "year": "2015",
    "title": "Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF383",
  "fields": {
    "reference_id": "17490902",
    "type": "PMID",
    "year": "2018",
    "title": "SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF384",
  "fields": {
    "reference_id": "12467734",
    "type": "PMID",
    "year": "2003",
    "title": "The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF385",
  "fields": {
    "reference_id": "20346435",
    "type": "PMID",
    "year": "2010",
    "title": "Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF386",
  "fields": {
    "reference_id": "28886269",
    "type": "PMID",
    "year": "2018",
    "title": "Loss-of-Function GRHL3 Variants Detected in African Patients with Isolated Cleft Palate."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF387",
  "fields": {
    "reference_id": "25678248",
    "type": "PMID",
    "year": "2015",
    "title": "Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF388",
  "fields": {
    "reference_id": "28133914",
    "type": "PMID",
    "year": "2017",
    "title": "Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF389",
  "fields": {
    "reference_id": "18421074",
    "type": "PMID",
    "year": "2008",
    "title": "Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF39",
  "fields": {
    "reference_id": "26667830",
    "type": "PMID",
    "year": "2017",
    "title": "Genotype-guided tacrolimus dosing in African-American kidney transplant recipients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF390",
  "fields": {
    "reference_id": "14569121",
    "type": "PMID",
    "year": "2003",
    "title": "Homozygosity mapping of a gene for arterial tortuosity syndrome to chromosome 20q13."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF391",
  "fields": {
    "reference_id": "21294448",
    "type": "PMID",
    "year": "2010",
    "title": "Analysis of common MEFV mutations in Egyptian patients with familial Mediterranean fever: molecular characterisation of the disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF392",
  "fields": {
    "reference_id": "10969262",
    "type": "PMID",
    "year": "2000",
    "title": "Case-control study of factors associated with nutritional rickets in Nigerian children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF393",
  "fields": {
    "reference_id": "21204799",
    "type": "PMID",
    "year": "2012",
    "title": "A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF394",
  "fields": {
    "reference_id": "20233677",
    "type": "PMID",
    "year": "2010",
    "title": "Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF395",
  "fields": {
    "reference_id": "12164927",
    "type": "PMID",
    "year": "2002",
    "title": "Homozygosity mapping of a locus for a novel syndromic ichthyosis to chromosome 3q27-q28."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF396",
  "fields": {
    "reference_id": "16435195",
    "type": "PMID",
    "year": "2005",
    "title": "Mucopolysaccharidosis I: Alpha-L-Iduronidase mutations in three Tunisian families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF397",
  "fields": {
    "reference_id": "24372583",
    "type": "PMID",
    "year": "2015",
    "title": "Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF398",
  "fields": {
    "reference_id": "28215593",
    "type": "PMID",
    "year": "2017",
    "title": "Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF399",
  "fields": {
    "reference_id": "19039607",
    "type": "PMID",
    "year": "2009",
    "title": "A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF4",
  "fields": {
    "reference_id": "15094935",
    "type": "PMID",
    "year": "2004",
    "title": "CYP2C9 genetic polymorphisms and warfarin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF40",
  "fields": {
    "reference_id": "25240575",
    "type": "PMID",
    "year": "2015",
    "title": "Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF400",
  "fields": {
    "reference_id": "20933457",
    "type": "PMID",
    "year": "2010",
    "title": "LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF401",
  "fields": {
    "reference_id": "16240353",
    "type": "PMID",
    "year": "2005",
    "title": "G2019S LRRK2 mutation in French and North African families with Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF402",
  "fields": {
    "reference_id": "25986072",
    "type": "PMID",
    "year": "2015",
    "title": "Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF403",
  "fields": {
    "reference_id": "21497535",
    "type": "PMID",
    "year": "2012",
    "title": "Association of interleukin-4 receptor gene polymorphisms with rheumatoid arthritis in Egyptian female patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF404",
  "fields": {
    "reference_id": "10518276",
    "type": "PMID",
    "year": "1999",
    "title": "Transcobalamin II deficiency with methylmalonic aciduria in three sisters."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF405",
  "fields": {
    "reference_id": "17922257",
    "type": "PMID",
    "year": "2007",
    "title": "Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF406",
  "fields": {
    "reference_id": "19243074",
    "type": "PMID",
    "year": "2009",
    "title": "Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF407",
  "fields": {
    "reference_id": "2153943",
    "type": "PMID",
    "year": "1990",
    "title": "Giant axonal neuropathy with inherited multisystem degeneration in a Tunisian kindred."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF408",
  "fields": {
    "reference_id": "23518707",
    "type": "PMID",
    "year": "2013",
    "title": "Autosomal recessive cortical myoclonic tremor and epilepsy: association with a mutation in the potassium channel associated gene CNTN2."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF409",
  "fields": {
    "reference_id": "18250615",
    "type": "PMID",
    "year": "2007",
    "title": "Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF41",
  "fields": {
    "reference_id": "30100615",
    "type": "PMID",
    "year": "2019",
    "title": "An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF410",
  "fields": {
    "reference_id": "15531542",
    "type": "PMID",
    "year": "2004",
    "title": "A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF411",
  "fields": {
    "reference_id": "24332549",
    "type": "PMID",
    "year": "2014",
    "title": "E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF412",
  "fields": {
    "reference_id": "16401616",
    "type": "PMID",
    "year": "2006",
    "title": "Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF413",
  "fields": {
    "reference_id": "24052401",
    "type": "PMID",
    "year": "2013",
    "title": "Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF414",
  "fields": {
    "reference_id": "19526372",
    "type": "PMID",
    "year": "2009",
    "title": "A genome-wide linkage scan in Tunisian families identifies a novel locus for non-syndromic posterior microphthalmia to chromosome 2q37.1."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF415",
  "fields": {
    "reference_id": "19777236",
    "type": "PMID",
    "year": "2010",
    "title": "MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF416",
  "fields": {
    "reference_id": "18590551",
    "type": "PMID",
    "year": "2008",
    "title": "Lack of adequate sun protection for children with oculocutaneous albinism in South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF417",
  "fields": {
    "reference_id": "27236921",
    "type": "PMID",
    "year": "2016",
    "title": "Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF418",
  "fields": {
    "reference_id": "20647424",
    "type": "PMID",
    "year": "2010",
    "title": "Association of trypanolytic ApoL1 variants with kidney disease in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF419",
  "fields": {
    "reference_id": "18569450",
    "type": "PMID",
    "year": "2008",
    "title": "Autosomal recessive ataxia caused by three distinct gene defects in a single consanguineous family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF42",
  "fields": {
    "reference_id": "22111602",
    "type": "PMID",
    "year": "2012",
    "title": "Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF420",
  "fields": {
    "reference_id": "19168821",
    "type": "PMID",
    "year": "2009",
    "title": "Megalencephalic leukoencephalopathy with subcortical cysts in a Tunisian boy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF421",
  "fields": {
    "reference_id": "28543275",
    "type": "PMID",
    "year": "2017",
    "title": "The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF422",
  "fields": {
    "reference_id": "21378380",
    "type": "PMID",
    "year": "2011",
    "title": "C14ORF179 encoding IFT43 is mutated in Sensenbrenner syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF423",
  "fields": {
    "reference_id": "3126987",
    "type": "PMID",
    "year": "1988",
    "title": "[Hereditary elliptocytosis in West Africa: frequency and repartition of spectrin variants]."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF424",
  "fields": {
    "reference_id": "1917531",
    "type": "PMID",
    "year": "1991",
    "title": "Beta-thalassemia, HB S-beta-thalassemia and sickle cell anemia among Tunisians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF425",
  "fields": {
    "reference_id": "22035446",
    "type": "PMID",
    "year": "2012",
    "title": "A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF426",
  "fields": {
    "reference_id": "20151816",
    "type": "PMID",
    "year": "2010",
    "title": "MEFV gene mutations in Egyptian patients with familial Mediterranean fever."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF427",
  "fields": {
    "reference_id": "12827451",
    "type": "PMID",
    "year": "2003",
    "title": "Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF428",
  "fields": {
    "reference_id": "17434720",
    "type": "PMID",
    "year": "2007",
    "title": "An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF429",
  "fields": {
    "reference_id": "19789650",
    "type": "PMID",
    "year": "2009",
    "title": "Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF43",
  "fields": {
    "reference_id": "28673292",
    "type": "PMID",
    "year": "2017",
    "title": "Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF430",
  "fields": {
    "reference_id": "20579331",
    "type": "PMID",
    "year": "2010",
    "title": "Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF431",
  "fields": {
    "reference_id": "10602116",
    "type": "PMID",
    "year": "2000",
    "title": "Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF432",
  "fields": {
    "reference_id": "14722929",
    "type": "PMID",
    "year": "2004",
    "title": "Low frequency of deafness-associated GJB2 variants in Kenya and Sudan and novel GJB2 variants."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF433",
  "fields": {
    "reference_id": "24093092",
    "type": "PMID",
    "year": "2013",
    "title": "Particular Mal de Meleda phenotypes in Tunisia and mutations founder effect in the Mediterranean region."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF434",
  "fields": {
    "reference_id": "26593283",
    "type": "PMID",
    "year": "2016",
    "title": "PEX6 is Expressed in Photoreceptor Cilia and Mutated in Deafblindness with Enamel Dysplasia and Microcephaly."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF435",
  "fields": {
    "reference_id": "7706766",
    "type": "PMID",
    "year": "1995",
    "title": "A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF436",
  "fields": {
    "reference_id": "18766990",
    "type": "PMID",
    "year": "2008",
    "title": "The frequency of the H402 allele of CFH and its involvement with age-related maculopathy in an aged Black African Xhosa population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF437",
  "fields": {
    "reference_id": "25372704",
    "type": "PMID",
    "year": "2014",
    "title": "Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF438",
  "fields": {
    "reference_id": "27528495",
    "type": "PMID",
    "year": "2016",
    "title": "Mild clinical presentation in KLHL40-related nemaline myopathy (NEM 8)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF439",
  "fields": {
    "reference_id": "23856378",
    "type": "PMID",
    "year": "2013",
    "title": "Compound heterozygosity for dominant and recessive GJB2 mutations in a Tunisian family and association with successful cochlear implant outcome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF44",
  "fields": {
    "reference_id": "17324110",
    "type": "PMID",
    "year": "2007",
    "title": "Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF440",
  "fields": {
    "reference_id": "17962469",
    "type": "PMID",
    "year": "2007",
    "title": "Novel TULP1 mutation causing leber congenital amaurosis or early onset retinal degeneration."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF441",
  "fields": {
    "reference_id": "18621010",
    "type": "PMID",
    "year": "2008",
    "title": "Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF442",
  "fields": {
    "reference_id": "27259055",
    "type": "PMID",
    "year": "2016",
    "title": "Mutations in CDC14A, Encoding a Protein Phosphatase Involved in Hair Cell Ciliogenesis, Cause Autosomal-Recessive Severe to Profound Deafness."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF443",
  "fields": {
    "reference_id": "24718721",
    "type": "PMID",
    "year": "2014",
    "title": "High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?"
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF444",
  "fields": {
    "reference_id": "8589684",
    "type": "PMID",
    "year": "1995",
    "title": "Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF445",
  "fields": {
    "reference_id": "9132277",
    "type": "PMID",
    "year": "1997",
    "title": "Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF446",
  "fields": {
    "reference_id": "15481894",
    "type": "PMID",
    "year": "2004",
    "title": "A novel alpha-thalassemia nonsense mutation in codon 23 of the alpha2-globin gene (GAG-->TAG) in a Tunisian family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF447",
  "fields": {
    "reference_id": "19343596",
    "type": "PMID",
    "year": "2009",
    "title": "The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF449",
  "fields": {
    "reference_id": "21324156",
    "type": "PMID",
    "year": "2011",
    "title": "Social and cultural factors underlying generational differences in overweight: a cross-sectional study among ethnic minorities in the Netherlands."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF45",
  "fields": {
    "reference_id": "26877068",
    "type": "PMID",
    "year": "2016",
    "title": "Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF450",
  "fields": {
    "reference_id": "20484391",
    "type": "PMID",
    "year": "2010",
    "title": "CISH and susceptibility to infectious diseases."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF451",
  "fields": {
    "reference_id": "2579336",
    "type": "PMID",
    "year": "1985",
    "title": "Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF452",
  "fields": {
    "reference_id": "9856479",
    "type": "PMID",
    "year": "1998",
    "title": "Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF453",
  "fields": {
    "reference_id": "22237057",
    "type": "PMID",
    "year": "2012",
    "title": "Helicobacter pylori serologic status has no influence on the association between fucosyltransferase 2 polymorphism (FUT2 461 G->A) and vitamin B-12 in Europe and West Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF454",
  "fields": {
    "reference_id": "18679828",
    "type": "PMID",
    "year": "2009",
    "title": "Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF455",
  "fields": {
    "reference_id": "11359068",
    "type": "PMID",
    "year": "2001",
    "title": "Mutation analysis of a Mauritian hereditary breast cancer family reveals the BRCA2 6503deITT mutation previously found to recur in different ethnic populations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF456",
  "fields": {
    "reference_id": "12601111",
    "type": "PMID",
    "year": "2003",
    "title": "Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF457",
  "fields": {
    "reference_id": "23332917",
    "type": "PMID",
    "year": "2013",
    "title": "Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF458",
  "fields": {
    "reference_id": "17455289",
    "type": "PMID",
    "year": "2007",
    "title": "Mutation of a potassium channel-related gene in progressive myoclonic epilepsy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF459",
  "fields": {
    "reference_id": "17592559",
    "type": "PMID",
    "year": "2007",
    "title": "Clinical and molecular diagnosis of Familial Mediterranean Fever in Egyptian children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF46",
  "fields": {
    "reference_id": "18779360",
    "type": "PMID",
    "year": "2008",
    "title": "Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF460",
  "fields": {
    "reference_id": "8751444",
    "type": "PMID",
    "year": "1996",
    "title": "Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF461",
  "fields": {
    "reference_id": "16909383",
    "type": "PMID",
    "year": "2006",
    "title": "A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF462",
  "fields": {
    "reference_id": "22350545",
    "type": "PMID",
    "year": "2012",
    "title": "Clinical variability of isovaleric acidemia in a genetically homogeneous population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF463",
  "fields": {
    "reference_id": "16938236",
    "type": "PMID",
    "year": "2006",
    "title": "[Hypertrophic cardiomyopathy: infrequent mutation of the cardiac beta-myosin heavy-chain gene]."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF464",
  "fields": {
    "reference_id": "2283297",
    "type": "PMID",
    "year": "1990",
    "title": "A new beta-thalassemia mutation produced by a single nucleotide substitution in the conserved dinucleotide sequence of the IVS-I consensus acceptor site (AG----AA)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF465",
  "fields": {
    "reference_id": "16436457",
    "type": "PMID",
    "year": "2006",
    "title": "Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF466",
  "fields": {
    "reference_id": "23322442",
    "type": "PMID",
    "year": "2013",
    "title": "Molecular defects in Moroccan patients with ataxia-telangiectasia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF467",
  "fields": {
    "reference_id": "15521008",
    "type": "PMID",
    "year": "2004",
    "title": "Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF468",
  "fields": {
    "reference_id": "20144596",
    "type": "PMID",
    "year": "2010",
    "title": "Moderate phenotypic expression of familial hypercholesterolemia in Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF469",
  "fields": {
    "reference_id": "21426550",
    "type": "PMID",
    "year": "2011",
    "title": "The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF47",
  "fields": {
    "reference_id": "17588543",
    "type": "PMID",
    "year": "2008",
    "title": "Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF470",
  "fields": {
    "reference_id": "23829277",
    "type": "PMID",
    "year": "2014",
    "title": "Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF471",
  "fields": {
    "reference_id": "29447211",
    "type": "PMID",
    "year": "2018",
    "title": "Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF472",
  "fields": {
    "reference_id": "17354266",
    "type": "PMID",
    "year": "2007",
    "title": "Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD locus."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF473",
  "fields": {
    "reference_id": "26779637",
    "type": "PMID",
    "year": "2016",
    "title": "Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?"
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF474",
  "fields": {
    "reference_id": "10631139",
    "type": "PMID",
    "year": "2000",
    "title": "Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF475",
  "fields": {
    "reference_id": "26336027",
    "type": "PMID",
    "year": "2018",
    "title": "The Bedouin mutation c.155-166del of the TBCE gene in a patient with Sanjad-Sakati syndrome of Moroccan origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF476",
  "fields": {
    "reference_id": "26153217",
    "type": "PMID",
    "year": "2016",
    "title": "A nonsense variant in HERC1 is associated with intellectual disability, megalencephaly, thick corpus callosum and cerebellar atrophy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF477",
  "fields": {
    "reference_id": "8514861",
    "type": "PMID",
    "year": "1993",
    "title": "Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF478",
  "fields": {
    "reference_id": "24342785",
    "type": "PMID",
    "year": "2019",
    "title": "[Clinical characterization of the Stargardt disease and molecular exploration of the c.2041C>T mutation (ABCA4 gene) in Tunisian patients]."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF479",
  "fields": {
    "reference_id": "12378576",
    "type": "PMID",
    "year": "2002",
    "title": "Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF48",
  "fields": {
    "reference_id": "30767719",
    "type": "PMID",
    "year": "2019",
    "title": "Impact of pharmacogenetics and pregnancy on tenofovir and emtricitabine pharmacokinetics."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF480",
  "fields": {
    "reference_id": "20839240",
    "type": "PMID",
    "year": "2010",
    "title": "RYR1 mutations are a common cause of congenital myopathies with central nuclei."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF481",
  "fields": {
    "reference_id": "18925663",
    "type": "PMID",
    "year": "2008",
    "title": "Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF482",
  "fields": {
    "reference_id": "24689757",
    "type": "PMID",
    "year": "2015",
    "title": "Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in Egypt."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF483",
  "fields": {
    "reference_id": "21443744",
    "type": "PMID",
    "year": "2011",
    "title": "Frequent mutation in North African patients with MUTYH-associated polyposis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF484",
  "fields": {
    "reference_id": "1464748",
    "type": "PMID",
    "year": "1992",
    "title": "Identification and properties of the proline664-leucine mutant LDL receptor in South Africans of Indian origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF485",
  "fields": {
    "reference_id": "15712650",
    "type": "PMID",
    "year": "2005",
    "title": "CARD15/NOD2 in a Tunisian population with Crohn's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF486",
  "fields": {
    "reference_id": "19250380",
    "type": "PMID",
    "year": "2009",
    "title": "Skoura - a genetic island for congenital insensitivity to pain and anhidrosis among Moroccan Jews, as determined by a novel mutation in the NTRK1 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF487",
  "fields": {
    "reference_id": "9400791",
    "type": "PMID",
    "year": "1997",
    "title": "Sorsby fundus dystrophy: reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF488",
  "fields": {
    "reference_id": "8844212",
    "type": "PMID",
    "year": "1996",
    "title": "Novel mutations and polymorphisms in the Fanconi anemia group C gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF489",
  "fields": {
    "reference_id": "7987300",
    "type": "PMID",
    "year": "1994",
    "title": "Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF49",
  "fields": {
    "reference_id": "11823760",
    "type": "PMID",
    "year": "2002",
    "title": "The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF490",
  "fields": {
    "reference_id": "18286824",
    "type": "PMID",
    "year": "2007",
    "title": "Phenotypic variability in Micro syndrome: report of new cases."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF491",
  "fields": {
    "reference_id": "19375528",
    "type": "PMID",
    "year": "2017",
    "title": "Molecular screening of deafness in Algeria: high genetic heterogeneity involving DFNB1 and the Usher loci, DFNB2/USH1B, DFNB12/USH1D and DFNB23/USH1F."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF492",
  "fields": {
    "reference_id": "11854439",
    "type": "PMID",
    "year": "2002",
    "title": "Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF493",
  "fields": {
    "reference_id": "19368707",
    "type": "PMID",
    "year": "2009",
    "title": "Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF494",
  "fields": {
    "reference_id": "25602518",
    "type": "PMID",
    "year": "2015",
    "title": "Mutation spectrum of RB1 gene in unilateral retinoblastoma cases from Tunisia and correlations with clinical features."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF495",
  "fields": {
    "reference_id": "24269995",
    "type": "PMID",
    "year": "2014",
    "title": "The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF496",
  "fields": {
    "reference_id": "21311894",
    "type": "PMID",
    "year": "2011",
    "title": "Lynch syndrome in Tunisia: first description of clinical features and germline mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF497",
  "fields": {
    "reference_id": "18443202",
    "type": "PMID",
    "year": "2008",
    "title": "Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF498",
  "fields": {
    "reference_id": "21507922",
    "type": "PMID",
    "year": "2011",
    "title": "Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF499",
  "fields": {
    "reference_id": "26721323",
    "type": "PMID",
    "year": "2016",
    "title": "An Ashkenazi founder mutation in the PKHD1 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF5",
  "fields": {
    "reference_id": "23158458",
    "type": "PMID",
    "year": "2013",
    "title": "Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF50",
  "fields": {
    "reference_id": "28686080",
    "type": "PMID",
    "year": "2017",
    "title": "Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF500",
  "fields": {
    "reference_id": "25406098",
    "type": "PMID",
    "year": "2015",
    "title": "TNFAIP3 and IL12B gene polymorphisms associated with psoriasis vulgaris in an Egyptian cohort."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF501",
  "fields": {
    "reference_id": "29381699",
    "type": "PMID",
    "year": "2018",
    "title": "Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF502",
  "fields": {
    "reference_id": "9835960",
    "type": "PMID",
    "year": "1998",
    "title": "[Dermatophytic disease: exuberant hyperkeratosis with cutaneous horns]."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF503",
  "fields": {
    "reference_id": "2891298",
    "type": "PMID",
    "year": "1987",
    "title": "Globin gene-associated restriction-fragment-length polymorphisms in southern African peoples."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF504",
  "fields": {
    "reference_id": "24898818",
    "type": "PMID",
    "year": "2014",
    "title": "Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF505",
  "fields": {
    "reference_id": "18940309",
    "type": "PMID",
    "year": "2008",
    "title": "Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF506",
  "fields": {
    "reference_id": "15317751",
    "type": "PMID",
    "year": "2004",
    "title": "Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF507",
  "fields": {
    "reference_id": "19939582",
    "type": "PMID",
    "year": "2011",
    "title": "JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF508",
  "fields": {
    "reference_id": "11297590",
    "type": "PMID",
    "year": "2001",
    "title": "Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF509",
  "fields": {
    "reference_id": "11462234",
    "type": "PMID",
    "year": "2001",
    "title": "Novel missense mutations of TMPRSS3 in two consanguineous Tunisian families with non-syndromic autosomal recessive deafness."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF51",
  "fields": {
    "reference_id": "28816644",
    "type": "PMID",
    "year": "2017",
    "title": "CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF510",
  "fields": {
    "reference_id": "27843126",
    "type": "PMID",
    "year": "2016",
    "title": "Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF511",
  "fields": {
    "reference_id": "17486495",
    "type": "PMID",
    "year": "2007",
    "title": "Genotypic correlation between six common beta-thalassemia mutations and the XmnI polymorphism in the Moroccan population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF512",
  "fields": {
    "reference_id": "24894595",
    "type": "PMID",
    "year": "2015",
    "title": "Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF513",
  "fields": {
    "reference_id": "23358556",
    "type": "PMID",
    "year": "2013",
    "title": "Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF514",
  "fields": {
    "reference_id": "24355527",
    "type": "PMID",
    "year": "2014",
    "title": "Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF515",
  "fields": {
    "reference_id": "2393712",
    "type": "PMID",
    "year": "1990",
    "title": "A new mutation at IVS1 nt 2(T----A), in beta-thalassemia from Algeria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF516",
  "fields": {
    "reference_id": "10401000",
    "type": "PMID",
    "year": "1999",
    "title": "Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF517",
  "fields": {
    "reference_id": "2569482",
    "type": "PMID",
    "year": "1989",
    "title": "Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF518",
  "fields": {
    "reference_id": "23108490",
    "type": "PMID",
    "year": "2013",
    "title": "The frequency of spinocerebellar ataxia type 23 in a UK population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF519",
  "fields": {
    "reference_id": "12112081",
    "type": "PMID",
    "year": "2002",
    "title": "A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF52",
  "fields": {
    "reference_id": "21332319",
    "type": "PMID",
    "year": "2011",
    "title": "Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF520",
  "fields": {
    "reference_id": "18850119",
    "type": "PMID",
    "year": "2009",
    "title": "A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF521",
  "fields": {
    "reference_id": "17765244",
    "type": "PMID",
    "year": "2008",
    "title": "Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF522",
  "fields": {
    "reference_id": "26018198",
    "type": "PMID",
    "year": "2016",
    "title": "Adrenal Insufficiency in Mitochondrial Disease: A Rare Case of GFER-Related Mitochondrial Encephalomyopathy and Review of the Literature."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF523",
  "fields": {
    "reference_id": "20691405",
    "type": "PMID",
    "year": "2010",
    "title": "Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF524",
  "fields": {
    "reference_id": "22497971",
    "type": "PMID",
    "year": "2012",
    "title": "Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF525",
  "fields": {
    "reference_id": "9727745",
    "type": "PMID",
    "year": "1998",
    "title": "Familial hypercholesterolemia: potential diagnostic value of mutation screening in a pediatric population of South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF526",
  "fields": {
    "reference_id": "11112389",
    "type": "PMID",
    "year": "2000",
    "title": "A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD \"Rehovot\") in a Jewish Ethiopian family with variable phenotypes."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF527",
  "fields": {
    "reference_id": "9336442",
    "type": "PMID",
    "year": "1997",
    "title": "Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF528",
  "fields": {
    "reference_id": "16534102",
    "type": "PMID",
    "year": "2006",
    "title": "Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF529",
  "fields": {
    "reference_id": "12676897",
    "type": "PMID",
    "year": "2003",
    "title": "Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF53",
  "fields": {
    "reference_id": "15830237",
    "type": "PMID",
    "year": "2005",
    "title": "Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF530",
  "fields": {
    "reference_id": "9338583",
    "type": "PMID",
    "year": "1997",
    "title": "Tay-Sachs disease and HEXA mutations among Moroccan Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF531",
  "fields": {
    "reference_id": "12915478",
    "type": "PMID",
    "year": "2003",
    "title": "Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF532",
  "fields": {
    "reference_id": "2567189",
    "type": "PMID",
    "year": "1989",
    "title": "Molecular basis of Sp alpha I/65 hereditary elliptocytosis in North Africa: insertion of a TTG triplet between codons 147 and 149 in the alpha-spectrin gene from five unrelated families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF533",
  "fields": {
    "reference_id": "23289006",
    "type": "PMID",
    "year": "2013",
    "title": "Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF534",
  "fields": {
    "reference_id": "11743579",
    "type": "PMID",
    "year": "2002",
    "title": "Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF535",
  "fields": {
    "reference_id": "15295099",
    "type": "PMID",
    "year": "2004",
    "title": "Chemical chaperones protect from effects of apoptosis-inducing mutation in carbonic anhydrase IV identified in retinitis pigmentosa 17."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF536",
  "fields": {
    "reference_id": "6668188",
    "type": "PMID",
    "year": "1983",
    "title": "Silent beta-thalassemia associated with Hb Knossos beta 27 (B9) Ala replaced by Ser in Algeria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF537",
  "fields": {
    "reference_id": "22887808",
    "type": "PMID",
    "year": "2012",
    "title": "A novel nonsense CDK5RAP2 mutation in a Somali child with primary microcephaly and sensorineural hearing loss."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF538",
  "fields": {
    "reference_id": "19945510",
    "type": "PMID",
    "year": "2010",
    "title": "Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF539",
  "fields": {
    "reference_id": "25617386",
    "type": "PMID",
    "year": "2015",
    "title": "\u00df-Globin Mutations in Egyptian Patients With \u00df-Thalassemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF54",
  "fields": {
    "reference_id": "26615671",
    "type": "PMID",
    "year": "2015",
    "title": "Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF540",
  "fields": {
    "reference_id": "16085442",
    "type": "PMID",
    "year": "2006",
    "title": "Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF541",
  "fields": {
    "reference_id": "23519070",
    "type": "PMID",
    "year": "2012",
    "title": "Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF542",
  "fields": {
    "reference_id": "3775688",
    "type": "PMID",
    "year": "1986",
    "title": "Homozygous variant of antithrombin III: AT III Fontainebleau."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF543",
  "fields": {
    "reference_id": "21739173",
    "type": "PMID",
    "year": "2012",
    "title": "X-linked adrenal hypoplasia congenita: a novel DAX1 missense mutation and challenges for clinical diagnosis in Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF544",
  "fields": {
    "reference_id": "26691667",
    "type": "PMID",
    "year": "2016",
    "title": "A novel homozygous missense mutation in the insulin receptor gene results in an atypical presentation of Rabson-Mendenhall syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF545",
  "fields": {
    "reference_id": "6268660",
    "type": "PMID",
    "year": "1981",
    "title": "Sickle gene. Its origin and diffusion from West Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF546",
  "fields": {
    "reference_id": "7903269",
    "type": "PMID",
    "year": "1993",
    "title": "South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF547",
  "fields": {
    "reference_id": "20880762",
    "type": "PMID",
    "year": "2010",
    "title": "[R74W,R1070W,D1270N]: a new complex allele responsible for cystic fibrosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF548",
  "fields": {
    "reference_id": "9279329",
    "type": "PMID",
    "year": "1997",
    "title": "Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF549",
  "fields": {
    "reference_id": "19339160",
    "type": "PMID",
    "year": "2009",
    "title": "Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF55",
  "fields": {
    "reference_id": "12811367",
    "type": "PMID",
    "year": "2003",
    "title": "Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF550",
  "fields": {
    "reference_id": "28683740",
    "type": "PMID",
    "year": "2017",
    "title": "Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF551",
  "fields": {
    "reference_id": "20683152",
    "type": "PMID",
    "year": "2010",
    "title": "BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF552",
  "fields": {
    "reference_id": "14734204",
    "type": "PMID",
    "year": "2004",
    "title": "Clinical and molecular aspects of haemoglobinopathies in Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF553",
  "fields": {
    "reference_id": "23246290",
    "type": "PMID",
    "year": "2013",
    "title": "Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF554",
  "fields": {
    "reference_id": "23362846",
    "type": "PMID",
    "year": "2013",
    "title": "Association of single nucleotide polymorphisms in CFH, ARMS2 and HTRA1 genes with risk of age-related macular degeneration in Egyptian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF555",
  "fields": {
    "reference_id": "22266422",
    "type": "PMID",
    "year": "2012",
    "title": "The first mutations in the MYH gene reported in Moroccan colon cancer patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF556",
  "fields": {
    "reference_id": "12707439",
    "type": "PMID",
    "year": "2003",
    "title": "Fukutin-related protein gene mutated in the original kindred limb-girdle MD 2I."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF557",
  "fields": {
    "reference_id": "19241467",
    "type": "PMID",
    "year": "2009",
    "title": "Transglutaminase-1 gene mutations in autosomal recessive congenital ichthyosis: summary of mutations (including 23 novel) and modeling of TGase-1."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF558",
  "fields": {
    "reference_id": "23790189",
    "type": "PMID",
    "year": "2013",
    "title": "Association of IL-10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF559",
  "fields": {
    "reference_id": "1672732",
    "type": "PMID",
    "year": "1991",
    "title": "Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF56",
  "fields": {
    "reference_id": "26513304",
    "type": "PMID",
    "year": "2016",
    "title": "Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modeling."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF560",
  "fields": {
    "reference_id": "24636221",
    "type": "PMID",
    "year": "2015",
    "title": "Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF561",
  "fields": {
    "reference_id": "19542079",
    "type": "PMID",
    "year": "2010",
    "title": "Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF562",
  "fields": {
    "reference_id": "24157263",
    "type": "PMID",
    "year": "2014",
    "title": "Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF563",
  "fields": {
    "reference_id": "26617890",
    "type": "PMID",
    "year": "2015",
    "title": "Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF564",
  "fields": {
    "reference_id": "1351274",
    "type": "PMID",
    "year": "1992",
    "title": "Transmission of spongiform encephalopathy from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF565",
  "fields": {
    "reference_id": "8444470",
    "type": "PMID",
    "year": "1993",
    "title": "An alpha-spectrin mutation responsible for hereditary elliptocytosis associated in cis with the alpha v/41 polymorphism."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF566",
  "fields": {
    "reference_id": "25889455",
    "type": "PMID",
    "year": "2015",
    "title": "TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF567",
  "fields": {
    "reference_id": "17277775",
    "type": "PMID",
    "year": "2007",
    "title": "Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF568",
  "fields": {
    "reference_id": "27956278",
    "type": "PMID",
    "year": "2017",
    "title": "The M694I/M694I genotype: A genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF569",
  "fields": {
    "reference_id": "18317237",
    "type": "PMID",
    "year": "2008",
    "title": "Population and disease-based prevalence of the common mutations associated with surfactant deficiency."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF57",
  "fields": {
    "reference_id": "19710077",
    "type": "PMID",
    "year": "2009",
    "title": "Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF570",
  "fields": {
    "reference_id": "20199544",
    "type": "PMID",
    "year": "2010",
    "title": "Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF571",
  "fields": {
    "reference_id": "18483695",
    "type": "PMID",
    "year": "2008",
    "title": "Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF572",
  "fields": {
    "reference_id": "25259511",
    "type": "PMID",
    "year": "2014",
    "title": "Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF573",
  "fields": {
    "reference_id": "9218625",
    "type": "PMID",
    "year": "1997",
    "title": "Molecular bases of C7 deficiency: three different defects."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF574",
  "fields": {
    "reference_id": "10526198",
    "type": "PMID",
    "year": "1999",
    "title": "Mutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF575",
  "fields": {
    "reference_id": "12384774",
    "type": "PMID",
    "year": "2002",
    "title": "Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF576",
  "fields": {
    "reference_id": "9259198",
    "type": "PMID",
    "year": "1997",
    "title": "Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF577",
  "fields": {
    "reference_id": "3114175",
    "type": "PMID",
    "year": "1987",
    "title": "Hemoglobin Knossos [alpha 2 beta 2(27)(B9)Ala----Ser] in Egypt."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF578",
  "fields": {
    "reference_id": "7772513",
    "type": "PMID",
    "year": "1995",
    "title": "A point mutation in the protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF579",
  "fields": {
    "reference_id": "21056933",
    "type": "PMID",
    "year": "2011",
    "title": "A monozygotic twin pair with highly discordant Gaucher phenotypes."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF58",
  "fields": {
    "reference_id": "17267622",
    "type": "PMID",
    "year": "2007",
    "title": "A novel duplication type of CYP2A6 gene in African-American population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF580",
  "fields": {
    "reference_id": "8529127",
    "type": "PMID",
    "year": "1995",
    "title": "Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF581",
  "fields": {
    "reference_id": "11567215",
    "type": "PMID",
    "year": "2001",
    "title": "Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF582",
  "fields": {
    "reference_id": "1798423",
    "type": "PMID",
    "year": "1991",
    "title": "Genetic and environmental factors determining the development of Creutzfeldt-Jakob disease in Libyan Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF583",
  "fields": {
    "reference_id": "10394929",
    "type": "PMID",
    "year": "1999",
    "title": "The mutation spectrum of the bestrophin protein--functional implications."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF584",
  "fields": {
    "reference_id": "18671187",
    "type": "PMID",
    "year": "2008",
    "title": "Variable cardiac involvement in Tunisian siblings harboring FKRP gene mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF585",
  "fields": {
    "reference_id": "17284928",
    "type": "PMID",
    "year": "2007",
    "title": "A novel missense mutation in CIAS1 encoding the pyrin-like protein, cryopyrin, causes familial cold autoinflammatory syndrome in a family of Ethiopian origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF586",
  "fields": {
    "reference_id": "8530633",
    "type": "PMID",
    "year": "1995",
    "title": "Absence of steroid biosynthetic defects in heterozygote individuals for classic 11 beta-hydroxylase deficiency due to a R448H mutation in the CYP11B1 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF587",
  "fields": {
    "reference_id": "9450866",
    "type": "PMID",
    "year": "1998",
    "title": "Piebaldism with deafness: molecular evidence for an expanded syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF588",
  "fields": {
    "reference_id": "20039086",
    "type": "PMID",
    "year": "2010",
    "title": "Hereditary spastic paraplegia and amyotrophy associated with a novel locus on chromosome 19."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF589",
  "fields": {
    "reference_id": "20113284",
    "type": "PMID",
    "year": "2010",
    "title": "Hemoglobinopathies in North Africa: a review."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF59",
  "fields": {
    "reference_id": "20837591",
    "type": "PMID",
    "year": "2010",
    "title": "Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF590",
  "fields": {
    "reference_id": "10870850",
    "type": "PMID",
    "year": "2000",
    "title": "Homozygous variegate porphyria in South Africa: genotypic analysis in two cases."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF591",
  "fields": {
    "reference_id": "7913755",
    "type": "PMID",
    "year": "1994",
    "title": "Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF592",
  "fields": {
    "reference_id": "10072046",
    "type": "PMID",
    "year": "1999",
    "title": "Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF593",
  "fields": {
    "reference_id": "19332161",
    "type": "PMID",
    "year": "2016",
    "title": "Compound heterozygous ASPM mutations associated with microcephaly and simplified cortical gyration in a consanguineous Algerian family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF594",
  "fields": {
    "reference_id": "22763381",
    "type": "PMID",
    "year": "2013",
    "title": "Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF595",
  "fields": {
    "reference_id": "10422804",
    "type": "PMID",
    "year": "1999",
    "title": "Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF596",
  "fields": {
    "reference_id": "22522442",
    "type": "PMID",
    "year": "2012",
    "title": "A rare recessive distal hereditary motor neuropathy with HSJ1 chaperone mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF597",
  "fields": {
    "reference_id": "19357115",
    "type": "PMID",
    "year": "2009",
    "title": "Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF598",
  "fields": {
    "reference_id": "14616769",
    "type": "PMID",
    "year": "2003",
    "title": "A-61C and C-101G Hp gene promoter polymorphisms are, respectively, associated with ahaptoglobinaemia and hypohaptoglobinaemia in Ghana."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF599",
  "fields": {
    "reference_id": "17433753",
    "type": "PMID",
    "year": "2008",
    "title": "A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF6",
  "fields": {
    "reference_id": "28692529",
    "type": "PMID",
    "year": "2017",
    "title": "CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF60",
  "fields": {
    "reference_id": "19663669",
    "type": "PMID",
    "year": "2009",
    "title": "CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF600",
  "fields": {
    "reference_id": "9153448",
    "type": "PMID",
    "year": "1997",
    "title": "Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF601",
  "fields": {
    "reference_id": "11053687",
    "type": "PMID",
    "year": "2000",
    "title": "Charcot-Marie-Tooth 2-like presentation of an Algerian family with giant axonal neuropathy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF602",
  "fields": {
    "reference_id": "22328824",
    "type": "PMID",
    "year": "2012",
    "title": "Stargardt macular dystrophy: common ABCA4 mutations in South Africa--establishment of a rapid genetic test and relating risk to patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF603",
  "fields": {
    "reference_id": "25633957",
    "type": "PMID",
    "year": "2015",
    "title": "Novel mutations confirm that COL11A2 is responsible for autosomal recessive non-syndromic hearing loss DFNB53."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF604",
  "fields": {
    "reference_id": "21940684",
    "type": "PMID",
    "year": "2012",
    "title": "Novel mutations in the C-terminal region of the MECP2 gene in Tunisian Rett syndrome patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF605",
  "fields": {
    "reference_id": "20721913",
    "type": "PMID",
    "year": "2010",
    "title": "Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF606",
  "fields": {
    "reference_id": "9298746",
    "type": "PMID",
    "year": "1997",
    "title": "GAPO syndrome: first Egyptian case with ultrastructural changes in the gingiva."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF607",
  "fields": {
    "reference_id": "1679439",
    "type": "PMID",
    "year": "1991",
    "title": "Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF608",
  "fields": {
    "reference_id": "12559847",
    "type": "PMID",
    "year": "2003",
    "title": "The AGT gene in Africa: a distinctive minor allele haplotype, a polymorphism (V326I), and a novel PH1 mutation (A112D) in Black Africans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF609",
  "fields": {
    "reference_id": "25330418",
    "type": "PMID",
    "year": "2014",
    "title": "Disease penetrance of late-onset parkinsonism: a meta-analysis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF61",
  "fields": {
    "reference_id": "26831894",
    "type": "PMID",
    "year": "2016",
    "title": "Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF610",
  "fields": {
    "reference_id": "15366237",
    "type": "PMID",
    "year": "2004",
    "title": "[Creutzfeldt-Jakob encephalopathy with mutation E200K. Report of a \"sporadic\" case]."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF611",
  "fields": {
    "reference_id": "11992256",
    "type": "PMID",
    "year": "2002",
    "title": "New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF612",
  "fields": {
    "reference_id": "24369383",
    "type": "PMID",
    "year": "2014",
    "title": "Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF613",
  "fields": {
    "reference_id": "21848462",
    "type": "PMID",
    "year": "2011",
    "title": "Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF614",
  "fields": {
    "reference_id": "23146719",
    "type": "PMID",
    "year": "2013",
    "title": "Analysis of the genetic variants of glucose-6-phosphate dehydrogenase in inhabitants of the 4th Nile cataract region in Sudan."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF615",
  "fields": {
    "reference_id": "20082991",
    "type": "PMID",
    "year": "2009",
    "title": "Clinical features of LRRK2 parkinsonism."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF616",
  "fields": {
    "reference_id": "24862656",
    "type": "PMID",
    "year": "2014",
    "title": "MEFV mutations in Egyptian children with systemic-onset juvenile idiopathic arthritis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF617",
  "fields": {
    "reference_id": "20304616",
    "type": "PMID",
    "year": "2011",
    "title": "The G3057A LEPR polymorphism is associated with obesity in Tunisian women."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF618",
  "fields": {
    "reference_id": "20083419",
    "type": "PMID",
    "year": "2010",
    "title": "The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF619",
  "fields": {
    "reference_id": "23746546",
    "type": "PMID",
    "year": "2013",
    "title": "Mutations in RAB28, encoding a farnesylated small GTPase, are associated with autosomal-recessive cone-rod dystrophy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF62",
  "fields": {
    "reference_id": "29580174",
    "type": "PMID",
    "year": "2018",
    "title": "Effect of hydrochlorothiazide on serum uric acid concentration: a genome-wide association study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF620",
  "fields": {
    "reference_id": "3422218",
    "type": "PMID",
    "year": "1988",
    "title": "The peculiar spectrum of beta-thalassemia genes in Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF621",
  "fields": {
    "reference_id": "6469698",
    "type": "PMID",
    "year": "1984",
    "title": "Two new cases of heterozygosity for hemoglobin Knossos alpha 2 beta 2 27 Ala----Ser detected in the French West Indies and Algeria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF622",
  "fields": {
    "reference_id": "18461161",
    "type": "PMID",
    "year": "2008",
    "title": "Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF623",
  "fields": {
    "reference_id": "24185611",
    "type": "PMID",
    "year": "2014",
    "title": "A genome-wide association study of prostate cancer in West African men."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF624",
  "fields": {
    "reference_id": "25091951",
    "type": "PMID",
    "year": "2014",
    "title": "Novel ADAM9 homozygous mutation in a consanguineous Egyptian family with severe cone-rod dystrophy and cataract."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF625",
  "fields": {
    "reference_id": "26626202",
    "type": "PMID",
    "year": "2016",
    "title": "Functional polymorphisms of Monocyte Chemoattractant Protein-1 gene and Pott's disease risk."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF626",
  "fields": {
    "reference_id": "1376298",
    "type": "PMID",
    "year": "1992",
    "title": "A novel sickle cell mutation of yet another origin in Africa: the Cameroon type."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF627",
  "fields": {
    "reference_id": "22056842",
    "type": "PMID",
    "year": "2012",
    "title": "Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF628",
  "fields": {
    "reference_id": "26700404",
    "type": "PMID",
    "year": "2016",
    "title": "Association of genetic variants in the FTO gene with metabolic syndrome: A case-control study in the Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF629",
  "fields": {
    "reference_id": "14999562",
    "type": "PMID",
    "year": "2004",
    "title": "A novel I247T missense mutation in the haptoglobin 2 beta-chain decreases the expression of the protein and is associated with ahaptoglobinemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF63",
  "fields": {
    "reference_id": "28481785",
    "type": "PMID",
    "year": "2017",
    "title": "Brief Report: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in Botswana."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF630",
  "fields": {
    "reference_id": "2389793",
    "type": "PMID",
    "year": "1990",
    "title": "Beukes familial hip dysplasia: an autosomal dominant entity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF631",
  "fields": {
    "reference_id": "18098276",
    "type": "PMID",
    "year": "2008",
    "title": "Spastic paraplegia 15: linkage and clinical description of three Tunisian families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF632",
  "fields": {
    "reference_id": "19442771",
    "type": "PMID",
    "year": "2009",
    "title": "DYNC2H1 mutations cause asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type III."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF633",
  "fields": {
    "reference_id": "25750861",
    "type": "PMID",
    "year": "2015",
    "title": "Mutation analysis of methylmalonyl CoA mutase gene exon 2 in Egyptian families: Identification of 25 novel allelic variants."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF634",
  "fields": {
    "reference_id": "22089644",
    "type": "PMID",
    "year": "2012",
    "title": "Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF635",
  "fields": {
    "reference_id": "17945526",
    "type": "PMID",
    "year": "2008",
    "title": "Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF636",
  "fields": {
    "reference_id": "11968090",
    "type": "PMID",
    "year": "2002",
    "title": "Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF637",
  "fields": {
    "reference_id": "19418241",
    "type": "PMID",
    "year": "2009",
    "title": "Negative screening tests in classical galactosaemia caused by S135L homozygosity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF638",
  "fields": {
    "reference_id": "20101775",
    "type": "PMID",
    "year": "2010",
    "title": "Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF639",
  "fields": {
    "reference_id": "21623199",
    "type": "PMID",
    "year": "2011",
    "title": "Screening for NLRP7 mutations in familial and sporadic recurrent hydatidiform moles: report of 2 Tunisian families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF64",
  "fields": {
    "reference_id": "26779253",
    "type": "PMID",
    "year": "2015",
    "title": "An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF640",
  "fields": {
    "reference_id": "24698316",
    "type": "PMID",
    "year": "2014",
    "title": "Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF641",
  "fields": {
    "reference_id": "23838597",
    "type": "PMID",
    "year": "2014",
    "title": "Autosomal dominant SCA5 and autosomal recessive infantile SCA are allelic conditions resulting from SPTBN2 mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF642",
  "fields": {
    "reference_id": "19182162",
    "type": "PMID",
    "year": "2009",
    "title": "Multiple congenital anomalies/mental retardation syndrome with multiple circumferential skin creases: a new syndrome?"
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF643",
  "fields": {
    "reference_id": "23207808",
    "type": "PMID",
    "year": "2013",
    "title": "High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF644",
  "fields": {
    "reference_id": "11402400",
    "type": "PMID",
    "year": "2001",
    "title": "A common ancestral origin of the frequent and widespread 2299delG USH2A mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF645",
  "fields": {
    "reference_id": "20525945",
    "type": "PMID",
    "year": "2011",
    "title": "Molecular-clinical correlation in a family with a novel heteroplasmic Leigh syndrome missense mutation in the mitochondrial cytochrome c oxidase III gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF646",
  "fields": {
    "reference_id": "26519441",
    "type": "PMID",
    "year": "2016",
    "title": "Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF647",
  "fields": {
    "reference_id": "3021139",
    "type": "PMID",
    "year": "1986",
    "title": "Beta thalassemia due to a novel mutation in IVS 1 sequence donor site consensus sequence creating a restriction site."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF648",
  "fields": {
    "reference_id": "9012407",
    "type": "PMID",
    "year": "1997",
    "title": "Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF649",
  "fields": {
    "reference_id": "14652796",
    "type": "PMID",
    "year": "2004",
    "title": "New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF65",
  "fields": {
    "reference_id": "12152006",
    "type": "PMID",
    "year": "2002",
    "title": "Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF650",
  "fields": {
    "reference_id": "20668430",
    "type": "PMID",
    "year": "2010",
    "title": "A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF651",
  "fields": {
    "reference_id": "23013406",
    "type": "PMID",
    "year": "2013",
    "title": "Genome-wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF652",
  "fields": {
    "reference_id": "9192783",
    "type": "PMID",
    "year": "1997",
    "title": "Spectrin St Claude, a splicing mutation of the human alpha-spectrin gene associated with severe poikilocytic anemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF653",
  "fields": {
    "reference_id": "26788538",
    "type": "PMID",
    "year": "2016",
    "title": "Allelic variants of the Melanocortin 4 receptor (MC4R) gene in a South African study group."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF654",
  "fields": {
    "reference_id": "21833526",
    "type": "PMID",
    "year": "2012",
    "title": "A Tunisian case-control association study of a 6q polymorphism in rheumatoid arthritis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF655",
  "fields": {
    "reference_id": "7663524",
    "type": "PMID",
    "year": "1995",
    "title": "Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF656",
  "fields": {
    "reference_id": "12325020",
    "type": "PMID",
    "year": "2002",
    "title": "Novel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF657",
  "fields": {
    "reference_id": "11030413",
    "type": "PMID",
    "year": "2000",
    "title": "Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF658",
  "fields": {
    "reference_id": "23430903",
    "type": "PMID",
    "year": "2012",
    "title": "Deficiency of Subunit 6 of the Conserved Oligomeric Golgi Complex (COG6-CDG): Second Patient, Different Phenotype."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF659",
  "fields": {
    "reference_id": "12850492",
    "type": "PMID",
    "year": "2019",
    "title": "The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF66",
  "fields": {
    "reference_id": "16220110",
    "type": "PMID",
    "year": "2005",
    "title": "CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF660",
  "fields": {
    "reference_id": "12107443",
    "type": "PMID",
    "year": "2002",
    "title": "Allelic and locus heterogeneity in autosomal recessive gelatinous drop-like corneal dystrophy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF661",
  "fields": {
    "reference_id": "26358778",
    "type": "PMID",
    "year": "2015",
    "title": "CDC174, a novel component of the exon junction complex whose mutation underlies a syndrome of hypotonia and psychomotor developmental delay."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF662",
  "fields": {
    "reference_id": "25337068",
    "type": "PMID",
    "year": "2014",
    "title": "Clinical and Molecular Findings of Tunisian Patients with RASopathies."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF663",
  "fields": {
    "reference_id": "8817334",
    "type": "PMID",
    "year": "1996",
    "title": "Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF664",
  "fields": {
    "reference_id": "19412725",
    "type": "PMID",
    "year": "2009",
    "title": "The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF665",
  "fields": {
    "reference_id": "20413974",
    "type": "PMID",
    "year": "2010",
    "title": "LRRK2 G2019S in the North African population: a review."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF666",
  "fields": {
    "reference_id": "21517828",
    "type": "PMID",
    "year": "2012",
    "title": "Clinical and molecular findings of 13 families from Saudi Arabia and a family from Sudan with homocystinuria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF667",
  "fields": {
    "reference_id": "19054016",
    "type": "PMID",
    "year": "2009",
    "title": "Homozygous NLRP7 mutations in a Moroccan woman with recurrent reproductive failure."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF668",
  "fields": {
    "reference_id": "17287630",
    "type": "PMID",
    "year": "2007",
    "title": "Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF669",
  "fields": {
    "reference_id": "17252003",
    "type": "PMID",
    "year": "2007",
    "title": "Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF67",
  "fields": {
    "reference_id": "29259946",
    "type": "PMID",
    "year": "2017",
    "title": "Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF670",
  "fields": {
    "reference_id": "17376234",
    "type": "PMID",
    "year": "2007",
    "title": "Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF671",
  "fields": {
    "reference_id": "24319291",
    "type": "PMID",
    "year": "2014",
    "title": "KIF1C mutations in two families with hereditary spastic paraparesis and cerebellar dysfunction."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF672",
  "fields": {
    "reference_id": "21910705",
    "type": "PMID",
    "year": "2012",
    "title": "Extended haplotype studies in South African and Dutch variegate porphyria families carrying the recurrent p.R59W mutation confirm a common ancestry."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF673",
  "fields": {
    "reference_id": "19327736",
    "type": "PMID",
    "year": "2009",
    "title": "TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF674",
  "fields": {
    "reference_id": "21229382",
    "type": "PMID",
    "year": "2011",
    "title": "Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF675",
  "fields": {
    "reference_id": "3995789",
    "type": "PMID",
    "year": "1985",
    "title": "On the paradoxically high relative prevalence of osteogenesis imperfecta type III in the black population of South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF676",
  "fields": {
    "reference_id": "2564729",
    "type": "PMID",
    "year": "1989",
    "title": "Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF677",
  "fields": {
    "reference_id": "19440220",
    "type": "PMID",
    "year": "2009",
    "title": "A missense mutation in TGM5 causes acral peeling skin syndrome in a Tunisian family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF678",
  "fields": {
    "reference_id": "17470138",
    "type": "PMID",
    "year": "2007",
    "title": "Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF679",
  "fields": {
    "reference_id": "26806765",
    "type": "PMID",
    "year": "2016",
    "title": "Unusual presentations in patients with E200K familial Creutzfeldt-Jakob disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF68",
  "fields": {
    "reference_id": "21206424",
    "type": "PMID",
    "year": "2011",
    "title": "Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF680",
  "fields": {
    "reference_id": "14614227",
    "type": "PMID",
    "year": "2003",
    "title": "PROP-1 gene mutation (R120C) causing combined pituitary hormone deficiencies with variable clinical course in eight siblings of one Jewish Moroccan family."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF681",
  "fields": {
    "reference_id": "18976160",
    "type": "PMID",
    "year": "2008",
    "title": "Molecular basis of beta-thalassemia in Morocco: possible origins of the molecular heterogeneity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF682",
  "fields": {
    "reference_id": "9529363",
    "type": "PMID",
    "year": "1998",
    "title": "Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF683",
  "fields": {
    "reference_id": "18073304",
    "type": "PMID",
    "year": "2008",
    "title": "The leucine-rich repeat-containing G protein-coupled receptor 8 gene T222P mutation does not cause cryptorchidism."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF684",
  "fields": {
    "reference_id": "8014582",
    "type": "PMID",
    "year": "1994",
    "title": "Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF685",
  "fields": {
    "reference_id": "28480960",
    "type": "PMID",
    "year": "2017",
    "title": "ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF686",
  "fields": {
    "reference_id": "19880068",
    "type": "PMID",
    "year": "2009",
    "title": "Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF687",
  "fields": {
    "reference_id": "26915939",
    "type": "PMID",
    "year": "2016",
    "title": "Breast cancer in high-risk Afrikaner families: Is BRCA founder mutation testing sufficient?"
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF688",
  "fields": {
    "reference_id": "9861406",
    "type": "PMID",
    "year": "2019",
    "title": "Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF689",
  "fields": {
    "reference_id": "26746433",
    "type": "PMID",
    "year": "2016",
    "title": "Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF69",
  "fields": {
    "reference_id": "27426203",
    "type": "PMID",
    "year": "2016",
    "title": "Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF690",
  "fields": {
    "reference_id": "26626498",
    "type": "PMID",
    "year": "2016",
    "title": "Refining the phenotype associated with CASC5 mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF691",
  "fields": {
    "reference_id": "21955071",
    "type": "PMID",
    "year": "2012",
    "title": "Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF692",
  "fields": {
    "reference_id": "8105686",
    "type": "PMID",
    "year": "1993",
    "title": "High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF693",
  "fields": {
    "reference_id": "20593214",
    "type": "PMID",
    "year": "2010",
    "title": "A new locus (SPG46) maps to 9p21.2-q21.12 in a Tunisian family with a complicated autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF694",
  "fields": {
    "reference_id": "26864382",
    "type": "PMID",
    "year": "2016",
    "title": "Identification of a founder BRCA1 mutation in the Moroccan population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF695",
  "fields": {
    "reference_id": "21783258",
    "type": "PMID",
    "year": "2012",
    "title": "Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF696",
  "fields": {
    "reference_id": "10210316",
    "type": "PMID",
    "year": "1999",
    "title": "A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF697",
  "fields": {
    "reference_id": "12730724",
    "type": "PMID",
    "year": "2003",
    "title": "Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF698",
  "fields": {
    "reference_id": "20431720",
    "type": "PMID",
    "year": "2010",
    "title": "Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF699",
  "fields": {
    "reference_id": "28739549",
    "type": "PMID",
    "year": "2017",
    "title": "Mutations in the ABCG8 gene are associated with sitosterolaemia in the homozygous form and xanthelasmas in the heterozygous form."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF7",
  "fields": {
    "reference_id": "18466099",
    "type": "PMID",
    "year": "2008",
    "title": "Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF70",
  "fields": {
    "reference_id": "18057928",
    "type": "PMID",
    "year": "2008",
    "title": "High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF700",
  "fields": {
    "reference_id": "25798947",
    "type": "PMID",
    "year": "2015",
    "title": "Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF701",
  "fields": {
    "reference_id": "15327549",
    "type": "PMID",
    "year": "2004",
    "title": "Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF702",
  "fields": {
    "reference_id": "22939635",
    "type": "PMID",
    "year": "2012",
    "title": "Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF703",
  "fields": {
    "reference_id": "26997744",
    "type": "PMID",
    "year": "2016",
    "title": "Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF704",
  "fields": {
    "reference_id": "15954104",
    "type": "PMID",
    "year": "2005",
    "title": "Mutation analysis of the GJB2 (connexin 26) gene in Egypt."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF705",
  "fields": {
    "reference_id": "12524354",
    "type": "PMID",
    "year": "2002",
    "title": "Nucleotide variability at G6pd and the signature of malarial selection in humans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF706",
  "fields": {
    "reference_id": "20463673",
    "type": "PMID",
    "year": "2010",
    "title": "Founder mutations in xeroderma pigmentosum."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF707",
  "fields": {
    "reference_id": "26167078",
    "type": "PMID",
    "year": "2015",
    "title": "NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF708",
  "fields": {
    "reference_id": "12722177",
    "type": "PMID",
    "year": "2003",
    "title": "Phenotypic presentation of frontotemporal dementia with Parkinsonism-chromosome 17 type P301S in a patient of Jewish-Algerian origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF709",
  "fields": {
    "reference_id": "15059726",
    "type": "PMID",
    "year": "2004",
    "title": "An unusual clinical phenotype of Avellino corneal dystrophy associated with an Arg124His beta iG-H3 mutation in an African-American woman."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF71",
  "fields": {
    "reference_id": "29315502",
    "type": "PMID",
    "year": "2018",
    "title": "A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF710",
  "fields": {
    "reference_id": "8105682",
    "type": "PMID",
    "year": "1993",
    "title": "Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF711",
  "fields": {
    "reference_id": "8968760",
    "type": "PMID",
    "year": "1996",
    "title": "Ataxia-telangiectasia: founder effect among north African Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF712",
  "fields": {
    "reference_id": "2898142",
    "type": "PMID",
    "year": "1988",
    "title": "Structural analysis of the 5' flanking region of the beta-globin gene in African sickle cell anemia patients: further evidence for three origins of the sickle cell mutation in Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF713",
  "fields": {
    "reference_id": "24447396",
    "type": "PMID",
    "year": "2014",
    "title": "Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF714",
  "fields": {
    "reference_id": "26544806",
    "type": "PMID",
    "year": "2015",
    "title": "Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF715",
  "fields": {
    "reference_id": "28062682",
    "type": "PMID",
    "year": "2017",
    "title": "Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF716",
  "fields": {
    "reference_id": "24598713",
    "type": "PMID",
    "year": "2014",
    "title": "Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF717",
  "fields": {
    "reference_id": "26243156",
    "type": "PMID",
    "year": "2015",
    "title": "Functional and Structural Impact of ATP-Binding Cassette Transporter A1 R219K and I883M Gene Polymorphisms in Obese Children and Adolescents."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF718",
  "fields": {
    "reference_id": "17596714",
    "type": "PMID",
    "year": "2007",
    "title": "Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF719",
  "fields": {
    "reference_id": "23420653",
    "type": "PMID",
    "year": "2014",
    "title": "Elevated serum creatine kinase and small cerebellum prompt diagnosis of congenital muscular dystrophy due to FKRP mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF72",
  "fields": {
    "reference_id": "25676789",
    "type": "PMID",
    "year": "2015",
    "title": "Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF720",
  "fields": {
    "reference_id": "7049883",
    "type": "PMID",
    "year": "1982",
    "title": "Clinical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF721",
  "fields": {
    "reference_id": "15025720",
    "type": "PMID",
    "year": "2004",
    "title": "Novel CFTR mutations in black cystic fibrosis patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF722",
  "fields": {
    "reference_id": "28388302",
    "type": "PMID",
    "year": "2017",
    "title": "Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF723",
  "fields": {
    "reference_id": "11254458",
    "type": "PMID",
    "year": "2001",
    "title": "Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF724",
  "fields": {
    "reference_id": "12668616",
    "type": "PMID",
    "year": "2003",
    "title": "Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF725",
  "fields": {
    "reference_id": "2022736",
    "type": "PMID",
    "year": "1991",
    "title": "A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF726",
  "fields": {
    "reference_id": "22739995",
    "type": "PMID",
    "year": "2012",
    "title": "Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF727",
  "fields": {
    "reference_id": "19786003",
    "type": "PMID",
    "year": "2010",
    "title": "Mutation analysis of phenylketonuria patients from Morocco: high prevalence of mutation G352fsdelG and detection of a novel mutation p.K85X."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF728",
  "fields": {
    "reference_id": "9886305",
    "type": "PMID",
    "year": "1998",
    "title": "A new sickle cell disease phenotype associating Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an alpha2 globin gene variant (Hb Conakry)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF729",
  "fields": {
    "reference_id": "19017867",
    "type": "PMID",
    "year": "2009",
    "title": "Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF73",
  "fields": {
    "reference_id": "23353631",
    "type": "PMID",
    "year": "2013",
    "title": "Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF730",
  "fields": {
    "reference_id": "22180149",
    "type": "PMID",
    "year": "2017",
    "title": "Homozygous mutation in MERTK causes severe autosomal recessive retinitis pigmentosa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF731",
  "fields": {
    "reference_id": "27754803",
    "type": "PMID",
    "year": "2017",
    "title": "Familial Multiplicity of Estrogen Insensitivity Associated With a Loss-of-Function ESR1 Mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF732",
  "fields": {
    "reference_id": "12509511",
    "type": "PMID",
    "year": "2003",
    "title": "Natural selection shaped regional mtDNA variation in humans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF733",
  "fields": {
    "reference_id": "8290408",
    "type": "PMID",
    "year": "1993",
    "title": "Homozygous variegate porphyria: an evolving clinical syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF734",
  "fields": {
    "reference_id": "28155230",
    "type": "PMID",
    "year": "2017",
    "title": "Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to data sharing of whole exome sequencing data."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF735",
  "fields": {
    "reference_id": "10570183",
    "type": "PMID",
    "year": "1999",
    "title": "Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF736",
  "fields": {
    "reference_id": "23857908",
    "type": "PMID",
    "year": "2013",
    "title": "Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF737",
  "fields": {
    "reference_id": "20631224",
    "type": "PMID",
    "year": "2010",
    "title": "Mutational analysis of the MECP2 gene in Tunisian patients with Rett syndrome: a novel double mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF738",
  "fields": {
    "reference_id": "26383609",
    "type": "PMID",
    "year": "2015",
    "title": "AGXT Gene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF739",
  "fields": {
    "reference_id": "8225311",
    "type": "PMID",
    "year": "1993",
    "title": "Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF74",
  "fields": {
    "reference_id": "25712185",
    "type": "PMID",
    "year": "2015",
    "title": "Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF740",
  "fields": {
    "reference_id": "24059590",
    "type": "PMID",
    "year": "2013",
    "title": "The TCF7L2 rs7903146 (T) allele is associated with type 2 diabetes in urban Ghana: a hospital-based case-control study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF741",
  "fields": {
    "reference_id": "23049979",
    "type": "PMID",
    "year": "2012",
    "title": "Fc ? receptor IIIB (Fc?RIIIB) polymorphisms are associated with clinical malaria in Ghanaian children."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF742",
  "fields": {
    "reference_id": "22425665",
    "type": "PMID",
    "year": "2012",
    "title": "BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF743",
  "fields": {
    "reference_id": "15883926",
    "type": "PMID",
    "year": "2005",
    "title": "Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF744",
  "fields": {
    "reference_id": "12687498",
    "type": "PMID",
    "year": "2003",
    "title": "Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF745",
  "fields": {
    "reference_id": "26917049",
    "type": "PMID",
    "year": "2016",
    "title": "Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF746",
  "fields": {
    "reference_id": "24312262",
    "type": "PMID",
    "year": "2013",
    "title": "Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF747",
  "fields": {
    "reference_id": "10234513",
    "type": "PMID",
    "year": "1999",
    "title": "A novel locus for Usher syndrome type II, USH2B, maps to chromosome 3 at p23-24.2."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF748",
  "fields": {
    "reference_id": "9471561",
    "type": "PMID",
    "year": "1998",
    "title": "Connexin 26 R143W mutation associated with recessive nonsyndromic sensorineural deafness in Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF749",
  "fields": {
    "reference_id": "8883260",
    "type": "PMID",
    "year": "1996",
    "title": "Ala244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF75",
  "fields": {
    "reference_id": "17517247",
    "type": "PMID",
    "year": "2007",
    "title": "The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF750",
  "fields": {
    "reference_id": "26068213",
    "type": "PMID",
    "year": "2015",
    "title": "Molecular and clinical study of a cohort of 110 Algerian patients with autosomal recessive ataxia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF751",
  "fields": {
    "reference_id": "19754354",
    "type": "PMID",
    "year": "2009",
    "title": "Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF752",
  "fields": {
    "reference_id": "11439000",
    "type": "PMID",
    "year": "2001",
    "title": "Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF753",
  "fields": {
    "reference_id": "20732827",
    "type": "PMID",
    "year": "2015",
    "title": "Glutaric aciduria type 1 in South Africa-high incidence of glutaryl-CoA dehydrogenase deficiency in black South Africans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF754",
  "fields": {
    "reference_id": "26996948",
    "type": "PMID",
    "year": "2016",
    "title": "Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF755",
  "fields": {
    "reference_id": "23609612",
    "type": "PMID",
    "year": "2013",
    "title": "Patterns of nucleotide and haplotype diversity at ICAM-1 across global human populations with varying levels of malaria exposure."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF756",
  "fields": {
    "reference_id": "29025994",
    "type": "PMID",
    "year": "2017",
    "title": "Loci associated with skin pigmentation identified in African populations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF757",
  "fields": {
    "reference_id": "16399879",
    "type": "PMID",
    "year": "2006",
    "title": "Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF758",
  "fields": {
    "reference_id": "16544999",
    "type": "PMID",
    "year": "2006",
    "title": "Screening of Nijmegen breakage syndrome 1 mutations in four unrelated families by polymerase chain reaction using sequence-specific primers."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF759",
  "fields": {
    "reference_id": "18539535",
    "type": "PMID",
    "year": "2008",
    "title": "LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF76",
  "fields": {
    "reference_id": "16415111",
    "type": "PMID",
    "year": "2006",
    "title": "CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF760",
  "fields": {
    "reference_id": "27043015",
    "type": "PMID",
    "year": "2016",
    "title": "Association of MicroRNA-196a2 Variant with Response to Short-Acting \u00df2-Agonist in COPD: An Egyptian Pilot Study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF761",
  "fields": {
    "reference_id": "24012869",
    "type": "PMID",
    "year": "2013",
    "title": "A double mutation in AGXT gene in families with primary hyperoxaluria type 1."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF762",
  "fields": {
    "reference_id": "22052668",
    "type": "PMID",
    "year": "2012",
    "title": "Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF763",
  "fields": {
    "reference_id": "19757147",
    "type": "PMID",
    "year": "2009",
    "title": "High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF764",
  "fields": {
    "reference_id": "8530604",
    "type": "PMID",
    "year": "1995",
    "title": "A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency--a clinical research center study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF765",
  "fields": {
    "reference_id": "23423671",
    "type": "PMID",
    "year": "2013",
    "title": "Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF766",
  "fields": {
    "reference_id": "15106124",
    "type": "PMID",
    "year": "2004",
    "title": "The T allele of a single-nucleotide polymorphism 13.9 kb upstream of the lactase gene (LCT) (C-13.9kbT) does not predict or cause the lactase-persistence phenotype in Africans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF767",
  "fields": {
    "reference_id": "17020472",
    "type": "PMID",
    "year": "2006",
    "title": "The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF768",
  "fields": {
    "reference_id": "25165692",
    "type": "PMID",
    "year": "2014",
    "title": "Evidence for association of the E23K variant of KCNJ11 gene with type 2 diabetes in Tunisian population: population-based study and meta-analysis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF769",
  "fields": {
    "reference_id": "17476472",
    "type": "PMID",
    "year": "2007",
    "title": "TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF77",
  "fields": {
    "reference_id": "20881953",
    "type": "PMID",
    "year": "2010",
    "title": "Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF770",
  "fields": {
    "reference_id": "19654085",
    "type": "PMID",
    "year": "2009",
    "title": "[Biochemical and molecular diagnosis of alpha 1 antitrypsin deficiency in a Tunisian family]."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF771",
  "fields": {
    "reference_id": "18657335",
    "type": "PMID",
    "year": "2008",
    "title": "Effect of ENPP1/PC-1-K121Q and PPARgamma-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF772",
  "fields": {
    "reference_id": "1867200",
    "type": "PMID",
    "year": "1991",
    "title": "A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF773",
  "fields": {
    "reference_id": "24552312",
    "type": "PMID",
    "year": "2014",
    "title": "Carrier frequency of the c.525delT mutation in the SGCG gene and estimated prevalence of limb girdle muscular dystrophy type 2C among the Moroccan population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF774",
  "fields": {
    "reference_id": "12442284",
    "type": "PMID",
    "year": "2002",
    "title": "Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF775",
  "fields": {
    "reference_id": "22158424",
    "type": "PMID",
    "year": "2012",
    "title": "CAPN3 mRNA processing alteration caused by splicing mutation associated with novel genomic rearrangement of Alu elements."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF776",
  "fields": {
    "reference_id": "21532487",
    "type": "PMID",
    "year": "2011",
    "title": "Detection of a frequent duplicated CYP21A2 gene carrying a Q318X mutation in a general population with quantitative PCR methods."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF777",
  "fields": {
    "reference_id": "26934379",
    "type": "PMID",
    "year": "2016",
    "title": "Homozygous nonsense mutation in SGCA is a common cause of limb-girdle muscular dystrophy in Assiut, Egypt."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF778",
  "fields": {
    "reference_id": "26076679",
    "type": "PMID",
    "year": "2015",
    "title": "IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF779",
  "fields": {
    "reference_id": "20470430",
    "type": "PMID",
    "year": "2010",
    "title": "Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF78",
  "fields": {
    "reference_id": "26902539",
    "type": "PMID",
    "year": "2017",
    "title": "The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF780",
  "fields": {
    "reference_id": "16924012",
    "type": "PMID",
    "year": "2006",
    "title": "Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF781",
  "fields": {
    "reference_id": "19465909",
    "type": "PMID",
    "year": "2009",
    "title": "Genome-wide and fine-resolution association analysis of malaria in West Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF782",
  "fields": {
    "reference_id": "26006263",
    "type": "PMID",
    "year": "2016",
    "title": "Recent Positive Selection Drives the Expansion of a Schizophrenia Risk Nonsynonymous Variant at SLC39A8 in Europeans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF783",
  "fields": {
    "reference_id": "23107108",
    "type": "PMID",
    "year": "2012",
    "title": "Lack of association between genetic polymorphisms within KCNQ1 locus and type 2 diabetes in Tunisian Arabs."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF784",
  "fields": {
    "reference_id": "8504303",
    "type": "PMID",
    "year": "1993",
    "title": "Fucosidosis: four new mutations and a new polymorphism."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF785",
  "fields": {
    "reference_id": "22744763",
    "type": "PMID",
    "year": "2012",
    "title": "High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF786",
  "fields": {
    "reference_id": "1952806",
    "type": "PMID",
    "year": "1991",
    "title": "The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF787",
  "fields": {
    "reference_id": "17881276",
    "type": "PMID",
    "year": "2008",
    "title": "An analysis of genetic studies of Parkinson's disease in Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF788",
  "fields": {
    "reference_id": "18332254",
    "type": "PMID",
    "year": "2008",
    "title": "Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF789",
  "fields": {
    "reference_id": "15841483",
    "type": "PMID",
    "year": "2005",
    "title": "Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF79",
  "fields": {
    "reference_id": "26892777",
    "type": "PMID",
    "year": "2016",
    "title": "Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF790",
  "fields": {
    "reference_id": "15525557",
    "type": "PMID",
    "year": "2004",
    "title": "The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF791",
  "fields": {
    "reference_id": "19250854",
    "type": "PMID",
    "year": "2009",
    "title": "PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF792",
  "fields": {
    "reference_id": "23754960",
    "type": "PMID",
    "year": "2013",
    "title": "Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF793",
  "fields": {
    "reference_id": "22991222",
    "type": "PMID",
    "year": "2012",
    "title": "An inherited LMNA gene mutation in atypical Progeria syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF794",
  "fields": {
    "reference_id": "19715466",
    "type": "PMID",
    "year": "2009",
    "title": "Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF795",
  "fields": {
    "reference_id": "12491487",
    "type": "PMID",
    "year": "2003",
    "title": "Breast cancer genetics in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF796",
  "fields": {
    "reference_id": "897853",
    "type": "PMID",
    "year": "1977",
    "title": "Progressive familial heart block--two types."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF797",
  "fields": {
    "reference_id": "17440812",
    "type": "PMID",
    "year": "2007",
    "title": "LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF798",
  "fields": {
    "reference_id": "15657175",
    "type": "PMID",
    "year": "2005",
    "title": "A common Fanconi anemia mutation in black populations of sub-Saharan Africa."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF799",
  "fields": {
    "reference_id": "23192621",
    "type": "PMID",
    "year": "2013",
    "title": "Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF8",
  "fields": {
    "reference_id": "25974723",
    "type": "PMID",
    "year": "2015",
    "title": "Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF80",
  "fields": {
    "reference_id": "19119263",
    "type": "PMID",
    "year": "2009",
    "title": "G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF800",
  "fields": {
    "reference_id": "27245532",
    "type": "PMID",
    "year": "2016",
    "title": "Bardet Biedl syndrome in South Africa: A single founder mutation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF801",
  "fields": {
    "reference_id": "11477083",
    "type": "PMID",
    "year": "2001",
    "title": "Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF802",
  "fields": {
    "reference_id": "20004764",
    "type": "PMID",
    "year": "2009",
    "title": "Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF803",
  "fields": {
    "reference_id": "10196714",
    "type": "PMID",
    "year": "2004",
    "title": "Haplotypes and mutations of the PAH locus in Egyptian families with PKU."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF804",
  "fields": {
    "reference_id": "17324573",
    "type": "PMID",
    "year": "2007",
    "title": "Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF805",
  "fields": {
    "reference_id": "20128824",
    "type": "PMID",
    "year": "2010",
    "title": "Two missense mutations in SLC26A4 gene: a molecular and functional study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF806",
  "fields": {
    "reference_id": "25682733",
    "type": "PMID",
    "year": "2015",
    "title": "Replication of the association of GLT6D1 with aggressive periodontitis in a Sudanese population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF807",
  "fields": {
    "reference_id": "27440999",
    "type": "PMID",
    "year": "2016",
    "title": "Genetic analysis of Tunisian families with Usher syndrome type 1: toward improving early molecular diagnosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF808",
  "fields": {
    "reference_id": "10471498",
    "type": "PMID",
    "year": "1999",
    "title": "Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF809",
  "fields": {
    "reference_id": "22417841",
    "type": "PMID",
    "year": "2012",
    "title": "Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF81",
  "fields": {
    "reference_id": "24497997",
    "type": "PMID",
    "year": "2014",
    "title": "Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF810",
  "fields": {
    "reference_id": "1638030",
    "type": "PMID",
    "year": "1992",
    "title": "Spectrin Jendouba: an alpha II/31 spectrin variant that is associated with elliptocytosis and carries a mutation distant from the dimer self-association site."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF811",
  "fields": {
    "reference_id": "21910976",
    "type": "PMID",
    "year": "2011",
    "title": "Molecular characterization of MPS IIIA, MPS IIIB and MPS IIIC in Tunisian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF812",
  "fields": {
    "reference_id": "16575393",
    "type": "PMID",
    "year": "2006",
    "title": "An autosomal recessive form of monilethrix is caused by mutations in DSG4: clinical overlap with localized autosomal recessive hypotrichosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF813",
  "fields": {
    "reference_id": "10738000",
    "type": "PMID",
    "year": "2000",
    "title": "Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF814",
  "fields": {
    "reference_id": "24127073",
    "type": "PMID",
    "year": "2014",
    "title": "A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF815",
  "fields": {
    "reference_id": "23432027",
    "type": "PMID",
    "year": "2014",
    "title": "Clinical and genetic characterization of Bardet-Biedl syndrome in Tunisia: defining a strategy for molecular diagnosis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF816",
  "fields": {
    "reference_id": "23949880",
    "type": "PMID",
    "year": "2014",
    "title": "Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF817",
  "fields": {
    "reference_id": "9222768",
    "type": "PMID",
    "year": "1997",
    "title": "Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF82",
  "fields": {
    "reference_id": "21635147",
    "type": "PMID",
    "year": "2011",
    "title": "Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF83",
  "fields": {
    "reference_id": "22304537",
    "type": "PMID",
    "year": "2012",
    "title": "Frequencies of CYP3A5*1/*3 variants in a Moroccan population and effect on tacrolimus daily dose requirements in renal transplant patients."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF84",
  "fields": {
    "reference_id": "24729586",
    "type": "PMID",
    "year": "2014",
    "title": "Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF85",
  "fields": {
    "reference_id": "27142945",
    "type": "PMID",
    "year": "2016",
    "title": "Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF86",
  "fields": {
    "reference_id": "22481606",
    "type": "PMID",
    "year": "2012",
    "title": "Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF87",
  "fields": {
    "reference_id": "9918137",
    "type": "PMID",
    "year": "1998",
    "title": "CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF88",
  "fields": {
    "reference_id": "15630486",
    "type": "PMID",
    "year": "2005",
    "title": "Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF89",
  "fields": {
    "reference_id": "19369910",
    "type": "PMID",
    "year": "2009",
    "title": "The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF9",
  "fields": {
    "reference_id": "28187506",
    "type": "PMID",
    "year": "2017",
    "title": "The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF90",
  "fields": {
    "reference_id": "26751406",
    "type": "PMID",
    "year": "2016",
    "title": "Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF91",
  "fields": {
    "reference_id": "26086348",
    "type": "PMID",
    "year": "2015",
    "title": "URAT1 gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemia."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF92",
  "fields": {
    "reference_id": "20072124",
    "type": "PMID",
    "year": "2010",
    "title": "Genetic and clinical predictors of warfarin dose requirements in African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF93",
  "fields": {
    "reference_id": "16267764",
    "type": "PMID",
    "year": "2005",
    "title": "Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF94",
  "fields": {
    "reference_id": "18797399",
    "type": "PMID",
    "year": "2008",
    "title": "Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF95",
  "fields": {
    "reference_id": "30506689",
    "type": "PMID",
    "year": "2019",
    "title": "Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF96",
  "fields": {
    "reference_id": "26729753",
    "type": "PMID",
    "year": "2016",
    "title": "Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to \u00df-Blockers in Hypertensive African Americans."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF97",
  "fields": {
    "reference_id": "30368523",
    "type": "PMID",
    "year": "2019",
    "title": "Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF98",
  "fields": {
    "reference_id": "25831219",
    "type": "PMID",
    "year": "2015",
    "title": "Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study."
  }
},
{
  "model": "agmp_app.study",
  "pk": "REF99",
  "fields": {
    "reference_id": "23612435",
    "type": "PMID",
    "year": "2013",
    "title": "An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE100",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "LOXL1-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE101",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "LOXL1",
    "uniprot_id": "Q08397",
    "function": "Active on elastin and collagen substrates."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE102",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "FANCC",
    "uniprot_id": "Q00597",
    "function": "DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Upon IFNG induction, may facilitate STAT1 activation by recruiting STAT1 to IFNGR1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE103",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "CYP1B1-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE104",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "CYP1B1",
    "uniprot_id": "Q16678",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Exhibits catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2- and 4-hydroxy E1 and E2. Displays a predominant hydroxylase activity toward E2 at the C-4 position. Metabolizes testosterone and progesterone to B or D ring hydroxylated metabolites. May act as a major enzyme for all-trans retinoic acid biosynthesis in extrahepatic tissues. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid. Catalyzes the epoxidation of double bonds of certain PUFA. Converts arachidonic acid toward epoxyeicosatrienoic acid (EpETrE) regioisomers, 8,9-, 11,12-, and 14,15- EpETrE, that function as lipid mediators in the vascular system. Additionally, displays dehydratase activity toward oxygenated eicosanoids hydroperoxyeicosatetraenoates (HpETEs). This activity is independent of cytochrome P450 reductase, NADPH, and O2. Also involved in the oxidative metabolism of xenobiotics, particularly converting polycyclic aromatic hydrocarbons and heterocyclic aryl amines procarcinogens to DNA-damaging products. Plays an important role in retinal vascular development. Under hyperoxic O2 conditions, promotes retinal angiogenesis and capillary morphogenesis, likely by metabolizing the oxygenated products generated during the oxidative stress. Also, contributes to oxidative homeostasis and ultrastructural organization and function of trabecular meshwork tissue through modulation of POSTN expression (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE105",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "SGCB",
    "uniprot_id": "Q16585",
    "function": "Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE106",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "GDAP1",
    "uniprot_id": "Q8TB36",
    "function": "Regulates the mitochondrial network by promoting mitochondrial fission."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE107",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "CDKN2A",
    "uniprot_id": "P42771",
    "function": "Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE108",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "CDKN2A",
    "uniprot_id": "Q8N726",
    "function": "Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with COMMD1 and promotes its 'Lys63'-linked polyubiquitination. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development. Isoform smARF may be involved in regulation of autophagy and caspase-independent cell death, the short-lived mitochondrial isoform is stabilized by C1QBP."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE109",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "XPA",
    "uniprot_id": "P23025",
    "function": "Involved in DNA excision repair. Initiates repair by binding to damaged sites with various affinities, depending on the photoproduct and the transcriptional state of the region. Required for UV-induced CHEK1 phosphorylation and the recruitment of CEP164 to cyclobutane pyrimidine dimmers (CPD), sites of DNA damage after UV irradiation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE110",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "TYR",
    "uniprot_id": "P14679",
    "function": "This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds. Catalyzes the initial and rate limiting step in the cascade of reactions leading to melanin production from tyrosine. In addition to hydroxylating tyrosine to DOPA (3,4-dihydroxyphenylalanine), also catalyzes the oxidation of DOPA to DOPA-quinone, and possibly the oxidation of DHI (5,6-dihydroxyindole) to indole-5,6 quinone."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE111",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "GJB2",
    "uniprot_id": "P29033",
    "function": "Structural component of gap junctions. Gap junctions are dodecameric channels that connect the cytoplasm of adjoining cells. They are formed by the docking of two hexameric hemichannels, one from each cell membrane. Small molecules and ions diffuse from one cell to a neighboring cell via the central pore ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE112",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "HP",
    "uniprot_id": "P00738",
    "function": "As a result of hemolysis, hemoglobin is found to accumulate in the kidney and is secreted in the urine. Haptoglobin captures, and combines with free plasma hemoglobin to allow hepatic recycling of heme iron and to prevent kidney damage. Haptoglobin also acts as an antioxidant, has antibacterial activity, and plays a role in modulating many aspects of the acute phase response. Hemoglobin/haptoglobin complexes are rapidly cleared by the macrophage CD163 scavenger receptor expressed on the surface of liver Kupfer cells through an endocytic lysosomal degradation pathway."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE113",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "TXNL4B",
    "uniprot_id": "Q9NX01",
    "function": "Essential role in pre-mRNA splicing. Required in cell cycle progression for S/G(2) transition."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE114",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "CA4",
    "uniprot_id": "P22748",
    "function": "Reversible hydration of carbon dioxide. May stimulate the sodium/bicarbonate transporter activity of SLC4A4 that acts in pH homeostasis. It is essential for acid overload removal from the retina and retina epithelium, and acid release in the choriocapillaris in the choroid."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE115",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "FKRP",
    "uniprot_id": "Q9H9S5",
    "function": "Catalyzes the transfer of CDP-ribitol to ribitol 5-phosphate previously attached by FKTN/fukutin of to the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1). This constitutes the second step in the formation of the ribose 5-phosphate tandem repeat which links the phosphorylated O-mannosyl trisaccharide to the ligand binding moiety composed of repeats of 3-xylosyl-alpha-1,3-glucuronic acid-beta-1 ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE116",
  "fields": {
    "chromosome_patch": "X",
    "gene_name": "RP2",
    "uniprot_id": "O75695",
    "function": "Acts as a GTPase-activating protein (GAP) involved in trafficking between the Golgi and the ciliary membrane. Involved in localization of proteins, such as NPHP3, to the cilium membrane by inducing hydrolysis of GTP ARL3, leading to the release of UNC119 (or UNC119B). Acts as a GTPase-activating protein (GAP) for tubulin in concert with tubulin-specific chaperone C, but does not enhance tubulin heterodimerization. Acts as guanine nucleotide dissociation inhibitor towards ADP-ribosylation factor-like proteins."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE117",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "MEFV",
    "uniprot_id": "O15553",
    "function": "Involved in the regulation of innate immunity and the inflammatory response in response to IFNG/IFN-gamma. Organizes autophagic machinery by serving as a platform for the assembly of ULK1, Beclin 1/BECN1, ATG16L1, and ATG8 family members and recognizes specific autophagy targets, thus coordinating target recognition with assembly of the autophagic apparatus and initiation of autophagy. Acts as an autophagy receptor for the degradation of several inflammasome components, including CASP1, NLRP1 and NLRP3, hence preventing excessive IL1B- and IL18-mediated inflammation. However, it may also have a positive effect in the inflammatory pathway. In different experimental systems, it has been shown to activate IL1B production. It has also been shown to be required for PSTPIP1-induced PYCARD oligomerization and for formation of inflammasomes. Recruits PSTPIP1 to inflammasomes, and is required for PSTPIP1 oligomerization ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE118",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "NLRP7",
    "uniprot_id": "Q8WX94",
    "function": "Inhibits CASP1/caspase-1-dependent IL1B secretion."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE119",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "ARMS2",
    "uniprot_id": "P0C7Q2",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE120",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "HGD",
    "uniprot_id": "Q93099",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE121",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "IL15",
    "uniprot_id": "P40933",
    "function": "Cytokine that stimulates the proliferation of T-lymphocytes. Stimulation by IL15 requires interaction of IL15 with components of the IL2 receptor, including IL2RB and probably IL2RG but not IL2RA. In neutrophils, stimulates phagocytosis probably by signaling through the IL15 receptor, composed of the subunits IL15RA, IL2RB and IL2RG, which results in kinase SYK activation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE122",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "SACS",
    "uniprot_id": "Q9NZJ4",
    "function": "Co-chaperone which acts as a regulator of the Hsp70 chaperone machinery and may be involved in the processing of other ataxia-linked proteins."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE123",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "MLC1",
    "uniprot_id": "Q15049",
    "function": "Regulates the response of astrocytes to hypo-osmosis by promoting calcium influx."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE124",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "ATP7B",
    "uniprot_id": "P35670",
    "function": "Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE125",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "PIEZO2",
    "uniprot_id": "Q9H5I5",
    "function": "Component of a mechanosensitive channel required for rapidly adapting mechanically activated (MA) currents. Required for Merkel-cell mechanotransduction. Plays a major role in light-touch mechanosensation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE126",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "AP001180.4",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE127",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "CFH",
    "uniprot_id": "P08603",
    "function": "Glycoprotein that plays an essential role in maintaining a well-balanced immune response by modulating complement activation. Acts as a soluble inhibitor of complement, where its binding to self markers such as glycan structures prevents complement activation and amplification on cell surfaces. Accelerates the decay of the complement alternative pathway (AP) C3 convertase C3bBb, thus preventing local formation of more C3b, the central player of the complement amplification loop. As a cofactor of the serine protease factor I, CFH also regulates proteolytic degradation of already-deposited C3b. In addition, mediates several cellular responses through interaction with specific receptors. For example, interacts with CR3/ITGAM receptor and thereby mediates the adhesion of human neutrophils to different pathogens. In turn, these pathogens are phagocytosed and destroyed ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE128",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "ADIPOQ",
    "uniprot_id": "Q15848",
    "function": "Important adipokine involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic and anti-inflammatory activities. Stimulates AMPK phosphorylation and activation in the liver and the skeletal muscle, enhancing glucose utilization and fatty-acid combustion. Antagonizes TNF-alpha by negatively regulating its expression in various tissues such as liver and macrophages, and also by counteracting its effects. Inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. May play a role in cell growth, angiogenesis and tissue remodeling by binding and sequestering various growth factors with distinct binding affinities, depending on the type of complex, LMW, MMW or HMW."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE129",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "ATP2B4",
    "uniprot_id": "P23634",
    "function": "Calcium/calmodulin-regulated and magnesium-dependent enzyme that catalyzes the hydrolysis of ATP coupled with the transport of calcium out of the cell. By regulating sperm cell calcium homeostasis, may play a role in sperm motility (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE130",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "AC025946.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE131",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "THEM7P",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE132",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "SLC26A4",
    "uniprot_id": "O43511",
    "function": "Sodium-independent transporter of chloride and iodide."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE133",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "HFE",
    "uniprot_id": "Q30201",
    "function": "Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE134",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "CEP85L",
    "uniprot_id": "Q5SZL2",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE135",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "PLN",
    "uniprot_id": "P26678",
    "function": "Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. ATP2A2 inhibition is alleviated by PLN phosphorylation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE136",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "GALT",
    "uniprot_id": "P07902",
    "function": "Plays an important role in galactose metabolism."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE137",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "PJVK",
    "uniprot_id": "Q0ZLH3",
    "function": "Essential in the activity of auditory pathway neurons."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE138",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "IL23R",
    "uniprot_id": "Q5VWK5",
    "function": "Associates with IL12RB1 to form the interleukin-23 receptor. Binds IL23 and mediates T-cells, NK cells and possibly certain macrophage/myeloid cells stimulation probably through activation of the Jak-Stat signaling cascade. IL23 functions in innate and adaptive immunity and may participate in acute response to infection in peripheral tissues. IL23 may be responsible for autoimmune inflammatory diseases and be important for tumorigenesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE139",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "EIF4G1",
    "uniprot_id": "Q04637",
    "function": "Component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE140",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "TGM5",
    "uniprot_id": "O43548",
    "function": "Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. Contributes to the formation of the cornified cell envelope of keratinocytes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE141",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "ITPA",
    "uniprot_id": "Q9BY32",
    "function": "Pyrophosphatase that hydrolyzes the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP) as well as 2'-deoxy-N-6-hydroxylaminopurine triposphate (dHAPTP) and xanthosine 5'-triphosphate (XTP) to their respective monophosphate derivatives. The enzyme does not distinguish between the deoxy- and ribose forms. Probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal lesions."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE142",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "ESR1",
    "uniprot_id": "P03372",
    "function": "Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements, the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full-length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE143",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "LINC00944",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE144",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHA1",
    "uniprot_id": "Q9Y5I3",
    "function": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE145",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHA3",
    "uniprot_id": "Q9Y5H8",
    "function": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE146",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHA2",
    "uniprot_id": "Q9Y5H9",
    "function": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE147",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHA4",
    "uniprot_id": "Q9UN74",
    "function": "Calcium-dependent cell-adhesion protein involved in cells self-recognition and non-self discrimination. Thereby, it is involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE148",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "BBS1",
    "uniprot_id": "Q8NFJ9",
    "function": "The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization. Plays a role in olfactory cilium biogenesis/maintenance and trafficking (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE149",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "ZDHHC24",
    "uniprot_id": "Q6UX98",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE150",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "CFTR",
    "uniprot_id": "P13569",
    "function": "Epithelial ion channel that plays an important role in the regulation of epithelial ion and water transport and fluid homeostasis. Mediates the transport of chloride ions across the cell membrane. Channel activity is coupled to ATP hydrolysis. The ion channel is also permeable to HCO(3-), selectivity depends on the extracellular chloride concentration. Exerts its function also by modulating the activity of other ion channels and transporters. Plays an important role in airway fluid homeostasis. Contributes to the regulation of the pH and the ion content of the airway surface fluid layer and thereby plays an important role in defense against pathogens. Modulates the activity of the epithelial sodium channel (ENaC) complex, in part by regulating the cell surface expression of the ENaC complex. Inhibits the activity of the ENaC channel containing subunits SCNN1A, SCNN1B and SCNN1G. Inhibits the activity of the ENaC channel containing subunits SCNN1D, SCNN1B and SCNN1G, but not of the ENaC channel containing subunits SCNN1A, SCNN1B and SCNN1G. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the transporter SLC4A7. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE151",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "PYGM",
    "uniprot_id": "P11217",
    "function": "Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE152",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "FRG1-DT",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE153",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "GRM7",
    "uniprot_id": "Q14831",
    "function": "G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE154",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "GRM7-AS2",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE155",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "CPA6",
    "uniprot_id": "Q8N4T0",
    "function": "May be involved in the proteolytic inactivation of enkephalins and neurotensin in some brain areas. May convert inactive angiotensin I into the biologically active angiotensin II. Releases a C-terminal amino acid, with preference for large hydrophobic C-terminal amino acids and shows only very weak activity toward small amino acids and histidine ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE156",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "IK",
    "uniprot_id": "Q13123",
    "function": "Involved in pre-mRNA splicing as a component of the spliceosome. Auxiliary spliceosomal protein that regulates selection of alternative splice sites in a small set of target pre-mRNA species (Probable). Required for normal mitotic cell cycle progression. Recruits MAD1L1 and MAD2L1 to kinetochores, and is required to trigger the spindle assembly checkpoint. Required for normal accumulation of SMU1 ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE157",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "PRNP",
    "uniprot_id": "P04156",
    "function": "Its primary physiological function is unclear. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May promote myelin homeostasis through acting as an agonist for ADGRG6 receptor. May play a role in iron uptake and iron homeostasis. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (By similarity). Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also provides Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate side chains (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE158",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "TP53",
    "uniprot_id": "P04637",
    "function": "Acts as a tumor suppressor in many tumor types, induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2. However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis, the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE159",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "KRT8",
    "uniprot_id": "P05787",
    "function": "Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE160",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "SLC40A1",
    "uniprot_id": "Q9NP59",
    "function": "May be involved in iron export from duodenal epithelial cell and also in transfer of iron between maternal and fetal circulation. Mediates iron efflux in the presence of a ferroxidase (hephaestin and/or ceruloplasmin)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE161",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "BRCA2",
    "uniprot_id": "P51587",
    "function": "Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks, together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE162",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "GIGYF2",
    "uniprot_id": "Q6Y7W6",
    "function": "Key component of the 4EHP-GYF2 complex, a multiprotein complex that acts as a repressor of translation initiation. In 4EHP-GYF2 the complex, acts as a factor that bridges EIF4E2 to ZFP36/TTP, linking translation repression with mRNA decay (By similarity). May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling, including IGF1 and insulin receptors ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE163",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "TOMM40",
    "uniprot_id": "O96008",
    "function": "Channel-forming protein essential for import of protein precursors into mitochondria."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE164",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "PKLR",
    "uniprot_id": "P30613",
    "function": "Plays a key role in glycolysis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE165",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "MIR196A2",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE166",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "HOXC6",
    "uniprot_id": "P09630",
    "function": "Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE167",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "AC005906.2",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE168",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "NPC2",
    "uniprot_id": "P61916",
    "function": "Intracellular cholesterol transporter which acts in concert with NPC1 and plays an important role in the egress of cholesterol from the lysosomal compartment. Unesterified cholesterol that has been released from LDLs in the lumen of the late endosomes/lysosomes is transferred by NPC2 to the cholesterol-binding pocket in the N-terminal domain of NPC1. May bind and mobilize cholesterol that is associated with membranes. NPC2 binds cholesterol with a 1:1 stoichiometry. Can bind a variety of sterols, including lathosterol, desmosterol and the plant sterols stigmasterol and beta-sitosterol. The secreted form of NCP2 regulates biliary cholesterol secretion via stimulation of ABCG5/ABCG8-mediated cholesterol transport (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE169",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "CYP4F22",
    "uniprot_id": "Q6NT55",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE170",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "RYR1",
    "uniprot_id": "P21817",
    "function": "Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering muscle contraction following depolarization of T-tubules. Repeated very high-level exercise increases the open probability of the channel and leads to Ca(2+) leaking into the cytoplasm. Can also mediate the release of Ca(2+) from intracellular stores in neurons, and may thereby promote prolonged Ca(2+) signaling in the brain. Required for normal embryonic development of muscle fibers and skeletal muscle. Required for normal heart morphogenesis, skin development and ossification during embryogenesis (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE171",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "NDUFAF5",
    "uniprot_id": "Q5TEU4",
    "function": "Arginine hydroxylase involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1) at early stages. Acts by mediating hydroxylation of 'Arg-111' of NDUFS7. May also have methyltransferase activity (Probable)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE172",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "SPG11",
    "uniprot_id": "Q96JI7",
    "function": "May play a role in neurite plasticity by maintaining cytoskeleton stability and regulating synaptic vesicle transport."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE173",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "MFSD8",
    "uniprot_id": "Q8NHS3",
    "function": "May be a carrier that transport small solutes by using chemiosmotic ion gradients."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE174",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "CCT5",
    "uniprot_id": "P48643",
    "function": "Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. The TRiC complex plays a role in the folding of actin and tubulin (Probable)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE175",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "ZFYVE26",
    "uniprot_id": "Q68DK2",
    "function": "Phosphatidylinositol 3-phosphate-binding protein required for the abcission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abcission. May also be required for efficient homologous recombination DNA double-strand break repair."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE176",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "HMBS",
    "uniprot_id": "P08397",
    "function": "Tetrapolymerization of the monopyrrole PBG into the hydroxymethylbilane pre-uroporphyrinogen in several discrete steps."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE177",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "GAN",
    "uniprot_id": "Q9H2C0",
    "function": "Probable cytoskeletal component that directly or indirectly plays an important role in neurofilament architecture. May act as a substrate-specific adapter of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Controls degradation of TBCB. Controls degradation of MAP1B and MAP1S, and is critical for neuronal maintenance and survival."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE178",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "SMPD1",
    "uniprot_id": "P17405",
    "function": "Converts sphingomyelin to ceramide. Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE179",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "SBF2",
    "uniprot_id": "Q86WG5",
    "function": "Guanine nucleotide exchange factor (GEF) which activates RAB21 and possibly RAB28. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. In response to starvation-induced autophagy, activates RAB21 which in turn binds to and regulates SNARE protein VAMP8 endolysosomal transport required for SNARE-mediated autophagosome-lysosome fusion. Acts as an adapter for the phosphatase MTMR2 (By similarity). Increases MTMR2 catalytic activity towards phosphatidylinositol 3,5-bisphosphate and to a lesser extent towards phosphatidylinositol 3-phosphate (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE180",
  "fields": {
    "chromosome_patch": "21",
    "gene_name": "AIRE",
    "uniprot_id": "O43918",
    "function": "Transcription factor playing an essential role to promote self-tolerance in the thymus by regulating the expression of a wide array of self-antigens that have the commonality of being tissue-restricted in their expression pattern in the periphery, called tissue restricted antigens (TRA). Binds to G-doublets in an A/T-rich environment, the preferred motif is a tandem repeat of 5'-ATTGGTTA-3' combined with a 5'-TTATTA-3' box. Binds to nucleosomes (By similarity). Binds to chromatin and interacts selectively with histone H3 that is not methylated at 'Lys-4', not phosphorylated at 'Thr-3' and not methylated at 'Arg-2'. Functions as a sensor of histone H3 modifications that are important for the epigenetic regulation of gene expression. Mainly expressed by medullary thymic epithelial cells (mTECs), induces the expression of thousands of tissue-restricted proteins, which are presented on major histocompatibility complex class I (MHC-I) and MHC-II molecules to developing T-cells percolating through the thymic medulla. Also induces self-tolerance through other mechanisms such as the regulation of the mTEC differentiation program. Controls the medullary accumulation of thymic dendritic cells and the development of regulatory T-cell through the regulation of XCL1 expression. Regulates the production of CCR4 and CCR7 ligands in medullary thymic epithelial cells and alters the coordinated maturation and migration of thymocytes. In thimic B-cells, allows the presentation of licensing-dependent endogenous self-anitgen for negative selection. In secondary lymphoid organs, induces functional inactivation of CD4(+) T-cells. Expressed by a distinct bone marrow-derived population, induces self-tolerance through a mechanism that does not require regulatory T-cells and is resitant to innate inflammatory stimuli (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE181",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "SLC39A4",
    "uniprot_id": "Q6P5W5",
    "function": "Plays an important role in cellular zinc homeostasis as a zinc transporter. Regulated in response to zinc availability (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE182",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "GCDH",
    "uniprot_id": "Q92947",
    "function": "Catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. Isoform Short is inactive."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE183",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "TMEM126A",
    "uniprot_id": "Q9H061",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE184",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "KIFBP",
    "uniprot_id": "Q96EK5",
    "function": "Required for organization of axonal microtubules, and axonal outgrowth and maintenance during peripheral and central nervous system development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE185",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "FANCA",
    "uniprot_id": "O15360",
    "function": "DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be involved in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE186",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "HEXA",
    "uniprot_id": "P06865",
    "function": "Responsible for the degradation of GM2 gangliosides, and a variety of other molecules containing terminal N-acetyl hexosamines, in the brain and other tissues. The form B is active against certain oligosaccharides. The form S has no measurable activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE187",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "CYP27A1",
    "uniprot_id": "Q02318",
    "function": "Cytochrome P450 monooxygenase that catalyzes regio- and stereospecific hydroxylation of cholesterol and its derivatives. Hydroxylates (with R stereochemistry) the terminal methyl group of cholesterol side-chain in a three step reaction to yield at first a C26 alcohol, then a C26 aldehyde and finally a C26 acid. Regulates cholesterol homeostasis by catalyzing the conversion of excess cholesterol to bile acids via both the 'neutral' (classic) and the 'acid' (alternative) pathways. May also regulate cholesterol homeostasis via generation of active oxysterols, which act as ligands for NR1H2 and NR1H3 nuclear receptors, modulating the transcription of genes involved in lipid metabolism. Plays a role in cholestanol metabolism in the cerebellum. Similarly to cholesterol, hydroxylates cholestanol and may facilitate sterol diffusion through the blood-brain barrier to the systemic circulation for further degradation. Also hydroxylates retinal 7-ketocholesterol, a noxious oxysterol with pro-inflammatory and pro-apoptotic effects, and may play a role in its elimination from the retinal pigment epithelium. May play a redundant role in vitamin D biosynthesis. Catalyzes 25-hydroxylation of vitamin D3 that is required for its conversion to a functionally active form ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE188",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "EDARADD",
    "uniprot_id": "Q8WWZ3",
    "function": "Adapter protein that interacts with EDAR DEATH domain and couples the receptor to EDA signaling pathway during morphogenesis of ectodermal organs. Mediates the activation of NF-kappa-B."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE189",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "NLRP3",
    "uniprot_id": "Q96P20",
    "function": "As the sensor component of the NLRP3 inflammasome, plays a crucial role in innate immunity and inflammation. In response to pathogens and other damage-associated signals, initiates the formation of the inflammasome polymeric complex, made of NLRP3, PYCARD and CASP1 (and possibly CASP4 and CASP5). Recruitment of proCASP1 to the inflammasome promotes its activation and CASP1-catalyzed IL1B and IL18 maturation and secretion in the extracellular milieu. Activation of NLRP3 inflammasome is also required for HMGB1 secretion. The active cytokines and HMGB1 stimulate inflammatory responses. Inflammasomes can also induce pyroptosis, an inflammatory form of programmed cell death. Under resting conditions, NLRP3 is autoinhibited. NLRP3 activation stimuli include extracellular ATP, reactive oxygen species, K(+) efflux, crystals of monosodium urate or cholesterol, amyloid-beta fibers, environmental or industrial particles and nanoparticles, cytosolic dsRNA, etc. However, it is unclear what constitutes the direct NLRP3 activator. Activation in presence of cytosolic dsRNA is mediated by DHX33. Independently of inflammasome activation, regulates the differentiation of T helper 2 (Th2) cells and has a role in Th2 cell-dependent asthma and tumor growth (By similarity). During Th2 differentiation, required for optimal IRF4 binding to IL4 promoter and for IRF4-dependent IL4 transcription. Binds to the consensus DNA sequence 5'-GRRGGNRGAG-3'. May also participate in the transcription of IL5, IL13, GATA3, CCR3, CCR4 and MAF (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE190",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "BBS2",
    "uniprot_id": "Q9BXC9",
    "function": "The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE191",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "GFER",
    "uniprot_id": "P55789",
    "function": "FAD-dependent sulfhydryl oxidase that regenerates the redox-active disulfide bonds in CHCHD4/MIA40, a chaperone essential for disulfide bond formation and protein folding in the mitochondrial intermembrane space. The reduced form of CHCHD4/MIA40 forms a transient intermolecular disulfide bridge with GFER/ERV1, resulting in regeneration of the essential disulfide bonds in CHCHD4/MIA40, while GFER/ERV1 becomes re-oxidized by donating electrons to cytochrome c or molecular oxygen."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE192",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "HGSNAT",
    "uniprot_id": "Q68CP4",
    "function": "Lysosomal acetyltransferase that acetylates the non-reducing terminal alpha-glucosamine residue of intralysosomal heparin or heparan sulfate, converting it into a substrate for luminal alpha-N-acetyl glucosaminidase."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE193",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "SLURP1",
    "uniprot_id": "P55000",
    "function": "Has an antitumor activity. Was found to be a marker of late differentiation of the skin. Implicated in maintaining the physiological and structural integrity of the keratinocyte layers of the skin. In vitro down-regulates keratinocyte proliferation, the function may involve the proposed role as modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits alpha-7-dependent nAChR currents in an allosteric manner. In T cells may be involved in regulation of intracellular Ca(2+) signaling. Seems to have an immunomodulatory function in the cornea (By similarity). The function may implicate a possible role as a scavenger receptor for PLAU thereby blocking PLAU-dependent functions of PLAUR such as in cell migration and proliferation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE194",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "SLC7A9",
    "uniprot_id": "P82251",
    "function": "Involved in the high-affinity, sodium-independent transport of cystine and neutral and dibasic amino acids (system b(0,+)-like activity). Thought to be responsible for the high-affinity reabsorption of cystine in the kidney tubule."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE195",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "AGXT",
    "uniprot_id": "P21549",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE196",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "CYP7B1",
    "uniprot_id": "O75881",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of endogenous oxysterols and steroid hormones, including neurosteroids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR, NADPH-ferrihemoprotein reductase). Catalyzes the hydroxylation of carbon hydrogen bonds of steroids with a preference for 7-alpha position. Usually metabolizes steroids carrying a hydroxy group at position 3, functioning as a 3-hydroxy steroid 7-alpha hydroxylase. Hydroxylates oxysterols, including 25-hydroxycholesterol and (25R)-cholest-5-ene-3beta,26-diol toward 7-alpha hydroxy derivatives, which may be transported to the liver and converted to bile acids. Via its product 7-alpha,25-dihydroxycholesterol, a ligand for the chemotactic G protein-coupled receptor GPR183/EBI2, regulates B cell migration in germinal centers of lymphoid organs, thus guiding efficient maturation of plasma B cells and overall antigen-specific humoral immune response (By similarity). 7-alpha hydroxylates neurosteroids, including 3beta-hydroxyandrost-5-en-17-one (dehydroepiandrosterone) and pregnenolone, both involved in hippocampus-associated memory and learning. Metabolizes androstanoids toward 6- or 7-alpha hydroxy derivatives ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE197",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "ASS1",
    "uniprot_id": "P00966",
    "function": "One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE198",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "SLC7A7",
    "uniprot_id": "Q9UM01",
    "function": "Involved in the sodium-independent uptake of dibasic amino acids and sodium-dependent uptake of some neutral amino acids. Requires coexpression with SLC3A2/4F2hc to mediate the uptake of arginine, leucine and glutamine. Plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine. Involved in the transport of L-arginine in monocytes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE199",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "TGFBI",
    "uniprot_id": "Q15582",
    "function": "Plays a role in cell adhesion. May play a role in cell-collagen interactions (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE200",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "GHR",
    "uniprot_id": "P10912",
    "function": "Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE201",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "SERPINC1",
    "uniprot_id": "P01008",
    "function": "Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade. AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa. Its inhibitory activity is greatly enhanced in the presence of heparin."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE202",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "ADGRV1",
    "uniprot_id": "Q8WXG9",
    "function": "G-protein coupled receptor which has an essential role in the development of hearing and vision. Couples to G-alpha(i)-proteins, GNAI1/2/3, G-alpha(q)-proteins, GNAQ, as well as G-alpha(s)-proteins, GNAS, inhibiting adenylate cyclase (AC) activity and cAMP production. Required for the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells of the inner ear. In response to extracellular calcium, activates kinases PKA and PKC to regulate myelination by inhibiting the ubiquitination of MAG, thus enhancing the stability of this protein in myelin-forming cells of the auditory pathway. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport. Involved in the regulation of bone metabolism."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE203",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "SLC29A3",
    "uniprot_id": "Q9BZD2",
    "function": "Mediates both influx and efflux of nucleosides across the membrane (equilibrative transporter). Mediates transport of adenine, adenosine and uridine, as well as several nucleoside analog drugs, such as anticancer and antiviral agents, including cladribine, cordycepin, tubercidin and AZT. Does not transport hypoxanthine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE204",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "FREM1",
    "uniprot_id": "Q5H8C1",
    "function": "Extracellular matrix protein that plays a role in epidermal differentiation and is required for epidermal adhesion during embryonic development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE205",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "COL9A1",
    "uniprot_id": "P20849",
    "function": "Structural component of hyaline cartilage and vitreous of the eye."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE206",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "RB1",
    "uniprot_id": "P06400",
    "function": "Key regulator of entry into cell division that acts as a tumor suppressor. Promotes G0-G1 transition when phosphorylated by CDK3/cyclin-C. Acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE207",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "APC",
    "uniprot_id": "P25054",
    "function": "Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE208",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "KIT",
    "uniprot_id": "P10721",
    "function": "Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Activated KIT also transmits signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3, STAT5A and STAT5B. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KIT signaling is modulated by protein phosphatases, and by rapid internalization and degradation of the receptor. Activated KIT promotes phosphorylation of the protein phosphatases PTPN6/SHP-1 and PTPRU, and of the transcription factors STAT1, STAT3, STAT5A and STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoform Crk-II), LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE209",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "EPB42",
    "uniprot_id": "P16452",
    "function": "Probably plays an important role in the regulation of erythrocyte shape and mechanical properties."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE210",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "SFTPC",
    "uniprot_id": "P11686",
    "function": "Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE211",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PROP1",
    "uniprot_id": "O75360",
    "function": "Possibly involved in the ontogenesis of pituitary gonadotropes, as well as somatotropes, lactotropes and caudomedial thyrotropes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE212",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "TTPA",
    "uniprot_id": "P49638",
    "function": "Binds alpha-tocopherol, enhances its transfer between separate membranes, and stimulates its release from liver cells. Binds both phosphatidylinol 3,4-bisphosphate and phosphatidylinol 4,5-bisphosphate, the resulting conformation change is important for the release of the bound alpha-tocopherol (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE213",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "UROD",
    "uniprot_id": "P06132",
    "function": "Catalyzes the decarboxylation of four acetate groups of uroporphyrinogen-III to yield coproporphyrinogen-III."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE214",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "OCA2",
    "uniprot_id": "Q04671",
    "function": "Could be involved in the transport of tyrosine, the precursor to melanin synthesis, within the melanocyte. Regulates the pH of melanosome and the melanosome maturation. One of the components of the mammalian pigmentary system. Seems to regulate the post-translational processing of tyrosinase, which catalyzes the limiting reaction in melanin synthesis. May serve as a key control point at which ethnic skin color variation is determined. Major determinant of brown and/or blue eye color."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE215",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "MMUT",
    "uniprot_id": "P22033",
    "function": "Involved in the degradation of several amino acids, odd-chain fatty acids and cholesterol via propionyl-CoA to the tricarboxylic acid cycle. MCM has different functions in other species."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE216",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "FERMT1",
    "uniprot_id": "Q9BQL6",
    "function": "Involved in cell adhesion. Contributes to integrin activation. When coexpressed with talin, potentiates activation of ITGA2B. Required for normal keratinocyte proliferation. Required for normal polarization of basal keratinocytes in skin, and for normal cell shape. Required for normal adhesion of keratinocytes to fibronectin and laminin, and for normal keratinocyte migration to wound sites. May mediate TGF-beta 1 signaling in tumor progression."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE217",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "RXFP2",
    "uniprot_id": "Q8WXD0",
    "function": "Receptor for relaxin. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. May also be a receptor for Leydig insulin-like peptide (INSL3)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE218",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "PPOX",
    "uniprot_id": "P50336",
    "function": "Catalyzes the 6-electron oxidation of protoporphyrinogen-IX to form protoporphyrin-IX."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE219",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "SLC25A22",
    "uniprot_id": "Q9H936",
    "function": "Involved in the transport of glutamate across the inner mitochondrial membrane. Glutamate is cotransported with H(+)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE220",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "CARD9",
    "uniprot_id": "Q9H257",
    "function": "Adapter protein that plays a key role in innate immune response to a number of intracellular pathogens, such as C.albicans and L.monocytogenes. Is at the crossroads of ITAM-tyrosine kinase and the Toll-like receptors (TLR) and NOD2 signaling pathways. Probably controls various innate immune response pathways depending on the intracellular pathogen. In response to L.monocytogenes infection, acts by connecting NOD2 recognition of peptidoglycan to downstream activation of MAP kinases (MAPK) without activating NF-kappa-B. Also involved in activation of myeloid cells via classical ITAM-associated receptors and TLR: required for TLR-mediated activation of MAPK, while it is not required for TLR-induced activation of NF-kappa-B (By similarity). Controls CLEC7A (dectin-1)-mediated myeloid cell activation induced by the yeast cell wall component zymosan, leading to cytokine production and innate anti-fungal immunity: acts by regulating BCL10-MALT1-mediated NF-kappa-B activation pathway. Activates NF-kappa-B via BCL10. In response to the hyphal form of C.albicans, mediates CLEC6A (dectin-2)-induced I-kappa-B kinase ubiquitination, leading to NF-kappa-B activation via interaction with BCL10. In response to fungal infection, may be required for the development and subsequent differentiation of interleukin 17-producing T helper (TH-17) cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE221",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "PDE6B",
    "uniprot_id": "P35913",
    "function": "This protein participates in processes of transmission and amplification of the visual signal. Necessary for the formation of a functional phosphodiesterase holoenzyme."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE222",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "SPTA1",
    "uniprot_id": "P02549",
    "function": "Spectrin is the major constituent of the cytoskeletal network underlying the erythrocyte plasma membrane. It associates with band 4.1 and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE223",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "TSHB",
    "uniprot_id": "P01222",
    "function": "Indispensable for the control of thyroid structure and metabolism."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE224",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "FGFR2",
    "uniprot_id": "P21802",
    "function": "Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE225",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "TNNT2",
    "uniprot_id": "P45379",
    "function": "Troponin T is the tropomyosin-binding subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE226",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "C7",
    "uniprot_id": "P10643",
    "function": "Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE227",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "F7",
    "uniprot_id": "P08709",
    "function": "Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE228",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "DLD",
    "uniprot_id": "P09622",
    "function": "Lipoamide dehydrogenase is a component of the glycine cleavage system as well as an E3 component of three alpha-ketoacid dehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, and branched-chain amino acid-dehydrogenase complex). The 2-oxoglutarate dehydrogenase complex is mainly active in the mitochondrion. A fraction of the 2-oxoglutarate dehydrogenase complex also localizes in the nucleus and is required for lysine succinylation of histones: associates with KAT2A on chromatin and provides succinyl-CoA to histone succinyltransferase KAT2A. In monomeric form may have additional moonlighting function as serine protease. Involved in the hyperactivation of spermatazoa during capacitation and in the spermatazoal acrosome reaction (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE229",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "IDUA",
    "uniprot_id": "P35475",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE230",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "SLC26A1",
    "uniprot_id": "Q9H2B4",
    "function": "Mediates sulfate transport with high affinity. Mediates oxalate transport. Mediates bicarbonate transport (By similarity). Does not accept succinate as cosubstrate (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE231",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "TCF7L2",
    "uniprot_id": "Q9NQB0",
    "function": "Participates in the Wnt signaling pathway and modulates MYC expression by binding to its promoter in a sequence-specific manner. Acts as repressor in the absence of CTNNB1, and as activator in its presence. Activates transcription from promoters with several copies of the Tcf motif 5'-CCTTTGATC-3' in the presence of CTNNB1. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7L2/TCF4 and CTNNB1. Expression of dominant-negative mutants results in cell-cycle arrest in G1. Necessary for the maintenance of the epithelial stem-cell compartment of the small intestine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE232",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "AC092813.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE233",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "COL27A1",
    "uniprot_id": "Q8IZC6",
    "function": "Plays a role during the calcification of cartilage and the transition of cartilage to bone."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE234",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "KCNQ1",
    "uniprot_id": "P51787",
    "function": "Potassium channel that plays an important role in a number of tissues, including heart, inner ear, stomach and colon (By similarity). Associates with KCNE beta subunits that modulates current kinetics (By similarity). Induces a voltage-dependent by rapidly activating and slowly deactivating potassium-selective outward current (By similarity). Promotes also a delayed voltage activated potassium current showing outward rectification characteristic (By similarity). During beta-adrenergic receptor stimulation participates in cardiac repolarization by associating with KCNE1 to form the I(Ks) cardiac potassium current that increases the amplitude and slows down the activation kinetics of outward potassium current I(Ks) (By similarity). Muscarinic agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current. When associated with KCNE3, forms the potassium channel that is important for cyclic AMP-stimulated intestinal secretion of chloride ions. This interaction with KCNE3 is reduced by 17beta-estradiol, resulting in the reduction of currents (By similarity). During conditions of increased substrate load, maintains the driving force for proximal tubular and intestinal sodium ions absorption, gastric acid secretion, and cAMP-induced jejunal chloride ions secretion (By similarity). Allows the provision of potassium ions to the luminal membrane of the secretory canaliculus in the resting state as well as during stimulated acid secretion (By similarity). When associated with KCNE2, forms a heterooligomer complex leading to currents with an apparently instantaneous activation, a rapid deactivation process and a linear current-voltage relationship and decreases the amplitude of the outward current. When associated with KCNE4, inhibits voltage-gated potassium channel activity. When associated with KCNE5, this complex only conducts current upon strong and continued depolarization. Also forms a heterotetramer with KCNQ5, has a voltage-gated potassium channel activity. Binds with phosphatidylinositol 4,5-bisphosphate ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE235",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "MMP26",
    "uniprot_id": "Q9NRE1",
    "function": "May hydrolyze collagen type IV, fibronectin, fibrinogen, beta-casein, type I gelatin and alpha-1 proteinase inhibitor. Is also able to activate progelatinase B."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE236",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "OR51F1",
    "uniprot_id": "A6NGY5",
    "function": "Odorant receptor."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE237",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "SLC39A8",
    "uniprot_id": "Q9C0K1",
    "function": "Acts as a manganese and zinc influx transporter. Plays a role in manganese reabsorption in the proximal tubule of the kidney and in manganese uptake into the brain ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE238",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "ERCC2",
    "uniprot_id": "P18074",
    "function": "ATP-dependent 5'-3' DNA helicase, component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. The ATP-dependent helicase activity of XPD/ERCC2 is required for DNA opening. In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. XPD/ERCC2 acts by forming a bridge between CAK and the core-TFIIH complex. Involved in the regulation of vitamin-D receptor activity. As part of the mitotic spindle-associated MMXD complex it plays a role in chromosome segregation. Might have a role in aging process and could play a causative role in the generation of skin cancers."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE239",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "SLC30A8",
    "uniprot_id": "Q8IWU4",
    "function": "Facilitates the accumulation of zinc from the cytoplasm into intracellular vesicles, being a zinc-efflux transporter. May be a major component for providing zinc to insulin maturation and/or storage processes in insulin-secreting pancreatic beta-cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE240",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "PCAT1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE241",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "POU5F1B",
    "uniprot_id": "Q06416",
    "function": "Shows weak transcriptional activator activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE242",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "CASC8",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE243",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "DEC1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE244",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "TNC",
    "uniprot_id": "P24821",
    "function": "Extracellular matrix protein implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity as well as neuronal regeneration. Promotes neurite outgrowth from cortical neurons grown on a monolayer of astrocytes. Ligand for integrins alpha-8/beta-1, alpha-9/beta-1, alpha-V/beta-3 and alpha-V/beta-6. In tumors, stimulates angiogenesis by elongation, migration and sprouting of endothelial cells ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE245",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "SGCA",
    "uniprot_id": "Q16586",
    "function": "Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE246",
  "fields": {
    "chromosome_patch": "21",
    "gene_name": "TMPRSS3",
    "uniprot_id": "P57727",
    "function": "Probable serine protease that plays a role in hearing. Acts as a permissive factor for cochlear hair cell survival and activation at the onset of hearing and is required for saccular hair cell survival (By similarity). Activates ENaC (in vitro)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE247",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "PCDH15",
    "uniprot_id": "Q96QU1",
    "function": "Calcium-dependent cell-adhesion protein. Essential for maintenance of normal retinal and cochlear function."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE248",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "DYNC2H1",
    "uniprot_id": "Q8NCM8",
    "function": "May function as a motor for intraflagellar retrograde transport. Functions in cilia biogenesis. May play a role in transport between endoplasmic reticulum and Golgi or organization of the Golgi in cells (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE249",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "ZRANB3",
    "uniprot_id": "Q5FWF4",
    "function": "DNA annealing helicase and endonuclease required to maintain genome stability at stalled or collapsed replication forks by facilitating fork restart and limiting inappropriate recombination that could occur during template switching events. Recruited to the sites of stalled DNA replication by polyubiquitinated PCNA and acts as a structure-specific endonuclease that cleaves the replication fork D-loop intermediate, generating an accessible 3'-OH group in the template of the leading strand, which is amenable to extension by DNA polymerase. In addition to endonuclease activity, also catalyzes the fork regression via annealing helicase activity in order to prevent disintegration of the replication fork and the formation of double-strand breaks ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE250",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "RAB3GAP1",
    "uniprot_id": "Q15042",
    "function": "Probable catalytic subunit of a GTPase activating protein that has specificity for Rab3 subfamily (RAB3A, RAB3B, RAB3C and RAB3D). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones. Specifically converts active Rab3-GTP to the inactive form Rab3-GDP. Required for normal eye and brain development. May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non-synaptic vesicular release of neurotransmitters."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE251",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "SAR1B",
    "uniprot_id": "Q9Y6B6",
    "function": "Involved in transport from the endoplasmic reticulum to the Golgi apparatus. Activated by the guanine nucleotide exchange factor PREB. Involved in the selection of the protein cargo and the assembly of the COPII coat complex."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE252",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "TIMP3",
    "uniprot_id": "P35625",
    "function": "Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. May form part of a tissue-specific acute response to remodeling stimuli. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, MMP-14 and MMP-15."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE253",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "SYN3",
    "uniprot_id": "O14994",
    "function": "May be involved in the regulation of neurotransmitter release and synaptogenesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE254",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "AP4E1",
    "uniprot_id": "Q9UPM8",
    "function": "Component of the adaptor protein complex 4 (AP-4). Adaptor protein complexes are vesicle coat components involved both in vesicle formation and cargo selection. They control the vesicular transport of proteins in different trafficking pathways. AP-4 forms a non clathrin-associated coat on vesicles departing the trans-Golgi network (TGN) and may be involved in the targeting of proteins from the trans-Golgi network (TGN) to the endosomal-lysosomal system. It is also involved in protein sorting to the basolateral membrane in epithelial cells and the proper asymmetric localization of somatodendritic proteins in neurons. AP-4 is involved in the recognition and binding of tyrosine-based sorting signals found in the cytoplasmic part of cargos, but may also recognize other types of sorting signal (Probable)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE255",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "BAIAP2",
    "uniprot_id": "Q9UQB8",
    "function": "Adapter protein that links membrane-bound small G-proteins to cytoplasmic effector proteins. Necessary for CDC42-mediated reorganization of the actin cytoskeleton and for RAC1-mediated membrane ruffling. Involved in the regulation of the actin cytoskeleton by WASF family members and the Arp2/3 complex. Plays a role in neurite growth. Acts syngeristically with ENAH to promote filipodia formation. Plays a role in the reorganization of the actin cytoskeleton in response to bacterial infection. Participates in actin bundling when associated with EPS8, promoting filopodial protrusions."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE256",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "AC011287.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE257",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "STX6",
    "uniprot_id": "O43752",
    "function": "Involved in intracellular vesicle trafficking."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE258",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "TULP1",
    "uniprot_id": "O00294",
    "function": "Required for normal development of photoreceptor synapses. Required for normal photoreceptor function and for long-term survival of photoreceptor cells. Interacts with cytoskeleton proteins and may play a role in protein transport in photoreceptor cells (By similarity). Binds lipids, especially phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 3,4,5-bisphosphate, phosphatidylserine and phosphatidic acid (in vitro). Contribute to stimulation of phagocytosis of apoptotic retinal pigment epithelium (RPE) cells and macrophages."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE259",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "SLC24A5",
    "uniprot_id": "Q71RS6",
    "function": "Cation exchanger involved in pigmentation, possibly by participating in ion transport in melanosomes. Predominant sodium-Calcium exchanger in melanocytes. Probably transports 1 Ca(2+) and 1 K(+) to the melanosome in exchange for 4 cytoplasmic Na(+)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE260",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "BCL11A",
    "uniprot_id": "Q9H165",
    "function": "Transcription factor associated with the BAF SWI/SNF chromatin remodeling complex (By similarity). Repressor of fetal hemoglobin (HbF) level. Involved in brain development. May play a role in hematopoiesis. Essential factor in lymphopoiesis required for B-cell formation in fetal liver. May function as a modulator of the transcriptional repression activity of ARP1 (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE261",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "IVD",
    "uniprot_id": "P26440",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE262",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "FAM155A",
    "uniprot_id": "B1AL88",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE263",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "SERPINB8",
    "uniprot_id": "P50452",
    "function": "Has an important role in epithelial desmosome-mediated cell-cell adhesion."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE264",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "ASPM",
    "uniprot_id": "Q8IZT6",
    "function": "Involved in mitotic spindle regulation and coordination of mitotic processes. The function in regulating microtubule dynamics at spindle poles including spindle orientation, astral microtubule density and poleward microtubule flux seems to depend on the association with the katanin complex formed by KATNA1 and KATNB1. Enhances the microtubule lattice severing activity of KATNA1 by recruiting the katanin complex to microtubules. Can block microtubule minus-end growth and reversely this function can be enhanced by the katanin complex. May have a preferential role in regulating neurogenesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE265",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "MCM6",
    "uniprot_id": "Q14566",
    "function": "Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE266",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "CARD14",
    "uniprot_id": "Q9BXL6",
    "function": "Acts as a scaffolding protein that can activate the inflammatory transcription factor NF-kappa-B and p38/JNK MAP kinase signaling pathways. Forms a signaling complex with BCL10 and MALT1, and activates MALT1 proteolytic activity and inflammatory gene expression. MALT1 is indispensable for CARD14-induced activation of NF-kappa-B and p38/JNK MAP kinases. May play a role in signaling mediated by TRAF2, TRAF3 and TRAF6 and protects cells against apoptosis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE267",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "PAEP",
    "uniprot_id": "P09466",
    "function": "Glycoprotein that regulates critical steps during fertilization and also has immunomonomodulatory effects. Four glycoforms, namely glycodelin-S, -A, -F and -C have been identified in reproductive tissues that differ in glycosylation and biological activity. Glycodelin-A has contraceptive and immunosuppressive activities. Glycodelin-C stimulates binding of spermatozoa to the zona pellucida. Glycodelin-F inhibits spermatozoa-zona pellucida binding and significantly suppresses progesterone-induced acrosome reaction of spermatozoa. Glycodelin-S in seminal plasma maintains the uncapacitated state of human spermatozoa ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE268",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "IGF2BP2",
    "uniprot_id": "Q9Y6M1",
    "function": "RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation (By similarity). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binding is isoform-specific. Binds to beta-actin/ACTB and MYC transcripts."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE269",
  "fields": {
    "chromosome_patch": "21",
    "gene_name": "CSTB",
    "uniprot_id": "P04080",
    "function": "This is an intracellular thiol proteinase inhibitor. Tightly binding reversible inhibitor of cathepsins L, H and B."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE270",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "CSMD1",
    "uniprot_id": "Q96PZ7",
    "function": "Potential suppressor of squamous cell carcinomas."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE271",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "PKHD1",
    "uniprot_id": "P08F94",
    "function": "May be required for correct bipolar cell division through the regulation of centrosome duplication and mitotic spindle assembly. May be a receptor protein that acts in collecting-duct and biliary differentiation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE272",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "ABCA3",
    "uniprot_id": "Q99758",
    "function": "Plays an important role in the formation of pulmonary surfactant, probably by transporting lipids such as cholesterol."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE273",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "GLT6D1",
    "uniprot_id": "Q7Z4J2",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE274",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "OR51N1P",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE275",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "SLC11A1",
    "uniprot_id": "P49279",
    "function": "Divalent transition metal (iron and manganese) transporter involved in iron metabolism and host resistance to certain pathogens. Macrophage-specific membrane transport function. Controls natural resistance to infection with intracellular parasites. Pathogen resistance involves sequestration of Fe(2+) and Mn(2+), cofactors of both prokaryotic and eukaryotic catalases and superoxide dismutases, not only to protect the macrophage against its own generation of reactive oxygen species, but to deny the cations to the pathogen for synthesis of its protective enzymes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE276",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "NOD2",
    "uniprot_id": "Q9HC29",
    "function": "Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3, INAVA and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages. Component of an autophagy-mediated antibacterial pathway together with ATG16L1. Plays also a role in sensing single-stranded RNA (ssRNA) from viruses. Interacts with mitochondrial antiviral signaling/MAVS, leading to activation of interferon regulatory factor-3/IRF3 and expression of type I interferon ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE277",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "NALCN",
    "uniprot_id": "Q8IZF0",
    "function": "Voltage-independent, cation-nonselective channel which is permeable to sodium, potassium and calcium ions. Regulates the resting membrane potential and controls neuronal excitability. Neuropeptides such as neurotensin and substance P (SP) stimulate the firing of action potentials by activating NALCN through a SRC family kinases-dependent pathway. In addition to its baseline activity, NALCN activity is enhanced/modulated by several GPCRs. Required for normal respiratory rhythm and neonatal survival. Involved in systemic osmoregulation by controlling the serum sodium concentration. NALCN is partly responsible for the substance P-induced depolarization and regulation of the intestinal pace-making activity in the interstitial cells of Cajal. Plays a critical role in both maintenance of spontaneous firing of substantia nigra pars reticulata (SNr) neurons and physiological modulation of SNr neuron excitability (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE278",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "ERCC5",
    "uniprot_id": "P28715",
    "function": "Single-stranded structure-specific DNA endonuclease involved in DNA excision repair. Makes the 3'incision in DNA nucleotide excision repair (NER). Acts as a cofactor for a DNA glycosylase that removes oxidized pyrimidines from DNA. May also be involved in transcription-coupled repair of this kind of damage, in transcription by RNA polymerase II, and perhaps in other processes too."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE279",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "BIVM-ERCC5",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE280",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "LINC00871",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE281",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "CCR2",
    "uniprot_id": "P41597",
    "function": "Key functional receptor for CCL2 but can also bind CCL7 and CCL12. Its binding with CCL2 on monocytes and macrophages mediates chemotaxis and migration induction through the activation of the PI3K cascade, the small G protein Rac and lamellipodium protrusion (Probable). Also acts as a receptor for the beta-defensin DEFB106A/DEFB106B. Regulates the expression of T-cell inflammatory cytokines and T-cell differentiation, promoting the differentiation of T-cells into T-helper 17 cells (Th17) during inflammation (By similarity). Facilitates the export of mature thymocytes by enhancing directional movement of thymocytes to sphingosine-1-phosphate stimulation and up-regulation of S1P1R expression, signals through the JAK-STAT pathway to regulate FOXO1 activity leading to an increased expression of S1P1R (By similarity). Plays an important role in mediating peripheral nerve injury-induced neuropathic pain (By similarity). Increases NMDA-mediated synaptic transmission in both dopamine D1 and D2 receptor-containing neurons, which may be caused by MAPK/ERK-dependent phosphorylation of GRIN2B/NMDAR2B (By similarity). Mediates the recruitment of macrophages and monocytes to the injury site following brain injury (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE282",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "NOS3",
    "uniprot_id": "P29474",
    "function": "Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE283",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "MBL2",
    "uniprot_id": "P11226",
    "function": "Calcium-dependent lectin involved in innate immune defense. Binds mannose, fucose and N-acetylglucosamine on different microorganisms and activates the lectin complement pathway. Binds to late apoptotic cells, as well as to apoptotic blebs and to necrotic cells, but not to early apoptotic cells, facilitating their uptake by macrophages. May bind DNA."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE284",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "ABCA4",
    "uniprot_id": "P78363",
    "function": "Catalyzes the translocation of specific phospholipids from the extracellular/lumenal to the cytoplasmic leaflet of membrane coupled to the hydrolysis of ATP. Transports preferentially phosphatidylethanolamine. In the visual cycle, acts as an inward-directed retinoid flipase, retinoid substrates imported by ABCA4 from the extracellular or intradiscal (rod) membrane surfaces to the cytoplasmic membrane surface are all-trans-retinaldehyde (ATR) and N-retinyl-phosphatidyl-ethanolamine (NR-PE). Once transported to the cytoplasmic surface, ATR is reduced to vitamin A by trans-retinol dehydrogenase (tRDH) and then transferred to the retinal pigment epithelium (RPE) where it is converted to 11-cis-retinal. May play a role in photoresponse, removing ATR/NR-PE from the extracellular photoreceptor surfaces during bleach recovery."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE285",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "IL19",
    "uniprot_id": "Q9UHD0",
    "function": "May play some important roles in inflammatory responses. Up-regulates IL-6 and TNF-alpha and induces apoptosis (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE286",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "IL10",
    "uniprot_id": "P22301",
    "function": "Major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation. Mechanistically, IL10 binds to its heterotetrameric receptor comprising IL10RA and IL10RB leading to JAK1 and STAT2-mediated phosphorylation of STAT3. In turn, STAT3 translocates to the nucleus where it drives expression of anti-inflammatory mediators. Targets antigen-presenting cells (APCs) such as macrophages and monocytes and inhibits their release of pro-inflammatory cytokines including granulocyte-macrophage colony-stimulating factor /GM-CSF, granulocyte colony-stimulating factor/G-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8 and TNF-alpha. Interferes also with antigen presentation by reducing the expression of MHC-class II and co-stimulatory molecules, thereby inhibiting their ability to induce T cell activation. In addition, controls the inflammatory response of macrophages by reprogramming essential metabolic pathways including mTOR signaling (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE287",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "G6PC",
    "uniprot_id": "P35575",
    "function": "Hydrolyzes glucose-6-phosphate to glucose in the endoplasmic reticulum. Forms with the glucose-6-phosphate transporter (SLC37A4/G6PT) the complex responsible for glucose production through glycogenolysis and gluconeogenesis. Hence, it is the key enzyme in homeostatic regulation of blood glucose levels."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE288",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "IL4R",
    "uniprot_id": "P24394",
    "function": "Receptor for both interleukin 4 and interleukin 13. Couples to the JAK1/2/3-STAT6 pathway. The IL4 response is involved in promoting Th2 differentiation. The IL4/IL13 responses are involved in regulating IgE production and, chemokine and mucus production at sites of allergic inflammation. In certain cell types, can signal through activation of insulin receptor substrates, IRS1/IRS2."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE289",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "PPARG",
    "uniprot_id": "P37231",
    "function": "Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of ARNTL/BMAL1 in the blood vessels (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE290",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "PALB2",
    "uniprot_id": "Q86YC2",
    "function": "Plays a critical role in homologous recombination repair (HRR) through its ability to recruit BRCA2 and RAD51 to DNA breaks. Strongly stimulates the DNA strand-invasion activity of RAD51, stabilizes the nucleoprotein filament against a disruptive BRC3-BRC4 polypeptide and helps RAD51 to overcome the suppressive effect of replication protein A (RPA). Functionally cooperates with RAD51AP1 in promoting of D-loop formation by RAD51. Serves as the molecular scaffold in the formation of the BRCA1-PALB2-BRCA2 complex which is essential for homologous recombination. Via its WD repeats is proposed to scaffold a HR complex containing RAD51C and BRCA2 which is thought to play a role in HR-mediated DNA repair. Essential partner of BRCA2 that promotes the localization and stability of BRCA2. Also enables its recombinational repair and checkpoint functions of BRCA2. May act by promoting stable association of BRCA2 with nuclear structures, allowing BRCA2 to escape the effects of proteasome-mediated degradation. Binds DNA with high affinity for D loop, which comprises single-stranded, double-stranded and branched DNA structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks, together with BRCA2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE291",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "LEPR",
    "uniprot_id": "P48357",
    "function": "Receptor for hormone LEP/leptin (Probable). On ligand binding, mediates LEP central and peripheral effects through the activation of different signaling pathways such as JAK2/STAT3 and MAPK cascade/FOS. In the hypothalamus, LEP acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones (By similarity). In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic and affects innate and adaptive immunity. Control of energy homeostasis and melanocortin production (stimulation of POMC and full repression of AgRP transcription) is mediated by STAT3 signaling, whereas distinct signals regulate NPY and the control of fertility, growth and glucose homeostasis. Involved in the regulation of counter-regulatory response to hypoglycemia by inhibiting neurons of the parabrachial nucleus. Has a specific effect on T lymphocyte responses, differentially regulating the proliferation of naive and memory T -ells. Leptin increases Th1 and suppresses Th2 cytokine production (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE292",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "BTD",
    "uniprot_id": "P43251",
    "function": "Catalytic release of biotin from biocytin, the product of biotin-dependent carboxylases degradation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE293",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "PTPRQ",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE294",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "AC107223.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE295",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "TENM3-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE296",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "VPS35",
    "uniprot_id": "Q96QK1",
    "function": "Acts as component of the retromer cargo-selective complex (CSC). The CSC is believed to be the core functional component of retromer or respective retromer complex variants acting to prevent missorting of selected transmembrane cargo proteins into the lysosomal degradation pathway. The recruitment of the CSC to the endosomal membrane involves RAB7A and SNX3. The CSC seems to associate with the cytoplasmic domain of cargo proteins predominantly via VPS35, however, these interactions seem to be of low affinity and retromer SNX proteins may also contribute to cargo selectivity thus questioning the classical function of the CSC. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX3-retromer mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway. The SNX27-retromer is believed to be involved in endosome-to-plasma membrane trafficking and recycling of a broad spectrum of cargo proteins. The CSC seems to act as recruitment hub for other proteins, such as the WASH complex and TBC1D5 (Probable). Required for retrograde transport of lysosomal enzyme receptor IGF2R and SLC11A2. Required to regulate transcytosis of the polymeric immunoglobulin receptor (pIgR-pIgA). Required for endosomal localization of WASHC2C. Mediates the association of the CSC with the WASH complex via WASHC2. Required for the endosomal localization of TBC1D5 ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE297",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "AP002989.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE298",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "PKP2",
    "uniprot_id": "Q99959",
    "function": "May play a role in junctional plaques."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE299",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "TBXAS1",
    "uniprot_id": "P24557",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE300",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "NIPAL4",
    "uniprot_id": "Q0D2K0",
    "function": "Acts as a Mg(2+) transporter. Can also transport other divalent cations such as Ba(2+), Mn(2+), Sr(2+) and Co(2+) but to a much less extent than Mg(2+) (By similarity). May be a receptor for ligands (trioxilins A3 and B3) from the hepoxilin pathway."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE301",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "ADAM19",
    "uniprot_id": "Q9H013",
    "function": "Participates in the proteolytic processing of beta-type neuregulin isoforms which are involved in neurogenesis and synaptogenesis, suggesting a regulatory role in glial cell. Also cleaves alpha-2 macroglobulin. May be involved in osteoblast differentiation and/or osteoblast activity in bone (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE302",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "PAH",
    "uniprot_id": "P00439",
    "function": "Catalyzes the hydroxylation of L-phenylalanine to L-tyrosine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE303",
  "fields": {
    "chromosome_patch": "MT",
    "gene_name": "MT-ND6",
    "uniprot_id": "P03923",
    "function": "Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE304",
  "fields": {
    "chromosome_patch": "MT",
    "gene_name": "MT-ATP6",
    "uniprot_id": "P00846",
    "function": "Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Key component of the proton channel, it may play a direct role in the translocation of protons across the membrane."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE305",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "GDF1",
    "uniprot_id": "P27539",
    "function": "May mediate cell differentiation events during embryonic development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE306",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "CERS1",
    "uniprot_id": "P27544",
    "function": "Ceramide synthase that catalyzes formation of ceramide from sphinganine and acyl-CoA substrates, with high selectivity toward stearoyl-CoA (octadecanoyl-CoA, C18:0-CoA)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE307",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "IRF5",
    "uniprot_id": "Q13568",
    "function": "Transcription factor involved in the induction of interferons IFNA and INFB and inflammatory cytokines upon virus infection. Activated by TLR7 or TLR8 signaling."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE308",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "KCTD7",
    "uniprot_id": "Q96MP8",
    "function": "May be involved in the control of excitability of cortical neurons."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE309",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UNC80",
    "uniprot_id": "Q8N2C7",
    "function": "Component of the NALCN sodium channel complex, required for channel regulation. This complex is a cation channel activated by neuropeptides substance P, neurotensin, and extracellular calcium that regulates neuronal excitability by controlling the sizes of NALCN-dependent sodium-leak current. UNC80 is essential for NALCN sensitivity to extracellular calcium."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE310",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "GFPT1",
    "uniprot_id": "Q06210",
    "function": "Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins. Regulates the circadian expression of clock genes ARNTL/BMAL1 and CRY1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE311",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "SLC26A4-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE312",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "CA2",
    "uniprot_id": "P00918",
    "function": "Essential for bone resorption and osteoclast differentiation (By similarity). Reversible hydration of carbon dioxide. Can hydrate cyanamide to urea. Involved in the regulation of fluid secretion into the anterior chamber of the eye. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption. Stimulates the chloride-bicarbonate exchange activity of SLC26A6."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE313",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "IL13",
    "uniprot_id": "P35225",
    "function": "Cytokine. Inhibits inflammatory cytokine production. Synergizes with IL2 in regulating interferon-gamma synthesis. May be critical in regulating inflammatory and immune responses. Positively regulates IL31RA expression in macrophages (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE314",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "TH2LCRR",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE315",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "ABCA1",
    "uniprot_id": "O95477",
    "function": "Catalyzes the translocation of specific phospholipids from the cytoplasmic to the extracellular/lumenal leaflet of membrane coupled to the hydrolysis of ATP. Thereby, participates to phospholipids transfer to apoliproteins to form nascent high density lipoproteins/HDLs. Transports preferentially phosphatidylcholine over phosphatidylserine. May play a similar role in the efflux of intracellular cholesterol to apoliproteins and the formation of nascent high density lipoproteins/HDLs ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE316",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "AL360015.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE317",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "AC093495.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE318",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "XPC",
    "uniprot_id": "Q01831",
    "function": "Involved in global genome nucleotide excision repair (GG-NER) by acting as damage sensing and DNA-binding factor component of the XPC complex. Has only a low DNA repair activity by itself which is stimulated by RAD23B and RAD23A. Has a preference to bind DNA containing a short single-stranded segment but not to damaged oligonucleotides. This feature is proposed to be related to a dynamic sensor function: XPC can rapidly screen duplex DNA for non-hydrogen-bonded bases by forming a transient nucleoprotein intermediate complex which matures into a stable recognition complex through an intrinsic single-stranded DNA-binding activity. The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, XPA, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex. The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs. The orientation of XPC complex binding appears to be crucial for inducing a productive NER. XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery. Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair. In vitro, the XPC:RAD23B dimer is sufficient to initiate NER, it preferentially binds to cisplatin and UV-damaged double-stranded DNA and also binds to a variety of chemically and structurally diverse DNA adducts. XPC:RAD23B contacts DNA both 5' and 3' of a cisplatin lesion with a preference for the 5' side. XPC:RAD23B induces a bend in DNA upon binding. XPC:RAD23B stimulates the activity of DNA glycosylases TDG and SMUG1 ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE319",
  "fields": {
    "chromosome_patch": "21",
    "gene_name": "IFNAR2",
    "uniprot_id": "P48551",
    "function": "Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 3 is a potent inhibitor of type I IFN receptor activity ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE320",
  "fields": {
    "chromosome_patch": "CHR_HSCHR11_1_CTG7",
    "gene_name": "KCNQ1",
    "uniprot_id": "P51787",
    "function": "Potassium channel that plays an important role in a number of tissues, including heart, inner ear, stomach and colon (By similarity). Associates with KCNE beta subunits that modulates current kinetics (By similarity). Induces a voltage-dependent by rapidly activating and slowly deactivating potassium-selective outward current (By similarity). Promotes also a delayed voltage activated potassium current showing outward rectification characteristic (By similarity). During beta-adrenergic receptor stimulation participates in cardiac repolarization by associating with KCNE1 to form the I(Ks) cardiac potassium current that increases the amplitude and slows down the activation kinetics of outward potassium current I(Ks) (By similarity). Muscarinic agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current. When associated with KCNE3, forms the potassium channel that is important for cyclic AMP-stimulated intestinal secretion of chloride ions. This interaction with KCNE3 is reduced by 17beta-estradiol, resulting in the reduction of currents (By similarity). During conditions of increased substrate load, maintains the driving force for proximal tubular and intestinal sodium ions absorption, gastric acid secretion, and cAMP-induced jejunal chloride ions secretion (By similarity). Allows the provision of potassium ions to the luminal membrane of the secretory canaliculus in the resting state as well as during stimulated acid secretion (By similarity). When associated with KCNE2, forms a heterooligomer complex leading to currents with an apparently instantaneous activation, a rapid deactivation process and a linear current-voltage relationship and decreases the amplitude of the outward current. When associated with KCNE4, inhibits voltage-gated potassium channel activity. When associated with KCNE5, this complex only conducts current upon strong and continued depolarization. Also forms a heterotetramer with KCNQ5, has a voltage-gated potassium channel activity. Binds with phosphatidylinositol 4,5-bisphosphate ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE321",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "APOL1",
    "uniprot_id": "O14791",
    "function": "May play a role in lipid exchange and transport throughout the body. May participate in reverse cholesterol transport from peripheral cells to the liver."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE322",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "ADIPOQ-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE323",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "HNF1A",
    "uniprot_id": "P20823",
    "function": "Transcriptional activator that regulates the tissue specific expression of multiple genes, especially in pancreatic islet cells and in liver (By similarity). Binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Activates the transcription of CYP1A2, CYP2E1 and CYP3A11 (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE324",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "CTLA4",
    "uniprot_id": "P16410",
    "function": "Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE325",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "IL17F",
    "uniprot_id": "Q96PD4",
    "function": "Ligand for IL17RA and IL17RC. The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC. Involved in stimulating the production of other cytokines such as IL6, IL8 and CSF2, and in regulation of cartilage matrix turnover. Also involved in stimulating the proliferation of peripheral blood mononuclear cells and T-cells and in inhibition of angiogenesis. Plays a role in the induction of neutrophilia in the lungs and in the exacerbation of antigen-induced pulmonary allergic inflammation (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE326",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "METTL25",
    "uniprot_id": "Q8N6Q8",
    "function": "Putative methyltransferase."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE327",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "AL137856.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE328",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "PTPN22",
    "uniprot_id": "Q9Y2R2",
    "function": "Acts as negative regulator of T-cell receptor (TCR) signaling by direct dephosphorylation of the Src family kinases LCK and FYN, ITAMs of the TCRz/CD3 complex, as well as ZAP70, VAV, VCP and other key signaling molecules. Associates with and probably dephosphorylates CBL. Dephosphorylates LCK at its activating 'Tyr-394' residue. Dephosphorylates ZAP70 at its activating 'Tyr-493' residue. Dephosphorylates the immune system activator SKAP2. Positively regulates toll-like receptor (TLR)-induced type 1 interferon production. Promotes host antiviral responses mediated by type 1 interferon (By similarity). Regulates NOD2-induced pro-inflammatory cytokine secretion and autophagy ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE329",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "SLC14A2-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE330",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "SLC14A2",
    "uniprot_id": "Q15849",
    "function": "Specialized low-affinity vasopressin-regulated urea transporter. Mediates rapid transepithelial urea transport across the inner medullary collecting duct and plays a major role in the urinary concentrating mechanism."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE331",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "AGL",
    "uniprot_id": "P35573",
    "function": "Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE332",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "DSG1-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE333",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "DSG4",
    "uniprot_id": "Q86SJ6",
    "function": "Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion. Coordinates the transition from proliferation to differentiation in hair follicle keratinocytes (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE334",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "PTPN11",
    "uniprot_id": "Q06124",
    "function": "Acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus. Positively regulates MAPK signal transduction pathway. Dephosphorylates GAB1, ARHGAP35 and EGFR. Dephosphorylates ROCK2 at 'Tyr-722' resulting in stimulatation of its RhoA binding activity. Dephosphorylates CDC73 ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE335",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "NECTIN4",
    "uniprot_id": "Q96NY8",
    "function": "Seems to be involved in cell adhesion through trans-homophilic and -heterophilic interactions, the latter including specifically interactions with NECTIN1. Does not act as receptor for alpha-herpesvirus entry into cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE336",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "SEPSECS",
    "uniprot_id": "Q9HD40",
    "function": "Converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) required for selenoprotein biosynthesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE337",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "TRAPPC9",
    "uniprot_id": "Q96Q05",
    "function": "Functions as an activator of NF-kappa-B through increased phosphorylation of the IKK complex. May function in neuronal cells differentiation. May play a role in vesicular transport from endoplasmic reticulum to Golgi."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE338",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "TRPM4",
    "uniprot_id": "Q8TD43",
    "function": "Calcium-activated non selective (CAN) cation channel that mediates membrane depolarization. While it is activated by increase in intracellular Ca(2+), it is impermeable to it. Mediates transport of monovalent cations (Na(+) > K(+) > Cs(+) > Li(+)), leading to depolarize the membrane. It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, endocrine pancreas cells, kidney epithelial cells, cochlea hair cells etc. Participates in T-cell activation by modulating Ca(2+) oscillations after T lymphocyte activation, which is required for NFAT-dependent IL2 production. Involved in myogenic constriction of cerebral arteries. Controls insulin secretion in pancreatic beta-cells. May also be involved in pacemaking or could cause irregular electrical activity under conditions of Ca(2+) overload. Affects T-helper 1 (Th1) and T-helper 2 (Th2) cell motility and cytokine production through differential regulation of calcium signaling and NFATC1 localization. Enhances cell proliferation through up-regulation of the beta-catenin signaling pathway."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE339",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "PEX6",
    "uniprot_id": "Q13608",
    "function": "Involved in peroxisome biosynthesis. Required for stability of the PTS1 receptor. Anchored by PEX26 to peroxisome membranes, possibly to form heteromeric AAA ATPase complexes required for the import of proteins into peroxisomes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE340",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "PGM3",
    "uniprot_id": "O95394",
    "function": "Catalyzes the conversion of GlcNAc-6-P into GlcNAc-1-P during the synthesis of uridine diphosphate/UDP-GlcNAc, a sugar nucleotide critical to multiple glycosylation pathways including protein N- and O-glycosylation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE341",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "DOP1A",
    "uniprot_id": "Q5JWR5",
    "function": "May be involved in protein traffic between late Golgi and early endosomes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE342",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "MYH7",
    "uniprot_id": "P12883",
    "function": "Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE343",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "ACKR1",
    "uniprot_id": "Q16570",
    "function": "Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Has a promiscuous chemokine-binding profile, interacting with inflammatory chemokines of both the CXC and the CC subfamilies but not with homeostatic chemokines. Acts as a receptor for chemokines including CCL2, CCL5, CCL7, CCL11, CCL13, CCL14, CCL17, CXCL5, CXCL6, IL8/CXCL8, CXCL11, GRO, RANTES, MCP-1, TARC and also for the malaria parasites P.vivax and P.knowlesi. May regulate chemokine bioavailability and, consequently, leukocyte recruitment through two distinct mechanisms: when expressed in endothelial cells, it sustains the abluminal to luminal transcytosis of tissue-derived chemokines and their subsequent presentation to circulating leukocytes, when expressed in erythrocytes, serves as blood reservoir of cognate chemokines but also as a chemokine sink, buffering potential surges in plasma chemokine levels."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE344",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "CADM3-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE345",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "FGF3",
    "uniprot_id": "P11487",
    "function": "Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal ear development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE346",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "HBB",
    "uniprot_id": "P68871",
    "function": "Involved in oxygen transport from the lung to the various peripheral tissues."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE347",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "HBA2",
    "uniprot_id": "P69905",
    "function": "Involved in oxygen transport from the lung to the various peripheral tissues."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE348",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "BEST1",
    "uniprot_id": "O76090",
    "function": "Forms calcium-sensitive chloride channels. Highly permeable to bicarbonate."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE349",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "ABCC6",
    "uniprot_id": "O95255",
    "function": "May participate directly in the active transport of drugs into subcellular organelles or influence drug distribution indirectly. Transports glutathione conjugates as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE350",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "BRCA1",
    "uniprot_id": "P38398",
    "function": "E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE351",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "CRYGD",
    "uniprot_id": "P07320",
    "function": "Crystallins are the dominant structural components of the vertebrate eye lens."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE352",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "CYP11B1",
    "uniprot_id": "P15538",
    "function": "A cytochrome P450 monooxygenase involved in the biosynthesis of adrenal corticoids. Catalyzes the hydroxylation of carbon hydrogen bond at 11-beta position of 11-deoxycortisol and 11-deoxycorticosterone/21-hydroxyprogesterone yielding cortisol or corticosterone, respectively. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate and reducing the second into a water molecule. Two electrons are provided by NADPH via a two-protein mitochondrial transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin) ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE353",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "GML",
    "uniprot_id": "Q99445",
    "function": "May play a role in the apoptotic pathway or cell-cycle regulation induced by p53/TP53 after DNA damage."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE354",
  "fields": {
    "chromosome_patch": "X",
    "gene_name": "MECP2",
    "uniprot_id": "P51608",
    "function": "Chromosomal protein that binds to methylated DNA. It can bind specifically to a single methyl-CpG pair. It is not influenced by sequences flanking the methyl-CpGs. Mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A. Binds both 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)-containing DNA, with a preference for 5-methylcytosine (5mC)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE355",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "ABCA12",
    "uniprot_id": "Q86UK0",
    "function": "Probable transporter involved in lipid homeostasis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE356",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "KLHL3",
    "uniprot_id": "Q9UH77",
    "function": "Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that acts as a regulator of ion transport in the distal nephron. The BCR(KLHL3) complex acts by mediating ubiquitination of WNK4, an inhibitor of potassium channel KCNJ1, leading to WNK4 degradation. The BCR(KLHL3) complex also mediates ubiquitination and degradation of CLDN8, a tight-junction protein required for paracellular chloride transport in the kidney (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE357",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "MYT1",
    "uniprot_id": "Q01538",
    "function": "Binds to the promoter region of genes encoding proteolipid proteins of the central nervous system. May play a role in the development of neurons and oligodendroglia in the CNS. May regulate a critical transition point in oligodendrocyte lineage development by modulating oligodendrocyte progenitor proliferation relative to terminal differentiation and up-regulation of myelin gene transcription."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE358",
  "fields": {
    "chromosome_patch": "CHR_HSCHR20_1_CTG3",
    "gene_name": "MYT1",
    "uniprot_id": "Q01538",
    "function": "Binds to the promoter region of genes encoding proteolipid proteins of the central nervous system. May play a role in the development of neurons and oligodendroglia in the CNS. May regulate a critical transition point in oligodendrocyte lineage development by modulating oligodendrocyte progenitor proliferation relative to terminal differentiation and up-regulation of myelin gene transcription."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE359",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "CCR5AS",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE360",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "CCR5",
    "uniprot_id": "P51681",
    "function": "Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE361",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "LRRK2",
    "uniprot_id": "Q5S007",
    "function": "Serine/threonine-protein kinase which phosphorylates a broad range of proteins involved in multiple processes such as neuronal plasticity, autophagy, and vesicle trafficking. Is a key regulator of RAB GTPases by regulating the GTP/GDP exchange and interaction partners of RABs through phosphorylation. Phosphorylates RAB3A, RAB3B, RAB3C, RAB3D, RAB5A, RAB5B, RAB5C, RAB8A, RAB8B, RAB10, RAB12, RAB35, and RAB43. Regulates the RAB3IP-catalyzed GDP/GTP exchange for RAB8A through the phosphorylation of 'Thr-72' on RAB8A. Inhibits the interaction between RAB8A and GDI1 and/or GDI2 by phosphorylating 'Thr-72' on RAB8A. Regulates primary ciliogenesis through phosphorylation of RAB8A and RAB10, which promotes SHH signaling in the brain. Together with RAB29, plays a role in the retrograde trafficking pathway for recycling proteins, such as mannose-6-phosphate receptor (M6PR), between lysosomes and the Golgi apparatus in a retromer-dependent manner. Regulates neuronal process morphology in the intact central nervous system (CNS). Plays a role in synaptic vesicle trafficking. Plays an important role in recruiting SEC16A to endoplasmic reticulum exit sites (ERES) and in regulating ER to Golgi vesicle-mediated transport and ERES organization. Positively regulates autophagy through a calcium-dependent activation of the CaMKK/AMPK signaling pathway. The process involves activation of nicotinic acid adenine dinucleotide phosphate (NAADP) receptors, increase in lysosomal pH, and calcium release from lysosomes. Phosphorylates PRDX3. By phosphorylating APP on 'Thr-743', which promotes the production and the nuclear translocation of the APP intracellular domain (AICD), regulates dopaminergic neuron apoptosis. Independent of its kinase activity, inhibits the proteosomal degradation of MAPT, thus promoting MAPT oligomerization and secretion. In addition, has GTPase activity via its Roc domain which regulates LRRK2 kinase activity ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE362",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "MUTYH",
    "uniprot_id": "Q9UIF7",
    "function": "Involved in oxidative DNA damage repair. Initiates repair of A*oxoG to C*G by removing the inappropriately paired adenine base from the DNA backbone. Possesses both adenine and 2-OH-A DNA glycosylase activities."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE363",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "HBG2",
    "uniprot_id": "P69892",
    "function": "Gamma chains make up the fetal hemoglobin F, in combination with alpha chains."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE364",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "GBA",
    "uniprot_id": "P04062",
    "function": "Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose. Thereby, plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides, participates to the PKC-activated salvage pathway of ceramide formation. Also plays a role in cholesterol metabolism. May either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol. The short chain saturated C8:0-GlcCer and the mono-unsaturated C18:0-GlcCer being the most effective glucose donors for that transglucosylation reaction. Under specific conditions, may alternatively catalyze the reverse reaction, transferring glucose from cholesteryl-beta-D-glucoside to ceramide. Finally, may also hydrolyze cholesteryl-beta-D-glucoside to produce D-glucose and cholesterol ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE365",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "MYBPC3",
    "uniprot_id": "Q14896",
    "function": "Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE366",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "ASAH1",
    "uniprot_id": "Q13510",
    "function": "Lysosomal ceramidase that hydrolyzes sphingolipid ceramides into sphingosine and free fatty acids at acidic pH. Ceramides, sphingosine, and its phosphorylated form sphingosine-1-phosphate are bioactive lipids that mediate cellular signaling pathways regulating several biological processes including cell proliferation, apoptosis and differentiation. Has a higher catalytic efficiency towards C12-ceramides versus other ceramides. Also catalyzes the reverse reaction allowing the synthesis of ceramides from fatty acids and sphingosine. For the reverse synthetic reaction, the natural sphingosine D-erythro isomer is more efficiently utilized as a substrate compared to D-erythro-dihydrosphingosine and D-erythro-phytosphingosine, while the fatty acids with chain lengths of 12 or 14 carbons are the most efficiently used. Has also an N-acylethanolamine hydrolase activity. By regulating the levels of ceramides, sphingosine and sphingosine-1-phosphate in the epidermis, mediates the calcium-induced differentiation of epidermal keratinocytes. Also indirectly regulates tumor necrosis factor/TNF-induced apoptosis (By similarity). By regulating the intracellular balance between ceramides and sphingosine, in adrenocortical cells, probably also acts as a regulator of steroidogenesis ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE367",
  "fields": {
    "chromosome_patch": "MT",
    "gene_name": "MT-TW",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE368",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "MERTK",
    "uniprot_id": "Q12866",
    "function": "Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with GRB2 or PLCG2 and induces phosphorylation of MAPK1, MAPK2, FAK/PTK2 or RAC1. MERTK signaling plays a role in various processes such as macrophage clearance of apoptotic cells, platelet aggregation, cytoskeleton reorganization and engulfment. Functions in the retinal pigment epithelium (RPE) as a regulator of rod outer segments fragments phagocytosis. Plays also an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE369",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "HBE1",
    "uniprot_id": "P02100",
    "function": "The epsilon chain is a beta-type chain of early mammalian embryonic hemoglobin."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE370",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "OR51B5",
    "uniprot_id": "Q9H339",
    "function": "Odorant receptor."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE371",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "PIGG",
    "uniprot_id": "Q5H8A4",
    "function": "Ethanolamine phosphate transferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers ethanolamine phosphate to the GPI second mannose."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE372",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "ADGRE1",
    "uniprot_id": "Q14246",
    "function": "Orphan receptor involved in cell adhesion and probably in cell-cell interactions specifically involving cells of the immune system. May play a role in regulatory T-cells (Treg) development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE373",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "USH2A",
    "uniprot_id": "O75445",
    "function": "Involved in hearing and vision as member of the USH2 complex. In the inner ear, required for the maintenance of the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE374",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "HMSD",
    "uniprot_id": "A8MTL9",
    "function": "Putative serine protease inhibitor."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE375",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "HMSD",
    "uniprot_id": "P0C7T4",
    "function": "This allelic splice variant of HMSD is the precursor of the histocompatibility antigen ACC-6. More generally, minor histocompatibility antigens (mHags) refer to immunogenic peptide which, when complexed with MHC, can generate an immune response after recognition by specific T-cells. The peptides are derived from polymorphic intracellular proteins, which are cleaved by normal pathways of antigen processing. The binding of these peptides to MHC class I or class II molecules and its expression on the cell surface can stimulate T-cell responses and thereby trigger graft rejection or graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation from HLA-identical sibling donor. GVHD is a frequent complication after bone marrow transplantation (BMT), due to mismatch of minor histocompatibility antigen in HLA-matched sibling marrow transplants. However, associated with GVHD, a favorable graft-versus-leukemia (GVL) can be induced by donor-recipient disparities in mHags. ACC-6 is presented to the cell surface by MHC HLA-B*4403. This complex specifically elicits donor-cytotoxic T-lymphocyte (CTL) reactivity against hematologic malignancies after treatment by HLA-identical allogenic BMT. It induces cell recognition and lysis by CTL. Immunogenicity of most autosomal mHags results from single-nucleotide polymorphisms that cause amino-acid substitutions within epitopes, leading to the differential recognition of peptides between donor and recipient."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE376",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "CAPN3",
    "uniprot_id": "P20807",
    "function": "Calcium-regulated non-lysosomal thiol-protease."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE377",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "CTNS",
    "uniprot_id": "O60931",
    "function": "Cystine/H(+) symporter thought to transport cystine out of lysosomes. Plays an important role in melanin synthesis, possibly by preventing melanosome acidification and subsequent degradation of tyrosinase TYR."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE378",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "C19orf12",
    "uniprot_id": "Q9NSK7",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE379",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "AC119427.2",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE380",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "MYO7A",
    "uniprot_id": "Q13402",
    "function": "Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. In the retina, plays an important role in the renewal of the outer photoreceptor disks. Plays an important role in the distribution and migration of retinal pigment epithelial (RPE) melanosomes and phagosomes, and in the regulation of opsin transport in retinal photoreceptors. In the inner ear, plays an important role in differentiation, morphogenesis and organization of cochlear hair cell bundles. Involved in hair-cell vesicle trafficking of aminoglycosides, which are known to induce ototoxicity (By similarity). Motor protein that is a part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for normal hearing."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE381",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "FIG4",
    "uniprot_id": "Q92562",
    "function": "The PI(3,5)P2 regulatory complex regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). In vitro, hydrolyzes all three D5-phosphorylated polyphosphoinositide substrates in the order PtdIns(4,5)P2 > PtdIns(3,5)P2 > PtdIns(3,4,5)P3. Plays a role in the biogenesis of endosome carrier vesicles (ECV) / multivesicular bodies (MVB) transport intermediates from early endosomes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE382",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "CAPN10",
    "uniprot_id": "Q9HC96",
    "function": "Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. May play a role in insulin-stimulated glucose uptake."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE383",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "LPA",
    "uniprot_id": "P08519",
    "function": "Apo(a) is the main constituent of lipoprotein(a) (Lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1. Lp(a) may be a ligand for megalin/Gp 330."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE384",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "GATA3",
    "uniprot_id": "P23771",
    "function": "Transcriptional activator which binds to the enhancer of the T-cell receptor alpha and delta genes. Binds to the consensus sequence 5'-AGATAG-3'. Required for the T-helper 2 (Th2) differentiation process following immune and inflammatory responses."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE385",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "ALS2",
    "uniprot_id": "Q96Q42",
    "function": "May act as a GTPase regulator. Controls survival and growth of spinal motoneurons (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE386",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "AGA",
    "uniprot_id": "P20933",
    "function": "Cleaves the GlcNAc-Asn bond which joins oligosaccharides to the peptide of asparagine-linked glycoproteins."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE387",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "AMN",
    "uniprot_id": "Q9BXJ7",
    "function": "Membrane-bound component of the endocytic receptor formed by AMN and CUBN. Required for normal CUBN glycosylation and trafficking to the cell surface. The complex formed by AMN and CUBN is required for efficient absorption of vitamin B12. Required for normal CUBN-mediated protein transport in the kidney (Probable)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE388",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "TPRN",
    "uniprot_id": "Q4KMQ1",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE389",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "IL36RN",
    "uniprot_id": "Q9UBH0",
    "function": "Inhibits the activity of interleukin-36 (IL36A,IL36B and IL36G) by binding to receptor IL1RL2 and preventing its association with the coreceptor IL1RAP for signaling. Part of the IL-36 signaling system that is thought to be present in epithelial barriers and to take part in local inflammatory response, similar to the IL-1 system with which it shares the coreceptor. Proposed to play a role in skin inflammation. May be involved in the innate immune response to fungal pathogens, such as Aspergillus fumigatus. May activate an anti-inflammatory signaling pathway by recruiting SIGIRR."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE390",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "COG6",
    "uniprot_id": "Q9Y2V7",
    "function": "Required for normal Golgi function."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE391",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "IER3IP1",
    "uniprot_id": "Q9Y5U9",
    "function": "May be implicated in the regulation of apoptosis. May be involved in protein transport between endoplasmic reticulum and Golgi apparatus (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE392",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "IFT43",
    "uniprot_id": "Q96FT9",
    "function": "As a component of IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs), it is involved in ciliogenesis. Involved in retrograde ciliary transport along microtubules from the ciliary tip to the base ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE393",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "VAX1",
    "uniprot_id": "Q5SQQ9",
    "function": "Transcription factor that may function in dorsoventral specification of the forebrain. Required for axon guidance and major tract formation in the developing forebrain. May contribute to the differentiation of the neuroretina, pigmented epithelium and optic stalk (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE394",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "KIF1A",
    "uniprot_id": "Q12756",
    "function": "Motor for anterograde axonal transport of synaptic vesicle precursors. Also required for neuronal dense core vesicles (DCVs) transport to the dendritic spines. The interaction calcium-dependent with CALM1 increases vesicle motility and interaction with the scaffolding proteins PPFIA2 and TANC2 recruits DCVs to synaptic sites."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE395",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "CRTAP",
    "uniprot_id": "O75718",
    "function": "Necessary for efficient 3-hydroxylation of fibrillar collagen prolyl residues."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE396",
  "fields": {
    "chromosome_patch": "X",
    "gene_name": "NR0B1",
    "uniprot_id": "P51843",
    "function": "Orphan nuclear receptor. Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis. Acts as a coregulatory protein that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions. May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE397",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "DNAJC13",
    "uniprot_id": "O75165",
    "function": "Involved in membrane trafficking through early endosomes, such as the early endosome to recycling endosome transport implicated in the recycling of transferrin and the early endosome to late endosome transport implicated in degradation of EGF and EGFR. Involved in the regulation of endosomal membrane tubulation and regulates th dynamics of SNX1 on the endosomal membrane, via association with WASHC2 may link the WASH complex to the retromer SNX-BAR subcomplex ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE398",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "CCL2",
    "uniprot_id": "P13500",
    "function": "Acts as a ligand for C-C chemokine receptor CCR2. Signals through binding and activation of CCR2 and induces a strong chemotactic response and mobilization of intracellular calcium ions. Exhibits a chemotactic activity for monocytes and basophils but not neutrophils or eosinophils. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE399",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "ANTXR1",
    "uniprot_id": "Q9H6X2",
    "function": "Plays a role in cell attachment and migration. Interacts with extracellular matrix proteins and with the actin cytoskeleton. Mediates adhesion of cells to type 1 collagen and gelatin, reorganization of the actin cytoskeleton and promotes cell spreading. Plays a role in the angiogenic response of cultured umbilical vein endothelial cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE400",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "CNTN2",
    "uniprot_id": "Q02246",
    "function": "In conjunction with another transmembrane protein, CNTNAP2, contributes to the organization of axonal domains at nodes of Ranvier by maintaining voltage-gated potassium channels at the juxtaparanodal region. May be involved in cell adhesion."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE401",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "NTRK1",
    "uniprot_id": "P04629",
    "function": "Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand. Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival (By similarity). Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE402",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "BMP1",
    "uniprot_id": "P13497",
    "function": "Cleaves the C-terminal propeptides of procollagen I, II and III. Induces cartilage and bone formation. May participate in dorsoventral patterning during early development by cleaving chordin (CHRD). Responsible for the proteolytic activation of lysyl oxidase LOX."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE403",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "TGM1",
    "uniprot_id": "P22735",
    "function": "Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. Responsible for cross-linking epidermal proteins during formation of the stratum corneum. Involved in cell proliferation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE404",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "CDK5RAP2",
    "uniprot_id": "Q96SN8",
    "function": "Potential regulator of CDK5 activity via its interaction with CDK5R1. Negative regulator of centriole disengagement (licensing) which maintains centriole engagement and cohesion. Involved in regulation of mitotic spindle orientation (By similarity). Plays a role in the spindle checkpoint activation by acting as a transcriptional regulator of both BUBR1 and MAD2 promoter. Together with EB1/MAPRE1, may promote microtubule polymerization, bundle formation, growth and dynamics at the plus ends. Regulates centrosomal maturation by recruitment of the gamma-tubulin ring complex (gamma-TuRC) onto centrosomes. In complex with PDE4DIP isoform 13/MMG8/SMYLE, MAPRE1 and AKAP9, contributes to microtubules nucleation and extension from the centrosome to the cell periphery. Required for the recruitment of AKAP9 to centrosomes. Plays a role in neurogenesis (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE405",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "GBA2",
    "uniprot_id": "Q9HCG7",
    "function": "Non-lysosomal glucosylceramidase that catalyzes the hydrolysis of glucosylceramide (GlcCer) to free glucose and ceramide. Glucosylceramides are membrane glycosphingolipids that have a wide intracellular distribution (By similarity). They are the main precursors of more complex glycosphingolipids that play a role in cellular growth, differentiation, adhesion, signaling, cytoskeletal dynamics and membrane properties (By similarity). Also involved in the transglucosylation of cholesterol, transferring glucose from glucosylceramides, thereby modifying its water solubility and biological properties (By similarity). Under specific conditions, may catalyze the reverse reaction, transferring glucose from cholesteryl-beta-D-glucoside to ceramide (By similarity). Finally, may also play a role in the metabolism of bile acids. It is able to hydrolyze bile acid 3-O-glucosides but also to produce bile acid-glucose conjugates thanks to a bile acid glucosyl transferase activity. However, the relevance of both activities is unclear in vivo (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE406",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "RAB28",
    "uniprot_id": "P51157",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE407",
  "fields": {
    "chromosome_patch": "21",
    "gene_name": "CBS",
    "uniprot_id": "P35520",
    "function": "Hydro-lyase catalyzing the first step of the transsulfuration pathway, where the hydroxyl group of L-serine is displaced by L-homocysteine in a beta-replacement reaction to form L-cystathionine, the precursor of L-cysteine. This catabolic route allows the elimination of L-methionine and the toxic metabolite L-homocysteine. Also involved in the production of hydrogen sulfide, a gasotransmitter with signaling and cytoprotective effects on neurons (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE408",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "MAPKAPK3",
    "uniprot_id": "Q16644",
    "function": "Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE409",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "PINK1-AS",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE410",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "PINK1",
    "uniprot_id": "Q9BXM7",
    "function": "Protects against mitochondrial dysfunction during cellular stress by phosphorylating mitochondrial proteins. Involved in the clearance of damaged mitochondria via selective autophagy (mitophagy) by mediating activation and translocation of PRKN. Targets PRKN to dysfunctional depolarized mitochondria through the phosphorylation of MFN2. Activates PRKN in 2 steps: (1) by mediating phosphorylation at 'Ser-65' of PRKN and (2) mediating phosphorylation of ubiquitin, converting PRKN to its fully-active form. Required for ubiquinone reduction by mitochondrial complex I by mediating phosphorylation of complex I subunit NDUFA10 (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE411",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "TLR1",
    "uniprot_id": "Q15399",
    "function": "Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides. Cooperates with TLR2 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. Forms the activation cluster TLR2:TLR1:CD14 in response to triacylated lipopeptides, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE412",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "AC068993.2",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE413",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "POMGNT2",
    "uniprot_id": "Q8NAT1",
    "function": "O-linked mannose beta-1,4-N-acetylglucosaminyltransferase that transfers UDP-N-acetyl-D-glucosamine to the 4-position of the mannose to generate N-acetyl-D-glucosamine-beta-1,4-O-D-mannosylprotein. Involved in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE414",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "SMAD7",
    "uniprot_id": "O15105",
    "function": "Antagonist of signaling by TGF-beta (transforming growth factor) type 1 receptor superfamily members, has been shown to inhibit TGF-beta (Transforming growth factor) and activin signaling by associating with their receptors thus preventing SMAD2 access. Functions as an adapter to recruit SMURF2 to the TGF-beta receptor complex. Also acts by recruiting the PPP1R15A-PP1 complex to TGFBR1, which promotes its dephosphorylation. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE415",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "TLR4",
    "uniprot_id": "O00206",
    "function": "Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni(2+). Responses triggered by Ni(2+) require non-conserved histidines and are, therefore, species-specific. Both M.tuberculosis HSP70 (dnaK) and HSP65 (groEL-2) act via this protein to stimulate NF-kappa-B expression. In complex with TLR6, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion. Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-). Stimulation of monocytes in vitro with M.tuberculosis PstS1 induces p38 MAPK and ERK1/2 activation primarily via TLR2, but also partially via this receptor ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE416",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "FCGR3B",
    "uniprot_id": "O75015",
    "function": "Receptor for the Fc region of immunoglobulins gamma. Low affinity receptor. Binds complexed or aggregated IgG and also monomeric IgG. Contrary to III-A, is not capable to mediate antibody-dependent cytotoxicity and phagocytosis. May serve as a trap for immune complexes in the peripheral circulation which does not activate neutrophils."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE417",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "ABO",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE418",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "KCNJ11",
    "uniprot_id": "Q14654",
    "function": "This receptor is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium, as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium (By similarity). Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with ABCC9. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE419",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "H6PD",
    "uniprot_id": "O95479",
    "function": "Oxidizes glucose-6-phosphate and glucose, as well as other hexose-6-phosphates."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE420",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "RTN3",
    "uniprot_id": "O95197",
    "function": "May be involved in membrane trafficking in the early secretory pathway. Inhibits BACE1 activity and amyloid precursor protein processing. May induce caspase-8 cascade and apoptosis. May favor BCL2 translocation to the mitochondria upon endoplasmic reticulum stress. In case of enteroviruses infection, RTN3 may be involved in the viral replication or pathogenesis. Induces the formation of endoplasmic reticulum tubules ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE421",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "ICAM1",
    "uniprot_id": "P05362",
    "function": "ICAM proteins are ligands for the leukocyte adhesion protein LFA-1 (integrin alpha-L/beta-2). During leukocyte trans-endothelial migration, ICAM1 engagement promotes the assembly of endothelial apical cups through ARHGEF26/SGEF and RHOG activation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE422",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "AC011511.2",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE423",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "BBS10",
    "uniprot_id": "Q8TAM1",
    "function": "Probable molecular chaperone that assists the folding of proteins upon ATP hydrolysis. Plays a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Involved in adipogenic differentiation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE424",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "LRRK1",
    "uniprot_id": "Q38SD2",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE425",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "ATM",
    "uniprot_id": "Q13315",
    "function": "Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FANCD2, NFKBIA, BRCA1, CTIP, nibrin (NBN), TERF1, RAD9, UBQLN4 and DCLRE1C. May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Plays a role in replication-dependent histone mRNA degradation. Binds DNA ends. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation. Phosphorylates ATF2 which stimulates its function in DNA damage response. Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE426",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "MASP2",
    "uniprot_id": "O00187",
    "function": "Serum protease that plays an important role in the activation of the complement system via mannose-binding lectin. After activation by auto-catalytic cleavage it cleaves C2 and C4, leading to their activation and to the formation of C3 convertase."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE427",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "LMNA",
    "uniprot_id": "P02545",
    "function": "Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation. Required for osteoblastogenesis and bone formation. Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone. Required for cardiac homeostasis ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE428",
  "fields": {
    "chromosome_patch": "MT",
    "gene_name": "MT-CO3",
    "uniprot_id": "P00414",
    "function": "Subunits I, II and III form the functional core of the enzyme complex."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE429",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "SLC2A10",
    "uniprot_id": "O95528",
    "function": "Facilitative glucose transporter required for the development of the cardiovascular system."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE430",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "FANCG",
    "uniprot_id": "O15287",
    "function": "DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Candidate tumor suppressor gene."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE431",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "NBN",
    "uniprot_id": "O60934",
    "function": "Component of the MRE11-RAD50-NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11. RAD50 may be required to bind DNA ends and hold them in close proximity. NBN modulate the DNA damage signal sensing by recruiting PI3/PI4-kinase family members ATM, ATR, and probably DNA-PKcs to the DNA damage sites and activating their functions. It can also recruit MRE11 and RAD50 to the proximity of DSBs by an interaction with the histone H2AX. NBN also functions in telomere length maintenance by generating the 3' overhang which serves as a primer for telomerase dependent telomere elongation. NBN is a major player in the control of intra-S-phase checkpoint and there is some evidence that NBN is involved in G1 and G2 checkpoints. The roles of NBS1/MRN encompass DNA damage sensor, signal transducer, and effector, which enable cells to maintain DNA integrity and genomic stability. Forms a complex with RBBP8 to link DNA double-strand break sensing to resection. Enhances AKT1 phosphorylation possibly by association with the mTORC2 complex."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE432",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "SNRPE",
    "uniprot_id": "P62304",
    "function": "Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome. As part of the U7 snRNP it is involved in histone 3'-end processing. May indirectly play a role in hair development ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE433",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "CERS3",
    "uniprot_id": "Q8IU89",
    "function": "Ceramide synthase that catalyzes formation of ceramide from sphinganine and acyl-CoA substrates, with high selectivity toward very-long (C22:0-C24:0) and ultra long chain (more than C26:0) as acyl donor. It is crucial for the synthesis of ultra long-chain ceramides in the epidermis, to maintain epidermal lipid homeostasis and terminal. differentiation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE434",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "KIF1C",
    "uniprot_id": "O43896",
    "function": "Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end-directed motility."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE435",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "VPS53",
    "uniprot_id": "Q5VIR6",
    "function": "Acts as component of the GARP complex that is involved in retrograde transport from early and late endosomes to the trans-Golgi network (TGN). The GARP complex is required for the maintenance of the cycling of mannose 6-phosphate receptors between the TGN and endosomes, this cycling is necessary for proper lysosomal sorting of acid hydrolases such as CTSD. Acts as component of the EARP complex that is involved in endocytic recycling. The EARP complex associates with Rab4-positive endosomes and promotes recycling of internalized transferrin receptor (TFRC) to the plasma membrane ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE436",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "EPS8",
    "uniprot_id": "Q12929",
    "function": "Signaling adapter that controls various cellular protrusions by regulating actin cytoskeleton dynamics and architecture. Depending on its association with other signal transducers, can regulate different processes. Together with SOS1 and ABI1, forms a trimeric complex that participates in transduction of signals from Ras to Rac by activating the Rac-specific guanine nucleotide exchange factor (GEF) activity. Acts as a direct regulator of actin dynamics by binding actin filaments and has both barbed-end actin filament capping and actin bundling activities depending on the context. Displays barbed-end actin capping activity when associated with ABI1, thereby regulating actin-based motility process: capping activity is auto-inhibited and inhibition is relieved upon ABI1 interaction. Also shows actin bundling activity when associated with BAIAP2, enhancing BAIAP2-dependent membrane extensions and promoting filopodial protrusions. Involved in the regulation of processes such as axonal filopodia growth, stereocilia length, dendritic cell migration and cancer cell migration and invasion. Acts as a regulator of axonal filopodia formation in neurons: in the absence of neurotrophic factors, negatively regulates axonal filopodia formation via actin-capping activity. In contrast, it is phosphorylated in the presence of BDNF leading to inhibition of its actin-capping activity and stimulation of filopodia formation. Component of a complex with WHRN and MYO15A that localizes at stereocilia tips and is required for elongation of the stereocilia actin core. Indirectly involved in cell cycle progression, its degradation following ubiquitination being required during G2 phase to promote cell shape changes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE437",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "SASH1",
    "uniprot_id": "O94885",
    "function": "Is a positive regulator of NF-kappa-B signaling downstream of TLR4 activation. It acts as a scaffold molecule to assemble a molecular complex that includes TRAF6, MAP3K7, CHUK and IKBKB, thereby facilitating NF-kappa-B signaling activation. Regulates TRAF6 and MAP3K7 ubiquitination. Involved in the regulation of cell mobility. Regulates lipolysaccharide (LPS)-induced endothelial cell migration. Is involved in the regulation of skin pigmentation through the control of melanocyte migration in the epidermis ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE438",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "CELSR1",
    "uniprot_id": "Q9NYQ6",
    "function": "Receptor that may have an important role in cell/cell signaling during nervous system formation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE439",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "FUT2",
    "uniprot_id": "Q10981",
    "function": "Mediates the transfer of fucose to the terminal galactose on glycan chains of cell surface glycoproteins and glycolipids. The resulting epitope plays a role in cell-cell interaction including host-microbe interaction. Mediates interaction with intestinal microbiota influencing its composition. Creates a soluble precursor oligosaccharide FuC-alpha ((1,2)Galbeta-) called the H antigen which is an essential substrate for the final step in the soluble ABO blood group antigen synthesis pathway ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE440",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "NFATC2",
    "uniprot_id": "Q13469",
    "function": "Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2, IL-3, IL-4, TNF-alpha or GM-CSF. Promotes invasive migration through the activation of GPC6 expression and WNT5A signaling pathway."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE441",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "TCN2",
    "uniprot_id": "P20062",
    "function": "Primary vitamin B12-binding and transport protein. Delivers cobalamin to cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE442",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "KHDC3L",
    "uniprot_id": "Q587J8",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE443",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "COL11A2",
    "uniprot_id": "P13942",
    "function": "May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE444",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "TNFAIP3",
    "uniprot_id": "P21580",
    "function": "Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways, affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG, the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin, polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE445",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "RNF24",
    "uniprot_id": "Q9Y225",
    "function": "May play a role in TRPCs intracellular trafficking."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE446",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "CYP2R1",
    "uniprot_id": "Q6VVX0",
    "function": "Has a D-25-hydroxylase activity on both forms of vitamin D, vitamin D(2) and D(3)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE447",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "ADA",
    "uniprot_id": "P00813",
    "function": "Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine. Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4. Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion. Enhances dendritic cell immunogenicity by affecting dendritic cell costimulatory molecule expression and cytokines and chemokines secretion (By similarity). Enhances CD4+ T-cell differentiation and proliferation. Acts as a positive modulator of adenosine receptors ADORA1 and ADORA2A, by enhancing their ligand affinity via conformational change. Stimulates plasminogen activation. Plays a role in male fertility. Plays a protective role in early postimplantation embryonic development (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE448",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHGA1",
    "uniprot_id": "Q9Y5H4",
    "function": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE449",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHGA2",
    "uniprot_id": "Q9Y5H1",
    "function": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE450",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "SPG7",
    "uniprot_id": "Q9UQ90",
    "function": "ATP-dependent zinc metalloprotease. Plays a role in the formation and regulation of the mitochondrial permeability transition pore (mPTP) and its proteolytic activity is dispensable for this function ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE451",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "SCNN1B",
    "uniprot_id": "P51168",
    "function": "Sodium permeable non-voltage-sensitive ion channel inhibited by the diuretic amiloride. Mediates the electrodiffusion of the luminal sodium (and water, which follows osmotically) through the apical membrane of epithelial cells. Plays an essential role in electrolyte and blood pressure homeostasis, but also in airway surface liquid homeostasis, which is important for proper clearance of mucus. Controls the reabsorption of sodium in kidney, colon, lung and sweat glands. Also plays a role in taste perception."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE452",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "SERPINA1",
    "uniprot_id": "P01009",
    "function": "Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE453",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "MAPK6",
    "uniprot_id": "Q16659",
    "function": "Atypical MAPK protein. Phosphorylates microtubule-associated protein 2 (MAP2) and MAPKAPK5. The precise role of the complex formed with MAPKAPK5 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPKAPK5, ERK3/MAPK6 is phosphorylated at Ser-189 and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6. May promote entry in the cell cycle (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE454",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "POT1-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE455",
  "fields": {
    "chromosome_patch": "X",
    "gene_name": "RS1",
    "uniprot_id": "O15537",
    "function": "Binds negatively charged membrane lipids, such as phosphatidylserine and phosphoinositides (By similarity). May play a role in cell-cell adhesion processes in the retina, via homomeric interaction between octamers present on the surface of two neighboring cells. Required for normal structure and function of the retina ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE456",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A3",
    "uniprot_id": "P35503",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE457",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A9",
    "uniprot_id": "O60656",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE458",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A4",
    "uniprot_id": "P22310",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1 (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE459",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A6",
    "uniprot_id": "P19224",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols. Isoform 3 lacks transferase activity but acts as a negative regulator of isoform 1 (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE460",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A7",
    "uniprot_id": "Q9HAW7",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE461",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A8",
    "uniprot_id": "Q9HAW9",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE462",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A10",
    "uniprot_id": "Q9HAW8",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE463",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A5",
    "uniprot_id": "P35504",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1 (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE464",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "BDNF",
    "uniprot_id": "P23560",
    "function": "Important signaling molecule that activates signaling cascades downstream of NTRK2. During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribution to a range of adaptive neuronal responses including long-term potentiation (LTP), long-term depression (LTD), certain forms of short-term synaptic plasticity, as well as homeostatic regulation of intrinsic neuronal excitability."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE465",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "BDNF-AS",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE466",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "MSH2",
    "uniprot_id": "P43246",
    "function": "Component of the post-replicative DNA mismatch repair system (MMR). Forms two different heterodimers: MutS alpha (MSH2-MSH6 heterodimer) and MutS beta (MSH2-MSH3 heterodimer) which binds to DNA mismatches thereby initiating DNA repair. When bound, heterodimers bend the DNA helix and shields approximately 20 base pairs. MutS alpha recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. MutS beta recognizes larger insertion-deletion loops up to 13 nucleotides long. After mismatch binding, MutS alpha or beta forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. Recruits DNA helicase MCM9 to chromatin which unwinds the mismatch containing DNA strand. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. In melanocytes may modulate both UV-B-induced cell cycle regulation and apoptosis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE467",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "MAPT",
    "uniprot_id": "P10636",
    "function": "Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE468",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "KIAA1257",
    "uniprot_id": "Q9ULG3",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE469",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "CYP21A2",
    "uniprot_id": "P08686",
    "function": "Specifically catalyzes the 21-hydroxylation of steroids. Required for the adrenal synthesis of mineralocorticoids and glucocorticoids ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE470",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "PON1",
    "uniprot_id": "P27169",
    "function": "Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE471",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "CPNE4",
    "uniprot_id": "Q96A23",
    "function": "Probable calcium-dependent phospholipid-binding protein that may play a role in calcium-mediated intracellular processes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE472",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "IL17RD",
    "uniprot_id": "Q8NFM7",
    "function": "Feedback inhibitor of fibroblast growth factor mediated Ras-MAPK signaling and ERK activation. May inhibit FGF-induced FGFR1 tyrosine phosphorylation. Regulates the nuclear ERK signaling pathway by spatially blocking nuclear translocation of activated ERK without inhibiting cytoplasmic phosphorylation of ERK. Mediates JNK activation and may be involved in apoptosis. Might have a role in the early stages of fate specification of GnRH-secreting neurons (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE473",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHA6",
    "uniprot_id": "Q9UN73",
    "function": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE474",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHA5",
    "uniprot_id": "Q9Y5H7",
    "function": "Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE475",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "PCDHA7",
    "uniprot_id": "Q9UN72",
    "function": "Calcium-dependent cell-adhesion protein involved in cells self-recognition and non-self discrimination. Thereby, it is involved in the establishment and maintenance of specific neuronal connections in the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE476",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "SRA1",
    "uniprot_id": "Q9HD15",
    "function": "Functional RNA which acts as a transcriptional coactivator that selectively enhances steroid receptor-mediated transactivation ligand-independently through a mechanism involving the modulating N-terminal domain (AF-1) of steroid receptors. Also mediates transcriptional coactivation of steroid receptors ligand-dependently through the steroid-binding domain (AF-2). Enhances cellular proliferation and differentiation and promotes apoptosis in vivo. May play a role in tumorigenesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE477",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "INS-IGF2",
    "uniprot_id": "F8WCM5",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE478",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "INS",
    "uniprot_id": "P01308",
    "function": "Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE479",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "AL356234.2",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE480",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "CD2AP",
    "uniprot_id": "Q9Y5K6",
    "function": "Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton. In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity). May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By similarity). May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis. Plays a role in epithelial cell junctions formation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE481",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "ELMO1",
    "uniprot_id": "Q92556",
    "function": "Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Acts in association with DOCK1 and CRK. Was initially proposed to be required in complex with DOCK1 to activate Rac Rho small GTPases. May enhance the guanine nucleotide exchange factor (GEF) activity of DOCK1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE482",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "IL17RC",
    "uniprot_id": "Q8NAC3",
    "function": "Receptor for IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RA. Receptor for the heterodimer formed by IL17A and IL17B as part of a heterodimeric complex with IL17RA. Has also been shown to be the cognate receptor for IL17F and to bind IL17A with high affinity without the need for IL17RA. Activation of IL17RC leads to induction of expression of inflammatory chemokines and cytokines such as CXCL1 ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE483",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "SLC19A3",
    "uniprot_id": "Q9BZV2",
    "function": "Mediates high affinity thiamine uptake, probably via a proton anti-port mechanism. Has no folate transport activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE484",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "GH1",
    "uniprot_id": "P01241",
    "function": "Plays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF-1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE485",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "CSHL1",
    "uniprot_id": "Q14406",
    "function": "May be a novel gestational hormone required to compensate for absence of other members of the GH/CS cluster during gestation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE486",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "COL1A1",
    "uniprot_id": "P02452",
    "function": "Type I collagen is a member of group I collagen (fibrillar forming collagen)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE487",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "COL1A2",
    "uniprot_id": "P08123",
    "function": "Type I collagen is a member of group I collagen (fibrillar forming collagen)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE488",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "P3H1",
    "uniprot_id": "Q32P28",
    "function": "Basement membrane-associated chondroitin sulfate proteoglycan (CSPG). Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens, especially types IV and V. May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE489",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "GLB1",
    "uniprot_id": "P16278",
    "function": "Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE490",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "PRSS56",
    "uniprot_id": "P0CW18",
    "function": "Serine protease required during eye development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE491",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "PNPLA3",
    "uniprot_id": "Q9NST1",
    "function": "Specifically catalyzes coenzyme A (CoA)-dependent acylation of 1-acyl-sn-glycerol 3-phosphate (2-lysophosphatidic acid/LPA) to generate phosphatidic acid (PA), an important metabolic intermediate and precursor for both triglycerides and glycerophospholipids. Does not esterify other lysophospholipids. Acyl donors are long chain (at least C16) fatty acyl-CoAs: arachidonoyl-CoA, linoleoyl-CoA, oleoyl-CoA and at a lesser extent palmitoyl-CoA. Additionally possesses low triacylglycerol lipase and CoA-independent acylglycerol transacylase activities and thus may play a role in acyl-chain remodeling of triglycerides ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE492",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "MC4R",
    "uniprot_id": "P32245",
    "function": "Receptor specific to the heptapeptide core common to adrenocorticotropic hormone and alpha-, beta-, and gamma-MSH. Plays a central role in energy homeostasis and somatic growth. This receptor is mediated by G proteins that stimulate adenylate cyclase (cAMP)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE493",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "AL160269.1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE494",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "HSD17B3",
    "uniprot_id": "P37058",
    "function": "Favors the reduction of androstenedione to testosterone. Uses NADPH while the two other EDH17B enzymes use NADH."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE495",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "GNE",
    "uniprot_id": "Q9Y223",
    "function": "Regulates and initiates biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. Plays an essential role in early development (By similarity). Required for normal sialylation in hematopoietic cells. Sialylation is implicated in cell adhesion, signal transduction, tumorigenicity and metastatic behavior of malignant cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE496",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "CLTA",
    "uniprot_id": "P09496",
    "function": "Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Acts as component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE497",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "C1orf141",
    "uniprot_id": "Q5JVX7",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE498",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "IFNGR1",
    "uniprot_id": "P15260",
    "function": "Associates with IFNGR2 to form a receptor for the cytokine interferon gamma (IFNG). Ligand binding stimulates activation of the JAK/STAT signaling pathway. Plays an essential role in the IFN-gamma pathway that is required for the cellular response to infectious agents ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE499",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "BBS12",
    "uniprot_id": "Q6ZW61",
    "function": "Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Involved in adipogenic differentiation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE500",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "HERC1",
    "uniprot_id": "Q15751",
    "function": "Involved in membrane trafficking via some guanine nucleotide exchange factor (GEF) activity and its ability to bind clathrin. Acts as a GEF for Arf and Rab, by exchanging bound GDP for free GTP. Binds phosphatidylinositol 4,5-bisphosphate, which is required for GEF activity. May also act as a E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE501",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "OTOF",
    "uniprot_id": "Q9HC10",
    "function": "Key calcium ion sensor involved in the Ca(2+)-triggered synaptic vesicle-plasma membrane fusion and in the control of neurotransmitter release at these output synapses. Interacts in a calcium-dependent manner to the presynaptic SNARE proteins at ribbon synapses of cochlear inner hair cells (IHCs) to trigger exocytosis of neurotransmitter. Also essential to synaptic exocytosis in immature outer hair cells (OHCs). May also play a role within the recycling of endosomes (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE502",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "ZMYM6",
    "uniprot_id": "O95789",
    "function": "Plays a role in the regulation of cell morphology and cytoskeletal organization."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE503",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "DNAJB2",
    "uniprot_id": "P25686",
    "function": "Functions as a co-chaperone, regulating the substrate binding and activating the ATPase activity of chaperones of the HSP70/heat shock protein 70 family. In parallel, also contributes to the ubiquitin-dependent proteasomal degradation of misfolded proteins. Thereby, may regulate the aggregation and promote the functional recovery of misfolded proteins like HTT, MC4R, PRKN, RHO and SOD1 and be crucial for many biological processes. Isoform 1 which is localized to the endoplasmic reticulum membranes may specifically function in ER-associated protein degradation of misfolded proteins ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE504",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "STAT4",
    "uniprot_id": "Q14765",
    "function": "Carries out a dual function: signal transduction and activation of transcription. Involved in IL12 signaling."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE505",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "KLHL40",
    "uniprot_id": "Q2TBA0",
    "function": "Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that acts as a key regulator of skeletal muscle development. The BCR(KLHL40) complex acts by mediating ubiquitination and degradation of TFDP1, thereby regulating the activity of the E2F:DP transcription factor complex (By similarity). Promotes stabilization of LMOD3 by acting as a negative regulator of LMOD3 ubiquitination, the molecular process by which it negatively regulates ubiquitination of LMOD3 is however unclear (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE506",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "KIDINS220",
    "uniprot_id": "Q9ULH0",
    "function": "Promotes a prolonged MAP-kinase signaling by neurotrophins through activation of a Rap1-dependent mechanism. Provides a docking site for the CRKL-C3G complex, resulting in Rap1-dependent sustained ERK activation. May play an important role in regulating postsynaptic signal transduction through the syntrophin-mediated localization of receptor tyrosine kinases such as EPHA4. In cooperation with SNTA1 can enhance EPHA4-induced JAK/STAT activation. Plays a role in nerve growth factor (NGF)-induced recruitment of RAPGEF2 to late endosomes and neurite outgrowth. May play a role in neurotrophin- and ephrin-mediated neuronal outgrowth and in axon guidance during neural development and in neuronal regeneration (By similarity). Modulates stress-induced apoptosis of melanoma cells via regulation of the MEK/ERK signaling pathway."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE507",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "RET",
    "uniprot_id": "P07949",
    "function": "Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis, involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Acts as a dependence receptor, in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers, these diseases are characterized by aberrant integrins-regulated cell migration. Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which induces inhibition of food-intake. Activates MAPK- and AKT-signaling pathways. Isoform 1 in complex with GFRAL induces higher activation of MAPK-signaling pathway than isoform 2 in complex with GFRAL ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE508",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "CXCR4",
    "uniprot_id": "P61073",
    "function": "Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ion levels and enhancing MAPK1/MAPK3 activation. Involved in the AKT signaling cascade. Plays a role in regulation of cell migration, e.g. during wound healing. Acts as a receptor for extracellular ubiquitin, leading to enhanced intracellular calcium ions and reduced cellular cAMP levels. Binds bacterial lipopolysaccharide (LPS) et mediates LPS-induced inflammatory response, including TNF secretion by monocytes. Involved in hematopoiesis and in cardiac ventricular septum formation. Also plays an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. Involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE509",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "PTPRG",
    "uniprot_id": "P23470",
    "function": "Possesses tyrosine phosphatase activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE510",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "KNL1",
    "uniprot_id": "Q8NG31",
    "function": "Performs two crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Required for attachment of the kinetochores to the spindle microtubules. Directly links BUB1 and BUB1B to kinetochores. Part of the MIS12 complex, which may be fundamental for kinetochore formation and proper chromosome segregation during mitosis. Acts in coordination with CENPK to recruit the NDC80 complex to the outer kinetochore."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE511",
  "fields": {
    "chromosome_patch": "Y",
    "gene_name": "SRY",
    "uniprot_id": "Q05066",
    "function": "Transcriptional regulator that controls a genetic switch in male development. It is necessary and sufficient for initiating male sex determination by directing the development of supporting cell precursors (pre-Sertoli cells) as Sertoli rather than granulosa cells (By similarity). In male adult brain involved in the maintenance of motor functions of dopaminergic neurons (By similarity). Involved in different aspects of gene regulation including promoter activation or repression (By similarity). Promotes DNA bending. SRY HMG box recognizes DNA by partial intercalation in the minor groove. Also involved in pre-mRNA splicing. Binds to the DNA consensus sequence 5'-[AT]AACAA[AT]-3'."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE512",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "TBCE",
    "uniprot_id": "Q15813",
    "function": "Tubulin-folding protein, involved in the second step of the tubulin folding pathway and in the regulation of tubulin heterodimer dissociation. Required for correct organization of microtubule cytoskeleton and mitotic splindle, and maintenance of the neuronal microtubule network."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE513",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "TTR",
    "uniprot_id": "P02766",
    "function": "Thyroid hormone-binding protein. Probably transports thyroxine from the bloodstream to the brain."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE514",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "SPTBN2",
    "uniprot_id": "O15020",
    "function": "Probably plays an important role in neuronal membrane skeleton."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE515",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "C11orf65",
    "uniprot_id": "Q8NCR3",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE516",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "HARS1",
    "uniprot_id": "P12081",
    "function": "Cytoplasmic histidine--tRNA ligase (Probable). Plays a role in axon guidance."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE517",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "SGSH",
    "uniprot_id": "P51688",
    "function": "Catalyzes a step in lysosomal heparan sulfate degradation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE518",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "SUB1",
    "uniprot_id": "P53999",
    "function": "General coactivator that functions cooperatively with TAFs and mediates functional interactions between upstream activators and the general transcriptional machinery. May be involved in stabilizing the multiprotein transcription complex. Binds single-stranded DNA. Also binds, in vitro, non-specifically to double-stranded DNA (ds DNA)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE519",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "CHRNE",
    "uniprot_id": "Q04844",
    "function": "After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE520",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "JAK2",
    "uniprot_id": "O60674",
    "function": "Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO), or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins. Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, cell stimulation with erythropoietin (EPO) during erythropoiesis leads to JAK2 autophosphorylation, activation, and its association with erythropoietin receptor (EPOR) that becomes phosphorylated in its cytoplasmic domain. Then, STAT5 (STAT5A or STAT5B) is recruited, phosphorylated and activated by JAK2. Once activated, dimerized STAT5 translocates into the nucleus and promotes the transcription of several essential genes involved in the modulation of erythropoiesis. Part of a signaling cascade that is activated by increased cellular retinol and that leads to the activation of STAT5 (STAT5A or STAT5B). In addition, JAK2 mediates angiotensin-2-induced ARHGEF1 phosphorylation. Plays a role in cell cycle by phosphorylating CDKN1B. Cooperates with TEC through reciprocal phosphorylation to mediate cytokine-driven activation of FOS transcription. In the nucleus, plays a key role in chromatin by specifically mediating phosphorylation of 'Tyr-41' of histone H3 (H3Y41ph), a specific tag that promotes exclusion of CBX5 (HP1 alpha) from chromatin ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE521",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "PDYN-AS1",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE522",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "PDYN",
    "uniprot_id": "P01213",
    "function": "Leu-enkephalins compete with and mimic the effects of opiate drugs. They play a role in a number of physiologic functions, including pain perception and responses to stress (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE523",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "TREM2",
    "uniprot_id": "Q9NZC2",
    "function": "Forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding. Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia. Binding to amyloid-beta 42 mediates microglial activation, proliferation, migration, apoptosis and expression of pro-inflammatory cytokines, such as IL6R and CCL3, and the anti-inflammatory cytokine ARG1 (By similarity). Acts as a receptor for lipoprotein particles such as LDL, VLDL, and HDL and for apolipoproteins such as APOA1, APOA2, APOB, APOE, APOE2, APOE3, APOE4, and CLU and enhances their uptake in microglia. Binds phospholipids (preferably anionic lipids) such as phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol and sphingomyelin. Regulates microglial proliferation by acting as an upstream regulator of the Wnt/beta-catenin signaling cascade (By similarity). Required for microglial phagocytosis of apoptotic neurons. Also required for microglial activation and phagocytosis of myelin debris after neuronal injury and of neuronal synapses during synapse elimination in the developing brain (By similarity). Regulates microglial chemotaxis and process outgrowth, and also the microglial response to oxidative stress and lipopolysaccharide (By similarity). It suppresses PI3K and NF-kappa-B signaling in response to lipopolysaccharide, thus promoting phagocytosis, suppressing pro-inflammatory cytokine and nitric oxide production, inhibiting apoptosis and increasing expression of IL10 and TGFB (By similarity). During oxidative stress, it promotes anti-apoptotic NF-kappa-B signaling and ERK signaling (By similarity). Plays a role in microglial MTOR activation and metabolism (By similarity). Regulates age-related changes in microglial numbers. Triggers activation of the immune responses in macrophages and dendritic cells. Mediates cytokine-induced formation of multinucleated giant cells which are formed by the fusion of macrophages (By similarity). In dendritic cells, it mediates up-regulation of chemokine receptor CCR7 and dendritic cell maturation and survival. Involved in the positive regulation of osteoclast differentiation ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE524",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "CDKAL1",
    "uniprot_id": "Q5VV42",
    "function": "Catalyzes the methylthiolation of N6-threonylcarbamoyladenosine (t(6)A), leading to the formation of 2-methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE525",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "CDC14A",
    "uniprot_id": "Q9UNH5",
    "function": "Dual-specificity phosphatase. Required for centrosome separation and productive cytokinesis during cell division. Dephosphorylates SIRT2 around early anaphase. May dephosphorylate the APC subunit FZR1/CDH1, thereby promoting APC-FZR1 dependent degradation of mitotic cyclins and subsequent exit from mitosis. Required for normal hearing ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE526",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "MLXIPL",
    "uniprot_id": "Q9NP71",
    "function": "Transcriptional repressor. Binds to the canonical and non-canonical E box sequences 5'-CACGTG-3' (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE527",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "KIF7",
    "uniprot_id": "Q2M1P5",
    "function": "Essential for hedgehog signaling regulation: acts as both a negative and positive regulator of sonic hedgehog (Shh) and Indian hedgehog (Ihh) pathways, acting downstream of SMO, through both SUFU-dependent and -independent mechanisms. Involved in the regulation of microtubular dynamics. Required for proper organization of the ciliary tip and control of ciliary localization of SUFU-GLI2 complexes (By similarity). Required for localization of GLI3 to cilia in response to Shh. Negatively regulates Shh signaling by preventing inappropriate activation of the transcriptional activator GLI2 in the absence of ligand. Positively regulates Shh signaling by preventing the processing of the transcription factor GLI3 into its repressor form. In keratinocytes, promotes the dissociation of SUFU-GLI2 complexes, GLI2 nuclear translocation and Shh signaling activation (By similarity). Involved in the regulation of epidermal differentiation and chondrocyte development (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE528",
  "fields": {
    "chromosome_patch": "X",
    "gene_name": "SLC35A2",
    "uniprot_id": "P78381",
    "function": "Transports nucleotide sugars from the cytosol into Golgi vesicles where glycosyltransferases function."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE529",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "MCFD2",
    "uniprot_id": "Q8NI22",
    "function": "The MCFD2-LMAN1 complex forms a specific cargo receptor for the ER-to-Golgi transport of selected proteins. Plays a role in the secretion of coagulation factors."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE530",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "IL12B",
    "uniprot_id": "P29460",
    "function": "Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE531",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "SDHB",
    "uniprot_id": "P21912",
    "function": "Iron-sulfur protein (IP) subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE532",
  "fields": {
    "chromosome_patch": "13",
    "gene_name": "SGCG",
    "uniprot_id": "Q13326",
    "function": "Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE533",
  "fields": {
    "chromosome_patch": "X",
    "gene_name": "CDKL5",
    "uniprot_id": "O76039",
    "function": "Mediates phosphorylation of MECP2. May regulate ciliogenesis ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE534",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "USB1",
    "uniprot_id": "Q9BQ65",
    "function": "Phosphodiesterase responsible for the U6 snRNA 3' end processing. Acts as an exoribonuclease (RNase) responsible for trimming the poly(U) tract of the last nucleotides in the pre-U6 snRNA molecule, leading to the formation of mature U6 snRNA 3' end-terminated with a 2',3'-cyclic phosphate."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE535",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "ADAM9",
    "uniprot_id": "Q13443",
    "function": "Cleaves and releases a number of molecules with important roles in tumorigenesis and angiogenesis, such as TEK, KDR, EPHB4, CD40, VCAM1 and CDH5. May mediate cell-cell, cell-matrix interactions and regulate the motility of cells via interactions with integrins."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE536",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "DCDC2",
    "uniprot_id": "Q9UHG0",
    "function": "Protein that plays a role in the inhibition of canonical Wnt signaling pathway. May be involved in neuronal migration during development of the cerebral neocortex (By similarity). Involved in the control of ciliogenesis and ciliary length ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE537",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "UFSP2",
    "uniprot_id": "Q9NUQ7",
    "function": "Thiol protease which recognizes and hydrolyzes the peptide bond at the C-terminal Gly of UFM1, a ubiquitin-like modifier protein bound to a number of target proteins. Does not hydrolyze SUMO1 or ISG15 ubiquitin-like proteins. Through TRIP4 deufmylation may regulate intracellular nuclear receptors transactivation and thereby regulate cell proliferation and differentiation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE538",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "GRHL3",
    "uniprot_id": "Q8TE85",
    "function": "Transcription factor playing important roles in primary neurulation and in the differentiation of stratified epithelia of both ectodermal and endodermal origin (By similarity). Binds directly to the consensus DNA sequence 5'-AACCGGTT-3' acting as an activator and repressor on distinct target genes. xhibits functional redundancy with GRHL2 in epidermal morphogenetic events and epidermal wound repair (By similarity). Exhibits functional redundancy with GRHL2 in epidermal morphogenetic events and epidermal wound repair but is essential to form the epidermal barrier with TGM3 as critical direct target gene among others. Despite being dispensable during normal epidermal homeostasis in the adulthood, is again required for barrier repair after immune-mediated epidermal damage, regulates distinct gene batteries in embryonic epidermal differentiation and adult epidermal barrier reformation after injury. Plays unique and cooperative roles with GRHL2 in establishing distinct zones of primary neurulation. Essential for spinal closure, functions cooperatively with GRHL2 in closure 2 (forebrain/midbrain boundary) and posterior neuropore closure (By similarity). Also required for proper development of the oral periderm. No genetic interaction with GRHL3, no functional cooperativity due to diverse target gene selectivity ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE539",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "SIX1",
    "uniprot_id": "Q15475",
    "function": "Transcription factor that is involved in the regulation of cell proliferation, apoptosis and embryonic development. Plays an important role in the development of several organs, including kidney, muscle and inner ear. Depending on context, functions as transcriptional repressor or activator. Lacks an activation domain, and requires interaction with EYA family members for transcription activation. Mediates nuclear translocation of EYA1 and EYA2. Binds the 5'-TCA[AG][AG]TTNC-3' motif present in the MEF3 element in the MYOG promoter. Regulates the expression of numerous genes, including MYC, CCND1 and EZR. Acts as activator of the IGFBP5 promoter, probably coactivated by EYA2. Repression of precursor cell proliferation in myoblasts is switched to activation through recruitment of EYA3 to the SIX1-DACH1 complex. During myogenesis, seems to act together with EYA2 and DACH2 (By similarity). Regulates the expression of CCNA1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE540",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "DAG1",
    "uniprot_id": "Q14118",
    "function": "The dystroglycan complex is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE541",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "SH3TC2",
    "uniprot_id": "Q8TF17",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE542",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "FUCA1",
    "uniprot_id": "P04066",
    "function": "Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-linked fucose joined to the reducing-end N-acetylglucosamine of the carbohydrate moieties of glycoproteins."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE543",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "TACSTD2",
    "uniprot_id": "P09758",
    "function": "May function as a growth factor receptor."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE544",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "TOX3",
    "uniprot_id": "O15405",
    "function": "Transcriptional coactivator of the p300/CBP-mediated transcription complex. Activates transactivation through cAMP response element (CRE) sites. Protects against cell death by inducing antiapoptotic and repressing pro-apoptotic transcripts. Stimulates transcription from the estrogen-responsive or BCL-2 promoters. Required for depolarization-induced transcription activation of the C-FOS promoter in neurons. Associates with chromatin to the estrogen-responsive C3 promoter region."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE545",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "FTO",
    "uniprot_id": "Q9C0B1",
    "function": "RNA demethylase that mediates oxidative demethylation of different RNA species, such as mRNAs, tRNAs and snRNAs, and acts as a regulator of fat mass, adipogenesis and energy homeostasis. Specifically demethylates N(6)-methyladenosine (m6A) RNA, the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes. M6A demethylation by FTO affects mRNA expression and stability. Also able to demethylate m6A in U6 small nuclear RNA (snRNA). Mediates demethylation of N(6),2'-O-dimethyladenosine cap (m6A(m)), by demethylating the N(6)-methyladenosine at the second transcribed position of mRNAs and U6 snRNA. Demethylation of m6A(m) in the 5'-cap by FTO affects mRNA stability by promoting susceptibility to decapping. Also acts as a tRNA demethylase by removing N(1)-methyladenine from various tRNAs. Has no activity towards 1-methylguanine. Has no detectable activity towards double-stranded DNA. Also able to repair alkylated DNA and RNA by oxidative demethylation: demethylates single-stranded RNA containing 3-methyluracil, single-stranded DNA containing 3-methylthymine and has low demethylase activity towards single-stranded DNA containing 1-methyladenine or 3-methylcytosine. Ability to repair alkylated DNA and RNA is however unsure in vivo. Involved in the regulation of fat mass, adipogenesis and body weight, thereby contributing to the regulation of body size and body fat accumulation. Involved in the regulation of thermogenesis and the control of adipocyte differentiation into brown or white fat cells. Regulates activity of the dopaminergic midbrain circuitry via its ability to demethylate m6A in mRNAs (By similarity). Plays an oncogenic role in a number of acute myeloid leukemias by enhancing leukemic oncogene-mediated cell transformation: acts by mediating m6A demethylation of target transcripts such as MYC, CEBPA, ASB2 and RARA, leading to promote their expression ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE546",
  "fields": {
    "chromosome_patch": "CHR_HG2030_PATCH",
    "gene_name": "ABO",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE547",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "TMPRSS6",
    "uniprot_id": "Q8IU80",
    "function": "Serine protease which hydrolyzes a range of proteins including type I collagen, fibronectin and fibrinogen. Can also activate urokinase-type plasminogen activator with low efficiency. May play a specialized role in matrix remodeling processes in liver. Through the cleavage of HJV, a regulator of the expression of the iron absorption-regulating hormone hepicidin/HAMP, plays a role in iron homeostasis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE548",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "CLDN1",
    "uniprot_id": "O95832",
    "function": "Claudins function as major constituents of the tight junction complexes that regulate the permeability of epithelia. While some claudin family members play essential roles in the formation of impermeable barriers, others mediate the permeability to ions and small molecules. Often, several claudin family members are coexpressed and interact with each other, and this determines the overall permeability. CLDN1 is required to prevent the paracellular diffusion of small molecules through tight junctions in the epidermis and is required for the normal barrier function of the skin. Required for normal water homeostasis and to prevent excessive water loss through the skin, probably via an indirect effect on the expression levels of other proteins, since CLDN1 itself seems to be dispensable for water barrier formation in keratinocyte tight junctions ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE549",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "MAPRE2",
    "uniprot_id": "Q15555",
    "function": "May be involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. May play a role in cell migration (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE550",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "SPAST",
    "uniprot_id": "Q9UBP0",
    "function": "ATP-dependent microtubule severing protein that specifically recognizes and cuts microtubules that are polyglutamylated. Preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold. Severing activity is not dependent on tubulin acetylation or detyrosination. Microtubule severing promotes reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. It is critical for the biogenesis and maintenance of complex microtubule arrays in axons, spindles and cilia. SPAST is involved in abscission step of cytokinesis and nuclear envelope reassembly during anaphase in cooperation with the ESCRT-III complex. Recruited at the midbody, probably by IST1, and participates in membrane fission during abscission together with the ESCRT-III complex. Recruited to the nuclear membrane by IST1 and mediates microtubule severing, promoting nuclear envelope sealing and mitotic spindle disassembly during late anaphase. Required for membrane traffic from the endoplasmic reticulum (ER) to the Golgi and endosome recycling. Recruited by IST1 to endosomes and regulates early endosomal tubulation and recycling by mediating microtubule severing. Probably plays a role in axon growth and the formation of axonal branches ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE551",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "CCDC174",
    "uniprot_id": "Q6PII3",
    "function": "Probably involved in neuronal development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE552",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "ECM1",
    "uniprot_id": "Q16610",
    "function": "Involved in endochondral bone formation as negative regulator of bone mineralization. Stimulates the proliferation of endothelial cells and promotes angiogenesis. Inhibits MMP9 proteolytic activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE553",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "WHRN",
    "uniprot_id": "Q9P202",
    "function": "Involved in hearing and vision as member of the USH2 complex. Necessary for elongation and maintenance of inner and outer hair cell stereocilia in the organ of Corti in the inner ear. Involved in the maintenance of the hair bundle ankle region, which connects stereocilia in cochlear hair cells of the inner ear. In retina photoreceptors, required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE554",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "USH1C",
    "uniprot_id": "Q9Y6N9",
    "function": "Anchoring/scaffolding protein that is a part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for normal development and maintenance of cochlear hair cell bundles (By similarity). As part of the intermicrovillar adhesion complex/IMAC plays a role in brush border differentiation, controlling microvilli organization and length. Probably plays a central regulatory role in the assembly of the complex, recruiting CDHR2, CDHR5 and MYO7B to the microvilli tips ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE555",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "RP1",
    "uniprot_id": "P56715",
    "function": "Microtubule-associated protein regulating the stability and length of the microtubule-based axoneme of photoreceptors. Required for the differentiation of photoreceptor cells, it plays a role in the organization of the outer segment of rod and cone photoreceptors ensuring the correct orientation and higher-order stacking of outer segment disks along the photoreceptor axoneme (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE556",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "HMCN1",
    "uniprot_id": "Q96RW7",
    "function": "Promotes cleavage furrow maturation during cytokinesis in preimplantation embryos. May play a role in the architecture of adhesive and flexible epithelial cell junctions. May play a role during myocardial remodeling by imparting an effect on cardiac fibroblast migration."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE557",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "INSR",
    "uniprot_id": "P06213",
    "function": "Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD, regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. In adipocytes, inhibits lipolysis (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE558",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "NNT",
    "uniprot_id": "Q13423",
    "function": "The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane (By similarity). May play a role in reactive oxygen species (ROS) detoxification in the adrenal gland ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE559",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "TREML4",
    "uniprot_id": "Q6UXN2",
    "function": "Positively regulates Toll-like receptor TLR7 signaling in macrophages."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE560",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "ABCG8",
    "uniprot_id": "Q9H221",
    "function": "ABCG5 and ABCG8 form an obligate heterodimer that mediates Mg(2+)- and ATP-dependent sterol transport across the cell membrane. Plays an essential role in the selective transport of the dietary cholesterol in and out of the enterocytes and in the selective sterol excretion by the liver into bile. Required for normal sterol homeostasis. The heterodimer with ABCG5 has ATPase activity ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE561",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "CDH13",
    "uniprot_id": "P55290",
    "function": "Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells, cadherins may thus contribute to the sorting of heterogeneous cell types. May act as a negative regulator of neural cell growth."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE96",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "SPATA3",
    "uniprot_id": "Q8NHX4",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE97",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "ENPP1",
    "uniprot_id": "P22413",
    "function": "Nucleotide pyrophosphatase that generates diphosphate (PPi) and functions in bone mineralization and soft tissue calcification by regulating pyrophosphate levels (By similarity). PPi inhibits bone mineralization and soft tissue calcification by binding to nascent hydroxyapatite crystals, thereby preventing further growth of these crystals. Preferentially hydrolyzes ATP, but can also hydrolyze other nucleoside 5' triphosphates such as GTP, CTP, TTP and UTP to their corresponding monophosphates with release of pyrophosphate and diadenosine polyphosphates, and also 3',5'-cAMP to AMP. May also be involved in the regulation of the availability of nucleotide sugars in the endoplasmic reticulum and Golgi, and the regulation of purinergic signaling. Inhibits ectopic joint calcification and maintains articular chondrocytes by repressing hedgehog signaling, it is however unclear whether hedgehog inhibition is direct or indirect (By similarity). Appears to modulate insulin sensitivity and function. Also involved in melanogenesis. Also able to hydrolyze 2'-3'-cGAMP (cyclic GMP-AMP), a second messenger that activates TMEM173/STING and triggers type-I interferon production. 2'-3'-cGAMP degradation takes place in the lumen or extracellular space, and not in the cytosol where it is produced, the role of 2'-3'-cGAMP hydrolysis is therefore unclear. Not able to hydrolyze the 2'-3'-cGAMP linkage isomer 3'-3'-cGAMP ."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE98",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "CTSC",
    "uniprot_id": "P53634",
    "function": "Thiol protease. Has dipeptidylpeptidase activity. Active against a broad range of dipeptide substrates composed of both polar and hydrophobic amino acids. Proline cannot occupy the P1 position and arginine cannot occupy the P2 position of the substrate. Can act as both an exopeptidase and endopeptidase. Activates serine proteases such as elastase, cathepsin G and granzymes A and B. Can also activate neuraminidase and factor XIII."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "DISGENE99",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "PRRC2A",
    "uniprot_id": "P48634",
    "function": "May play a role in the regulation of pre-mRNA splicing."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE1",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "ABCB1",
    "uniprot_id": "P08183",
    "function": "Translocates drugs and phospholipids across the membrane. Catalyzes the flop of phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane. Participates mainly to the flop of phosphatidylcholine, phosphatidylethanolamine, beta-D-glucosylceramides and sphingomyelins. Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE10",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "AOX1",
    "uniprot_id": "Q06278",
    "function": "Oxidase with broad substrate specificity, oxidizing aromatic azaheterocycles, such as N1-methylnicotinamide, N-methylphthalazinium and phthalazine, as well as aldehydes, such as benzaldehyde, retinal, pyridoxal, and vanillin. Plays a key role in the metabolism of xenobiotics and drugs containing aromatic azaheterocyclic substituents. Participates in the bioactivation of prodrugs such as famciclovir, catalyzing the oxidation step from 6-deoxypenciclovir to penciclovir, which is a potent antiviral agent. Is probably involved in the regulation of reactive oxygen species homeostasis. May be a prominent source of superoxide generation via the one-electron reduction of molecular oxygen. Also may catalyze nitric oxide (NO) production via the reduction of nitrite to NO with NADH or aldehyde as electron donor. May play a role in adipogenesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE11",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "APOC1",
    "uniprot_id": "P02654",
    "function": "Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10% of the protein of the VLDL and 2% of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE12",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "APOE",
    "uniprot_id": "P02649",
    "function": "APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but shows a preferential binding to high-density lipoproteins (HDL). It also binds a wide range of cellular receptors including the LDL receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8 and the very low-density lipoprotein receptor/VLDLR that mediate the cellular uptake of the APOE-containing lipoprotein particles. Finally, APOE has also a heparin-binding activity and binds heparan-sulfate proteoglycans on the surface of cells, a property that supports the capture and the receptor-mediated uptake of APOE-containing lipoproteins by cells. A main function of APOE is to mediate lipoprotein clearance through the uptake of chylomicrons, VLDLs, and HDLs by hepatocytes. APOE is also involved in the biosynthesis by the liver of VLDLs as well as their uptake by peripheral tissues ensuring the delivery of triglycerides and energy storage in muscle, heart and adipose tissues. By participating to the lipoprotein-mediated distribution of lipids among tissues, APOE plays a critical role in plasma and tissues lipid homeostasis. APOE is also involved in two steps of reverse cholesterol transport, the HDLs-mediated transport of cholesterol from peripheral tissues to the liver, and thereby plays an important role in cholesterol homeostasis. First, it is functionally associated with ABCA1 in the biogenesis of HDLs in tissues. Second, it is enriched in circulating HDLs and mediates their uptake by hepatocytes. APOE also plays an important role in lipid transport in the central nervous system, regulating neuron survival and sprouting. APOE in also involved in innate and adaptive immune responses, controlling for instance the survival of myeloid-derived suppressor cells (By similarity). APOE, may also play a role in transcription regulation through a receptor-dependent and cholesterol-independent mechanism, that activates MAP3K12 and a non-canonical MAPK signal transduction pathway that results in enhanced AP-1-mediated transcription of APP."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE13",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "BRINP3",
    "uniprot_id": "Q76B58",
    "function": "Inhibits neuronal cell proliferation by negative regulation of the cell cycle transition. Promotes pituitary gonadotrope cell proliferation, migration and invasion, when overexpressed. May play a role in cell pituitary tumor development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE14",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "CALU",
    "uniprot_id": "O43852",
    "function": "Involved in regulation of vitamin K-dependent carboxylation of multiple N-terminal glutamate residues. Seems to inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low affinity (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE15",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "CAPZA1",
    "uniprot_id": "P52907",
    "function": "F-actin-capping proteins bind in a Ca2+-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. May play a role in the formation of epithelial cell junctions."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE16",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "CES1P1",
    "uniprot_id": "Q9UKY3",
    "function": "Has no esterase activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE17",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "CHIC2",
    "uniprot_id": "Q9UKJ5",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE18",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "COMT",
    "uniprot_id": "P21964",
    "function": "Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE19",
  "fields": {
    "chromosome_patch": "15",
    "gene_name": "CYP1A2",
    "uniprot_id": "P05177",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2. Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis. May act as a major enzyme for all-trans retinoic acid biosynthesis in the liver. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid. Primarily catalyzes stereoselective epoxidation of the last double bond of polyunsaturated fatty acids (PUFA), displaying a strong preference for the (R,S) stereoisomer. Catalyzes bisallylic hydroxylation and omega-1 hydroxylation of PUFA. May also participate in eicosanoids metabolism by converting hydroperoxide species into oxo metabolites (lipoxygenase-like reaction, NADPH-independent). Plays a role in the oxidative metabolism of xenobiotics. Catalyzes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin. Metabolizes caffeine via N3-demethylation (Probable)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE2",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "ABCB11",
    "uniprot_id": "O95342",
    "function": "Catalyzes the secretion of conjugated bile salts across the canalicular membrane of hepatocytes in an ATP-dependent manner. Transports taurine-conjugated bile salts more rapidly than glycine-conjugated bile salts."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE20",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "CYP2A6",
    "uniprot_id": "P11509",
    "function": "Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1,4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity"
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE21",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "CYP2B6",
    "uniprot_id": "P20813",
    "function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,4-cineole 2-exo-monooxygenase"
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE22",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "CYP2C18",
    "uniprot_id": "P33260",
    "function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE23",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "CYP2C19",
    "uniprot_id": "P33261",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of polyunsaturated fatty acids (PUFA). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Hydroxylates PUFA specifically at the omega-1 position. Catalyzes the epoxidation of double bonds of PUFA . Also metabolizes plant monoterpenes such as limonene. Oxygenates (R)- and (S)-limonene to produce carveol and perillyl alcohol. Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine. Hydroxylates fenbendazole at the 4' position."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE24",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "CYP2C8",
    "uniprot_id": "P10632",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Primarily catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFA) with a preference for the last double bond. Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes all trans-retinoic acid toward its 4-hydroxylated form. Displays 16-alpha hydroxylase activity toward estrogen steroid hormones, 17beta-estradiol (E2) and estrone (E1). Plays a role in the oxidative metabolism of xenobiotics. It is the principal enzyme responsible for the metabolism of the anti-cancer drug paclitaxel (taxol)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE25",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "CYP2C9",
    "uniprot_id": "P11712",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids and steroids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFA). Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis. Exhibits low catalytic activity for the formation of catechol estrogens from 17beta-estradiol (E2) and estrone (E1), namely 2-hydroxy E1 and E2. Catalyzes bisallylic hydroxylation and hydroxylation with double-bond migration of polyunsaturated fatty acids (PUFA). Also metabolizes plant monoterpenes such as limonene. Oxygenates (R)- and (S)-limonene to produce carveol and perillyl alcohol. Contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE26",
  "fields": {
    "chromosome_patch": "22",
    "gene_name": "CYP2D6",
    "uniprot_id": "P10635",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of fatty acids, steroids and retinoids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFA). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 20-hydroxyeicosatetraenoic acid ethanolamide (20-HETE-EA) and 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling. Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis. Catalyzes the oxidative transformations of all-trans retinol to all-trans retinal, a precursor for the active form all-trans-retinoic acid. Also involved in the oxidative metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE27",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "CYP3A4",
    "uniprot_id": "P08684",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position. Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone. Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones. Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis. Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond. Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling. Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance. Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole. Hydroxylates antimalarial drug quinine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE28",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "CYP3A5",
    "uniprot_id": "P20815",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of catechol estrogens from 17beta-estradiol (E2) and estrone (E1), namely 2-hydroxy E1 and E2. Catalyzes 6beta-hydroxylation of the steroid hormones testosterone, progesterone, and androstenedione. Catalyzes the oxidative conversion of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA). Further metabolizes all trans-retinoic acid (atRA) to 4-hydroxyretinoate and may play a role in hepatic atRA clearance. Also involved in the oxidative metabolism of xenobiotics, including calcium channel blocking drug nifedipine and immunosuppressive drug cyclosporine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE29",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "CYP3A7",
    "uniprot_id": "P24462",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of steroid hormones and vitamins during embryogenesis. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes 3beta-hydroxyandrost-5-en-17-one (dehydroepiandrosterone, DHEA), a precursor in the biosynthesis of androgen and estrogen steroid hormones. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1), particularly D-ring hydroxylated estrone at the C16-alpha position. Mainly hydroxylates all trans-retinoic acid (atRA) to 4-hydroxyretinoate and may play a role in atRA clearance during fetal development. Also involved in the oxidative metabolism of xenobiotics including anticonvulsants."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE3",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "ABCC2",
    "uniprot_id": "Q92887",
    "function": "Mediates hepatobiliary excretion of numerous organic anions and conjugated organic anions such as methotrexate, 17beta-estradiol 17-glucosiduronic acid and leukotriene C4. Also transports sulfated bile salt such as taurolithocholate sulfate. May function as a cellular cisplatin transporter."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE30",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "CYP4F2",
    "uniprot_id": "P78329",
    "function": "A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, eicosanoids and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR, NADPH-ferrihemoprotein reductase). Catalyzes predominantly the oxidation of the terminal carbon (omega-oxidation) of long- and very long-chain fatty acids. Displays high omega-hydroxylase activity toward polyunsaturated fatty acids (PUFAs). Participates in the conversion of arachidonic acid to omega-hydroxyeicosatetraenoic acid (20-HETE), a signaling molecule acting both as vasoconstrictive and natriuretic with overall effect on arterial blood pressure. Plays a role in the oxidative inactivation of eicosanoids, including both proinflammatory and anti-inflammatory mediators such as leukotriene B4 (LTB4), lipoxin A4 (LXA4), and several HETEs. Catalyzes omega-hydroxylation of 3-hydroxy fatty acids. Converts monoepoxides of linoleic acid leukotoxin and isoleukotoxin to omega-hydroxylated metabolites. Contributes to the degradation of very long-chain fatty acids (VLCFAs) by catalyzing successive omega-oxidations and chain shortening. Plays an important role in vitamin metabolism by chain shortening. Catalyzes omega-hydroxylation of the phytyl chain of tocopherols (forms of vitamin E), with preference for gamma-tocopherols over alpha-tocopherols, thus promoting retention of alpha-tocopherols in tissues . Omega-hydroxylates and inactivates phylloquinone (vitamin K1), and menaquinone-4 (MK-4, a form of vitamin K2), both acting as cofactors in blood coagulation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE31",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "DOT1L",
    "uniprot_id": "Q8TEK3",
    "function": "Histone methyltransferase. Methylates 'Lys-79' of histone H3. Nucleosomes are preferred as substrate compared to free histones. Binds to DNA."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE32",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "DRD1",
    "uniprot_id": "P21728",
    "function": "Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE33",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "DRD2",
    "uniprot_id": "P14416",
    "function": "Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE34",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "DTNBP1",
    "uniprot_id": "Q96EV8",
    "function": "Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex to facilitate the transport of TYRP1 independent of AP-3 function. Plays a role in synaptic vesicle trafficking and in neurotransmitter release. Plays a role in the regulation of cell surface exposure of DRD2. May play a role in actin cytoskeleton reorganization and neurite outgrowth. May modulate MAPK8 phosphorylation. Appears to promote neuronal transmission and viability through regulating the expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signaling and influencing glutamatergic release. Regulates the expression of SYN1 through binding to its promoter. Modulates prefrontal cortical activity via the dopamine/D2 pathway."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE35",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "DUSP1",
    "uniprot_id": "P28562",
    "function": "Dual specificity phosphatase that dephosphorylates MAP kinase MAPK1/ERK2 on both 'Thr-183' and 'Tyr-185', regulating its activity during the meiotic cell cycle."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE36",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "EDNRA",
    "uniprot_id": "P25101",
    "function": "Receptor for endothelin-1. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of binding affinities for ET-A is: ET1 > ET2 >> ET3."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE37",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "EPHX1",
    "uniprot_id": "P07099",
    "function": "Biotransformation enzyme that catalyzes the hydrolysis of arene and aliphatic epoxides to less reactive and more water soluble dihydrodiols by the trans addition of water (By similarity). May play a role in the metabolism of endogenous lipids such as epoxide-containing fatty acids"
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE38",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "FGF2",
    "uniprot_id": "P09038",
    "function": "Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4. Also acts as an integrin ligand which is required for FGF2 signaling. Binds to integrin ITGAV:ITGB3. Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Can induce angiogenesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE39",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "FMO3",
    "uniprot_id": "P31513",
    "function": "Essential hepatic enzyme that catalyzes the oxygenation of a wide variety of nitrogen- and sulfur-containing compounds including drugs as well as dietary compounds. Plays an important role in the metabolism of trimethylamine (TMA), via the production of trimethylamine N-oxide (TMAO) metabolite. TMA is generated by the action of gut microbiota using dietary precursors such as choline, choline containing compounds, betaine or L-carnitine. By regulating TMAO concentration, FMO3 directly impacts both platelet responsiveness and rate of thrombus formation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE4",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "ABCG2",
    "uniprot_id": "Q9UNQ0",
    "function": "High-capacity urate exporter functioning in both renal and extrarenal urate excretion. Plays a role in porphyrin homeostasis as it is able to mediates the export of protoporhyrin IX (PPIX) both from mitochondria to cytosol and from cytosol to extracellular space, and cellular export of hemin, and heme. Xenobiotic transporter that may play an important role in the exclusion of xenobiotics from the brain. Appears to play a major role in the multidrug resistance phenotype of several cancer cell lines. Implicated in the efflux of numerous drugs and xenobiotics: mitoxantrone, the photosensitizer pheophorbide, camptothecin, methotrexate, azidothymidine (AZT), and the anthracyclines daunorubicin and doxorubicin."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE40",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "FOXA3",
    "uniprot_id": "P55318",
    "function": "Transcription factor that is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites (By similarity). Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis, binds to and activates transcription from the G6PC promoter. Binds to the CYP3A4 promoter and activates its transcription in cooperation with CEBPA. Binds to the CYP3A7 promoter together with members of the CTF/NF-I family. Involved in regulation of neuronal-specific transcription. May be involved in regulation of spermatogenesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE41",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "FPGS",
    "uniprot_id": "Q05932",
    "function": "Catalyzes conversion of folates to polyglutamate derivatives allowing concentration of folate compounds in the cell and the intracellular retention of these cofactors, which are important substrates for most of the folate-dependent enzymes that are involved in one-carbon transfer reactions involved in purine, pyrimidine and amino acid synthesis. Unsubstituted reduced folates are the preferred substrates. Metabolizes methotrexate (MTX) to polyglutamates."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE42",
  "fields": {
    "chromosome_patch": "X",
    "gene_name": "G6PD",
    "uniprot_id": "P11413",
    "function": "Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. The main function of this enzyme is to provide reducing power (NADPH) and pentose phosphates for fatty acid and nucleic acid synthesis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE43",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "GGCX",
    "uniprot_id": "P38435",
    "function": "Mediates the vitamin K-dependent carboxylation of glutamate residues to calcium-binding gamma-carboxyglutamate (Gla) residues with the concomitant conversion of the reduced hydroquinone form of vitamin K to vitamin K epoxide."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE44",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "GNB3",
    "uniprot_id": "P16520",
    "function": "Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE45",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "GRIN1",
    "uniprot_id": "Q05586",
    "function": "Component of NMDA receptor complexes that function as heterotetrameric, ligand-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Channel activation requires binding of the neurotransmitter glutamate to the epsilon subunit, glycine binding to the zeta subunit, plus membrane depolarization to eliminate channel inhibition by Mg2+. Sensitivity to glutamate and channel kinetics depend on the subunit composition."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE46",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "GRK4",
    "uniprot_id": "P32298",
    "function": "Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin, the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE47",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "GRK5",
    "uniprot_id": "P34947",
    "function": "Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein-coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors, muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70-interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2-mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor. Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE48",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "HLA-A",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE49",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "HLA-B",
    "uniprot_id": "",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE5",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "ACE",
    "uniprot_id": "P12821",
    "function": "Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. Inhibitors of ACE are commonly used to treat hypertension and some types of renal and cardiac dysfunction. The glycosidase activity probably uses different active site residues than the metalloprotease activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE50",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "HMGCR",
    "uniprot_id": "P04035",
    "function": "Transmembrane glycoprotein that is the rate-limiting enzyme in cholesterol biosynthesis as well as in the biosynthesis of nonsterol isoprenoids that are essential for normal cell function including ubiquinone and geranylgeranyl proteins."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE51",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "HNF4A",
    "uniprot_id": "P41235",
    "function": "Transcriptional regulator which controls the expression of hepatic genes during the transition of endodermal cells to hepatic progenitor cells, facilitating the recruitment of RNA pol II to the promoters of target genes. Activates the transcription of CYP2C38 (By similarity). Represses the CLOCK-ARNTL/BMAL1 transcriptional activity and is essential for circadian rhythm maintenance and period regulation in the liver and colon cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE52",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "IFNL3",
    "uniprot_id": "Q8IZI9",
    "function": "Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE53",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "IFNL4",
    "uniprot_id": "K9M1U5",
    "function": "Cytokine that may trigger an antiviral response activating the JAK-STAT pathway and up-regulating specifically some interferon-stimulated genes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE54",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "LDLR",
    "uniprot_id": "P01130",
    "function": "Binds LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. (Microbial infection) Acts as a receptor for hepatitis C virus in hepatocytes, but not through a direct interaction with viral proteins. (Microbial infection) Acts as a receptor for Vesicular stomatitis virus. (Microbial infection) In case of HIV-1 infection, may function as a receptor for extracellular Tat in neurons, mediating its internalization in uninfected cells."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE55",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "LRRC15",
    "uniprot_id": "Q8TF66",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE56",
  "fields": {
    "chromosome_patch": "20",
    "gene_name": "MMP9",
    "uniprot_id": "P14780",
    "function": "May play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption. Cleaves KiSS1 at a Gly-"
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE57",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "MOV10",
    "uniprot_id": "Q9HCE1",
    "function": "5' to 3' RNA helicase contributing to UPF1 mRNA target degradation by translocation along 3' UTRs. Required for microRNA (miRNA)-mediated gene silencing by the RNA-induced silencing complex (RISC). Required for both miRNA-mediated translational repression and miRNA-mediated cleavage of complementary mRNAs by RISC. In cooperation with FMR1, regulates miRNA-mediated translational repression by AGO2. Restricts retrotransposition of long interspersed element-1 (LINE-1) in cooperation with TUT4 and TUT7 counteracting the RNA chaperonne activity of L1RE1. Facilitates LINE-1 uridylation by TUT4 and TUT7. Required for embryonic viability and for normal central nervous system development and function. Plays two critical roles in early brain development: suppresses retroelements in the nucleus by directly inhibiting cDNA synthesis, while regulates cytoskeletal mRNAs to influence neurite outgrowth in the cytosol (By similarity). May function as a messenger ribonucleoprotein (mRNP) clearance factor."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE58",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "MTHFR",
    "uniprot_id": "P42898",
    "function": "Catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE59",
  "fields": {
    "chromosome_patch": "18",
    "gene_name": "NEDD4L",
    "uniprot_id": "Q96PU5",
    "function": "E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Inhibits TGF-beta signaling by triggering SMAD2 and TGFBR1 ubiquitination and proteasome-dependent degradation. Promotes ubiquitination and internalization of various plasma membrane channels such as ENaC, SCN2A/Nav1.2, SCN3A/Nav1.3, SCN5A/Nav1.5, SCN9A/Nav1.7, SCN10A/Nav1.8, KCNA3/Kv1.3, KCNH2, EAAT1, KCNQ2/Kv7.2, KCNQ3/Kv7.3 or CLC5. Promotes ubiquitination and degradation of SGK1 and TNK2. Ubiquitinates BRAT1 and this ubiquitination is enhanced in the presence of NDFIP1. Plays a role in dendrite formation by melanocytes. Involved in the regulation of TOR signaling. Ubiquitinates and regulates protein levels of NTRK1 once this one is activated by NGF."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE6",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "ADRB1",
    "uniprot_id": "P08588",
    "function": "Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE60",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "NR1I2",
    "uniprot_id": "O75469",
    "function": "Nuclear receptor that binds and is activated by variety of endogenous and xenobiotic compounds. Transcription factor that activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs and endogenous compounds. Activated by the antibiotic rifampicin and various plant metabolites, such as hyperforin, guggulipid, colupulone, and isoflavones. Response to specific ligands is species-specific. Activated by naturally occurring steroids, such as pregnenolone and progesterone. Binds to a response element in the promoters of the CYP3A4 and ABCB1/MDR1 genes."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE61",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "NR1I3",
    "uniprot_id": "Q14994",
    "function": "Binds and transactivates the retinoic acid response elements that control expression of the retinoic acid receptor beta 2 and alcohol dehydrogenase 3 genes. Transactivates both the phenobarbital responsive element module of the human CYP2B6 gene and the CYP3A4 xenobiotic response element."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE62",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "OPRD1",
    "uniprot_id": "P41143",
    "function": "G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE63",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "OPRK1",
    "uniprot_id": "P41145",
    "function": "G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain. Plays a role in mediating reduced physical activity upon treatment with synthetic opioids. Plays a role in the regulation of salivation in response to synthetic opioids. May play a role in arousal and regulation of autonomic and neuroendocrine functions."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE64",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "OPRM1",
    "uniprot_id": "P35372",
    "function": "Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effector. The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extent to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15. They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B. Also couples to adenylate cyclase stimulatory G alpha proteins. The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4. Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization. Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction. The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins. The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation. Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling. Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling. Endogenous ligands induce rapid desensitization, endocytosis and recycling whereas morphine induces only low desensitization and endocytosis. Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties. Involved in neurogenesis. Isoform 12 couples to GNAS and is proposed to be involved in excitatory effects. Isoform 16 and isoform 17 do not bind agonists but may act through oligomerization with binding-competent OPRM1 isoforms and reduce their ligand binding activity."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE65",
  "fields": {
    "chromosome_patch": "3",
    "gene_name": "P2RY12",
    "uniprot_id": "Q9H244",
    "function": "Receptor for ADP and ATP coupled to G-proteins that inhibit the adenylyl cyclase second messenger system. Not activated by UDP and UTP. Required for normal platelet aggregation and blood coagulation."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE66",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "PADI4",
    "uniprot_id": "Q9UM07",
    "function": "Catalyzes the citrullination/deimination of arginine residues of proteins such as histones, thereby playing a key role in histone code and regulation of stem cell maintenance. Citrullinates histone H1 at 'Arg-54' (to form H1R54ci), histone H3 at 'Arg-2', 'Arg-8', 'Arg-17' and/or 'Arg-26' (to form H3R2ci, H3R8ci, H3R17ci, H3R26ci, respectively) and histone H4 at 'Arg-3' (to form H4R3ci). Acts as a key regulator of stem cell maintenance by mediating citrullination of histone H1: citrullination of 'Arg-54' of histone H1 (H1R54ci) results in H1 displacement from chromatin and global chromatin decondensation, thereby promoting pluripotency and stem cell maintenance. Promotes profound chromatin decondensation during the innate immune response to infection in neutrophils by mediating formation of H1R54ci. Citrullination of histone H3 prevents their methylation by CARM1 and HRMT1L2/PRMT1 and represses transcription. Citrullinates EP300/P300 at 'Arg-2142', which favors its interaction with NCOA2/GRIP1"
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE67",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "PCSK9",
    "uniprot_id": "Q8NBP7",
    "function": "Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation. Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway. Inhibits epithelial Na+ channel (ENaC)-mediated Na+ absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE68",
  "fields": {
    "chromosome_patch": "7",
    "gene_name": "POR",
    "uniprot_id": "P16435",
    "function": "This enzyme is required for electron transfer from NADP to cytochrome P450 in microsomes. It can also provide electron transfer to heme oxygenase and cytochrome B5."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE69",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "PRSS53",
    "uniprot_id": "Q2L4Q9",
    "function": "In vitro can degrade the fibrinogen alpha chain of as well as pro-urokinase-type plasminogen activator."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE7",
  "fields": {
    "chromosome_patch": "5",
    "gene_name": "ADRB2",
    "uniprot_id": "P07550",
    "function": "Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE70",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "PTPRD",
    "uniprot_id": "P23468",
    "function": "Can bidirectionally induce pre- and post-synaptic differentiation of neurons by mediating interaction with IL1RAP and IL1RAPL1 trans-synaptically. Involved in pre-synaptic differentiation through interaction with SLITRK2."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE71",
  "fields": {
    "chromosome_patch": "1",
    "gene_name": "RGS4",
    "uniprot_id": "P49798",
    "function": "Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Activity on G(z)-alpha is inhibited by phosphorylation of the G-protein. Activity on G(z)-alpha and G(i)-alpha-1 is inhibited by palmitoylation of the G-protein."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE72",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "RRM1",
    "uniprot_id": "P23921",
    "function": "Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE73",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "RRM2",
    "uniprot_id": "P31350",
    "function": "Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. Inhibits Wnt signaling."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE74",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "RRM2B",
    "uniprot_id": "Q7LG56",
    "function": "Plays a pivotal role in cell survival by repairing damaged DNA in a p53/TP53-dependent manner. Supplies deoxyribonucleotides for DNA repair in cells arrested at G1 or G2. Contains an iron-tyrosyl free radical center required for catalysis. Forms an active ribonucleotide reductase (RNR) complex with RRM1 which is expressed both in resting and proliferating cells in response to DNA damage."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE75",
  "fields": {
    "chromosome_patch": "9",
    "gene_name": "RXRA",
    "uniprot_id": "P19793",
    "function": "Receptor for retinoic acid that acts as a transcription factor. Forms homo- or heterodimers with retinoic acid receptors (RARs) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5 to regulate transcription. The high affinity ligand for retinoid X receptors (RXRs) is 9-cis retinoic acid. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone deacetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and coactivators are recruited leading to transcriptional activation. Serves as a common heterodimeric partner for a number of nuclear receptors, such as RARA, RARB and PPARA. The RXRA/RARB heterodimer can act as a transcriptional repressor or transcriptional activator, depending on the RARE DNA element context. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes. Together with RARA, positively regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1 signaling response to pulsatile shear stress in vascular endothelial cells. Acts as an enhancer of RARA binding to RARE DNA element. May facilitate the nuclear import of heterodimerization partners such as VDR and NR4A1. Promotes myelin debris phagocytosis and remyelination by macrophages. Plays a role in the attenuation of the innate immune system in response to viral infections, possibly by negatively regulating the transcription of antiviral genes such as type I IFN genes. Involved in the regulation of calcium signaling by repressing ITPR2 gene expression, thereby controlling cellular senescence."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE76",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "SH2B3",
    "uniprot_id": "Q9UQQ2",
    "function": "Links T-cell receptor activation signal to phospholipase C-gamma-1, GRB2 and phosphatidylinositol 3-kinase."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE77",
  "fields": {
    "chromosome_patch": "14",
    "gene_name": "SLC10A1",
    "uniprot_id": "Q14973",
    "function": "The hepatic sodium/bile acid uptake system exhibits broad substrate specificity and transports various non-bile acid organic compounds as well. It is strictly dependent on the extracellular presence of sodium."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE78",
  "fields": {
    "chromosome_patch": "10",
    "gene_name": "SLC18A2",
    "uniprot_id": "Q05940",
    "function": "Involved in the ATP-dependent vesicular transport of biogenic amine neurotransmitters. Pumps cytosolic monoamines including dopamine, norepinephrine, serotonin, and histamine into synaptic vesicles. Requisite for vesicular amine storage prior to secretion via exocytosis."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE79",
  "fields": {
    "chromosome_patch": "11",
    "gene_name": "SLC22A12",
    "uniprot_id": "Q96S37",
    "function": "Required for efficient urate re-absorption in the kidney. Regulates blood urate levels. Mediates saturable urate uptake by facilitating the exchange of urate against organic anions."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE8",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "ANGPT1",
    "uniprot_id": "Q15389",
    "function": "Binds and activates TEK/TIE2 receptor by inducing its dimerization and tyrosine phosphorylation. Plays an important role in the regulation of angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Required for normal angiogenesis and heart development during embryogenesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts. In quiescent vessels, ANGPT1 oligomers recruit TEK to cell-cell contacts, forming complexes with TEK molecules from adjoining cells, and this leads to preferential activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascades. In migrating endothelial cells that lack cell-cell adhesions, ANGT1 recruits TEK to contacts with the extracellular matrix, leading to the formation of focal adhesion complexes, activation of PTK2/FAK and of the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, and ultimately to the stimulation of sprouting angiogenesis. Mediates blood vessel maturation/stability. Implicated in endothelial developmental processes later and distinct from that of VEGF. Appears to play a crucial role in mediating reciprocal interactions between the endothelium and surrounding matrix and mesenchyme. It may have a potential therapeutic utility since it can be used for specifically targeting tumor vasculature or for promoting angiogenic processes in certain organs such as an ischemic heart."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE80",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "SLC25A31",
    "uniprot_id": "Q9H0C2",
    "function": "Catalyzes the exchange of cytoplasmic ADP with mitochondrial ATP across the mitochondrial inner membrane. May serve to mediate energy generating and energy consuming processes in the distal flagellum, possibly as a nucleotide shuttle between flagellar glycolysis, protein phosphorylation and mechanisms of motility."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE81",
  "fields": {
    "chromosome_patch": "17",
    "gene_name": "SLC6A4",
    "uniprot_id": "P31645",
    "function": "Serotonin transporter whose primary function in the central nervous system involves the regulation of serotonergic signaling via transport of serotonin molecules from the synaptic cleft back into the pre-synaptic terminal for re-utilization. Plays a key role in mediating regulation of the availability of serotonin to other receptors of serotonergic systems. Terminates the action of serotonin and recycles it in a sodium-dependent manner."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE82",
  "fields": {
    "chromosome_patch": "12",
    "gene_name": "SLCO1B1",
    "uniprot_id": "Q9Y6L6",
    "function": "Mediates the Na+-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. Involved in the clearance of bile acids and organic anions from the liver."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE83",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "SORCS2",
    "uniprot_id": "Q96PQ0",
    "function": "The heterodimer formed by NGFR and SORCS2 functions as receptor for the precursor forms of NGF (proNGF) and BDNF (proBDNF). ProNGF and proBDNF binding both promote axon growth cone collapse (in vitro). Plays a role in the regulation of dendritic spine density in hippocampus neurons (By similarity). Required for normal neurite branching and extension in response to BDNF. Plays a role in BDNF-dependent hippocampal synaptic plasticity. Together with NGFR and NTRK2, is required both for BDNF-mediated synaptic long-term depression and long-term potentiation. ProNGF binding promotes dissociation of TRIO from the heterodimer, which leads to inactivation of RAC1 and/or RAC2 and subsequent reorganization of the actin cytoskeleton. Together with the retromer complex subunit VPS35, required for normal expression of GRIN2A at synapses and dendritic cell membranes. Required for normal expression of the amino acid transporter SLC1A1 at the cell membrane, and thereby contributes to protect cells against oxidative stress (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE84",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "STX1B",
    "uniprot_id": "P61266",
    "function": "Potentially involved in docking of synaptic vesicles at presynaptic active zones. May mediate Ca2+-regulation of exocytosis acrosomal reaction in sperm (By similarity)"
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE85",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "SULT1A1",
    "uniprot_id": "P50225",
    "function": "Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of catecholamines, phenolic drugs and neurotransmitters. Has also estrogen sulfotransferase activity. responsible for the sulfonation and activation of minoxidil. Is Mediates the metabolic activation of carcinogenic N-hydroxyarylamines to DNA binding products and could so participate as modulating factor of cancer risk."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE86",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "UGT1A1",
    "uniprot_id": "P22309",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE87",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "UGT2B10",
    "uniprot_id": "P36537",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE88",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "UGT2B15",
    "uniprot_id": "P54855",
    "function": "UDPGTs are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isozyme displays activity toward several classes of xenobiotic substrates, including simple phenolic compounds, 7-hydroxylated coumarins, flavonoids, anthraquinones, and certain drugs and their hydroxylated metabolites. It also catalyzes the glucuronidation of endogenous estrogens and androgens."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE89",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "UGT2B7",
    "uniprot_id": "P16662",
    "function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Its unique specificity for 3,4-catechol estrogens and estriol suggests it may play an important role in regulating the level and activity of these potent and active estrogen metabolites. Is also active with androsterone, hyodeoxycholic acid and tetrachlorocatechol (in vitro)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE9",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "ANGPT2",
    "uniprot_id": "O15123",
    "function": "Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling. Can induce tyrosine phosphorylation of TEK/TIE2 in the absence of ANGPT1. In the absence of angiogenic inducers, such as VEGF, ANGPT2-mediated loosening of cell-matrix contacts may induce endothelial cell apoptosis with consequent vascular regression. In concert with VEGF, it may facilitate endothelial cell migration and proliferation, thus serving as a permissive angiogenic signal."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE90",
  "fields": {
    "chromosome_patch": "6",
    "gene_name": "VEGFA",
    "uniprot_id": "P15692",
    "function": "Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth. Binding to NRP1 receptor initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (By similarity)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE91",
  "fields": {
    "chromosome_patch": "4",
    "gene_name": "VEGFC",
    "uniprot_id": "P49767",
    "function": "Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates KDR/VEGFR2 and FLT4/VEGFR3 receptors."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE92",
  "fields": {
    "chromosome_patch": "16",
    "gene_name": "VKORC1",
    "uniprot_id": "Q9BQB6",
    "function": "Involved in vitamin K metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K. Vitamin K is required for the gamma-carboxylation of various proteins, including clotting factors, and is required for normal blood coagulation, but also for normal bone development."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE93",
  "fields": {
    "chromosome_patch": "2",
    "gene_name": "XDH",
    "uniprot_id": "P47989",
    "function": "Key enzyme in purine degradation. Catalyzes the oxidation of hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric acid. Contributes to the generation of reactive oxygen species. Has also low oxidase activity towards aldehydes (in vitro)."
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE94",
  "fields": {
    "chromosome_patch": "8",
    "gene_name": "ZMAT4",
    "uniprot_id": "Q9H898",
    "function": ""
  }
},
{
  "model": "agmp_app.pharmacogenes",
  "pk": "PHARGENE95",
  "fields": {
    "chromosome_patch": "19",
    "gene_name": "ZNF536",
    "uniprot_id": "O15090",
    "function": ""
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1,
  "fields": {
    "snp_id": "SNP1",
    "rs_id": "rs28371685",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "608431789",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2,
  "fields": {
    "snp_id": "SNP1",
    "rs_id": "rs28371685",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "608431789",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 3,
  "fields": {
    "snp_id": "SNP2",
    "rs_id": "rs28371686",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "608431793",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 4,
  "fields": {
    "snp_id": "SNP2",
    "rs_id": "rs28371686",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "608431793",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 5,
  "fields": {
    "snp_id": "SNP3",
    "rs_id": "rs7900194",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased dose of warfarin as compared to allele G.",
    "reference": "REF92",
    "p_value": "0.023",
    "source": "PharmGKB",
    "id_in_source": "608431781",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 6,
  "fields": {
    "snp_id": "SNP3",
    "rs_id": "rs7900194",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased dose of warfarin as compared to allele G.",
    "reference": "REF92",
    "p_value": "0.023",
    "source": "PharmGKB",
    "id_in_source": "608431781",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 7,
  "fields": {
    "snp_id": "SNP4",
    "rs_id": "rs9332131",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "DEL",
    "association_with": "Genotype DEL is associated with decreased dose of warfarin.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "608431785",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 8,
  "fields": {
    "snp_id": "SNP4",
    "rs_id": "rs9332131",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "DEL",
    "association_with": "Genotype DEL is associated with decreased dose of warfarin.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "608431785",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 9,
  "fields": {
    "snp_id": "SNP70",
    "rs_id": "rs1057910",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "982037860",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 10,
  "fields": {
    "snp_id": "SNP70",
    "rs_id": "rs1057910",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "982037860",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 11,
  "fields": {
    "snp_id": "SNP82",
    "rs_id": "rs1799853",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "982037879",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 12,
  "fields": {
    "snp_id": "SNP82",
    "rs_id": "rs1799853",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "982037879",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 13,
  "fields": {
    "snp_id": "SNP72",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "982037894",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 14,
  "fields": {
    "snp_id": "SNP72",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "982037894",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 15,
  "fields": {
    "snp_id": "SNP79",
    "rs_id": "rs2884737",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF92",
    "p_value": "0.027",
    "source": "PharmGKB",
    "id_in_source": "982037919",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 16,
  "fields": {
    "snp_id": "SNP79",
    "rs_id": "rs2884737",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF92",
    "p_value": "0.027",
    "source": "PharmGKB",
    "id_in_source": "982037919",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 17,
  "fields": {
    "snp_id": "SNP80",
    "rs_id": "rs17880887",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with decreased dose of warfarin as compared to allele G.",
    "reference": "REF92",
    "p_value": "0.119",
    "source": "PharmGKB",
    "id_in_source": "982037888",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 18,
  "fields": {
    "snp_id": "SNP80",
    "rs_id": "rs17880887",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with decreased dose of warfarin as compared to allele G.",
    "reference": "REF92",
    "p_value": "0.119",
    "source": "PharmGKB",
    "id_in_source": "982037888",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 19,
  "fields": {
    "snp_id": "SNP81",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "982037942",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 20,
  "fields": {
    "snp_id": "SNP81",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF92",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "982037942",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 21,
  "fields": {
    "snp_id": "SNP16",
    "rs_id": "rs7089580",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin.",
    "reference": "REF32",
    "p_value": "0.035",
    "source": "PharmGKB",
    "id_in_source": "769245708",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 22,
  "fields": {
    "snp_id": "SNP16",
    "rs_id": "rs7089580",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin.",
    "reference": "REF32",
    "p_value": "0.035",
    "source": "PharmGKB",
    "id_in_source": "769245708",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 23,
  "fields": {
    "snp_id": "SNP15",
    "rs_id": "rs61162043",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased dose of warfarin.",
    "reference": "REF32",
    "p_value": "0.0041",
    "source": "PharmGKB",
    "id_in_source": "769245704",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 24,
  "fields": {
    "snp_id": "SNP15",
    "rs_id": "rs61162043",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased dose of warfarin.",
    "reference": "REF32",
    "p_value": "0.0041",
    "source": "PharmGKB",
    "id_in_source": "769245704",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 25,
  "fields": {
    "snp_id": "SNP138",
    "rs_id": "rs7089580",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "AT",
    "association_with": "Genotype AT is associated with increased dose of warfarin as compared to genotype AA.",
    "reference": "REF34",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "1444608095",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 26,
  "fields": {
    "snp_id": "SNP138",
    "rs_id": "rs7089580",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "AT",
    "association_with": "Genotype AT is associated with increased dose of warfarin as compared to genotype AA.",
    "reference": "REF34",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "1444608095",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 27,
  "fields": {
    "snp_id": "SNP139",
    "rs_id": "rs7089580",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "AT",
    "association_with": "Genotype AT is associated with increased clearance of warfarin as compared to genotype AA.",
    "reference": "REF34",
    "p_value": "0.04",
    "source": "PharmGKB",
    "id_in_source": "1444608101",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 28,
  "fields": {
    "snp_id": "SNP139",
    "rs_id": "rs7089580",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "AT",
    "association_with": "Genotype AT is associated with increased clearance of warfarin as compared to genotype AA.",
    "reference": "REF34",
    "p_value": "0.04",
    "source": "PharmGKB",
    "id_in_source": "1444608101",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 29,
  "fields": {
    "snp_id": "SNP251",
    "rs_id": "rs28371686",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele C.",
    "reference": "REF125",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449005488",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 30,
  "fields": {
    "snp_id": "SNP251",
    "rs_id": "rs28371686",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele C.",
    "reference": "REF125",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449005488",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 31,
  "fields": {
    "snp_id": "SNP254",
    "rs_id": "rs9332131",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "del",
    "association_with": "Allele del is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele A.",
    "reference": "REF125",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449005482",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 32,
  "fields": {
    "snp_id": "SNP254",
    "rs_id": "rs9332131",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "del",
    "association_with": "Allele del is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele A.",
    "reference": "REF125",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449005482",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 33,
  "fields": {
    "snp_id": "SNP250",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is not associated with dose of warfarin in Pulmonary Embolism as compared to allele C.",
    "reference": "REF125",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449005494",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 34,
  "fields": {
    "snp_id": "SNP250",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is not associated with dose of warfarin in Pulmonary Embolism as compared to allele C.",
    "reference": "REF125",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449005494",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 35,
  "fields": {
    "snp_id": "SNP299",
    "rs_id": "rs202201137",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin.",
    "reference": "REF126",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1450180271",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Puerto Rico",
    "latitude": "18.2208330",
    "longitude": "-66.5901490"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 36,
  "fields": {
    "snp_id": "SNP299",
    "rs_id": "rs202201137",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin.",
    "reference": "REF126",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1450180271",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Puerto Rico",
    "latitude": "18.2208330",
    "longitude": "-66.5901490"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 37,
  "fields": {
    "snp_id": "SNP302",
    "rs_id": "rs28371686",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "827864554",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 38,
  "fields": {
    "snp_id": "SNP302",
    "rs_id": "rs28371686",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "827864554",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 39,
  "fields": {
    "snp_id": "SNP303",
    "rs_id": "rs1799853",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "827864546",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 40,
  "fields": {
    "snp_id": "SNP303",
    "rs_id": "rs1799853",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased dose of warfarin as compared to allele C.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "827864546",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 41,
  "fields": {
    "snp_id": "SNP305",
    "rs_id": "rs7900194",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased dose of warfarin as compared to allele G.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "827864548",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 42,
  "fields": {
    "snp_id": "SNP305",
    "rs_id": "rs7900194",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased dose of warfarin as compared to allele G.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "827864548",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 43,
  "fields": {
    "snp_id": "SNP308",
    "rs_id": "rs1057910",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "827864562",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 44,
  "fields": {
    "snp_id": "SNP308",
    "rs_id": "rs1057910",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "827864562",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 45,
  "fields": {
    "snp_id": "SNP316",
    "rs_id": "rs56165452",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is associated with decreased dose of warfarin as compared to genotype TT.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "982034970",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 46,
  "fields": {
    "snp_id": "SNP316",
    "rs_id": "rs56165452",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is associated with decreased dose of warfarin as compared to genotype TT.",
    "reference": "REF29",
    "p_value": "0.0004",
    "source": "PharmGKB",
    "id_in_source": "982034970",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 47,
  "fields": {
    "snp_id": "SNP301",
    "rs_id": "rs339097",
    "gene": "PHARGENE14",
    "drug": "DRUG1",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.",
    "reference": "REF29",
    "p_value": "0.066",
    "source": "PharmGKB",
    "id_in_source": "827864550",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 48,
  "fields": {
    "snp_id": "SNP301",
    "rs_id": "rs339097",
    "gene": "PHARGENE14",
    "drug": "DRUG60",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.",
    "reference": "REF29",
    "p_value": "0.066",
    "source": "PharmGKB",
    "id_in_source": "827864550",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 49,
  "fields": {
    "snp_id": "SNP300",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.",
    "reference": "REF29",
    "p_value": "< 1.0E-4",
    "source": "PharmGKB",
    "id_in_source": "827864552",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 50,
  "fields": {
    "snp_id": "SNP300",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.",
    "reference": "REF29",
    "p_value": "< 1.0E-4",
    "source": "PharmGKB",
    "id_in_source": "827864552",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 51,
  "fields": {
    "snp_id": "SNP304",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG1",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with decreased dose of warfarin as compared to allele T.",
    "reference": "REF29",
    "p_value": "0.31",
    "source": "PharmGKB",
    "id_in_source": "827864558",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 52,
  "fields": {
    "snp_id": "SNP304",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG60",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with decreased dose of warfarin as compared to allele T.",
    "reference": "REF29",
    "p_value": "0.31",
    "source": "PharmGKB",
    "id_in_source": "827864558",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 53,
  "fields": {
    "snp_id": "SNP5",
    "rs_id": "rs339097",
    "gene": "PHARGENE14",
    "drug": "DRUG1",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased dose of warfarin.",
    "reference": "REF106",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "637879876",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 54,
  "fields": {
    "snp_id": "SNP5",
    "rs_id": "rs339097",
    "gene": "PHARGENE14",
    "drug": "DRUG60",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased dose of warfarin.",
    "reference": "REF106",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "637879876",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 55,
  "fields": {
    "snp_id": "SNP118",
    "rs_id": "rs7294",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin as compared to allele C.",
    "reference": "REF82",
    "p_value": "0.032",
    "source": "PharmGKB",
    "id_in_source": "1185002294",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 56,
  "fields": {
    "snp_id": "SNP118",
    "rs_id": "rs7294",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin as compared to allele C.",
    "reference": "REF82",
    "p_value": "0.032",
    "source": "PharmGKB",
    "id_in_source": "1185002294",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 57,
  "fields": {
    "snp_id": "SNP119",
    "rs_id": "rs7200749",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with increased dose of warfarin as compared to allele G.",
    "reference": "REF82",
    "p_value": "0.032",
    "source": "PharmGKB",
    "id_in_source": "1185002301",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 58,
  "fields": {
    "snp_id": "SNP119",
    "rs_id": "rs7200749",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with increased dose of warfarin as compared to allele G.",
    "reference": "REF82",
    "p_value": "0.032",
    "source": "PharmGKB",
    "id_in_source": "1185002301",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 59,
  "fields": {
    "snp_id": "SNP131",
    "rs_id": "rs72547529",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin as compared to allele C.",
    "reference": "REF139",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1445401050",
    "region": "Sub-Saharan African",
    "country_of_participants": "Brazil",
    "latitude": "-14.2350040",
    "longitude": "-51.9252820"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 60,
  "fields": {
    "snp_id": "SNP131",
    "rs_id": "rs72547529",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin as compared to allele C.",
    "reference": "REF139",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1445401050",
    "region": "Sub-Saharan African",
    "country_of_participants": "Brazil",
    "latitude": "-14.2350040",
    "longitude": "-51.9252820"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 61,
  "fields": {
    "snp_id": "SNP132",
    "rs_id": "rs72547529",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin as compared to allele C.",
    "reference": "REF88",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1445401057",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "UK",
    "latitude": "55.3780520",
    "longitude": "-3.4359730"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 62,
  "fields": {
    "snp_id": "SNP132",
    "rs_id": "rs72547529",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin as compared to allele C.",
    "reference": "REF88",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1445401057",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "UK",
    "latitude": "55.3780520",
    "longitude": "-3.4359730"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 63,
  "fields": {
    "snp_id": "SNP133",
    "rs_id": "rs72547529",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin as compared to allele C.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1445401065",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 64,
  "fields": {
    "snp_id": "SNP133",
    "rs_id": "rs72547529",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of warfarin as compared to allele C.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1445401065",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 65,
  "fields": {
    "snp_id": "SNP134",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 66,
  "fields": {
    "snp_id": "SNP134",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 67,
  "fields": {
    "snp_id": "SNP135",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296694",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 68,
  "fields": {
    "snp_id": "SNP135",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296694",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 69,
  "fields": {
    "snp_id": "SNP140",
    "rs_id": "rs7294",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.",
    "reference": "REF7",
    "p_value": "0.008",
    "source": "PharmGKB",
    "id_in_source": "1447519684",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 70,
  "fields": {
    "snp_id": "SNP140",
    "rs_id": "rs7294",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.",
    "reference": "REF7",
    "p_value": "0.008",
    "source": "PharmGKB",
    "id_in_source": "1447519684",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 71,
  "fields": {
    "snp_id": "SNP152",
    "rs_id": "rs2359612",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.",
    "reference": "REF7",
    "p_value": "< 0.005",
    "source": "PharmGKB",
    "id_in_source": "1447519671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 72,
  "fields": {
    "snp_id": "SNP152",
    "rs_id": "rs2359612",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.",
    "reference": "REF7",
    "p_value": "< 0.005",
    "source": "PharmGKB",
    "id_in_source": "1447519671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 73,
  "fields": {
    "snp_id": "SNP153",
    "rs_id": "rs8050894",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CG + GG",
    "association_with": "Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.",
    "reference": "REF7",
    "p_value": "0.15",
    "source": "PharmGKB",
    "id_in_source": "1447519677",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 74,
  "fields": {
    "snp_id": "SNP153",
    "rs_id": "rs8050894",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CG + GG",
    "association_with": "Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.",
    "reference": "REF7",
    "p_value": "0.15",
    "source": "PharmGKB",
    "id_in_source": "1447519677",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 75,
  "fields": {
    "snp_id": "SNP154",
    "rs_id": "rs72547529",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased response to warfarin as compared to allele C.",
    "reference": "REF56",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447520668",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 76,
  "fields": {
    "snp_id": "SNP154",
    "rs_id": "rs72547529",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased response to warfarin as compared to allele C.",
    "reference": "REF56",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447520668",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 77,
  "fields": {
    "snp_id": "SNP204",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573250",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 78,
  "fields": {
    "snp_id": "SNP204",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573250",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 79,
  "fields": {
    "snp_id": "SNP248",
    "rs_id": "rs4889606",
    "gene": "PHARGENE84",
    "drug": "DRUG1",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573185",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 80,
  "fields": {
    "snp_id": "SNP248",
    "rs_id": "rs4889606",
    "gene": "PHARGENE84",
    "drug": "DRUG60",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573185",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 81,
  "fields": {
    "snp_id": "SNP310",
    "rs_id": "rs61742245",
    "gene": "PHARGENE92",
    "drug": "DRUG1",
    "disease": "",
    "allele": "AA + AC",
    "association_with": "Genotypes AA + AC are associated with increased dose of warfarin as compared to genotype CC.",
    "reference": "REF138",
    "p_value": "< 0.03",
    "source": "PharmGKB",
    "id_in_source": "981862284",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 82,
  "fields": {
    "snp_id": "SNP310",
    "rs_id": "rs61742245",
    "gene": "PHARGENE92",
    "drug": "DRUG60",
    "disease": "",
    "allele": "AA + AC",
    "association_with": "Genotypes AA + AC are associated with increased dose of warfarin as compared to genotype CC.",
    "reference": "REF138",
    "p_value": "< 0.03",
    "source": "PharmGKB",
    "id_in_source": "981862284",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 83,
  "fields": {
    "snp_id": "SNP167",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.",
    "reference": "REF45",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447952609",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 84,
  "fields": {
    "snp_id": "SNP167",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.",
    "reference": "REF45",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447952609",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 85,
  "fields": {
    "snp_id": "SNP252",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT is not associated with increased dose of warfarin in people with Atrial Fibrillation, Cardiomyopathies, heart valve replacement, Peripheral Vascular Diseases, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC.",
    "reference": "REF102",
    "p_value": "0.128",
    "source": "PharmGKB",
    "id_in_source": "1448602262",
    "region": "Sub-Saharan African",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 86,
  "fields": {
    "snp_id": "SNP252",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT is not associated with increased dose of warfarin in people with Atrial Fibrillation, Cardiomyopathies, heart valve replacement, Peripheral Vascular Diseases, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC.",
    "reference": "REF102",
    "p_value": "0.128",
    "source": "PharmGKB",
    "id_in_source": "1448602262",
    "region": "Sub-Saharan African",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 87,
  "fields": {
    "snp_id": "SNP110",
    "rs_id": "rs7856096",
    "gene": "PHARGENE41",
    "drug": "DRUG1",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF141",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184512419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 88,
  "fields": {
    "snp_id": "SNP110",
    "rs_id": "rs7856096",
    "gene": "PHARGENE41",
    "drug": "DRUG60",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF141",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184512419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 89,
  "fields": {
    "snp_id": "SNP111",
    "rs_id": "rs7856096",
    "gene": "PHARGENE41",
    "drug": "DRUG1",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF141",
    "p_value": "0.0000393",
    "source": "PharmGKB",
    "id_in_source": "1184512426",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 90,
  "fields": {
    "snp_id": "SNP111",
    "rs_id": "rs7856096",
    "gene": "PHARGENE41",
    "drug": "DRUG60",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased dose of warfarin as compared to allele A.",
    "reference": "REF141",
    "p_value": "0.0000393",
    "source": "PharmGKB",
    "id_in_source": "1184512426",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 91,
  "fields": {
    "snp_id": "SNP326",
    "rs_id": "rs7856096",
    "gene": "PHARGENE41",
    "drug": "DRUG1",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is not associated with dose of warfarin as compared to genotypes AG + GG.",
    "reference": "REF90",
    "p_value": "0.86",
    "source": "PharmGKB",
    "id_in_source": "1447677830",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 92,
  "fields": {
    "snp_id": "SNP326",
    "rs_id": "rs7856096",
    "gene": "PHARGENE41",
    "drug": "DRUG60",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is not associated with dose of warfarin as compared to genotypes AG + GG.",
    "reference": "REF90",
    "p_value": "0.86",
    "source": "PharmGKB",
    "id_in_source": "1447677830",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 93,
  "fields": {
    "snp_id": "SNP328",
    "rs_id": "rs4889606",
    "gene": "PHARGENE84",
    "drug": "DRUG1",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are associated with decreased dose of warfarin as compared to genotype AA.",
    "reference": "REF90",
    "p_value": "0.0001",
    "source": "PharmGKB",
    "id_in_source": "1447677865",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 94,
  "fields": {
    "snp_id": "SNP328",
    "rs_id": "rs4889606",
    "gene": "PHARGENE84",
    "drug": "DRUG60",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are associated with decreased dose of warfarin as compared to genotype AA.",
    "reference": "REF90",
    "p_value": "0.0001",
    "source": "PharmGKB",
    "id_in_source": "1447677865",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 95,
  "fields": {
    "snp_id": "SNP325",
    "rs_id": "rs12714145",
    "gene": "PHARGENE43",
    "drug": "DRUG1",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.",
    "reference": "REF90",
    "p_value": "0.24",
    "source": "PharmGKB",
    "id_in_source": "1447677818",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 96,
  "fields": {
    "snp_id": "SNP325",
    "rs_id": "rs12714145",
    "gene": "PHARGENE43",
    "drug": "DRUG60",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.",
    "reference": "REF90",
    "p_value": "0.24",
    "source": "PharmGKB",
    "id_in_source": "1447677818",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 97,
  "fields": {
    "snp_id": "SNP241",
    "rs_id": "rs12777823",
    "gene": "PHARGENE22",
    "drug": "DRUG1",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with dose of warfarin as compared to allele G.",
    "reference": "REF50",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448636878",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 98,
  "fields": {
    "snp_id": "SNP241",
    "rs_id": "rs12777823",
    "gene": "PHARGENE22",
    "drug": "DRUG60",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with dose of warfarin as compared to allele G.",
    "reference": "REF50",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448636878",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 99,
  "fields": {
    "snp_id": "SNP17",
    "rs_id": "rs28371686",
    "gene": "PHARGENE25",
    "drug": "DRUG8",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype CC.",
    "reference": "REF66",
    "p_value": "0.001",
    "source": "PharmGKB",
    "id_in_source": "769249016",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 100,
  "fields": {
    "snp_id": "SNP18",
    "rs_id": "rs7900194",
    "gene": "PHARGENE25",
    "drug": "DRUG8",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype GG.",
    "reference": "REF66",
    "p_value": "0.001",
    "source": "PharmGKB",
    "id_in_source": "769249039",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 101,
  "fields": {
    "snp_id": "SNP19",
    "rs_id": "rs28371685",
    "gene": "PHARGENE25",
    "drug": "DRUG8",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased metabolism of phenytoin in people with no disease as compared to genotype CC.",
    "reference": "REF66",
    "p_value": "0.001",
    "source": "PharmGKB",
    "id_in_source": "769249040",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 102,
  "fields": {
    "snp_id": "SNP20",
    "rs_id": "rs9332131",
    "gene": "PHARGENE25",
    "drug": "DRUG8",
    "disease": "",
    "allele": "DEL",
    "association_with": "Genotype DEL is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype AA.",
    "reference": "REF66",
    "p_value": "0.001",
    "source": "PharmGKB",
    "id_in_source": "769249041",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 103,
  "fields": {
    "snp_id": "SNP341",
    "rs_id": "rs1043550",
    "gene": "PHARGENE14",
    "drug": "DRUG27",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele A.",
    "reference": "REF13",
    "p_value": "0.009",
    "source": "PharmGKB",
    "id_in_source": "1449188291",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 104,
  "fields": {
    "snp_id": "SNP341",
    "rs_id": "rs1043550",
    "gene": "PHARGENE14",
    "drug": "DRUG59",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele A.",
    "reference": "REF13",
    "p_value": "0.009",
    "source": "PharmGKB",
    "id_in_source": "1449188291",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 105,
  "fields": {
    "snp_id": "SNP340",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG27",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele C.",
    "reference": "REF13",
    "p_value": "0.047",
    "source": "PharmGKB",
    "id_in_source": "1449188284",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 106,
  "fields": {
    "snp_id": "SNP340",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG59",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele C.",
    "reference": "REF13",
    "p_value": "0.047",
    "source": "PharmGKB",
    "id_in_source": "1449188284",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 107,
  "fields": {
    "snp_id": "SNP311",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG27",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with dose of acenocoumarol as compared to genotype CT.",
    "reference": "REF35",
    "p_value": "0.135",
    "source": "PharmGKB",
    "id_in_source": "982010028",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 108,
  "fields": {
    "snp_id": "SNP311",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG59",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with dose of acenocoumarol as compared to genotype CT.",
    "reference": "REF35",
    "p_value": "0.135",
    "source": "PharmGKB",
    "id_in_source": "982010028",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 109,
  "fields": {
    "snp_id": "SNP312",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG27",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with decreased dose of acenocoumarol as compared to genotype CC.",
    "reference": "REF35",
    "p_value": "0.0015",
    "source": "PharmGKB",
    "id_in_source": "981859299",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 110,
  "fields": {
    "snp_id": "SNP312",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG59",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with decreased dose of acenocoumarol as compared to genotype CC.",
    "reference": "REF35",
    "p_value": "0.0015",
    "source": "PharmGKB",
    "id_in_source": "981859299",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 111,
  "fields": {
    "snp_id": "SNP313",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG27",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with increased dose of acenocoumarol as compared to genotype CT.",
    "reference": "REF35",
    "p_value": "0.005",
    "source": "PharmGKB",
    "id_in_source": "982010039",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 112,
  "fields": {
    "snp_id": "SNP313",
    "rs_id": "rs9923231",
    "gene": "PHARGENE92",
    "drug": "DRUG59",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with increased dose of acenocoumarol as compared to genotype CT.",
    "reference": "REF35",
    "p_value": "0.005",
    "source": "PharmGKB",
    "id_in_source": "982010039",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 113,
  "fields": {
    "snp_id": "SNP309",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG27",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with dose of acenocoumarol as compared to genotype CC.",
    "reference": "REF35",
    "p_value": "0.086",
    "source": "PharmGKB",
    "id_in_source": "982010056",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 114,
  "fields": {
    "snp_id": "SNP309",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG59",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with dose of acenocoumarol as compared to genotype CC.",
    "reference": "REF35",
    "p_value": "0.086",
    "source": "PharmGKB",
    "id_in_source": "982010056",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 115,
  "fields": {
    "snp_id": "SNP314",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG27",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is not associated with dose of acenocoumarol as compared to genotype CC.",
    "reference": "REF35",
    "p_value": "0.456",
    "source": "PharmGKB",
    "id_in_source": "982010069",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 116,
  "fields": {
    "snp_id": "SNP314",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG59",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is not associated with dose of acenocoumarol as compared to genotype CC.",
    "reference": "REF35",
    "p_value": "0.456",
    "source": "PharmGKB",
    "id_in_source": "982010069",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 117,
  "fields": {
    "snp_id": "SNP315",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG27",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased dose of acenocoumarol as compared to genotype CT.",
    "reference": "REF35",
    "p_value": "0.028",
    "source": "PharmGKB",
    "id_in_source": "982010017",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 118,
  "fields": {
    "snp_id": "SNP315",
    "rs_id": "rs2108622",
    "gene": "PHARGENE30",
    "drug": "DRUG59",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased dose of acenocoumarol as compared to genotype CT.",
    "reference": "REF35",
    "p_value": "0.028",
    "source": "PharmGKB",
    "id_in_source": "982010017",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 119,
  "fields": {
    "snp_id": "SNP6",
    "rs_id": "rs909706",
    "gene": "PHARGENE34",
    "drug": "DRUG2",
    "disease": "",
    "allele": "TC",
    "association_with": "Genotype TC is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype CC.",
    "reference": "REF89",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "608178665",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 120,
  "fields": {
    "snp_id": "SNP7",
    "rs_id": "rs742105",
    "gene": "PHARGENE34",
    "drug": "DRUG3",
    "disease": "",
    "allele": "TT + CT",
    "association_with": "Genotypes TT + CT are associated with increased response to clozapine in people with Schizophrenia as compared to genotype CC.",
    "reference": "REF89",
    "p_value": "0.005",
    "source": "PharmGKB",
    "id_in_source": "699642395",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 121,
  "fields": {
    "snp_id": "SNP10",
    "rs_id": "rs1799732",
    "gene": "PHARGENE33",
    "drug": "DRUG3",
    "disease": "",
    "allele": "DEL",
    "association_with": "Genotype DEL is not associated with increased response to clozapine in people with Schizophrenia as compared to allele G.",
    "reference": "REF53",
    "p_value": "0.903",
    "source": "PharmGKB",
    "id_in_source": "637879842",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Canada",
    "latitude": "56.1303670",
    "longitude": "-106.3467710"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 122,
  "fields": {
    "snp_id": "SNP27",
    "rs_id": "rs11146020",
    "gene": "PHARGENE45",
    "drug": "DRUG3",
    "disease": "",
    "allele": "CC + CG",
    "association_with": "Genotypes CC + CG are not associated with increased response to clozapine in people with Schizophrenia as compared to genotype GG.",
    "reference": "REF52",
    "p_value": "0.551",
    "source": "PharmGKB",
    "id_in_source": "827789188",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 123,
  "fields": {
    "snp_id": "SNP64",
    "rs_id": "rs686",
    "gene": "PHARGENE32",
    "drug": "DRUG3",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.",
    "reference": "REF11",
    "p_value": "1.3",
    "source": "PharmGKB",
    "id_in_source": "982025903",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 124,
  "fields": {
    "snp_id": "SNP65",
    "rs_id": "rs265976",
    "gene": "PHARGENE32",
    "drug": "DRUG3",
    "disease": "",
    "allele": "GT",
    "association_with": "Genotype GT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes GG + TT.",
    "reference": "REF11",
    "p_value": "0.108",
    "source": "PharmGKB",
    "id_in_source": "982025734",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 125,
  "fields": {
    "snp_id": "SNP66",
    "rs_id": "rs265981",
    "gene": "PHARGENE32",
    "drug": "DRUG3",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.",
    "reference": "REF11",
    "p_value": "1.4",
    "source": "PharmGKB",
    "id_in_source": "982025895",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 126,
  "fields": {
    "snp_id": "SNP67",
    "rs_id": "rs4532",
    "gene": "PHARGENE32",
    "drug": "DRUG3",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to clozapine in people with Schizophrenia as compared to allele T.",
    "reference": "REF11",
    "p_value": "2.4",
    "source": "PharmGKB",
    "id_in_source": "982025774",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 127,
  "fields": {
    "snp_id": "SNP8",
    "rs_id": "rs11188072",
    "gene": "PHARGENE23",
    "drug": "DRUG4",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased metabolism of mephenytoin in people with no disease as compared to genotype CC.",
    "reference": "REF148",
    "p_value": "0.013",
    "source": "PharmGKB",
    "id_in_source": "655387714",
    "region": "Sub-Saharan African",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 128,
  "fields": {
    "snp_id": "SNP9",
    "rs_id": "rs12248560",
    "gene": "PHARGENE23",
    "drug": "DRUG4",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased metabolism of mephenytoin in people with no disease as compared to genotype CC.",
    "reference": "REF148",
    "p_value": "0.013",
    "source": "PharmGKB",
    "id_in_source": "655387719",
    "region": "Sub-Saharan African",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 129,
  "fields": {
    "snp_id": "SNP342",
    "rs_id": "rs12248560",
    "gene": "PHARGENE23",
    "drug": "DRUG68",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased metabolism of omeprazole in people with no disease as compared to genotype CC.",
    "reference": "REF148",
    "p_value": "0.013",
    "source": "PharmGKB",
    "id_in_source": "655387718",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sweden",
    "latitude": "60.1281620",
    "longitude": "18.6435010"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 130,
  "fields": {
    "snp_id": "SNP24",
    "rs_id": "rs4244285",
    "gene": "PHARGENE23",
    "drug": "DRUG13",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is associated with decreased metabolism of nelfinavir in people with HIV Infections as compared to genotype GG.",
    "reference": "REF93",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "827695410",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Italy",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 131,
  "fields": {
    "snp_id": "SNP247",
    "rs_id": "rs1799732",
    "gene": "PHARGENE33",
    "drug": "DRUG54",
    "disease": "",
    "allele": "G/del",
    "association_with": "Genotype G/del is associated with decreased response to aripiprazole in people with schizoaffective disorder.",
    "reference": "REF115",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449140243",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 132,
  "fields": {
    "snp_id": "SNP11",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF146",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "769170863",
    "region": "Sub-Saharan African",
    "country_of_participants": "Stockholm (with Africans)",
    "latitude": "59.3293230",
    "longitude": "18.0685810"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 133,
  "fields": {
    "snp_id": "SNP105",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele G (assigned as extensive metabolizer phenotype) .",
    "reference": "REF27",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184471369",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Haiti",
    "latitude": "18.9711880",
    "longitude": "-72.2852170"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 134,
  "fields": {
    "snp_id": "SNP106",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele T (assigned as extensive metabolizer phenotype) .",
    "reference": "REF27",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184471365",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Haiti",
    "latitude": "18.9711880",
    "longitude": "-72.2852170"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 135,
  "fields": {
    "snp_id": "SNP107",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype GG (assigned as extensive metabolizer phenotype) .",
    "reference": "REF27",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184471312",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Haiti",
    "latitude": "18.9711880",
    "longitude": "-72.2852170"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 136,
  "fields": {
    "snp_id": "SNP108",
    "rs_id": "rs36118214",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.",
    "reference": "REF27",
    "p_value": "0.001",
    "source": "PharmGKB",
    "id_in_source": "1184471413",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Haiti",
    "latitude": "18.9711880",
    "longitude": "-72.2852170"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 137,
  "fields": {
    "snp_id": "SNP25",
    "rs_id": "rs28399433",
    "gene": "PHARGENE20",
    "drug": "DRUG5",
    "disease": "",
    "allele": "AC",
    "association_with": "Genotype AC is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.",
    "reference": "REF27",
    "p_value": "0.019",
    "source": "PharmGKB",
    "id_in_source": "827704966",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Haiti",
    "latitude": "18.9711880",
    "longitude": "-72.2852170"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 138,
  "fields": {
    "snp_id": "SNP109",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with decreased clearance of efavirenz in children with HIV Infections as compared to genotype GG.",
    "reference": "REF101",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184512470",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 139,
  "fields": {
    "snp_id": "SNP120",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF159",
    "p_value": "0.012",
    "source": "PharmGKB",
    "id_in_source": "1184988306",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Uganda",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 140,
  "fields": {
    "snp_id": "SNP121",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF159",
    "p_value": "0.001",
    "source": "PharmGKB",
    "id_in_source": "1184988315",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Uganda",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 141,
  "fields": {
    "snp_id": "SNP127",
    "rs_id": "rs35303484",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with concentrations of efavirenz in people with HIV as compared to allele A.",
    "reference": "REF12",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1185234929",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 142,
  "fields": {
    "snp_id": "SNP128",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT is associated with concentrations of efavirenz in people with HIV as compared to genotype GG.",
    "reference": "REF12",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1185234900",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 143,
  "fields": {
    "snp_id": "SNP126",
    "rs_id": "rs3842",
    "gene": "PHARGENE1",
    "drug": "DRUG5",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with concentrations of efavirenz in people with HIV as compared to allele T.",
    "reference": "REF12",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1185234940",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 144,
  "fields": {
    "snp_id": "SNP158",
    "rs_id": "rs4803419",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF64",
    "p_value": "0.0045",
    "source": "PharmGKB",
    "id_in_source": "1447680740",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 145,
  "fields": {
    "snp_id": "SNP159",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele G.",
    "reference": "REF64",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1447680746",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 146,
  "fields": {
    "snp_id": "SNP169",
    "rs_id": "rs35303484",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AG + GG.",
    "reference": "REF64",
    "p_value": "0.7802",
    "source": "PharmGKB",
    "id_in_source": "1447680733",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 147,
  "fields": {
    "snp_id": "SNP170",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with increased concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF64",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1447680778",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 148,
  "fields": {
    "snp_id": "SNP171",
    "rs_id": "rs707265",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AG + GG.",
    "reference": "REF64",
    "p_value": "0.7919",
    "source": "PharmGKB",
    "id_in_source": "1447680801",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 149,
  "fields": {
    "snp_id": "SNP172",
    "rs_id": "rs1042389",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CC + CT.",
    "reference": "REF64",
    "p_value": "0.0065",
    "source": "PharmGKB",
    "id_in_source": "1447680819",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 150,
  "fields": {
    "snp_id": "SNP187",
    "rs_id": "rs2279343",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased concentrations of efavirenz in people with HIV as compared to allele A.",
    "reference": "REF64",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1447680752",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 151,
  "fields": {
    "snp_id": "SNP142",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF64",
    "p_value": "0.863",
    "source": "PharmGKB",
    "id_in_source": "1447680825",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 152,
  "fields": {
    "snp_id": "SNP150",
    "rs_id": "rs7668258",
    "gene": "PHARGENE89",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF64",
    "p_value": "0.2885",
    "source": "PharmGKB",
    "id_in_source": "1447680853",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 153,
  "fields": {
    "snp_id": "SNP157",
    "rs_id": "rs28399454",
    "gene": "PHARGENE20",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF64",
    "p_value": "0.192",
    "source": "PharmGKB",
    "id_in_source": "1447680725",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 154,
  "fields": {
    "snp_id": "SNP146",
    "rs_id": "rs3732360",
    "gene": "PHARGENE60",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF64",
    "p_value": "0.9843",
    "source": "PharmGKB",
    "id_in_source": "1447680859",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 155,
  "fields": {
    "snp_id": "SNP147",
    "rs_id": "rs1054190",
    "gene": "PHARGENE60",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF64",
    "p_value": "0.7802",
    "source": "PharmGKB",
    "id_in_source": "1447680865",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 156,
  "fields": {
    "snp_id": "SNP148",
    "rs_id": "rs1054191",
    "gene": "PHARGENE60",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AA + AG.",
    "reference": "REF64",
    "p_value": "0.1553",
    "source": "PharmGKB",
    "id_in_source": "1447680871",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 157,
  "fields": {
    "snp_id": "SNP149",
    "rs_id": "rs3814057",
    "gene": "PHARGENE60",
    "drug": "DRUG5",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AC + CC.",
    "reference": "REF64",
    "p_value": "0.3185",
    "source": "PharmGKB",
    "id_in_source": "1447680877",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 158,
  "fields": {
    "snp_id": "SNP155",
    "rs_id": "rs762551",
    "gene": "PHARGENE19",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AA + AC.",
    "reference": "REF64",
    "p_value": "0.2734",
    "source": "PharmGKB",
    "id_in_source": "1447680695",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 159,
  "fields": {
    "snp_id": "SNP156",
    "rs_id": "rs45564134",
    "gene": "PHARGENE19",
    "drug": "DRUG5",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with concentrations of efavirenz in people with HIV as compared to genotypes G/del + del/del.",
    "reference": "REF64",
    "p_value": "0.8789",
    "source": "PharmGKB",
    "id_in_source": "1447680719",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 160,
  "fields": {
    "snp_id": "SNP162",
    "rs_id": "rs4803419",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele C.",
    "reference": "REF104",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1446905219",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 161,
  "fields": {
    "snp_id": "SNP163",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele G.",
    "reference": "REF104",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1446905193",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 162,
  "fields": {
    "snp_id": "SNP164",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with increased concentrations of efavirenz in people with HIV as compared to allele T.",
    "reference": "REF104",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1446905210",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 163,
  "fields": {
    "snp_id": "SNP195",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.",
    "reference": "REF86",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1448997257",
    "region": "Sub-Saharan African",
    "country_of_participants": "Rwanda",
    "latitude": "-1.9402780",
    "longitude": "29.8738880"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 164,
  "fields": {
    "snp_id": "SNP196",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is associated with increased concentrations of efavirenz in children with HIV as compared to genotype TT.",
    "reference": "REF86",
    "p_value": "0.01",
    "source": "PharmGKB",
    "id_in_source": "1448997264",
    "region": "Sub-Saharan African",
    "country_of_participants": "Rwanda",
    "latitude": "-1.9402780",
    "longitude": "29.8738880"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 165,
  "fields": {
    "snp_id": "SNP197",
    "rs_id": "rs2279343",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are associated with increased concentrations of efavirenz in children with HIV as compared to genotype AA.",
    "reference": "REF86",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1448997270",
    "region": "Sub-Saharan African",
    "country_of_participants": "Rwanda",
    "latitude": "-1.9402780",
    "longitude": "29.8738880"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 166,
  "fields": {
    "snp_id": "SNP198",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased concentrations of efavirenz in people with HIV as compared to genotypes GG + GT.",
    "reference": "REF70",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448997691",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 167,
  "fields": {
    "snp_id": "SNP199",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.",
    "reference": "REF51",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1448663995",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 168,
  "fields": {
    "snp_id": "SNP200",
    "rs_id": "rs2279343",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with increased concentrations of efavirenz in children with HIV as compared to allele A.",
    "reference": "REF51",
    "p_value": "0.546",
    "source": "PharmGKB",
    "id_in_source": "1448665077",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 169,
  "fields": {
    "snp_id": "SNP243",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is associated with increased concentrations of efavirenz in children with HIV as compared to genotype TT.",
    "reference": "REF51",
    "p_value": "0.028",
    "source": "PharmGKB",
    "id_in_source": "1448665545",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 170,
  "fields": {
    "snp_id": "SNP201",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT is associated with decreased clearance of efavirenz in people with HIV as compared to genotype GG.",
    "reference": "REF6",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448636173",
    "region": "Sub-Saharan African",
    "country_of_participants": "Botswana",
    "latitude": "-22.3284740",
    "longitude": "24.6848660"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 171,
  "fields": {
    "snp_id": "SNP202",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC + CT",
    "association_with": "Genotypes CC + CT is associated with decreased clearance of efavirenz in people with HIV as compared to genotype TT.",
    "reference": "REF6",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448636182",
    "region": "Sub-Saharan African",
    "country_of_participants": "Botswana",
    "latitude": "-22.3284740",
    "longitude": "24.6848660"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 172,
  "fields": {
    "snp_id": "SNP203",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with increased concentrations of efavirenz in people with HIV as compared to genotype GG.",
    "reference": "REF8",
    "p_value": "0.01",
    "source": "PharmGKB",
    "id_in_source": "1448993691",
    "region": "Sub-Saharan African",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 173,
  "fields": {
    "snp_id": "SNP205",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.",
    "reference": "REF61",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448997108",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 174,
  "fields": {
    "snp_id": "SNP246",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with increased concentrations of efavirenz in women with HIV as compared to genotype GG.",
    "reference": "REF9",
    "p_value": "0.011",
    "source": "PharmGKB",
    "id_in_source": "1448684688",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 175,
  "fields": {
    "snp_id": "SNP244",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG53",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with decreased concentrations of levonorgestrel in women with HIV as compared to genotype GG.",
    "reference": "REF9",
    "p_value": "0.021",
    "source": "PharmGKB",
    "id_in_source": "1448684673",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 176,
  "fields": {
    "snp_id": "SNP245",
    "rs_id": "rs4803419",
    "gene": "PHARGENE21",
    "drug": "DRUG53",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is associated with decreased concentrations of levonorgestrel in women with HIV as compared to genotype CC.",
    "reference": "REF9",
    "p_value": "0.023",
    "source": "PharmGKB",
    "id_in_source": "1448684682",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 177,
  "fields": {
    "snp_id": "SNP249",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT is associated with increased concentrations of efavirenz in people with HIV as compared to genotype GG.",
    "reference": "REF98",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1448997218",
    "region": "Sub-Saharan African",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 178,
  "fields": {
    "snp_id": "SNP253",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with decreased resistance to efavirenz in people with HIV as compared to genotype GG.",
    "reference": "REF63",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "1448617505",
    "region": "Sub-Saharan African",
    "country_of_participants": "Botswana",
    "latitude": "-22.3284740",
    "longitude": "24.6848660"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 179,
  "fields": {
    "snp_id": "SNP346",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with increased concentrations of efavirenz as compared to genotype GG.",
    "reference": "REF33",
    "p_value": "0.016",
    "source": "PharmGKB",
    "id_in_source": "1448997483",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 180,
  "fields": {
    "snp_id": "SNP102",
    "rs_id": "rs28365062",
    "gene": "PHARGENE89",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotypes AA + AG.",
    "reference": "REF84",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184467530",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 181,
  "fields": {
    "snp_id": "SNP104",
    "rs_id": "rs28399433",
    "gene": "PHARGENE20",
    "drug": "DRUG5",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele A.",
    "reference": "REF84",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184467517",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 182,
  "fields": {
    "snp_id": "SNP101",
    "rs_id": "rs3842",
    "gene": "PHARGENE1",
    "drug": "DRUG5",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with metabolism of efavirenz in people with HIV as compared to allele T.",
    "reference": "REF81",
    "p_value": "0.0012",
    "source": "PharmGKB",
    "id_in_source": "1183944307",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 183,
  "fields": {
    "snp_id": "SNP297",
    "rs_id": "rs3842",
    "gene": "PHARGENE1",
    "drug": "DRUG5",
    "disease": "",
    "allele": "CC + CT",
    "association_with": "Genotypes CC + CT is associated with increased trough concentration of efavirenz in people with HIV and Tuberculosis as compared to genotype TT.",
    "reference": "REF3",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447984401",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 184,
  "fields": {
    "snp_id": "SNP184",
    "rs_id": "rs2307424",
    "gene": "PHARGENE61",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype AG.",
    "reference": "REF2",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184512556",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 185,
  "fields": {
    "snp_id": "SNP185",
    "rs_id": "rs3003596",
    "gene": "PHARGENE61",
    "drug": "DRUG5",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is associated with increased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.",
    "reference": "REF2",
    "p_value": "0.015",
    "source": "PharmGKB",
    "id_in_source": "1184512504",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 186,
  "fields": {
    "snp_id": "SNP186",
    "rs_id": "rs2502815",
    "gene": "PHARGENE61",
    "drug": "DRUG5",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype GG.",
    "reference": "REF2",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184512552",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 187,
  "fields": {
    "snp_id": "SNP29",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG14",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG.",
    "reference": "REF42",
    "p_value": "0.05",
    "source": "PharmGKB",
    "id_in_source": "827823670",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 188,
  "fields": {
    "snp_id": "SNP32",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG14",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with decreased clearance of nevirapine in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF42",
    "p_value": "0.5101",
    "source": "PharmGKB",
    "id_in_source": "827823747",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 189,
  "fields": {
    "snp_id": "SNP33",
    "rs_id": "rs28371706",
    "gene": "PHARGENE26",
    "drug": "DRUG14",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV as compared to genotype GG.",
    "reference": "REF42",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "827823698",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 190,
  "fields": {
    "snp_id": "SNP34",
    "rs_id": "rs2472677",
    "gene": "PHARGENE60",
    "drug": "DRUG14",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype CC.",
    "reference": "REF42",
    "p_value": "0.3883",
    "source": "PharmGKB",
    "id_in_source": "827823858",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 191,
  "fields": {
    "snp_id": "SNP35",
    "rs_id": "rs1523130",
    "gene": "PHARGENE60",
    "drug": "DRUG14",
    "disease": "",
    "allele": "CC + CT",
    "association_with": "Genotypes CC + CT are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype TT.",
    "reference": "REF42",
    "p_value": "0.8535",
    "source": "PharmGKB",
    "id_in_source": "827823838",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 192,
  "fields": {
    "snp_id": "SNP45",
    "rs_id": "rs3842689",
    "gene": "PHARGENE60",
    "drug": "DRUG14",
    "disease": "",
    "allele": "GAGAAG/DEL + DEL/DEL",
    "association_with": "Genotypes GAGAAG/DEL + DEL/DEL are associated with increased clearance of nevirapine in people with HIV as compared to genotype GAGAAG/GAGAAG.",
    "reference": "REF42",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "827823690",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 193,
  "fields": {
    "snp_id": "SNP40",
    "rs_id": "rs1045642",
    "gene": "PHARGENE1",
    "drug": "DRUG14",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG.",
    "reference": "REF42",
    "p_value": "0.6735",
    "source": "PharmGKB",
    "id_in_source": "827823804",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 194,
  "fields": {
    "snp_id": "SNP136",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG14",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT is associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG.",
    "reference": "REF25",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1296598965",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 195,
  "fields": {
    "snp_id": "SNP137",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG14",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is associated with decreased clearance of nevirapine in people with HIV as compared to genotype TT.",
    "reference": "REF25",
    "p_value": " < 0.01",
    "source": "PharmGKB",
    "id_in_source": "1296598953",
    "region": "Sub-Saharan African",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 196,
  "fields": {
    "snp_id": "SNP175",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG14",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased concentrations of nevirapine in women as compared to allele G.",
    "reference": "REF118",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448108757",
    "region": "Sub-Saharan African",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 197,
  "fields": {
    "snp_id": "SNP176",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG14",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with increased concentrations of nevirapine in women as compared to allele T.",
    "reference": "REF118",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448108791",
    "region": "Sub-Saharan African",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 198,
  "fields": {
    "snp_id": "SNP190",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG14",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased concentrations of nevirapine in people with HIV as compared to genotypes GG + GT.",
    "reference": "REF165",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1448110402",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 199,
  "fields": {
    "snp_id": "SNP191",
    "rs_id": "rs762551",
    "gene": "PHARGENE19",
    "drug": "DRUG14",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with increased response to nevirapine in people with HIV as compared to genotypes AA + AC.",
    "reference": "REF165",
    "p_value": "0.014",
    "source": "PharmGKB",
    "id_in_source": "1448110413",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 200,
  "fields": {
    "snp_id": "SNP193",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG50",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T.",
    "reference": "REF43",
    "p_value": "0.85",
    "source": "PharmGKB",
    "id_in_source": "1449003516",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 201,
  "fields": {
    "snp_id": "SNP194",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG50",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele G.",
    "reference": "REF43",
    "p_value": "0.85",
    "source": "PharmGKB",
    "id_in_source": "1449003506",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 202,
  "fields": {
    "snp_id": "SNP219",
    "rs_id": "rs3745274",
    "gene": "PHARGENE21",
    "drug": "DRUG50",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele G.",
    "reference": "REF43",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1449003645",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 203,
  "fields": {
    "snp_id": "SNP220",
    "rs_id": "rs28399499",
    "gene": "PHARGENE21",
    "drug": "DRUG50",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele T.",
    "reference": "REF43",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1449003652",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 204,
  "fields": {
    "snp_id": "SNP206",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG50",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with increased concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T.",
    "reference": "REF43",
    "p_value": "0.24",
    "source": "PharmGKB",
    "id_in_source": "1449003545",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 205,
  "fields": {
    "snp_id": "SNP218",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG50",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased response to lumefantrine in women with Malaria and Pregnancy as compared to allele C.",
    "reference": "REF43",
    "p_value": "0.018",
    "source": "PharmGKB",
    "id_in_source": "1449003637",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 206,
  "fields": {
    "snp_id": "SNP213",
    "rs_id": "rs3842",
    "gene": "PHARGENE1",
    "drug": "DRUG50",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T.",
    "reference": "REF43",
    "p_value": "0.28",
    "source": "PharmGKB",
    "id_in_source": "1449003619",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 207,
  "fields": {
    "snp_id": "SNP214",
    "rs_id": "rs3842",
    "gene": "PHARGENE1",
    "drug": "DRUG50",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele C.",
    "reference": "REF43",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1449003680",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 208,
  "fields": {
    "snp_id": "SNP12",
    "rs_id": "rs2246709",
    "gene": "PHARGENE27",
    "drug": "DRUG6",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are associated with increased response to amlodipine in people with Hypertension as compared to genotype AA.",
    "reference": "REF111",
    "p_value": "0.01",
    "source": "PharmGKB",
    "id_in_source": "769169820",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 209,
  "fields": {
    "snp_id": "SNP77",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG6",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are associated with increased response to amlodipine in women with Hypertension as compared to genotype CC.",
    "reference": "REF111",
    "p_value": "0.02",
    "source": "PharmGKB",
    "id_in_source": "982043591",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 210,
  "fields": {
    "snp_id": "SNP85",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG6",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are not associated with response to amlodipine in women with Hypertension as compared to genotype CC.",
    "reference": "REF111",
    "p_value": "0.29",
    "source": "PharmGKB",
    "id_in_source": "982043679",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 211,
  "fields": {
    "snp_id": "SNP86",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG6",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are not associated with response to amlodipine in people with Hypertension as compared to genotype CC.",
    "reference": "REF111",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "982043670",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 212,
  "fields": {
    "snp_id": "SNP87",
    "rs_id": "rs2246709",
    "gene": "PHARGENE27",
    "drug": "DRUG6",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are not associated with response to amlodipine in men with Hypertension as compared to genotype AA.",
    "reference": "REF111",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "982043687",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 213,
  "fields": {
    "snp_id": "SNP88",
    "rs_id": "rs2246709",
    "gene": "PHARGENE27",
    "drug": "DRUG6",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are not associated with response to amlodipine in women with Hypertension as compared to genotype AA.",
    "reference": "REF111",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "982043698",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 214,
  "fields": {
    "snp_id": "SNP89",
    "rs_id": "rs2246709",
    "gene": "PHARGENE27",
    "drug": "DRUG6",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG are not associated with response to amlodipine in people with Hypertension as compared to genotype AA.",
    "reference": "REF111",
    "p_value": "0.34",
    "source": "PharmGKB",
    "id_in_source": "982043709",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 215,
  "fields": {
    "snp_id": "SNP92",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG6",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are not associated with response to amlodipine in men with Hypertension as compared to genotype CC.",
    "reference": "REF111",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "982043660",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 216,
  "fields": {
    "snp_id": "SNP48",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG21",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotypes CC + CT.",
    "reference": "REF117",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "981501734",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 217,
  "fields": {
    "snp_id": "SNP50",
    "rs_id": "rs28365063",
    "gene": "PHARGENE89",
    "drug": "DRUG21",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to genotypes AG + GG.",
    "reference": "REF117",
    "p_value": "0.004",
    "source": "PharmGKB",
    "id_in_source": "981501889",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 218,
  "fields": {
    "snp_id": "SNP58",
    "rs_id": "rs3814055",
    "gene": "PHARGENE60",
    "drug": "DRUG21",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to allele C.",
    "reference": "REF117",
    "p_value": "0.04",
    "source": "PharmGKB",
    "id_in_source": "981501880",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 219,
  "fields": {
    "snp_id": "SNP47",
    "rs_id": "rs4148740",
    "gene": "PHARGENE1",
    "drug": "DRUG21",
    "disease": "",
    "allele": "AG",
    "association_with": "Genotype AG is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to genotype AA.",
    "reference": "REF117",
    "p_value": "0.026",
    "source": "PharmGKB",
    "id_in_source": "981501809",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 220,
  "fields": {
    "snp_id": "SNP51",
    "rs_id": "rs1128503",
    "gene": "PHARGENE1",
    "drug": "DRUG21",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG.",
    "reference": "REF117",
    "p_value": "0.036",
    "source": "PharmGKB",
    "id_in_source": "981501792",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 221,
  "fields": {
    "snp_id": "SNP59",
    "rs_id": "rs4148739",
    "gene": "PHARGENE1",
    "drug": "DRUG21",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotype CT.",
    "reference": "REF117",
    "p_value": "0.023",
    "source": "PharmGKB",
    "id_in_source": "981501801",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 222,
  "fields": {
    "snp_id": "SNP46",
    "rs_id": "rs2234922",
    "gene": "PHARGENE37",
    "drug": "DRUG21",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is not associated with clearance of carbamazepine in people with Epilepsy as compared to genotypes AA + AG.",
    "reference": "REF117",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981501779",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 223,
  "fields": {
    "snp_id": "SNP49",
    "rs_id": "rs1051740",
    "gene": "PHARGENE37",
    "drug": "DRUG21",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotypes CC + CT.",
    "reference": "REF117",
    "p_value": "0.026",
    "source": "PharmGKB",
    "id_in_source": "981501753",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 224,
  "fields": {
    "snp_id": "SNP52",
    "rs_id": "rs2273697",
    "gene": "PHARGENE3",
    "drug": "DRUG21",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG.",
    "reference": "REF117",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "981501817",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 225,
  "fields": {
    "snp_id": "SNP60",
    "rs_id": "rs4148386",
    "gene": "PHARGENE3",
    "drug": "DRUG21",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG.",
    "reference": "REF117",
    "p_value": "0.012",
    "source": "PharmGKB",
    "id_in_source": "981501842",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 226,
  "fields": {
    "snp_id": "SNP177",
    "rs_id": "rs35599367",
    "gene": "PHARGENE27",
    "drug": "DRUG48",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with concentrations of lopinavir in people with HIV.",
    "reference": "REF85",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447986089",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa & Malawi",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 227,
  "fields": {
    "snp_id": "SNP179",
    "rs_id": "rs2740574",
    "gene": "PHARGENE27",
    "drug": "DRUG48",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT is not associated with concentrations of lopinavir in people with HIV as compared to genotype CC.",
    "reference": "REF85",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447986082",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa & Malawi",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 228,
  "fields": {
    "snp_id": "SNP173",
    "rs_id": "rs7910642",
    "gene": "PHARGENE3",
    "drug": "DRUG48",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV as compared to genotype GG.",
    "reference": "REF85",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447986105",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa & Malawi",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 229,
  "fields": {
    "snp_id": "SNP174",
    "rs_id": "rs2306283",
    "gene": "PHARGENE82",
    "drug": "DRUG48",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV as compared to genotype GG.",
    "reference": "REF85",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447986111",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa & Malawi",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 230,
  "fields": {
    "snp_id": "SNP178",
    "rs_id": "rs4149056",
    "gene": "PHARGENE82",
    "drug": "DRUG48",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with concentrations of lopinavir in people with HIV.",
    "reference": "REF85",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447986096",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa & Malawi",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 231,
  "fields": {
    "snp_id": "SNP180",
    "rs_id": "rs4149044",
    "gene": "PHARGENE82",
    "drug": "DRUG48",
    "disease": "",
    "allele": "AA + AT",
    "association_with": "Genotypes AA + AT is not associated with concentrations of lopinavir in people with HIV as compared to genotype TT.",
    "reference": "REF85",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447986122",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa & Malawi",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 232,
  "fields": {
    "snp_id": "SNP181",
    "rs_id": "rs4149045",
    "gene": "PHARGENE82",
    "drug": "DRUG48",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG is not associated with concentrations of lopinavir in people with HIV as compared to genotype AA.",
    "reference": "REF85",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447986129",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa & Malawi",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 233,
  "fields": {
    "snp_id": "SNP182",
    "rs_id": "rs4149057",
    "gene": "PHARGENE82",
    "drug": "DRUG48",
    "disease": "",
    "allele": "CC + CT",
    "association_with": "Genotypes CC + CT is not associated with concentrations of lopinavir in people with HIV as compared to genotype TT.",
    "reference": "REF85",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447986136",
    "region": "Sub-Saharan African",
    "country_of_participants": "South Africa & Malawi",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 234,
  "fields": {
    "snp_id": "SNP260",
    "rs_id": "rs2242480",
    "gene": "PHARGENE27",
    "drug": "DRUG11",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C.",
    "reference": "REF120",
    "p_value": "0.0000000191",
    "source": "PharmGKB",
    "id_in_source": "1449163561",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 235,
  "fields": {
    "snp_id": "SNP261",
    "rs_id": "rs4646437",
    "gene": "PHARGENE27",
    "drug": "DRUG11",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.",
    "reference": "REF120",
    "p_value": "0.0000000886",
    "source": "PharmGKB",
    "id_in_source": "1449163570",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 236,
  "fields": {
    "snp_id": "SNP263",
    "rs_id": "rs4646450",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.",
    "reference": "REF120",
    "p_value": "0.000000491",
    "source": "PharmGKB",
    "id_in_source": "1449163533",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 237,
  "fields": {
    "snp_id": "SNP259",
    "rs_id": "rs2257401",
    "gene": "PHARGENE29",
    "drug": "DRUG11",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.",
    "reference": "REF120",
    "p_value": "0.015",
    "source": "PharmGKB",
    "id_in_source": "1449163553",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 238,
  "fields": {
    "snp_id": "SNP276",
    "rs_id": "rs1045642",
    "gene": "PHARGENE1",
    "drug": "DRUG11",
    "disease": "",
    "allele": "AG",
    "association_with": "Genotype AG is not associated with concentrations of tacrolimus in people with Kidney Transplantation as compared to genotype GG.",
    "reference": "REF109",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449171233",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 239,
  "fields": {
    "snp_id": "SNP320",
    "rs_id": "rs4646437",
    "gene": "PHARGENE27",
    "drug": "DRUG61",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG is associated with increased dose-adjusted trough concentrations of cyclosporine in people with Kidney Transplantation as compared to genotype AA.",
    "reference": "REF40",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1185012200",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 240,
  "fields": {
    "snp_id": "SNP321",
    "rs_id": "rs4646437",
    "gene": "PHARGENE27",
    "drug": "DRUG61",
    "disease": "",
    "allele": "AG + GG",
    "association_with": "Genotypes AG + GG is associated with increased response to cyclosporine in people with Kidney Transplantation as compared to genotype AA.",
    "reference": "REF40",
    "p_value": "0.034",
    "source": "PharmGKB",
    "id_in_source": "1185012251",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 241,
  "fields": {
    "snp_id": "SNP318",
    "rs_id": "rs2032582",
    "gene": "PHARGENE1",
    "drug": "DRUG61",
    "disease": "",
    "allele": "AC + CC",
    "association_with": "Genotypes AC + CC is associated with increased dose of cyclosporine in people with Kidney Transplantation as compared to genotypes AA + CT.",
    "reference": "REF40",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1185012207",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 242,
  "fields": {
    "snp_id": "SNP319",
    "rs_id": "rs2032582",
    "gene": "PHARGENE1",
    "drug": "DRUG61",
    "disease": "",
    "allele": "AC + CC",
    "association_with": "Genotypes AC + CC is associated with decreased dose-adjusted trough concentrations of cyclosporine in people with Kidney Transplantation as compared to genotypes AA + CT.",
    "reference": "REF40",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1185012234",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 243,
  "fields": {
    "snp_id": "SNP13",
    "rs_id": "rs881152",
    "gene": "PHARGENE35",
    "drug": "DRUG7",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased response to salbutamol in people with Asthma as compared to allele A.",
    "reference": "REF38",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "769174162",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 244,
  "fields": {
    "snp_id": "SNP14",
    "rs_id": "rs881152",
    "gene": "PHARGENE35",
    "drug": "DRUG7",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with increased response to salbutamol in people with Asthma as compared to allele A.",
    "reference": "REF38",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "769174165",
    "region": "Sub-Saharan African",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 245,
  "fields": {
    "snp_id": "SNP21",
    "rs_id": "rs28365062",
    "gene": "PHARGENE89",
    "drug": "DRUG9",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased metabolism of zidovudine as compared to allele A.",
    "reference": "REF122",
    "p_value": "0.004",
    "source": "PharmGKB",
    "id_in_source": "769259039",
    "region": "Sub-Saharan African",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 246,
  "fields": {
    "snp_id": "SNP96",
    "rs_id": "rs140471703",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC.",
    "reference": "REF156",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1183701955",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 247,
  "fields": {
    "snp_id": "SNP97",
    "rs_id": "rs376817657",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC.",
    "reference": "REF156",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1183701942",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 248,
  "fields": {
    "snp_id": "SNP98",
    "rs_id": "rs143690364",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC.",
    "reference": "REF156",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1183701959",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 249,
  "fields": {
    "snp_id": "SNP99",
    "rs_id": "rs2266782",
    "gene": "PHARGENE39",
    "drug": "DRUG18",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG is associated with decreased metabolism of nicotine in CYP2A6 reduced, but not normal, metabolizers as compared to genotype GG.",
    "reference": "REF151",
    "p_value": "0.07",
    "source": "PharmGKB",
    "id_in_source": "1183703319",
    "region": "Sub-Saharan African",
    "country_of_participants": "Canada",
    "latitude": "56.1303670",
    "longitude": "-106.3467710"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 250,
  "fields": {
    "snp_id": "SNP100",
    "rs_id": "rs1057868",
    "gene": "PHARGENE68",
    "drug": "DRUG18",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT is associated with increased metabolism of nicotine in CYP2A6 normal, but not reduced, metabolizers as compared to genotype CC.",
    "reference": "REF151",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "1183703328",
    "region": "Sub-Saharan African",
    "country_of_participants": "Canada",
    "latitude": "56.1303670",
    "longitude": "-106.3467710"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 251,
  "fields": {
    "snp_id": "SNP234",
    "rs_id": "rs2266782",
    "gene": "PHARGENE39",
    "drug": "DRUG18",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with metabolism of nicotine in people with Tobacco Use Disorder as compared to allele A.",
    "reference": "REF10",
    "p_value": "0.11",
    "source": "PharmGKB",
    "id_in_source": "1448602097",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 252,
  "fields": {
    "snp_id": "SNP236",
    "rs_id": "rs61750900",
    "gene": "PHARGENE87",
    "drug": "DRUG18",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is not associated with metabolism of nicotine in people with Tobacco Use Disorder as compared to genotype GT.",
    "reference": "REF10",
    "p_value": "0.003",
    "source": "PharmGKB",
    "id_in_source": "1448602085",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 253,
  "fields": {
    "snp_id": "SNP238",
    "rs_id": "rs2942857",
    "gene": "PHARGENE87",
    "drug": "DRUG18",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with increased exposure to nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AC.",
    "reference": "REF10",
    "p_value": "0.319",
    "source": "PharmGKB",
    "id_in_source": "1448602059",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 254,
  "fields": {
    "snp_id": "SNP239",
    "rs_id": "rs2942857",
    "gene": "PHARGENE87",
    "drug": "DRUG18",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with increased clearance of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AC.",
    "reference": "REF10",
    "p_value": "0.092",
    "source": "PharmGKB",
    "id_in_source": "1448602065",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 255,
  "fields": {
    "snp_id": "SNP233",
    "rs_id": "rs2266782",
    "gene": "PHARGENE39",
    "drug": "DRUG52",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with metabolism of cotinine in people with Tobacco Use Disorder as compared to allele A.",
    "reference": "REF10",
    "p_value": "0.09",
    "source": "PharmGKB",
    "id_in_source": "1448602091",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 256,
  "fields": {
    "snp_id": "SNP235",
    "rs_id": "rs61750900",
    "gene": "PHARGENE87",
    "drug": "DRUG52",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is not associated with metabolism of cotinine in people with Tobacco Use Disorder as compared to genotype GT.",
    "reference": "REF10",
    "p_value": "0.003",
    "source": "PharmGKB",
    "id_in_source": "1448602077",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 257,
  "fields": {
    "snp_id": "SNP237",
    "rs_id": "rs2942857",
    "gene": "PHARGENE87",
    "drug": "DRUG52",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with increased exposure to cotinine in people with Tobacco Use Disorder as compared to genotypes AA + AC.",
    "reference": "REF10",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "1448602052",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 258,
  "fields": {
    "snp_id": "SNP240",
    "rs_id": "rs2942857",
    "gene": "PHARGENE87",
    "drug": "DRUG52",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with decreased clearance of cotinine in people with Tobacco Use Disorder as compared to genotypes AA + AC.",
    "reference": "REF10",
    "p_value": "0.003",
    "source": "PharmGKB",
    "id_in_source": "1448602071",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 259,
  "fields": {
    "snp_id": "SNP207",
    "rs_id": "rs185430475",
    "gene": "PHARGENE95",
    "drug": "DRUG18",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with metabolism of nicotine as compared to allele C.",
    "reference": "REF132",
    "p_value": "0.0000000194",
    "source": "PharmGKB",
    "id_in_source": "1448996513",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Canada",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 260,
  "fields": {
    "snp_id": "SNP31",
    "rs_id": "rs2269879",
    "gene": "PHARGENE31",
    "drug": "DRUG17",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are not associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC.",
    "reference": "REF157",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "981239001",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 261,
  "fields": {
    "snp_id": "SNP31",
    "rs_id": "rs2269879",
    "gene": "PHARGENE31",
    "drug": "DRUG44",
    "disease": "",
    "allele": "CT + TT",
    "association_with": "Genotypes CT + TT are not associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC.",
    "reference": "REF157",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "981239001",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 262,
  "fields": {
    "snp_id": "SNP55",
    "rs_id": "rs4149601",
    "gene": "PHARGENE59",
    "drug": "DRUG17",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele A.",
    "reference": "REF73",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981732098",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 263,
  "fields": {
    "snp_id": "SNP55",
    "rs_id": "rs4149601",
    "gene": "PHARGENE59",
    "drug": "DRUG44",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele A.",
    "reference": "REF73",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981732098",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 264,
  "fields": {
    "snp_id": "SNP61",
    "rs_id": "rs1008899",
    "gene": "PHARGENE59",
    "drug": "DRUG17",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.",
    "reference": "REF73",
    "p_value": "0.2",
    "source": "PharmGKB",
    "id_in_source": "981747509",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 265,
  "fields": {
    "snp_id": "SNP61",
    "rs_id": "rs1008899",
    "gene": "PHARGENE59",
    "drug": "DRUG44",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.",
    "reference": "REF73",
    "p_value": "0.2",
    "source": "PharmGKB",
    "id_in_source": "981747509",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 266,
  "fields": {
    "snp_id": "SNP62",
    "rs_id": "rs292449",
    "gene": "PHARGENE59",
    "drug": "DRUG17",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.",
    "reference": "REF73",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981741019",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 267,
  "fields": {
    "snp_id": "SNP62",
    "rs_id": "rs292449",
    "gene": "PHARGENE59",
    "drug": "DRUG44",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.",
    "reference": "REF73",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981741019",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 268,
  "fields": {
    "snp_id": "SNP84",
    "rs_id": "rs3184504",
    "gene": "PHARGENE76",
    "drug": "DRUG17",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele C.",
    "reference": "REF112",
    "p_value": "0.047",
    "source": "PharmGKB",
    "id_in_source": "1183491528",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 269,
  "fields": {
    "snp_id": "SNP84",
    "rs_id": "rs3184504",
    "gene": "PHARGENE76",
    "drug": "DRUG44",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele C.",
    "reference": "REF112",
    "p_value": "0.047",
    "source": "PharmGKB",
    "id_in_source": "1183491528",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 270,
  "fields": {
    "snp_id": "SNP83",
    "rs_id": "rs871606",
    "gene": "PHARGENE17",
    "drug": "DRUG32",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C.",
    "reference": "REF112",
    "p_value": "0.06",
    "source": "PharmGKB",
    "id_in_source": "1183491521",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 271,
  "fields": {
    "snp_id": "SNP83",
    "rs_id": "rs871606",
    "gene": "PHARGENE17",
    "drug": "DRUG43",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C.",
    "reference": "REF112",
    "p_value": "0.06",
    "source": "PharmGKB",
    "id_in_source": "1183491521",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 272,
  "fields": {
    "snp_id": "SNP93",
    "rs_id": "rs12076902",
    "gene": "PHARGENE15",
    "drug": "DRUG32",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.",
    "reference": "REF112",
    "p_value": "0.02",
    "source": "PharmGKB",
    "id_in_source": "1183491537",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 273,
  "fields": {
    "snp_id": "SNP93",
    "rs_id": "rs12076902",
    "gene": "PHARGENE15",
    "drug": "DRUG43",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.",
    "reference": "REF112",
    "p_value": "0.02",
    "source": "PharmGKB",
    "id_in_source": "1183491537",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 274,
  "fields": {
    "snp_id": "SNP94",
    "rs_id": "rs12069113",
    "gene": "PHARGENE57",
    "drug": "DRUG32",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to atenolol in people with Hypertension as compared to allele T.",
    "reference": "REF112",
    "p_value": "0.042",
    "source": "PharmGKB",
    "id_in_source": "1183491533",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 275,
  "fields": {
    "snp_id": "SNP94",
    "rs_id": "rs12069113",
    "gene": "PHARGENE57",
    "drug": "DRUG43",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to atenolol in people with Hypertension as compared to allele T.",
    "reference": "REF112",
    "p_value": "0.042",
    "source": "PharmGKB",
    "id_in_source": "1183491533",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 276,
  "fields": {
    "snp_id": "SNP290",
    "rs_id": "rs12721616",
    "gene": "PHARGENE60",
    "drug": "DRUG56",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.",
    "reference": "REF41",
    "p_value": "0.01",
    "source": "PharmGKB",
    "id_in_source": "1449733085",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 277,
  "fields": {
    "snp_id": "SNP265",
    "rs_id": "rs8187692",
    "gene": "PHARGENE3",
    "drug": "DRUG56",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G.",
    "reference": "REF41",
    "p_value": "0.003",
    "source": "PharmGKB",
    "id_in_source": "1449733103",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 278,
  "fields": {
    "snp_id": "SNP270",
    "rs_id": "rs17216198",
    "gene": "PHARGENE3",
    "drug": "DRUG56",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.",
    "reference": "REF41",
    "p_value": "0.015",
    "source": "PharmGKB",
    "id_in_source": "1449733162",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 279,
  "fields": {
    "snp_id": "SNP271",
    "rs_id": "rs17216177",
    "gene": "PHARGENE3",
    "drug": "DRUG56",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.",
    "reference": "REF41",
    "p_value": "0.006",
    "source": "PharmGKB",
    "id_in_source": "1449733189",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 280,
  "fields": {
    "snp_id": "SNP272",
    "rs_id": "rs3740066",
    "gene": "PHARGENE3",
    "drug": "DRUG56",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.",
    "reference": "REF41",
    "p_value": "0.01",
    "source": "PharmGKB",
    "id_in_source": "1449733168",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 281,
  "fields": {
    "snp_id": "SNP273",
    "rs_id": "rs7899457",
    "gene": "PHARGENE3",
    "drug": "DRUG56",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.",
    "reference": "REF41",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "1449733176",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 282,
  "fields": {
    "snp_id": "SNP274",
    "rs_id": "rs8187706",
    "gene": "PHARGENE3",
    "drug": "DRUG56",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.",
    "reference": "REF41",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "1449733184",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 283,
  "fields": {
    "snp_id": "SNP275",
    "rs_id": "rs8187710",
    "gene": "PHARGENE3",
    "drug": "DRUG56",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.",
    "reference": "REF41",
    "p_value": "0.01",
    "source": "PharmGKB",
    "id_in_source": "1449733194",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 284,
  "fields": {
    "snp_id": "SNP291",
    "rs_id": "rs11045854",
    "gene": "PHARGENE82",
    "drug": "DRUG56",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.",
    "reference": "REF41",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "1449733034",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 285,
  "fields": {
    "snp_id": "SNP292",
    "rs_id": "rs12305884",
    "gene": "PHARGENE82",
    "drug": "DRUG56",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.",
    "reference": "REF41",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "1449733045",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 286,
  "fields": {
    "snp_id": "SNP293",
    "rs_id": "rs11045873",
    "gene": "PHARGENE82",
    "drug": "DRUG56",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.",
    "reference": "REF41",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "1449733054",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 287,
  "fields": {
    "snp_id": "SNP294",
    "rs_id": "rs11045874",
    "gene": "PHARGENE82",
    "drug": "DRUG56",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.",
    "reference": "REF41",
    "p_value": "0.002",
    "source": "PharmGKB",
    "id_in_source": "1449733062",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 288,
  "fields": {
    "snp_id": "SNP295",
    "rs_id": "rs34671512",
    "gene": "PHARGENE82",
    "drug": "DRUG56",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele A.",
    "reference": "REF41",
    "p_value": "0.016",
    "source": "PharmGKB",
    "id_in_source": "1449733067",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 289,
  "fields": {
    "snp_id": "SNP264",
    "rs_id": "rs3212207",
    "gene": "PHARGENE51",
    "drug": "DRUG56",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G.",
    "reference": "REF41",
    "p_value": "0.01",
    "source": "PharmGKB",
    "id_in_source": "1449733134",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 290,
  "fields": {
    "snp_id": "SNP266",
    "rs_id": "rs1805343",
    "gene": "PHARGENE75",
    "drug": "DRUG56",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with increased exposure to rosuvastatin in healthy individuals.",
    "reference": "REF41",
    "p_value": "0.001",
    "source": "PharmGKB",
    "id_in_source": "1449733142",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 291,
  "fields": {
    "snp_id": "SNP267",
    "rs_id": "rs7579275",
    "gene": "PHARGENE2",
    "drug": "DRUG56",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.",
    "reference": "REF41",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "1449733115",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 292,
  "fields": {
    "snp_id": "SNP268",
    "rs_id": "rs2287622",
    "gene": "PHARGENE2",
    "drug": "DRUG56",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.",
    "reference": "REF41",
    "p_value": "0.003",
    "source": "PharmGKB",
    "id_in_source": "1449733121",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 293,
  "fields": {
    "snp_id": "SNP269",
    "rs_id": "rs16980091",
    "gene": "PHARGENE40",
    "drug": "DRUG56",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele C.",
    "reference": "REF41",
    "p_value": "0.04",
    "source": "PharmGKB",
    "id_in_source": "1449733152",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 294,
  "fields": {
    "snp_id": "SNP296",
    "rs_id": "rs56903885",
    "gene": "PHARGENE77",
    "drug": "DRUG56",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.",
    "reference": "REF41",
    "p_value": "0.007",
    "source": "PharmGKB",
    "id_in_source": "1449733079",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Tanzania",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 295,
  "fields": {
    "snp_id": "SNP355",
    "rs_id": "rs1523130",
    "gene": "PHARGENE60",
    "drug": "DRUG39",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotypes CT + TT.",
    "reference": "REF79",
    "p_value": "0.82",
    "source": "PharmGKB",
    "id_in_source": "1447947686",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "South Africa, Peru & USA",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 296,
  "fields": {
    "snp_id": "SNP356",
    "rs_id": "rs2472677",
    "gene": "PHARGENE60",
    "drug": "DRUG39",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT (assigned as deficiency phenotype) is associated with decreased concentrations of atazanavir in people with HIV as compared to genotypes CC + TT.",
    "reference": "REF79",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "1447947668",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "South Africa, Peru & USA",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 297,
  "fields": {
    "snp_id": "SNP353",
    "rs_id": "rs2306283",
    "gene": "PHARGENE82",
    "drug": "DRUG39",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotypes AA + AG.",
    "reference": "REF79",
    "p_value": "0.88",
    "source": "PharmGKB",
    "id_in_source": "1447947654",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "South Africa, Peru & USA",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 298,
  "fields": {
    "snp_id": "SNP354",
    "rs_id": "rs4149056",
    "gene": "PHARGENE82",
    "drug": "DRUG39",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotype TT.",
    "reference": "REF79",
    "p_value": "0.57",
    "source": "PharmGKB",
    "id_in_source": "1447947662",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "South Africa, Peru & USA",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 299,
  "fields": {
    "snp_id": "SNP124",
    "rs_id": "rs887829",
    "gene": "PHARGENE86",
    "drug": "DRUG39",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased discontinuation of atazanavir in people with HIV as compared to genotypes CC + CT.",
    "reference": "REF114",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296945",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Puerto Rico",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 300,
  "fields": {
    "snp_id": "SNP255",
    "rs_id": "rs887829",
    "gene": "PHARGENE86",
    "drug": "DRUG39",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with increased discontinuation of atazanavir as compared to genotype CC.",
    "reference": "REF127",
    "p_value": "0.45",
    "source": "PharmGKB",
    "id_in_source": "1449154896",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 301,
  "fields": {
    "snp_id": "SNP256",
    "rs_id": "rs887829",
    "gene": "PHARGENE86",
    "drug": "DRUG39",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is not associated with increased discontinuation of atazanavir as compared to genotype CC.",
    "reference": "REF127",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1449154902",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 302,
  "fields": {
    "snp_id": "SNP277",
    "rs_id": "rs73208473",
    "gene": "PHARGENE83",
    "drug": "DRUG39",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased exposure to atazanavir in women with HIV as compared to allele C.",
    "reference": "REF71",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1450042840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 303,
  "fields": {
    "snp_id": "SNP36",
    "rs_id": "rs2960306",
    "gene": "PHARGENE46",
    "drug": "DRUG19",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with decreased response to metoprolol in men with hypertensive nephrosclerosis.",
    "reference": "REF80",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827864080",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 304,
  "fields": {
    "snp_id": "SNP36",
    "rs_id": "rs2960306",
    "gene": "PHARGENE46",
    "drug": "DRUG38",
    "disease": "",
    "allele": "GT + TT",
    "association_with": "Genotypes GT + TT are associated with decreased response to metoprolol in men with hypertensive nephrosclerosis.",
    "reference": "REF80",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827864080",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 305,
  "fields": {
    "snp_id": "SNP37",
    "rs_id": "rs1024323",
    "gene": "PHARGENE46",
    "drug": "DRUG19",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT.",
    "reference": "REF80",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "827864047",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 306,
  "fields": {
    "snp_id": "SNP37",
    "rs_id": "rs1024323",
    "gene": "PHARGENE46",
    "drug": "DRUG38",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT.",
    "reference": "REF80",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "827864047",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 307,
  "fields": {
    "snp_id": "SNP38",
    "rs_id": "rs1024323",
    "gene": "PHARGENE46",
    "drug": "DRUG19",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT.",
    "reference": "REF80",
    "p_value": "0.9",
    "source": "PharmGKB",
    "id_in_source": "827864069",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 308,
  "fields": {
    "snp_id": "SNP38",
    "rs_id": "rs1024323",
    "gene": "PHARGENE46",
    "drug": "DRUG38",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT.",
    "reference": "REF80",
    "p_value": "0.9",
    "source": "PharmGKB",
    "id_in_source": "827864069",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 309,
  "fields": {
    "snp_id": "SNP39",
    "rs_id": "rs1801058",
    "gene": "PHARGENE46",
    "drug": "DRUG19",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype CC.",
    "reference": "REF80",
    "p_value": "0.05",
    "source": "PharmGKB",
    "id_in_source": "827864109",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 310,
  "fields": {
    "snp_id": "SNP39",
    "rs_id": "rs1801058",
    "gene": "PHARGENE46",
    "drug": "DRUG38",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype CC.",
    "reference": "REF80",
    "p_value": "0.05",
    "source": "PharmGKB",
    "id_in_source": "827864109",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 311,
  "fields": {
    "snp_id": "SNP42",
    "rs_id": "rs2960306",
    "gene": "PHARGENE46",
    "drug": "DRUG19",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG.",
    "reference": "REF80",
    "p_value": "0.21",
    "source": "PharmGKB",
    "id_in_source": "827864125",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 312,
  "fields": {
    "snp_id": "SNP42",
    "rs_id": "rs2960306",
    "gene": "PHARGENE46",
    "drug": "DRUG38",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG.",
    "reference": "REF80",
    "p_value": "0.21",
    "source": "PharmGKB",
    "id_in_source": "827864125",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 313,
  "fields": {
    "snp_id": "SNP44",
    "rs_id": "rs1801058",
    "gene": "PHARGENE46",
    "drug": "DRUG19",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC.",
    "reference": "REF80",
    "p_value": "0.25",
    "source": "PharmGKB",
    "id_in_source": "827864092",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 314,
  "fields": {
    "snp_id": "SNP44",
    "rs_id": "rs1801058",
    "gene": "PHARGENE46",
    "drug": "DRUG38",
    "disease": "",
    "allele": "CT",
    "association_with": "Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC.",
    "reference": "REF80",
    "p_value": "0.25",
    "source": "PharmGKB",
    "id_in_source": "827864092",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 315,
  "fields": {
    "snp_id": "SNP183",
    "rs_id": "rs1045642",
    "gene": "PHARGENE1",
    "drug": "DRUG49",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG is associated with decreased trough concentration of imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype GG.",
    "reference": "REF69",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1448125824",
    "region": "Sub-Saharan African",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 316,
  "fields": {
    "snp_id": "SNP331",
    "rs_id": "rs1128503",
    "gene": "PHARGENE1",
    "drug": "DRUG49",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.",
    "reference": "REF154",
    "p_value": "0.12",
    "source": "PharmGKB",
    "id_in_source": "1449005428",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 317,
  "fields": {
    "snp_id": "SNP332",
    "rs_id": "rs2032582",
    "gene": "PHARGENE1",
    "drug": "DRUG49",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.",
    "reference": "REF154",
    "p_value": "0.28",
    "source": "PharmGKB",
    "id_in_source": "1449005435",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 318,
  "fields": {
    "snp_id": "SNP333",
    "rs_id": "rs1045642",
    "gene": "PHARGENE1",
    "drug": "DRUG49",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.",
    "reference": "REF154",
    "p_value": "0.21",
    "source": "PharmGKB",
    "id_in_source": "1449005441",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 319,
  "fields": {
    "snp_id": "SNP367",
    "rs_id": "rs2273897",
    "gene": "PHARGENE3",
    "drug": "DRUG80",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with increased concentrations of emtricitabine in people with HIV and Pregnancy as compared to genotypes CC + CT.",
    "reference": "REF48",
    "p_value": "0.028",
    "source": "PharmGKB",
    "id_in_source": "1450377018",
    "region": "Sub-Saharan African",
    "country_of_participants": "NIgeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 320,
  "fields": {
    "snp_id": "SNP56",
    "rs_id": "rs25531",
    "gene": "PHARGENE81",
    "drug": "DRUG26",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to citalopram in people with Depression as compared to allele T.",
    "reference": "REF136",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981477870",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 321,
  "fields": {
    "snp_id": "SNP112",
    "rs_id": "rs1801252",
    "gene": "PHARGENE6",
    "drug": "DRUG26",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.",
    "reference": "REF94",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184749202",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 322,
  "fields": {
    "snp_id": "SNP113",
    "rs_id": "rs1801253",
    "gene": "PHARGENE6",
    "drug": "DRUG26",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.",
    "reference": "REF94",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184749213",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 323,
  "fields": {
    "snp_id": "SNP114",
    "rs_id": "rs363371",
    "gene": "PHARGENE78",
    "drug": "DRUG26",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.",
    "reference": "REF94",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184749158",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 324,
  "fields": {
    "snp_id": "SNP115",
    "rs_id": "rs363390",
    "gene": "PHARGENE78",
    "drug": "DRUG26",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.",
    "reference": "REF94",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184749184",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 325,
  "fields": {
    "snp_id": "SNP116",
    "rs_id": "rs363343",
    "gene": "PHARGENE78",
    "drug": "DRUG26",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele C.",
    "reference": "REF94",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184749190",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 326,
  "fields": {
    "snp_id": "SNP117",
    "rs_id": "rs929493",
    "gene": "PHARGENE78",
    "drug": "DRUG26",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele T.",
    "reference": "REF94",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184749196",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 327,
  "fields": {
    "snp_id": "SNP63",
    "rs_id": "rs737865",
    "gene": "PHARGENE18",
    "drug": "DRUG22",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is associated with decreased response to bupropion in smokers as compared to genotypes AG + GG.",
    "reference": "REF131",
    "p_value": "0.05",
    "source": "PharmGKB",
    "id_in_source": "981419313",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 328,
  "fields": {
    "snp_id": "SNP339",
    "rs_id": "rs4680",
    "gene": "PHARGENE18",
    "drug": "DRUG66",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with dose of morphine in people with Pain as compared to allele A.",
    "reference": "REF67",
    "p_value": "0.2928",
    "source": "PharmGKB",
    "id_in_source": "1449182349",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 329,
  "fields": {
    "snp_id": "SNP335",
    "rs_id": "rs17174629",
    "gene": "PHARGENE64",
    "drug": "DRUG66",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with dose of morphine in people with Pain as compared to allele A.",
    "reference": "REF67",
    "p_value": "0.0984",
    "source": "PharmGKB",
    "id_in_source": "1449182316",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 330,
  "fields": {
    "snp_id": "SNP336",
    "rs_id": "rs1799972",
    "gene": "PHARGENE64",
    "drug": "DRUG66",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with dose of morphine in people with Pain as compared to allele C.",
    "reference": "REF67",
    "p_value": "0.3441",
    "source": "PharmGKB",
    "id_in_source": "1449182334",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 331,
  "fields": {
    "snp_id": "SNP337",
    "rs_id": "rs1799971",
    "gene": "PHARGENE64",
    "drug": "DRUG66",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with dose of morphine in people with Pain as compared to allele A.",
    "reference": "REF67",
    "p_value": "0.149",
    "source": "PharmGKB",
    "id_in_source": "1449182322",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 332,
  "fields": {
    "snp_id": "SNP338",
    "rs_id": "rs1051660",
    "gene": "PHARGENE63",
    "drug": "DRUG66",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is associated with decreased dose of morphine in people with Pain as compared to allele C.",
    "reference": "REF67",
    "p_value": "0.0278",
    "source": "PharmGKB",
    "id_in_source": "1449182301",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 333,
  "fields": {
    "snp_id": "SNP69",
    "rs_id": "rs17161788",
    "gene": "PHARGENE28",
    "drug": "DRUG29",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to genotypes CC + CT.",
    "reference": "REF103",
    "p_value": "0.467",
    "source": "PharmGKB",
    "id_in_source": "982044239",
    "region": "Sub-Saharan African",
    "country_of_participants": "Brazil",
    "latitude": "-14.2350040",
    "longitude": "-51.9252820"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 334,
  "fields": {
    "snp_id": "SNP71",
    "rs_id": "rs4359",
    "gene": "PHARGENE5",
    "drug": "DRUG30",
    "disease": "",
    "allele": "CC + TT",
    "association_with": "Genotypes CC + TT are associated with increased response to ramipril in people with Hypertension as compared to genotype CT.",
    "reference": "REF36",
    "p_value": "0.003",
    "source": "PharmGKB",
    "id_in_source": "982048078",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 335,
  "fields": {
    "snp_id": "SNP74",
    "rs_id": "rs4344",
    "gene": "PHARGENE5",
    "drug": "DRUG30",
    "disease": "",
    "allele": "AA + GG",
    "association_with": "Genotypes AA + GG are associated with increased response to ramipril in people with Hypertension as compared to genotype AG.",
    "reference": "REF36",
    "p_value": "0.03",
    "source": "PharmGKB",
    "id_in_source": "982048062",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 336,
  "fields": {
    "snp_id": "SNP76",
    "rs_id": "rs4363",
    "gene": "PHARGENE5",
    "drug": "DRUG30",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG are not associated with increased response to ramipril in people with Hypertension as compared to genotype GG.",
    "reference": "REF36",
    "p_value": "0.9",
    "source": "PharmGKB",
    "id_in_source": "982048083",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 337,
  "fields": {
    "snp_id": "SNP129",
    "rs_id": "rs2053044",
    "gene": "PHARGENE7",
    "drug": "DRUG30",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG is associated with increased response to ramipril in people with Hypertension as compared to genotype GG.",
    "reference": "REF24",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1444929453",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 338,
  "fields": {
    "snp_id": "SNP189",
    "rs_id": "rs3785161",
    "gene": "PHARGENE16",
    "drug": "DRUG45",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to trandolapril in people with Hypertension as compared to allele A.",
    "reference": "REF16",
    "p_value": "0.52",
    "source": "PharmGKB",
    "id_in_source": "1447979801",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 339,
  "fields": {
    "snp_id": "SNP221",
    "rs_id": "rs2515462",
    "gene": "PHARGENE9",
    "drug": "DRUG51",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.",
    "reference": "REF37",
    "p_value": "1",
    "source": "PharmGKB",
    "id_in_source": "1448995772",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 340,
  "fields": {
    "snp_id": "SNP222",
    "rs_id": "rs13269021",
    "gene": "PHARGENE9",
    "drug": "DRUG51",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.",
    "reference": "REF37",
    "p_value": "1",
    "source": "PharmGKB",
    "id_in_source": "1448995786",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 341,
  "fields": {
    "snp_id": "SNP223",
    "rs_id": "rs1375668",
    "gene": "PHARGENE9",
    "drug": "DRUG51",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.",
    "reference": "REF37",
    "p_value": "1",
    "source": "PharmGKB",
    "id_in_source": "1448995793",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 342,
  "fields": {
    "snp_id": "SNP231",
    "rs_id": "rs2515409",
    "gene": "PHARGENE9",
    "drug": "DRUG51",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele T.",
    "reference": "REF37",
    "p_value": "1",
    "source": "PharmGKB",
    "id_in_source": "1448995758",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 343,
  "fields": {
    "snp_id": "SNP232",
    "rs_id": "rs10102851",
    "gene": "PHARGENE9",
    "drug": "DRUG51",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.",
    "reference": "REF37",
    "p_value": "0.4322",
    "source": "PharmGKB",
    "id_in_source": "1448995765",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 344,
  "fields": {
    "snp_id": "SNP224",
    "rs_id": "rs2445365",
    "gene": "PHARGENE8",
    "drug": "DRUG51",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.",
    "reference": "REF37",
    "p_value": "1",
    "source": "PharmGKB",
    "id_in_source": "1448995748",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 345,
  "fields": {
    "snp_id": "SNP225",
    "rs_id": "rs2274755",
    "gene": "PHARGENE56",
    "drug": "DRUG51",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.",
    "reference": "REF37",
    "p_value": "1",
    "source": "PharmGKB",
    "id_in_source": "1448995807",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 346,
  "fields": {
    "snp_id": "SNP226",
    "rs_id": "rs2236416",
    "gene": "PHARGENE56",
    "drug": "DRUG51",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.",
    "reference": "REF37",
    "p_value": "0.6181",
    "source": "PharmGKB",
    "id_in_source": "1448995815",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 347,
  "fields": {
    "snp_id": "SNP227",
    "rs_id": "rs17577",
    "gene": "PHARGENE56",
    "drug": "DRUG51",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.",
    "reference": "REF37",
    "p_value": "1",
    "source": "PharmGKB",
    "id_in_source": "1448995822",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 348,
  "fields": {
    "snp_id": "SNP228",
    "rs_id": "rs1960669",
    "gene": "PHARGENE38",
    "drug": "DRUG51",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele C.",
    "reference": "REF37",
    "p_value": "0.6445",
    "source": "PharmGKB",
    "id_in_source": "1448995800",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 349,
  "fields": {
    "snp_id": "SNP229",
    "rs_id": "rs833068",
    "gene": "PHARGENE90",
    "drug": "DRUG51",
    "disease": "",
    "allele": "A",
    "association_with": "Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.",
    "reference": "REF37",
    "p_value": "0.4569",
    "source": "PharmGKB",
    "id_in_source": "1448995829",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 350,
  "fields": {
    "snp_id": "SNP230",
    "rs_id": "rs833069",
    "gene": "PHARGENE90",
    "drug": "DRUG51",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele T.",
    "reference": "REF37",
    "p_value": "0.4505",
    "source": "PharmGKB",
    "id_in_source": "1448995836",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 351,
  "fields": {
    "snp_id": "SNP278",
    "rs_id": "rs678849",
    "gene": "PHARGENE62",
    "drug": "DRUG55",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT.",
    "reference": "REF97",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1449753059",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 352,
  "fields": {
    "snp_id": "SNP279",
    "rs_id": "rs678849",
    "gene": "PHARGENE62",
    "drug": "DRUG58",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is not associated with response to methadone in people with Opioid-Related Disorders as compared to genotypes CT + TT.",
    "reference": "REF97",
    "p_value": "0.087",
    "source": "PharmGKB",
    "id_in_source": "1449753070",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 353,
  "fields": {
    "snp_id": "SNP280",
    "rs_id": "rs678849",
    "gene": "PHARGENE62",
    "drug": "DRUG55",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT.",
    "reference": "REF99",
    "p_value": "0.008",
    "source": "PharmGKB",
    "id_in_source": "1449157145",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 354,
  "fields": {
    "snp_id": "SNP284",
    "rs_id": "rs529520",
    "gene": "PHARGENE62",
    "drug": "DRUG55",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.",
    "reference": "REF99",
    "p_value": "0.28",
    "source": "PharmGKB",
    "id_in_source": "1449157166",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 355,
  "fields": {
    "snp_id": "SNP286",
    "rs_id": "rs581111",
    "gene": "PHARGENE62",
    "drug": "DRUG55",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.",
    "reference": "REF99",
    "p_value": "0.84",
    "source": "PharmGKB",
    "id_in_source": "1449157174",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 356,
  "fields": {
    "snp_id": "SNP288",
    "rs_id": "rs2234918",
    "gene": "PHARGENE62",
    "drug": "DRUG55",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.",
    "reference": "REF99",
    "p_value": "0.76",
    "source": "PharmGKB",
    "id_in_source": "1449157181",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 357,
  "fields": {
    "snp_id": "SNP281",
    "rs_id": "rs678849",
    "gene": "PHARGENE62",
    "drug": "DRUG58",
    "disease": "",
    "allele": "CC",
    "association_with": "Genotype CC is associated with increased response to methadone in people with Opioid-Related Disorders as compared to genotypes CT + TT.",
    "reference": "REF99",
    "p_value": "0.001",
    "source": "PharmGKB",
    "id_in_source": "1449157237",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 358,
  "fields": {
    "snp_id": "SNP285",
    "rs_id": "rs529520",
    "gene": "PHARGENE62",
    "drug": "DRUG58",
    "disease": "",
    "allele": "C",
    "association_with": "Allele C is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.",
    "reference": "REF99",
    "p_value": "0.44",
    "source": "PharmGKB",
    "id_in_source": "1449157257",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 359,
  "fields": {
    "snp_id": "SNP287",
    "rs_id": "rs581111",
    "gene": "PHARGENE62",
    "drug": "DRUG58",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.",
    "reference": "REF99",
    "p_value": "0.17",
    "source": "PharmGKB",
    "id_in_source": "1449157264",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 360,
  "fields": {
    "snp_id": "SNP289",
    "rs_id": "rs2234918",
    "gene": "PHARGENE62",
    "drug": "DRUG58",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele C.",
    "reference": "REF99",
    "p_value": "0.07",
    "source": "PharmGKB",
    "id_in_source": "1449157271",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 361,
  "fields": {
    "snp_id": "SNP330",
    "rs_id": "rs1801133",
    "gene": "PHARGENE58",
    "drug": "DRUG64",
    "disease": "",
    "allele": "AA + AG",
    "association_with": "Genotypes AA + AG is associated with increased exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.",
    "reference": "REF105",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1446898629",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 362,
  "fields": {
    "snp_id": "SNP334",
    "rs_id": "rs2046934",
    "gene": "PHARGENE65",
    "drug": "DRUG65",
    "disease": "",
    "allele": "G",
    "association_with": "Allele G is associated with resistance to clopidogrel in people with Acute coronary syndrome as compared to allele A.",
    "reference": "REF107",
    "p_value": "0.45",
    "source": "PharmGKB",
    "id_in_source": "1448604375",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 363,
  "fields": {
    "snp_id": "SNP344",
    "rs_id": "rs2842030",
    "gene": "PHARGENE71",
    "drug": "DRUG71",
    "disease": "",
    "allele": "GG",
    "association_with": "Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes TT + GT.",
    "reference": "REF47",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "608431255",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 364,
  "fields": {
    "snp_id": "SNP352",
    "rs_id": "rs2231142",
    "gene": "PHARGENE4",
    "drug": "DRUG75",
    "disease": "",
    "allele": "T",
    "association_with": "Allele T is associated with decreased response to allopurinol in people with Gout as compared to allele G.",
    "reference": "REF72",
    "p_value": "0.00000002",
    "source": "PharmGKB",
    "id_in_source": "1444703466",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 365,
  "fields": {
    "snp_id": "SNP362",
    "rs_id": "rs9282861",
    "gene": "PHARGENE85",
    "drug": "DRUG77",
    "disease": "",
    "allele": "TT",
    "association_with": "Genotype TT is not associated with decreased metabolism of acetaminophen in healthy individuals as compared to genotypes CC + CT.",
    "reference": "REF116",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448639937",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 366,
  "fields": {
    "snp_id": "SNP363",
    "rs_id": "rs1902023",
    "gene": "PHARGENE88",
    "drug": "DRUG77",
    "disease": "",
    "allele": "AA",
    "association_with": "Genotype AA is associated with increased metabolism of acetaminophen in healthy individuals as compared to genotypes AC + CC.",
    "reference": "REF116",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448639952",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 367,
  "fields": {
    "snp_id": "SNP366",
    "rs_id": "rs5333",
    "gene": "PHARGENE36",
    "drug": "DRUG79",
    "disease": "",
    "allele": "CC + CT",
    "association_with": "Genotypes CC + CT is associated with increased resistance to prednisone in children with Nephrotic Syndrome as compared to genotype TT.",
    "reference": "REF145",
    "p_value": "0.016",
    "source": "PharmGKB",
    "id_in_source": "1450367980",
    "region": "Sub-Saharan African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 368,
  "fields": {
    "snp_id": "SNP369",
    "rs_id": "rs10192428",
    "gene": "DISGENE96",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "0.00000051",
    "source": "DisGeNET",
    "id_in_source": "rs10192428",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 369,
  "fields": {
    "snp_id": "SNP370",
    "rs_id": "rs1044498",
    "gene": "DISGENE97",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF222",
    "p_value": "0.919",
    "source": "DisGeNET",
    "id_in_source": "rs1044498",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 370,
  "fields": {
    "snp_id": "SNP371",
    "rs_id": "rs1044703733",
    "gene": "DISGENE98",
    "drug": "",
    "disease": "DIS415",
    "allele": "",
    "association_with": "Papillon-Lefevre Disease",
    "reference": "REF261",
    "p_value": "0.919",
    "source": "DisGeNET",
    "id_in_source": "rs1044703733",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 371,
  "fields": {
    "snp_id": "SNP372",
    "rs_id": "rs1046089",
    "gene": "DISGENE99",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF399",
    "p_value": "< 0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs1046089",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 372,
  "fields": {
    "snp_id": "SNP373",
    "rs_id": "rs1048661",
    "gene": "DISGENE100",
    "drug": "",
    "disease": "DIS187",
    "allele": "",
    "association_with": "Exfoliation Syndrome",
    "reference": "REF389",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1048661",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Ghana, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 373,
  "fields": {
    "snp_id": "SNP374",
    "rs_id": "rs1048661",
    "gene": "DISGENE101",
    "drug": "",
    "disease": "DIS187",
    "allele": "",
    "association_with": "Exfoliation Syndrome",
    "reference": "REF389",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1048661",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Ghana, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 374,
  "fields": {
    "snp_id": "SNP375",
    "rs_id": "rs104886457",
    "gene": "DISGENE102",
    "drug": "",
    "disease": "DIS197",
    "allele": "",
    "association_with": "Fanconi Anemia, Complementation Group C",
    "reference": "REF488",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104886457",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Asia, Europe",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 375,
  "fields": {
    "snp_id": "SNP376",
    "rs_id": "rs104886457",
    "gene": "DISGENE102",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF488",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104886457",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Asia, Europe",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 376,
  "fields": {
    "snp_id": "SNP377",
    "rs_id": "rs104893628",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893628",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 377,
  "fields": {
    "snp_id": "SNP378",
    "rs_id": "rs104893628",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893628",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 378,
  "fields": {
    "snp_id": "SNP379",
    "rs_id": "rs104893628",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893628",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 379,
  "fields": {
    "snp_id": "SNP380",
    "rs_id": "rs104893628",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893628",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 380,
  "fields": {
    "snp_id": "SNP381",
    "rs_id": "rs104893628",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893628",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 381,
  "fields": {
    "snp_id": "SNP382",
    "rs_id": "rs104893628",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893628",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 382,
  "fields": {
    "snp_id": "SNP383",
    "rs_id": "rs104893628",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893628",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 383,
  "fields": {
    "snp_id": "SNP384",
    "rs_id": "rs104893628",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893628",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 384,
  "fields": {
    "snp_id": "SNP385",
    "rs_id": "rs104893629",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893629",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 385,
  "fields": {
    "snp_id": "SNP386",
    "rs_id": "rs104893629",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893629",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 386,
  "fields": {
    "snp_id": "SNP387",
    "rs_id": "rs104893629",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893629",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 387,
  "fields": {
    "snp_id": "SNP388",
    "rs_id": "rs104893629",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF366",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893629",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 388,
  "fields": {
    "snp_id": "SNP389",
    "rs_id": "rs104893869",
    "gene": "DISGENE105",
    "drug": "",
    "disease": "DIS310",
    "allele": "",
    "association_with": "Limb-Girdle Muscular Dystrophy, Type 2E",
    "reference": "REF244",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104893869",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 389,
  "fields": {
    "snp_id": "SNP390",
    "rs_id": "rs104894075",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS94",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Axonal, Type 2K",
    "reference": "REF534",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894075",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 390,
  "fields": {
    "snp_id": "SNP391",
    "rs_id": "rs104894075",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS98",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)",
    "reference": "REF534",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894075",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 391,
  "fields": {
    "snp_id": "SNP392",
    "rs_id": "rs104894075",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS97",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form",
    "reference": "REF534",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894075",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 392,
  "fields": {
    "snp_id": "SNP393",
    "rs_id": "rs104894075",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS93",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease",
    "reference": "REF380",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894075",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 393,
  "fields": {
    "snp_id": "SNP394",
    "rs_id": "rs104894075",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS94",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Axonal, Type 2K",
    "reference": "REF380",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894075",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 394,
  "fields": {
    "snp_id": "SNP395",
    "rs_id": "rs104894075",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS98",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)",
    "reference": "REF380",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894075",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 395,
  "fields": {
    "snp_id": "SNP396",
    "rs_id": "rs104894075",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS97",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form",
    "reference": "REF380",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894075",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 396,
  "fields": {
    "snp_id": "SNP397",
    "rs_id": "rs104894076",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS98",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)",
    "reference": "REF534",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894076",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 397,
  "fields": {
    "snp_id": "SNP398",
    "rs_id": "rs104894099",
    "gene": "DISGENE107",
    "drug": "",
    "disease": "DIS340",
    "allele": "",
    "association_with": "Melanoma",
    "reference": "REF353",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894099",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2550000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 398,
  "fields": {
    "snp_id": "SNP399",
    "rs_id": "rs104894099",
    "gene": "DISGENE108",
    "drug": "",
    "disease": "DIS340",
    "allele": "",
    "association_with": "Melanoma",
    "reference": "REF353",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894099",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2550000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 399,
  "fields": {
    "snp_id": "SNP400",
    "rs_id": "rs104894099",
    "gene": "DISGENE107",
    "drug": "",
    "disease": "DIS342",
    "allele": "",
    "association_with": "Melanoma-Pancreatic Cancer Syndrome",
    "reference": "REF353",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894099",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2550000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 400,
  "fields": {
    "snp_id": "SNP401",
    "rs_id": "rs104894099",
    "gene": "DISGENE108",
    "drug": "",
    "disease": "DIS342",
    "allele": "",
    "association_with": "Melanoma-Pancreatic Cancer Syndrome",
    "reference": "REF353",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894099",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2550000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 401,
  "fields": {
    "snp_id": "SNP402",
    "rs_id": "rs104894099",
    "gene": "DISGENE107",
    "drug": "",
    "disease": "DIS341",
    "allele": "",
    "association_with": "Melanoma, Cutaneous Malignant, Susceptibility To, 2",
    "reference": "REF353",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894099",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2550000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 402,
  "fields": {
    "snp_id": "SNP403",
    "rs_id": "rs104894099",
    "gene": "DISGENE108",
    "drug": "",
    "disease": "DIS341",
    "allele": "",
    "association_with": "Melanoma, Cutaneous Malignant, Susceptibility To, 2",
    "reference": "REF353",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894099",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2550000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 403,
  "fields": {
    "snp_id": "SNP404",
    "rs_id": "rs104894099",
    "gene": "DISGENE107",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF353",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894099",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2550000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 404,
  "fields": {
    "snp_id": "SNP405",
    "rs_id": "rs104894099",
    "gene": "DISGENE108",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF353",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894099",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2550000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 405,
  "fields": {
    "snp_id": "SNP406",
    "rs_id": "rs104894132",
    "gene": "DISGENE109",
    "drug": "",
    "disease": "DIS551",
    "allele": "",
    "association_with": "Xeroderma Pigmentosum, Group A",
    "reference": "REF570",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894132",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 406,
  "fields": {
    "snp_id": "SNP407",
    "rs_id": "rs104894132",
    "gene": "DISGENE109",
    "drug": "",
    "disease": "DIS551",
    "allele": "",
    "association_with": "Xeroderma Pigmentosum, Group A",
    "reference": "REF692",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894132",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 407,
  "fields": {
    "snp_id": "SNP408",
    "rs_id": "rs104894215",
    "gene": "DISGENE98",
    "drug": "",
    "disease": "DIS415",
    "allele": "",
    "association_with": "Papillon-Lefevre Disease",
    "reference": "REF261",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894215",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 408,
  "fields": {
    "snp_id": "SNP409",
    "rs_id": "rs104894216",
    "gene": "DISGENE98",
    "drug": "",
    "disease": "DIS415",
    "allele": "",
    "association_with": "Papillon-Lefevre Disease",
    "reference": "REF261",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894216",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 409,
  "fields": {
    "snp_id": "SNP410",
    "rs_id": "rs104894313",
    "gene": "DISGENE110",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF416",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894313",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 410,
  "fields": {
    "snp_id": "SNP411",
    "rs_id": "rs104894397",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS153",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive (Disorder)",
    "reference": "REF452",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894397",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 411,
  "fields": {
    "snp_id": "SNP412",
    "rs_id": "rs104894398",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF752",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894398",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 412,
  "fields": {
    "snp_id": "SNP413",
    "rs_id": "rs104894398",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF175",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894398",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 413,
  "fields": {
    "snp_id": "SNP414",
    "rs_id": "rs104894398",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF527",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894398",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 414,
  "fields": {
    "snp_id": "SNP415",
    "rs_id": "rs104894401",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS143",
    "allele": "",
    "association_with": "Deafness, Autosomal Dominant 3A (Disorder)",
    "reference": "REF439",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894401",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 415,
  "fields": {
    "snp_id": "SNP416",
    "rs_id": "rs104894401",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF397",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894401",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 416,
  "fields": {
    "snp_id": "SNP417",
    "rs_id": "rs104894402",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS143",
    "allele": "",
    "association_with": "Deafness, Autosomal Dominant 3A (Disorder)",
    "reference": "REF452",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894402",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 417,
  "fields": {
    "snp_id": "SNP418",
    "rs_id": "rs104894517",
    "gene": "DISGENE112",
    "drug": "",
    "disease": "DIS29",
    "allele": "",
    "association_with": "Anhaptoglobinemia",
    "reference": "REF598",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894517",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 418,
  "fields": {
    "snp_id": "SNP419",
    "rs_id": "rs104894517",
    "gene": "DISGENE113",
    "drug": "",
    "disease": "DIS29",
    "allele": "",
    "association_with": "Anhaptoglobinemia",
    "reference": "REF598",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894517",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 419,
  "fields": {
    "snp_id": "SNP420",
    "rs_id": "rs104894517",
    "gene": "DISGENE112",
    "drug": "",
    "disease": "DIS29",
    "allele": "",
    "association_with": "Anhaptoglobinemia",
    "reference": "REF629",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894517",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 420,
  "fields": {
    "snp_id": "SNP421",
    "rs_id": "rs104894517",
    "gene": "DISGENE113",
    "drug": "",
    "disease": "DIS29",
    "allele": "",
    "association_with": "Anhaptoglobinemia",
    "reference": "REF629",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894517",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 421,
  "fields": {
    "snp_id": "SNP422",
    "rs_id": "rs104894517",
    "gene": "DISGENE112",
    "drug": "",
    "disease": "DIS263",
    "allele": "",
    "association_with": "Hypohaptoglobinemia (Disorder)",
    "reference": "REF629",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894517",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 422,
  "fields": {
    "snp_id": "SNP423",
    "rs_id": "rs104894517",
    "gene": "DISGENE113",
    "drug": "",
    "disease": "DIS263",
    "allele": "",
    "association_with": "Hypohaptoglobinemia (Disorder)",
    "reference": "REF629",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894517",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 423,
  "fields": {
    "snp_id": "SNP424",
    "rs_id": "rs104894559",
    "gene": "DISGENE114",
    "drug": "",
    "disease": "DIS471",
    "allele": "",
    "association_with": "Retinitis Pigmentosa",
    "reference": "REF535",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894559",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 424,
  "fields": {
    "snp_id": "SNP425",
    "rs_id": "rs104894682",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS368",
    "allele": "",
    "association_with": "Muscular Dystrophy, Limb-Girdle, Type 2I",
    "reference": "REF556",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894682",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 425,
  "fields": {
    "snp_id": "SNP426",
    "rs_id": "rs104894927",
    "gene": "DISGENE116",
    "drug": "",
    "disease": "DIS473",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 2 (Disorder)",
    "reference": "REF316",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104894927",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 426,
  "fields": {
    "snp_id": "SNP427",
    "rs_id": "rs104895091",
    "gene": "DISGENE117",
    "drug": "",
    "disease": "DIS192",
    "allele": "",
    "association_with": "Familial Mediterranean Fever",
    "reference": "REF459",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104895091",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 427,
  "fields": {
    "snp_id": "SNP428",
    "rs_id": "rs104895506",
    "gene": "DISGENE118",
    "drug": "",
    "disease": "DIS212",
    "allele": "",
    "association_with": "Gestational Trophoblastic Disease",
    "reference": "REF667",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs104895506",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 428,
  "fields": {
    "snp_id": "SNP429",
    "rs_id": "rs10490924",
    "gene": "DISGENE119",
    "drug": "",
    "disease": "DIS15",
    "allele": "",
    "association_with": "Age Related Macular Degeneration",
    "reference": "REF554",
    "p_value": "< 0.017",
    "source": "DisGeNET",
    "id_in_source": "rs10490924",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 429,
  "fields": {
    "snp_id": "SNP430",
    "rs_id": "rs1049246177",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "< 0.017",
    "source": "DisGeNET",
    "id_in_source": "rs1049246177",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 430,
  "fields": {
    "snp_id": "SNP431",
    "rs_id": "rs1050828",
    "gene": "PHARGENE42",
    "drug": "",
    "disease": "DIS27",
    "allele": "",
    "association_with": "Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency",
    "reference": "REF705",
    "p_value": "< 0.017",
    "source": "DisGeNET",
    "id_in_source": "rs1050828",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 431,
  "fields": {
    "snp_id": "SNP432",
    "rs_id": "rs1050828",
    "gene": "PHARGENE42",
    "drug": "",
    "disease": "DIS158",
    "allele": "",
    "association_with": "Deficiency Of Glucose-6-Phosphate Dehydrogenase",
    "reference": "REF429",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1050828",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 432,
  "fields": {
    "snp_id": "SNP433",
    "rs_id": "rs1050828",
    "gene": "PHARGENE42",
    "drug": "",
    "disease": "DIS83",
    "allele": "",
    "association_with": "Cataract",
    "reference": "REF614",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1050828",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 433,
  "fields": {
    "snp_id": "SNP434",
    "rs_id": "rs1050828",
    "gene": "PHARGENE42",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF368",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs1050828",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 434,
  "fields": {
    "snp_id": "SNP435",
    "rs_id": "rs1050829",
    "gene": "PHARGENE42",
    "drug": "",
    "disease": "DIS83",
    "allele": "",
    "association_with": "Cataract",
    "reference": "REF614",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1050829",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 435,
  "fields": {
    "snp_id": "SNP436",
    "rs_id": "rs1050829",
    "gene": "PHARGENE42",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF368",
    "p_value": "0.005",
    "source": "DisGeNET",
    "id_in_source": "rs1050829",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 436,
  "fields": {
    "snp_id": "SNP437",
    "rs_id": "rs10519612",
    "gene": "DISGENE121",
    "drug": "",
    "disease": "DIS11",
    "allele": "",
    "association_with": "Acute Lymphocytic Leukemia",
    "reference": "REF482",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs10519612",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 437,
  "fields": {
    "snp_id": "SNP438",
    "rs_id": "rs1057516362",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF682",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1057516362",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 438,
  "fields": {
    "snp_id": "SNP439",
    "rs_id": "rs1057516467",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1057516467",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 439,
  "fields": {
    "snp_id": "SNP440",
    "rs_id": "rs1057516689",
    "gene": "DISGENE122",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF354",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1057516689",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 440,
  "fields": {
    "snp_id": "SNP441",
    "rs_id": "rs1057516766",
    "gene": "DISGENE123",
    "drug": "",
    "disease": "DIS338",
    "allele": "",
    "association_with": "Megalencephalic Leukoencephalopathy With Subcortical Cysts",
    "reference": "REF420",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1057516766",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 441,
  "fields": {
    "snp_id": "SNP442",
    "rs_id": "rs1057517233",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF571",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1057517233",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 442,
  "fields": {
    "snp_id": "SNP443",
    "rs_id": "rs1057519425",
    "gene": "DISGENE125",
    "drug": "",
    "disease": "DIS35",
    "allele": "",
    "association_with": "Arthrogryposis, Distal, With Impaired Proprioception And Touch",
    "reference": "REF510",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1057519425",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Asia",
    "latitude": "34.0479000",
    "longitude": "100.6197000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 443,
  "fields": {
    "snp_id": "SNP444",
    "rs_id": "rs1057519425",
    "gene": "DISGENE126",
    "drug": "",
    "disease": "DIS35",
    "allele": "",
    "association_with": "Arthrogryposis, Distal, With Impaired Proprioception And Touch",
    "reference": "REF510",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1057519425",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Asia",
    "latitude": "34.0479000",
    "longitude": "100.6197000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 444,
  "fields": {
    "snp_id": "SNP445",
    "rs_id": "rs1057519626",
    "gene": "DISGENE125",
    "drug": "",
    "disease": "DIS35",
    "allele": "",
    "association_with": "Arthrogryposis, Distal, With Impaired Proprioception And Touch",
    "reference": "REF510",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1057519626",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Asia",
    "latitude": "34.0479000",
    "longitude": "100.6197000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 445,
  "fields": {
    "snp_id": "SNP446",
    "rs_id": "rs1061170",
    "gene": "DISGENE127",
    "drug": "",
    "disease": "DIS15",
    "allele": "",
    "association_with": "Age Related Macular Degeneration",
    "reference": "REF213",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1061170",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 446,
  "fields": {
    "snp_id": "SNP447",
    "rs_id": "rs1061170",
    "gene": "DISGENE127",
    "drug": "",
    "disease": "DIS222",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type Ii",
    "reference": "REF213",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1061170",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 447,
  "fields": {
    "snp_id": "SNP448",
    "rs_id": "rs1061170",
    "gene": "DISGENE127",
    "drug": "",
    "disease": "DIS15",
    "allele": "",
    "association_with": "Age Related Macular Degeneration",
    "reference": "REF436",
    "p_value": "0.2",
    "source": "DisGeNET",
    "id_in_source": "rs1061170",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 448,
  "fields": {
    "snp_id": "SNP449",
    "rs_id": "rs1061170",
    "gene": "DISGENE127",
    "drug": "",
    "disease": "DIS15",
    "allele": "",
    "association_with": "Age Related Macular Degeneration",
    "reference": "REF291",
    "p_value": "2.62E-016",
    "source": "DisGeNET",
    "id_in_source": "rs1061170",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 449,
  "fields": {
    "snp_id": "SNP450",
    "rs_id": "rs1061170",
    "gene": "DISGENE127",
    "drug": "",
    "disease": "DIS15",
    "allele": "",
    "association_with": "Age Related Macular Degeneration",
    "reference": "REF554",
    "p_value": "< 0.017",
    "source": "DisGeNET",
    "id_in_source": "rs1061170",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 450,
  "fields": {
    "snp_id": "SNP451",
    "rs_id": "rs1063538",
    "gene": "DISGENE128",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF524",
    "p_value": "0.02",
    "source": "DisGeNET",
    "id_in_source": "rs1063538",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 451,
  "fields": {
    "snp_id": "SNP452",
    "rs_id": "rs10900585",
    "gene": "DISGENE129",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.0000000061",
    "source": "DisGeNET",
    "id_in_source": "rs10900585",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 452,
  "fields": {
    "snp_id": "SNP453",
    "rs_id": "rs10900585",
    "gene": "DISGENE129",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.0052",
    "source": "DisGeNET",
    "id_in_source": "rs10900585",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 453,
  "fields": {
    "snp_id": "SNP454",
    "rs_id": "rs10905371",
    "gene": "DISGENE130",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000277",
    "source": "DisGeNET",
    "id_in_source": "rs10905371",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 454,
  "fields": {
    "snp_id": "SNP455",
    "rs_id": "rs10905374",
    "gene": "DISGENE130",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000443",
    "source": "DisGeNET",
    "id_in_source": "rs10905374",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 455,
  "fields": {
    "snp_id": "SNP456",
    "rs_id": "rs11031728",
    "gene": "DISGENE131",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF272",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs11031728",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Ghana, Russia, Indonesia",
    "latitude": "-0.7893000",
    "longitude": "113.9213000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 456,
  "fields": {
    "snp_id": "SNP457",
    "rs_id": "rs111033307",
    "gene": "DISGENE132",
    "drug": "",
    "disease": "DIS177",
    "allele": "",
    "association_with": "Enlarged Vestibular Aqueduct",
    "reference": "REF431",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033307",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 457,
  "fields": {
    "snp_id": "SNP458",
    "rs_id": "rs111033307",
    "gene": "DISGENE132",
    "drug": "",
    "disease": "DIS427",
    "allele": "",
    "association_with": "Pendred'S Syndrome",
    "reference": "REF431",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033307",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 458,
  "fields": {
    "snp_id": "SNP459",
    "rs_id": "rs111033307",
    "gene": "DISGENE132",
    "drug": "",
    "disease": "DIS177",
    "allele": "",
    "association_with": "Enlarged Vestibular Aqueduct",
    "reference": "REF805",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033307",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 459,
  "fields": {
    "snp_id": "SNP460",
    "rs_id": "rs111033307",
    "gene": "DISGENE132",
    "drug": "",
    "disease": "DIS427",
    "allele": "",
    "association_with": "Pendred'S Syndrome",
    "reference": "REF805",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033307",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 460,
  "fields": {
    "snp_id": "SNP461",
    "rs_id": "rs111033558",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS231",
    "allele": "",
    "association_with": "Hemochromatosis, Type 1",
    "reference": "REF516",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033558",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 461,
  "fields": {
    "snp_id": "SNP462",
    "rs_id": "rs111033558",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS241",
    "allele": "",
    "association_with": "Hereditary Hemochromatosis",
    "reference": "REF516",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033558",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 462,
  "fields": {
    "snp_id": "SNP463",
    "rs_id": "rs111033559",
    "gene": "DISGENE134",
    "drug": "",
    "disease": "DIS79",
    "allele": "",
    "association_with": "Cardiomyopathy, Familial Idiopathic",
    "reference": "REF745",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033559",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 463,
  "fields": {
    "snp_id": "SNP464",
    "rs_id": "rs111033559",
    "gene": "DISGENE135",
    "drug": "",
    "disease": "DIS79",
    "allele": "",
    "association_with": "Cardiomyopathy, Familial Idiopathic",
    "reference": "REF745",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033559",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 464,
  "fields": {
    "snp_id": "SNP465",
    "rs_id": "rs111033690",
    "gene": "DISGENE136",
    "drug": "",
    "disease": "DIS107",
    "allele": "",
    "association_with": "Classical Galactosemia",
    "reference": "REF286",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033690",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 465,
  "fields": {
    "snp_id": "SNP466",
    "rs_id": "rs111033690",
    "gene": "DISGENE136",
    "drug": "",
    "disease": "DIS107",
    "allele": "",
    "association_with": "Classical Galactosemia",
    "reference": "REF275",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033690",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 466,
  "fields": {
    "snp_id": "SNP467",
    "rs_id": "rs111033690",
    "gene": "DISGENE136",
    "drug": "",
    "disease": "DIS107",
    "allele": "",
    "association_with": "Classical Galactosemia",
    "reference": "REF637",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111033690",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 467,
  "fields": {
    "snp_id": "SNP468",
    "rs_id": "rs111706634",
    "gene": "DISGENE137",
    "drug": "",
    "disease": "DIS41",
    "allele": "",
    "association_with": "Auditory Neuropathy",
    "reference": "REF345",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111706634",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 468,
  "fields": {
    "snp_id": "SNP469",
    "rs_id": "rs111706634",
    "gene": "DISGENE137",
    "drug": "",
    "disease": "DIS42",
    "allele": "",
    "association_with": "Auditory Neuropathy Spectrum Disorder",
    "reference": "REF345",
    "p_value": "0.00000000525",
    "source": "DisGeNET",
    "id_in_source": "rs111706634",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 469,
  "fields": {
    "snp_id": "SNP470",
    "rs_id": "rs11209026",
    "gene": "DISGENE138",
    "drug": "",
    "disease": "DIS134",
    "allele": "",
    "association_with": "Crohn Disease",
    "reference": "REF572",
    "p_value": "0.00038",
    "source": "DisGeNET",
    "id_in_source": "rs11209026",
    "region": "Mixed Population, African American",
    "country_of_participants": "Puerto Rico",
    "latitude": "18.2208330",
    "longitude": "-66.5901490"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 470,
  "fields": {
    "snp_id": "SNP471",
    "rs_id": "rs11209026",
    "gene": "DISGENE138",
    "drug": "",
    "disease": "DIS464",
    "allele": "",
    "association_with": "Psoriasis",
    "reference": "REF500",
    "p_value": "0.23",
    "source": "DisGeNET",
    "id_in_source": "rs11209026",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 471,
  "fields": {
    "snp_id": "SNP472",
    "rs_id": "rs11209026",
    "gene": "DISGENE138",
    "drug": "",
    "disease": "DIS286",
    "allele": "",
    "association_with": "Inflammatory Bowel Diseases",
    "reference": "REF324",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs11209026",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 472,
  "fields": {
    "snp_id": "SNP473",
    "rs_id": "rs112176450",
    "gene": "DISGENE139",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF296",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs112176450",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 473,
  "fields": {
    "snp_id": "SNP474",
    "rs_id": "rs112292549",
    "gene": "DISGENE140",
    "drug": "",
    "disease": "DIS424",
    "allele": "",
    "association_with": "Peeling Skin Syndrome",
    "reference": "REF677",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs112292549",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 474,
  "fields": {
    "snp_id": "SNP475",
    "rs_id": "rs1127354",
    "gene": "DISGENE141",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF685",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1127354",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 475,
  "fields": {
    "snp_id": "SNP476",
    "rs_id": "rs1127354",
    "gene": "DISGENE141",
    "drug": "",
    "disease": "DIS237",
    "allele": "",
    "association_with": "Hepatitis C, Chronic",
    "reference": "REF685",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1127354",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 476,
  "fields": {
    "snp_id": "SNP477",
    "rs_id": "rs1127354",
    "gene": "DISGENE141",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF421",
    "p_value": "0.012",
    "source": "DisGeNET",
    "id_in_source": "rs1127354",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 477,
  "fields": {
    "snp_id": "SNP478",
    "rs_id": "rs1131692059",
    "gene": "DISGENE142",
    "drug": "",
    "disease": "DIS186",
    "allele": "",
    "association_with": "Estrogen Resistance",
    "reference": "REF731",
    "p_value": "0.012",
    "source": "DisGeNET",
    "id_in_source": "rs1131692059",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 478,
  "fields": {
    "snp_id": "SNP479",
    "rs_id": "rs11335470",
    "gene": "DISGENE143",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.0000904",
    "source": "DisGeNET",
    "id_in_source": "rs11335470",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 479,
  "fields": {
    "snp_id": "SNP480",
    "rs_id": "rs113425597",
    "gene": "DISGENE144",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000636",
    "source": "DisGeNET",
    "id_in_source": "rs113425597",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 480,
  "fields": {
    "snp_id": "SNP481",
    "rs_id": "rs113425597",
    "gene": "DISGENE145",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000636",
    "source": "DisGeNET",
    "id_in_source": "rs113425597",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 481,
  "fields": {
    "snp_id": "SNP482",
    "rs_id": "rs113425597",
    "gene": "DISGENE146",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000636",
    "source": "DisGeNET",
    "id_in_source": "rs113425597",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 482,
  "fields": {
    "snp_id": "SNP483",
    "rs_id": "rs113425597",
    "gene": "DISGENE147",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000636",
    "source": "DisGeNET",
    "id_in_source": "rs113425597",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 483,
  "fields": {
    "snp_id": "SNP484",
    "rs_id": "rs113624356",
    "gene": "DISGENE148",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF177",
    "p_value": "0.000000636",
    "source": "DisGeNET",
    "id_in_source": "rs113624356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 484,
  "fields": {
    "snp_id": "SNP485",
    "rs_id": "rs113624356",
    "gene": "DISGENE149",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF177",
    "p_value": "0.000000636",
    "source": "DisGeNET",
    "id_in_source": "rs113624356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 485,
  "fields": {
    "snp_id": "SNP486",
    "rs_id": "rs113993959",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF794",
    "p_value": "0.000000636",
    "source": "DisGeNET",
    "id_in_source": "rs113993959",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 486,
  "fields": {
    "snp_id": "SNP487",
    "rs_id": "rs114073621",
    "gene": "DISGENE151",
    "drug": "",
    "disease": "DIS224",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type V",
    "reference": "REF804",
    "p_value": "0.000000636",
    "source": "DisGeNET",
    "id_in_source": "rs114073621",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 487,
  "fields": {
    "snp_id": "SNP488",
    "rs_id": "rs114169033",
    "gene": "DISGENE152",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.000000562",
    "source": "DisGeNET",
    "id_in_source": "rs114169033",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 488,
  "fields": {
    "snp_id": "SNP489",
    "rs_id": "rs114246623",
    "gene": "DISGENE153",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.00000077",
    "source": "DisGeNET",
    "id_in_source": "rs114246623",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 489,
  "fields": {
    "snp_id": "SNP490",
    "rs_id": "rs114246623",
    "gene": "DISGENE154",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.00000077",
    "source": "DisGeNET",
    "id_in_source": "rs114246623",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 490,
  "fields": {
    "snp_id": "SNP491",
    "rs_id": "rs114402678",
    "gene": "DISGENE155",
    "drug": "",
    "disease": "DIS201",
    "allele": "",
    "association_with": "Febrile Seizures, Familial, 11",
    "reference": "REF183",
    "p_value": "0.00000077",
    "source": "DisGeNET",
    "id_in_source": "rs114402678",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 491,
  "fields": {
    "snp_id": "SNP492",
    "rs_id": "rs115338764",
    "gene": "DISGENE156",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000198",
    "source": "DisGeNET",
    "id_in_source": "rs115338764",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 492,
  "fields": {
    "snp_id": "SNP493",
    "rs_id": "rs11538758",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF574",
    "p_value": "0.000000198",
    "source": "DisGeNET",
    "id_in_source": "rs11538758",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 493,
  "fields": {
    "snp_id": "SNP494",
    "rs_id": "rs11540654",
    "gene": "DISGENE158",
    "drug": "",
    "disease": "DIS65",
    "allele": "",
    "association_with": "Breast Cancer, Familial",
    "reference": "REF394",
    "p_value": "0.0052",
    "source": "DisGeNET",
    "id_in_source": "rs11540654",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 494,
  "fields": {
    "snp_id": "SNP495",
    "rs_id": "rs11540654",
    "gene": "DISGENE158",
    "drug": "",
    "disease": "DIS67",
    "allele": "",
    "association_with": "Breast Carcinoma, Sporadic",
    "reference": "REF394",
    "p_value": "0.237",
    "source": "DisGeNET",
    "id_in_source": "rs11540654",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 495,
  "fields": {
    "snp_id": "SNP496",
    "rs_id": "rs11540654",
    "gene": "DISGENE158",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF394",
    "p_value": "0.237",
    "source": "DisGeNET",
    "id_in_source": "rs11540654",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 496,
  "fields": {
    "snp_id": "SNP497",
    "rs_id": "rs11540654",
    "gene": "DISGENE158",
    "drug": "",
    "disease": "DIS313",
    "allele": "",
    "association_with": "Liver Carcinoma",
    "reference": "REF566",
    "p_value": "0.0006",
    "source": "DisGeNET",
    "id_in_source": "rs11540654",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 497,
  "fields": {
    "snp_id": "SNP498",
    "rs_id": "rs11554495",
    "gene": "DISGENE159",
    "drug": "",
    "disease": "DIS330",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Pancreas",
    "reference": "REF258",
    "p_value": "0.0006",
    "source": "DisGeNET",
    "id_in_source": "rs11554495",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Ethiopia, Europe",
    "latitude": "9.1450000",
    "longitude": "40.4897000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 498,
  "fields": {
    "snp_id": "SNP499",
    "rs_id": "rs11554495",
    "gene": "DISGENE159",
    "drug": "",
    "disease": "DIS410",
    "allele": "",
    "association_with": "Pancreatic Carcinoma",
    "reference": "REF258",
    "p_value": "0.0006",
    "source": "DisGeNET",
    "id_in_source": "rs11554495",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Ethiopia, Europe",
    "latitude": "9.1450000",
    "longitude": "40.4897000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 499,
  "fields": {
    "snp_id": "SNP500",
    "rs_id": "rs11554495",
    "gene": "DISGENE159",
    "drug": "",
    "disease": "DIS412",
    "allele": "",
    "association_with": "Pancreatitis",
    "reference": "REF258",
    "p_value": "0.0006",
    "source": "DisGeNET",
    "id_in_source": "rs11554495",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Ethiopia, Europe",
    "latitude": "9.1450000",
    "longitude": "40.4897000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 500,
  "fields": {
    "snp_id": "SNP501",
    "rs_id": "rs11568350",
    "gene": "DISGENE160",
    "drug": "",
    "disease": "DIS288",
    "allele": "",
    "association_with": "Iron Overload",
    "reference": "REF383",
    "p_value": "0.0006",
    "source": "DisGeNET",
    "id_in_source": "rs11568350",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "South Africa, Swaziland, Zimbabwe, UK, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 501,
  "fields": {
    "snp_id": "SNP502",
    "rs_id": "rs11571658",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS69",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2",
    "reference": "REF455",
    "p_value": "0.0006",
    "source": "DisGeNET",
    "id_in_source": "rs11571658",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mauritius",
    "latitude": "-20.3484000",
    "longitude": "57.5522000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 502,
  "fields": {
    "snp_id": "SNP503",
    "rs_id": "rs11571658",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF455",
    "p_value": "0.0006",
    "source": "DisGeNET",
    "id_in_source": "rs11571658",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mauritius",
    "latitude": "-20.3484000",
    "longitude": "57.5522000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 503,
  "fields": {
    "snp_id": "SNP504",
    "rs_id": "rs116074753",
    "gene": "DISGENE162",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF791",
    "p_value": "0.0006",
    "source": "DisGeNET",
    "id_in_source": "rs116074753",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 504,
  "fields": {
    "snp_id": "SNP505",
    "rs_id": "rs1160985",
    "gene": "DISGENE163",
    "drug": "",
    "disease": "DIS128",
    "allele": "",
    "association_with": "C-Reactive Protein Measurement",
    "reference": "REF702",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs1160985",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 505,
  "fields": {
    "snp_id": "SNP506",
    "rs_id": "rs116100695",
    "gene": "DISGENE164",
    "drug": "",
    "disease": "DIS160",
    "allele": "",
    "association_with": "Deficiency Of Pyruvate Kinase",
    "reference": "REF388",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs116100695",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 506,
  "fields": {
    "snp_id": "SNP507",
    "rs_id": "rs11614913",
    "gene": "DISGENE165",
    "drug": "",
    "disease": "DIS104",
    "allele": "",
    "association_with": "Chronic Obstructive Airway Disease",
    "reference": "REF760",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs11614913",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 507,
  "fields": {
    "snp_id": "SNP508",
    "rs_id": "rs11614913",
    "gene": "DISGENE166",
    "drug": "",
    "disease": "DIS104",
    "allele": "",
    "association_with": "Chronic Obstructive Airway Disease",
    "reference": "REF760",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs11614913",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 508,
  "fields": {
    "snp_id": "SNP511",
    "rs_id": "rs11694",
    "gene": "DISGENE168",
    "drug": "",
    "disease": "DIS391",
    "allele": "",
    "association_with": "Niemann-Pick Disease, Type C2",
    "reference": "REF581",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs11694",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 509,
  "fields": {
    "snp_id": "SNP512",
    "rs_id": "rs116987552",
    "gene": "DISGENE151",
    "drug": "",
    "disease": "DIS224",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type V",
    "reference": "REF804",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs116987552",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 510,
  "fields": {
    "snp_id": "SNP513",
    "rs_id": "rs118091316",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS275",
    "allele": "",
    "association_with": "Ichthyosis, Lamellar, 3",
    "reference": "REF465",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118091316",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 511,
  "fields": {
    "snp_id": "SNP514",
    "rs_id": "rs118091316",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS277",
    "allele": "",
    "association_with": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive",
    "reference": "REF465",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118091316",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 512,
  "fields": {
    "snp_id": "SNP515",
    "rs_id": "rs118192164",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS88",
    "allele": "",
    "association_with": "Central Core Disease, Autosomal Recessive",
    "reference": "REF519",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118192164",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 513,
  "fields": {
    "snp_id": "SNP516",
    "rs_id": "rs118192164",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS89",
    "allele": "",
    "association_with": "Central Core Myopathy (Disorder)",
    "reference": "REF519",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118192164",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 514,
  "fields": {
    "snp_id": "SNP517",
    "rs_id": "rs118192164",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS356",
    "allele": "",
    "association_with": "Minicore Myopathy, Moderate, With Hand Involvement",
    "reference": "REF519",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118192164",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 515,
  "fields": {
    "snp_id": "SNP518",
    "rs_id": "rs118192164",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS363",
    "allele": "",
    "association_with": "Multicore Myopathy, Moderate, With Hand Involvement",
    "reference": "REF519",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118192164",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 516,
  "fields": {
    "snp_id": "SNP519",
    "rs_id": "rs118192164",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS364",
    "allele": "",
    "association_with": "Multiminicore Disease, Moderate, With Hand Involvement",
    "reference": "REF519",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118192164",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 517,
  "fields": {
    "snp_id": "SNP520",
    "rs_id": "rs118192164",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS384",
    "allele": "",
    "association_with": "Neuromuscular Disease, Congenital, With Uniform Type 1 Fiber (Disorder)",
    "reference": "REF519",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118192164",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 518,
  "fields": {
    "snp_id": "SNP521",
    "rs_id": "rs118192172",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF480",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118192172",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 519,
  "fields": {
    "snp_id": "SNP522",
    "rs_id": "rs118192178",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF480",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118192178",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 520,
  "fields": {
    "snp_id": "SNP523",
    "rs_id": "rs118203929",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS357",
    "allele": "",
    "association_with": "Mitochondrial Complex I Deficiency",
    "reference": "REF505",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203929",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 521,
  "fields": {
    "snp_id": "SNP524",
    "rs_id": "rs118203929",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS375",
    "allele": "",
    "association_with": "NAdh:Q(1) Oxidoreductase Deficiency",
    "reference": "REF505",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203929",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 522,
  "fields": {
    "snp_id": "SNP525",
    "rs_id": "rs118203935",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS275",
    "allele": "",
    "association_with": "Ichthyosis, Lamellar, 3",
    "reference": "REF465",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203935",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 523,
  "fields": {
    "snp_id": "SNP526",
    "rs_id": "rs118203935",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS277",
    "allele": "",
    "association_with": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive",
    "reference": "REF465",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203935",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 524,
  "fields": {
    "snp_id": "SNP527",
    "rs_id": "rs118203936",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS275",
    "allele": "",
    "association_with": "Ichthyosis, Lamellar, 3",
    "reference": "REF465",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203936",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 525,
  "fields": {
    "snp_id": "SNP528",
    "rs_id": "rs118203936",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS277",
    "allele": "",
    "association_with": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive",
    "reference": "REF465",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203936",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 526,
  "fields": {
    "snp_id": "SNP529",
    "rs_id": "rs118203937",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS275",
    "allele": "",
    "association_with": "Ichthyosis, Lamellar, 3",
    "reference": "REF465",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203937",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 527,
  "fields": {
    "snp_id": "SNP530",
    "rs_id": "rs118203937",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS277",
    "allele": "",
    "association_with": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive",
    "reference": "REF465",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203937",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 528,
  "fields": {
    "snp_id": "SNP531",
    "rs_id": "rs118203963",
    "gene": "DISGENE172",
    "drug": "",
    "disease": "DIS95",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Axonal, Type 2X",
    "reference": "REF788",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203963",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 529,
  "fields": {
    "snp_id": "SNP532",
    "rs_id": "rs118203963",
    "gene": "DISGENE172",
    "drug": "",
    "disease": "DIS497",
    "allele": "",
    "association_with": "Spastic Paraplegia 11, Autosomal Recessive",
    "reference": "REF788",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203963",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 530,
  "fields": {
    "snp_id": "SNP533",
    "rs_id": "rs118203978",
    "gene": "DISGENE173",
    "drug": "",
    "disease": "DIS90",
    "allele": "",
    "association_with": "Ceroid Lipofuscinosis, Neuronal, 7",
    "reference": "REF520",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203978",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 531,
  "fields": {
    "snp_id": "SNP534",
    "rs_id": "rs118203986",
    "gene": "DISGENE174",
    "drug": "",
    "disease": "DIS385",
    "allele": "",
    "association_with": "Neuropathy, Hereditary Sensory, With Spastic Paraplegia, Autosomal Recessive",
    "reference": "REF757",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203986",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 532,
  "fields": {
    "snp_id": "SNP535",
    "rs_id": "rs118203988",
    "gene": "DISGENE137",
    "drug": "",
    "disease": "DIS41",
    "allele": "",
    "association_with": "Auditory Neuropathy",
    "reference": "REF345",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203988",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 533,
  "fields": {
    "snp_id": "SNP536",
    "rs_id": "rs118203988",
    "gene": "DISGENE137",
    "drug": "",
    "disease": "DIS42",
    "allele": "",
    "association_with": "Auditory Neuropathy Spectrum Disorder",
    "reference": "REF345",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118203988",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 534,
  "fields": {
    "snp_id": "SNP537",
    "rs_id": "rs118204050",
    "gene": "DISGENE175",
    "drug": "",
    "disease": "DIS498",
    "allele": "",
    "association_with": "Spastic Paraplegia 15, Autosomal Recessive",
    "reference": "REF631",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118204050",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 535,
  "fields": {
    "snp_id": "SNP538",
    "rs_id": "rs118204089",
    "gene": "DISGENE164",
    "drug": "",
    "disease": "DIS160",
    "allele": "",
    "association_with": "Deficiency Of Pyruvate Kinase",
    "reference": "REF728",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118204089",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Guinea",
    "latitude": "9.9456000",
    "longitude": "-9.6966000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 536,
  "fields": {
    "snp_id": "SNP539",
    "rs_id": "rs118204094",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS10",
    "allele": "",
    "association_with": "Acute Intermittent Porphyria",
    "reference": "REF657",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118204094",
    "region": "Mixed Population, North Africa, Sub-Saharan Africa",
    "country_of_participants": "Morocco, Algeria, Cameroon, Mali, Burkina Faso, French West Indies",
    "latitude": "12.2383000",
    "longitude": "-1.5616000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 537,
  "fields": {
    "snp_id": "SNP540",
    "rs_id": "rs118204094",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS101",
    "allele": "",
    "association_with": "Chester-Type Porphyria",
    "reference": "REF657",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118204094",
    "region": "Mixed Population, North Africa, Sub-Saharan Africa",
    "country_of_participants": "Morocco, Algeria, Cameroon, Mali, Burkina Faso, French West Indies",
    "latitude": "12.2383000",
    "longitude": "-1.5616000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 538,
  "fields": {
    "snp_id": "SNP541",
    "rs_id": "rs118204094",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS254",
    "allele": "",
    "association_with": "Hydroxymethylbilane Synthase Deficiency",
    "reference": "REF657",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118204094",
    "region": "Mixed Population, North Africa, Sub-Saharan Africa",
    "country_of_participants": "Algeria, Burkina Faso, Cameroon, Mali, Morocco, French West Indies",
    "latitude": "12.2383000",
    "longitude": "-1.5616000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 539,
  "fields": {
    "snp_id": "SNP542",
    "rs_id": "rs118204094",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS450",
    "allele": "",
    "association_with": "Porphyria, Acute Intermittent, Nonerythroid Variant",
    "reference": "REF657",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs118204094",
    "region": "Mixed Population, North Africa, Sub-Saharan Africa",
    "country_of_participants": "Morocco, Algeria, Cameroon, Mali, Burkina Faso, French West Indies",
    "latitude": "12.2383000",
    "longitude": "-1.5616000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 540,
  "fields": {
    "snp_id": "SNP543",
    "rs_id": "rs119103259",
    "gene": "DISGENE151",
    "drug": "",
    "disease": "DIS224",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type V",
    "reference": "REF804",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs119103259",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 541,
  "fields": {
    "snp_id": "SNP544",
    "rs_id": "rs119485092",
    "gene": "DISGENE177",
    "drug": "",
    "disease": "DIS214",
    "allele": "",
    "association_with": "Giant Axonal Neuropathy 1",
    "reference": "REF601",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs119485092",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 542,
  "fields": {
    "snp_id": "SNP545",
    "rs_id": "rs119485093",
    "gene": "DISGENE177",
    "drug": "",
    "disease": "DIS214",
    "allele": "",
    "association_with": "Giant Axonal Neuropathy 1",
    "reference": "REF407",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs119485093",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 543,
  "fields": {
    "snp_id": "SNP546",
    "rs_id": "rs120074118",
    "gene": "DISGENE178",
    "drug": "",
    "disease": "DIS388",
    "allele": "",
    "association_with": "Niemann-Pick Disease, Type A",
    "reference": "REF739",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs120074118",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 544,
  "fields": {
    "snp_id": "SNP547",
    "rs_id": "rs120074118",
    "gene": "DISGENE178",
    "drug": "",
    "disease": "DIS389",
    "allele": "",
    "association_with": "Niemann-Pick Disease, Type B",
    "reference": "REF739",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs120074118",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 545,
  "fields": {
    "snp_id": "SNP548",
    "rs_id": "rs120074137",
    "gene": "DISGENE179",
    "drug": "",
    "disease": "DIS100",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma",
    "reference": "REF744",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs120074137",
    "region": "North African",
    "country_of_participants": "Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 546,
  "fields": {
    "snp_id": "SNP549",
    "rs_id": "rs120074138",
    "gene": "DISGENE179",
    "drug": "",
    "disease": "DIS100",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma",
    "reference": "REF744",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs120074138",
    "region": "North African",
    "country_of_participants": "Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 547,
  "fields": {
    "snp_id": "SNP550",
    "rs_id": "rs120074173",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF682",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs120074173",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 548,
  "fields": {
    "snp_id": "SNP551",
    "rs_id": "rs121434254",
    "gene": "DISGENE180",
    "drug": "",
    "disease": "DIS444",
    "allele": "",
    "association_with": "Polyglandular Type I Autoimmune Syndrome",
    "reference": "REF276",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121434254",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 549,
  "fields": {
    "snp_id": "SNP552",
    "rs_id": "rs121434256",
    "gene": "DISGENE180",
    "drug": "",
    "disease": "DIS444",
    "allele": "",
    "association_with": "Polyglandular Type I Autoimmune Syndrome",
    "reference": "REF301",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121434256",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 550,
  "fields": {
    "snp_id": "SNP553",
    "rs_id": "rs121434291",
    "gene": "DISGENE181",
    "drug": "",
    "disease": "DIS7",
    "allele": "",
    "association_with": "Acrodermatitis Enteropathica",
    "reference": "REF723",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121434291",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Jordan",
    "latitude": "30.5852000",
    "longitude": "36.2384000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 551,
  "fields": {
    "snp_id": "SNP554",
    "rs_id": "rs121434371",
    "gene": "DISGENE182",
    "drug": "",
    "disease": "DIS219",
    "allele": "",
    "association_with": "Glutaric Aciduria, Type 1",
    "reference": "REF753",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121434371",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 552,
  "fields": {
    "snp_id": "SNP555",
    "rs_id": "rs121434508",
    "gene": "DISGENE183",
    "drug": "",
    "disease": "DIS399",
    "allele": "",
    "association_with": "Optic Atrophy 7 (Disorder)",
    "reference": "REF673",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121434508",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 553,
  "fields": {
    "snp_id": "SNP556",
    "rs_id": "rs121434508",
    "gene": "DISGENE183",
    "drug": "",
    "disease": "DIS399",
    "allele": "",
    "association_with": "Optic Atrophy 7 (Disorder)",
    "reference": "REF315",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121434508",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 554,
  "fields": {
    "snp_id": "SNP557",
    "rs_id": "rs121434514",
    "gene": "DISGENE184",
    "drug": "",
    "disease": "DIS490",
    "allele": "",
    "association_with": "Shprintzen-Goldberg Syndrome",
    "reference": "REF743",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121434514",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 555,
  "fields": {
    "snp_id": "SNP558",
    "rs_id": "rs121434515",
    "gene": "DISGENE184",
    "drug": "",
    "disease": "DIS490",
    "allele": "",
    "association_with": "Shprintzen-Goldberg Syndrome",
    "reference": "REF743",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121434515",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 556,
  "fields": {
    "snp_id": "SNP559",
    "rs_id": "rs1217691063",
    "gene": "PHARGENE58",
    "drug": "",
    "disease": "DIS82",
    "allele": "",
    "association_with": "Cardiovascular Diseases",
    "reference": "REF398",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs1217691063",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 557,
  "fields": {
    "snp_id": "SNP560",
    "rs_id": "rs1217691063",
    "gene": "PHARGENE58",
    "drug": "",
    "disease": "DIS480",
    "allele": "",
    "association_with": "Rheumatoid Arthritis",
    "reference": "REF398",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs1217691063",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 558,
  "fields": {
    "snp_id": "SNP561",
    "rs_id": "rs121907930",
    "gene": "DISGENE185",
    "drug": "",
    "disease": "DIS196",
    "allele": "",
    "association_with": "Fanconi Anemia, Complementation Group A (Disorder)",
    "reference": "REF427",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907930",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 559,
  "fields": {
    "snp_id": "SNP562",
    "rs_id": "rs121907952",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS225",
    "allele": "",
    "association_with": "Gm2-Gangliosidosis, Adult Chronic Type",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907952",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 560,
  "fields": {
    "snp_id": "SNP563",
    "rs_id": "rs121907952",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS226",
    "allele": "",
    "association_with": "Gm2-Gangliosidosis, Variant B1",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907952",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 561,
  "fields": {
    "snp_id": "SNP564",
    "rs_id": "rs121907952",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS245",
    "allele": "",
    "association_with": "Hexosaminidase A Deficiency, Adult Type",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907952",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 562,
  "fields": {
    "snp_id": "SNP565",
    "rs_id": "rs121907952",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS521",
    "allele": "",
    "association_with": "Tay-Sachs Disease",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907952",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 563,
  "fields": {
    "snp_id": "SNP566",
    "rs_id": "rs121907952",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS522",
    "allele": "",
    "association_with": "Tay-Sachs Disease, Juvenile",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907952",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 564,
  "fields": {
    "snp_id": "SNP567",
    "rs_id": "rs121907952",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS523",
    "allele": "",
    "association_with": "Tay-Sachs Disease, Pseudo-Ab Variant",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907952",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 565,
  "fields": {
    "snp_id": "SNP568",
    "rs_id": "rs121907952",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS524",
    "allele": "",
    "association_with": "Tay-Sachs Disease, Variant B1",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907952",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 566,
  "fields": {
    "snp_id": "SNP569",
    "rs_id": "rs121907957",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS225",
    "allele": "",
    "association_with": "Gm2-Gangliosidosis, Adult Chronic Type",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907957",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 567,
  "fields": {
    "snp_id": "SNP570",
    "rs_id": "rs121907957",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS226",
    "allele": "",
    "association_with": "Gm2-Gangliosidosis, Variant B1",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907957",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 568,
  "fields": {
    "snp_id": "SNP571",
    "rs_id": "rs121907957",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS245",
    "allele": "",
    "association_with": "Hexosaminidase A Deficiency, Adult Type",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907957",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 569,
  "fields": {
    "snp_id": "SNP572",
    "rs_id": "rs121907957",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS521",
    "allele": "",
    "association_with": "Tay-Sachs Disease",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907957",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 570,
  "fields": {
    "snp_id": "SNP573",
    "rs_id": "rs121907957",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS522",
    "allele": "",
    "association_with": "Tay-Sachs Disease, Juvenile",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907957",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 571,
  "fields": {
    "snp_id": "SNP574",
    "rs_id": "rs121907957",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS523",
    "allele": "",
    "association_with": "Tay-Sachs Disease, Pseudo-Ab Variant",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907957",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 572,
  "fields": {
    "snp_id": "SNP575",
    "rs_id": "rs121907957",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS524",
    "allele": "",
    "association_with": "Tay-Sachs Disease, Variant B1",
    "reference": "REF530",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907957",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 573,
  "fields": {
    "snp_id": "SNP576",
    "rs_id": "rs121907960",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS521",
    "allele": "",
    "association_with": "Tay-Sachs Disease",
    "reference": "REF209",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907960",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 574,
  "fields": {
    "snp_id": "SNP577",
    "rs_id": "rs121907960",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS521",
    "allele": "",
    "association_with": "Tay-Sachs Disease",
    "reference": "REF313",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907960",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 575,
  "fields": {
    "snp_id": "SNP578",
    "rs_id": "rs121907969",
    "gene": "DISGENE186",
    "drug": "",
    "disease": "DIS521",
    "allele": "",
    "association_with": "Tay-Sachs Disease",
    "reference": "REF209",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121907969",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 576,
  "fields": {
    "snp_id": "SNP579",
    "rs_id": "rs121908024",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF234",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908024",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 577,
  "fields": {
    "snp_id": "SNP580",
    "rs_id": "rs121908027",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF772",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908027",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 578,
  "fields": {
    "snp_id": "SNP581",
    "rs_id": "rs121908028",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF786",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908028",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 579,
  "fields": {
    "snp_id": "SNP582",
    "rs_id": "rs121908028",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF197",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908028",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 580,
  "fields": {
    "snp_id": "SNP583",
    "rs_id": "rs121908028",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF517",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908028",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 581,
  "fields": {
    "snp_id": "SNP584",
    "rs_id": "rs121908028",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF517",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908028",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 582,
  "fields": {
    "snp_id": "SNP585",
    "rs_id": "rs121908028",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS315",
    "allele": "",
    "association_with": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2",
    "reference": "REF517",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908028",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 583,
  "fields": {
    "snp_id": "SNP586",
    "rs_id": "rs121908028",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF234",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908028",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 584,
  "fields": {
    "snp_id": "SNP587",
    "rs_id": "rs121908028",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF230",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908028",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 585,
  "fields": {
    "snp_id": "SNP588",
    "rs_id": "rs121908029",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF234",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908029",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 586,
  "fields": {
    "snp_id": "SNP589",
    "rs_id": "rs121908030",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF234",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908030",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 587,
  "fields": {
    "snp_id": "SNP590",
    "rs_id": "rs121908030",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF230",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908030",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 588,
  "fields": {
    "snp_id": "SNP591",
    "rs_id": "rs121908033",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF372",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908033",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 589,
  "fields": {
    "snp_id": "SNP592",
    "rs_id": "rs121908033",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF517",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908033",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 590,
  "fields": {
    "snp_id": "SNP593",
    "rs_id": "rs121908033",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS315",
    "allele": "",
    "association_with": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2",
    "reference": "REF517",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908033",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 591,
  "fields": {
    "snp_id": "SNP594",
    "rs_id": "rs121908102",
    "gene": "DISGENE187",
    "drug": "",
    "disease": "DIS549",
    "allele": "",
    "association_with": "Xanthomatosis, Cerebrotendinous",
    "reference": "REF684",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908102",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco",
    "latitude": "31.7917000",
    "longitude": "-7.0926000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 592,
  "fields": {
    "snp_id": "SNP595",
    "rs_id": "rs121908112",
    "gene": "DISGENE106",
    "drug": "",
    "disease": "DIS98",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 4A (Disorder)",
    "reference": "REF534",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908112",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 593,
  "fields": {
    "snp_id": "SNP596",
    "rs_id": "rs121908116",
    "gene": "DISGENE188",
    "drug": "",
    "disease": "DIS170",
    "allele": "",
    "association_with": "Ectodermal Dysplasia 11A, Hypohidrotic/Hair/Tooth Type, Autosomal Dominant",
    "reference": "REF472",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908116",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 594,
  "fields": {
    "snp_id": "SNP597",
    "rs_id": "rs121908116",
    "gene": "DISGENE188",
    "drug": "",
    "disease": "DIS172",
    "allele": "",
    "association_with": "Ectodermal Dysplasia 3, Anhidrotic",
    "reference": "REF472",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908116",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 595,
  "fields": {
    "snp_id": "SNP598",
    "rs_id": "rs121908150",
    "gene": "DISGENE189",
    "drug": "",
    "disease": "DIS190",
    "allele": "",
    "association_with": "Familial Cold Urticaria",
    "reference": "REF611",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908150",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 596,
  "fields": {
    "snp_id": "SNP599",
    "rs_id": "rs121908150",
    "gene": "DISGENE189",
    "drug": "",
    "disease": "DIS360",
    "allele": "",
    "association_with": "Muckle-Wells Syndrome",
    "reference": "REF611",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908150",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 597,
  "fields": {
    "snp_id": "SNP600",
    "rs_id": "rs121908151",
    "gene": "DISGENE189",
    "drug": "",
    "disease": "DIS360",
    "allele": "",
    "association_with": "Muckle-Wells Syndrome",
    "reference": "REF611",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908151",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 598,
  "fields": {
    "snp_id": "SNP601",
    "rs_id": "rs121908177",
    "gene": "DISGENE190",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF177",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908177",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 599,
  "fields": {
    "snp_id": "SNP602",
    "rs_id": "rs121908179",
    "gene": "DISGENE190",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF349",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908179",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 600,
  "fields": {
    "snp_id": "SNP603",
    "rs_id": "rs121908192",
    "gene": "DISGENE191",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF522",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908192",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 601,
  "fields": {
    "snp_id": "SNP604",
    "rs_id": "rs121908192",
    "gene": "DISGENE191",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF734",
    "p_value": "0.000000000000419",
    "source": "DisGeNET",
    "id_in_source": "rs121908192",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 602,
  "fields": {
    "snp_id": "SNP605",
    "rs_id": "rs121908285",
    "gene": "DISGENE192",
    "drug": "",
    "disease": "DIS359",
    "allele": "",
    "association_with": "Mps Iii C",
    "reference": "REF182",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908285",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 603,
  "fields": {
    "snp_id": "SNP606",
    "rs_id": "rs121908286",
    "gene": "DISGENE192",
    "drug": "",
    "disease": "DIS359",
    "allele": "",
    "association_with": "Mps Iii C",
    "reference": "REF182",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908286",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 604,
  "fields": {
    "snp_id": "SNP607",
    "rs_id": "rs121908317",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF252",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908317",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Croatia",
    "latitude": "45.1000000",
    "longitude": "15.2000000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 605,
  "fields": {
    "snp_id": "SNP608",
    "rs_id": "rs121908319",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF267",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908319",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 606,
  "fields": {
    "snp_id": "SNP609",
    "rs_id": "rs121908320",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF267",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908320",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 607,
  "fields": {
    "snp_id": "SNP610",
    "rs_id": "rs121908320",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF433",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908320",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 608,
  "fields": {
    "snp_id": "SNP611",
    "rs_id": "rs121908345",
    "gene": "DISGENE123",
    "drug": "",
    "disease": "DIS338",
    "allele": "",
    "association_with": "Megalencephalic Leukoencephalopathy With Subcortical Cysts",
    "reference": "REF290",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908345",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 609,
  "fields": {
    "snp_id": "SNP612",
    "rs_id": "rs121908479",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS138",
    "allele": "",
    "association_with": "Cystinuria",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908479",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 610,
  "fields": {
    "snp_id": "SNP613",
    "rs_id": "rs121908479",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS139",
    "allele": "",
    "association_with": "Cystinuria, Type A",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908479",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 611,
  "fields": {
    "snp_id": "SNP614",
    "rs_id": "rs121908479",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS140",
    "allele": "",
    "association_with": "Cystinuria, Type A-B",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908479",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 612,
  "fields": {
    "snp_id": "SNP615",
    "rs_id": "rs121908479",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS141",
    "allele": "",
    "association_with": "Cystinuria, Type B",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908479",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 613,
  "fields": {
    "snp_id": "SNP616",
    "rs_id": "rs121908479",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS138",
    "allele": "",
    "association_with": "Cystinuria",
    "reference": "REF226",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908479",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 614,
  "fields": {
    "snp_id": "SNP617",
    "rs_id": "rs121908480",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS138",
    "allele": "",
    "association_with": "Cystinuria",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908480",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 615,
  "fields": {
    "snp_id": "SNP618",
    "rs_id": "rs121908480",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS139",
    "allele": "",
    "association_with": "Cystinuria, Type A",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908480",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 616,
  "fields": {
    "snp_id": "SNP619",
    "rs_id": "rs121908480",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS140",
    "allele": "",
    "association_with": "Cystinuria, Type A-B",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908480",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 617,
  "fields": {
    "snp_id": "SNP620",
    "rs_id": "rs121908480",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS141",
    "allele": "",
    "association_with": "Cystinuria, Type B",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908480",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 618,
  "fields": {
    "snp_id": "SNP621",
    "rs_id": "rs121908482",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS138",
    "allele": "",
    "association_with": "Cystinuria",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908482",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 619,
  "fields": {
    "snp_id": "SNP622",
    "rs_id": "rs121908482",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS139",
    "allele": "",
    "association_with": "Cystinuria, Type A",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908482",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 620,
  "fields": {
    "snp_id": "SNP623",
    "rs_id": "rs121908482",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS140",
    "allele": "",
    "association_with": "Cystinuria, Type A-B",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908482",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 621,
  "fields": {
    "snp_id": "SNP624",
    "rs_id": "rs121908482",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS141",
    "allele": "",
    "association_with": "Cystinuria, Type B",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908482",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 622,
  "fields": {
    "snp_id": "SNP625",
    "rs_id": "rs121908483",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS138",
    "allele": "",
    "association_with": "Cystinuria",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908483",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 623,
  "fields": {
    "snp_id": "SNP626",
    "rs_id": "rs121908483",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS139",
    "allele": "",
    "association_with": "Cystinuria, Type A",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908483",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 624,
  "fields": {
    "snp_id": "SNP627",
    "rs_id": "rs121908483",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS140",
    "allele": "",
    "association_with": "Cystinuria, Type A-B",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908483",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 625,
  "fields": {
    "snp_id": "SNP628",
    "rs_id": "rs121908483",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS141",
    "allele": "",
    "association_with": "Cystinuria, Type B",
    "reference": "REF808",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908483",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 626,
  "fields": {
    "snp_id": "SNP629",
    "rs_id": "rs121908524",
    "gene": "DISGENE195",
    "drug": "",
    "disease": "DIS455",
    "allele": "",
    "association_with": "Primary Hyperoxaluria, Type I",
    "reference": "REF190",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908524",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 627,
  "fields": {
    "snp_id": "SNP630",
    "rs_id": "rs121908525",
    "gene": "DISGENE195",
    "drug": "",
    "disease": "DIS455",
    "allele": "",
    "association_with": "Primary Hyperoxaluria, Type I",
    "reference": "REF190",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908525",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 628,
  "fields": {
    "snp_id": "SNP631",
    "rs_id": "rs121908525",
    "gene": "DISGENE195",
    "drug": "",
    "disease": "DIS455",
    "allele": "",
    "association_with": "Primary Hyperoxaluria, Type I",
    "reference": "REF761",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908525",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 629,
  "fields": {
    "snp_id": "SNP632",
    "rs_id": "rs121908525",
    "gene": "DISGENE195",
    "drug": "",
    "disease": "DIS455",
    "allele": "",
    "association_with": "Primary Hyperoxaluria, Type I",
    "reference": "REF738",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908525",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 630,
  "fields": {
    "snp_id": "SNP633",
    "rs_id": "rs121908530",
    "gene": "DISGENE195",
    "drug": "",
    "disease": "DIS455",
    "allele": "",
    "association_with": "Primary Hyperoxaluria, Type I",
    "reference": "REF249",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908530",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 631,
  "fields": {
    "snp_id": "SNP634",
    "rs_id": "rs121908611",
    "gene": "DISGENE196",
    "drug": "",
    "disease": "DIS503",
    "allele": "",
    "association_with": "Spastic Paraplegia 5A, Autosomal Recessive (Disorder)",
    "reference": "REF489",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908611",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 632,
  "fields": {
    "snp_id": "SNP635",
    "rs_id": "rs121908614",
    "gene": "DISGENE196",
    "drug": "",
    "disease": "DIS503",
    "allele": "",
    "association_with": "Spastic Paraplegia 5A, Autosomal Recessive (Disorder)",
    "reference": "REF489",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908614",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 633,
  "fields": {
    "snp_id": "SNP636",
    "rs_id": "rs121908641",
    "gene": "DISGENE197",
    "drug": "",
    "disease": "DIS106",
    "allele": "",
    "association_with": "Citrullinemia",
    "reference": "REF360",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908641",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 634,
  "fields": {
    "snp_id": "SNP637",
    "rs_id": "rs121908676",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908676",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 635,
  "fields": {
    "snp_id": "SNP638",
    "rs_id": "rs121908679",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121908679",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 636,
  "fields": {
    "snp_id": "SNP639",
    "rs_id": "rs121909211",
    "gene": "DISGENE199",
    "drug": "",
    "disease": "DIS45",
    "allele": "",
    "association_with": "Avellino Corneal Dystrophy",
    "reference": "REF709",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121909211",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 637,
  "fields": {
    "snp_id": "SNP640",
    "rs_id": "rs121909358",
    "gene": "DISGENE200",
    "drug": "",
    "disease": "DIS301",
    "allele": "",
    "association_with": "Laron Syndrome",
    "reference": "REF236",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121909358",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Africa, America, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 638,
  "fields": {
    "snp_id": "SNP641",
    "rs_id": "rs121909363",
    "gene": "DISGENE200",
    "drug": "",
    "disease": "DIS301",
    "allele": "",
    "association_with": "Laron Syndrome",
    "reference": "REF236",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121909363",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Africa, America, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 639,
  "fields": {
    "snp_id": "SNP642",
    "rs_id": "rs121909547",
    "gene": "DISGENE201",
    "drug": "",
    "disease": "DIS31",
    "allele": "",
    "association_with": "Antithrombin Iii Deficiency",
    "reference": "REF542",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121909547",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 640,
  "fields": {
    "snp_id": "SNP643",
    "rs_id": "rs121909763",
    "gene": "DISGENE202",
    "drug": "",
    "disease": "DIS533",
    "allele": "",
    "association_with": "Usher Syndrome, Type 2C",
    "reference": "REF747",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121909763",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 641,
  "fields": {
    "snp_id": "SNP644",
    "rs_id": "rs121909763",
    "gene": "DISGENE202",
    "drug": "",
    "disease": "DIS533",
    "allele": "",
    "association_with": "Usher Syndrome, Type 2C",
    "reference": "REF363",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121909763",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 642,
  "fields": {
    "snp_id": "SNP645",
    "rs_id": "rs121912583",
    "gene": "DISGENE203",
    "drug": "",
    "disease": "DIS248",
    "allele": "",
    "association_with": "Histiocytosis With Joint Contractures And Sensorineural Deafness",
    "reference": "REF512",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121912583",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 643,
  "fields": {
    "snp_id": "SNP646",
    "rs_id": "rs121912609",
    "gene": "DISGENE204",
    "drug": "",
    "disease": "DIS57",
    "allele": "",
    "association_with": "Bifid Nose With Or Without Anorectal And Renal Anomalies",
    "reference": "REF189",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121912609",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 644,
  "fields": {
    "snp_id": "SNP647",
    "rs_id": "rs121912610",
    "gene": "DISGENE204",
    "drug": "",
    "disease": "DIS57",
    "allele": "",
    "association_with": "Bifid Nose With Or Without Anorectal And Renal Anomalies",
    "reference": "REF189",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121912610",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 645,
  "fields": {
    "snp_id": "SNP648",
    "rs_id": "rs121912654",
    "gene": "DISGENE158",
    "drug": "",
    "disease": "DIS313",
    "allele": "",
    "association_with": "Liver Carcinoma",
    "reference": "REF559",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121912654",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Asia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 646,
  "fields": {
    "snp_id": "SNP649",
    "rs_id": "rs121912931",
    "gene": "DISGENE205",
    "drug": "",
    "disease": "DIS511",
    "allele": "",
    "association_with": "Stickler Syndrome (Disorder)",
    "reference": "REF461",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121912931",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 647,
  "fields": {
    "snp_id": "SNP650",
    "rs_id": "rs121912931",
    "gene": "DISGENE205",
    "drug": "",
    "disease": "DIS512",
    "allele": "",
    "association_with": "Stickler Syndrome, Type 1",
    "reference": "REF461",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121912931",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 648,
  "fields": {
    "snp_id": "SNP651",
    "rs_id": "rs121912931",
    "gene": "DISGENE205",
    "drug": "",
    "disease": "DIS513",
    "allele": "",
    "association_with": "Stickler Syndrome, Type Iv",
    "reference": "REF461",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121912931",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 649,
  "fields": {
    "snp_id": "SNP652",
    "rs_id": "rs121913301",
    "gene": "DISGENE206",
    "drug": "",
    "disease": "DIS478",
    "allele": "",
    "association_with": "Retinoblastoma",
    "reference": "REF335",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121913301",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 650,
  "fields": {
    "snp_id": "SNP653",
    "rs_id": "rs121913302",
    "gene": "DISGENE206",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF335",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121913302",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 651,
  "fields": {
    "snp_id": "SNP654",
    "rs_id": "rs121913329",
    "gene": "DISGENE207",
    "drug": "",
    "disease": "DIS114",
    "allele": "",
    "association_with": "Colorectal Neoplasms",
    "reference": "REF248",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121913329",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 652,
  "fields": {
    "snp_id": "SNP655",
    "rs_id": "rs121913332",
    "gene": "DISGENE207",
    "drug": "",
    "disease": "DIS114",
    "allele": "",
    "association_with": "Colorectal Neoplasms",
    "reference": "REF248",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121913332",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 653,
  "fields": {
    "snp_id": "SNP656",
    "rs_id": "rs121913684",
    "gene": "DISGENE208",
    "drug": "",
    "disease": "DIS433",
    "allele": "",
    "association_with": "Piebaldism",
    "reference": "REF587",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121913684",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 654,
  "fields": {
    "snp_id": "SNP657",
    "rs_id": "rs121913684",
    "gene": "DISGENE208",
    "drug": "",
    "disease": "DIS434",
    "allele": "",
    "association_with": "Piebaldism With Sensorineural Deafness",
    "reference": "REF587",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121913684",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 655,
  "fields": {
    "snp_id": "SNP658",
    "rs_id": "rs121917734",
    "gene": "DISGENE209",
    "drug": "",
    "disease": "DIS505",
    "allele": "",
    "association_with": "Spherocytosis, Type 5",
    "reference": "REF191",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917734",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 656,
  "fields": {
    "snp_id": "SNP659",
    "rs_id": "rs121917734",
    "gene": "DISGENE209",
    "drug": "",
    "disease": "DIS505",
    "allele": "",
    "association_with": "Spherocytosis, Type 5",
    "reference": "REF578",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917734",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 657,
  "fields": {
    "snp_id": "SNP660",
    "rs_id": "rs121917777",
    "gene": "DISGENE148",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF177",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917777",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 658,
  "fields": {
    "snp_id": "SNP661",
    "rs_id": "rs121917777",
    "gene": "DISGENE149",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF177",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917777",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 659,
  "fields": {
    "snp_id": "SNP662",
    "rs_id": "rs121917784",
    "gene": "DISGENE102",
    "drug": "",
    "disease": "DIS197",
    "allele": "",
    "association_with": "Fanconi Anemia, Complementation Group C",
    "reference": "REF488",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917784",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Asia, Europe",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 660,
  "fields": {
    "snp_id": "SNP663",
    "rs_id": "rs121917785",
    "gene": "DISGENE102",
    "drug": "",
    "disease": "DIS197",
    "allele": "",
    "association_with": "Fanconi Anemia, Complementation Group C",
    "reference": "REF488",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917785",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Asia, Europe",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 661,
  "fields": {
    "snp_id": "SNP664",
    "rs_id": "rs121917834",
    "gene": "DISGENE210",
    "drug": "",
    "disease": "DIS470",
    "allele": "",
    "association_with": "Respiratory Distress Syndrome, Newborn",
    "reference": "REF569",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917834",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Norway, South Korea, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 662,
  "fields": {
    "snp_id": "SNP665",
    "rs_id": "rs121917839",
    "gene": "DISGENE211",
    "drug": "",
    "disease": "DIS435",
    "allele": "",
    "association_with": "Pituitary Dwarfism Type 3",
    "reference": "REF680",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917839",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 663,
  "fields": {
    "snp_id": "SNP666",
    "rs_id": "rs121917843",
    "gene": "DISGENE211",
    "drug": "",
    "disease": "DIS168",
    "allele": "",
    "association_with": "Dwarfism",
    "reference": "REF410",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917843",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 664,
  "fields": {
    "snp_id": "SNP667",
    "rs_id": "rs121917843",
    "gene": "DISGENE211",
    "drug": "",
    "disease": "DIS414",
    "allele": "",
    "association_with": "Panhypopituitarism",
    "reference": "REF410",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917843",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 665,
  "fields": {
    "snp_id": "SNP668",
    "rs_id": "rs121917843",
    "gene": "DISGENE211",
    "drug": "",
    "disease": "DIS435",
    "allele": "",
    "association_with": "Pituitary Dwarfism Type 3",
    "reference": "REF410",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917843",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 666,
  "fields": {
    "snp_id": "SNP669",
    "rs_id": "rs121917851",
    "gene": "DISGENE212",
    "drug": "",
    "disease": "DIS40",
    "allele": "",
    "association_with": "Ataxia With Vitamin E Deficiency",
    "reference": "REF612",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121917851",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 667,
  "fields": {
    "snp_id": "SNP670",
    "rs_id": "rs121918057",
    "gene": "DISGENE213",
    "drug": "",
    "disease": "DIS238",
    "allele": "",
    "association_with": "Hepatoerythropoietic Porphyria",
    "reference": "REF367",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918057",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Guinea",
    "latitude": "9.9456000",
    "longitude": "-9.6966000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 668,
  "fields": {
    "snp_id": "SNP671",
    "rs_id": "rs121918057",
    "gene": "DISGENE213",
    "drug": "",
    "disease": "DIS194",
    "allele": "",
    "association_with": "Familial Porphyria Cutanea Tarda",
    "reference": "REF435",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918057",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Spain",
    "latitude": "40.4637000",
    "longitude": "-3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 669,
  "fields": {
    "snp_id": "SNP672",
    "rs_id": "rs121918057",
    "gene": "DISGENE213",
    "drug": "",
    "disease": "DIS238",
    "allele": "",
    "association_with": "Hepatoerythropoietic Porphyria",
    "reference": "REF435",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918057",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Spain",
    "latitude": "40.4637000",
    "longitude": "-3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 670,
  "fields": {
    "snp_id": "SNP673",
    "rs_id": "rs121918057",
    "gene": "DISGENE213",
    "drug": "",
    "disease": "DIS451",
    "allele": "",
    "association_with": "Porphyria Cutanea Tarda",
    "reference": "REF435",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918057",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 671,
  "fields": {
    "snp_id": "SNP674",
    "rs_id": "rs121918057",
    "gene": "DISGENE213",
    "drug": "",
    "disease": "DIS451",
    "allele": "",
    "association_with": "Porphyria Cutanea Tarda",
    "reference": "REF435",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918057",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Spain",
    "latitude": "40.4637000",
    "longitude": "-3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 672,
  "fields": {
    "snp_id": "SNP675",
    "rs_id": "rs121918167",
    "gene": "DISGENE214",
    "drug": "",
    "disease": "DIS16",
    "allele": "",
    "association_with": "Albinism, Oculocutaneous",
    "reference": "REF277",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918167",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 673,
  "fields": {
    "snp_id": "SNP676",
    "rs_id": "rs121918168",
    "gene": "DISGENE214",
    "drug": "",
    "disease": "DIS71",
    "allele": "",
    "association_with": "Brown Oculocutaneous Albinism",
    "reference": "REF277",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918168",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 674,
  "fields": {
    "snp_id": "SNP677",
    "rs_id": "rs121918168",
    "gene": "DISGENE214",
    "drug": "",
    "disease": "DIS398",
    "allele": "",
    "association_with": "Oculocutaneous Albinism Type 2",
    "reference": "REF277",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918168",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 675,
  "fields": {
    "snp_id": "SNP678",
    "rs_id": "rs121918257",
    "gene": "DISGENE215",
    "drug": "",
    "disease": "DIS348",
    "allele": "",
    "association_with": "Methylmalonic Aciduria Due To Methylmalonyl-Coa Mutase Deficiency",
    "reference": "REF633",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918257",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 676,
  "fields": {
    "snp_id": "SNP679",
    "rs_id": "rs121918292",
    "gene": "DISGENE216",
    "drug": "",
    "disease": "DIS437",
    "allele": "",
    "association_with": "Poikiloderma Of Kindler",
    "reference": "REF724",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918292",
    "region": "North African",
    "country_of_participants": "Algeria, Senegal",
    "latitude": "14.4974000",
    "longitude": "-14.4524000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 677,
  "fields": {
    "snp_id": "SNP680",
    "rs_id": "rs121918303",
    "gene": "DISGENE217",
    "drug": "",
    "disease": "DIS135",
    "allele": "",
    "association_with": "Cryptorchidism",
    "reference": "REF683",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918303",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 678,
  "fields": {
    "snp_id": "SNP681",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF516",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 679,
  "fields": {
    "snp_id": "SNP682",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF590",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 680,
  "fields": {
    "snp_id": "SNP683",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF590",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 681,
  "fields": {
    "snp_id": "SNP684",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF590",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 682,
  "fields": {
    "snp_id": "SNP685",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF672",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Netherlands",
    "latitude": "52.1326000",
    "longitude": "5.2913000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 683,
  "fields": {
    "snp_id": "SNP686",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF733",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 684,
  "fields": {
    "snp_id": "SNP687",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF219",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 685,
  "fields": {
    "snp_id": "SNP688",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF219",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 686,
  "fields": {
    "snp_id": "SNP689",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF219",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 687,
  "fields": {
    "snp_id": "SNP690",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 688,
  "fields": {
    "snp_id": "SNP691",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 689,
  "fields": {
    "snp_id": "SNP692",
    "rs_id": "rs121918324",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918324",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 690,
  "fields": {
    "snp_id": "SNP693",
    "rs_id": "rs121918325",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF219",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918325",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 691,
  "fields": {
    "snp_id": "SNP694",
    "rs_id": "rs121918325",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF219",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918325",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 692,
  "fields": {
    "snp_id": "SNP695",
    "rs_id": "rs121918325",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF219",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918325",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 693,
  "fields": {
    "snp_id": "SNP696",
    "rs_id": "rs121918325",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918325",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 694,
  "fields": {
    "snp_id": "SNP697",
    "rs_id": "rs121918325",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918325",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 695,
  "fields": {
    "snp_id": "SNP698",
    "rs_id": "rs121918325",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918325",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 696,
  "fields": {
    "snp_id": "SNP699",
    "rs_id": "rs121918326",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918326",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 697,
  "fields": {
    "snp_id": "SNP700",
    "rs_id": "rs121918326",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918326",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 698,
  "fields": {
    "snp_id": "SNP701",
    "rs_id": "rs121918326",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF663",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918326",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 699,
  "fields": {
    "snp_id": "SNP702",
    "rs_id": "rs121918335",
    "gene": "DISGENE219",
    "drug": "",
    "disease": "DIS169",
    "allele": "",
    "association_with": "Early Myoclonic Encephalopathy",
    "reference": "REF373",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918335",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 700,
  "fields": {
    "snp_id": "SNP703",
    "rs_id": "rs121918338",
    "gene": "DISGENE220",
    "drug": "",
    "disease": "DIS109",
    "allele": "",
    "association_with": "Colitis",
    "reference": "REF289",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918338",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Asia",
    "latitude": "34.0479000",
    "longitude": "100.6197000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 701,
  "fields": {
    "snp_id": "SNP704",
    "rs_id": "rs121918583",
    "gene": "DISGENE221",
    "drug": "",
    "disease": "DIS475",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 40 (Disorder)",
    "reference": "REF747",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918583",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 702,
  "fields": {
    "snp_id": "SNP705",
    "rs_id": "rs121918583",
    "gene": "DISGENE221",
    "drug": "",
    "disease": "DIS475",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 40 (Disorder)",
    "reference": "REF363",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918583",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 703,
  "fields": {
    "snp_id": "SNP706",
    "rs_id": "rs121918641",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS174",
    "allele": "",
    "association_with": "Elliptocytosis 2 (Disorder)",
    "reference": "REF607",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918641",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 704,
  "fields": {
    "snp_id": "SNP707",
    "rs_id": "rs121918641",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS244",
    "allele": "",
    "association_with": "Hereditary Pyropoikilocytosis",
    "reference": "REF607",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918641",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 705,
  "fields": {
    "snp_id": "SNP708",
    "rs_id": "rs121918641",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS174",
    "allele": "",
    "association_with": "Elliptocytosis 2 (Disorder)",
    "reference": "REF225",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918641",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 706,
  "fields": {
    "snp_id": "SNP709",
    "rs_id": "rs121918641",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS244",
    "allele": "",
    "association_with": "Hereditary Pyropoikilocytosis",
    "reference": "REF225",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918641",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 707,
  "fields": {
    "snp_id": "SNP710",
    "rs_id": "rs121918642",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS174",
    "allele": "",
    "association_with": "Elliptocytosis 2 (Disorder)",
    "reference": "REF607",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918642",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 708,
  "fields": {
    "snp_id": "SNP711",
    "rs_id": "rs121918642",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS244",
    "allele": "",
    "association_with": "Hereditary Pyropoikilocytosis",
    "reference": "REF607",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918642",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 709,
  "fields": {
    "snp_id": "SNP712",
    "rs_id": "rs121918643",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS174",
    "allele": "",
    "association_with": "Elliptocytosis 2 (Disorder)",
    "reference": "REF565",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918643",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 710,
  "fields": {
    "snp_id": "SNP713",
    "rs_id": "rs121918643",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS244",
    "allele": "",
    "association_with": "Hereditary Pyropoikilocytosis",
    "reference": "REF565",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918643",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 711,
  "fields": {
    "snp_id": "SNP714",
    "rs_id": "rs121918670",
    "gene": "DISGENE223",
    "drug": "",
    "disease": "DIS265",
    "allele": "",
    "association_with": "Hypothyroidism, Congenital, Nongoitrous, 4",
    "reference": "REF508",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs121918670",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 712,
  "fields": {
    "snp_id": "SNP715",
    "rs_id": "rs1219648",
    "gene": "DISGENE224",
    "drug": "",
    "disease": "DIS66",
    "allele": "",
    "association_with": "Breast Carcinoma",
    "reference": "REF241",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs1219648",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 713,
  "fields": {
    "snp_id": "SNP716",
    "rs_id": "rs1219648",
    "gene": "DISGENE224",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF241",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs1219648",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 714,
  "fields": {
    "snp_id": "SNP717",
    "rs_id": "rs121964856",
    "gene": "DISGENE225",
    "drug": "",
    "disease": "DIS76",
    "allele": "",
    "association_with": "Cardiomyopathy, Dilated, 1D (Disorder)",
    "reference": "REF338",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121964856",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 715,
  "fields": {
    "snp_id": "SNP718",
    "rs_id": "rs121964856",
    "gene": "DISGENE225",
    "drug": "",
    "disease": "DIS78",
    "allele": "",
    "association_with": "Cardiomyopathy, Familial Hypertrophic, 2",
    "reference": "REF338",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121964856",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 716,
  "fields": {
    "snp_id": "SNP719",
    "rs_id": "rs121964856",
    "gene": "DISGENE225",
    "drug": "",
    "disease": "DIS80",
    "allele": "",
    "association_with": "Cardiomyopathy, Familial Restrictive, 3 (Disorder)",
    "reference": "REF338",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121964856",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 717,
  "fields": {
    "snp_id": "SNP720",
    "rs_id": "rs121964921",
    "gene": "DISGENE226",
    "drug": "",
    "disease": "DIS115",
    "allele": "",
    "association_with": "Complement Component 7 Deficiency",
    "reference": "REF573",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121964921",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 718,
  "fields": {
    "snp_id": "SNP721",
    "rs_id": "rs121964931",
    "gene": "DISGENE227",
    "drug": "",
    "disease": "DIS189",
    "allele": "",
    "association_with": "Factor Vii Deficiency",
    "reference": "REF749",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121964931",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 719,
  "fields": {
    "snp_id": "SNP722",
    "rs_id": "rs121964990",
    "gene": "DISGENE228",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF246",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121964990",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 720,
  "fields": {
    "snp_id": "SNP723",
    "rs_id": "rs121964990",
    "gene": "DISGENE228",
    "drug": "",
    "disease": "DIS299",
    "allele": "",
    "association_with": "Lactic Acidosis, Congenital Infantile, Due To Lad Deficiency",
    "reference": "REF246",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121964990",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 721,
  "fields": {
    "snp_id": "SNP724",
    "rs_id": "rs121964990",
    "gene": "DISGENE228",
    "drug": "",
    "disease": "DIS374",
    "allele": "",
    "association_with": "NAdh Cytochrome B5 Reductase Deficiency",
    "reference": "REF246",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121964990",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 722,
  "fields": {
    "snp_id": "SNP725",
    "rs_id": "rs121965021",
    "gene": "DISGENE229",
    "drug": "",
    "disease": "DIS429",
    "allele": "",
    "association_with": "Pfaundler-Hurler Syndrome",
    "reference": "REF271",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121965021",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 723,
  "fields": {
    "snp_id": "SNP726",
    "rs_id": "rs121965021",
    "gene": "DISGENE229",
    "drug": "",
    "disease": "DIS429",
    "allele": "",
    "association_with": "Pfaundler-Hurler Syndrome",
    "reference": "REF396",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121965021",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 724,
  "fields": {
    "snp_id": "SNP727",
    "rs_id": "rs121965022",
    "gene": "DISGENE229",
    "drug": "",
    "disease": "DIS429",
    "allele": "",
    "association_with": "Pfaundler-Hurler Syndrome",
    "reference": "REF256",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121965022",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 725,
  "fields": {
    "snp_id": "SNP728",
    "rs_id": "rs121965022",
    "gene": "DISGENE230",
    "drug": "",
    "disease": "DIS429",
    "allele": "",
    "association_with": "Pfaundler-Hurler Syndrome",
    "reference": "REF256",
    "p_value": "0.001",
    "source": "DisGeNET",
    "id_in_source": "rs121965022",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 726,
  "fields": {
    "snp_id": "SNP729",
    "rs_id": "rs12255372",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF678",
    "p_value": "0.017",
    "source": "DisGeNET",
    "id_in_source": "rs12255372",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Nigeria, Mexico, Spain",
    "latitude": "40.4637000",
    "longitude": "-3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 727,
  "fields": {
    "snp_id": "SNP730",
    "rs_id": "rs12255372",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF329",
    "p_value": "0.56",
    "source": "DisGeNET",
    "id_in_source": "rs12255372",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 728,
  "fields": {
    "snp_id": "SNP731",
    "rs_id": "rs12255372",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF562",
    "p_value": "0.56",
    "source": "DisGeNET",
    "id_in_source": "rs12255372",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 729,
  "fields": {
    "snp_id": "SNP732",
    "rs_id": "rs12255372",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS440",
    "allele": "",
    "association_with": "Polycystic Ovary Syndrome",
    "reference": "REF387",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs12255372",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, UK, China",
    "latitude": "35.8617000",
    "longitude": "104.1954000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 730,
  "fields": {
    "snp_id": "SNP733",
    "rs_id": "rs12405994",
    "gene": "DISGENE232",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "0.00000082",
    "source": "DisGeNET",
    "id_in_source": "rs12405994",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 731,
  "fields": {
    "snp_id": "SNP734",
    "rs_id": "rs1249744",
    "gene": "DISGENE233",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1249744",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 732,
  "fields": {
    "snp_id": "SNP735",
    "rs_id": "rs12720459",
    "gene": "DISGENE234",
    "drug": "",
    "disease": "DIS481",
    "allele": "",
    "association_with": "Romano-Ward Syndrome",
    "reference": "REF255",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs12720459",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 733,
  "fields": {
    "snp_id": "SNP736",
    "rs_id": "rs12720459",
    "gene": "DISGENE320",
    "drug": "",
    "disease": "DIS481",
    "allele": "",
    "association_with": "Romano-Ward Syndrome",
    "reference": "REF255",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs12720459",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 734,
  "fields": {
    "snp_id": "SNP737",
    "rs_id": "rs12788102",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs12788102",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 735,
  "fields": {
    "snp_id": "SNP738",
    "rs_id": "rs12788102",
    "gene": "DISGENE236",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs12788102",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 736,
  "fields": {
    "snp_id": "SNP739",
    "rs_id": "rs12789492",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs12789492",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 737,
  "fields": {
    "snp_id": "SNP740",
    "rs_id": "rs12801757",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs12801757",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 738,
  "fields": {
    "snp_id": "SNP741",
    "rs_id": "rs12806476",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs12806476",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 739,
  "fields": {
    "snp_id": "SNP742",
    "rs_id": "rs12808215",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs12808215",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 740,
  "fields": {
    "snp_id": "SNP743",
    "rs_id": "rs12979860",
    "gene": "PHARGENE53",
    "drug": "",
    "disease": "DIS314",
    "allele": "",
    "association_with": "Liver Diseases",
    "reference": "REF181",
    "p_value": "0.0017",
    "source": "DisGeNET",
    "id_in_source": "rs12979860",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 741,
  "fields": {
    "snp_id": "SNP744",
    "rs_id": "rs12979860",
    "gene": "PHARGENE53",
    "drug": "",
    "disease": "DIS237",
    "allele": "",
    "association_with": "Hepatitis C, Chronic",
    "reference": "REF513",
    "p_value": "0.0005",
    "source": "DisGeNET",
    "id_in_source": "rs12979860",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 742,
  "fields": {
    "snp_id": "SNP745",
    "rs_id": "rs12979860",
    "gene": "PHARGENE53",
    "drug": "",
    "disease": "DIS314",
    "allele": "",
    "association_with": "Liver Diseases",
    "reference": "REF513",
    "p_value": "0.0532",
    "source": "DisGeNET",
    "id_in_source": "rs12979860",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 743,
  "fields": {
    "snp_id": "SNP746",
    "rs_id": "rs13107325",
    "gene": "DISGENE237",
    "drug": "",
    "disease": "DIS483",
    "allele": "",
    "association_with": "Schizophrenia",
    "reference": "REF782",
    "p_value": "0.0000027",
    "source": "DisGeNET",
    "id_in_source": "rs13107325",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Africa, Asia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 744,
  "fields": {
    "snp_id": "SNP747",
    "rs_id": "rs13181",
    "gene": "DISGENE238",
    "drug": "",
    "disease": "DIS60",
    "allele": "",
    "association_with": "Bladder Neoplasm",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs13181",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 745,
  "fields": {
    "snp_id": "SNP748",
    "rs_id": "rs13181",
    "gene": "DISGENE238",
    "drug": "",
    "disease": "DIS74",
    "allele": "",
    "association_with": "Carcinoma Of Bladder",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs13181",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 746,
  "fields": {
    "snp_id": "SNP749",
    "rs_id": "rs13181",
    "gene": "DISGENE238",
    "drug": "",
    "disease": "DIS331",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Urinary Bladder",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs13181",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 747,
  "fields": {
    "snp_id": "SNP750",
    "rs_id": "rs13181",
    "gene": "DISGENE238",
    "drug": "",
    "disease": "DIS308",
    "allele": "",
    "association_with": "Leukemia",
    "reference": "REF166",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs13181",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 748,
  "fields": {
    "snp_id": "SNP751",
    "rs_id": "rs13266634",
    "gene": "DISGENE239",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF222",
    "p_value": "0.0004",
    "source": "DisGeNET",
    "id_in_source": "rs13266634",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 749,
  "fields": {
    "snp_id": "SNP752",
    "rs_id": "rs13281615",
    "gene": "DISGENE240",
    "drug": "",
    "disease": "DIS66",
    "allele": "",
    "association_with": "Breast Carcinoma",
    "reference": "REF241",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs13281615",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 750,
  "fields": {
    "snp_id": "SNP753",
    "rs_id": "rs13281615",
    "gene": "DISGENE241",
    "drug": "",
    "disease": "DIS66",
    "allele": "",
    "association_with": "Breast Carcinoma",
    "reference": "REF241",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs13281615",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 751,
  "fields": {
    "snp_id": "SNP754",
    "rs_id": "rs13281615",
    "gene": "DISGENE242",
    "drug": "",
    "disease": "DIS66",
    "allele": "",
    "association_with": "Breast Carcinoma",
    "reference": "REF241",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs13281615",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 752,
  "fields": {
    "snp_id": "SNP755",
    "rs_id": "rs13281615",
    "gene": "DISGENE240",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF241",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs13281615",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 753,
  "fields": {
    "snp_id": "SNP756",
    "rs_id": "rs13281615",
    "gene": "DISGENE241",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF241",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs13281615",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 754,
  "fields": {
    "snp_id": "SNP757",
    "rs_id": "rs13281615",
    "gene": "DISGENE242",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF241",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs13281615",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 755,
  "fields": {
    "snp_id": "SNP758",
    "rs_id": "rs1330363",
    "gene": "DISGENE243",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "0.02",
    "source": "DisGeNET",
    "id_in_source": "rs1330363",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 756,
  "fields": {
    "snp_id": "SNP759",
    "rs_id": "rs1330363",
    "gene": "DISGENE244",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "0.02",
    "source": "DisGeNET",
    "id_in_source": "rs1330363",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 757,
  "fields": {
    "snp_id": "SNP760",
    "rs_id": "rs13321",
    "gene": "DISGENE243",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs13321",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 758,
  "fields": {
    "snp_id": "SNP761",
    "rs_id": "rs13321",
    "gene": "DISGENE244",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs13321",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 759,
  "fields": {
    "snp_id": "SNP762",
    "rs_id": "rs137852347",
    "gene": "PHARGENE42",
    "drug": "",
    "disease": "DIS27",
    "allele": "",
    "association_with": "Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency",
    "reference": "REF526",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137852347",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 760,
  "fields": {
    "snp_id": "SNP763",
    "rs_id": "rs137852621",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF655",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137852621",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 761,
  "fields": {
    "snp_id": "SNP764",
    "rs_id": "rs137852621",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF600",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137852621",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 762,
  "fields": {
    "snp_id": "SNP765",
    "rs_id": "rs137852999",
    "gene": "DISGENE246",
    "drug": "",
    "disease": "DIS144",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 10",
    "reference": "REF509",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137852999",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 763,
  "fields": {
    "snp_id": "SNP766",
    "rs_id": "rs137852999",
    "gene": "DISGENE246",
    "drug": "",
    "disease": "DIS154",
    "allele": "",
    "association_with": "Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8",
    "reference": "REF509",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137852999",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 764,
  "fields": {
    "snp_id": "SNP767",
    "rs_id": "rs137853003",
    "gene": "DISGENE247",
    "drug": "",
    "disease": "DIS538",
    "allele": "",
    "association_with": "Usher Syndrome, Type If",
    "reference": "REF807",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853003",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 765,
  "fields": {
    "snp_id": "SNP768",
    "rs_id": "rs137853016",
    "gene": "DISGENE122",
    "drug": "",
    "disease": "DIS496",
    "allele": "",
    "association_with": "Spastic Ataxia, Charlevoix-Saguenay Type",
    "reference": "REF354",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853016",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 766,
  "fields": {
    "snp_id": "SNP769",
    "rs_id": "rs137853017",
    "gene": "DISGENE122",
    "drug": "",
    "disease": "DIS496",
    "allele": "",
    "association_with": "Spastic Ataxia, Charlevoix-Saguenay Type",
    "reference": "REF354",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853017",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 767,
  "fields": {
    "snp_id": "SNP770",
    "rs_id": "rs137853025",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS482",
    "allele": "",
    "association_with": "Saldino-Noonan Syndrome",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853025",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 768,
  "fields": {
    "snp_id": "SNP771",
    "rs_id": "rs137853025",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS489",
    "allele": "",
    "association_with": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853025",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 769,
  "fields": {
    "snp_id": "SNP772",
    "rs_id": "rs137853027",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS482",
    "allele": "",
    "association_with": "Saldino-Noonan Syndrome",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853027",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 770,
  "fields": {
    "snp_id": "SNP773",
    "rs_id": "rs137853027",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS489",
    "allele": "",
    "association_with": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853027",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 771,
  "fields": {
    "snp_id": "SNP774",
    "rs_id": "rs137853028",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS482",
    "allele": "",
    "association_with": "Saldino-Noonan Syndrome",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853028",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 772,
  "fields": {
    "snp_id": "SNP775",
    "rs_id": "rs137853028",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS489",
    "allele": "",
    "association_with": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853028",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 773,
  "fields": {
    "snp_id": "SNP776",
    "rs_id": "rs137853034",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS482",
    "allele": "",
    "association_with": "Saldino-Noonan Syndrome",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853034",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 774,
  "fields": {
    "snp_id": "SNP777",
    "rs_id": "rs137853034",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS489",
    "allele": "",
    "association_with": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853034",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 775,
  "fields": {
    "snp_id": "SNP778",
    "rs_id": "rs137853035",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS482",
    "allele": "",
    "association_with": "Saldino-Noonan Syndrome",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853035",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 776,
  "fields": {
    "snp_id": "SNP779",
    "rs_id": "rs137853035",
    "gene": "DISGENE248",
    "drug": "",
    "disease": "DIS489",
    "allele": "",
    "association_with": "Short Rib-Polydactyly Syndrome, Verma-NAumoff Type",
    "reference": "REF632",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853035",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 777,
  "fields": {
    "snp_id": "SNP780",
    "rs_id": "rs137853052",
    "gene": "DISGENE249",
    "drug": "",
    "disease": "DIS546",
    "allele": "",
    "association_with": "Warburg Sjo Fledelius Syndrome",
    "reference": "REF490",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853052",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 778,
  "fields": {
    "snp_id": "SNP781",
    "rs_id": "rs137853052",
    "gene": "DISGENE250",
    "drug": "",
    "disease": "DIS546",
    "allele": "",
    "association_with": "Warburg Sjo Fledelius Syndrome",
    "reference": "REF490",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853052",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 779,
  "fields": {
    "snp_id": "SNP782",
    "rs_id": "rs137853125",
    "gene": "DISGENE251",
    "drug": "",
    "disease": "DIS105",
    "allele": "",
    "association_with": "Chylomicron Retention Disease",
    "reference": "REF635",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853125",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 780,
  "fields": {
    "snp_id": "SNP783",
    "rs_id": "rs137853126",
    "gene": "DISGENE251",
    "drug": "",
    "disease": "DIS105",
    "allele": "",
    "association_with": "Chylomicron Retention Disease",
    "reference": "REF635",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853126",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 781,
  "fields": {
    "snp_id": "SNP784",
    "rs_id": "rs137853284",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853284",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 782,
  "fields": {
    "snp_id": "SNP785",
    "rs_id": "rs137853293",
    "gene": "DISGENE206",
    "drug": "",
    "disease": "DIS478",
    "allele": "",
    "association_with": "Retinoblastoma",
    "reference": "REF494",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853293",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 783,
  "fields": {
    "snp_id": "SNP786",
    "rs_id": "rs137853300",
    "gene": "DISGENE252",
    "drug": "",
    "disease": "DIS207",
    "allele": "",
    "association_with": "Fundus Dystrophy, Pseudoinflammatory, Of Sorsby",
    "reference": "REF487",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853300",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Canada, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7130000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 784,
  "fields": {
    "snp_id": "SNP787",
    "rs_id": "rs137853300",
    "gene": "DISGENE253",
    "drug": "",
    "disease": "DIS207",
    "allele": "",
    "association_with": "Fundus Dystrophy, Pseudoinflammatory, Of Sorsby",
    "reference": "REF487",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137853300",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Canada, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7130000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 785,
  "fields": {
    "snp_id": "SNP788",
    "rs_id": "rs137854575",
    "gene": "DISGENE207",
    "drug": "",
    "disease": "DIS447",
    "allele": "",
    "association_with": "Polyposis, Adenomatous Intestinal",
    "reference": "REF263",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137854575",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 786,
  "fields": {
    "snp_id": "SNP789",
    "rs_id": "rs137943601",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF303",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137943601",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 787,
  "fields": {
    "snp_id": "SNP790",
    "rs_id": "rs137943601",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS315",
    "allele": "",
    "association_with": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2",
    "reference": "REF303",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs137943601",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 788,
  "fields": {
    "snp_id": "SNP791",
    "rs_id": "rs138043021",
    "gene": "DISGENE190",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF349",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs138043021",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 789,
  "fields": {
    "snp_id": "SNP792",
    "rs_id": "rs139361635",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF525",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs139361635",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 790,
  "fields": {
    "snp_id": "SNP793",
    "rs_id": "rs139361635",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF525",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs139361635",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 791,
  "fields": {
    "snp_id": "SNP794",
    "rs_id": "rs139640763",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs139640763",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 792,
  "fields": {
    "snp_id": "SNP797",
    "rs_id": "rs140817150",
    "gene": "DISGENE256",
    "drug": "",
    "disease": "DIS436",
    "allele": "",
    "association_with": "Pneumococcal Bacteraemia",
    "reference": "REF417",
    "p_value": "< 1E+6",
    "source": "DisGeNET",
    "id_in_source": "rs140817150",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya",
    "latitude": "-0.0236000",
    "longitude": "37.9062000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 793,
  "fields": {
    "snp_id": "SNP798",
    "rs_id": "rs1411478",
    "gene": "DISGENE257",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF231",
    "p_value": "< 1E+6",
    "source": "DisGeNET",
    "id_in_source": "rs1411478",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Canada, Norway, Taiwan",
    "latitude": "23.6978000",
    "longitude": "120.9605000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 794,
  "fields": {
    "snp_id": "SNP799",
    "rs_id": "rs1411478",
    "gene": "DISGENE257",
    "drug": "",
    "disease": "DIS460",
    "allele": "",
    "association_with": "Progressive Supranuclear Palsy",
    "reference": "REF231",
    "p_value": "< 1E+6",
    "source": "DisGeNET",
    "id_in_source": "rs1411478",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Canada, Norway, Taiwan",
    "latitude": "23.6978000",
    "longitude": "120.9605000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 795,
  "fields": {
    "snp_id": "SNP800",
    "rs_id": "rs141278078",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "< 1E+6",
    "source": "DisGeNET",
    "id_in_source": "rs141278078",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 796,
  "fields": {
    "snp_id": "SNP801",
    "rs_id": "rs1417402",
    "gene": "DISGENE232",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "< 1E+6",
    "source": "DisGeNET",
    "id_in_source": "rs1417402",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 797,
  "fields": {
    "snp_id": "SNP802",
    "rs_id": "rs141980901",
    "gene": "DISGENE258",
    "drug": "",
    "disease": "DIS472",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 14",
    "reference": "REF440",
    "p_value": "< 1E+6",
    "source": "DisGeNET",
    "id_in_source": "rs141980901",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 798,
  "fields": {
    "snp_id": "SNP803",
    "rs_id": "rs1426654",
    "gene": "DISGENE259",
    "drug": "",
    "disease": "DIS495",
    "allele": "",
    "association_with": "Skin-Hair-Eye Pigmentation, Variation In, 4",
    "reference": "REF756",
    "p_value": "< 1E+6",
    "source": "DisGeNET",
    "id_in_source": "rs1426654",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Botswana, Ethiopia, Tanzania",
    "latitude": "9.1450000",
    "longitude": "40.4897000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 799,
  "fields": {
    "snp_id": "SNP804",
    "rs_id": "rs1427407",
    "gene": "DISGENE260",
    "drug": "",
    "disease": "DIS28",
    "allele": "",
    "association_with": "Anemia, Sickle Cell",
    "reference": "REF437",
    "p_value": "3.74E-053",
    "source": "DisGeNET",
    "id_in_source": "rs1427407",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 800,
  "fields": {
    "snp_id": "SNP805",
    "rs_id": "rs142761835",
    "gene": "DISGENE261",
    "drug": "",
    "disease": "DIS290",
    "allele": "",
    "association_with": "Isovaleryl-Coa Dehydrogenase Deficiency",
    "reference": "REF462",
    "p_value": "3.74E-053",
    "source": "DisGeNET",
    "id_in_source": "rs142761835",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 801,
  "fields": {
    "snp_id": "SNP806",
    "rs_id": "rs143570936",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF777",
    "p_value": "3.74E-053",
    "source": "DisGeNET",
    "id_in_source": "rs143570936",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 802,
  "fields": {
    "snp_id": "SNP807",
    "rs_id": "rs143570936",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF655",
    "p_value": "3.74E-053",
    "source": "DisGeNET",
    "id_in_source": "rs143570936",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 803,
  "fields": {
    "snp_id": "SNP808",
    "rs_id": "rs143570936",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF600",
    "p_value": "3.74E-053",
    "source": "DisGeNET",
    "id_in_source": "rs143570936",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 804,
  "fields": {
    "snp_id": "SNP809",
    "rs_id": "rs144312179",
    "gene": "DISGENE262",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs144312179",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 805,
  "fields": {
    "snp_id": "SNP810",
    "rs_id": "rs144666367",
    "gene": "DISGENE263",
    "drug": "",
    "disease": "DIS425",
    "allele": "",
    "association_with": "Peeling Skin Syndrome 5",
    "reference": "REF259",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs144666367",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 806,
  "fields": {
    "snp_id": "SNP811",
    "rs_id": "rs145489194",
    "gene": "DISGENE264",
    "drug": "",
    "disease": "DIS352",
    "allele": "",
    "association_with": "Microcephaly, Primary Autosomal Recessive, 5",
    "reference": "REF593",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs145489194",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 807,
  "fields": {
    "snp_id": "SNP812",
    "rs_id": "rs145513733",
    "gene": "DISGENE110",
    "drug": "",
    "disease": "DIS18",
    "allele": "",
    "association_with": "Albinism, Oculocutaneous, Type I, Temperature-Sensitive",
    "reference": "REF283",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs145513733",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Morocco, Tunisia, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 808,
  "fields": {
    "snp_id": "SNP813",
    "rs_id": "rs145513733",
    "gene": "DISGENE110",
    "drug": "",
    "disease": "DIS17",
    "allele": "",
    "association_with": "Albinism, Oculocutaneous, Type Ib (Disorder)",
    "reference": "REF283",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs145513733",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Morocco, Tunisia, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 809,
  "fields": {
    "snp_id": "SNP814",
    "rs_id": "rs145946881",
    "gene": "DISGENE265",
    "drug": "",
    "disease": "DIS298",
    "allele": "",
    "association_with": "Lactase Persistence",
    "reference": "REF370",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs145946881",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya, Sudan, Tanzania",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 810,
  "fields": {
    "snp_id": "SNP815",
    "rs_id": "rs146214639",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS465",
    "allele": "",
    "association_with": "Psoriasis 2",
    "reference": "REF220",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs146214639",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 811,
  "fields": {
    "snp_id": "SNP816",
    "rs_id": "rs147030232",
    "gene": "DISGENE190",
    "drug": "",
    "disease": "DIS50",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome 2 (Disorder)",
    "reference": "REF177",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs147030232",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 812,
  "fields": {
    "snp_id": "SNP817",
    "rs_id": "rs1470452230",
    "gene": "DISGENE267",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF685",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs1470452230",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 813,
  "fields": {
    "snp_id": "SNP818",
    "rs_id": "rs1470452230",
    "gene": "DISGENE267",
    "drug": "",
    "disease": "DIS237",
    "allele": "",
    "association_with": "Hepatitis C, Chronic",
    "reference": "REF685",
    "p_value": "0.00000135",
    "source": "DisGeNET",
    "id_in_source": "rs1470452230",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 814,
  "fields": {
    "snp_id": "SNP819",
    "rs_id": "rs1470579",
    "gene": "DISGENE268",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF622",
    "p_value": "0.22",
    "source": "DisGeNET",
    "id_in_source": "rs1470579",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 815,
  "fields": {
    "snp_id": "SNP820",
    "rs_id": "rs1470579",
    "gene": "DISGENE268",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF222",
    "p_value": "0.68",
    "source": "DisGeNET",
    "id_in_source": "rs1470579",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 816,
  "fields": {
    "snp_id": "SNP821",
    "rs_id": "rs147484110",
    "gene": "DISGENE269",
    "drug": "",
    "disease": "DIS373",
    "allele": "",
    "association_with": "Myoclonic Epilepsies, Progressive",
    "reference": "REF648",
    "p_value": "0.68",
    "source": "DisGeNET",
    "id_in_source": "rs147484110",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 817,
  "fields": {
    "snp_id": "SNP822",
    "rs_id": "rs147739031",
    "gene": "DISGENE270",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs147739031",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 818,
  "fields": {
    "snp_id": "SNP823",
    "rs_id": "rs148499164",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs148499164",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 819,
  "fields": {
    "snp_id": "SNP824",
    "rs_id": "rs148542782",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF366",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs148542782",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 820,
  "fields": {
    "snp_id": "SNP825",
    "rs_id": "rs148542782",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF366",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs148542782",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 821,
  "fields": {
    "snp_id": "SNP826",
    "rs_id": "rs148542782",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF366",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs148542782",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 822,
  "fields": {
    "snp_id": "SNP827",
    "rs_id": "rs148542782",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF366",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs148542782",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 823,
  "fields": {
    "snp_id": "SNP828",
    "rs_id": "rs148617572",
    "gene": "DISGENE271",
    "drug": "",
    "disease": "DIS44",
    "allele": "",
    "association_with": "Autosomal Recessive Polycystic Kidney Disease",
    "reference": "REF499",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs148617572",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Iraq",
    "latitude": "33.2232000",
    "longitude": "43.6793000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 824,
  "fields": {
    "snp_id": "SNP829",
    "rs_id": "rs149277003",
    "gene": "DISGENE185",
    "drug": "",
    "disease": "DIS185",
    "allele": "",
    "association_with": "Estren-Dameshek Variant Of Fanconi Pancytopenia",
    "reference": "REF696",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs149277003",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Iraq",
    "latitude": "33.2232000",
    "longitude": "43.6793000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 825,
  "fields": {
    "snp_id": "SNP830",
    "rs_id": "rs149330893",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF293",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs149330893",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 826,
  "fields": {
    "snp_id": "SNP831",
    "rs_id": "rs149989682",
    "gene": "DISGENE272",
    "drug": "",
    "disease": "DIS280",
    "allele": "",
    "association_with": "Idiopathic Pulmonary Fibrosis",
    "reference": "REF569",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs149989682",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Norway, South Korea, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 827,
  "fields": {
    "snp_id": "SNP832",
    "rs_id": "rs149989682",
    "gene": "DISGENE272",
    "drug": "",
    "disease": "DIS470",
    "allele": "",
    "association_with": "Respiratory Distress Syndrome, Newborn",
    "reference": "REF569",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs149989682",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Norway, South Korea, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 828,
  "fields": {
    "snp_id": "SNP833",
    "rs_id": "rs149989682",
    "gene": "DISGENE272",
    "drug": "",
    "disease": "DIS518",
    "allele": "",
    "association_with": "Surfactant Metabolism Dysfunction, Pulmonary, 3",
    "reference": "REF569",
    "p_value": "0.000000996",
    "source": "DisGeNET",
    "id_in_source": "rs149989682",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Norway, South Korea, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 829,
  "fields": {
    "snp_id": "SNP834",
    "rs_id": "rs1537415",
    "gene": "DISGENE273",
    "drug": "",
    "disease": "DIS12",
    "allele": "",
    "association_with": "Acute Periodontitis",
    "reference": "REF806",
    "p_value": "0.013",
    "source": "DisGeNET",
    "id_in_source": "rs1537415",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 830,
  "fields": {
    "snp_id": "SNP835",
    "rs_id": "rs1537415",
    "gene": "DISGENE273",
    "drug": "",
    "disease": "DIS428",
    "allele": "",
    "association_with": "Periodontitis, Juvenile",
    "reference": "REF806",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs1537415",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 831,
  "fields": {
    "snp_id": "SNP836",
    "rs_id": "rs1543061",
    "gene": "DISGENE96",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs1543061",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 832,
  "fields": {
    "snp_id": "SNP837",
    "rs_id": "rs1594812",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs1594812",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 833,
  "fields": {
    "snp_id": "SNP838",
    "rs_id": "rs17227978",
    "gene": "DISGENE274",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs17227978",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 834,
  "fields": {
    "snp_id": "SNP839",
    "rs_id": "rs17227978",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs17227978",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 835,
  "fields": {
    "snp_id": "SNP840",
    "rs_id": "rs17228092",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs17228092",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 836,
  "fields": {
    "snp_id": "SNP841",
    "rs_id": "rs17228176",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs17228176",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 837,
  "fields": {
    "snp_id": "SNP842",
    "rs_id": "rs17228183",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs17228183",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 838,
  "fields": {
    "snp_id": "SNP843",
    "rs_id": "rs17233141",
    "gene": "DISGENE185",
    "drug": "",
    "disease": "DIS184",
    "allele": "",
    "association_with": "Estren-Dameshek Variant Of Fanconi Anemia",
    "reference": "REF299",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs17233141",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Israel, India",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 839,
  "fields": {
    "snp_id": "SNP844",
    "rs_id": "rs17233141",
    "gene": "DISGENE185",
    "drug": "",
    "disease": "DIS185",
    "allele": "",
    "association_with": "Estren-Dameshek Variant Of Fanconi Pancytopenia",
    "reference": "REF299",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs17233141",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Israel, India",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 840,
  "fields": {
    "snp_id": "SNP845",
    "rs_id": "rs17233141",
    "gene": "DISGENE185",
    "drug": "",
    "disease": "DIS196",
    "allele": "",
    "association_with": "Fanconi Anemia, Complementation Group A (Disorder)",
    "reference": "REF299",
    "p_value": "0.0295",
    "source": "DisGeNET",
    "id_in_source": "rs17233141",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Israel, India",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 841,
  "fields": {
    "snp_id": "SNP846",
    "rs_id": "rs17235409",
    "gene": "DISGENE275",
    "drug": "",
    "disease": "DIS72",
    "allele": "",
    "association_with": "Buruli Ulcer, Susceptibility To",
    "reference": "REF229",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17235409",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 842,
  "fields": {
    "snp_id": "SNP847",
    "rs_id": "rs17313265",
    "gene": "DISGENE276",
    "drug": "",
    "disease": "DIS134",
    "allele": "",
    "association_with": "Crohn Disease",
    "reference": "REF572",
    "p_value": "0.000009",
    "source": "DisGeNET",
    "id_in_source": "rs17313265",
    "region": "Mixed Population, African American",
    "country_of_participants": "Puerto Rico",
    "latitude": "18.2208330",
    "longitude": "-66.5901490"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 843,
  "fields": {
    "snp_id": "SNP848",
    "rs_id": "rs17325567",
    "gene": "DISGENE274",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.000009",
    "source": "DisGeNET",
    "id_in_source": "rs17325567",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 844,
  "fields": {
    "snp_id": "SNP849",
    "rs_id": "rs17325567",
    "gene": "DISGENE235",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.000009",
    "source": "DisGeNET",
    "id_in_source": "rs17325567",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 845,
  "fields": {
    "snp_id": "SNP852",
    "rs_id": "rs17655",
    "gene": "DISGENE278",
    "drug": "",
    "disease": "DIS60",
    "allele": "",
    "association_with": "Bladder Neoplasm",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17655",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 846,
  "fields": {
    "snp_id": "SNP853",
    "rs_id": "rs17655",
    "gene": "DISGENE279",
    "drug": "",
    "disease": "DIS60",
    "allele": "",
    "association_with": "Bladder Neoplasm",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17655",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 847,
  "fields": {
    "snp_id": "SNP854",
    "rs_id": "rs17655",
    "gene": "DISGENE278",
    "drug": "",
    "disease": "DIS74",
    "allele": "",
    "association_with": "Carcinoma Of Bladder",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17655",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 848,
  "fields": {
    "snp_id": "SNP855",
    "rs_id": "rs17655",
    "gene": "DISGENE279",
    "drug": "",
    "disease": "DIS74",
    "allele": "",
    "association_with": "Carcinoma Of Bladder",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17655",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 849,
  "fields": {
    "snp_id": "SNP856",
    "rs_id": "rs17655",
    "gene": "DISGENE278",
    "drug": "",
    "disease": "DIS331",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Urinary Bladder",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17655",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 850,
  "fields": {
    "snp_id": "SNP857",
    "rs_id": "rs17655",
    "gene": "DISGENE279",
    "drug": "",
    "disease": "DIS331",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Urinary Bladder",
    "reference": "REF469",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17655",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 851,
  "fields": {
    "snp_id": "SNP858",
    "rs_id": "rs17655",
    "gene": "DISGENE278",
    "drug": "",
    "disease": "DIS308",
    "allele": "",
    "association_with": "Leukemia",
    "reference": "REF166",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17655",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 852,
  "fields": {
    "snp_id": "SNP859",
    "rs_id": "rs17655",
    "gene": "DISGENE279",
    "drug": "",
    "disease": "DIS308",
    "allele": "",
    "association_with": "Leukemia",
    "reference": "REF166",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs17655",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 853,
  "fields": {
    "snp_id": "SNP860",
    "rs_id": "rs17728971",
    "gene": "DISGENE280",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs17728971",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 854,
  "fields": {
    "snp_id": "SNP861",
    "rs_id": "rs179363877",
    "gene": "DISGENE180",
    "drug": "",
    "disease": "DIS43",
    "allele": "",
    "association_with": "Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant",
    "reference": "REF276",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs179363877",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 855,
  "fields": {
    "snp_id": "SNP862",
    "rs_id": "rs179363877",
    "gene": "DISGENE180",
    "drug": "",
    "disease": "DIS443",
    "allele": "",
    "association_with": "Polyglandular Deficiency Syndrome, Persian-Jewish Type",
    "reference": "REF276",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs179363877",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 856,
  "fields": {
    "snp_id": "SNP863",
    "rs_id": "rs179363877",
    "gene": "DISGENE180",
    "drug": "",
    "disease": "DIS444",
    "allele": "",
    "association_with": "Polyglandular Type I Autoimmune Syndrome",
    "reference": "REF276",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs179363877",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 857,
  "fields": {
    "snp_id": "SNP864",
    "rs_id": "rs179363880",
    "gene": "DISGENE180",
    "drug": "",
    "disease": "DIS43",
    "allele": "",
    "association_with": "Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant",
    "reference": "REF276",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs179363880",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 858,
  "fields": {
    "snp_id": "SNP865",
    "rs_id": "rs179363880",
    "gene": "DISGENE180",
    "drug": "",
    "disease": "DIS443",
    "allele": "",
    "association_with": "Polyglandular Deficiency Syndrome, Persian-Jewish Type",
    "reference": "REF276",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs179363880",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 859,
  "fields": {
    "snp_id": "SNP866",
    "rs_id": "rs179363880",
    "gene": "DISGENE180",
    "drug": "",
    "disease": "DIS444",
    "allele": "",
    "association_with": "Polyglandular Type I Autoimmune Syndrome",
    "reference": "REF276",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs179363880",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 860,
  "fields": {
    "snp_id": "SNP867",
    "rs_id": "rs1799864",
    "gene": "DISGENE281",
    "drug": "",
    "disease": "DIS5",
    "allele": "",
    "association_with": "Acquired Immunodeficiency Syndrome",
    "reference": "REF656",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs1799864",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 861,
  "fields": {
    "snp_id": "SNP868",
    "rs_id": "rs1799945",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS241",
    "allele": "",
    "association_with": "Hereditary Hemochromatosis",
    "reference": "REF516",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs1799945",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 862,
  "fields": {
    "snp_id": "SNP869",
    "rs_id": "rs1799945",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF516",
    "p_value": "0.00000065",
    "source": "DisGeNET",
    "id_in_source": "rs1799945",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 863,
  "fields": {
    "snp_id": "SNP870",
    "rs_id": "rs1799983",
    "gene": "DISGENE282",
    "drug": "",
    "disease": "DIS372",
    "allele": "",
    "association_with": "Myocardial Infarction",
    "reference": "REF208",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1799983",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 864,
  "fields": {
    "snp_id": "SNP871",
    "rs_id": "rs1799990",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF170",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1799990",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 865,
  "fields": {
    "snp_id": "SNP872",
    "rs_id": "rs1799990",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS199",
    "allele": "",
    "association_with": "Fatal Familial Insomnia",
    "reference": "REF170",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1799990",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 866,
  "fields": {
    "snp_id": "SNP873",
    "rs_id": "rs1800014",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF170",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800014",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 867,
  "fields": {
    "snp_id": "SNP874",
    "rs_id": "rs1800014",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS199",
    "allele": "",
    "association_with": "Fatal Familial Insomnia",
    "reference": "REF170",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800014",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 868,
  "fields": {
    "snp_id": "SNP875",
    "rs_id": "rs1800450",
    "gene": "DISGENE283",
    "drug": "",
    "disease": "DIS335",
    "allele": "",
    "association_with": "Mannose-Binding Protein Deficiency",
    "reference": "REF192",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800450",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "The Gambia, China, UK",
    "latitude": "35.8617000",
    "longitude": "104.1954000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 869,
  "fields": {
    "snp_id": "SNP876",
    "rs_id": "rs1800553",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS15",
    "allele": "",
    "association_with": "Age Related Macular Degeneration",
    "reference": "REF274",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800553",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Somalia, Australia, Switzerland, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 870,
  "fields": {
    "snp_id": "SNP877",
    "rs_id": "rs1800555",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS15",
    "allele": "",
    "association_with": "Age Related Macular Degeneration",
    "reference": "REF274",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800555",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Somalia, Australia, Switzerland, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 871,
  "fields": {
    "snp_id": "SNP878",
    "rs_id": "rs1800562",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS241",
    "allele": "",
    "association_with": "Hereditary Hemochromatosis",
    "reference": "REF516",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800562",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 872,
  "fields": {
    "snp_id": "SNP879",
    "rs_id": "rs1800562",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS231",
    "allele": "",
    "association_with": "Hemochromatosis, Type 1",
    "reference": "REF270",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800562",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Somalia, Australia, Switzerland, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 873,
  "fields": {
    "snp_id": "SNP880",
    "rs_id": "rs1800562",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS288",
    "allele": "",
    "association_with": "Iron Overload",
    "reference": "REF383",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800562",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "South Africa, Swaziland, Zimbabwe, UK, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 874,
  "fields": {
    "snp_id": "SNP881",
    "rs_id": "rs1800728",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS118",
    "allele": "",
    "association_with": "Cone-Rod Dystrophy 3 (Disorder)",
    "reference": "REF602",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800728",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 875,
  "fields": {
    "snp_id": "SNP882",
    "rs_id": "rs1800728",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF602",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800728",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 876,
  "fields": {
    "snp_id": "SNP883",
    "rs_id": "rs1800728",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS118",
    "allele": "",
    "association_with": "Cone-Rod Dystrophy 3 (Disorder)",
    "reference": "REF279",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800728",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 877,
  "fields": {
    "snp_id": "SNP884",
    "rs_id": "rs1800728",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF279",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1800728",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 878,
  "fields": {
    "snp_id": "SNP885",
    "rs_id": "rs1800871",
    "gene": "DISGENE285",
    "drug": "",
    "disease": "DIS91",
    "allele": "",
    "association_with": "Cervical Cancer",
    "reference": "REF778",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1800871",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 879,
  "fields": {
    "snp_id": "SNP886",
    "rs_id": "rs1800871",
    "gene": "DISGENE286",
    "drug": "",
    "disease": "DIS91",
    "allele": "",
    "association_with": "Cervical Cancer",
    "reference": "REF778",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1800871",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 880,
  "fields": {
    "snp_id": "SNP887",
    "rs_id": "rs1800871",
    "gene": "DISGENE285",
    "drug": "",
    "disease": "DIS92",
    "allele": "",
    "association_with": "Cervix Carcinoma",
    "reference": "REF778",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1800871",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 881,
  "fields": {
    "snp_id": "SNP888",
    "rs_id": "rs1800871",
    "gene": "DISGENE286",
    "drug": "",
    "disease": "DIS92",
    "allele": "",
    "association_with": "Cervix Carcinoma",
    "reference": "REF778",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1800871",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 882,
  "fields": {
    "snp_id": "SNP889",
    "rs_id": "rs1800871",
    "gene": "DISGENE285",
    "drug": "",
    "disease": "DIS333",
    "allele": "",
    "association_with": "Malignant Tumor Of Cervix",
    "reference": "REF778",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1800871",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 883,
  "fields": {
    "snp_id": "SNP890",
    "rs_id": "rs1800871",
    "gene": "DISGENE286",
    "drug": "",
    "disease": "DIS333",
    "allele": "",
    "association_with": "Malignant Tumor Of Cervix",
    "reference": "REF778",
    "p_value": "0.028",
    "source": "DisGeNET",
    "id_in_source": "rs1800871",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 884,
  "fields": {
    "snp_id": "SNP891",
    "rs_id": "rs1800872",
    "gene": "DISGENE285",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF558",
    "p_value": "< 0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs1800872",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 885,
  "fields": {
    "snp_id": "SNP892",
    "rs_id": "rs1800872",
    "gene": "DISGENE286",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF558",
    "p_value": "< 0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs1800872",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 886,
  "fields": {
    "snp_id": "SNP893",
    "rs_id": "rs1800872",
    "gene": "DISGENE285",
    "drug": "",
    "disease": "DIS91",
    "allele": "",
    "association_with": "Cervical Cancer",
    "reference": "REF778",
    "p_value": "0.037",
    "source": "DisGeNET",
    "id_in_source": "rs1800872",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 887,
  "fields": {
    "snp_id": "SNP894",
    "rs_id": "rs1800872",
    "gene": "DISGENE286",
    "drug": "",
    "disease": "DIS91",
    "allele": "",
    "association_with": "Cervical Cancer",
    "reference": "REF778",
    "p_value": "0.037",
    "source": "DisGeNET",
    "id_in_source": "rs1800872",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 888,
  "fields": {
    "snp_id": "SNP895",
    "rs_id": "rs1800872",
    "gene": "DISGENE285",
    "drug": "",
    "disease": "DIS92",
    "allele": "",
    "association_with": "Cervix Carcinoma",
    "reference": "REF778",
    "p_value": "0.037",
    "source": "DisGeNET",
    "id_in_source": "rs1800872",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 889,
  "fields": {
    "snp_id": "SNP896",
    "rs_id": "rs1800872",
    "gene": "DISGENE286",
    "drug": "",
    "disease": "DIS92",
    "allele": "",
    "association_with": "Cervix Carcinoma",
    "reference": "REF778",
    "p_value": "0.037",
    "source": "DisGeNET",
    "id_in_source": "rs1800872",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 890,
  "fields": {
    "snp_id": "SNP897",
    "rs_id": "rs1800872",
    "gene": "DISGENE285",
    "drug": "",
    "disease": "DIS333",
    "allele": "",
    "association_with": "Malignant Tumor Of Cervix",
    "reference": "REF778",
    "p_value": "0.037",
    "source": "DisGeNET",
    "id_in_source": "rs1800872",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 891,
  "fields": {
    "snp_id": "SNP898",
    "rs_id": "rs1800872",
    "gene": "DISGENE286",
    "drug": "",
    "disease": "DIS333",
    "allele": "",
    "association_with": "Malignant Tumor Of Cervix",
    "reference": "REF778",
    "p_value": "0.037",
    "source": "DisGeNET",
    "id_in_source": "rs1800872",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 892,
  "fields": {
    "snp_id": "SNP899",
    "rs_id": "rs1801002",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF752",
    "p_value": "0.037",
    "source": "DisGeNET",
    "id_in_source": "rs1801002",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 893,
  "fields": {
    "snp_id": "SNP900",
    "rs_id": "rs1801133",
    "gene": "PHARGENE58",
    "drug": "",
    "disease": "DIS480",
    "allele": "",
    "association_with": "Rheumatoid Arthritis",
    "reference": "REF398",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs1801133",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 894,
  "fields": {
    "snp_id": "SNP901",
    "rs_id": "rs1801175",
    "gene": "DISGENE287",
    "drug": "",
    "disease": "DIS221",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type I",
    "reference": "REF346",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs1801175",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 895,
  "fields": {
    "snp_id": "SNP902",
    "rs_id": "rs1801275",
    "gene": "DISGENE288",
    "drug": "",
    "disease": "DIS480",
    "allele": "",
    "association_with": "Rheumatoid Arthritis",
    "reference": "REF403",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs1801275",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 896,
  "fields": {
    "snp_id": "SNP903",
    "rs_id": "rs1801282",
    "gene": "DISGENE289",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF428",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs1801282",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Benin, Ethiopia, Ecuador, Italy",
    "latitude": "9.3077000",
    "longitude": "2.3158000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 897,
  "fields": {
    "snp_id": "SNP904",
    "rs_id": "rs1801282",
    "gene": "DISGENE289",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF409",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1801282",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 898,
  "fields": {
    "snp_id": "SNP905",
    "rs_id": "rs1801282",
    "gene": "DISGENE289",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF771",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs1801282",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 899,
  "fields": {
    "snp_id": "SNP906",
    "rs_id": "rs1801282",
    "gene": "DISGENE289",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF222",
    "p_value": "0.215",
    "source": "DisGeNET",
    "id_in_source": "rs1801282",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 900,
  "fields": {
    "snp_id": "SNP907",
    "rs_id": "rs1801282",
    "gene": "DISGENE289",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF713",
    "p_value": "0.215",
    "source": "DisGeNET",
    "id_in_source": "rs1801282",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 901,
  "fields": {
    "snp_id": "SNP908",
    "rs_id": "rs180177097",
    "gene": "DISGENE290",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF361",
    "p_value": "0.215",
    "source": "DisGeNET",
    "id_in_source": "rs180177097",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Nigeria, Italy, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 902,
  "fields": {
    "snp_id": "SNP909",
    "rs_id": "rs180177239",
    "gene": "DISGENE195",
    "drug": "",
    "disease": "DIS455",
    "allele": "",
    "association_with": "Primary Hyperoxaluria, Type I",
    "reference": "REF249",
    "p_value": "0.215",
    "source": "DisGeNET",
    "id_in_source": "rs180177239",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 903,
  "fields": {
    "snp_id": "SNP910",
    "rs_id": "rs180177430",
    "gene": "DISGENE189",
    "drug": "",
    "disease": "DIS360",
    "allele": "",
    "association_with": "Muckle-Wells Syndrome",
    "reference": "REF611",
    "p_value": "0.215",
    "source": "DisGeNET",
    "id_in_source": "rs180177430",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 904,
  "fields": {
    "snp_id": "SNP911",
    "rs_id": "rs180177478",
    "gene": "DISGENE189",
    "drug": "",
    "disease": "DIS190",
    "allele": "",
    "association_with": "Familial Cold Urticaria",
    "reference": "REF585",
    "p_value": "0.215",
    "source": "DisGeNET",
    "id_in_source": "rs180177478",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Ethiopia, Israel",
    "latitude": "9.1450000",
    "longitude": "40.4897000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 905,
  "fields": {
    "snp_id": "SNP912",
    "rs_id": "rs1805096",
    "gene": "DISGENE291",
    "drug": "",
    "disease": "DIS396",
    "allele": "",
    "association_with": "Obesity",
    "reference": "REF617",
    "p_value": "0.215",
    "source": "DisGeNET",
    "id_in_source": "rs1805096",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 906,
  "fields": {
    "snp_id": "SNP913",
    "rs_id": "rs1805096",
    "gene": "DISGENE291",
    "drug": "",
    "disease": "DIS128",
    "allele": "",
    "association_with": "C-Reactive Protein Measurement",
    "reference": "REF702",
    "p_value": "0.0000000022",
    "source": "DisGeNET",
    "id_in_source": "rs1805096",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 907,
  "fields": {
    "snp_id": "SNP914",
    "rs_id": "rs1805192",
    "gene": "DISGENE289",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF428",
    "p_value": "0.0000000022",
    "source": "DisGeNET",
    "id_in_source": "rs1805192",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Benin, Ethiopia, Ecuador, Italy",
    "latitude": "9.3077000",
    "longitude": "2.3158000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 908,
  "fields": {
    "snp_id": "SNP915",
    "rs_id": "rs1805192",
    "gene": "DISGENE289",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF771",
    "p_value": "0.0000000022",
    "source": "DisGeNET",
    "id_in_source": "rs1805192",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 909,
  "fields": {
    "snp_id": "SNP916",
    "rs_id": "rs181396238",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF763",
    "p_value": "0.0000000022",
    "source": "DisGeNET",
    "id_in_source": "rs181396238",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 910,
  "fields": {
    "snp_id": "SNP917",
    "rs_id": "rs183258549",
    "gene": "DISGENE293",
    "drug": "",
    "disease": "DIS152",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 84A",
    "reference": "REF385",
    "p_value": "0.0000000022",
    "source": "DisGeNET",
    "id_in_source": "rs183258549",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Netherlands",
    "latitude": "52.1326000",
    "longitude": "5.2913000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 911,
  "fields": {
    "snp_id": "SNP918",
    "rs_id": "rs186873296",
    "gene": "DISGENE294",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF168",
    "p_value": "0.0000000022",
    "source": "DisGeNET",
    "id_in_source": "rs186873296",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Burkina Faso, Cameroon, The Gambia, Kenya, Malawi, Mali, Tanzania",
    "latitude": "12.2383000",
    "longitude": "-1.5616000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 912,
  "fields": {
    "snp_id": "SNP919",
    "rs_id": "rs1878468",
    "gene": "DISGENE295",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs1878468",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 913,
  "fields": {
    "snp_id": "SNP920",
    "rs_id": "rs188286943",
    "gene": "DISGENE296",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF296",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs188286943",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 914,
  "fields": {
    "snp_id": "SNP921",
    "rs_id": "rs189159450",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS10",
    "allele": "",
    "association_with": "Acute Intermittent Porphyria",
    "reference": "REF322",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs189159450",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Scotland",
    "latitude": "56.4907000",
    "longitude": "4.2026000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 915,
  "fields": {
    "snp_id": "SNP922",
    "rs_id": "rs189159450",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS101",
    "allele": "",
    "association_with": "Chester-Type Porphyria",
    "reference": "REF322",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs189159450",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Scotland",
    "latitude": "56.4907000",
    "longitude": "4.2026000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 916,
  "fields": {
    "snp_id": "SNP923",
    "rs_id": "rs189159450",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS254",
    "allele": "",
    "association_with": "Hydroxymethylbilane Synthase Deficiency",
    "reference": "REF322",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs189159450",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Scotland",
    "latitude": "56.4907000",
    "longitude": "4.2026000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 917,
  "fields": {
    "snp_id": "SNP924",
    "rs_id": "rs189159450",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS450",
    "allele": "",
    "association_with": "Porphyria, Acute Intermittent, Nonerythroid Variant",
    "reference": "REF322",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs189159450",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Scotland",
    "latitude": "56.4907000",
    "longitude": "4.2026000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 918,
  "fields": {
    "snp_id": "SNP925",
    "rs_id": "rs1917445",
    "gene": "DISGENE297",
    "drug": "",
    "disease": "DIS386",
    "allele": "",
    "association_with": "Neutrophil Count (Procedure)",
    "reference": "REF498",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs1917445",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 919,
  "fields": {
    "snp_id": "SNP926",
    "rs_id": "rs193922107",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF571",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs193922107",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 920,
  "fields": {
    "snp_id": "SNP927",
    "rs_id": "rs193922109",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF571",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs193922109",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 921,
  "fields": {
    "snp_id": "SNP928",
    "rs_id": "rs193922109",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs193922109",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 922,
  "fields": {
    "snp_id": "SNP929",
    "rs_id": "rs193922674",
    "gene": "DISGENE298",
    "drug": "",
    "disease": "DIS32",
    "allele": "",
    "association_with": "Arrhythmogenic Right Ventricular Dysplasia",
    "reference": "REF686",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs193922674",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 923,
  "fields": {
    "snp_id": "SNP930",
    "rs_id": "rs193922837",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF480",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs193922837",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 924,
  "fields": {
    "snp_id": "SNP931",
    "rs_id": "rs199422114",
    "gene": "DISGENE299",
    "drug": "",
    "disease": "DIS213",
    "allele": "",
    "association_with": "Ghosal Hematodiaphyseal Syndrome",
    "reference": "REF374",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199422114",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Tunisia, France",
    "latitude": "46.2276000",
    "longitude": "2.2137000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 925,
  "fields": {
    "snp_id": "SNP932",
    "rs_id": "rs199422216",
    "gene": "DISGENE300",
    "drug": "",
    "disease": "DIS272",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "reference": "REF506",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199422216",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 926,
  "fields": {
    "snp_id": "SNP933",
    "rs_id": "rs199422216",
    "gene": "DISGENE301",
    "drug": "",
    "disease": "DIS272",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "reference": "REF506",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199422216",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 927,
  "fields": {
    "snp_id": "SNP934",
    "rs_id": "rs199422217",
    "gene": "DISGENE300",
    "drug": "",
    "disease": "DIS271",
    "allele": "",
    "association_with": "Ichthyosiform Erythroderma, Congenital",
    "reference": "REF506",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199422217",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 928,
  "fields": {
    "snp_id": "SNP935",
    "rs_id": "rs199422217",
    "gene": "DISGENE301",
    "drug": "",
    "disease": "DIS271",
    "allele": "",
    "association_with": "Ichthyosiform Erythroderma, Congenital",
    "reference": "REF506",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199422217",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 929,
  "fields": {
    "snp_id": "SNP936",
    "rs_id": "rs199422217",
    "gene": "DISGENE300",
    "drug": "",
    "disease": "DIS272",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "reference": "REF506",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199422217",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 930,
  "fields": {
    "snp_id": "SNP937",
    "rs_id": "rs199422217",
    "gene": "DISGENE301",
    "drug": "",
    "disease": "DIS272",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "reference": "REF506",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199422217",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 931,
  "fields": {
    "snp_id": "SNP938",
    "rs_id": "rs199475575",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF727",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199475575",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 932,
  "fields": {
    "snp_id": "SNP939",
    "rs_id": "rs199475579",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF381",
    "p_value": "0.00000081",
    "source": "DisGeNET",
    "id_in_source": "rs199475579",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 933,
  "fields": {
    "snp_id": "SNP940",
    "rs_id": "rs199476104",
    "gene": "DISGENE303",
    "drug": "",
    "disease": "DIS400",
    "allele": "",
    "association_with": "Optic Atrophy, Hereditary, Leber",
    "reference": "REF592",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs199476104",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy",
    "latitude": "41.8719000",
    "longitude": "12.5674000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 934,
  "fields": {
    "snp_id": "SNP941",
    "rs_id": "rs199476134",
    "gene": "DISGENE304",
    "drug": "",
    "disease": "DIS400",
    "allele": "",
    "association_with": "Optic Atrophy, Hereditary, Leber",
    "reference": "REF732",
    "p_value": "< 0.01 - 1.0",
    "source": "DisGeNET",
    "id_in_source": "rs199476134",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 935,
  "fields": {
    "snp_id": "SNP942",
    "rs_id": "rs200024180",
    "gene": "DISGENE305",
    "drug": "",
    "disease": "DIS182",
    "allele": "",
    "association_with": "Epilepsy, Progressive Myoclonic, 8",
    "reference": "REF406",
    "p_value": "< 0.01 - 1.0",
    "source": "DisGeNET",
    "id_in_source": "rs200024180",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 936,
  "fields": {
    "snp_id": "SNP943",
    "rs_id": "rs200024180",
    "gene": "DISGENE306",
    "drug": "",
    "disease": "DIS182",
    "allele": "",
    "association_with": "Epilepsy, Progressive Myoclonic, 8",
    "reference": "REF406",
    "p_value": "< 0.01 - 1.0",
    "source": "DisGeNET",
    "id_in_source": "rs200024180",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 937,
  "fields": {
    "snp_id": "SNP944",
    "rs_id": "rs2004640",
    "gene": "DISGENE307",
    "drug": "",
    "disease": "DIS480",
    "allele": "",
    "association_with": "Rheumatoid Arthritis",
    "reference": "REF205",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2004640",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 938,
  "fields": {
    "snp_id": "SNP945",
    "rs_id": "rs200652879",
    "gene": "DISGENE308",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF458",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs200652879",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 939,
  "fields": {
    "snp_id": "SNP946",
    "rs_id": "rs200659479",
    "gene": "DISGENE309",
    "drug": "",
    "disease": "DIS176",
    "allele": "",
    "association_with": "Encephalopathy Adverse Event",
    "reference": "REF240",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs200659479",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 940,
  "fields": {
    "snp_id": "SNP947",
    "rs_id": "rs200659479",
    "gene": "DISGENE309",
    "drug": "",
    "disease": "DIS267",
    "allele": "",
    "association_with": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2",
    "reference": "REF240",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs200659479",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 941,
  "fields": {
    "snp_id": "SNP948",
    "rs_id": "rs200678853",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs200678853",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 942,
  "fields": {
    "snp_id": "SNP949",
    "rs_id": "rs200731780",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS465",
    "allele": "",
    "association_with": "Psoriasis 2",
    "reference": "REF220",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs200731780",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 943,
  "fields": {
    "snp_id": "SNP950",
    "rs_id": "rs200790561",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS464",
    "allele": "",
    "association_with": "Psoriasis",
    "reference": "REF220",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs200790561",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 944,
  "fields": {
    "snp_id": "SNP951",
    "rs_id": "rs200790561",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS465",
    "allele": "",
    "association_with": "Psoriasis 2",
    "reference": "REF220",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs200790561",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 945,
  "fields": {
    "snp_id": "SNP952",
    "rs_id": "rs201124247",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF304",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201124247",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 946,
  "fields": {
    "snp_id": "SNP953",
    "rs_id": "rs201129618",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS275",
    "allele": "",
    "association_with": "Ichthyosis, Lamellar, 3",
    "reference": "REF465",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201129618",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 947,
  "fields": {
    "snp_id": "SNP954",
    "rs_id": "rs201129618",
    "gene": "DISGENE169",
    "drug": "",
    "disease": "DIS277",
    "allele": "",
    "association_with": "Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive",
    "reference": "REF465",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201129618",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 948,
  "fields": {
    "snp_id": "SNP955",
    "rs_id": "rs201285077",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS210",
    "allele": "",
    "association_with": "Generalized Pustular Psoriasis",
    "reference": "REF220",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201285077",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 949,
  "fields": {
    "snp_id": "SNP956",
    "rs_id": "rs201285077",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS465",
    "allele": "",
    "association_with": "Psoriasis 2",
    "reference": "REF220",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201285077",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 950,
  "fields": {
    "snp_id": "SNP957",
    "rs_id": "rs201285077",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS466",
    "allele": "",
    "association_with": "Psoriasis Vulgaris",
    "reference": "REF220",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201285077",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 951,
  "fields": {
    "snp_id": "SNP958",
    "rs_id": "rs201322234",
    "gene": "DISGENE310",
    "drug": "",
    "disease": "DIS370",
    "allele": "",
    "association_with": "Myasthenic Syndrome, Congenital, 12",
    "reference": "REF178",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201322234",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 952,
  "fields": {
    "snp_id": "SNP959",
    "rs_id": "rs201573863",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF303",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201573863",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 953,
  "fields": {
    "snp_id": "SNP960",
    "rs_id": "rs201573863",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS315",
    "allele": "",
    "association_with": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2",
    "reference": "REF303",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201573863",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 954,
  "fields": {
    "snp_id": "SNP961",
    "rs_id": "rs201636911",
    "gene": "DISGENE311",
    "drug": "",
    "disease": "DIS427",
    "allele": "",
    "association_with": "Pendred'S Syndrome",
    "reference": "REF175",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201636911",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 955,
  "fields": {
    "snp_id": "SNP962",
    "rs_id": "rs201636911",
    "gene": "DISGENE132",
    "drug": "",
    "disease": "DIS427",
    "allele": "",
    "association_with": "Pendred'S Syndrome",
    "reference": "REF175",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201636911",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 956,
  "fields": {
    "snp_id": "SNP963",
    "rs_id": "rs201928238",
    "gene": "DISGENE312",
    "drug": "",
    "disease": "DIS45",
    "allele": "",
    "association_with": "Avellino Corneal Dystrophy",
    "reference": "REF709",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs201928238",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 957,
  "fields": {
    "snp_id": "SNP964",
    "rs_id": "rs202033121",
    "gene": "DISGENE247",
    "drug": "",
    "disease": "DIS538",
    "allele": "",
    "association_with": "Usher Syndrome, Type If",
    "reference": "REF491",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs202033121",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 958,
  "fields": {
    "snp_id": "SNP965",
    "rs_id": "rs202179988",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS122",
    "allele": "",
    "association_with": "Congenital Bilateral Aplasia Of Vas Deferens",
    "reference": "REF547",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs202179988",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 959,
  "fields": {
    "snp_id": "SNP966",
    "rs_id": "rs202179988",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF547",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs202179988",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 960,
  "fields": {
    "snp_id": "SNP967",
    "rs_id": "rs20541",
    "gene": "DISGENE313",
    "drug": "",
    "disease": "DIS464",
    "allele": "",
    "association_with": "Psoriasis",
    "reference": "REF500",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs20541",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 961,
  "fields": {
    "snp_id": "SNP968",
    "rs_id": "rs20541",
    "gene": "DISGENE314",
    "drug": "",
    "disease": "DIS464",
    "allele": "",
    "association_with": "Psoriasis",
    "reference": "REF500",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs20541",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 962,
  "fields": {
    "snp_id": "SNP969",
    "rs_id": "rs2057178",
    "gene": "DISGENE131",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF272",
    "p_value": "0.000487",
    "source": "DisGeNET",
    "id_in_source": "rs2057178",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Ghana, Russia, Indonesia",
    "latitude": "-0.7893000",
    "longitude": "113.9213000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 963,
  "fields": {
    "snp_id": "SNP970",
    "rs_id": "rs2057178",
    "gene": "DISGENE131",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF272",
    "p_value": "0.00000000263",
    "source": "DisGeNET",
    "id_in_source": "rs2057178",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Ghana, Russia, Indonesia",
    "latitude": "-0.7893000",
    "longitude": "113.9213000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 964,
  "fields": {
    "snp_id": "SNP971",
    "rs_id": "rs2066714",
    "gene": "DISGENE315",
    "drug": "",
    "disease": "DIS396",
    "allele": "",
    "association_with": "Obesity",
    "reference": "REF717",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs2066714",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 965,
  "fields": {
    "snp_id": "SNP972",
    "rs_id": "rs2066714",
    "gene": "DISGENE315",
    "drug": "",
    "disease": "DIS407",
    "allele": "",
    "association_with": "Overweight",
    "reference": "REF717",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs2066714",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 966,
  "fields": {
    "snp_id": "SNP973",
    "rs_id": "rs2066844",
    "gene": "DISGENE276",
    "drug": "",
    "disease": "DIS134",
    "allele": "",
    "association_with": "Crohn Disease",
    "reference": "REF485",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs2066844",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 967,
  "fields": {
    "snp_id": "SNP974",
    "rs_id": "rs2066845",
    "gene": "DISGENE276",
    "drug": "",
    "disease": "DIS134",
    "allele": "",
    "association_with": "Crohn Disease",
    "reference": "REF707",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2066845",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 968,
  "fields": {
    "snp_id": "SNP975",
    "rs_id": "rs2070744",
    "gene": "DISGENE282",
    "drug": "",
    "disease": "DIS372",
    "allele": "",
    "association_with": "Myocardial Infarction",
    "reference": "REF208",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2070744",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 969,
  "fields": {
    "snp_id": "SNP976",
    "rs_id": "rs2104772",
    "gene": "DISGENE243",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "0.017",
    "source": "DisGeNET",
    "id_in_source": "rs2104772",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 970,
  "fields": {
    "snp_id": "SNP977",
    "rs_id": "rs2104772",
    "gene": "DISGENE244",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "0.017",
    "source": "DisGeNET",
    "id_in_source": "rs2104772",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 971,
  "fields": {
    "snp_id": "SNP978",
    "rs_id": "rs217086",
    "gene": "DISGENE98",
    "drug": "",
    "disease": "DIS415",
    "allele": "",
    "association_with": "Papillon-Lefevre Disease",
    "reference": "REF261",
    "p_value": "0.017",
    "source": "DisGeNET",
    "id_in_source": "rs217086",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 972,
  "fields": {
    "snp_id": "SNP979",
    "rs_id": "rs2185710",
    "gene": "DISGENE316",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.0000000595",
    "source": "DisGeNET",
    "id_in_source": "rs2185710",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 973,
  "fields": {
    "snp_id": "SNP982",
    "rs_id": "rs2228001",
    "gene": "DISGENE317",
    "drug": "",
    "disease": "DIS60",
    "allele": "",
    "association_with": "Bladder Neoplasm",
    "reference": "REF469",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs2228001",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 974,
  "fields": {
    "snp_id": "SNP983",
    "rs_id": "rs2228001",
    "gene": "DISGENE318",
    "drug": "",
    "disease": "DIS60",
    "allele": "",
    "association_with": "Bladder Neoplasm",
    "reference": "REF469",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs2228001",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 975,
  "fields": {
    "snp_id": "SNP984",
    "rs_id": "rs2228001",
    "gene": "DISGENE317",
    "drug": "",
    "disease": "DIS74",
    "allele": "",
    "association_with": "Carcinoma Of Bladder",
    "reference": "REF469",
    "p_value": "0.65",
    "source": "DisGeNET",
    "id_in_source": "rs2228001",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 976,
  "fields": {
    "snp_id": "SNP985",
    "rs_id": "rs2228001",
    "gene": "DISGENE318",
    "drug": "",
    "disease": "DIS74",
    "allele": "",
    "association_with": "Carcinoma Of Bladder",
    "reference": "REF469",
    "p_value": "0.65",
    "source": "DisGeNET",
    "id_in_source": "rs2228001",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 977,
  "fields": {
    "snp_id": "SNP986",
    "rs_id": "rs2228001",
    "gene": "DISGENE317",
    "drug": "",
    "disease": "DIS331",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Urinary Bladder",
    "reference": "REF469",
    "p_value": "0.06",
    "source": "DisGeNET",
    "id_in_source": "rs2228001",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 978,
  "fields": {
    "snp_id": "SNP987",
    "rs_id": "rs2228001",
    "gene": "DISGENE318",
    "drug": "",
    "disease": "DIS331",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Urinary Bladder",
    "reference": "REF469",
    "p_value": "0.06",
    "source": "DisGeNET",
    "id_in_source": "rs2228001",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 979,
  "fields": {
    "snp_id": "SNP988",
    "rs_id": "rs2228001",
    "gene": "DISGENE317",
    "drug": "",
    "disease": "DIS308",
    "allele": "",
    "association_with": "Leukemia",
    "reference": "REF166",
    "p_value": "0.0042",
    "source": "DisGeNET",
    "id_in_source": "rs2228001",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 980,
  "fields": {
    "snp_id": "SNP989",
    "rs_id": "rs2228001",
    "gene": "DISGENE318",
    "drug": "",
    "disease": "DIS308",
    "allele": "",
    "association_with": "Leukemia",
    "reference": "REF166",
    "p_value": "0.0042",
    "source": "DisGeNET",
    "id_in_source": "rs2228001",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 981,
  "fields": {
    "snp_id": "SNP990",
    "rs_id": "rs2229207",
    "gene": "DISGENE319",
    "drug": "",
    "disease": "DIS235",
    "allele": "",
    "association_with": "Hepatitis B Virus, Susceptibility To",
    "reference": "REF169",
    "p_value": "0.0003",
    "source": "DisGeNET",
    "id_in_source": "rs2229207",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 982,
  "fields": {
    "snp_id": "SNP991",
    "rs_id": "rs2230806",
    "gene": "DISGENE315",
    "drug": "",
    "disease": "DIS396",
    "allele": "",
    "association_with": "Obesity",
    "reference": "REF717",
    "p_value": "0.042",
    "source": "DisGeNET",
    "id_in_source": "rs2230806",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 983,
  "fields": {
    "snp_id": "SNP992",
    "rs_id": "rs2230806",
    "gene": "DISGENE315",
    "drug": "",
    "disease": "DIS407",
    "allele": "",
    "association_with": "Overweight",
    "reference": "REF717",
    "p_value": "0.042",
    "source": "DisGeNET",
    "id_in_source": "rs2230806",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 984,
  "fields": {
    "snp_id": "SNP993",
    "rs_id": "rs2231142",
    "gene": "PHARGENE4",
    "drug": "",
    "disease": "DIS102",
    "allele": "",
    "association_with": "Childhood Acute Lymphoblastic Leukemia",
    "reference": "REF443",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2231142",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 985,
  "fields": {
    "snp_id": "SNP996",
    "rs_id": "rs2237892",
    "gene": "DISGENE234",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF783",
    "p_value": "0.014",
    "source": "DisGeNET",
    "id_in_source": "rs2237892",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 986,
  "fields": {
    "snp_id": "SNP997",
    "rs_id": "rs2237892",
    "gene": "DISGENE320",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF783",
    "p_value": "0.014",
    "source": "DisGeNET",
    "id_in_source": "rs2237892",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 987,
  "fields": {
    "snp_id": "SNP998",
    "rs_id": "rs2237896",
    "gene": "DISGENE234",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF783",
    "p_value": "0.014",
    "source": "DisGeNET",
    "id_in_source": "rs2237896",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 988,
  "fields": {
    "snp_id": "SNP999",
    "rs_id": "rs2237896",
    "gene": "DISGENE320",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF783",
    "p_value": "0.014",
    "source": "DisGeNET",
    "id_in_source": "rs2237896",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 989,
  "fields": {
    "snp_id": "SNP1000",
    "rs_id": "rs2239785",
    "gene": "DISGENE321",
    "drug": "",
    "disease": "DIS203",
    "allele": "",
    "association_with": "Focal Glomerulosclerosis",
    "reference": "REF650",
    "p_value": "0.000000000000459",
    "source": "DisGeNET",
    "id_in_source": "rs2239785",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 990,
  "fields": {
    "snp_id": "SNP1001",
    "rs_id": "rs2241766",
    "gene": "DISGENE322",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF524",
    "p_value": "0.86",
    "source": "DisGeNET",
    "id_in_source": "rs2241766",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 991,
  "fields": {
    "snp_id": "SNP1002",
    "rs_id": "rs2241766",
    "gene": "DISGENE128",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF524",
    "p_value": "0.86",
    "source": "DisGeNET",
    "id_in_source": "rs2241766",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 992,
  "fields": {
    "snp_id": "SNP1003",
    "rs_id": "rs2241767",
    "gene": "DISGENE322",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF524",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs2241767",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 993,
  "fields": {
    "snp_id": "SNP1004",
    "rs_id": "rs2241767",
    "gene": "DISGENE128",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF524",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs2241767",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 994,
  "fields": {
    "snp_id": "SNP1005",
    "rs_id": "rs2259816",
    "gene": "DISGENE323",
    "drug": "",
    "disease": "DIS128",
    "allele": "",
    "association_with": "C-Reactive Protein Measurement",
    "reference": "REF702",
    "p_value": "0.0000000003",
    "source": "DisGeNET",
    "id_in_source": "rs2259816",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 995,
  "fields": {
    "snp_id": "SNP1006",
    "rs_id": "rs231775",
    "gene": "DISGENE324",
    "drug": "",
    "disease": "DIS236",
    "allele": "",
    "association_with": "Hepatitis C",
    "reference": "REF470",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs231775",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 996,
  "fields": {
    "snp_id": "SNP1007",
    "rs_id": "rs231775",
    "gene": "DISGENE324",
    "drug": "",
    "disease": "DIS321",
    "allele": "",
    "association_with": "Lymphoma, Non-Hodgkin",
    "reference": "REF470",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs231775",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 997,
  "fields": {
    "snp_id": "SNP1008",
    "rs_id": "rs2397084",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS175",
    "allele": "",
    "association_with": "Encephalitis, St. Louis",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2397084",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 998,
  "fields": {
    "snp_id": "SNP1009",
    "rs_id": "rs2397084",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS316",
    "allele": "",
    "association_with": "Lupus Erythematosus",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2397084",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 999,
  "fields": {
    "snp_id": "SNP1010",
    "rs_id": "rs2397084",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS317",
    "allele": "",
    "association_with": "Lupus Erythematosus, Discoid",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2397084",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1000,
  "fields": {
    "snp_id": "SNP1011",
    "rs_id": "rs2397084",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS318",
    "allele": "",
    "association_with": "Lupus Erythematosus, Systemic",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2397084",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1001,
  "fields": {
    "snp_id": "SNP1012",
    "rs_id": "rs2397084",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS319",
    "allele": "",
    "association_with": "Lupus Nephritis",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2397084",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1002,
  "fields": {
    "snp_id": "SNP1013",
    "rs_id": "rs2397084",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS320",
    "allele": "",
    "association_with": "Lupus Vulgaris",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2397084",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1003,
  "fields": {
    "snp_id": "SNP1014",
    "rs_id": "rs2397084",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS380",
    "allele": "",
    "association_with": "Nephritis",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2397084",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1004,
  "fields": {
    "snp_id": "SNP1015",
    "rs_id": "rs2401027",
    "gene": "DISGENE326",
    "drug": "",
    "disease": "DIS64",
    "allele": "",
    "association_with": "Body Mass Index",
    "reference": "REF206",
    "p_value": "0.000000148",
    "source": "DisGeNET",
    "id_in_source": "rs2401027",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Nigeria, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1005,
  "fields": {
    "snp_id": "SNP1016",
    "rs_id": "rs2476601",
    "gene": "DISGENE327",
    "drug": "",
    "disease": "DIS480",
    "allele": "",
    "association_with": "Rheumatoid Arthritis",
    "reference": "REF447",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1006,
  "fields": {
    "snp_id": "SNP1017",
    "rs_id": "rs2476601",
    "gene": "DISGENE328",
    "drug": "",
    "disease": "DIS480",
    "allele": "",
    "association_with": "Rheumatoid Arthritis",
    "reference": "REF447",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1007,
  "fields": {
    "snp_id": "SNP1018",
    "rs_id": "rs2476601",
    "gene": "DISGENE327",
    "drug": "",
    "disease": "DIS286",
    "allele": "",
    "association_with": "Inflammatory Bowel Diseases",
    "reference": "REF638",
    "p_value": "0.00001",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1008,
  "fields": {
    "snp_id": "SNP1019",
    "rs_id": "rs2476601",
    "gene": "DISGENE328",
    "drug": "",
    "disease": "DIS286",
    "allele": "",
    "association_with": "Inflammatory Bowel Diseases",
    "reference": "REF638",
    "p_value": "0.00001",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1009,
  "fields": {
    "snp_id": "SNP1020",
    "rs_id": "rs2476601",
    "gene": "DISGENE327",
    "drug": "",
    "disease": "DIS161",
    "allele": "",
    "association_with": "Diabetes",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1010,
  "fields": {
    "snp_id": "SNP1021",
    "rs_id": "rs2476601",
    "gene": "DISGENE328",
    "drug": "",
    "disease": "DIS161",
    "allele": "",
    "association_with": "Diabetes",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1011,
  "fields": {
    "snp_id": "SNP1022",
    "rs_id": "rs2476601",
    "gene": "DISGENE327",
    "drug": "",
    "disease": "DIS162",
    "allele": "",
    "association_with": "Diabetes Mellitus",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1012,
  "fields": {
    "snp_id": "SNP1023",
    "rs_id": "rs2476601",
    "gene": "DISGENE328",
    "drug": "",
    "disease": "DIS162",
    "allele": "",
    "association_with": "Diabetes Mellitus",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1013,
  "fields": {
    "snp_id": "SNP1024",
    "rs_id": "rs2476601",
    "gene": "DISGENE327",
    "drug": "",
    "disease": "DIS163",
    "allele": "",
    "association_with": "Diabetes Mellitus, Insulin-Dependent",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1014,
  "fields": {
    "snp_id": "SNP1025",
    "rs_id": "rs2476601",
    "gene": "DISGENE328",
    "drug": "",
    "disease": "DIS163",
    "allele": "",
    "association_with": "Diabetes Mellitus, Insulin-Dependent",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2476601",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1015,
  "fields": {
    "snp_id": "SNP1026",
    "rs_id": "rs2543007",
    "gene": "DISGENE329",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF272",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2543007",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Ghana, Russia, Indonesia",
    "latitude": "-0.7893000",
    "longitude": "113.9213000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1016,
  "fields": {
    "snp_id": "SNP1027",
    "rs_id": "rs2543007",
    "gene": "DISGENE330",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF272",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2543007",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Ghana, Russia, Indonesia",
    "latitude": "-0.7893000",
    "longitude": "113.9213000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1017,
  "fields": {
    "snp_id": "SNP1028",
    "rs_id": "rs267606640",
    "gene": "DISGENE331",
    "drug": "",
    "disease": "DIS223",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type Iii",
    "reference": "REF774",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606640",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, India, Italy",
    "latitude": "20.5937000",
    "longitude": "78.9629000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1018,
  "fields": {
    "snp_id": "SNP1029",
    "rs_id": "rs267606640",
    "gene": "DISGENE331",
    "drug": "",
    "disease": "DIS223",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type Iii",
    "reference": "REF643",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606640",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1019,
  "fields": {
    "snp_id": "SNP1030",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS357",
    "allele": "",
    "association_with": "Mitochondrial Complex I Deficiency",
    "reference": "REF505",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1020,
  "fields": {
    "snp_id": "SNP1031",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS302",
    "allele": "",
    "association_with": "Leigh Disease",
    "reference": "REF561",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1021,
  "fields": {
    "snp_id": "SNP1032",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS303",
    "allele": "",
    "association_with": "Leigh Syndrome Due To Mitochondrial Complex I Deficiency",
    "reference": "REF561",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1022,
  "fields": {
    "snp_id": "SNP1033",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS304",
    "allele": "",
    "association_with": "Leigh Syndrome Due To Mitochondrial Complex Ii Deficiency",
    "reference": "REF561",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1023,
  "fields": {
    "snp_id": "SNP1034",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS305",
    "allele": "",
    "association_with": "Leigh Syndrome Due To Mitochondrial Complex Iii Deficiency",
    "reference": "REF561",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1024,
  "fields": {
    "snp_id": "SNP1035",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS306",
    "allele": "",
    "association_with": "Leigh Syndrome Due To Mitochondrial Complex Iv Deficiency",
    "reference": "REF561",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1025,
  "fields": {
    "snp_id": "SNP1036",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS307",
    "allele": "",
    "association_with": "Leigh Syndrome Due To Mitochondrial Complex V Deficiency",
    "reference": "REF561",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1026,
  "fields": {
    "snp_id": "SNP1037",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS357",
    "allele": "",
    "association_with": "Mitochondrial Complex I Deficiency",
    "reference": "REF561",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1027,
  "fields": {
    "snp_id": "SNP1038",
    "rs_id": "rs267606689",
    "gene": "DISGENE171",
    "drug": "",
    "disease": "DIS376",
    "allele": "",
    "association_with": "Necrotizing Encephalopathy, Infantile Subacute, Of Leigh",
    "reference": "REF561",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606689",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1028,
  "fields": {
    "snp_id": "SNP1039",
    "rs_id": "rs267606776",
    "gene": "DISGENE332",
    "drug": "",
    "disease": "DIS269",
    "allele": "",
    "association_with": "Hypotrichosis 6",
    "reference": "REF812",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606776",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran, Iraq",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1029,
  "fields": {
    "snp_id": "SNP1040",
    "rs_id": "rs267606776",
    "gene": "DISGENE333",
    "drug": "",
    "disease": "DIS269",
    "allele": "",
    "association_with": "Hypotrichosis 6",
    "reference": "REF812",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606776",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran, Iraq",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1030,
  "fields": {
    "snp_id": "SNP1041",
    "rs_id": "rs267606777",
    "gene": "DISGENE332",
    "drug": "",
    "disease": "DIS269",
    "allele": "",
    "association_with": "Hypotrichosis 6",
    "reference": "REF812",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606777",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran, Iraq",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1031,
  "fields": {
    "snp_id": "SNP1042",
    "rs_id": "rs267606777",
    "gene": "DISGENE333",
    "drug": "",
    "disease": "DIS269",
    "allele": "",
    "association_with": "Hypotrichosis 6",
    "reference": "REF812",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606777",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran, Iraq",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1032,
  "fields": {
    "snp_id": "SNP1043",
    "rs_id": "rs267606990",
    "gene": "DISGENE334",
    "drug": "",
    "disease": "DIS395",
    "allele": "",
    "association_with": "Noonan Syndrome",
    "reference": "REF662",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606990",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1033,
  "fields": {
    "snp_id": "SNP1044",
    "rs_id": "rs267606991",
    "gene": "DISGENE335",
    "drug": "",
    "disease": "DIS173",
    "allele": "",
    "association_with": "Ectodermal Dysplasia-Syndactyly Syndrome 1",
    "reference": "REF523",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606991",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1034,
  "fields": {
    "snp_id": "SNP1045",
    "rs_id": "rs267606992",
    "gene": "DISGENE335",
    "drug": "",
    "disease": "DIS173",
    "allele": "",
    "association_with": "Ectodermal Dysplasia-Syndactyly Syndrome 1",
    "reference": "REF523",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267606992",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1035,
  "fields": {
    "snp_id": "SNP1046",
    "rs_id": "rs267607035",
    "gene": "DISGENE336",
    "drug": "",
    "disease": "DIS448",
    "allele": "",
    "association_with": "Pontocerebellar Hypoplasia, Type 2D",
    "reference": "REF317",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267607035",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iraq",
    "latitude": "33.2232000",
    "longitude": "43.6793000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1036,
  "fields": {
    "snp_id": "SNP1047",
    "rs_id": "rs267607036",
    "gene": "DISGENE336",
    "drug": "",
    "disease": "DIS448",
    "allele": "",
    "association_with": "Pontocerebellar Hypoplasia, Type 2D",
    "reference": "REF317",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267607036",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iraq",
    "latitude": "33.2232000",
    "longitude": "43.6793000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1037,
  "fields": {
    "snp_id": "SNP1048",
    "rs_id": "rs267607137",
    "gene": "DISGENE337",
    "drug": "",
    "disease": "DIS345",
    "allele": "",
    "association_with": "Mental Retardation, Autosomal Recessive 13",
    "reference": "REF802",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267607137",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1038,
  "fields": {
    "snp_id": "SNP1049",
    "rs_id": "rs267607142",
    "gene": "DISGENE338",
    "drug": "",
    "disease": "DIS459",
    "allele": "",
    "association_with": "Progressive Familial Heart Block, Type Ib",
    "reference": "REF796",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267607142",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1039,
  "fields": {
    "snp_id": "SNP1050",
    "rs_id": "rs267607199",
    "gene": "DISGENE308",
    "drug": "",
    "disease": "DIS181",
    "allele": "",
    "association_with": "Epilepsy, Progressive Myoclonic 3",
    "reference": "REF458",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267607199",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1040,
  "fields": {
    "snp_id": "SNP1051",
    "rs_id": "rs267608247",
    "gene": "DISGENE339",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF434",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267608247",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1041,
  "fields": {
    "snp_id": "SNP1052",
    "rs_id": "rs267608259",
    "gene": "DISGENE340",
    "drug": "",
    "disease": "DIS292",
    "allele": "",
    "association_with": "Job Syndrome",
    "reference": "REF640",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267608259",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1042,
  "fields": {
    "snp_id": "SNP1053",
    "rs_id": "rs267608260",
    "gene": "DISGENE340",
    "drug": "",
    "disease": "DIS281",
    "allele": "",
    "association_with": "Immunodeficiency 23",
    "reference": "REF640",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267608260",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1043,
  "fields": {
    "snp_id": "SNP1054",
    "rs_id": "rs267608260",
    "gene": "DISGENE340",
    "drug": "",
    "disease": "DIS292",
    "allele": "",
    "association_with": "Job Syndrome",
    "reference": "REF640",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267608260",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1044,
  "fields": {
    "snp_id": "SNP1055",
    "rs_id": "rs267608261",
    "gene": "DISGENE340",
    "drug": "",
    "disease": "DIS281",
    "allele": "",
    "association_with": "Immunodeficiency 23",
    "reference": "REF640",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267608261",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1045,
  "fields": {
    "snp_id": "SNP1056",
    "rs_id": "rs267608261",
    "gene": "DISGENE341",
    "drug": "",
    "disease": "DIS281",
    "allele": "",
    "association_with": "Immunodeficiency 23",
    "reference": "REF640",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267608261",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1046,
  "fields": {
    "snp_id": "SNP1057",
    "rs_id": "rs267608261",
    "gene": "DISGENE340",
    "drug": "",
    "disease": "DIS292",
    "allele": "",
    "association_with": "Job Syndrome",
    "reference": "REF640",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267608261",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1047,
  "fields": {
    "snp_id": "SNP1058",
    "rs_id": "rs267608261",
    "gene": "DISGENE341",
    "drug": "",
    "disease": "DIS292",
    "allele": "",
    "association_with": "Job Syndrome",
    "reference": "REF640",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs267608261",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1048,
  "fields": {
    "snp_id": "SNP1061",
    "rs_id": "rs2754158",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS37",
    "allele": "",
    "association_with": "Asymmetric Septal Hypertrophy",
    "reference": "REF463",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2754158",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1049,
  "fields": {
    "snp_id": "SNP1062",
    "rs_id": "rs2754158",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS77",
    "allele": "",
    "association_with": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)",
    "reference": "REF463",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2754158",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1050,
  "fields": {
    "snp_id": "SNP1063",
    "rs_id": "rs2754158",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS81",
    "allele": "",
    "association_with": "Cardiomyopathy, Hypertrophic, Familial",
    "reference": "REF463",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2754158",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1051,
  "fields": {
    "snp_id": "SNP1064",
    "rs_id": "rs2754158",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS278",
    "allele": "",
    "association_with": "Idiopathic Hypertrophic Subaortic Stenosis",
    "reference": "REF463",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2754158",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1052,
  "fields": {
    "snp_id": "SNP1065",
    "rs_id": "rs2814778",
    "gene": "DISGENE343",
    "drug": "",
    "disease": "DIS548",
    "allele": "",
    "association_with": "White Blood Cell Count Quantitative Trait Locus 1",
    "reference": "REF735",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2814778",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1053,
  "fields": {
    "snp_id": "SNP1066",
    "rs_id": "rs2814778",
    "gene": "DISGENE344",
    "drug": "",
    "disease": "DIS548",
    "allele": "",
    "association_with": "White Blood Cell Count Quantitative Trait Locus 1",
    "reference": "REF735",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2814778",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1054,
  "fields": {
    "snp_id": "SNP1067",
    "rs_id": "rs2814778",
    "gene": "DISGENE343",
    "drug": "",
    "disease": "DIS548",
    "allele": "",
    "association_with": "White Blood Cell Count Quantitative Trait Locus 1",
    "reference": "REF441",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2814778",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1055,
  "fields": {
    "snp_id": "SNP1068",
    "rs_id": "rs2814778",
    "gene": "DISGENE344",
    "drug": "",
    "disease": "DIS548",
    "allele": "",
    "association_with": "White Blood Cell Count Quantitative Trait Locus 1",
    "reference": "REF441",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2814778",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1056,
  "fields": {
    "snp_id": "SNP1069",
    "rs_id": "rs2814778",
    "gene": "DISGENE343",
    "drug": "",
    "disease": "DIS386",
    "allele": "",
    "association_with": "Neutrophil Count (Procedure)",
    "reference": "REF498",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2814778",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1057,
  "fields": {
    "snp_id": "SNP1070",
    "rs_id": "rs2814778",
    "gene": "DISGENE344",
    "drug": "",
    "disease": "DIS386",
    "allele": "",
    "association_with": "Neutrophil Count (Procedure)",
    "reference": "REF498",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2814778",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1058,
  "fields": {
    "snp_id": "SNP1071",
    "rs_id": "rs281860303",
    "gene": "DISGENE345",
    "drug": "",
    "disease": "DIS155",
    "allele": "",
    "association_with": "Deafness, Congenital, With Inner Ear Agenesis, Microtia, And Microdontia",
    "reference": "REF174",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281860303",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Somalia",
    "latitude": "5.1521000",
    "longitude": "46.1996000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1059,
  "fields": {
    "snp_id": "SNP1072",
    "rs_id": "rs281864519",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281864519",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1060,
  "fields": {
    "snp_id": "SNP1073",
    "rs_id": "rs281864819",
    "gene": "DISGENE347",
    "drug": "",
    "disease": "DIS23",
    "allele": "",
    "association_with": "Alpha-Thalassemia",
    "reference": "REF446",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281864819",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1061,
  "fields": {
    "snp_id": "SNP1074",
    "rs_id": "rs281865207",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS52",
    "allele": "",
    "association_with": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865207",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1062,
  "fields": {
    "snp_id": "SNP1075",
    "rs_id": "rs281865207",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS294",
    "allele": "",
    "association_with": "Juvenile-Onset Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865207",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1063,
  "fields": {
    "snp_id": "SNP1076",
    "rs_id": "rs281865207",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS544",
    "allele": "",
    "association_with": "Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865207",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1064,
  "fields": {
    "snp_id": "SNP1077",
    "rs_id": "rs281865224",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS52",
    "allele": "",
    "association_with": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865224",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1065,
  "fields": {
    "snp_id": "SNP1078",
    "rs_id": "rs281865224",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS294",
    "allele": "",
    "association_with": "Juvenile-Onset Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865224",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1066,
  "fields": {
    "snp_id": "SNP1079",
    "rs_id": "rs281865224",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS544",
    "allele": "",
    "association_with": "Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865224",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1067,
  "fields": {
    "snp_id": "SNP1080",
    "rs_id": "rs281865226",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS52",
    "allele": "",
    "association_with": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865226",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1068,
  "fields": {
    "snp_id": "SNP1081",
    "rs_id": "rs281865226",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS294",
    "allele": "",
    "association_with": "Juvenile-Onset Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865226",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1069,
  "fields": {
    "snp_id": "SNP1082",
    "rs_id": "rs281865226",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS544",
    "allele": "",
    "association_with": "Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865226",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1070,
  "fields": {
    "snp_id": "SNP1083",
    "rs_id": "rs281865234",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS52",
    "allele": "",
    "association_with": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865234",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1071,
  "fields": {
    "snp_id": "SNP1084",
    "rs_id": "rs281865234",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS294",
    "allele": "",
    "association_with": "Juvenile-Onset Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865234",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1072,
  "fields": {
    "snp_id": "SNP1085",
    "rs_id": "rs281865234",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS544",
    "allele": "",
    "association_with": "Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865234",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1073,
  "fields": {
    "snp_id": "SNP1086",
    "rs_id": "rs281865238",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS52",
    "allele": "",
    "association_with": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865238",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1074,
  "fields": {
    "snp_id": "SNP1087",
    "rs_id": "rs281865238",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS294",
    "allele": "",
    "association_with": "Juvenile-Onset Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865238",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1075,
  "fields": {
    "snp_id": "SNP1088",
    "rs_id": "rs281865238",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS544",
    "allele": "",
    "association_with": "Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865238",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1076,
  "fields": {
    "snp_id": "SNP1089",
    "rs_id": "rs281865250",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS52",
    "allele": "",
    "association_with": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865250",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1077,
  "fields": {
    "snp_id": "SNP1090",
    "rs_id": "rs281865250",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS294",
    "allele": "",
    "association_with": "Juvenile-Onset Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865250",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1078,
  "fields": {
    "snp_id": "SNP1091",
    "rs_id": "rs281865250",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS544",
    "allele": "",
    "association_with": "Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865250",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1079,
  "fields": {
    "snp_id": "SNP1092",
    "rs_id": "rs281865414",
    "gene": "DISGENE293",
    "drug": "",
    "disease": "DIS152",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 84A",
    "reference": "REF385",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865414",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Netherlands",
    "latitude": "52.1326000",
    "longitude": "5.2913000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1080,
  "fields": {
    "snp_id": "SNP1093",
    "rs_id": "rs281865527",
    "gene": "DISGENE110",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF416",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865527",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1081,
  "fields": {
    "snp_id": "SNP1094",
    "rs_id": "rs281865530",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS52",
    "allele": "",
    "association_with": "Best Vitelliform Macular Dystrophy, Multifocal (Disorder)",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865530",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1082,
  "fields": {
    "snp_id": "SNP1095",
    "rs_id": "rs281865530",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS294",
    "allele": "",
    "association_with": "Juvenile-Onset Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865530",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1083,
  "fields": {
    "snp_id": "SNP1096",
    "rs_id": "rs281865530",
    "gene": "DISGENE348",
    "drug": "",
    "disease": "DIS544",
    "allele": "",
    "association_with": "Vitelliform Macular Dystrophy",
    "reference": "REF583",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281865530",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1084,
  "fields": {
    "snp_id": "SNP1097",
    "rs_id": "rs281875215",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS464",
    "allele": "",
    "association_with": "Psoriasis",
    "reference": "REF651",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281875215",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1085,
  "fields": {
    "snp_id": "SNP1098",
    "rs_id": "rs281875215",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS464",
    "allele": "",
    "association_with": "Psoriasis",
    "reference": "REF220",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs281875215",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1086,
  "fields": {
    "snp_id": "SNP1099",
    "rs_id": "rs2856597",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS228",
    "allele": "",
    "association_with": "Gronblad-Strandberg Syndrome",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2856597",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1087,
  "fields": {
    "snp_id": "SNP1100",
    "rs_id": "rs2856597",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2856597",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1088,
  "fields": {
    "snp_id": "SNP1101",
    "rs_id": "rs2856597",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS463",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2856597",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1089,
  "fields": {
    "snp_id": "SNP1102",
    "rs_id": "rs2856597",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS467",
    "allele": "",
    "association_with": "Pxe, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs2856597",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1090,
  "fields": {
    "snp_id": "SNP1103",
    "rs_id": "rs28897672",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF551",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28897672",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1091,
  "fields": {
    "snp_id": "SNP1104",
    "rs_id": "rs28931594",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS486",
    "allele": "",
    "association_with": "Senter Syndrome",
    "reference": "REF237",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28931594",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1092,
  "fields": {
    "snp_id": "SNP1105",
    "rs_id": "rs28931605",
    "gene": "DISGENE351",
    "drug": "",
    "disease": "DIS84",
    "allele": "",
    "association_with": "Cataract 4, Multiple Types",
    "reference": "REF529",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28931605",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1093,
  "fields": {
    "snp_id": "SNP1106",
    "rs_id": "rs28931605",
    "gene": "DISGENE351",
    "drug": "",
    "disease": "DIS85",
    "allele": "",
    "association_with": "Cataract, Congenital, Cerulean Type, 3",
    "reference": "REF529",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28931605",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1094,
  "fields": {
    "snp_id": "SNP1107",
    "rs_id": "rs28931605",
    "gene": "DISGENE351",
    "drug": "",
    "disease": "DIS86",
    "allele": "",
    "association_with": "Cataract, Crystalline Aculeiform",
    "reference": "REF529",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28931605",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1095,
  "fields": {
    "snp_id": "SNP1108",
    "rs_id": "rs28931605",
    "gene": "DISGENE351",
    "drug": "",
    "disease": "DIS87",
    "allele": "",
    "association_with": "Cataract, Punctate, Progressive Juvenile-Onset",
    "reference": "REF529",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28931605",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1096,
  "fields": {
    "snp_id": "SNP1109",
    "rs_id": "rs28931605",
    "gene": "DISGENE351",
    "drug": "",
    "disease": "DIS393",
    "allele": "",
    "association_with": "Nonnuclear Polymorphic Congenital Cataract",
    "reference": "REF529",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28931605",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1097,
  "fields": {
    "snp_id": "SNP1110",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF326",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1098,
  "fields": {
    "snp_id": "SNP1111",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF201",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1099,
  "fields": {
    "snp_id": "SNP1112",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS199",
    "allele": "",
    "association_with": "Fatal Familial Insomnia",
    "reference": "REF201",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1100,
  "fields": {
    "snp_id": "SNP1113",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF201",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1101,
  "fields": {
    "snp_id": "SNP1114",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF564",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1102,
  "fields": {
    "snp_id": "SNP1115",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS252",
    "allele": "",
    "association_with": "Huntington Disease-Like 1",
    "reference": "REF610",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1103,
  "fields": {
    "snp_id": "SNP1116",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF196",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1104,
  "fields": {
    "snp_id": "SNP1117",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS199",
    "allele": "",
    "association_with": "Fatal Familial Insomnia",
    "reference": "REF196",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1105,
  "fields": {
    "snp_id": "SNP1118",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF582",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1106,
  "fields": {
    "snp_id": "SNP1119",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS199",
    "allele": "",
    "association_with": "Fatal Familial Insomnia",
    "reference": "REF582",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1107,
  "fields": {
    "snp_id": "SNP1120",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF582",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1108,
  "fields": {
    "snp_id": "SNP1121",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF285",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1109,
  "fields": {
    "snp_id": "SNP1122",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS130",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease, Familial",
    "reference": "REF382",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1110,
  "fields": {
    "snp_id": "SNP1123",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS130",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease, Familial",
    "reference": "REF679",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1111,
  "fields": {
    "snp_id": "SNP1124",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF591",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1112,
  "fields": {
    "snp_id": "SNP1125",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS130",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease, Familial",
    "reference": "REF591",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1113,
  "fields": {
    "snp_id": "SNP1126",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS131",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease, Heidenhain Variant",
    "reference": "REF591",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1114,
  "fields": {
    "snp_id": "SNP1127",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS132",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease, Sporadic",
    "reference": "REF591",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1115,
  "fields": {
    "snp_id": "SNP1128",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS387",
    "allele": "",
    "association_with": "New Variant Creutzfeldt-Jakob Disease",
    "reference": "REF591",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1116,
  "fields": {
    "snp_id": "SNP1129",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF710",
    "p_value": "< 0.025",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1117,
  "fields": {
    "snp_id": "SNP1130",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS199",
    "allele": "",
    "association_with": "Fatal Familial Insomnia",
    "reference": "REF710",
    "p_value": "< 0.027",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1118,
  "fields": {
    "snp_id": "SNP1131",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF710",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1119,
  "fields": {
    "snp_id": "SNP1132",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF580",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1120,
  "fields": {
    "snp_id": "SNP1133",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF580",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1121,
  "fields": {
    "snp_id": "SNP1134",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF269",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1122,
  "fields": {
    "snp_id": "SNP1135",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS130",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease, Familial",
    "reference": "REF269",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1123,
  "fields": {
    "snp_id": "SNP1136",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS406",
    "allele": "",
    "association_with": "Other Creutzfeldt-Jakob Disease",
    "reference": "REF269",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1124,
  "fields": {
    "snp_id": "SNP1137",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF548",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1125,
  "fields": {
    "snp_id": "SNP1138",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS199",
    "allele": "",
    "association_with": "Fatal Familial Insomnia",
    "reference": "REF548",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1126,
  "fields": {
    "snp_id": "SNP1139",
    "rs_id": "rs28933385",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF548",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933385",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1127,
  "fields": {
    "snp_id": "SNP1140",
    "rs_id": "rs28933386",
    "gene": "DISGENE334",
    "drug": "",
    "disease": "DIS395",
    "allele": "",
    "association_with": "Noonan Syndrome",
    "reference": "REF235",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933386",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1128,
  "fields": {
    "snp_id": "SNP1141",
    "rs_id": "rs28933693",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF655",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933693",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1129,
  "fields": {
    "snp_id": "SNP1142",
    "rs_id": "rs28933693",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF600",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28933693",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1130,
  "fields": {
    "snp_id": "SNP1143",
    "rs_id": "rs28934586",
    "gene": "DISGENE352",
    "drug": "",
    "disease": "DIS120",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "reference": "REF239",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1131,
  "fields": {
    "snp_id": "SNP1144",
    "rs_id": "rs28934586",
    "gene": "DISGENE353",
    "drug": "",
    "disease": "DIS120",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "reference": "REF239",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1132,
  "fields": {
    "snp_id": "SNP1145",
    "rs_id": "rs28934586",
    "gene": "DISGENE352",
    "drug": "",
    "disease": "DIS159",
    "allele": "",
    "association_with": "Deficiency Of Monooxygenase",
    "reference": "REF239",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1133,
  "fields": {
    "snp_id": "SNP1146",
    "rs_id": "rs28934586",
    "gene": "DISGENE353",
    "drug": "",
    "disease": "DIS159",
    "allele": "",
    "association_with": "Deficiency Of Monooxygenase",
    "reference": "REF239",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1134,
  "fields": {
    "snp_id": "SNP1147",
    "rs_id": "rs28934586",
    "gene": "DISGENE352",
    "drug": "",
    "disease": "DIS1",
    "allele": "",
    "association_with": "11-Beta-Hydroxylase Deficiency",
    "reference": "REF725",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1135,
  "fields": {
    "snp_id": "SNP1148",
    "rs_id": "rs28934586",
    "gene": "DISGENE353",
    "drug": "",
    "disease": "DIS1",
    "allele": "",
    "association_with": "11-Beta-Hydroxylase Deficiency",
    "reference": "REF725",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1136,
  "fields": {
    "snp_id": "SNP1149",
    "rs_id": "rs28934586",
    "gene": "DISGENE352",
    "drug": "",
    "disease": "DIS120",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "reference": "REF725",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1137,
  "fields": {
    "snp_id": "SNP1150",
    "rs_id": "rs28934586",
    "gene": "DISGENE353",
    "drug": "",
    "disease": "DIS120",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "reference": "REF725",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1138,
  "fields": {
    "snp_id": "SNP1151",
    "rs_id": "rs28934586",
    "gene": "DISGENE352",
    "drug": "",
    "disease": "DIS120",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "reference": "REF720",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Turkey, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1139,
  "fields": {
    "snp_id": "SNP1152",
    "rs_id": "rs28934586",
    "gene": "DISGENE353",
    "drug": "",
    "disease": "DIS120",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "reference": "REF720",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Tunisia, Turkey, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1140,
  "fields": {
    "snp_id": "SNP1153",
    "rs_id": "rs28934586",
    "gene": "DISGENE352",
    "drug": "",
    "disease": "DIS1",
    "allele": "",
    "association_with": "11-Beta-Hydroxylase Deficiency",
    "reference": "REF586",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1141,
  "fields": {
    "snp_id": "SNP1154",
    "rs_id": "rs28934586",
    "gene": "DISGENE353",
    "drug": "",
    "disease": "DIS1",
    "allele": "",
    "association_with": "11-Beta-Hydroxylase Deficiency",
    "reference": "REF586",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1142,
  "fields": {
    "snp_id": "SNP1155",
    "rs_id": "rs28934586",
    "gene": "DISGENE352",
    "drug": "",
    "disease": "DIS120",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "reference": "REF586",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1143,
  "fields": {
    "snp_id": "SNP1156",
    "rs_id": "rs28934586",
    "gene": "DISGENE353",
    "drug": "",
    "disease": "DIS120",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency",
    "reference": "REF586",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934586",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1144,
  "fields": {
    "snp_id": "SNP1157",
    "rs_id": "rs28934595",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS231",
    "allele": "",
    "association_with": "Hemochromatosis, Type 1",
    "reference": "REF516",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934595",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1145,
  "fields": {
    "snp_id": "SNP1158",
    "rs_id": "rs28934595",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS241",
    "allele": "",
    "association_with": "Hereditary Hemochromatosis",
    "reference": "REF516",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934595",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1146,
  "fields": {
    "snp_id": "SNP1159",
    "rs_id": "rs28934595",
    "gene": "DISGENE133",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF516",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934595",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1147,
  "fields": {
    "snp_id": "SNP1160",
    "rs_id": "rs28934906",
    "gene": "DISGENE354",
    "drug": "",
    "disease": "DIS479",
    "allele": "",
    "association_with": "Rett Syndrome",
    "reference": "REF737",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28934906",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1148,
  "fields": {
    "snp_id": "SNP1161",
    "rs_id": "rs28936700",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF284",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28936700",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1149,
  "fields": {
    "snp_id": "SNP1162",
    "rs_id": "rs28936700",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF284",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28936700",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1150,
  "fields": {
    "snp_id": "SNP1163",
    "rs_id": "rs28936700",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS454",
    "allele": "",
    "association_with": "Primary Congenital Glaucoma",
    "reference": "REF284",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28936700",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1151,
  "fields": {
    "snp_id": "SNP1164",
    "rs_id": "rs28936700",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS454",
    "allele": "",
    "association_with": "Primary Congenital Glaucoma",
    "reference": "REF284",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28936700",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1152,
  "fields": {
    "snp_id": "SNP1165",
    "rs_id": "rs28937888",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF252",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937888",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Croatia",
    "latitude": "45.1000000",
    "longitude": "15.2000000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1153,
  "fields": {
    "snp_id": "SNP1166",
    "rs_id": "rs28937888",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF260",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937888",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1154,
  "fields": {
    "snp_id": "SNP1167",
    "rs_id": "rs28937903",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS366",
    "allele": "",
    "association_with": "Muscular Dystrophy, Congenital, 1C",
    "reference": "REF649",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937903",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1155,
  "fields": {
    "snp_id": "SNP1168",
    "rs_id": "rs28937903",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS368",
    "allele": "",
    "association_with": "Muscular Dystrophy, Limb-Girdle, Type 2I",
    "reference": "REF649",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937903",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1156,
  "fields": {
    "snp_id": "SNP1169",
    "rs_id": "rs28937903",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS545",
    "allele": "",
    "association_with": "Walker-Warburg Congenital Muscular Dystrophy",
    "reference": "REF649",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937903",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1157,
  "fields": {
    "snp_id": "SNP1170",
    "rs_id": "rs28937903",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS366",
    "allele": "",
    "association_with": "Muscular Dystrophy, Congenital, 1C",
    "reference": "REF584",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937903",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1158,
  "fields": {
    "snp_id": "SNP1171",
    "rs_id": "rs28937903",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS545",
    "allele": "",
    "association_with": "Walker-Warburg Congenital Muscular Dystrophy",
    "reference": "REF584",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937903",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1159,
  "fields": {
    "snp_id": "SNP1172",
    "rs_id": "rs28937903",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS368",
    "allele": "",
    "association_with": "Muscular Dystrophy, Limb-Girdle, Type 2I",
    "reference": "REF719",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937903",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1160,
  "fields": {
    "snp_id": "SNP1173",
    "rs_id": "rs28937903",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS545",
    "allele": "",
    "association_with": "Walker-Warburg Congenital Muscular Dystrophy",
    "reference": "REF719",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937903",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1161,
  "fields": {
    "snp_id": "SNP1174",
    "rs_id": "rs28937904",
    "gene": "DISGENE115",
    "drug": "",
    "disease": "DIS366",
    "allele": "",
    "association_with": "Muscular Dystrophy, Congenital, 1C",
    "reference": "REF649",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28937904",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1162,
  "fields": {
    "snp_id": "SNP1175",
    "rs_id": "rs28939084",
    "gene": "DISGENE246",
    "drug": "",
    "disease": "DIS144",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 10",
    "reference": "REF509",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939084",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1163,
  "fields": {
    "snp_id": "SNP1176",
    "rs_id": "rs28939084",
    "gene": "DISGENE246",
    "drug": "",
    "disease": "DIS154",
    "allele": "",
    "association_with": "Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8",
    "reference": "REF509",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939084",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1164,
  "fields": {
    "snp_id": "SNP1177",
    "rs_id": "rs28939702",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS228",
    "allele": "",
    "association_with": "Gronblad-Strandberg Syndrome",
    "reference": "REF194",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939702",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Mexico",
    "latitude": "23.6345000",
    "longitude": "-102.5528000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1165,
  "fields": {
    "snp_id": "SNP1178",
    "rs_id": "rs28939702",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF194",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939702",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Mexico",
    "latitude": "23.6345000",
    "longitude": "-102.5528000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1166,
  "fields": {
    "snp_id": "SNP1179",
    "rs_id": "rs28939702",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS463",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "reference": "REF194",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939702",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Mexico",
    "latitude": "23.6345000",
    "longitude": "-102.5528000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1167,
  "fields": {
    "snp_id": "SNP1180",
    "rs_id": "rs28939702",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS467",
    "allele": "",
    "association_with": "Pxe, Modifier Of Severity Of",
    "reference": "REF194",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939702",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Mexico",
    "latitude": "23.6345000",
    "longitude": "-102.5528000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1168,
  "fields": {
    "snp_id": "SNP1181",
    "rs_id": "rs28939702",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS228",
    "allele": "",
    "association_with": "Gronblad-Strandberg Syndrome",
    "reference": "REF549",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939702",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1169,
  "fields": {
    "snp_id": "SNP1182",
    "rs_id": "rs28939702",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF549",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939702",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1170,
  "fields": {
    "snp_id": "SNP1183",
    "rs_id": "rs28939702",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS463",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939702",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1171,
  "fields": {
    "snp_id": "SNP1184",
    "rs_id": "rs28939702",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS467",
    "allele": "",
    "association_with": "Pxe, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28939702",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1172,
  "fields": {
    "snp_id": "SNP1185",
    "rs_id": "rs28940268",
    "gene": "DISGENE355",
    "drug": "",
    "disease": "DIS300",
    "allele": "",
    "association_with": "Lamellar Ichthyosis, Type 2",
    "reference": "REF531",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28940268",
    "region": "Mixed Population, Sub-Saharan Africa, North Africa",
    "country_of_participants": "Algeria, Mali, Morocco",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1173,
  "fields": {
    "snp_id": "SNP1186",
    "rs_id": "rs28940268",
    "gene": "DISGENE355",
    "drug": "",
    "disease": "DIS300",
    "allele": "",
    "association_with": "Lamellar Ichthyosis, Type 2",
    "reference": "REF311",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28940268",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1174,
  "fields": {
    "snp_id": "SNP1187",
    "rs_id": "rs28940269",
    "gene": "DISGENE355",
    "drug": "",
    "disease": "DIS300",
    "allele": "",
    "association_with": "Lamellar Ichthyosis, Type 2",
    "reference": "REF531",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28940269",
    "region": "Mixed Population, Sub-Saharan Africa, North Africa",
    "country_of_participants": "Algeria, Mali, Morocco",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1175,
  "fields": {
    "snp_id": "SNP1188",
    "rs_id": "rs28940269",
    "gene": "DISGENE355",
    "drug": "",
    "disease": "DIS300",
    "allele": "",
    "association_with": "Lamellar Ichthyosis, Type 2",
    "reference": "REF311",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28940269",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1176,
  "fields": {
    "snp_id": "SNP1189",
    "rs_id": "rs28940270",
    "gene": "DISGENE355",
    "drug": "",
    "disease": "DIS300",
    "allele": "",
    "association_with": "Lamellar Ichthyosis, Type 2",
    "reference": "REF531",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28940270",
    "region": "Mixed Population, Sub-Saharan Africa, North Africa",
    "country_of_participants": "Algeria, Mali, Morocco",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1177,
  "fields": {
    "snp_id": "SNP1190",
    "rs_id": "rs28940271",
    "gene": "DISGENE355",
    "drug": "",
    "disease": "DIS300",
    "allele": "",
    "association_with": "Lamellar Ichthyosis, Type 2",
    "reference": "REF531",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28940271",
    "region": "Mixed Population, Sub-Saharan Africa, North Africa",
    "country_of_participants": "Algeria, Mali, Morocco",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1178,
  "fields": {
    "snp_id": "SNP1191",
    "rs_id": "rs28940568",
    "gene": "DISGENE355",
    "drug": "",
    "disease": "DIS300",
    "allele": "",
    "association_with": "Lamellar Ichthyosis, Type 2",
    "reference": "REF531",
    "p_value": "< 0.026",
    "source": "DisGeNET",
    "id_in_source": "rs28940568",
    "region": "Mixed Population, Sub-Saharan Africa, North Africa",
    "country_of_participants": "Algeria, Mali, Morocco",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1179,
  "fields": {
    "snp_id": "SNP1192",
    "rs_id": "rs28940578",
    "gene": "DISGENE117",
    "drug": "",
    "disease": "DIS192",
    "allele": "",
    "association_with": "Familial Mediterranean Fever",
    "reference": "REF568",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28940578",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1180,
  "fields": {
    "snp_id": "SNP1193",
    "rs_id": "rs28940579",
    "gene": "DISGENE117",
    "drug": "",
    "disease": "DIS192",
    "allele": "",
    "association_with": "Familial Mediterranean Fever",
    "reference": "REF415",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28940579",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1181,
  "fields": {
    "snp_id": "SNP1194",
    "rs_id": "rs28940579",
    "gene": "DISGENE117",
    "drug": "",
    "disease": "DIS520",
    "allele": "",
    "association_with": "Systemic Onset Juvenile Chronic Arthritis",
    "reference": "REF616",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28940579",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1182,
  "fields": {
    "snp_id": "SNP1195",
    "rs_id": "rs28940876",
    "gene": "DISGENE110",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF416",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28940876",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1183,
  "fields": {
    "snp_id": "SNP1196",
    "rs_id": "rs28941776",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF234",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28941776",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1184,
  "fields": {
    "snp_id": "SNP1197",
    "rs_id": "rs28942075",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942075",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1185,
  "fields": {
    "snp_id": "SNP1198",
    "rs_id": "rs28942078",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF786",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942078",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1186,
  "fields": {
    "snp_id": "SNP1199",
    "rs_id": "rs28942078",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF517",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942078",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1187,
  "fields": {
    "snp_id": "SNP1200",
    "rs_id": "rs28942078",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF517",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942078",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1188,
  "fields": {
    "snp_id": "SNP1201",
    "rs_id": "rs28942078",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS315",
    "allele": "",
    "association_with": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2",
    "reference": "REF517",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942078",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1189,
  "fields": {
    "snp_id": "SNP1202",
    "rs_id": "rs28942078",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF546",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942078",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1190,
  "fields": {
    "snp_id": "SNP1203",
    "rs_id": "rs28942081",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF234",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942081",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1191,
  "fields": {
    "snp_id": "SNP1204",
    "rs_id": "rs28942084",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF484",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942084",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1192,
  "fields": {
    "snp_id": "SNP1205",
    "rs_id": "rs28942084",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF484",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942084",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1193,
  "fields": {
    "snp_id": "SNP1206",
    "rs_id": "rs28942084",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS315",
    "allele": "",
    "association_with": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2",
    "reference": "REF484",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942084",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1194,
  "fields": {
    "snp_id": "SNP1207",
    "rs_id": "rs28942100",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942100",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1195,
  "fields": {
    "snp_id": "SNP1208",
    "rs_id": "rs28942109",
    "gene": "DISGENE251",
    "drug": "",
    "disease": "DIS105",
    "allele": "",
    "association_with": "Chylomicron Retention Disease",
    "reference": "REF635",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942109",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1196,
  "fields": {
    "snp_id": "SNP1209",
    "rs_id": "rs28942110",
    "gene": "DISGENE251",
    "drug": "",
    "disease": "DIS105",
    "allele": "",
    "association_with": "Chylomicron Retention Disease",
    "reference": "REF635",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942110",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1197,
  "fields": {
    "snp_id": "SNP1210",
    "rs_id": "rs28942111",
    "gene": "PHARGENE67",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF521",
    "p_value": "0.022",
    "source": "DisGeNET",
    "id_in_source": "rs28942111",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, New Zealand",
    "latitude": "-40.9006000",
    "longitude": "174.8860000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1198,
  "fields": {
    "snp_id": "SNP1211",
    "rs_id": "rs2967790",
    "gene": "DISGENE356",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.00000865",
    "source": "DisGeNET",
    "id_in_source": "rs2967790",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1199,
  "fields": {
    "snp_id": "SNP1212",
    "rs_id": "rs2981582",
    "gene": "DISGENE224",
    "drug": "",
    "disease": "DIS66",
    "allele": "",
    "association_with": "Breast Carcinoma",
    "reference": "REF241",
    "p_value": "0.000003",
    "source": "DisGeNET",
    "id_in_source": "rs2981582",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1200,
  "fields": {
    "snp_id": "SNP1213",
    "rs_id": "rs2981582",
    "gene": "DISGENE224",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF241",
    "p_value": "0.000003",
    "source": "DisGeNET",
    "id_in_source": "rs2981582",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1201,
  "fields": {
    "snp_id": "SNP1214",
    "rs_id": "rs2981582",
    "gene": "DISGENE224",
    "drug": "",
    "disease": "DIS378",
    "allele": "",
    "association_with": "Neoplasm Metastasis",
    "reference": "REF241",
    "p_value": "0.000003",
    "source": "DisGeNET",
    "id_in_source": "rs2981582",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1202,
  "fields": {
    "snp_id": "SNP1215",
    "rs_id": "rs3003172",
    "gene": "DISGENE357",
    "drug": "",
    "disease": "DIS64",
    "allele": "",
    "association_with": "Body Mass Index",
    "reference": "REF206",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs3003172",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Nigeria, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1203,
  "fields": {
    "snp_id": "SNP1216",
    "rs_id": "rs3003172",
    "gene": "DISGENE358",
    "drug": "",
    "disease": "DIS64",
    "allele": "",
    "association_with": "Body Mass Index",
    "reference": "REF206",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs3003172",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Nigeria, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1204,
  "fields": {
    "snp_id": "SNP1217",
    "rs_id": "rs312262720",
    "gene": "DISGENE172",
    "drug": "",
    "disease": "DIS25",
    "allele": "",
    "association_with": "Amyotrophic Lateral Sclerosis 5",
    "reference": "REF788",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs312262720",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1205,
  "fields": {
    "snp_id": "SNP1218",
    "rs_id": "rs312262720",
    "gene": "DISGENE172",
    "drug": "",
    "disease": "DIS497",
    "allele": "",
    "association_with": "Spastic Paraplegia 11, Autosomal Recessive",
    "reference": "REF788",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs312262720",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1206,
  "fields": {
    "snp_id": "SNP1219",
    "rs_id": "rs312262728",
    "gene": "DISGENE172",
    "drug": "",
    "disease": "DIS497",
    "allele": "",
    "association_with": "Spastic Paraplegia 11, Autosomal Recessive",
    "reference": "REF336",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs312262728",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1207,
  "fields": {
    "snp_id": "SNP1220",
    "rs_id": "rs3218713",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS77",
    "allele": "",
    "association_with": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)",
    "reference": "REF338",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs3218713",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1208,
  "fields": {
    "snp_id": "SNP1221",
    "rs_id": "rs3218713",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS81",
    "allele": "",
    "association_with": "Cardiomyopathy, Hypertrophic, Familial",
    "reference": "REF338",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs3218713",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1209,
  "fields": {
    "snp_id": "SNP1222",
    "rs_id": "rs3218716",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS77",
    "allele": "",
    "association_with": "Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)",
    "reference": "REF338",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs3218716",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1210,
  "fields": {
    "snp_id": "SNP1223",
    "rs_id": "rs3218716",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS81",
    "allele": "",
    "association_with": "Cardiomyopathy, Hypertrophic, Familial",
    "reference": "REF338",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs3218716",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1211,
  "fields": {
    "snp_id": "SNP1224",
    "rs_id": "rs3218716",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS262",
    "allele": "",
    "association_with": "Hypertrophic Cardiomyopathy",
    "reference": "REF338",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs3218716",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1212,
  "fields": {
    "snp_id": "SNP1225",
    "rs_id": "rs333",
    "gene": "DISGENE359",
    "drug": "",
    "disease": "DIS547",
    "allele": "",
    "association_with": "West Nile Virus, Susceptibility To (Finding)",
    "reference": "REF460",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs333",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1213,
  "fields": {
    "snp_id": "SNP1226",
    "rs_id": "rs333",
    "gene": "DISGENE360",
    "drug": "",
    "disease": "DIS547",
    "allele": "",
    "association_with": "West Nile Virus, Susceptibility To (Finding)",
    "reference": "REF460",
    "p_value": "0.000000934",
    "source": "DisGeNET",
    "id_in_source": "rs333",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1214,
  "fields": {
    "snp_id": "SNP1227",
    "rs_id": "rs333",
    "gene": "DISGENE359",
    "drug": "",
    "disease": "DIS547",
    "allele": "",
    "association_with": "West Nile Virus, Susceptibility To (Finding)",
    "reference": "REF445",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs333",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1215,
  "fields": {
    "snp_id": "SNP1228",
    "rs_id": "rs333",
    "gene": "DISGENE360",
    "drug": "",
    "disease": "DIS547",
    "allele": "",
    "association_with": "West Nile Virus, Susceptibility To (Finding)",
    "reference": "REF445",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs333",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1216,
  "fields": {
    "snp_id": "SNP1229",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS28",
    "allele": "",
    "association_with": "Anemia, Sickle Cell",
    "reference": "REF626",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1217,
  "fields": {
    "snp_id": "SNP1230",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF626",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1218,
  "fields": {
    "snp_id": "SNP1231",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS28",
    "allele": "",
    "association_with": "Anemia, Sickle Cell",
    "reference": "REF202",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Burkina Faso",
    "latitude": "12.2383000",
    "longitude": "1.5616000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1219,
  "fields": {
    "snp_id": "SNP1232",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "1.3E-028",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1220,
  "fields": {
    "snp_id": "SNP1233",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS492",
    "allele": "",
    "association_with": "Sickle Cell Trait/ Trachoma",
    "reference": "REF282",
    "p_value": "< 0.07",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1221,
  "fields": {
    "snp_id": "SNP1234",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF185",
    "p_value": "< 0.07",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "North African",
    "country_of_participants": "Mauritania",
    "latitude": "21.0079000",
    "longitude": "-10.9408000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1222,
  "fields": {
    "snp_id": "SNP1235",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "1.4E-038",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1223,
  "fields": {
    "snp_id": "SNP1236",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF746",
    "p_value": "0.0000000711",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1224,
  "fields": {
    "snp_id": "SNP1237",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF746",
    "p_value": "0.0000000711",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1225,
  "fields": {
    "snp_id": "SNP1238",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS491",
    "allele": "",
    "association_with": "Sickle Cell Trait",
    "reference": "REF746",
    "p_value": "0.0000000711",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1226,
  "fields": {
    "snp_id": "SNP1239",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS28",
    "allele": "",
    "association_with": "Anemia, Sickle Cell",
    "reference": "REF451",
    "p_value": "0.0000000711",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Benin, Senegal",
    "latitude": "9.3077000",
    "longitude": "2.3158000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1227,
  "fields": {
    "snp_id": "SNP1240",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS28",
    "allele": "",
    "association_with": "Anemia, Sickle Cell",
    "reference": "REF503",
    "p_value": "0.0000000711",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1228,
  "fields": {
    "snp_id": "SNP1241",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS28",
    "allele": "",
    "association_with": "Anemia, Sickle Cell",
    "reference": "REF712",
    "p_value": "0.0000000711",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Benin, Congo, Senegal",
    "latitude": "9.3077000",
    "longitude": "2.3158000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1229,
  "fields": {
    "snp_id": "SNP1242",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.00000000181",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1230,
  "fields": {
    "snp_id": "SNP1243",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS28",
    "allele": "",
    "association_with": "Anemia, Sickle Cell",
    "reference": "REF545",
    "p_value": "0.00000000181",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sub-Saharan Africa",
    "latitude": "23.8060780",
    "longitude": "11.2884520"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1231,
  "fields": {
    "snp_id": "SNP1244",
    "rs_id": "rs334",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS28",
    "allele": "",
    "association_with": "Anemia, Sickle Cell",
    "reference": "REF262",
    "p_value": "0.00000000181",
    "source": "DisGeNET",
    "id_in_source": "rs334",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "North Africa, Sub-Saharan Africa",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1232,
  "fields": {
    "snp_id": "SNP1245",
    "rs_id": "rs33915217",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF424",
    "p_value": "0.00000000181",
    "source": "DisGeNET",
    "id_in_source": "rs33915217",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1233,
  "fields": {
    "snp_id": "SNP1246",
    "rs_id": "rs33915217",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF647",
    "p_value": "0.00000000181",
    "source": "DisGeNET",
    "id_in_source": "rs33915217",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1234,
  "fields": {
    "snp_id": "SNP1247",
    "rs_id": "rs33915217",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS55",
    "allele": "",
    "association_with": "Beta^+^ Thalassemia",
    "reference": "REF647",
    "p_value": "0.00000000181",
    "source": "DisGeNET",
    "id_in_source": "rs33915217",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1235,
  "fields": {
    "snp_id": "SNP1248",
    "rs_id": "rs33930165",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF295",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33930165",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mali",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1236,
  "fields": {
    "snp_id": "SNP1249",
    "rs_id": "rs33930165",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF344",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33930165",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1237,
  "fields": {
    "snp_id": "SNP1250",
    "rs_id": "rs33931746",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF552",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33931746",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1238,
  "fields": {
    "snp_id": "SNP1251",
    "rs_id": "rs33931746",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF681",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33931746",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1239,
  "fields": {
    "snp_id": "SNP1252",
    "rs_id": "rs33943001",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF464",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33943001",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1240,
  "fields": {
    "snp_id": "SNP1253",
    "rs_id": "rs33945777",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF620",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33945777",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1241,
  "fields": {
    "snp_id": "SNP1254",
    "rs_id": "rs33945777",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS53",
    "allele": "",
    "association_with": "Beta^0^ Thalassemia",
    "reference": "REF620",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33945777",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1242,
  "fields": {
    "snp_id": "SNP1255",
    "rs_id": "rs33949390",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS421",
    "allele": "",
    "association_with": "Parkinson Disease, Familial, Type 1",
    "reference": "REF615",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33949390",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Asia",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1243,
  "fields": {
    "snp_id": "SNP1256",
    "rs_id": "rs33950507",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS55",
    "allele": "",
    "association_with": "Beta^+^ Thalassemia",
    "reference": "REF659",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33950507",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1244,
  "fields": {
    "snp_id": "SNP1257",
    "rs_id": "rs33950507",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS233",
    "allele": "",
    "association_with": "Hemoglobin E/Beta Thalassemia Disease",
    "reference": "REF659",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33950507",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1245,
  "fields": {
    "snp_id": "SNP1258",
    "rs_id": "rs33956879",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF515",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33956879",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1246,
  "fields": {
    "snp_id": "SNP1259",
    "rs_id": "rs33971440",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF464",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33971440",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1247,
  "fields": {
    "snp_id": "SNP1260",
    "rs_id": "rs33980857",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF424",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs33980857",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1248,
  "fields": {
    "snp_id": "SNP1261",
    "rs_id": "rs34116584",
    "gene": "DISGENE195",
    "drug": "",
    "disease": "DIS455",
    "allele": "",
    "association_with": "Primary Hyperoxaluria, Type I",
    "reference": "REF761",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs34116584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1249,
  "fields": {
    "snp_id": "SNP1262",
    "rs_id": "rs34213790",
    "gene": "PHARGENE49",
    "drug": "",
    "disease": "DIS249",
    "allele": "",
    "association_with": "Hiv Infections",
    "reference": "REF715",
    "p_value": "0.00000115",
    "source": "DisGeNET",
    "id_in_source": "rs34213790",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1250,
  "fields": {
    "snp_id": "SNP1263",
    "rs_id": "rs34218908",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF552",
    "p_value": "0.00000115",
    "source": "DisGeNET",
    "id_in_source": "rs34218908",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1251,
  "fields": {
    "snp_id": "SNP1264",
    "rs_id": "rs34612342",
    "gene": "DISGENE362",
    "drug": "",
    "disease": "DIS111",
    "allele": "",
    "association_with": "Colorectal Adenomatous Polyposis, Autosomal Recessive",
    "reference": "REF555",
    "p_value": "0.1",
    "source": "DisGeNET",
    "id_in_source": "rs34612342",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1252,
  "fields": {
    "snp_id": "SNP1265",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF401",
    "p_value": "0.1",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, France",
    "latitude": "46.2276000",
    "longitude": "2.2137000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1253,
  "fields": {
    "snp_id": "SNP1266",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS420",
    "allele": "",
    "association_with": "Parkinson Disease 8 (Disorder)",
    "reference": "REF401",
    "p_value": "0.1",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, France",
    "latitude": "46.2276000",
    "longitude": "2.2137000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1254,
  "fields": {
    "snp_id": "SNP1267",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS421",
    "allele": "",
    "association_with": "Parkinson Disease, Familial, Type 1",
    "reference": "REF401",
    "p_value": "0.1",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, France",
    "latitude": "46.2276000",
    "longitude": "2.2137000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1255,
  "fields": {
    "snp_id": "SNP1268",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF233",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, USA",
    "latitude": "37.0900000",
    "longitude": "-95.7130000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1256,
  "fields": {
    "snp_id": "SNP1269",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS420",
    "allele": "",
    "association_with": "Parkinson Disease 8 (Disorder)",
    "reference": "REF233",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, USA",
    "latitude": "37.0900000",
    "longitude": "-95.7130000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1257,
  "fields": {
    "snp_id": "SNP1270",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF323",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, USA, Europe, Middle East",
    "latitude": "46.2276000",
    "longitude": "2.2137000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1258,
  "fields": {
    "snp_id": "SNP1271",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF599",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, USA, Europe, Middle East",
    "latitude": "46.2276000",
    "longitude": "2.2137000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1259,
  "fields": {
    "snp_id": "SNP1272",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF797",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Asia, Europe",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1260,
  "fields": {
    "snp_id": "SNP1273",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF718",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, France",
    "latitude": "46.2276000",
    "longitude": "2.2137000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1261,
  "fields": {
    "snp_id": "SNP1274",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF787",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "North African",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1262,
  "fields": {
    "snp_id": "SNP1275",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF759",
    "p_value": "0.85",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1263,
  "fields": {
    "snp_id": "SNP1276",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS421",
    "allele": "",
    "association_with": "Parkinson Disease, Familial, Type 1",
    "reference": "REF597",
    "p_value": "0.85",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, France",
    "latitude": "46.2276000",
    "longitude": "2.2137000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1264,
  "fields": {
    "snp_id": "SNP1277",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF664",
    "p_value": "0.000001",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iraq",
    "latitude": "33.2232000",
    "longitude": "43.6793000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1265,
  "fields": {
    "snp_id": "SNP1278",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF538",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1266,
  "fields": {
    "snp_id": "SNP1279",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS423",
    "allele": "",
    "association_with": "Parkinsonian Disorders",
    "reference": "REF224",
    "p_value": "0.061",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1267,
  "fields": {
    "snp_id": "SNP1280",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF665",
    "p_value": "0.061",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "North African",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1268,
  "fields": {
    "snp_id": "SNP1281",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF605",
    "p_value": "0.061",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1269,
  "fields": {
    "snp_id": "SNP1282",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF400",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1270,
  "fields": {
    "snp_id": "SNP1283",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS423",
    "allele": "",
    "association_with": "Parkinsonian Disorders",
    "reference": "REF400",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1271,
  "fields": {
    "snp_id": "SNP1284",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF207",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1272,
  "fields": {
    "snp_id": "SNP1285",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF627",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1273,
  "fields": {
    "snp_id": "SNP1286",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS383",
    "allele": "",
    "association_with": "Neurodegenerative Disorders",
    "reference": "REF514",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1274,
  "fields": {
    "snp_id": "SNP1287",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF514",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1275,
  "fields": {
    "snp_id": "SNP1288",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS423",
    "allele": "",
    "association_with": "Parkinsonian Disorders",
    "reference": "REF514",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1276,
  "fields": {
    "snp_id": "SNP1289",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF609",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1277,
  "fields": {
    "snp_id": "SNP1290",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF369",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1278,
  "fields": {
    "snp_id": "SNP1291",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS191",
    "allele": "",
    "association_with": "Familial (Fpah)",
    "reference": "REF550",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1279,
  "fields": {
    "snp_id": "SNP1292",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS508",
    "allele": "",
    "association_with": "Sporadic Parkinson Disease",
    "reference": "REF550",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1280,
  "fields": {
    "snp_id": "SNP1293",
    "rs_id": "rs34637584",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF198",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34637584",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1281,
  "fields": {
    "snp_id": "SNP1294",
    "rs_id": "rs34731820",
    "gene": "DISGENE214",
    "drug": "",
    "disease": "DIS16",
    "allele": "",
    "association_with": "Albinism, Oculocutaneous",
    "reference": "REF277",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34731820",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1282,
  "fields": {
    "snp_id": "SNP1295",
    "rs_id": "rs34778348",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF797",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34778348",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Asia, Europe",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1283,
  "fields": {
    "snp_id": "SNP1296",
    "rs_id": "rs34778348",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS421",
    "allele": "",
    "association_with": "Parkinson Disease, Familial, Type 1",
    "reference": "REF615",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34778348",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Asia",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1284,
  "fields": {
    "snp_id": "SNP1297",
    "rs_id": "rs34809449",
    "gene": "DISGENE363",
    "drug": "",
    "disease": "DIS202",
    "allele": "",
    "association_with": "Fetal Hemoglobin Quantitative Trait Locus 1",
    "reference": "REF199",
    "p_value": "< 0.001",
    "source": "DisGeNET",
    "id_in_source": "rs34809449",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1285,
  "fields": {
    "snp_id": "SNP1298",
    "rs_id": "rs34889882",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF539",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs34889882",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1286,
  "fields": {
    "snp_id": "SNP1299",
    "rs_id": "rs35269064",
    "gene": "DISGENE197",
    "drug": "",
    "disease": "DIS106",
    "allele": "",
    "association_with": "Citrullinemia",
    "reference": "REF360",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35269064",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1287,
  "fields": {
    "snp_id": "SNP1300",
    "rs_id": "rs35424040",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS54",
    "allele": "",
    "association_with": "Beta-Knossos-Thalassemia",
    "reference": "REF577",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35424040",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1288,
  "fields": {
    "snp_id": "SNP1301",
    "rs_id": "rs35424040",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS55",
    "allele": "",
    "association_with": "Beta^+^ Thalassemia",
    "reference": "REF577",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35424040",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1289,
  "fields": {
    "snp_id": "SNP1302",
    "rs_id": "rs35424040",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS54",
    "allele": "",
    "association_with": "Beta-Knossos-Thalassemia",
    "reference": "REF621",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35424040",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1290,
  "fields": {
    "snp_id": "SNP1303",
    "rs_id": "rs35424040",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS55",
    "allele": "",
    "association_with": "Beta^+^ Thalassemia",
    "reference": "REF621",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35424040",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1291,
  "fields": {
    "snp_id": "SNP1304",
    "rs_id": "rs35424040",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS54",
    "allele": "",
    "association_with": "Beta-Knossos-Thalassemia",
    "reference": "REF536",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35424040",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1292,
  "fields": {
    "snp_id": "SNP1305",
    "rs_id": "rs35424040",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS55",
    "allele": "",
    "association_with": "Beta^+^ Thalassemia",
    "reference": "REF536",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35424040",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1293,
  "fields": {
    "snp_id": "SNP1306",
    "rs_id": "rs35870237",
    "gene": "DISGENE361",
    "drug": "",
    "disease": "DIS421",
    "allele": "",
    "association_with": "Parkinson Disease, Familial, Type 1",
    "reference": "REF615",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35870237",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Asia",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1294,
  "fields": {
    "snp_id": "SNP1307",
    "rs_id": "rs35894115",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF221",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35894115",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1295,
  "fields": {
    "snp_id": "SNP1308",
    "rs_id": "rs35894115",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF179",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35894115",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1296,
  "fields": {
    "snp_id": "SNP1309",
    "rs_id": "rs35894115",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF589",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs35894115",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1297,
  "fields": {
    "snp_id": "SNP1310",
    "rs_id": "rs36015961",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF295",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs36015961",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mali",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1298,
  "fields": {
    "snp_id": "SNP1311",
    "rs_id": "rs36053993",
    "gene": "DISGENE362",
    "drug": "",
    "disease": "DIS111",
    "allele": "",
    "association_with": "Colorectal Adenomatous Polyposis, Autosomal Recessive",
    "reference": "REF785",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs36053993",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1299,
  "fields": {
    "snp_id": "SNP1312",
    "rs_id": "rs36053993",
    "gene": "DISGENE362",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF785",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs36053993",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1300,
  "fields": {
    "snp_id": "SNP1313",
    "rs_id": "rs36053993",
    "gene": "DISGENE362",
    "drug": "",
    "disease": "DIS514",
    "allele": "",
    "association_with": "Stomach Neoplasms",
    "reference": "REF785",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs36053993",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1301,
  "fields": {
    "snp_id": "SNP1314",
    "rs_id": "rs364897",
    "gene": "DISGENE364",
    "drug": "",
    "disease": "DIS208",
    "allele": "",
    "association_with": "Gaucher Disease",
    "reference": "REF579",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs364897",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1302,
  "fields": {
    "snp_id": "SNP1315",
    "rs_id": "rs367947846",
    "gene": "DISGENE365",
    "drug": "",
    "disease": "DIS81",
    "allele": "",
    "association_with": "Cardiomyopathy, Hypertrophic, Familial",
    "reference": "REF338",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs367947846",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1303,
  "fields": {
    "snp_id": "SNP1316",
    "rs_id": "rs368345612",
    "gene": "DISGENE366",
    "drug": "",
    "disease": "DIS295",
    "allele": "",
    "association_with": "Keloid",
    "reference": "REF278",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs368345612",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1304,
  "fields": {
    "snp_id": "SNP1317",
    "rs_id": "rs368420430",
    "gene": "DISGENE160",
    "drug": "",
    "disease": "DIS232",
    "allele": "",
    "association_with": "Hemochromatosis, Type 4",
    "reference": "REF211",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs368420430",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1305,
  "fields": {
    "snp_id": "SNP1318",
    "rs_id": "rs369973784",
    "gene": "DISGENE331",
    "drug": "",
    "disease": "DIS223",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type Iii",
    "reference": "REF634",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs369973784",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1306,
  "fields": {
    "snp_id": "SNP1319",
    "rs_id": "rs370471013",
    "gene": "DISGENE367",
    "drug": "",
    "disease": "DIS302",
    "allele": "",
    "association_with": "Leigh Disease",
    "reference": "REF331",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs370471013",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1307,
  "fields": {
    "snp_id": "SNP1320",
    "rs_id": "rs370792293",
    "gene": "DISGENE331",
    "drug": "",
    "disease": "DIS220",
    "allele": "",
    "association_with": "Glycogen Storage Disease Iiia",
    "reference": "REF774",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs370792293",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, India, Italy",
    "latitude": "20.5937000",
    "longitude": "78.9629000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1308,
  "fields": {
    "snp_id": "SNP1321",
    "rs_id": "rs370792293",
    "gene": "DISGENE331",
    "drug": "",
    "disease": "DIS223",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type Iii",
    "reference": "REF774",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs370792293",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, India, Italy",
    "latitude": "20.5937000",
    "longitude": "78.9629000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1309,
  "fields": {
    "snp_id": "SNP1322",
    "rs_id": "rs370860696",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF230",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs370860696",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1310,
  "fields": {
    "snp_id": "SNP1323",
    "rs_id": "rs371482223",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF546",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs371482223",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1311,
  "fields": {
    "snp_id": "SNP1324",
    "rs_id": "rs371482223",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF546",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs371482223",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1312,
  "fields": {
    "snp_id": "SNP1325",
    "rs_id": "rs371675217",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF655",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs371675217",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1313,
  "fields": {
    "snp_id": "SNP1326",
    "rs_id": "rs371675217",
    "gene": "DISGENE245",
    "drug": "",
    "disease": "DIS22",
    "allele": "",
    "association_with": "Alpha-Sarcoglycanopathies",
    "reference": "REF600",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs371675217",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1314,
  "fields": {
    "snp_id": "SNP1327",
    "rs_id": "rs371898076",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS262",
    "allele": "",
    "association_with": "Hypertrophic Cardiomyopathy",
    "reference": "REF338",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs371898076",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1315,
  "fields": {
    "snp_id": "SNP1328",
    "rs_id": "rs371956016",
    "gene": "DISGENE368",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF345",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs371956016",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1316,
  "fields": {
    "snp_id": "SNP1329",
    "rs_id": "rs371956016",
    "gene": "DISGENE368",
    "drug": "",
    "disease": "DIS474",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 38 (Disorder)",
    "reference": "REF345",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs371956016",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1317,
  "fields": {
    "snp_id": "SNP1330",
    "rs_id": "rs372091",
    "gene": "DISGENE369",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.000000000000011",
    "source": "DisGeNET",
    "id_in_source": "rs372091",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1318,
  "fields": {
    "snp_id": "SNP1331",
    "rs_id": "rs372091",
    "gene": "DISGENE370",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.000000000000011",
    "source": "DisGeNET",
    "id_in_source": "rs372091",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1319,
  "fields": {
    "snp_id": "SNP1332",
    "rs_id": "rs372091",
    "gene": "DISGENE363",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.000000000000011",
    "source": "DisGeNET",
    "id_in_source": "rs372091",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1320,
  "fields": {
    "snp_id": "SNP1333",
    "rs_id": "rs372091",
    "gene": "DISGENE369",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.085",
    "source": "DisGeNET",
    "id_in_source": "rs372091",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1321,
  "fields": {
    "snp_id": "SNP1334",
    "rs_id": "rs372091",
    "gene": "DISGENE370",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.085",
    "source": "DisGeNET",
    "id_in_source": "rs372091",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1322,
  "fields": {
    "snp_id": "SNP1335",
    "rs_id": "rs372091",
    "gene": "DISGENE363",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.085",
    "source": "DisGeNET",
    "id_in_source": "rs372091",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1323,
  "fields": {
    "snp_id": "SNP1336",
    "rs_id": "rs372392424",
    "gene": "DISGENE371",
    "drug": "",
    "disease": "DIS346",
    "allele": "",
    "association_with": "Mental Retardation, Autosomal Recessive 53",
    "reference": "REF754",
    "p_value": "0.085",
    "source": "DisGeNET",
    "id_in_source": "rs372392424",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Pakistan",
    "latitude": "30.3753000",
    "longitude": "69.3451000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1324,
  "fields": {
    "snp_id": "SNP1337",
    "rs_id": "rs372479885",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "0.085",
    "source": "DisGeNET",
    "id_in_source": "rs372479885",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1325,
  "fields": {
    "snp_id": "SNP1338",
    "rs_id": "rs373135339",
    "gene": "DISGENE191",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF522",
    "p_value": "0.085",
    "source": "DisGeNET",
    "id_in_source": "rs373135339",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1326,
  "fields": {
    "snp_id": "SNP1339",
    "rs_id": "rs373135339",
    "gene": "DISGENE191",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF734",
    "p_value": "0.085",
    "source": "DisGeNET",
    "id_in_source": "rs373135339",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1327,
  "fields": {
    "snp_id": "SNP1340",
    "rs_id": "rs373533",
    "gene": "DISGENE372",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF368",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs373533",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1328,
  "fields": {
    "snp_id": "SNP1341",
    "rs_id": "rs373599651",
    "gene": "DISGENE373",
    "drug": "",
    "disease": "DIS540",
    "allele": "",
    "association_with": "Usher Syndrome, Type Iia",
    "reference": "REF813",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs373599651",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1329,
  "fields": {
    "snp_id": "SNP1342",
    "rs_id": "rs373921680",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF682",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs373921680",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1330,
  "fields": {
    "snp_id": "SNP1343",
    "rs_id": "rs3743930",
    "gene": "DISGENE117",
    "drug": "",
    "disease": "DIS192",
    "allele": "",
    "association_with": "Familial Mediterranean Fever",
    "reference": "REF426",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs3743930",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1331,
  "fields": {
    "snp_id": "SNP1344",
    "rs_id": "rs374473331",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs374473331",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1332,
  "fields": {
    "snp_id": "SNP1345",
    "rs_id": "rs374612640",
    "gene": "DISGENE263",
    "drug": "",
    "disease": "DIS425",
    "allele": "",
    "association_with": "Peeling Skin Syndrome 5",
    "reference": "REF259",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs374612640",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia. Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1333,
  "fields": {
    "snp_id": "SNP1346",
    "rs_id": "rs374612640",
    "gene": "DISGENE374",
    "drug": "",
    "disease": "DIS425",
    "allele": "",
    "association_with": "Peeling Skin Syndrome 5",
    "reference": "REF259",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs374612640",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia. Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1334,
  "fields": {
    "snp_id": "SNP1347",
    "rs_id": "rs374612640",
    "gene": "DISGENE375",
    "drug": "",
    "disease": "DIS425",
    "allele": "",
    "association_with": "Peeling Skin Syndrome 5",
    "reference": "REF259",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs374612640",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia. Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1335,
  "fields": {
    "snp_id": "SNP1348",
    "rs_id": "rs374665929",
    "gene": "DISGENE376",
    "drug": "",
    "disease": "DIS309",
    "allele": "",
    "association_with": "Limb-Girdle Muscular Dystrophy Type 2A",
    "reference": "REF775",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs374665929",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1336,
  "fields": {
    "snp_id": "SNP1349",
    "rs_id": "rs374946172",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF794",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs374946172",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1337,
  "fields": {
    "snp_id": "SNP1350",
    "rs_id": "rs375495026",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF697",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs375495026",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1338,
  "fields": {
    "snp_id": "SNP1351",
    "rs_id": "rs375624435",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS464",
    "allele": "",
    "association_with": "Psoriasis",
    "reference": "REF220",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs375624435",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1339,
  "fields": {
    "snp_id": "SNP1352",
    "rs_id": "rs375624435",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS465",
    "allele": "",
    "association_with": "Psoriasis 2",
    "reference": "REF220",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs375624435",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1340,
  "fields": {
    "snp_id": "SNP1353",
    "rs_id": "rs375688767",
    "gene": "DISGENE301",
    "drug": "",
    "disease": "DIS272",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "reference": "REF506",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs375688767",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1341,
  "fields": {
    "snp_id": "SNP1354",
    "rs_id": "rs375688767",
    "gene": "DISGENE300",
    "drug": "",
    "disease": "DIS272",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "reference": "REF506",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs375688767",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1342,
  "fields": {
    "snp_id": "SNP1355",
    "rs_id": "rs375952052",
    "gene": "DISGENE377",
    "drug": "",
    "disease": "DIS137",
    "allele": "",
    "association_with": "Cystinosis, Benign, Nonnephropathic",
    "reference": "REF300",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs375952052",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1343,
  "fields": {
    "snp_id": "SNP1356",
    "rs_id": "rs375952052",
    "gene": "DISGENE377",
    "drug": "",
    "disease": "DIS293",
    "allele": "",
    "association_with": "Juvenile Nephropathic Cystinosis (Disorder)",
    "reference": "REF300",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs375952052",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1344,
  "fields": {
    "snp_id": "SNP1357",
    "rs_id": "rs376103979",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS381",
    "allele": "",
    "association_with": "Neurodegeneration With Brain Iron Accumulation 4",
    "reference": "REF588",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs376103979",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mali",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1345,
  "fields": {
    "snp_id": "SNP1358",
    "rs_id": "rs376103979",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS500",
    "allele": "",
    "association_with": "Spastic Paraplegia 43, Autosomal Recessive",
    "reference": "REF588",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs376103979",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mali",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1346,
  "fields": {
    "snp_id": "SNP1359",
    "rs_id": "rs376103979",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS382",
    "allele": "",
    "association_with": "Neurodegeneration With Brain Iron Accumulation (Nbia)",
    "reference": "REF736",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs376103979",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Mali, Brazil",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1347,
  "fields": {
    "snp_id": "SNP1360",
    "rs_id": "rs376103979",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS381",
    "allele": "",
    "association_with": "Neurodegeneration With Brain Iron Accumulation 4",
    "reference": "REF736",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs376103979",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Mali, Brazil",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1348,
  "fields": {
    "snp_id": "SNP1361",
    "rs_id": "rs376103979",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS500",
    "allele": "",
    "association_with": "Spastic Paraplegia 43, Autosomal Recessive",
    "reference": "REF736",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs376103979",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Mali, Brazil",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1349,
  "fields": {
    "snp_id": "SNP1362",
    "rs_id": "rs376306240",
    "gene": "DISGENE190",
    "drug": "",
    "disease": "DIS477",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 74",
    "reference": "REF349",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs376306240",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1350,
  "fields": {
    "snp_id": "SNP1363",
    "rs_id": "rs376923877",
    "gene": "DISGENE379",
    "drug": "",
    "disease": "DIS81",
    "allele": "",
    "association_with": "Cardiomyopathy, Hypertrophic, Familial",
    "reference": "REF338",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs376923877",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1351,
  "fields": {
    "snp_id": "SNP1364",
    "rs_id": "rs376923877",
    "gene": "DISGENE225",
    "drug": "",
    "disease": "DIS81",
    "allele": "",
    "association_with": "Cardiomyopathy, Hypertrophic, Familial",
    "reference": "REF338",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs376923877",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1352,
  "fields": {
    "snp_id": "SNP1365",
    "rs_id": "rs377267777",
    "gene": "DISGENE380",
    "drug": "",
    "disease": "DIS534",
    "allele": "",
    "association_with": "Usher Syndrome, Type I",
    "reference": "REF700",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs377267777",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1353,
  "fields": {
    "snp_id": "SNP1366",
    "rs_id": "rs377267777",
    "gene": "DISGENE380",
    "drug": "",
    "disease": "DIS539",
    "allele": "",
    "association_with": "Usher Syndrome, Type I, French Variety, Formerly",
    "reference": "REF700",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs377267777",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1354,
  "fields": {
    "snp_id": "SNP1367",
    "rs_id": "rs377267777",
    "gene": "DISGENE380",
    "drug": "",
    "disease": "DIS535",
    "allele": "",
    "association_with": "Usher Syndrome, Type Ia, Formerly",
    "reference": "REF700",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs377267777",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1355,
  "fields": {
    "snp_id": "SNP1368",
    "rs_id": "rs377267777",
    "gene": "DISGENE380",
    "drug": "",
    "disease": "DIS536",
    "allele": "",
    "association_with": "Usher Syndrome, Type Ib (Disorder)",
    "reference": "REF700",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs377267777",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1356,
  "fields": {
    "snp_id": "SNP1369",
    "rs_id": "rs377294947",
    "gene": "DISGENE102",
    "drug": "",
    "disease": "DIS197",
    "allele": "",
    "association_with": "Fanconi Anemia, Complementation Group C",
    "reference": "REF488",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs377294947",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Asia, Europe",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1357,
  "fields": {
    "snp_id": "SNP1370",
    "rs_id": "rs377357931",
    "gene": "DISGENE381",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF716",
    "p_value": "0.003",
    "source": "DisGeNET",
    "id_in_source": "rs377357931",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1358,
  "fields": {
    "snp_id": "SNP1371",
    "rs_id": "rs3792267",
    "gene": "DISGENE382",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF779",
    "p_value": "0.034",
    "source": "DisGeNET",
    "id_in_source": "rs3792267",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1359,
  "fields": {
    "snp_id": "SNP1372",
    "rs_id": "rs3798220",
    "gene": "DISGENE383",
    "drug": "",
    "disease": "DIS126",
    "allele": "",
    "association_with": "Coronary Artery Disease",
    "reference": "REF347",
    "p_value": "0.034",
    "source": "DisGeNET",
    "id_in_source": "rs3798220",
    "region": "Mixed Population, Sub-Saharan Africa, North Africa",
    "country_of_participants": "Gabon, Egypt, South Africa",
    "latitude": "-0.8036900",
    "longitude": "11.6094400"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1360,
  "fields": {
    "snp_id": "SNP1373",
    "rs_id": "rs3824662",
    "gene": "DISGENE384",
    "drug": "",
    "disease": "DIS11",
    "allele": "",
    "association_with": "Acute Lymphocytic Leukemia",
    "reference": "REF245",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs3824662",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1361,
  "fields": {
    "snp_id": "SNP1374",
    "rs_id": "rs3824662",
    "gene": "DISGENE384",
    "drug": "",
    "disease": "DIS13",
    "allele": "",
    "association_with": "Adult Acute Lymphocytic Leukemia",
    "reference": "REF245",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs3824662",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1362,
  "fields": {
    "snp_id": "SNP1375",
    "rs_id": "rs3824662",
    "gene": "DISGENE384",
    "drug": "",
    "disease": "DIS102",
    "allele": "",
    "association_with": "Childhood Acute Lymphoblastic Leukemia",
    "reference": "REF245",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs3824662",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1363,
  "fields": {
    "snp_id": "SNP1376",
    "rs_id": "rs3825942",
    "gene": "DISGENE100",
    "drug": "",
    "disease": "DIS187",
    "allele": "",
    "association_with": "Exfoliation Syndrome",
    "reference": "REF389",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs3825942",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Ghana, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1364,
  "fields": {
    "snp_id": "SNP1377",
    "rs_id": "rs3825942",
    "gene": "DISGENE101",
    "drug": "",
    "disease": "DIS187",
    "allele": "",
    "association_with": "Exfoliation Syndrome",
    "reference": "REF389",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs3825942",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Ghana, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1365,
  "fields": {
    "snp_id": "SNP1378",
    "rs_id": "rs3825942",
    "gene": "DISGENE100",
    "drug": "",
    "disease": "DIS187",
    "allele": "",
    "association_with": "Exfoliation Syndrome",
    "reference": "REF698",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs3825942",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1366,
  "fields": {
    "snp_id": "SNP1379",
    "rs_id": "rs3825942",
    "gene": "DISGENE101",
    "drug": "",
    "disease": "DIS187",
    "allele": "",
    "association_with": "Exfoliation Syndrome",
    "reference": "REF698",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs3825942",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1367,
  "fields": {
    "snp_id": "SNP1380",
    "rs_id": "rs386134173",
    "gene": "DISGENE385",
    "drug": "",
    "disease": "DIS24",
    "allele": "",
    "association_with": "Amyotrophic Lateral Sclerosis 2, Juvenile (Disorder)",
    "reference": "REF318",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386134173",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1368,
  "fields": {
    "snp_id": "SNP1381",
    "rs_id": "rs386833435",
    "gene": "DISGENE386",
    "drug": "",
    "disease": "DIS36",
    "allele": "",
    "association_with": "Aspartylglucosaminuria",
    "reference": "REF227",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833435",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mauritius",
    "latitude": "-20.3484000",
    "longitude": "57.5522000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1369,
  "fields": {
    "snp_id": "SNP1382",
    "rs_id": "rs386833437",
    "gene": "DISGENE386",
    "drug": "",
    "disease": "DIS36",
    "allele": "",
    "association_with": "Aspartylglucosaminuria",
    "reference": "REF227",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833437",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mauritius",
    "latitude": "-20.3484000",
    "longitude": "57.5522000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1370,
  "fields": {
    "snp_id": "SNP1383",
    "rs_id": "rs386833441",
    "gene": "DISGENE269",
    "drug": "",
    "disease": "DIS531",
    "allele": "",
    "association_with": "Unverricht-Lundborg Syndrome",
    "reference": "REF648",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833441",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1371,
  "fields": {
    "snp_id": "SNP1384",
    "rs_id": "rs386833799",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833799",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1372,
  "fields": {
    "snp_id": "SNP1385",
    "rs_id": "rs386833800",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833800",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1373,
  "fields": {
    "snp_id": "SNP1386",
    "rs_id": "rs386833805",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833805",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1374,
  "fields": {
    "snp_id": "SNP1387",
    "rs_id": "rs386833812",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833812",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1375,
  "fields": {
    "snp_id": "SNP1388",
    "rs_id": "rs386833817",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833817",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1376,
  "fields": {
    "snp_id": "SNP1389",
    "rs_id": "rs386833818",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833818",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1377,
  "fields": {
    "snp_id": "SNP1390",
    "rs_id": "rs386833827",
    "gene": "DISGENE198",
    "drug": "",
    "disease": "DIS322",
    "allele": "",
    "association_with": "Lysinuric Protein Intolerance",
    "reference": "REF474",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386833827",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Italy, Japan",
    "latitude": "36.2048000",
    "longitude": "138.2529000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1378,
  "fields": {
    "snp_id": "SNP1391",
    "rs_id": "rs386834170",
    "gene": "DISGENE387",
    "drug": "",
    "disease": "DIS339",
    "allele": "",
    "association_with": "Megaloblastic Anemia Due To Inborn Errors Of Metabolism",
    "reference": "REF251",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs386834170",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1379,
  "fields": {
    "snp_id": "SNP1392",
    "rs_id": "rs387906220",
    "gene": "DISGENE388",
    "drug": "",
    "disease": "DIS151",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 79",
    "reference": "REF273",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906220",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1380,
  "fields": {
    "snp_id": "SNP1393",
    "rs_id": "rs387906221",
    "gene": "DISGENE388",
    "drug": "",
    "disease": "DIS151",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 79",
    "reference": "REF273",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906221",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1381,
  "fields": {
    "snp_id": "SNP1394",
    "rs_id": "rs387906222",
    "gene": "DISGENE388",
    "drug": "",
    "disease": "DIS151",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 79",
    "reference": "REF273",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906222",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1382,
  "fields": {
    "snp_id": "SNP1395",
    "rs_id": "rs387906301",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF303",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906301",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1383,
  "fields": {
    "snp_id": "SNP1396",
    "rs_id": "rs387906301",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF234",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906301",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1384,
  "fields": {
    "snp_id": "SNP1397",
    "rs_id": "rs387906563",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF795",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906563",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1385,
  "fields": {
    "snp_id": "SNP1398",
    "rs_id": "rs387906563",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF795",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906563",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1386,
  "fields": {
    "snp_id": "SNP1399",
    "rs_id": "rs387906563",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF795",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906563",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1387,
  "fields": {
    "snp_id": "SNP1400",
    "rs_id": "rs387906563",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF726",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906563",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Nigeria, Barbados, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1388,
  "fields": {
    "snp_id": "SNP1401",
    "rs_id": "rs387906563",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF726",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906563",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Nigeria, Barbados, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1389,
  "fields": {
    "snp_id": "SNP1402",
    "rs_id": "rs387906914",
    "gene": "DISGENE389",
    "drug": "",
    "disease": "DIS6",
    "allele": "",
    "association_with": "Acrodermatitis Continua Of Hallopeau",
    "reference": "REF613",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906914",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1390,
  "fields": {
    "snp_id": "SNP1403",
    "rs_id": "rs387906914",
    "gene": "DISGENE389",
    "drug": "",
    "disease": "DIS210",
    "allele": "",
    "association_with": "Generalized Pustular Psoriasis",
    "reference": "REF613",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906914",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1391,
  "fields": {
    "snp_id": "SNP1404",
    "rs_id": "rs387906959",
    "gene": "DISGENE390",
    "drug": "",
    "disease": "DIS123",
    "allele": "",
    "association_with": "Congenital Disorder Of Glycosylation, Type Iil",
    "reference": "REF658",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387906959",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1392,
  "fields": {
    "snp_id": "SNP1405",
    "rs_id": "rs387907012",
    "gene": "DISGENE391",
    "drug": "",
    "disease": "DIS350",
    "allele": "",
    "association_with": "Microcephaly, Epilepsy, And Diabetes Syndrome",
    "reference": "REF257",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907012",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1393,
  "fields": {
    "snp_id": "SNP1406",
    "rs_id": "rs387907107",
    "gene": "DISGENE392",
    "drug": "",
    "disease": "DIS127",
    "allele": "",
    "association_with": "Cranioectodermal Dysplasia 3",
    "reference": "REF422",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907107",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1394,
  "fields": {
    "snp_id": "SNP1407",
    "rs_id": "rs387907252",
    "gene": "DISGENE393",
    "drug": "",
    "disease": "DIS14",
    "allele": "",
    "association_with": "Agenesis Of Corpus Callosum",
    "reference": "REF250",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907252",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1395,
  "fields": {
    "snp_id": "SNP1408",
    "rs_id": "rs387907252",
    "gene": "DISGENE393",
    "drug": "",
    "disease": "DIS354",
    "allele": "",
    "association_with": "Microphthalmia, Syndromic 11",
    "reference": "REF250",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907252",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1396,
  "fields": {
    "snp_id": "SNP1409",
    "rs_id": "rs387907252",
    "gene": "DISGENE393",
    "drug": "",
    "disease": "DIS355",
    "allele": "",
    "association_with": "Microphthalmos",
    "reference": "REF250",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907252",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1397,
  "fields": {
    "snp_id": "SNP1410",
    "rs_id": "rs387907259",
    "gene": "DISGENE394",
    "drug": "",
    "disease": "DIS499",
    "allele": "",
    "association_with": "Spastic Paraplegia 30, Autosomal Recessive (Disorder)",
    "reference": "REF215",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907259",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1398,
  "fields": {
    "snp_id": "SNP1411",
    "rs_id": "rs387907267",
    "gene": "DISGENE365",
    "drug": "",
    "disease": "DIS262",
    "allele": "",
    "association_with": "Hypertrophic Cardiomyopathy",
    "reference": "REF338",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907267",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1399,
  "fields": {
    "snp_id": "SNP1412",
    "rs_id": "rs387907314",
    "gene": "DISGENE368",
    "drug": "",
    "disease": "DIS474",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 38 (Disorder)",
    "reference": "REF730",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907314",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1400,
  "fields": {
    "snp_id": "SNP1413",
    "rs_id": "rs387907333",
    "gene": "DISGENE395",
    "drug": "",
    "disease": "DIS403",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta Type Vii",
    "reference": "REF691",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907333",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1401,
  "fields": {
    "snp_id": "SNP1414",
    "rs_id": "rs387907373",
    "gene": "DISGENE396",
    "drug": "",
    "disease": "DIS552",
    "allele": "",
    "association_with": "X-Linked Adrenal Hypoplasia",
    "reference": "REF543",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907373",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Congo",
    "latitude": "-4.0383000",
    "longitude": "21.7587000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1402,
  "fields": {
    "snp_id": "SNP1415",
    "rs_id": "rs387907571",
    "gene": "DISGENE397",
    "drug": "",
    "disease": "DIS422",
    "allele": "",
    "association_with": "Parkinson Disease, Late-Onset",
    "reference": "REF172",
    "p_value": "0.00000000000052",
    "source": "DisGeNET",
    "id_in_source": "rs387907571",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Canada, Norway, Taiwan, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1403,
  "fields": {
    "snp_id": "SNP1416",
    "rs_id": "rs3917887",
    "gene": "DISGENE398",
    "drug": "",
    "disease": "DIS530",
    "allele": "",
    "association_with": "Tuberculosis, Spinal",
    "reference": "REF625",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs3917887",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1404,
  "fields": {
    "snp_id": "SNP1417",
    "rs_id": "rs397507173",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF618",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397507173",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, India, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1405,
  "fields": {
    "snp_id": "SNP1418",
    "rs_id": "rs397507858",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS69",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2",
    "reference": "REF393",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397507858",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1406,
  "fields": {
    "snp_id": "SNP1419",
    "rs_id": "rs397508538",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF794",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397508538",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1407,
  "fields": {
    "snp_id": "SNP1420",
    "rs_id": "rs397508604",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF304",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397508604",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1408,
  "fields": {
    "snp_id": "SNP1421",
    "rs_id": "rs397508700",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF817",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397508700",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1409,
  "fields": {
    "snp_id": "SNP1422",
    "rs_id": "rs397508988",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF393",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397508988",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1410,
  "fields": {
    "snp_id": "SNP1423",
    "rs_id": "rs397508988",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF288",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397508988",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1411,
  "fields": {
    "snp_id": "SNP1424",
    "rs_id": "rs397508988",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF687",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397508988",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1412,
  "fields": {
    "snp_id": "SNP1425",
    "rs_id": "rs397509050",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF742",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397509050",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1413,
  "fields": {
    "snp_id": "SNP1426",
    "rs_id": "rs397509050",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF742",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397509050",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1414,
  "fields": {
    "snp_id": "SNP1427",
    "rs_id": "rs397509050",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF742",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397509050",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1415,
  "fields": {
    "snp_id": "SNP1428",
    "rs_id": "rs397509050",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF533",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397509050",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1416,
  "fields": {
    "snp_id": "SNP1429",
    "rs_id": "rs397509050",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF210",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397509050",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1417,
  "fields": {
    "snp_id": "SNP1430",
    "rs_id": "rs397514341",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF763",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397514341",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1418,
  "fields": {
    "snp_id": "SNP1431",
    "rs_id": "rs397514357",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF763",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397514357",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1419,
  "fields": {
    "snp_id": "SNP1432",
    "rs_id": "rs397514386",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF618",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397514386",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, India, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1420,
  "fields": {
    "snp_id": "SNP1433",
    "rs_id": "rs397514398",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF618",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397514398",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, India, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1421,
  "fields": {
    "snp_id": "SNP1434",
    "rs_id": "rs397514409",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF763",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397514409",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1422,
  "fields": {
    "snp_id": "SNP1435",
    "rs_id": "rs397514411",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF618",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397514411",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, India, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1423,
  "fields": {
    "snp_id": "SNP1436",
    "rs_id": "rs397514414",
    "gene": "DISGENE292",
    "drug": "",
    "disease": "DIS58",
    "allele": "",
    "association_with": "Biotinidase Deficiency",
    "reference": "REF618",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397514414",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, India, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1424,
  "fields": {
    "snp_id": "SNP1437",
    "rs_id": "rs397514701",
    "gene": "DISGENE399",
    "drug": "",
    "disease": "DIS229",
    "allele": "",
    "association_with": "Growth Retardation, Alopecia, Pseudoanodontia And Optic Atrophy",
    "reference": "REF606",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397514701",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1425,
  "fields": {
    "snp_id": "SNP1438",
    "rs_id": "rs397515353",
    "gene": "DISGENE187",
    "drug": "",
    "disease": "DIS549",
    "allele": "",
    "association_with": "Xanthomatosis, Cerebrotendinous",
    "reference": "REF477",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397515353",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1426,
  "fields": {
    "snp_id": "SNP1439",
    "rs_id": "rs397515354",
    "gene": "DISGENE187",
    "drug": "",
    "disease": "DIS549",
    "allele": "",
    "association_with": "Xanthomatosis, Cerebrotendinous",
    "reference": "REF477",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397515354",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1427,
  "fields": {
    "snp_id": "SNP1440",
    "rs_id": "rs397515377",
    "gene": "DISGENE212",
    "drug": "",
    "disease": "DIS40",
    "allele": "",
    "association_with": "Ataxia With Vitamin E Deficiency",
    "reference": "REF612",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397515377",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1428,
  "fields": {
    "snp_id": "SNP1441",
    "rs_id": "rs397515377",
    "gene": "DISGENE212",
    "drug": "",
    "disease": "DIS40",
    "allele": "",
    "association_with": "Ataxia With Vitamin E Deficiency",
    "reference": "REF750",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397515377",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1429,
  "fields": {
    "snp_id": "SNP1442",
    "rs_id": "rs397515518",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF682",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397515518",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1430,
  "fields": {
    "snp_id": "SNP1443",
    "rs_id": "rs397516074",
    "gene": "DISGENE365",
    "drug": "",
    "disease": "DIS262",
    "allele": "",
    "association_with": "Hypertrophic Cardiomyopathy",
    "reference": "REF338",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397516074",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1431,
  "fields": {
    "snp_id": "SNP1444",
    "rs_id": "rs397516127",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS81",
    "allele": "",
    "association_with": "Cardiomyopathy, Hypertrophic, Familial",
    "reference": "REF338",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397516127",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1432,
  "fields": {
    "snp_id": "SNP1445",
    "rs_id": "rs397516127",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS262",
    "allele": "",
    "association_with": "Hypertrophic Cardiomyopathy",
    "reference": "REF338",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397516127",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1433,
  "fields": {
    "snp_id": "SNP1446",
    "rs_id": "rs397516986",
    "gene": "DISGENE298",
    "drug": "",
    "disease": "DIS32",
    "allele": "",
    "association_with": "Arrhythmogenic Right Ventricular Dysplasia",
    "reference": "REF686",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397516986",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1434,
  "fields": {
    "snp_id": "SNP1447",
    "rs_id": "rs397517021",
    "gene": "DISGENE298",
    "drug": "",
    "disease": "DIS32",
    "allele": "",
    "association_with": "Arrhythmogenic Right Ventricular Dysplasia",
    "reference": "REF686",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397517021",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1435,
  "fields": {
    "snp_id": "SNP1448",
    "rs_id": "rs397517963",
    "gene": "DISGENE373",
    "drug": "",
    "disease": "DIS540",
    "allele": "",
    "association_with": "Usher Syndrome, Type Iia",
    "reference": "REF813",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs397517963",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1436,
  "fields": {
    "snp_id": "SNP1449",
    "rs_id": "rs398122363",
    "gene": "DISGENE220",
    "drug": "",
    "disease": "DIS73",
    "allele": "",
    "association_with": "Candidiasis, Familial, 2",
    "reference": "REF378",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122363",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1437,
  "fields": {
    "snp_id": "SNP1450",
    "rs_id": "rs398122363",
    "gene": "DISGENE220",
    "drug": "",
    "disease": "DIS344",
    "allele": "",
    "association_with": "Meningoencephalitis",
    "reference": "REF289",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122363",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Asia",
    "latitude": "34.0479000",
    "longitude": "100.6197000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1438,
  "fields": {
    "snp_id": "SNP1451",
    "rs_id": "rs398122363",
    "gene": "DISGENE220",
    "drug": "",
    "disease": "DIS73",
    "allele": "",
    "association_with": "Candidiasis, Familial, 2",
    "reference": "REF502",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122363",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1439,
  "fields": {
    "snp_id": "SNP1452",
    "rs_id": "rs398122364",
    "gene": "DISGENE220",
    "drug": "",
    "disease": "DIS73",
    "allele": "",
    "association_with": "Candidiasis, Familial, 2",
    "reference": "REF378",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122364",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1440,
  "fields": {
    "snp_id": "SNP1453",
    "rs_id": "rs398122387",
    "gene": "DISGENE400",
    "drug": "",
    "disease": "DIS179",
    "allele": "",
    "association_with": "Epilepsy, Familial Adult Myoclonic, 5",
    "reference": "REF408",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122387",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1441,
  "fields": {
    "snp_id": "SNP1454",
    "rs_id": "rs398122409",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS381",
    "allele": "",
    "association_with": "Neurodegeneration With Brain Iron Accumulation 4",
    "reference": "REF736",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122409",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Mali, Brazil",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1442,
  "fields": {
    "snp_id": "SNP1455",
    "rs_id": "rs398122810",
    "gene": "DISGENE401",
    "drug": "",
    "disease": "DIS251",
    "allele": "",
    "association_with": "Hsan Type Iv",
    "reference": "REF486",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122810",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1443,
  "fields": {
    "snp_id": "SNP1456",
    "rs_id": "rs398122891",
    "gene": "DISGENE402",
    "drug": "",
    "disease": "DIS405",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta, Type Xiii",
    "reference": "REF762",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122891",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1444,
  "fields": {
    "snp_id": "SNP1457",
    "rs_id": "rs398122905",
    "gene": "DISGENE403",
    "drug": "",
    "disease": "DIS271",
    "allele": "",
    "association_with": "Ichthyosiform Erythroderma, Congenital",
    "reference": "REF557",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122905",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1445,
  "fields": {
    "snp_id": "SNP1458",
    "rs_id": "rs398122971",
    "gene": "DISGENE404",
    "drug": "",
    "disease": "DIS351",
    "allele": "",
    "association_with": "Microcephaly, Primary Autosomal Recessive, 3",
    "reference": "REF537",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398122971",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Somalia",
    "latitude": "5.1521000",
    "longitude": "46.1996000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1446,
  "fields": {
    "snp_id": "SNP1459",
    "rs_id": "rs398123012",
    "gene": "DISGENE405",
    "drug": "",
    "disease": "DIS501",
    "allele": "",
    "association_with": "Spastic Paraplegia 46, Autosomal Recessive",
    "reference": "REF693",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398123012",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1447,
  "fields": {
    "snp_id": "SNP1460",
    "rs_id": "rs398123014",
    "gene": "DISGENE405",
    "drug": "",
    "disease": "DIS501",
    "allele": "",
    "association_with": "Spastic Paraplegia 46, Autosomal Recessive",
    "reference": "REF457",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398123014",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1448,
  "fields": {
    "snp_id": "SNP1461",
    "rs_id": "rs398123015",
    "gene": "DISGENE405",
    "drug": "",
    "disease": "DIS501",
    "allele": "",
    "association_with": "Spastic Paraplegia 46, Autosomal Recessive",
    "reference": "REF457",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398123015",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1449,
  "fields": {
    "snp_id": "SNP1462",
    "rs_id": "rs398123044",
    "gene": "DISGENE406",
    "drug": "",
    "disease": "DIS117",
    "allele": "",
    "association_with": "Cone-Rod Dystrophy 18",
    "reference": "REF619",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398123044",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1450,
  "fields": {
    "snp_id": "SNP1463",
    "rs_id": "rs398123044",
    "gene": "DISGENE406",
    "drug": "",
    "disease": "DIS471",
    "allele": "",
    "association_with": "Retinitis Pigmentosa",
    "reference": "REF619",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398123044",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1451,
  "fields": {
    "snp_id": "SNP1464",
    "rs_id": "rs398123151",
    "gene": "DISGENE407",
    "drug": "",
    "disease": "DIS257",
    "allele": "",
    "association_with": "Hyperhomocysteinemia, Thrombotic, Cbs-Related",
    "reference": "REF666",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398123151",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Sudan, Saudi Arabia",
    "latitude": "23.8859000",
    "longitude": "45.0792000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1452,
  "fields": {
    "snp_id": "SNP1465",
    "rs_id": "rs398124208",
    "gene": "DISGENE151",
    "drug": "",
    "disease": "DIS224",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type V",
    "reference": "REF804",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398124208",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1453,
  "fields": {
    "snp_id": "SNP1466",
    "rs_id": "rs398124484",
    "gene": "DISGENE271",
    "drug": "",
    "disease": "DIS44",
    "allele": "",
    "association_with": "Autosomal Recessive Polycystic Kidney Disease",
    "reference": "REF499",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs398124484",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Iraq",
    "latitude": "33.2232000",
    "longitude": "43.6793000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1454,
  "fields": {
    "snp_id": "SNP1467",
    "rs_id": "rs41293463",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF365",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs41293463",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1455,
  "fields": {
    "snp_id": "SNP1468",
    "rs_id": "rs41380347",
    "gene": "DISGENE265",
    "drug": "",
    "disease": "DIS298",
    "allele": "",
    "association_with": "Lactase Persistence",
    "reference": "REF370",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs41380347",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya, Sudan, Tanzania",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1456,
  "fields": {
    "snp_id": "SNP1469",
    "rs_id": "rs414171",
    "gene": "DISGENE408",
    "drug": "",
    "disease": "DIS47",
    "allele": "",
    "association_with": "Bacteremia, Susceptibility To, 2",
    "reference": "REF450",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs414171",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Ghambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1457,
  "fields": {
    "snp_id": "SNP1470",
    "rs_id": "rs414171",
    "gene": "DISGENE408",
    "drug": "",
    "disease": "DIS327",
    "allele": "",
    "association_with": "Malaria, Susceptibility To (Finding)",
    "reference": "REF450",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs414171",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Ghambia, Kenya",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1458,
  "fields": {
    "snp_id": "SNP1471",
    "rs_id": "rs4143245",
    "gene": "DISGENE233",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4143245",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1459,
  "fields": {
    "snp_id": "SNP1472",
    "rs_id": "rs41525747",
    "gene": "DISGENE265",
    "drug": "",
    "disease": "DIS298",
    "allele": "",
    "association_with": "Lactase Persistence",
    "reference": "REF370",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs41525747",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya, Sudan, Tanzania",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1460,
  "fields": {
    "snp_id": "SNP1473",
    "rs_id": "rs4402960",
    "gene": "DISGENE268",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs4402960",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1461,
  "fields": {
    "snp_id": "SNP1474",
    "rs_id": "rs4402960",
    "gene": "DISGENE268",
    "drug": "",
    "disease": "DIS261",
    "allele": "",
    "association_with": "Hypertensive Disease",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs4402960",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1462,
  "fields": {
    "snp_id": "SNP1475",
    "rs_id": "rs4402960",
    "gene": "DISGENE268",
    "drug": "",
    "disease": "DIS396",
    "allele": "",
    "association_with": "Obesity",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs4402960",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1463,
  "fields": {
    "snp_id": "SNP1476",
    "rs_id": "rs4402960",
    "gene": "DISGENE268",
    "drug": "",
    "disease": "DIS407",
    "allele": "",
    "association_with": "Overweight",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs4402960",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1464,
  "fields": {
    "snp_id": "SNP1477",
    "rs_id": "rs4402960",
    "gene": "DISGENE268",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF504",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs4402960",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1465,
  "fields": {
    "snp_id": "SNP1478",
    "rs_id": "rs4506565",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF329",
    "p_value": "0.61",
    "source": "DisGeNET",
    "id_in_source": "rs4506565",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1466,
  "fields": {
    "snp_id": "SNP1479",
    "rs_id": "rs4506565",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF562",
    "p_value": "0.61",
    "source": "DisGeNET",
    "id_in_source": "rs4506565",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1467,
  "fields": {
    "snp_id": "SNP1480",
    "rs_id": "rs45467995",
    "gene": "DISGENE409",
    "drug": "",
    "disease": "DIS423",
    "allele": "",
    "association_with": "Parkinsonian Disorders",
    "reference": "REF358",
    "p_value": "0.61",
    "source": "DisGeNET",
    "id_in_source": "rs45467995",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1468,
  "fields": {
    "snp_id": "SNP1481",
    "rs_id": "rs45467995",
    "gene": "DISGENE410",
    "drug": "",
    "disease": "DIS423",
    "allele": "",
    "association_with": "Parkinsonian Disorders",
    "reference": "REF358",
    "p_value": "0.61",
    "source": "DisGeNET",
    "id_in_source": "rs45467995",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1469,
  "fields": {
    "snp_id": "SNP1482",
    "rs_id": "rs45539432",
    "gene": "DISGENE409",
    "drug": "",
    "disease": "DIS418",
    "allele": "",
    "association_with": "Parkinson Disease 6, Autosomal Recessive Early-Onset",
    "reference": "REF358",
    "p_value": "0.61",
    "source": "DisGeNET",
    "id_in_source": "rs45539432",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1470,
  "fields": {
    "snp_id": "SNP1483",
    "rs_id": "rs45539432",
    "gene": "DISGENE410",
    "drug": "",
    "disease": "DIS418",
    "allele": "",
    "association_with": "Parkinson Disease 6, Autosomal Recessive Early-Onset",
    "reference": "REF358",
    "p_value": "0.61",
    "source": "DisGeNET",
    "id_in_source": "rs45539432",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1471,
  "fields": {
    "snp_id": "SNP1484",
    "rs_id": "rs45539432",
    "gene": "DISGENE409",
    "drug": "",
    "disease": "DIS423",
    "allele": "",
    "association_with": "Parkinsonian Disorders",
    "reference": "REF358",
    "p_value": "0.61",
    "source": "DisGeNET",
    "id_in_source": "rs45539432",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1472,
  "fields": {
    "snp_id": "SNP1485",
    "rs_id": "rs45539432",
    "gene": "DISGENE410",
    "drug": "",
    "disease": "DIS423",
    "allele": "",
    "association_with": "Parkinsonian Disorders",
    "reference": "REF358",
    "p_value": "0.61",
    "source": "DisGeNET",
    "id_in_source": "rs45539432",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1473,
  "fields": {
    "snp_id": "SNP1486",
    "rs_id": "rs461645",
    "gene": "DISGENE372",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF368",
    "p_value": "0.02",
    "source": "DisGeNET",
    "id_in_source": "rs461645",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1474,
  "fields": {
    "snp_id": "SNP1487",
    "rs_id": "rs4833095",
    "gene": "DISGENE411",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF359",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs4833095",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1475,
  "fields": {
    "snp_id": "SNP1488",
    "rs_id": "rs4833095",
    "gene": "DISGENE411",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF359",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs4833095",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1476,
  "fields": {
    "snp_id": "SNP1489",
    "rs_id": "rs483352896",
    "gene": "DISGENE192",
    "drug": "",
    "disease": "DIS359",
    "allele": "",
    "association_with": "Mps Iii C",
    "reference": "REF182",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs483352896",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1477,
  "fields": {
    "snp_id": "SNP1490",
    "rs_id": "rs483352896",
    "gene": "DISGENE192",
    "drug": "",
    "disease": "DIS361",
    "allele": "",
    "association_with": "Mucopolysaccharidosis Iii",
    "reference": "REF182",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs483352896",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1478,
  "fields": {
    "snp_id": "SNP1491",
    "rs_id": "rs483352908",
    "gene": "DISGENE192",
    "drug": "",
    "disease": "DIS359",
    "allele": "",
    "association_with": "Mps Iii C",
    "reference": "REF182",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs483352908",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1479,
  "fields": {
    "snp_id": "SNP1492",
    "rs_id": "rs483352908",
    "gene": "DISGENE192",
    "drug": "",
    "disease": "DIS476",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 73",
    "reference": "REF182",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs483352908",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Spain",
    "latitude": "40.4637000",
    "longitude": "3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1480,
  "fields": {
    "snp_id": "SNP1493",
    "rs_id": "rs4842407",
    "gene": "DISGENE412",
    "drug": "",
    "disease": "DIS167",
    "allele": "",
    "association_with": "Drug-Induced Liver Disease",
    "reference": "REF722",
    "p_value": "0.00000053",
    "source": "DisGeNET",
    "id_in_source": "rs4842407",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1481,
  "fields": {
    "snp_id": "SNP1494",
    "rs_id": "rs4842407",
    "gene": "DISGENE412",
    "drug": "",
    "disease": "DIS249",
    "allele": "",
    "association_with": "Hiv Infections",
    "reference": "REF722",
    "p_value": "0.00000053",
    "source": "DisGeNET",
    "id_in_source": "rs4842407",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1482,
  "fields": {
    "snp_id": "SNP1495",
    "rs_id": "rs4842407",
    "gene": "DISGENE412",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF722",
    "p_value": "0.00000053",
    "source": "DisGeNET",
    "id_in_source": "rs4842407",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1483,
  "fields": {
    "snp_id": "SNP1496",
    "rs_id": "rs488069",
    "gene": "DISGENE413",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "0.00000076",
    "source": "DisGeNET",
    "id_in_source": "rs488069",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1484,
  "fields": {
    "snp_id": "SNP1497",
    "rs_id": "rs4939827",
    "gene": "DISGENE414",
    "drug": "",
    "disease": "DIS110",
    "allele": "",
    "association_with": "Colon Carcinoma",
    "reference": "REF473",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4939827",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1485,
  "fields": {
    "snp_id": "SNP1498",
    "rs_id": "rs4939827",
    "gene": "DISGENE414",
    "drug": "",
    "disease": "DIS112",
    "allele": "",
    "association_with": "Colorectal Cancer",
    "reference": "REF473",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4939827",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1486,
  "fields": {
    "snp_id": "SNP1499",
    "rs_id": "rs4939827",
    "gene": "DISGENE414",
    "drug": "",
    "disease": "DIS113",
    "allele": "",
    "association_with": "Colorectal Carcinoma",
    "reference": "REF473",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4939827",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1487,
  "fields": {
    "snp_id": "SNP1500",
    "rs_id": "rs4939827",
    "gene": "DISGENE414",
    "drug": "",
    "disease": "DIS334",
    "allele": "",
    "association_with": "Malignant Tumor Of Colon",
    "reference": "REF473",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4939827",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1488,
  "fields": {
    "snp_id": "SNP1501",
    "rs_id": "rs4939827",
    "gene": "DISGENE414",
    "drug": "",
    "disease": "DIS469",
    "allele": "",
    "association_with": "Rectal Carcinoma",
    "reference": "REF473",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4939827",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1489,
  "fields": {
    "snp_id": "SNP1502",
    "rs_id": "rs4951074",
    "gene": "DISGENE129",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.000000034",
    "source": "DisGeNET",
    "id_in_source": "rs4951074",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1490,
  "fields": {
    "snp_id": "SNP1503",
    "rs_id": "rs4951074",
    "gene": "DISGENE129",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs4951074",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1491,
  "fields": {
    "snp_id": "SNP1504",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF790",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1492,
  "fields": {
    "snp_id": "SNP1505",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS529",
    "allele": "",
    "association_with": "Tuberculosis, Pulmonary",
    "reference": "REF790",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1493,
  "fields": {
    "snp_id": "SNP1506",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF186",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1494,
  "fields": {
    "snp_id": "SNP1507",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS8",
    "allele": "",
    "association_with": "Active Tuberculosis",
    "reference": "REF187",
    "p_value": "0.79",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1495,
  "fields": {
    "snp_id": "SNP1508",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS528",
    "allele": "",
    "association_with": "Tuberculosis",
    "reference": "REF187",
    "p_value": "0.79",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1496,
  "fields": {
    "snp_id": "SNP1509",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS112",
    "allele": "",
    "association_with": "Colorectal Cancer",
    "reference": "REF816",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1497,
  "fields": {
    "snp_id": "SNP1510",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS113",
    "allele": "",
    "association_with": "Colorectal Carcinoma",
    "reference": "REF816",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1498,
  "fields": {
    "snp_id": "SNP1511",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS378",
    "allele": "",
    "association_with": "Neoplasm Metastasis",
    "reference": "REF816",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1499,
  "fields": {
    "snp_id": "SNP1512",
    "rs_id": "rs4986790",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS484",
    "allele": "",
    "association_with": "Secondary Malignant Neoplasm Of Lymph Node",
    "reference": "REF816",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986790",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1500,
  "fields": {
    "snp_id": "SNP1513",
    "rs_id": "rs4986791",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS112",
    "allele": "",
    "association_with": "Colorectal Cancer",
    "reference": "REF816",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986791",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1501,
  "fields": {
    "snp_id": "SNP1514",
    "rs_id": "rs4986791",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS113",
    "allele": "",
    "association_with": "Colorectal Carcinoma",
    "reference": "REF816",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986791",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1502,
  "fields": {
    "snp_id": "SNP1515",
    "rs_id": "rs4986791",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS378",
    "allele": "",
    "association_with": "Neoplasm Metastasis",
    "reference": "REF816",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986791",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1503,
  "fields": {
    "snp_id": "SNP1516",
    "rs_id": "rs4986791",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS484",
    "allele": "",
    "association_with": "Secondary Malignant Neoplasm Of Lymph Node",
    "reference": "REF816",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986791",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1504,
  "fields": {
    "snp_id": "SNP1517",
    "rs_id": "rs4986888",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF492",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986888",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1505,
  "fields": {
    "snp_id": "SNP1518",
    "rs_id": "rs4986888",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF492",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986888",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1506,
  "fields": {
    "snp_id": "SNP1519",
    "rs_id": "rs4986888",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF492",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986888",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1507,
  "fields": {
    "snp_id": "SNP1520",
    "rs_id": "rs4986888",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF492",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4986888",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1508,
  "fields": {
    "snp_id": "SNP1521",
    "rs_id": "rs4988235",
    "gene": "DISGENE265",
    "drug": "",
    "disease": "DIS298",
    "allele": "",
    "association_with": "Lactase Persistence",
    "reference": "REF766",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs4988235",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Ethiopia, Malawi, Nigeria, Senegal, Sudan, Uganda",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1509,
  "fields": {
    "snp_id": "SNP1522",
    "rs_id": "rs5010528",
    "gene": "PHARGENE49",
    "drug": "",
    "disease": "DIS249",
    "allele": "",
    "association_with": "Hiv Infections",
    "reference": "REF715",
    "p_value": "0.00603",
    "source": "DisGeNET",
    "id_in_source": "rs5010528",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1510,
  "fields": {
    "snp_id": "SNP1523",
    "rs_id": "rs5010528",
    "gene": "PHARGENE49",
    "drug": "",
    "disease": "DIS510",
    "allele": "",
    "association_with": "Stevens-Johnson Syndrome",
    "reference": "REF715",
    "p_value": "0.00000413",
    "source": "DisGeNET",
    "id_in_source": "rs5010528",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1511,
  "fields": {
    "snp_id": "SNP1524",
    "rs_id": "rs5010528",
    "gene": "PHARGENE49",
    "drug": "",
    "disease": "DIS526",
    "allele": "",
    "association_with": "Toxic Epidermal Necrolysis",
    "reference": "REF715",
    "p_value": "0.02",
    "source": "DisGeNET",
    "id_in_source": "rs5010528",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1512,
  "fields": {
    "snp_id": "SNP1525",
    "rs_id": "rs5030738",
    "gene": "DISGENE416",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF741",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5030738",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1513,
  "fields": {
    "snp_id": "SNP1526",
    "rs_id": "rs5030845",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF803",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5030845",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1514,
  "fields": {
    "snp_id": "SNP1527",
    "rs_id": "rs5030847",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF167",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5030847",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1515,
  "fields": {
    "snp_id": "SNP1528",
    "rs_id": "rs5030851",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF167",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5030851",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1516,
  "fields": {
    "snp_id": "SNP1529",
    "rs_id": "rs5030853",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF167",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5030853",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1517,
  "fields": {
    "snp_id": "SNP1530",
    "rs_id": "rs5030857",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF167",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5030857",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1518,
  "fields": {
    "snp_id": "SNP1531",
    "rs_id": "rs505151",
    "gene": "PHARGENE67",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF471",
    "p_value": "0.031",
    "source": "DisGeNET",
    "id_in_source": "rs505151",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mali",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1519,
  "fields": {
    "snp_id": "SNP1532",
    "rs_id": "rs505922",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.031",
    "source": "DisGeNET",
    "id_in_source": "rs505922",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1520,
  "fields": {
    "snp_id": "SNP1533",
    "rs_id": "rs505922",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.031",
    "source": "DisGeNET",
    "id_in_source": "rs505922",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1521,
  "fields": {
    "snp_id": "SNP1534",
    "rs_id": "rs515726205",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS381",
    "allele": "",
    "association_with": "Neurodegeneration With Brain Iron Accumulation 4",
    "reference": "REF736",
    "p_value": "0.031",
    "source": "DisGeNET",
    "id_in_source": "rs515726205",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Mali, Brazil",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1522,
  "fields": {
    "snp_id": "SNP1535",
    "rs_id": "rs5219",
    "gene": "DISGENE418",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF493",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5219",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1523,
  "fields": {
    "snp_id": "SNP1536",
    "rs_id": "rs5219",
    "gene": "DISGENE418",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF222",
    "p_value": "0.002",
    "source": "DisGeNET",
    "id_in_source": "rs5219",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1524,
  "fields": {
    "snp_id": "SNP1537",
    "rs_id": "rs5219",
    "gene": "DISGENE418",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF411",
    "p_value": "0.026",
    "source": "DisGeNET",
    "id_in_source": "rs5219",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Mauritius",
    "latitude": "-20.3484000",
    "longitude": "57.5522000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1525,
  "fields": {
    "snp_id": "SNP1538",
    "rs_id": "rs5219",
    "gene": "DISGENE418",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF768",
    "p_value": "0.007",
    "source": "DisGeNET",
    "id_in_source": "rs5219",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1526,
  "fields": {
    "snp_id": "SNP1539",
    "rs_id": "rs532063800",
    "gene": "DISGENE419",
    "drug": "",
    "disease": "DIS83",
    "allele": "",
    "association_with": "Cataract",
    "reference": "REF614",
    "p_value": "0.007",
    "source": "DisGeNET",
    "id_in_source": "rs532063800",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1527,
  "fields": {
    "snp_id": "SNP1540",
    "rs_id": "rs533478642",
    "gene": "DISGENE214",
    "drug": "",
    "disease": "DIS16",
    "allele": "",
    "association_with": "Albinism, Oculocutaneous",
    "reference": "REF277",
    "p_value": "0.007",
    "source": "DisGeNET",
    "id_in_source": "rs533478642",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1528,
  "fields": {
    "snp_id": "SNP1541",
    "rs_id": "rs533896621",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF521",
    "p_value": "0.007",
    "source": "DisGeNET",
    "id_in_source": "rs533896621",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, New Zealand",
    "latitude": "-40.9006000",
    "longitude": "174.8860000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1529,
  "fields": {
    "snp_id": "SNP1542",
    "rs_id": "rs536656846",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "0.007",
    "source": "DisGeNET",
    "id_in_source": "rs536656846",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1530,
  "fields": {
    "snp_id": "SNP1543",
    "rs_id": "rs542940704",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "0.007",
    "source": "DisGeNET",
    "id_in_source": "rs542940704",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1531,
  "fields": {
    "snp_id": "SNP1544",
    "rs_id": "rs542998",
    "gene": "DISGENE420",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF368",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs542998",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1532,
  "fields": {
    "snp_id": "SNP1545",
    "rs_id": "rs543287988",
    "gene": "DISGENE419",
    "drug": "",
    "disease": "DIS83",
    "allele": "",
    "association_with": "Cataract",
    "reference": "REF614",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs543287988",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1533,
  "fields": {
    "snp_id": "SNP1546",
    "rs_id": "rs544956641",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF540",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs544956641",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1534,
  "fields": {
    "snp_id": "SNP1547",
    "rs_id": "rs544956641",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs544956641",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1535,
  "fields": {
    "snp_id": "SNP1548",
    "rs_id": "rs5470",
    "gene": "DISGENE113",
    "drug": "",
    "disease": "DIS492",
    "allele": "",
    "association_with": "Sickle Cell Trait/ Trachoma",
    "reference": "REF282",
    "p_value": "< 0.07",
    "source": "DisGeNET",
    "id_in_source": "rs5470",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1536,
  "fields": {
    "snp_id": "SNP1549",
    "rs_id": "rs5470",
    "gene": "DISGENE112",
    "drug": "",
    "disease": "DIS492",
    "allele": "",
    "association_with": "Sickle Cell Trait/ Trachoma",
    "reference": "REF282",
    "p_value": "< 0.07",
    "source": "DisGeNET",
    "id_in_source": "rs5470",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1537,
  "fields": {
    "snp_id": "SNP1550",
    "rs_id": "rs5471",
    "gene": "DISGENE113",
    "drug": "",
    "disease": "DIS492",
    "allele": "",
    "association_with": "Sickle Cell Trait/ Trachoma",
    "reference": "REF282",
    "p_value": "< 0.07",
    "source": "DisGeNET",
    "id_in_source": "rs5471",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1538,
  "fields": {
    "snp_id": "SNP1551",
    "rs_id": "rs5471",
    "gene": "DISGENE112",
    "drug": "",
    "disease": "DIS492",
    "allele": "",
    "association_with": "Sickle Cell Trait/ Trachoma",
    "reference": "REF282",
    "p_value": "< 0.07",
    "source": "DisGeNET",
    "id_in_source": "rs5471",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1539,
  "fields": {
    "snp_id": "SNP1552",
    "rs_id": "rs5491",
    "gene": "DISGENE421",
    "drug": "",
    "disease": "DIS326",
    "allele": "",
    "association_with": "Malaria, Cerebral, Susceptibility To (Finding)",
    "reference": "REF755",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5491",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Chad, Kenya, Mozambique, Nigeria, Sudan, Tanzania",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1540,
  "fields": {
    "snp_id": "SNP1553",
    "rs_id": "rs5491",
    "gene": "DISGENE422",
    "drug": "",
    "disease": "DIS326",
    "allele": "",
    "association_with": "Malaria, Cerebral, Susceptibility To (Finding)",
    "reference": "REF755",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5491",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Chad, Kenya, Mozambique, Nigeria, Sudan, Tanzania",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1541,
  "fields": {
    "snp_id": "SNP1554",
    "rs_id": "rs5491",
    "gene": "DISGENE421",
    "drug": "",
    "disease": "DIS326",
    "allele": "",
    "association_with": "Malaria, Cerebral, Susceptibility To (Finding)",
    "reference": "REF688",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5491",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1542,
  "fields": {
    "snp_id": "SNP1555",
    "rs_id": "rs5491",
    "gene": "DISGENE422",
    "drug": "",
    "disease": "DIS326",
    "allele": "",
    "association_with": "Malaria, Cerebral, Susceptibility To (Finding)",
    "reference": "REF688",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs5491",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1543,
  "fields": {
    "snp_id": "SNP1556",
    "rs_id": "rs549625604",
    "gene": "DISGENE423",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF177",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs549625604",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1544,
  "fields": {
    "snp_id": "SNP1557",
    "rs_id": "rs550237440",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs550237440",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1545,
  "fields": {
    "snp_id": "SNP1558",
    "rs_id": "rs556450190",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS515",
    "allele": "",
    "association_with": "Stuttering",
    "reference": "REF714",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs556450190",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1546,
  "fields": {
    "snp_id": "SNP1559",
    "rs_id": "rs556450190",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS516",
    "allele": "",
    "association_with": "Stuttering, Developmental",
    "reference": "REF714",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs556450190",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1547,
  "fields": {
    "snp_id": "SNP1560",
    "rs_id": "rs556450190",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs556450190",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1548,
  "fields": {
    "snp_id": "SNP1561",
    "rs_id": "rs55739947",
    "gene": "DISGENE424",
    "drug": "",
    "disease": "DIS423",
    "allele": "",
    "association_with": "Parkinsonian Disorders",
    "reference": "REF224",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55739947",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1549,
  "fields": {
    "snp_id": "SNP1562",
    "rs_id": "rs55851803",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF365",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55851803",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1550,
  "fields": {
    "snp_id": "SNP1563",
    "rs_id": "rs55851803",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF365",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55851803",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1551,
  "fields": {
    "snp_id": "SNP1564",
    "rs_id": "rs55861249",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF466",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55861249",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1552,
  "fields": {
    "snp_id": "SNP1565",
    "rs_id": "rs55861249",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS39",
    "allele": "",
    "association_with": "Ataxia Telangiectasia",
    "reference": "REF711",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55861249",
    "region": "North African",
    "country_of_participants": "Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1553,
  "fields": {
    "snp_id": "SNP1566",
    "rs_id": "rs55861249",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF711",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55861249",
    "region": "North African",
    "country_of_participants": "Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1554,
  "fields": {
    "snp_id": "SNP1567",
    "rs_id": "rs55989760",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55989760",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1555,
  "fields": {
    "snp_id": "SNP1568",
    "rs_id": "rs55989760",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55989760",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1556,
  "fields": {
    "snp_id": "SNP1569",
    "rs_id": "rs55989760",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55989760",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1557,
  "fields": {
    "snp_id": "SNP1570",
    "rs_id": "rs55989760",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs55989760",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1558,
  "fields": {
    "snp_id": "SNP1571",
    "rs_id": "rs562853291",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF682",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs562853291",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1559,
  "fields": {
    "snp_id": "SNP1572",
    "rs_id": "rs563235254",
    "gene": "DISGENE214",
    "drug": "",
    "disease": "DIS16",
    "allele": "",
    "association_with": "Albinism, Oculocutaneous",
    "reference": "REF277",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs563235254",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1560,
  "fields": {
    "snp_id": "SNP1573",
    "rs_id": "rs56392418",
    "gene": "DISGENE426",
    "drug": "",
    "disease": "DIS336",
    "allele": "",
    "association_with": "Masp2 Deficiency",
    "reference": "REF669",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs56392418",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Zambia, Brazil, China, Denmark",
    "latitude": "35.8617000",
    "longitude": "104.1954000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1561,
  "fields": {
    "snp_id": "SNP1574",
    "rs_id": "rs565203731",
    "gene": "DISGENE122",
    "drug": "",
    "disease": "DIS496",
    "allele": "",
    "association_with": "Spastic Ataxia, Charlevoix-Saguenay Type",
    "reference": "REF419",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs565203731",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1562,
  "fields": {
    "snp_id": "SNP1575",
    "rs_id": "rs565203731",
    "gene": "DISGENE122",
    "drug": "",
    "disease": "DIS496",
    "allele": "",
    "association_with": "Spastic Ataxia, Charlevoix-Saguenay Type",
    "reference": "REF280",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs565203731",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1563,
  "fields": {
    "snp_id": "SNP1576",
    "rs_id": "rs566579877",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs566579877",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1564,
  "fields": {
    "snp_id": "SNP1577",
    "rs_id": "rs568612627",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF752",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs568612627",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1565,
  "fields": {
    "snp_id": "SNP1578",
    "rs_id": "rs568612627",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS156",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)",
    "reference": "REF752",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs568612627",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1566,
  "fields": {
    "snp_id": "SNP1579",
    "rs_id": "rs568612627",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS157",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "reference": "REF752",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs568612627",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1567,
  "fields": {
    "snp_id": "SNP1580",
    "rs_id": "rs569846003",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs569846003",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1568,
  "fields": {
    "snp_id": "SNP1581",
    "rs_id": "rs57077886",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF364",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57077886",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1569,
  "fields": {
    "snp_id": "SNP1582",
    "rs_id": "rs57077886",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF312",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57077886",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1570,
  "fields": {
    "snp_id": "SNP1583",
    "rs_id": "rs573931674",
    "gene": "DISGENE410",
    "drug": "",
    "disease": "DIS418",
    "allele": "",
    "association_with": "Parkinson Disease 6, Autosomal Recessive Early-Onset",
    "reference": "REF412",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs573931674",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Europe",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1571,
  "fields": {
    "snp_id": "SNP1584",
    "rs_id": "rs573931674",
    "gene": "DISGENE410",
    "drug": "",
    "disease": "DIS419",
    "allele": "",
    "association_with": "Parkinson Disease 6, Late-Onset, Susceptibility To",
    "reference": "REF412",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs573931674",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Europe",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1572,
  "fields": {
    "snp_id": "SNP1585",
    "rs_id": "rs574982768",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS465",
    "allele": "",
    "association_with": "Psoriasis 2",
    "reference": "REF220",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs574982768",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1573,
  "fields": {
    "snp_id": "SNP1586",
    "rs_id": "rs57749775",
    "gene": "DISGENE159",
    "drug": "",
    "disease": "DIS412",
    "allele": "",
    "association_with": "Pancreatitis",
    "reference": "REF258",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57749775",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Ethiopia, Europe",
    "latitude": "9.1450000",
    "longitude": "40.4897000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1574,
  "fields": {
    "snp_id": "SNP1587",
    "rs_id": "rs57749775",
    "gene": "DISGENE159",
    "drug": "",
    "disease": "DIS413",
    "allele": "",
    "association_with": "Pancreatitis, Chronic",
    "reference": "REF258",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57749775",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Ethiopia, Europe",
    "latitude": "9.1450000",
    "longitude": "40.4897000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1575,
  "fields": {
    "snp_id": "SNP1588",
    "rs_id": "rs577826548",
    "gene": "DISGENE214",
    "drug": "",
    "disease": "DIS16",
    "allele": "",
    "association_with": "Albinism, Oculocutaneous",
    "reference": "REF277",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs577826548",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1576,
  "fields": {
    "snp_id": "SNP1589",
    "rs_id": "rs57865060",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57865060",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1577,
  "fields": {
    "snp_id": "SNP1590",
    "rs_id": "rs57865060",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57865060",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1578,
  "fields": {
    "snp_id": "SNP1591",
    "rs_id": "rs57865060",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57865060",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1579,
  "fields": {
    "snp_id": "SNP1592",
    "rs_id": "rs57865060",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57865060",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1580,
  "fields": {
    "snp_id": "SNP1593",
    "rs_id": "rs57865060",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57865060",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1581,
  "fields": {
    "snp_id": "SNP1594",
    "rs_id": "rs57865060",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57865060",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1582,
  "fields": {
    "snp_id": "SNP1595",
    "rs_id": "rs57865060",
    "gene": "DISGENE103",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57865060",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1583,
  "fields": {
    "snp_id": "SNP1596",
    "rs_id": "rs57865060",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF366",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs57865060",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1584,
  "fields": {
    "snp_id": "SNP1597",
    "rs_id": "rs58596362",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS458",
    "allele": "",
    "association_with": "Progeria",
    "reference": "REF793",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs58596362",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1585,
  "fields": {
    "snp_id": "SNP1598",
    "rs_id": "rs587776416",
    "gene": "DISGENE290",
    "drug": "",
    "disease": "DIS65",
    "allele": "",
    "association_with": "Breast Cancer, Familial",
    "reference": "REF361",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776416",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Nigeria, Italy, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1586,
  "fields": {
    "snp_id": "SNP1599",
    "rs_id": "rs587776435",
    "gene": "DISGENE367",
    "drug": "",
    "disease": "DIS302",
    "allele": "",
    "association_with": "Leigh Disease",
    "reference": "REF331",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776435",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1587,
  "fields": {
    "snp_id": "SNP1600",
    "rs_id": "rs587776437",
    "gene": "DISGENE428",
    "drug": "",
    "disease": "DIS302",
    "allele": "",
    "association_with": "Leigh Disease",
    "reference": "REF645",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776437",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1588,
  "fields": {
    "snp_id": "SNP1601",
    "rs_id": "rs587776570",
    "gene": "DISGENE185",
    "drug": "",
    "disease": "DIS196",
    "allele": "",
    "association_with": "Fanconi Anemia, Complementation Group A (Disorder)",
    "reference": "REF427",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776570",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1589,
  "fields": {
    "snp_id": "SNP1602",
    "rs_id": "rs587776600",
    "gene": "DISGENE429",
    "drug": "",
    "disease": "DIS34",
    "allele": "",
    "association_with": "Arterial Tortuosity Syndrome",
    "reference": "REF390",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776600",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1590,
  "fields": {
    "snp_id": "SNP1603",
    "rs_id": "rs587776601",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF252",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776601",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Croatia",
    "latitude": "45.1000000",
    "longitude": "15.2000000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1591,
  "fields": {
    "snp_id": "SNP1604",
    "rs_id": "rs587776601",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF267",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776601",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1592,
  "fields": {
    "snp_id": "SNP1605",
    "rs_id": "rs587776601",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF433",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776601",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1593,
  "fields": {
    "snp_id": "SNP1606",
    "rs_id": "rs587776602",
    "gene": "DISGENE193",
    "drug": "",
    "disease": "DIS343",
    "allele": "",
    "association_with": "Meleda Disease",
    "reference": "REF252",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776602",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Croatia",
    "latitude": "45.1000000",
    "longitude": "15.2000000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1594,
  "fields": {
    "snp_id": "SNP1607",
    "rs_id": "rs587776640",
    "gene": "DISGENE430",
    "drug": "",
    "disease": "DIS198",
    "allele": "",
    "association_with": "Fanconi Anemia Complementation Group G",
    "reference": "REF265",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776640",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sub-Saharan Africa",
    "latitude": "23.8060780",
    "longitude": "11.2884520"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1595,
  "fields": {
    "snp_id": "SNP1608",
    "rs_id": "rs587776640",
    "gene": "DISGENE430",
    "drug": "",
    "disease": "DIS195",
    "allele": "",
    "association_with": "Fanconi Anemia",
    "reference": "REF798",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776640",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi, Mozambique, South Africa, Swaziland",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1596,
  "fields": {
    "snp_id": "SNP1609",
    "rs_id": "rs587776640",
    "gene": "DISGENE430",
    "drug": "",
    "disease": "DIS198",
    "allele": "",
    "association_with": "Fanconi Anemia Complementation Group G",
    "reference": "REF798",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776640",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi, Mozambique, South Africa, Swaziland",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1597,
  "fields": {
    "snp_id": "SNP1610",
    "rs_id": "rs587776640",
    "gene": "DISGENE430",
    "drug": "",
    "disease": "DIS196",
    "allele": "",
    "association_with": "Fanconi Anemia, Complementation Group A (Disorder)",
    "reference": "REF798",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776640",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi, Mozambique, South Africa, Swaziland",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1598,
  "fields": {
    "snp_id": "SNP1611",
    "rs_id": "rs587776650",
    "gene": "DISGENE431",
    "drug": "",
    "disease": "DIS392",
    "allele": "",
    "association_with": "Nijmegen Breakage Syndrome",
    "reference": "REF758",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776650",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Italy",
    "latitude": "41.8719000",
    "longitude": "12.5674000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1599,
  "fields": {
    "snp_id": "SNP1612",
    "rs_id": "rs587776783",
    "gene": "DISGENE206",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF356",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776783",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1600,
  "fields": {
    "snp_id": "SNP1613",
    "rs_id": "rs587776924",
    "gene": "DISGENE432",
    "drug": "",
    "disease": "DIS268",
    "allele": "",
    "association_with": "Hypotrichosis 11",
    "reference": "REF553",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776924",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, UK",
    "latitude": "55.3781000",
    "longitude": "-3.4360000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1601,
  "fields": {
    "snp_id": "SNP1614",
    "rs_id": "rs587776925",
    "gene": "DISGENE432",
    "drug": "",
    "disease": "DIS268",
    "allele": "",
    "association_with": "Hypotrichosis 11",
    "reference": "REF553",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776925",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, UK",
    "latitude": "55.3781000",
    "longitude": "-3.4360000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1602,
  "fields": {
    "snp_id": "SNP1615",
    "rs_id": "rs587776925",
    "gene": "DISGENE432",
    "drug": "",
    "disease": "DIS270",
    "allele": "",
    "association_with": "Hypotrichosis Simplex",
    "reference": "REF553",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776925",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, UK",
    "latitude": "55.3781000",
    "longitude": "-3.4360000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1603,
  "fields": {
    "snp_id": "SNP1616",
    "rs_id": "rs587776996",
    "gene": "DISGENE433",
    "drug": "",
    "disease": "DIS273",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 9",
    "reference": "REF792",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587776996",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1604,
  "fields": {
    "snp_id": "SNP1617",
    "rs_id": "rs587777197",
    "gene": "DISGENE434",
    "drug": "",
    "disease": "DIS38",
    "allele": "",
    "association_with": "Ataxia, Spastic, 2, Autosomal Recessive (Disorder)",
    "reference": "REF671",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777197",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Israel",
    "latitude": "41.8719000",
    "longitude": "12.5674000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1605,
  "fields": {
    "snp_id": "SNP1618",
    "rs_id": "rs587777198",
    "gene": "DISGENE434",
    "drug": "",
    "disease": "DIS38",
    "allele": "",
    "association_with": "Ataxia, Spastic, 2, Autosomal Recessive (Disorder)",
    "reference": "REF671",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777198",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Israel",
    "latitude": "41.8719000",
    "longitude": "12.5674000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1606,
  "fields": {
    "snp_id": "SNP1619",
    "rs_id": "rs587777416",
    "gene": "DISGENE340",
    "drug": "",
    "disease": "DIS281",
    "allele": "",
    "association_with": "Immunodeficiency 23",
    "reference": "REF640",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777416",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1607,
  "fields": {
    "snp_id": "SNP1620",
    "rs_id": "rs587777465",
    "gene": "DISGENE435",
    "drug": "",
    "disease": "DIS449",
    "allele": "",
    "association_with": "Pontocerebellar Hypoplasia, Type 2E",
    "reference": "REF264",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777465",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1608,
  "fields": {
    "snp_id": "SNP1621",
    "rs_id": "rs587777466",
    "gene": "DISGENE435",
    "drug": "",
    "disease": "DIS449",
    "allele": "",
    "association_with": "Pontocerebellar Hypoplasia, Type 2E",
    "reference": "REF264",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777466",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1609,
  "fields": {
    "snp_id": "SNP1622",
    "rs_id": "rs587777532",
    "gene": "DISGENE98",
    "drug": "",
    "disease": "DIS415",
    "allele": "",
    "association_with": "Papillon-Lefevre Disease",
    "reference": "REF261",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777532",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1610,
  "fields": {
    "snp_id": "SNP1623",
    "rs_id": "rs587777533",
    "gene": "DISGENE98",
    "drug": "",
    "disease": "DIS415",
    "allele": "",
    "association_with": "Papillon-Lefevre Disease",
    "reference": "REF261",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777533",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1611,
  "fields": {
    "snp_id": "SNP1624",
    "rs_id": "rs587777534",
    "gene": "DISGENE98",
    "drug": "",
    "disease": "DIS415",
    "allele": "",
    "association_with": "Papillon-Lefevre Disease",
    "reference": "REF261",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777534",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1612,
  "fields": {
    "snp_id": "SNP1625",
    "rs_id": "rs587777691",
    "gene": "DISGENE436",
    "drug": "",
    "disease": "DIS145",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 102",
    "reference": "REF379",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777691",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1613,
  "fields": {
    "snp_id": "SNP1626",
    "rs_id": "rs587777716",
    "gene": "DISGENE381",
    "drug": "",
    "disease": "DIS445",
    "allele": "",
    "association_with": "Polymicrogyria, Bilateral Occipital",
    "reference": "REF171",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777716",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1614,
  "fields": {
    "snp_id": "SNP1627",
    "rs_id": "rs587777716",
    "gene": "DISGENE381",
    "drug": "",
    "disease": "DIS445",
    "allele": "",
    "association_with": "Polymicrogyria, Bilateral Occipital",
    "reference": "REF716",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777716",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1615,
  "fields": {
    "snp_id": "SNP1628",
    "rs_id": "rs587777716",
    "gene": "DISGENE381",
    "drug": "",
    "disease": "DIS446",
    "allele": "",
    "association_with": "Polymicrogyria, Bilateral Temporooccipital",
    "reference": "REF716",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587777716",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1616,
  "fields": {
    "snp_id": "SNP1629",
    "rs_id": "rs587778812",
    "gene": "DISGENE187",
    "drug": "",
    "disease": "DIS549",
    "allele": "",
    "association_with": "Xanthomatosis, Cerebrotendinous",
    "reference": "REF477",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587778812",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1617,
  "fields": {
    "snp_id": "SNP1630",
    "rs_id": "rs587780078",
    "gene": "DISGENE362",
    "drug": "",
    "disease": "DIS110",
    "allele": "",
    "association_with": "Colon Carcinoma",
    "reference": "REF483",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587780078",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1618,
  "fields": {
    "snp_id": "SNP1631",
    "rs_id": "rs587780078",
    "gene": "DISGENE362",
    "drug": "",
    "disease": "DIS110",
    "allele": "",
    "association_with": "Colon Carcinoma",
    "reference": "REF785",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587780078",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1619,
  "fields": {
    "snp_id": "SNP1632",
    "rs_id": "rs587780078",
    "gene": "DISGENE362",
    "drug": "",
    "disease": "DIS111",
    "allele": "",
    "association_with": "Colorectal Adenomatous Polyposis, Autosomal Recessive",
    "reference": "REF785",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587780078",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1620,
  "fields": {
    "snp_id": "SNP1633",
    "rs_id": "rs587780078",
    "gene": "DISGENE362",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF785",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587780078",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1621,
  "fields": {
    "snp_id": "SNP1634",
    "rs_id": "rs587781245",
    "gene": "DISGENE437",
    "drug": "",
    "disease": "DIS20",
    "allele": "",
    "association_with": "Alopecia",
    "reference": "REF321",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587781245",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1622,
  "fields": {
    "snp_id": "SNP1635",
    "rs_id": "rs587781245",
    "gene": "DISGENE437",
    "drug": "",
    "disease": "DIS409",
    "allele": "",
    "association_with": "Palmoplantar Keratosis",
    "reference": "REF321",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587781245",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1623,
  "fields": {
    "snp_id": "SNP1636",
    "rs_id": "rs587781347",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS39",
    "allele": "",
    "association_with": "Ataxia Telangiectasia",
    "reference": "REF466",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587781347",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1624,
  "fields": {
    "snp_id": "SNP1637",
    "rs_id": "rs587781558",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS39",
    "allele": "",
    "association_with": "Ataxia Telangiectasia",
    "reference": "REF466",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587781558",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1625,
  "fields": {
    "snp_id": "SNP1638",
    "rs_id": "rs587781558",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF466",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587781558",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1626,
  "fields": {
    "snp_id": "SNP1639",
    "rs_id": "rs587783211",
    "gene": "DISGENE264",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF593",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587783211",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1627,
  "fields": {
    "snp_id": "SNP1640",
    "rs_id": "rs587783309",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs587783309",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1628,
  "fields": {
    "snp_id": "SNP1641",
    "rs_id": "rs5928",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF303",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs5928",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1629,
  "fields": {
    "snp_id": "SNP1642",
    "rs_id": "rs5928",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS315",
    "allele": "",
    "association_with": "Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2",
    "reference": "REF303",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs5928",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1630,
  "fields": {
    "snp_id": "SNP1643",
    "rs_id": "rs59885338",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS96",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 2B1",
    "reference": "REF242",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs59885338",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1631,
  "fields": {
    "snp_id": "SNP1644",
    "rs_id": "rs59885338",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS93",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease",
    "reference": "REF384",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs59885338",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1632,
  "fields": {
    "snp_id": "SNP1645",
    "rs_id": "rs59885338",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS93",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease",
    "reference": "REF312",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs59885338",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1633,
  "fields": {
    "snp_id": "SNP1646",
    "rs_id": "rs59885338",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS96",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 2B1",
    "reference": "REF312",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs59885338",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1634,
  "fields": {
    "snp_id": "SNP1647",
    "rs_id": "rs59885338",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS242",
    "allele": "",
    "association_with": "Hereditary Motor And Sensory-Neuropathy Type Ii",
    "reference": "REF312",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs59885338",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1635,
  "fields": {
    "snp_id": "SNP1648",
    "rs_id": "rs59885338",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS96",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 2B1",
    "reference": "REF266",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs59885338",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1636,
  "fields": {
    "snp_id": "SNP1649",
    "rs_id": "rs59885338",
    "gene": "DISGENE427",
    "drug": "",
    "disease": "DIS242",
    "allele": "",
    "association_with": "Hereditary Motor And Sensory-Neuropathy Type Ii",
    "reference": "REF266",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs59885338",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1637,
  "fields": {
    "snp_id": "SNP1650",
    "rs_id": "rs6008813",
    "gene": "DISGENE438",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000434",
    "source": "DisGeNET",
    "id_in_source": "rs6008813",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1638,
  "fields": {
    "snp_id": "SNP1651",
    "rs_id": "rs601338",
    "gene": "DISGENE439",
    "drug": "",
    "disease": "DIS285",
    "allele": "",
    "association_with": "Infection Caused By Helicobacter Pylori",
    "reference": "REF453",
    "p_value": "0.0008",
    "source": "DisGeNET",
    "id_in_source": "rs601338",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Sub-Saharan Africa, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1639,
  "fields": {
    "snp_id": "SNP1652",
    "rs_id": "rs6021191",
    "gene": "DISGENE440",
    "drug": "",
    "disease": "DIS11",
    "allele": "",
    "association_with": "Acute Lymphocytic Leukemia",
    "reference": "REF247",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs6021191",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1640,
  "fields": {
    "snp_id": "SNP1653",
    "rs_id": "rs6021191",
    "gene": "DISGENE440",
    "drug": "",
    "disease": "DIS453",
    "allele": "",
    "association_with": "Precursor Cell Lymphoblastic Leukemia Lymphoma",
    "reference": "REF247",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs6021191",
    "region": "Mixed Population",
    "country_of_participants": "Africa, America, Asia, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1641,
  "fields": {
    "snp_id": "SNP1654",
    "rs_id": "rs60431989",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF571",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs60431989",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1642,
  "fields": {
    "snp_id": "SNP1655",
    "rs_id": "rs606231119",
    "gene": "DISGENE441",
    "drug": "",
    "disease": "DIS527",
    "allele": "",
    "association_with": "Transcolabamin Ii Deficiency",
    "reference": "REF404",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs606231119",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1643,
  "fields": {
    "snp_id": "SNP1656",
    "rs_id": "rs606231234",
    "gene": "DISGENE442",
    "drug": "",
    "disease": "DIS116",
    "allele": "",
    "association_with": "Complete Hydatidiform Mole",
    "reference": "REF639",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs606231234",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1644,
  "fields": {
    "snp_id": "SNP1657",
    "rs_id": "rs606231276",
    "gene": "DISGENE140",
    "drug": "",
    "disease": "DIS426",
    "allele": "",
    "association_with": "Peeling Skin Syndrome, Acral Type",
    "reference": "REF677",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs606231276",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1645,
  "fields": {
    "snp_id": "SNP1658",
    "rs_id": "rs606231410",
    "gene": "DISGENE443",
    "drug": "",
    "disease": "DIS149",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 53",
    "reference": "REF603",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs606231410",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Turkey",
    "latitude": "38.9637000",
    "longitude": "35.2433000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1646,
  "fields": {
    "snp_id": "SNP1659",
    "rs_id": "rs606231410",
    "gene": "DISGENE443",
    "drug": "",
    "disease": "DIS394",
    "allele": "",
    "association_with": "Nonsyndromic Deafness",
    "reference": "REF603",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs606231410",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Turkey",
    "latitude": "38.9637000",
    "longitude": "35.2433000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1647,
  "fields": {
    "snp_id": "SNP1660",
    "rs_id": "rs60791294",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS228",
    "allele": "",
    "association_with": "Gronblad-Strandberg Syndrome",
    "reference": "REF549",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs60791294",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1648,
  "fields": {
    "snp_id": "SNP1661",
    "rs_id": "rs60791294",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF549",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs60791294",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1649,
  "fields": {
    "snp_id": "SNP1662",
    "rs_id": "rs60791294",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS463",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs60791294",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1650,
  "fields": {
    "snp_id": "SNP1663",
    "rs_id": "rs60791294",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS467",
    "allele": "",
    "association_with": "Pxe, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "0.000000041",
    "source": "DisGeNET",
    "id_in_source": "rs60791294",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1651,
  "fields": {
    "snp_id": "SNP1664",
    "rs_id": "rs60910145",
    "gene": "DISGENE321",
    "drug": "",
    "disease": "DIS204",
    "allele": "",
    "association_with": "Focal Segmental Glomerulosclerosis 4, Susceptibility To",
    "reference": "REF418",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs60910145",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1652,
  "fields": {
    "snp_id": "SNP1665",
    "rs_id": "rs610604",
    "gene": "DISGENE444",
    "drug": "",
    "disease": "DIS464",
    "allele": "",
    "association_with": "Psoriasis",
    "reference": "REF500",
    "p_value": "0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs610604",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1653,
  "fields": {
    "snp_id": "SNP1666",
    "rs_id": "rs6139258",
    "gene": "DISGENE445",
    "drug": "",
    "disease": "DIS167",
    "allele": "",
    "association_with": "Drug-Induced Liver Disease",
    "reference": "REF715",
    "p_value": "0.00000664",
    "source": "DisGeNET",
    "id_in_source": "rs6139258",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1654,
  "fields": {
    "snp_id": "SNP1667",
    "rs_id": "rs6139258",
    "gene": "DISGENE445",
    "drug": "",
    "disease": "DIS249",
    "allele": "",
    "association_with": "Hiv Infections",
    "reference": "REF715",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs6139258",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Malawi",
    "latitude": "-13.2543080",
    "longitude": "34.3015250"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1655,
  "fields": {
    "snp_id": "SNP1668",
    "rs_id": "rs61495246",
    "gene": "DISGENE446",
    "drug": "",
    "disease": "DIS543",
    "allele": "",
    "association_with": "Vitamin D Hydroxylation-Deficient Rickets, Type 1B",
    "reference": "REF392",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs61495246",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1656,
  "fields": {
    "snp_id": "SNP1669",
    "rs_id": "rs61495246",
    "gene": "DISGENE446",
    "drug": "",
    "disease": "DIS543",
    "allele": "",
    "association_with": "Vitamin D Hydroxylation-Deficient Rickets, Type 1B",
    "reference": "REF351",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs61495246",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1657,
  "fields": {
    "snp_id": "SNP1670",
    "rs_id": "rs61732239",
    "gene": "DISGENE447",
    "drug": "",
    "disease": "DIS411",
    "allele": "",
    "association_with": "Pancreatic Ductal Adenocarcinoma",
    "reference": "REF444",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs61732239",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Somalia",
    "latitude": "5.1521000",
    "longitude": "46.1996000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1658,
  "fields": {
    "snp_id": "SNP1671",
    "rs_id": "rs61738009",
    "gene": "DISGENE155",
    "drug": "",
    "disease": "DIS178",
    "allele": "",
    "association_with": "Epilepsies, Partial",
    "reference": "REF183",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs61738009",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1659,
  "fields": {
    "snp_id": "SNP1672",
    "rs_id": "rs61738009",
    "gene": "DISGENE155",
    "drug": "",
    "disease": "DIS180",
    "allele": "",
    "association_with": "Epilepsy, Familial Temporal Lobe, 5",
    "reference": "REF183",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs61738009",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1660,
  "fields": {
    "snp_id": "SNP1673",
    "rs_id": "rs61738009",
    "gene": "DISGENE155",
    "drug": "",
    "disease": "DIS183",
    "allele": "",
    "association_with": "Epilepsy, Temporal Lobe",
    "reference": "REF183",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs61738009",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1661,
  "fields": {
    "snp_id": "SNP1674",
    "rs_id": "rs61738009",
    "gene": "DISGENE155",
    "drug": "",
    "disease": "DIS200",
    "allele": "",
    "association_with": "Febrile Convulsions",
    "reference": "REF183",
    "p_value": "0.03",
    "source": "DisGeNET",
    "id_in_source": "rs61738009",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1662,
  "fields": {
    "snp_id": "SNP1675",
    "rs_id": "rs61749035",
    "gene": "DISGENE448",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61749035",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1663,
  "fields": {
    "snp_id": "SNP1676",
    "rs_id": "rs61749035",
    "gene": "DISGENE449",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61749035",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1664,
  "fields": {
    "snp_id": "SNP1677",
    "rs_id": "rs61749409",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF279",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61749409",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1665,
  "fields": {
    "snp_id": "SNP1678",
    "rs_id": "rs61749423",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF478",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61749423",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1666,
  "fields": {
    "snp_id": "SNP1679",
    "rs_id": "rs61751402",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF279",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61751402",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1667,
  "fields": {
    "snp_id": "SNP1680",
    "rs_id": "rs61751408",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF279",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61751408",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1668,
  "fields": {
    "snp_id": "SNP1681",
    "rs_id": "rs61752361",
    "gene": "DISGENE354",
    "drug": "",
    "disease": "DIS479",
    "allele": "",
    "association_with": "Rett Syndrome",
    "reference": "REF604",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61752361",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1669,
  "fields": {
    "snp_id": "SNP1682",
    "rs_id": "rs61752717",
    "gene": "DISGENE117",
    "drug": "",
    "disease": "DIS192",
    "allele": "",
    "association_with": "Familial Mediterranean Fever",
    "reference": "REF426",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61752717",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1670,
  "fields": {
    "snp_id": "SNP1683",
    "rs_id": "rs61752717",
    "gene": "DISGENE117",
    "drug": "",
    "disease": "DIS192",
    "allele": "",
    "association_with": "Familial Mediterranean Fever",
    "reference": "REF391",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61752717",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1671,
  "fields": {
    "snp_id": "SNP1684",
    "rs_id": "rs61753180",
    "gene": "DISGENE110",
    "drug": "",
    "disease": "DIS397",
    "allele": "",
    "association_with": "Oculocutaneous Albinism Type 1",
    "reference": "REF283",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61753180",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Morocco, Tunisia, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1672,
  "fields": {
    "snp_id": "SNP1685",
    "rs_id": "rs61753219",
    "gene": "DISGENE339",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF434",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61753219",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1673,
  "fields": {
    "snp_id": "SNP1686",
    "rs_id": "rs61754375",
    "gene": "DISGENE110",
    "drug": "",
    "disease": "DIS397",
    "allele": "",
    "association_with": "Oculocutaneous Albinism Type 1",
    "reference": "REF283",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61754375",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Morocco, Tunisia, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1674,
  "fields": {
    "snp_id": "SNP1687",
    "rs_id": "rs61754388",
    "gene": "DISGENE110",
    "drug": "",
    "disease": "DIS397",
    "allele": "",
    "association_with": "Oculocutaneous Albinism Type 1",
    "reference": "REF283",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61754388",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Morocco, Tunisia, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1675,
  "fields": {
    "snp_id": "SNP1688",
    "rs_id": "rs61755320",
    "gene": "DISGENE450",
    "drug": "",
    "disease": "DIS234",
    "allele": "",
    "association_with": "Henoch-Schoenlein Purpura",
    "reference": "REF528",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61755320",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Europe",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1676,
  "fields": {
    "snp_id": "SNP1689",
    "rs_id": "rs61755320",
    "gene": "DISGENE450",
    "drug": "",
    "disease": "DIS504",
    "allele": "",
    "association_with": "Spastic Paraplegia 7, Autosomal Recessive",
    "reference": "REF528",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61755320",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Europe",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1677,
  "fields": {
    "snp_id": "SNP1690",
    "rs_id": "rs61759921",
    "gene": "DISGENE451",
    "drug": "",
    "disease": "DIS70",
    "allele": "",
    "association_with": "Bronchiectasis With Or Without Elevated Sweat Chloride 1",
    "reference": "REF729",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61759921",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Rwanda",
    "latitude": "-1.9402780",
    "longitude": "29.8738880"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1678,
  "fields": {
    "snp_id": "SNP1691",
    "rs_id": "rs61761869",
    "gene": "DISGENE452",
    "drug": "",
    "disease": "DIS21",
    "allele": "",
    "association_with": "Alpha 1-Antitrypsin Deficiency",
    "reference": "REF308",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61761869",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Guinea",
    "latitude": "9.9456000",
    "longitude": "-9.6966000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1679,
  "fields": {
    "snp_id": "SNP1692",
    "rs_id": "rs61761869",
    "gene": "DISGENE452",
    "drug": "",
    "disease": "DIS21",
    "allele": "",
    "association_with": "Alpha 1-Antitrypsin Deficiency",
    "reference": "REF770",
    "p_value": "0.00000075",
    "source": "DisGeNET",
    "id_in_source": "rs61761869",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1680,
  "fields": {
    "snp_id": "SNP1695",
    "rs_id": "rs62477096",
    "gene": "DISGENE454",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62477096",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1681,
  "fields": {
    "snp_id": "SNP1696",
    "rs_id": "rs62508646",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF167",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508646",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1682,
  "fields": {
    "snp_id": "SNP1697",
    "rs_id": "rs62508646",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS108",
    "allele": "",
    "association_with": "Classical Phenylketonuria",
    "reference": "REF216",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508646",
    "region": "North African",
    "country_of_participants": "Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1683,
  "fields": {
    "snp_id": "SNP1698",
    "rs_id": "rs62508646",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF216",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508646",
    "region": "North African",
    "country_of_participants": "Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1684,
  "fields": {
    "snp_id": "SNP1699",
    "rs_id": "rs62508698",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS108",
    "allele": "",
    "association_with": "Classical Phenylketonuria",
    "reference": "REF676",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508698",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1685,
  "fields": {
    "snp_id": "SNP1700",
    "rs_id": "rs62508698",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS260",
    "allele": "",
    "association_with": "Hyperphenylalaninemia, Non-Pku Mild",
    "reference": "REF676",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508698",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1686,
  "fields": {
    "snp_id": "SNP1701",
    "rs_id": "rs62508698",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS430",
    "allele": "",
    "association_with": "Phenylketonuria, Maternal",
    "reference": "REF676",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508698",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1687,
  "fields": {
    "snp_id": "SNP1702",
    "rs_id": "rs62508698",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF676",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508698",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1688,
  "fields": {
    "snp_id": "SNP1703",
    "rs_id": "rs62508730",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF167",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508730",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1689,
  "fields": {
    "snp_id": "SNP1704",
    "rs_id": "rs62508734",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF676",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62508734",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1690,
  "fields": {
    "snp_id": "SNP1705",
    "rs_id": "rs62516094",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF727",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62516094",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1691,
  "fields": {
    "snp_id": "SNP1706",
    "rs_id": "rs62516146",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF167",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62516146",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1692,
  "fields": {
    "snp_id": "SNP1707",
    "rs_id": "rs62589000",
    "gene": "DISGENE455",
    "drug": "",
    "disease": "DIS396",
    "allele": "",
    "association_with": "Obesity",
    "reference": "REF617",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62589000",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1693,
  "fields": {
    "snp_id": "SNP1708",
    "rs_id": "rs62625011",
    "gene": "DISGENE456",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1694,
  "fields": {
    "snp_id": "SNP1709",
    "rs_id": "rs62625011",
    "gene": "DISGENE457",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1695,
  "fields": {
    "snp_id": "SNP1710",
    "rs_id": "rs62625011",
    "gene": "DISGENE458",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1696,
  "fields": {
    "snp_id": "SNP1711",
    "rs_id": "rs62625011",
    "gene": "DISGENE459",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1697,
  "fields": {
    "snp_id": "SNP1712",
    "rs_id": "rs62625011",
    "gene": "DISGENE460",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1698,
  "fields": {
    "snp_id": "SNP1713",
    "rs_id": "rs62625011",
    "gene": "DISGENE461",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1699,
  "fields": {
    "snp_id": "SNP1714",
    "rs_id": "rs62625011",
    "gene": "DISGENE462",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1700,
  "fields": {
    "snp_id": "SNP1715",
    "rs_id": "rs62625011",
    "gene": "PHARGENE86",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1701,
  "fields": {
    "snp_id": "SNP1716",
    "rs_id": "rs62625011",
    "gene": "DISGENE463",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62625011",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1702,
  "fields": {
    "snp_id": "SNP1717",
    "rs_id": "rs62642937",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS259",
    "allele": "",
    "association_with": "Hyperphenylalaninaemia",
    "reference": "REF167",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62642937",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1703,
  "fields": {
    "snp_id": "SNP1718",
    "rs_id": "rs62642937",
    "gene": "DISGENE302",
    "drug": "",
    "disease": "DIS431",
    "allele": "",
    "association_with": "Phenylketonurias",
    "reference": "REF167",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62642937",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Israel, Yemen",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1704,
  "fields": {
    "snp_id": "SNP1719",
    "rs_id": "rs62645944",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF279",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62645944",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1705,
  "fields": {
    "snp_id": "SNP1720",
    "rs_id": "rs62646861",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF602",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62646861",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1706,
  "fields": {
    "snp_id": "SNP1721",
    "rs_id": "rs62646861",
    "gene": "DISGENE284",
    "drug": "",
    "disease": "DIS509",
    "allele": "",
    "association_with": "Stargardt Disease 1 (Disorder)",
    "reference": "REF279",
    "p_value": "0.000000663",
    "source": "DisGeNET",
    "id_in_source": "rs62646861",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1707,
  "fields": {
    "snp_id": "SNP1722",
    "rs_id": "rs6265",
    "gene": "DISGENE464",
    "drug": "",
    "disease": "DIS483",
    "allele": "",
    "association_with": "Schizophrenia",
    "reference": "REF371",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs6265",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1708,
  "fields": {
    "snp_id": "SNP1723",
    "rs_id": "rs6265",
    "gene": "DISGENE465",
    "drug": "",
    "disease": "DIS483",
    "allele": "",
    "association_with": "Schizophrenia",
    "reference": "REF371",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs6265",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1709,
  "fields": {
    "snp_id": "SNP1724",
    "rs_id": "rs63749819",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF511",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749819",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1710,
  "fields": {
    "snp_id": "SNP1725",
    "rs_id": "rs63749819",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS53",
    "allele": "",
    "association_with": "Beta^0^ Thalassemia",
    "reference": "REF515",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749819",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1711,
  "fields": {
    "snp_id": "SNP1726",
    "rs_id": "rs63749823",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF575",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749823",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1712,
  "fields": {
    "snp_id": "SNP1727",
    "rs_id": "rs63749856",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF575",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749856",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1713,
  "fields": {
    "snp_id": "SNP1728",
    "rs_id": "rs63749856",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS228",
    "allele": "",
    "association_with": "Gronblad-Strandberg Syndrome",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749856",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1714,
  "fields": {
    "snp_id": "SNP1729",
    "rs_id": "rs63749856",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749856",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1715,
  "fields": {
    "snp_id": "SNP1730",
    "rs_id": "rs63749856",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS463",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749856",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1716,
  "fields": {
    "snp_id": "SNP1731",
    "rs_id": "rs63749856",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS467",
    "allele": "",
    "association_with": "Pxe, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749856",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1717,
  "fields": {
    "snp_id": "SNP1732",
    "rs_id": "rs63749991",
    "gene": "DISGENE466",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF496",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63749991",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1718,
  "fields": {
    "snp_id": "SNP1733",
    "rs_id": "rs63750414",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS228",
    "allele": "",
    "association_with": "Gronblad-Strandberg Syndrome",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63750414",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1719,
  "fields": {
    "snp_id": "SNP1734",
    "rs_id": "rs63750414",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63750414",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1720,
  "fields": {
    "snp_id": "SNP1735",
    "rs_id": "rs63750414",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS463",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63750414",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1721,
  "fields": {
    "snp_id": "SNP1736",
    "rs_id": "rs63750414",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS467",
    "allele": "",
    "association_with": "Pxe, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63750414",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1722,
  "fields": {
    "snp_id": "SNP1737",
    "rs_id": "rs63751208",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF552",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63751208",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1723,
  "fields": {
    "snp_id": "SNP1738",
    "rs_id": "rs63751208",
    "gene": "DISGENE346",
    "drug": "",
    "disease": "DIS56",
    "allele": "",
    "association_with": "Beta Thalassemia",
    "reference": "REF681",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63751208",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1724,
  "fields": {
    "snp_id": "SNP1739",
    "rs_id": "rs63751325",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF575",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63751325",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1725,
  "fields": {
    "snp_id": "SNP1740",
    "rs_id": "rs63751438",
    "gene": "DISGENE467",
    "drug": "",
    "disease": "DIS205",
    "allele": "",
    "association_with": "Frontotemporal Dementia",
    "reference": "REF708",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63751438",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1726,
  "fields": {
    "snp_id": "SNP1741",
    "rs_id": "rs63751453",
    "gene": "DISGENE466",
    "drug": "",
    "disease": "DIS243",
    "allele": "",
    "association_with": "Hereditary Nonpolyposis Colorectal Cancer",
    "reference": "REF496",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs63751453",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1727,
  "fields": {
    "snp_id": "SNP1742",
    "rs_id": "rs6439153",
    "gene": "DISGENE468",
    "drug": "",
    "disease": "DIS436",
    "allele": "",
    "association_with": "Pneumococcal Bacteraemia",
    "reference": "REF417",
    "p_value": "0.000000471",
    "source": "DisGeNET",
    "id_in_source": "rs6439153",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya",
    "latitude": "-0.0236000",
    "longitude": "37.9062000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1728,
  "fields": {
    "snp_id": "SNP1743",
    "rs_id": "rs6475",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS121",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency",
    "reference": "REF218",
    "p_value": "0.000000471",
    "source": "DisGeNET",
    "id_in_source": "rs6475",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1729,
  "fields": {
    "snp_id": "SNP1744",
    "rs_id": "rs6475",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS255",
    "allele": "",
    "association_with": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency",
    "reference": "REF218",
    "p_value": "0.000000471",
    "source": "DisGeNET",
    "id_in_source": "rs6475",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1730,
  "fields": {
    "snp_id": "SNP1745",
    "rs_id": "rs6475",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS103",
    "allele": "",
    "association_with": "Chronic Active Hepatitis",
    "reference": "REF310",
    "p_value": "0.000000471",
    "source": "DisGeNET",
    "id_in_source": "rs6475",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1731,
  "fields": {
    "snp_id": "SNP1746",
    "rs_id": "rs6572335",
    "gene": "DISGENE280",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF781",
    "p_value": "0.00000093",
    "source": "DisGeNET",
    "id_in_source": "rs6572335",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia",
    "latitude": "13.4432000",
    "longitude": "-15.3101000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1732,
  "fields": {
    "snp_id": "SNP1747",
    "rs_id": "rs662",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS66",
    "allele": "",
    "association_with": "Breast Carcinoma",
    "reference": "REF674",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs662",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1733,
  "fields": {
    "snp_id": "SNP1748",
    "rs_id": "rs662",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF674",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs662",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1734,
  "fields": {
    "snp_id": "SNP1749",
    "rs_id": "rs662",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS59",
    "allele": "",
    "association_with": "Bipolar I Disorder",
    "reference": "REF695",
    "p_value": "0.006",
    "source": "DisGeNET",
    "id_in_source": "rs662",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1735,
  "fields": {
    "snp_id": "SNP1750",
    "rs_id": "rs662",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS30",
    "allele": "",
    "association_with": "Antiphospholipid Syndrome",
    "reference": "REF375",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs662",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1736,
  "fields": {
    "snp_id": "SNP1751",
    "rs_id": "rs662",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS318",
    "allele": "",
    "association_with": "Lupus Erythematosus, Systemic",
    "reference": "REF375",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs662",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1737,
  "fields": {
    "snp_id": "SNP1752",
    "rs_id": "rs662",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS442",
    "allele": "",
    "association_with": "Polyendocrinopathies, Autoimmune",
    "reference": "REF375",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs662",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1738,
  "fields": {
    "snp_id": "SNP1753",
    "rs_id": "rs67561842",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS33",
    "allele": "",
    "association_with": "Arterial Calcification, Generalized, Of Infancy, 2",
    "reference": "REF575",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs67561842",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1739,
  "fields": {
    "snp_id": "SNP1754",
    "rs_id": "rs67561842",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF575",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs67561842",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1740,
  "fields": {
    "snp_id": "SNP1755",
    "rs_id": "rs6775745",
    "gene": "DISGENE471",
    "drug": "",
    "disease": "DIS386",
    "allele": "",
    "association_with": "Neutrophil Count (Procedure)",
    "reference": "REF498",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs6775745",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1741,
  "fields": {
    "snp_id": "SNP1756",
    "rs_id": "rs6780995",
    "gene": "DISGENE472",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF746",
    "p_value": "0.002",
    "source": "DisGeNET",
    "id_in_source": "rs6780995",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1742,
  "fields": {
    "snp_id": "SNP1757",
    "rs_id": "rs6780995",
    "gene": "DISGENE472",
    "drug": "",
    "disease": "DIS491",
    "allele": "",
    "association_with": "Sickle Cell Trait",
    "reference": "REF746",
    "p_value": "0.002",
    "source": "DisGeNET",
    "id_in_source": "rs6780995",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1743,
  "fields": {
    "snp_id": "SNP1758",
    "rs_id": "rs6880234",
    "gene": "DISGENE147",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000749",
    "source": "DisGeNET",
    "id_in_source": "rs6880234",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1744,
  "fields": {
    "snp_id": "SNP1759",
    "rs_id": "rs6880234",
    "gene": "DISGENE473",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000749",
    "source": "DisGeNET",
    "id_in_source": "rs6880234",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1745,
  "fields": {
    "snp_id": "SNP1760",
    "rs_id": "rs6880234",
    "gene": "DISGENE146",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000749",
    "source": "DisGeNET",
    "id_in_source": "rs6880234",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1746,
  "fields": {
    "snp_id": "SNP1761",
    "rs_id": "rs6880234",
    "gene": "DISGENE474",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000749",
    "source": "DisGeNET",
    "id_in_source": "rs6880234",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1747,
  "fields": {
    "snp_id": "SNP1762",
    "rs_id": "rs6880234",
    "gene": "DISGENE145",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000749",
    "source": "DisGeNET",
    "id_in_source": "rs6880234",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1748,
  "fields": {
    "snp_id": "SNP1763",
    "rs_id": "rs6880234",
    "gene": "DISGENE475",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000749",
    "source": "DisGeNET",
    "id_in_source": "rs6880234",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1749,
  "fields": {
    "snp_id": "SNP1764",
    "rs_id": "rs6880234",
    "gene": "DISGENE144",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000749",
    "source": "DisGeNET",
    "id_in_source": "rs6880234",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1750,
  "fields": {
    "snp_id": "SNP1765",
    "rs_id": "rs6889768",
    "gene": "DISGENE476",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000381",
    "source": "DisGeNET",
    "id_in_source": "rs6889768",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1751,
  "fields": {
    "snp_id": "SNP1766",
    "rs_id": "rs689",
    "gene": "DISGENE477",
    "drug": "",
    "disease": "DIS161",
    "allele": "",
    "association_with": "Diabetes",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs689",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1752,
  "fields": {
    "snp_id": "SNP1767",
    "rs_id": "rs689",
    "gene": "DISGENE478",
    "drug": "",
    "disease": "DIS161",
    "allele": "",
    "association_with": "Diabetes",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs689",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1753,
  "fields": {
    "snp_id": "SNP1768",
    "rs_id": "rs689",
    "gene": "DISGENE477",
    "drug": "",
    "disease": "DIS162",
    "allele": "",
    "association_with": "Diabetes Mellitus",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs689",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1754,
  "fields": {
    "snp_id": "SNP1769",
    "rs_id": "rs689",
    "gene": "DISGENE478",
    "drug": "",
    "disease": "DIS162",
    "allele": "",
    "association_with": "Diabetes Mellitus",
    "reference": "REF325",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs689",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1755,
  "fields": {
    "snp_id": "SNP1770",
    "rs_id": "rs6920220",
    "gene": "DISGENE479",
    "drug": "",
    "disease": "DIS480",
    "allele": "",
    "association_with": "Rheumatoid Arthritis",
    "reference": "REF654",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs6920220",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1756,
  "fields": {
    "snp_id": "SNP1771",
    "rs_id": "rs6940729",
    "gene": "DISGENE480",
    "drug": "",
    "disease": "DIS250",
    "allele": "",
    "association_with": "Homocysteine Measurement",
    "reference": "REF646",
    "p_value": "0.0000000471",
    "source": "DisGeNET",
    "id_in_source": "rs6940729",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Nigeria, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1757,
  "fields": {
    "snp_id": "SNP1772",
    "rs_id": "rs6942726",
    "gene": "DISGENE481",
    "drug": "",
    "disease": "DIS63",
    "allele": "",
    "association_with": "Body Height",
    "reference": "REF206",
    "p_value": "0.000000837",
    "source": "DisGeNET",
    "id_in_source": "rs6942726",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Nigeria, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1758,
  "fields": {
    "snp_id": "SNP1773",
    "rs_id": "rs6965492",
    "gene": "DISGENE454",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000692",
    "source": "DisGeNET",
    "id_in_source": "rs6965492",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1759,
  "fields": {
    "snp_id": "SNP1774",
    "rs_id": "rs708567",
    "gene": "DISGENE482",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF746",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs708567",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1760,
  "fields": {
    "snp_id": "SNP1775",
    "rs_id": "rs708567",
    "gene": "DISGENE482",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF746",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs708567",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1761,
  "fields": {
    "snp_id": "SNP1776",
    "rs_id": "rs708567",
    "gene": "DISGENE482",
    "drug": "",
    "disease": "DIS491",
    "allele": "",
    "association_with": "Sickle Cell Trait",
    "reference": "REF746",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs708567",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1762,
  "fields": {
    "snp_id": "SNP1777",
    "rs_id": "rs7096374",
    "gene": "DISGENE130",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000516",
    "source": "DisGeNET",
    "id_in_source": "rs7096374",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1763,
  "fields": {
    "snp_id": "SNP1778",
    "rs_id": "rs713993048",
    "gene": "DISGENE483",
    "drug": "",
    "disease": "DIS51",
    "allele": "",
    "association_with": "Basal Ganglia Disease, Biotin-Responsive",
    "reference": "REF765",
    "p_value": "0.000000516",
    "source": "DisGeNET",
    "id_in_source": "rs713993048",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1764,
  "fields": {
    "snp_id": "SNP1779",
    "rs_id": "rs713993048",
    "gene": "DISGENE483",
    "drug": "",
    "disease": "DIS302",
    "allele": "",
    "association_with": "Leigh Disease",
    "reference": "REF765",
    "p_value": "0.000000516",
    "source": "DisGeNET",
    "id_in_source": "rs713993048",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1765,
  "fields": {
    "snp_id": "SNP1780",
    "rs_id": "rs71640277",
    "gene": "DISGENE484",
    "drug": "",
    "disease": "DIS289",
    "allele": "",
    "association_with": "Isolated Growth Hormone Deficiency, Type Ii",
    "reference": "REF764",
    "p_value": "0.000000516",
    "source": "DisGeNET",
    "id_in_source": "rs71640277",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Sweden, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1766,
  "fields": {
    "snp_id": "SNP1781",
    "rs_id": "rs71640277",
    "gene": "DISGENE485",
    "drug": "",
    "disease": "DIS289",
    "allele": "",
    "association_with": "Isolated Growth Hormone Deficiency, Type Ii",
    "reference": "REF764",
    "p_value": "0.000000516",
    "source": "DisGeNET",
    "id_in_source": "rs71640277",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Sweden, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1767,
  "fields": {
    "snp_id": "SNP1782",
    "rs_id": "rs71785313",
    "gene": "DISGENE321",
    "drug": "",
    "disease": "DIS204",
    "allele": "",
    "association_with": "Focal Segmental Glomerulosclerosis 4, Susceptibility To",
    "reference": "REF418",
    "p_value": "0.000000438",
    "source": "DisGeNET",
    "id_in_source": "rs71785313",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1768,
  "fields": {
    "snp_id": "SNP1783",
    "rs_id": "rs71785313",
    "gene": "DISGENE321",
    "drug": "",
    "disease": "DIS204",
    "allele": "",
    "association_with": "Focal Segmental Glomerulosclerosis 4, Susceptibility To",
    "reference": "REF650",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs71785313",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1769,
  "fields": {
    "snp_id": "SNP1784",
    "rs_id": "rs72474224",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF432",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72474224",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya, Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1770,
  "fields": {
    "snp_id": "SNP1785",
    "rs_id": "rs72474224",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS156",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)",
    "reference": "REF432",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72474224",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya, Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1771,
  "fields": {
    "snp_id": "SNP1786",
    "rs_id": "rs72474224",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS157",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "reference": "REF432",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72474224",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya, Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1772,
  "fields": {
    "snp_id": "SNP1787",
    "rs_id": "rs72474224",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF200",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72474224",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1773,
  "fields": {
    "snp_id": "SNP1788",
    "rs_id": "rs72474224",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS156",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)",
    "reference": "REF200",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72474224",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1774,
  "fields": {
    "snp_id": "SNP1789",
    "rs_id": "rs72474224",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS157",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "reference": "REF200",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72474224",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1775,
  "fields": {
    "snp_id": "SNP1790",
    "rs_id": "rs72549378",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS215",
    "allele": "",
    "association_with": "Glaucoma 3, Primary Congenital, A",
    "reference": "REF366",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72549378",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1776,
  "fields": {
    "snp_id": "SNP1791",
    "rs_id": "rs72549378",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS216",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",
    "reference": "REF366",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72549378",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1777,
  "fields": {
    "snp_id": "SNP1792",
    "rs_id": "rs72549378",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS217",
    "allele": "",
    "association_with": "Glaucoma, Primary Open Angle, Juvenile-Onset",
    "reference": "REF366",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72549378",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1778,
  "fields": {
    "snp_id": "SNP1793",
    "rs_id": "rs72549378",
    "gene": "DISGENE104",
    "drug": "",
    "disease": "DIS253",
    "allele": "",
    "association_with": "Hydrophthalmos",
    "reference": "REF366",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72549378",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1779,
  "fields": {
    "snp_id": "SNP1794",
    "rs_id": "rs72550870",
    "gene": "DISGENE426",
    "drug": "",
    "disease": "DIS336",
    "allele": "",
    "association_with": "Masp2 Deficiency",
    "reference": "REF669",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72550870",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Zambia, Brazil, China, Denmark",
    "latitude": "35.8617000",
    "longitude": "104.1954000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1780,
  "fields": {
    "snp_id": "SNP1795",
    "rs_id": "rs72551351",
    "gene": "DISGENE456",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1781,
  "fields": {
    "snp_id": "SNP1796",
    "rs_id": "rs72551351",
    "gene": "DISGENE457",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1782,
  "fields": {
    "snp_id": "SNP1797",
    "rs_id": "rs72551351",
    "gene": "DISGENE458",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1783,
  "fields": {
    "snp_id": "SNP1798",
    "rs_id": "rs72551351",
    "gene": "DISGENE459",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1784,
  "fields": {
    "snp_id": "SNP1799",
    "rs_id": "rs72551351",
    "gene": "DISGENE460",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1785,
  "fields": {
    "snp_id": "SNP1800",
    "rs_id": "rs72551351",
    "gene": "DISGENE461",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1786,
  "fields": {
    "snp_id": "SNP1801",
    "rs_id": "rs72551351",
    "gene": "DISGENE462",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1787,
  "fields": {
    "snp_id": "SNP1802",
    "rs_id": "rs72551351",
    "gene": "PHARGENE86",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1788,
  "fields": {
    "snp_id": "SNP1803",
    "rs_id": "rs72551351",
    "gene": "DISGENE463",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF636",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1789,
  "fields": {
    "snp_id": "SNP1804",
    "rs_id": "rs72551351",
    "gene": "DISGENE456",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1790,
  "fields": {
    "snp_id": "SNP1805",
    "rs_id": "rs72551351",
    "gene": "DISGENE457",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1791,
  "fields": {
    "snp_id": "SNP1806",
    "rs_id": "rs72551351",
    "gene": "DISGENE458",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1792,
  "fields": {
    "snp_id": "SNP1807",
    "rs_id": "rs72551351",
    "gene": "DISGENE459",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1793,
  "fields": {
    "snp_id": "SNP1808",
    "rs_id": "rs72551351",
    "gene": "DISGENE460",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1794,
  "fields": {
    "snp_id": "SNP1809",
    "rs_id": "rs72551351",
    "gene": "DISGENE461",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1795,
  "fields": {
    "snp_id": "SNP1810",
    "rs_id": "rs72551351",
    "gene": "DISGENE462",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1796,
  "fields": {
    "snp_id": "SNP1811",
    "rs_id": "rs72551351",
    "gene": "PHARGENE86",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1797,
  "fields": {
    "snp_id": "SNP1812",
    "rs_id": "rs72551351",
    "gene": "DISGENE463",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1798,
  "fields": {
    "snp_id": "SNP1813",
    "rs_id": "rs72551351",
    "gene": "DISGENE456",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1799,
  "fields": {
    "snp_id": "SNP1814",
    "rs_id": "rs72551351",
    "gene": "DISGENE457",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1800,
  "fields": {
    "snp_id": "SNP1815",
    "rs_id": "rs72551351",
    "gene": "DISGENE458",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1801,
  "fields": {
    "snp_id": "SNP1816",
    "rs_id": "rs72551351",
    "gene": "DISGENE459",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1802,
  "fields": {
    "snp_id": "SNP1817",
    "rs_id": "rs72551351",
    "gene": "DISGENE460",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1803,
  "fields": {
    "snp_id": "SNP1818",
    "rs_id": "rs72551351",
    "gene": "DISGENE461",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1804,
  "fields": {
    "snp_id": "SNP1819",
    "rs_id": "rs72551351",
    "gene": "DISGENE462",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1805,
  "fields": {
    "snp_id": "SNP1820",
    "rs_id": "rs72551351",
    "gene": "PHARGENE86",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1806,
  "fields": {
    "snp_id": "SNP1821",
    "rs_id": "rs72551351",
    "gene": "DISGENE463",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551351",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1807,
  "fields": {
    "snp_id": "SNP1822",
    "rs_id": "rs72551352",
    "gene": "DISGENE456",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1808,
  "fields": {
    "snp_id": "SNP1823",
    "rs_id": "rs72551352",
    "gene": "DISGENE457",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1809,
  "fields": {
    "snp_id": "SNP1824",
    "rs_id": "rs72551352",
    "gene": "DISGENE458",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1810,
  "fields": {
    "snp_id": "SNP1825",
    "rs_id": "rs72551352",
    "gene": "DISGENE459",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1811,
  "fields": {
    "snp_id": "SNP1826",
    "rs_id": "rs72551352",
    "gene": "DISGENE460",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1812,
  "fields": {
    "snp_id": "SNP1827",
    "rs_id": "rs72551352",
    "gene": "DISGENE461",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1813,
  "fields": {
    "snp_id": "SNP1828",
    "rs_id": "rs72551352",
    "gene": "DISGENE462",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1814,
  "fields": {
    "snp_id": "SNP1829",
    "rs_id": "rs72551352",
    "gene": "PHARGENE86",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1815,
  "fields": {
    "snp_id": "SNP1830",
    "rs_id": "rs72551352",
    "gene": "DISGENE463",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551352",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1816,
  "fields": {
    "snp_id": "SNP1831",
    "rs_id": "rs72551354",
    "gene": "DISGENE456",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1817,
  "fields": {
    "snp_id": "SNP1832",
    "rs_id": "rs72551354",
    "gene": "DISGENE457",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1818,
  "fields": {
    "snp_id": "SNP1833",
    "rs_id": "rs72551354",
    "gene": "DISGENE458",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1819,
  "fields": {
    "snp_id": "SNP1834",
    "rs_id": "rs72551354",
    "gene": "DISGENE459",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1820,
  "fields": {
    "snp_id": "SNP1835",
    "rs_id": "rs72551354",
    "gene": "DISGENE460",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1821,
  "fields": {
    "snp_id": "SNP1836",
    "rs_id": "rs72551354",
    "gene": "DISGENE461",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1822,
  "fields": {
    "snp_id": "SNP1837",
    "rs_id": "rs72551354",
    "gene": "DISGENE462",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1823,
  "fields": {
    "snp_id": "SNP1838",
    "rs_id": "rs72551354",
    "gene": "PHARGENE86",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1824,
  "fields": {
    "snp_id": "SNP1839",
    "rs_id": "rs72551354",
    "gene": "DISGENE463",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551354",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1825,
  "fields": {
    "snp_id": "SNP1840",
    "rs_id": "rs72551355",
    "gene": "DISGENE456",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1826,
  "fields": {
    "snp_id": "SNP1841",
    "rs_id": "rs72551355",
    "gene": "DISGENE457",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1827,
  "fields": {
    "snp_id": "SNP1842",
    "rs_id": "rs72551355",
    "gene": "DISGENE458",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1828,
  "fields": {
    "snp_id": "SNP1843",
    "rs_id": "rs72551355",
    "gene": "DISGENE459",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1829,
  "fields": {
    "snp_id": "SNP1844",
    "rs_id": "rs72551355",
    "gene": "DISGENE460",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1830,
  "fields": {
    "snp_id": "SNP1845",
    "rs_id": "rs72551355",
    "gene": "DISGENE461",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1831,
  "fields": {
    "snp_id": "SNP1846",
    "rs_id": "rs72551355",
    "gene": "DISGENE462",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1832,
  "fields": {
    "snp_id": "SNP1847",
    "rs_id": "rs72551355",
    "gene": "PHARGENE86",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1833,
  "fields": {
    "snp_id": "SNP1848",
    "rs_id": "rs72551355",
    "gene": "DISGENE463",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551355",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1834,
  "fields": {
    "snp_id": "SNP1849",
    "rs_id": "rs72551356",
    "gene": "DISGENE456",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1835,
  "fields": {
    "snp_id": "SNP1850",
    "rs_id": "rs72551356",
    "gene": "DISGENE457",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1836,
  "fields": {
    "snp_id": "SNP1851",
    "rs_id": "rs72551356",
    "gene": "DISGENE458",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1837,
  "fields": {
    "snp_id": "SNP1852",
    "rs_id": "rs72551356",
    "gene": "DISGENE459",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1838,
  "fields": {
    "snp_id": "SNP1853",
    "rs_id": "rs72551356",
    "gene": "DISGENE460",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1839,
  "fields": {
    "snp_id": "SNP1854",
    "rs_id": "rs72551356",
    "gene": "DISGENE461",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1840,
  "fields": {
    "snp_id": "SNP1855",
    "rs_id": "rs72551356",
    "gene": "DISGENE462",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1841,
  "fields": {
    "snp_id": "SNP1856",
    "rs_id": "rs72551356",
    "gene": "PHARGENE86",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1842,
  "fields": {
    "snp_id": "SNP1857",
    "rs_id": "rs72551356",
    "gene": "DISGENE463",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF339",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72551356",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1843,
  "fields": {
    "snp_id": "SNP1858",
    "rs_id": "rs72552255",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72552255",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1844,
  "fields": {
    "snp_id": "SNP1859",
    "rs_id": "rs72552285",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF571",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72552285",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1845,
  "fields": {
    "snp_id": "SNP1860",
    "rs_id": "rs72552285",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72552285",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1846,
  "fields": {
    "snp_id": "SNP1861",
    "rs_id": "rs72554080",
    "gene": "DISGENE162",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF791",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72554080",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1847,
  "fields": {
    "snp_id": "SNP1862",
    "rs_id": "rs72554080",
    "gene": "DISGENE162",
    "drug": "",
    "disease": "DIS417",
    "allele": "",
    "association_with": "Parkinson Disease 11, Autosomal Dominant",
    "reference": "REF791",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72554080",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1848,
  "fields": {
    "snp_id": "SNP1863",
    "rs_id": "rs72558200",
    "gene": "PHARGENE3",
    "drug": "",
    "disease": "DIS291",
    "allele": "",
    "association_with": "Jaundice, Chronic Idiopathic",
    "reference": "REF801",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72558200",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1849,
  "fields": {
    "snp_id": "SNP1864",
    "rs_id": "rs72558200",
    "gene": "PHARGENE3",
    "drug": "",
    "disease": "DIS291",
    "allele": "",
    "association_with": "Jaundice, Chronic Idiopathic",
    "reference": "REF668",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72558200",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1850,
  "fields": {
    "snp_id": "SNP1865",
    "rs_id": "rs72558201",
    "gene": "PHARGENE3",
    "drug": "",
    "disease": "DIS291",
    "allele": "",
    "association_with": "Jaundice, Chronic Idiopathic",
    "reference": "REF801",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72558201",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1851,
  "fields": {
    "snp_id": "SNP1866",
    "rs_id": "rs72558201",
    "gene": "PHARGENE3",
    "drug": "",
    "disease": "DIS291",
    "allele": "",
    "association_with": "Jaundice, Chronic Idiopathic",
    "reference": "REF668",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72558201",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1852,
  "fields": {
    "snp_id": "SNP1867",
    "rs_id": "rs72653744",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF194",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653744",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Mexico",
    "latitude": "23.6345000",
    "longitude": "-102.5528000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1853,
  "fields": {
    "snp_id": "SNP1868",
    "rs_id": "rs72653772",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS228",
    "allele": "",
    "association_with": "Gronblad-Strandberg Syndrome",
    "reference": "REF549",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653772",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1854,
  "fields": {
    "snp_id": "SNP1869",
    "rs_id": "rs72653772",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF549",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653772",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1855,
  "fields": {
    "snp_id": "SNP1870",
    "rs_id": "rs72653772",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS463",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653772",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1856,
  "fields": {
    "snp_id": "SNP1871",
    "rs_id": "rs72653772",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS467",
    "allele": "",
    "association_with": "Pxe, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653772",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1857,
  "fields": {
    "snp_id": "SNP1872",
    "rs_id": "rs72653785",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS228",
    "allele": "",
    "association_with": "Gronblad-Strandberg Syndrome",
    "reference": "REF549",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653785",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1858,
  "fields": {
    "snp_id": "SNP1873",
    "rs_id": "rs72653785",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF549",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653785",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1859,
  "fields": {
    "snp_id": "SNP1874",
    "rs_id": "rs72653785",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS463",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653785",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1860,
  "fields": {
    "snp_id": "SNP1875",
    "rs_id": "rs72653785",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS467",
    "allele": "",
    "association_with": "Pxe, Modifier Of Severity Of",
    "reference": "REF549",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72653785",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1861,
  "fields": {
    "snp_id": "SNP1876",
    "rs_id": "rs72656330",
    "gene": "DISGENE486",
    "drug": "",
    "disease": "DIS401",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta, Recessive Perinatal Lethal",
    "reference": "REF268",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72656330",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1862,
  "fields": {
    "snp_id": "SNP1877",
    "rs_id": "rs72658200",
    "gene": "DISGENE487",
    "drug": "",
    "disease": "DIS402",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta Type Iii (Disorder)",
    "reference": "REF675",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72658200",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1863,
  "fields": {
    "snp_id": "SNP1878",
    "rs_id": "rs72659348",
    "gene": "DISGENE488",
    "drug": "",
    "disease": "DIS404",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta, Type Viii",
    "reference": "REF567",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72659348",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1864,
  "fields": {
    "snp_id": "SNP1879",
    "rs_id": "rs72659351",
    "gene": "DISGENE488",
    "drug": "",
    "disease": "DIS404",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta, Type Viii",
    "reference": "REF567",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72659351",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1865,
  "fields": {
    "snp_id": "SNP1880",
    "rs_id": "rs72659351",
    "gene": "DISGENE488",
    "drug": "",
    "disease": "DIS404",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta, Type Viii",
    "reference": "REF333",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72659351",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Ghana, Nigeria, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1866,
  "fields": {
    "snp_id": "SNP1881",
    "rs_id": "rs72659354",
    "gene": "DISGENE488",
    "drug": "",
    "disease": "DIS404",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta, Type Viii",
    "reference": "REF567",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72659354",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1867,
  "fields": {
    "snp_id": "SNP1882",
    "rs_id": "rs72659355",
    "gene": "DISGENE488",
    "drug": "",
    "disease": "DIS404",
    "allele": "",
    "association_with": "Osteogenesis Imperfecta, Type Viii",
    "reference": "REF567",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72659355",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1868,
  "fields": {
    "snp_id": "SNP1883",
    "rs_id": "rs72664288",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF575",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72664288",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1869,
  "fields": {
    "snp_id": "SNP1884",
    "rs_id": "rs72664297",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF575",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs72664297",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1870,
  "fields": {
    "snp_id": "SNP1885",
    "rs_id": "rs727503818",
    "gene": "DISGENE423",
    "drug": "",
    "disease": "DIS49",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome 10",
    "reference": "REF177",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs727503818",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1871,
  "fields": {
    "snp_id": "SNP1886",
    "rs_id": "rs727504409",
    "gene": "DISGENE342",
    "drug": "",
    "disease": "DIS81",
    "allele": "",
    "association_with": "Cardiomyopathy, Hypertrophic, Familial",
    "reference": "REF338",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs727504409",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1872,
  "fields": {
    "snp_id": "SNP1887",
    "rs_id": "rs727504432",
    "gene": "DISGENE298",
    "drug": "",
    "disease": "DIS32",
    "allele": "",
    "association_with": "Arrhythmogenic Right Ventricular Dysplasia",
    "reference": "REF686",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs727504432",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1873,
  "fields": {
    "snp_id": "SNP1888",
    "rs_id": "rs727504786",
    "gene": "DISGENE298",
    "drug": "",
    "disease": "DIS32",
    "allele": "",
    "association_with": "Arrhythmogenic Right Ventricular Dysplasia",
    "reference": "REF686",
    "p_value": "0.0000000682",
    "source": "DisGeNET",
    "id_in_source": "rs727504786",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1874,
  "fields": {
    "snp_id": "SNP1889",
    "rs_id": "rs73043340",
    "gene": "DISGENE489",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000376",
    "source": "DisGeNET",
    "id_in_source": "rs73043340",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1875,
  "fields": {
    "snp_id": "SNP1890",
    "rs_id": "rs730880131",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF468",
    "p_value": "0.000000376",
    "source": "DisGeNET",
    "id_in_source": "rs730880131",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1876,
  "fields": {
    "snp_id": "SNP1891",
    "rs_id": "rs730880260",
    "gene": "DISGENE335",
    "drug": "",
    "disease": "DIS173",
    "allele": "",
    "association_with": "Ectodermal Dysplasia-Syndactyly Syndrome 1",
    "reference": "REF523",
    "p_value": "0.000000376",
    "source": "DisGeNET",
    "id_in_source": "rs730880260",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1877,
  "fields": {
    "snp_id": "SNP1892",
    "rs_id": "rs730880281",
    "gene": "DISGENE200",
    "drug": "",
    "disease": "DIS301",
    "allele": "",
    "association_with": "Laron Syndrome",
    "reference": "REF236",
    "p_value": "0.000000376",
    "source": "DisGeNET",
    "id_in_source": "rs730880281",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Africa, America, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1878,
  "fields": {
    "snp_id": "SNP1893",
    "rs_id": "rs730882064",
    "gene": "DISGENE490",
    "drug": "",
    "disease": "DIS353",
    "allele": "",
    "association_with": "Microphthalmia, Isolated 6",
    "reference": "REF414",
    "p_value": "0.000000376",
    "source": "DisGeNET",
    "id_in_source": "rs730882064",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1879,
  "fields": {
    "snp_id": "SNP1894",
    "rs_id": "rs730882096",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF468",
    "p_value": "0.000000376",
    "source": "DisGeNET",
    "id_in_source": "rs730882096",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1880,
  "fields": {
    "snp_id": "SNP1895",
    "rs_id": "rs73505850",
    "gene": "DISGENE270",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.000012",
    "source": "DisGeNET",
    "id_in_source": "rs73505850",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1881,
  "fields": {
    "snp_id": "SNP1896",
    "rs_id": "rs738409",
    "gene": "DISGENE491",
    "drug": "",
    "disease": "DIS236",
    "allele": "",
    "association_with": "Hepatitis C",
    "reference": "REF495",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs738409",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1882,
  "fields": {
    "snp_id": "SNP1897",
    "rs_id": "rs738409",
    "gene": "DISGENE491",
    "drug": "",
    "disease": "DIS237",
    "allele": "",
    "association_with": "Hepatitis C, Chronic",
    "reference": "REF495",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs738409",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1883,
  "fields": {
    "snp_id": "SNP1898",
    "rs_id": "rs738409",
    "gene": "DISGENE491",
    "drug": "",
    "disease": "DIS312",
    "allele": "",
    "association_with": "Liver And Intrahepatic Biliary Tract Carcinoma",
    "reference": "REF495",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs738409",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1884,
  "fields": {
    "snp_id": "SNP1899",
    "rs_id": "rs738409",
    "gene": "DISGENE491",
    "drug": "",
    "disease": "DIS313",
    "allele": "",
    "association_with": "Liver Carcinoma",
    "reference": "REF495",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs738409",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1885,
  "fields": {
    "snp_id": "SNP1900",
    "rs_id": "rs738409",
    "gene": "DISGENE491",
    "drug": "",
    "disease": "DIS329",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Liver",
    "reference": "REF495",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs738409",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1886,
  "fields": {
    "snp_id": "SNP1901",
    "rs_id": "rs73885319",
    "gene": "DISGENE321",
    "drug": "",
    "disease": "DIS204",
    "allele": "",
    "association_with": "Focal Segmental Glomerulosclerosis 4, Susceptibility To",
    "reference": "REF418",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs73885319",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1887,
  "fields": {
    "snp_id": "SNP1902",
    "rs_id": "rs7418956",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS174",
    "allele": "",
    "association_with": "Elliptocytosis 2 (Disorder)",
    "reference": "REF810",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs7418956",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1888,
  "fields": {
    "snp_id": "SNP1903",
    "rs_id": "rs74315139",
    "gene": "DISGENE349",
    "drug": "",
    "disease": "DIS462",
    "allele": "",
    "association_with": "Pseudoxanthoma Elasticum",
    "reference": "REF575",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs74315139",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1889,
  "fields": {
    "snp_id": "SNP1904",
    "rs_id": "rs74315309",
    "gene": "DISGENE188",
    "drug": "",
    "disease": "DIS171",
    "allele": "",
    "association_with": "Ectodermal Dysplasia 11B, Hypohidrotic/Hair/Tooth Type, Autosomal Recessive",
    "reference": "REF472",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs74315309",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1890,
  "fields": {
    "snp_id": "SNP1905",
    "rs_id": "rs74315360",
    "gene": "DISGENE410",
    "drug": "",
    "disease": "DIS418",
    "allele": "",
    "association_with": "Parkinson Disease 6, Autosomal Recessive Early-Onset",
    "reference": "REF254",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs74315360",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1891,
  "fields": {
    "snp_id": "SNP1906",
    "rs_id": "rs74315360",
    "gene": "DISGENE410",
    "drug": "",
    "disease": "DIS419",
    "allele": "",
    "association_with": "Parkinson Disease 6, Late-Onset, Susceptibility To",
    "reference": "REF254",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs74315360",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1892,
  "fields": {
    "snp_id": "SNP1907",
    "rs_id": "rs74315407",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS129",
    "allele": "",
    "association_with": "Creutzfeldt-Jakob Disease",
    "reference": "REF574",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs74315407",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1893,
  "fields": {
    "snp_id": "SNP1908",
    "rs_id": "rs74315407",
    "gene": "DISGENE157",
    "drug": "",
    "disease": "DIS457",
    "allele": "",
    "association_with": "Prion Diseases",
    "reference": "REF574",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs74315407",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1894,
  "fields": {
    "snp_id": "SNP1909",
    "rs_id": "rs74315443",
    "gene": "DISGENE269",
    "drug": "",
    "disease": "DIS531",
    "allele": "",
    "association_with": "Unverricht-Lundborg Syndrome",
    "reference": "REF648",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs74315443",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1895,
  "fields": {
    "snp_id": "SNP1910",
    "rs_id": "rs746091400",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF595",
    "p_value": "1.07E-023",
    "source": "DisGeNET",
    "id_in_source": "rs746091400",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1896,
  "fields": {
    "snp_id": "SNP1911",
    "rs_id": "rs747681609",
    "gene": "DISGENE492",
    "drug": "",
    "disease": "DIS396",
    "allele": "",
    "association_with": "Obesity",
    "reference": "REF653",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs747681609",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1897,
  "fields": {
    "snp_id": "SNP1912",
    "rs_id": "rs747724352",
    "gene": "DISGENE493",
    "drug": "",
    "disease": "DIS2",
    "allele": "",
    "association_with": "17-Hydroxysteroid Dehydrogenase Deficiency",
    "reference": "REF314",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs747724352",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1898,
  "fields": {
    "snp_id": "SNP1913",
    "rs_id": "rs747724352",
    "gene": "DISGENE494",
    "drug": "",
    "disease": "DIS2",
    "allele": "",
    "association_with": "17-Hydroxysteroid Dehydrogenase Deficiency",
    "reference": "REF314",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs747724352",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1899,
  "fields": {
    "snp_id": "SNP1914",
    "rs_id": "rs747724352",
    "gene": "DISGENE493",
    "drug": "",
    "disease": "DIS4",
    "allele": "",
    "association_with": "46, Xy Disorders Of Sex Development",
    "reference": "REF314",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs747724352",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1900,
  "fields": {
    "snp_id": "SNP1915",
    "rs_id": "rs747724352",
    "gene": "DISGENE494",
    "drug": "",
    "disease": "DIS4",
    "allele": "",
    "association_with": "46, Xy Disorders Of Sex Development",
    "reference": "REF314",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs747724352",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1901,
  "fields": {
    "snp_id": "SNP1916",
    "rs_id": "rs747724352",
    "gene": "DISGENE493",
    "drug": "",
    "disease": "DIS439",
    "allele": "",
    "association_with": "Polycystic Ovarian Disease Due To 17-Ketosteroid Reductase Deficiency",
    "reference": "REF314",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs747724352",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1902,
  "fields": {
    "snp_id": "SNP1917",
    "rs_id": "rs747724352",
    "gene": "DISGENE494",
    "drug": "",
    "disease": "DIS439",
    "allele": "",
    "association_with": "Polycystic Ovarian Disease Due To 17-Ketosteroid Reductase Deficiency",
    "reference": "REF314",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs747724352",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1903,
  "fields": {
    "snp_id": "SNP1918",
    "rs_id": "rs747768373",
    "gene": "DISGENE381",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF716",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs747768373",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1904,
  "fields": {
    "snp_id": "SNP1919",
    "rs_id": "rs748949603",
    "gene": "DISGENE495",
    "drug": "",
    "disease": "DIS284",
    "allele": "",
    "association_with": "Inclusion Body Myopathy, Autosomal Recessive",
    "reference": "REF342",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs748949603",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Italy",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1905,
  "fields": {
    "snp_id": "SNP1920",
    "rs_id": "rs748949603",
    "gene": "DISGENE496",
    "drug": "",
    "disease": "DIS284",
    "allele": "",
    "association_with": "Inclusion Body Myopathy, Autosomal Recessive",
    "reference": "REF342",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs748949603",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Italy",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1906,
  "fields": {
    "snp_id": "SNP1921",
    "rs_id": "rs749785672",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS382",
    "allele": "",
    "association_with": "Neurodegeneration With Brain Iron Accumulation (Nbia)",
    "reference": "REF736",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs749785672",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Mali, Brazil",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1907,
  "fields": {
    "snp_id": "SNP1922",
    "rs_id": "rs749808170",
    "gene": "DISGENE419",
    "drug": "",
    "disease": "DIS83",
    "allele": "",
    "association_with": "Cataract",
    "reference": "REF614",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs749808170",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1908,
  "fields": {
    "snp_id": "SNP1923",
    "rs_id": "rs749980674",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF365",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs749980674",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1909,
  "fields": {
    "snp_id": "SNP1924",
    "rs_id": "rs750470654",
    "gene": "DISGENE287",
    "drug": "",
    "disease": "DIS221",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type I",
    "reference": "REF346",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs750470654",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1910,
  "fields": {
    "snp_id": "SNP1925",
    "rs_id": "rs751163782",
    "gene": "DISGENE406",
    "drug": "",
    "disease": "DIS117",
    "allele": "",
    "association_with": "Cone-Rod Dystrophy 18",
    "reference": "REF619",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs751163782",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1911,
  "fields": {
    "snp_id": "SNP1926",
    "rs_id": "rs7517847",
    "gene": "DISGENE497",
    "drug": "",
    "disease": "DIS313",
    "allele": "",
    "association_with": "Liver Carcinoma",
    "reference": "REF340",
    "p_value": "0.004",
    "source": "DisGeNET",
    "id_in_source": "rs7517847",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1912,
  "fields": {
    "snp_id": "SNP1927",
    "rs_id": "rs7517847",
    "gene": "DISGENE138",
    "drug": "",
    "disease": "DIS313",
    "allele": "",
    "association_with": "Liver Carcinoma",
    "reference": "REF340",
    "p_value": "0.004",
    "source": "DisGeNET",
    "id_in_source": "rs7517847",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1913,
  "fields": {
    "snp_id": "SNP1928",
    "rs_id": "rs7517847",
    "gene": "DISGENE497",
    "drug": "",
    "disease": "DIS332",
    "allele": "",
    "association_with": "Malignant Neoplasms",
    "reference": "REF340",
    "p_value": "0.004",
    "source": "DisGeNET",
    "id_in_source": "rs7517847",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1914,
  "fields": {
    "snp_id": "SNP1929",
    "rs_id": "rs7517847",
    "gene": "DISGENE138",
    "drug": "",
    "disease": "DIS332",
    "allele": "",
    "association_with": "Malignant Neoplasms",
    "reference": "REF340",
    "p_value": "0.004",
    "source": "DisGeNET",
    "id_in_source": "rs7517847",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1915,
  "fields": {
    "snp_id": "SNP1930",
    "rs_id": "rs752113778",
    "gene": "DISGENE498",
    "drug": "",
    "disease": "DIS282",
    "allele": "",
    "association_with": "Immunodeficiency 27A",
    "reference": "REF355",
    "p_value": "0.004",
    "source": "DisGeNET",
    "id_in_source": "rs752113778",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1916,
  "fields": {
    "snp_id": "SNP1931",
    "rs_id": "rs752202089",
    "gene": "DISGENE499",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF177",
    "p_value": "0.004",
    "source": "DisGeNET",
    "id_in_source": "rs752202089",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1917,
  "fields": {
    "snp_id": "SNP1932",
    "rs_id": "rs752942769",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF521",
    "p_value": "0.004",
    "source": "DisGeNET",
    "id_in_source": "rs752942769",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, New Zealand",
    "latitude": "-40.9006000",
    "longitude": "174.8860000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1918,
  "fields": {
    "snp_id": "SNP1933",
    "rs_id": "rs753085",
    "gene": "DISGENE233",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs753085",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1919,
  "fields": {
    "snp_id": "SNP1934",
    "rs_id": "rs753288303",
    "gene": "DISGENE215",
    "drug": "",
    "disease": "DIS347",
    "allele": "",
    "association_with": "Methylmalonic Acidemia",
    "reference": "REF633",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs753288303",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1920,
  "fields": {
    "snp_id": "SNP1935",
    "rs_id": "rs753780877",
    "gene": "DISGENE500",
    "drug": "",
    "disease": "DIS323",
    "allele": "",
    "association_with": "Macrocephaly, Dysmorphic Facies, And Psychomotor Retardation",
    "reference": "REF476",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs753780877",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1921,
  "fields": {
    "snp_id": "SNP1936",
    "rs_id": "rs75391579",
    "gene": "DISGENE136",
    "drug": "",
    "disease": "DIS107",
    "allele": "",
    "association_with": "Classical Galactosemia",
    "reference": "REF637",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs75391579",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1922,
  "fields": {
    "snp_id": "SNP1937",
    "rs_id": "rs754508360",
    "gene": "DISGENE501",
    "drug": "",
    "disease": "DIS41",
    "allele": "",
    "association_with": "Auditory Neuropathy",
    "reference": "REF345",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs754508360",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1923,
  "fields": {
    "snp_id": "SNP1938",
    "rs_id": "rs754508360",
    "gene": "DISGENE501",
    "drug": "",
    "disease": "DIS42",
    "allele": "",
    "association_with": "Auditory Neuropathy Spectrum Disorder",
    "reference": "REF345",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs754508360",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1924,
  "fields": {
    "snp_id": "SNP1939",
    "rs_id": "rs754532049",
    "gene": "DISGENE318",
    "drug": "",
    "disease": "DIS550",
    "allele": "",
    "association_with": "Xeroderma Pigmentosum, Complementation Group C",
    "reference": "REF204",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs754532049",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1925,
  "fields": {
    "snp_id": "SNP1940",
    "rs_id": "rs754532049",
    "gene": "DISGENE318",
    "drug": "",
    "disease": "DIS550",
    "allele": "",
    "association_with": "Xeroderma Pigmentosum, Complementation Group C",
    "reference": "REF203",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs754532049",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1926,
  "fields": {
    "snp_id": "SNP1941",
    "rs_id": "rs754532049",
    "gene": "DISGENE318",
    "drug": "",
    "disease": "DIS550",
    "allele": "",
    "association_with": "Xeroderma Pigmentosum, Complementation Group C",
    "reference": "REF706",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs754532049",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1927,
  "fields": {
    "snp_id": "SNP1942",
    "rs_id": "rs754676104",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF238",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs754676104",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1928,
  "fields": {
    "snp_id": "SNP1943",
    "rs_id": "rs75549581",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF721",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs75549581",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Senegal, French Guiana",
    "latitude": "3.9339000",
    "longitude": "-53.1258000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1929,
  "fields": {
    "snp_id": "SNP1944",
    "rs_id": "rs75549581",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF297",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs75549581",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Africa",
    "latitude": "-8.7832000",
    "longitude": "34.5085000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1930,
  "fields": {
    "snp_id": "SNP1947",
    "rs_id": "rs755667663",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF238",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs755667663",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1931,
  "fields": {
    "snp_id": "SNP1948",
    "rs_id": "rs755709270",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF571",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs755709270",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1932,
  "fields": {
    "snp_id": "SNP1949",
    "rs_id": "rs755709270",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs755709270",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1933,
  "fields": {
    "snp_id": "SNP1950",
    "rs_id": "rs755734596",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs755734596",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1934,
  "fields": {
    "snp_id": "SNP1951",
    "rs_id": "rs756134838",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs756134838",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1935,
  "fields": {
    "snp_id": "SNP1952",
    "rs_id": "rs756138074",
    "gene": "DISGENE170",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF480",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs756138074",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1936,
  "fields": {
    "snp_id": "SNP1953",
    "rs_id": "rs756572099",
    "gene": "DISGENE229",
    "drug": "",
    "disease": "DIS429",
    "allele": "",
    "association_with": "Pfaundler-Hurler Syndrome",
    "reference": "REF396",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs756572099",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1937,
  "fields": {
    "snp_id": "SNP1954",
    "rs_id": "rs756614404",
    "gene": "DISGENE503",
    "drug": "",
    "disease": "DIS506",
    "allele": "",
    "association_with": "Spinal Muscular Atrophy, Distal, Autosomal Recessive, 5",
    "reference": "REF596",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs756614404",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1938,
  "fields": {
    "snp_id": "SNP1955",
    "rs_id": "rs757147440",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS244",
    "allele": "",
    "association_with": "Hereditary Pyropoikilocytosis",
    "reference": "REF652",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs757147440",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1939,
  "fields": {
    "snp_id": "SNP1956",
    "rs_id": "rs757366142",
    "gene": "DISGENE281",
    "drug": "",
    "disease": "DIS5",
    "allele": "",
    "association_with": "Acquired Immunodeficiency Syndrome",
    "reference": "REF656",
    "p_value": "0.00000493",
    "source": "DisGeNET",
    "id_in_source": "rs757366142",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1940,
  "fields": {
    "snp_id": "SNP1957",
    "rs_id": "rs7574865",
    "gene": "DISGENE504",
    "drug": "",
    "disease": "DIS480",
    "allele": "",
    "association_with": "Rheumatoid Arthritis",
    "reference": "REF188",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs7574865",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1941,
  "fields": {
    "snp_id": "SNP1958",
    "rs_id": "rs757679761",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS174",
    "allele": "",
    "association_with": "Elliptocytosis 2 (Disorder)",
    "reference": "REF532",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs757679761",
    "region": "North African",
    "country_of_participants": "North African",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1942,
  "fields": {
    "snp_id": "SNP1959",
    "rs_id": "rs757679761",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS174",
    "allele": "",
    "association_with": "Elliptocytosis 2 (Disorder)",
    "reference": "REF423",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs757679761",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Benin, Togo",
    "latitude": "9.3077000",
    "longitude": "2.3158000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1943,
  "fields": {
    "snp_id": "SNP1960",
    "rs_id": "rs757988130",
    "gene": "DISGENE176",
    "drug": "",
    "disease": "DIS10",
    "allele": "",
    "association_with": "Acute Intermittent Porphyria",
    "reference": "REF657",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs757988130",
    "region": "Mixed Population, North Africa, Sub-Saharan Africa",
    "country_of_participants": "Algeria, Burkina Faso, Cameroon, Mali, Morocco, French West Indies",
    "latitude": "12.2383000",
    "longitude": "-1.5616000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1944,
  "fields": {
    "snp_id": "SNP1961",
    "rs_id": "rs758188096",
    "gene": "DISGENE505",
    "drug": "",
    "disease": "DIS377",
    "allele": "",
    "association_with": "Nemaline Myopathy 8",
    "reference": "REF438",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs758188096",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1945,
  "fields": {
    "snp_id": "SNP1962",
    "rs_id": "rs758236584",
    "gene": "DISGENE407",
    "drug": "",
    "disease": "DIS257",
    "allele": "",
    "association_with": "Hyperhomocysteinemia, Thrombotic, Cbs-Related",
    "reference": "REF666",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs758236584",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Sudan, Saudi Arabia",
    "latitude": "23.8859000",
    "longitude": "45.0792000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1946,
  "fields": {
    "snp_id": "SNP1963",
    "rs_id": "rs758355520",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF571",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs758355520",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1947,
  "fields": {
    "snp_id": "SNP1964",
    "rs_id": "rs758355520",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs758355520",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1948,
  "fields": {
    "snp_id": "SNP1965",
    "rs_id": "rs7587928",
    "gene": "DISGENE506",
    "drug": "",
    "disease": "DIS386",
    "allele": "",
    "association_with": "Neutrophil Count (Procedure)",
    "reference": "REF498",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs7587928",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1949,
  "fields": {
    "snp_id": "SNP1966",
    "rs_id": "rs759581558",
    "gene": "DISGENE177",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF601",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs759581558",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1950,
  "fields": {
    "snp_id": "SNP1967",
    "rs_id": "rs759581558",
    "gene": "DISGENE177",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF407",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs759581558",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1951,
  "fields": {
    "snp_id": "SNP1968",
    "rs_id": "rs759736443",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS121",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency",
    "reference": "REF218",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs759736443",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1952,
  "fields": {
    "snp_id": "SNP1969",
    "rs_id": "rs759736443",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS255",
    "allele": "",
    "association_with": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency",
    "reference": "REF218",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs759736443",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1953,
  "fields": {
    "snp_id": "SNP1970",
    "rs_id": "rs759834365",
    "gene": "DISGENE464",
    "drug": "",
    "disease": "DIS483",
    "allele": "",
    "association_with": "Schizophrenia",
    "reference": "REF371",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs759834365",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1954,
  "fields": {
    "snp_id": "SNP1971",
    "rs_id": "rs759834365",
    "gene": "DISGENE465",
    "drug": "",
    "disease": "DIS483",
    "allele": "",
    "association_with": "Schizophrenia",
    "reference": "REF371",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs759834365",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1955,
  "fields": {
    "snp_id": "SNP1972",
    "rs_id": "rs760021635",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS515",
    "allele": "",
    "association_with": "Stuttering",
    "reference": "REF714",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs760021635",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1956,
  "fields": {
    "snp_id": "SNP1973",
    "rs_id": "rs760021635",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS516",
    "allele": "",
    "association_with": "Stuttering, Developmental",
    "reference": "REF714",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs760021635",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1957,
  "fields": {
    "snp_id": "SNP1974",
    "rs_id": "rs760021635",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs760021635",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1958,
  "fields": {
    "snp_id": "SNP1975",
    "rs_id": "rs760318047",
    "gene": "DISGENE378",
    "drug": "",
    "disease": "DIS382",
    "allele": "",
    "association_with": "Neurodegeneration With Brain Iron Accumulation (Nbia)",
    "reference": "REF736",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs760318047",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Mali, Brazil",
    "latitude": "17.5707000",
    "longitude": "-3.9962000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1959,
  "fields": {
    "snp_id": "SNP1976",
    "rs_id": "rs76151636",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs76151636",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1960,
  "fields": {
    "snp_id": "SNP1977",
    "rs_id": "rs762364495",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS465",
    "allele": "",
    "association_with": "Psoriasis 2",
    "reference": "REF220",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs762364495",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1961,
  "fields": {
    "snp_id": "SNP1978",
    "rs_id": "rs762588484",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS258",
    "allele": "",
    "association_with": "Hyperlipoproteinemia Type Iia",
    "reference": "REF521",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs762588484",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, New Zealand",
    "latitude": "-40.9006000",
    "longitude": "174.8860000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1962,
  "fields": {
    "snp_id": "SNP1979",
    "rs_id": "rs76262710",
    "gene": "DISGENE507",
    "drug": "",
    "disease": "DIS193",
    "allele": "",
    "association_with": "Familial Medullary Thyroid Carcinoma",
    "reference": "REF576",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs76262710",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1963,
  "fields": {
    "snp_id": "SNP1980",
    "rs_id": "rs76262710",
    "gene": "DISGENE507",
    "drug": "",
    "disease": "DIS247",
    "allele": "",
    "association_with": "Hirschsprung Disease",
    "reference": "REF576",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs76262710",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1964,
  "fields": {
    "snp_id": "SNP1981",
    "rs_id": "rs76262710",
    "gene": "DISGENE507",
    "drug": "",
    "disease": "DIS337",
    "allele": "",
    "association_with": "Medullary Carcinoma Of Thyroid",
    "reference": "REF576",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs76262710",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1965,
  "fields": {
    "snp_id": "SNP1982",
    "rs_id": "rs76262710",
    "gene": "DISGENE507",
    "drug": "",
    "disease": "DIS432",
    "allele": "",
    "association_with": "Pheochromocytoma",
    "reference": "REF576",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs76262710",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1966,
  "fields": {
    "snp_id": "SNP1983",
    "rs_id": "rs763059810",
    "gene": "DISGENE508",
    "drug": "",
    "disease": "DIS5",
    "allele": "",
    "association_with": "Acquired Immunodeficiency Syndrome",
    "reference": "REF656",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs763059810",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1967,
  "fields": {
    "snp_id": "SNP1984",
    "rs_id": "rs763222239",
    "gene": "DISGENE139",
    "drug": "",
    "disease": "DIS416",
    "allele": "",
    "association_with": "Parkinson Disease",
    "reference": "REF296",
    "p_value": "0.008",
    "source": "DisGeNET",
    "id_in_source": "rs763222239",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1968,
  "fields": {
    "snp_id": "SNP1985",
    "rs_id": "rs7633054",
    "gene": "DISGENE509",
    "drug": "",
    "disease": "DIS46",
    "allele": "",
    "association_with": "Bacteremia",
    "reference": "REF417",
    "p_value": "0.00000118",
    "source": "DisGeNET",
    "id_in_source": "rs7633054",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Kenya",
    "latitude": "-0.0236000",
    "longitude": "37.9062000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1969,
  "fields": {
    "snp_id": "SNP1986",
    "rs_id": "rs763780",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS316",
    "allele": "",
    "association_with": "Lupus Erythematosus",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs763780",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1970,
  "fields": {
    "snp_id": "SNP1987",
    "rs_id": "rs763780",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS317",
    "allele": "",
    "association_with": "Lupus Erythematosus, Discoid",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs763780",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1971,
  "fields": {
    "snp_id": "SNP1988",
    "rs_id": "rs763780",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS318",
    "allele": "",
    "association_with": "Lupus Erythematosus, Systemic",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs763780",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1972,
  "fields": {
    "snp_id": "SNP1989",
    "rs_id": "rs763780",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS319",
    "allele": "",
    "association_with": "Lupus Nephritis",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs763780",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1973,
  "fields": {
    "snp_id": "SNP1990",
    "rs_id": "rs763780",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS320",
    "allele": "",
    "association_with": "Lupus Vulgaris",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs763780",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1974,
  "fields": {
    "snp_id": "SNP1991",
    "rs_id": "rs763780",
    "gene": "DISGENE325",
    "drug": "",
    "disease": "DIS380",
    "allele": "",
    "association_with": "Nephritis",
    "reference": "REF281",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs763780",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1975,
  "fields": {
    "snp_id": "SNP1992",
    "rs_id": "rs763915472",
    "gene": "DISGENE510",
    "drug": "",
    "disease": "DIS349",
    "allele": "",
    "association_with": "Microcephaly 4, Primary, Autosomal Recessive",
    "reference": "REF228",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs763915472",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1976,
  "fields": {
    "snp_id": "SNP1993",
    "rs_id": "rs763915472",
    "gene": "DISGENE510",
    "drug": "",
    "disease": "DIS349",
    "allele": "",
    "association_with": "Microcephaly 4, Primary, Autosomal Recessive",
    "reference": "REF690",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs763915472",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1977,
  "fields": {
    "snp_id": "SNP1994",
    "rs_id": "rs764249635",
    "gene": "DISGENE511",
    "drug": "",
    "disease": "DIS9",
    "allele": "",
    "association_with": "Acute Hiv Infection",
    "reference": "REF334",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs764249635",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Botswana",
    "latitude": "-22.3284740",
    "longitude": "24.6848660"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1978,
  "fields": {
    "snp_id": "SNP1995",
    "rs_id": "rs765219004",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs765219004",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1979,
  "fields": {
    "snp_id": "SNP1996",
    "rs_id": "rs765530357",
    "gene": "DISGENE264",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF593",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs765530357",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1980,
  "fields": {
    "snp_id": "SNP1997",
    "rs_id": "rs766209297",
    "gene": "DISGENE298",
    "drug": "",
    "disease": "DIS32",
    "allele": "",
    "association_with": "Arrhythmogenic Right Ventricular Dysplasia",
    "reference": "REF686",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs766209297",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1981,
  "fields": {
    "snp_id": "SNP1998",
    "rs_id": "rs766696884",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs766696884",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1982,
  "fields": {
    "snp_id": "SNP1999",
    "rs_id": "rs767004810",
    "gene": "DISGENE512",
    "drug": "",
    "disease": "DIS264",
    "allele": "",
    "association_with": "Hypoparathyroidism-Retardation-Dysmorphism Syndrome",
    "reference": "REF475",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767004810",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1983,
  "fields": {
    "snp_id": "SNP2000",
    "rs_id": "rs767004810",
    "gene": "DISGENE512",
    "drug": "",
    "disease": "DIS296",
    "allele": "",
    "association_with": "Kenny-Caffey Syndrome, Type 1",
    "reference": "REF475",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767004810",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1984,
  "fields": {
    "snp_id": "SNP2001",
    "rs_id": "rs767201131",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF682",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767201131",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1985,
  "fields": {
    "snp_id": "SNP2002",
    "rs_id": "rs767218895",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767218895",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1986,
  "fields": {
    "snp_id": "SNP2003",
    "rs_id": "rs767350733",
    "gene": "DISGENE385",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF456",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767350733",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Europe",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1987,
  "fields": {
    "snp_id": "SNP2004",
    "rs_id": "rs767419411",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF590",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767419411",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1988,
  "fields": {
    "snp_id": "SNP2005",
    "rs_id": "rs767419411",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF590",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767419411",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1989,
  "fields": {
    "snp_id": "SNP2006",
    "rs_id": "rs767419411",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF590",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767419411",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1990,
  "fields": {
    "snp_id": "SNP2007",
    "rs_id": "rs767423538",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767423538",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1991,
  "fields": {
    "snp_id": "SNP2008",
    "rs_id": "rs767522068",
    "gene": "DISGENE220",
    "drug": "",
    "disease": "DIS344",
    "allele": "",
    "association_with": "Meningoencephalitis",
    "reference": "REF289",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767522068",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Asia",
    "latitude": "34.0479000",
    "longitude": "100.6197000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1992,
  "fields": {
    "snp_id": "SNP2009",
    "rs_id": "rs767633598",
    "gene": "DISGENE309",
    "drug": "",
    "disease": "DIS267",
    "allele": "",
    "association_with": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2",
    "reference": "REF240",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs767633598",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1993,
  "fields": {
    "snp_id": "SNP2010",
    "rs_id": "rs76763715",
    "gene": "DISGENE364",
    "drug": "",
    "disease": "DIS209",
    "allele": "",
    "association_with": "Gaucher Disease, Type 1",
    "reference": "REF376",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs76763715",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1994,
  "fields": {
    "snp_id": "SNP2011",
    "rs_id": "rs768933093",
    "gene": "DISGENE423",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF177",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs768933093",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1995,
  "fields": {
    "snp_id": "SNP2012",
    "rs_id": "rs768933093",
    "gene": "DISGENE423",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF177",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs768933093",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1996,
  "fields": {
    "snp_id": "SNP2013",
    "rs_id": "rs769452432",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF357",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs769452432",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1997,
  "fields": {
    "snp_id": "SNP2014",
    "rs_id": "rs769452432",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF357",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs769452432",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1998,
  "fields": {
    "snp_id": "SNP2015",
    "rs_id": "rs769452432",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF357",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs769452432",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 1999,
  "fields": {
    "snp_id": "SNP2016",
    "rs_id": "rs76992529",
    "gene": "DISGENE513",
    "drug": "",
    "disease": "DIS75",
    "allele": "",
    "association_with": "Cardiomyopathies",
    "reference": "REF328",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs76992529",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Africa, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2000,
  "fields": {
    "snp_id": "SNP2017",
    "rs_id": "rs76992529",
    "gene": "DISGENE513",
    "drug": "",
    "disease": "DIS230",
    "allele": "",
    "association_with": "Heart Diseases",
    "reference": "REF328",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs76992529",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Africa, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2001,
  "fields": {
    "snp_id": "SNP2018",
    "rs_id": "rs76992529",
    "gene": "DISGENE513",
    "drug": "",
    "disease": "DIS485",
    "allele": "",
    "association_with": "Senile Cardiac Amyloidosis",
    "reference": "REF328",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs76992529",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Africa, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2002,
  "fields": {
    "snp_id": "SNP2019",
    "rs_id": "rs769987150",
    "gene": "DISGENE514",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF641",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs769987150",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2003,
  "fields": {
    "snp_id": "SNP2020",
    "rs_id": "rs77010898",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF794",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs77010898",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2004,
  "fields": {
    "snp_id": "SNP2021",
    "rs_id": "rs770556842",
    "gene": "DISGENE423",
    "drug": "",
    "disease": "DIS49",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome 10",
    "reference": "REF177",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs770556842",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2005,
  "fields": {
    "snp_id": "SNP2022",
    "rs_id": "rs770641163",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS39",
    "allele": "",
    "association_with": "Ataxia Telangiectasia",
    "reference": "REF466",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs770641163",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2006,
  "fields": {
    "snp_id": "SNP2023",
    "rs_id": "rs770641163",
    "gene": "DISGENE515",
    "drug": "",
    "disease": "DIS39",
    "allele": "",
    "association_with": "Ataxia Telangiectasia",
    "reference": "REF466",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs770641163",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2007,
  "fields": {
    "snp_id": "SNP2024",
    "rs_id": "rs770641163",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF466",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs770641163",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2008,
  "fields": {
    "snp_id": "SNP2025",
    "rs_id": "rs770641163",
    "gene": "DISGENE515",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF466",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs770641163",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2009,
  "fields": {
    "snp_id": "SNP2026",
    "rs_id": "rs7706544",
    "gene": "DISGENE516",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000194",
    "source": "DisGeNET",
    "id_in_source": "rs7706544",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2010,
  "fields": {
    "snp_id": "SNP2027",
    "rs_id": "rs770947426",
    "gene": "DISGENE517",
    "drug": "",
    "disease": "DIS362",
    "allele": "",
    "association_with": "Mucopolysaccharidosis Type Iiia",
    "reference": "REF811",
    "p_value": "0.000000194",
    "source": "DisGeNET",
    "id_in_source": "rs770947426",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2011,
  "fields": {
    "snp_id": "SNP2028",
    "rs_id": "rs771069887",
    "gene": "DISGENE331",
    "drug": "",
    "disease": "DIS220",
    "allele": "",
    "association_with": "Glycogen Storage Disease Iiia",
    "reference": "REF425",
    "p_value": "0.000000194",
    "source": "DisGeNET",
    "id_in_source": "rs771069887",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2012,
  "fields": {
    "snp_id": "SNP2029",
    "rs_id": "rs771594651",
    "gene": "DISGENE197",
    "drug": "",
    "disease": "DIS106",
    "allele": "",
    "association_with": "Citrullinemia",
    "reference": "REF360",
    "p_value": "0.000000194",
    "source": "DisGeNET",
    "id_in_source": "rs771594651",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2013,
  "fields": {
    "snp_id": "SNP2030",
    "rs_id": "rs7726475",
    "gene": "DISGENE518",
    "drug": "",
    "disease": "DIS61",
    "allele": "",
    "association_with": "Blood Pressure",
    "reference": "REF307",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs7726475",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2014,
  "fields": {
    "snp_id": "SNP2031",
    "rs_id": "rs7726475",
    "gene": "DISGENE518",
    "drug": "",
    "disease": "DIS62",
    "allele": "",
    "association_with": "Blood Pressure Finding",
    "reference": "REF307",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs7726475",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2015,
  "fields": {
    "snp_id": "SNP2032",
    "rs_id": "rs7726475",
    "gene": "DISGENE518",
    "drug": "",
    "disease": "DIS519",
    "allele": "",
    "association_with": "Systemic Arterial Pressure",
    "reference": "REF307",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs7726475",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2016,
  "fields": {
    "snp_id": "SNP2033",
    "rs_id": "rs773429181",
    "gene": "DISGENE501",
    "drug": "",
    "disease": "DIS41",
    "allele": "",
    "association_with": "Auditory Neuropathy",
    "reference": "REF345",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs773429181",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2017,
  "fields": {
    "snp_id": "SNP2034",
    "rs_id": "rs773429181",
    "gene": "DISGENE501",
    "drug": "",
    "disease": "DIS42",
    "allele": "",
    "association_with": "Auditory Neuropathy Spectrum Disorder",
    "reference": "REF345",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs773429181",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2018,
  "fields": {
    "snp_id": "SNP2035",
    "rs_id": "rs773526895",
    "gene": "DISGENE519",
    "drug": "",
    "disease": "DIS371",
    "allele": "",
    "association_with": "Myasthenic Syndrome, Congenital, Associated With Acetylcholine Receptor Deficiency",
    "reference": "REF287",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs773526895",
    "region": "North African",
    "country_of_participants": "Algeria, Libya, Morocco. Tunisia",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2019,
  "fields": {
    "snp_id": "SNP2036",
    "rs_id": "rs77375493",
    "gene": "DISGENE520",
    "drug": "",
    "disease": "DIS441",
    "allele": "",
    "association_with": "Polycythemia Vera",
    "reference": "REF507",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs77375493",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2020,
  "fields": {
    "snp_id": "SNP2037",
    "rs_id": "rs77375493",
    "gene": "DISGENE520",
    "drug": "",
    "disease": "DIS441",
    "allele": "",
    "association_with": "Polycythemia Vera",
    "reference": "REF563",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs77375493",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2021,
  "fields": {
    "snp_id": "SNP2038",
    "rs_id": "rs77375493",
    "gene": "DISGENE520",
    "drug": "",
    "disease": "DIS456",
    "allele": "",
    "association_with": "Primary Myelofibrosis",
    "reference": "REF563",
    "p_value": "< 0.0015",
    "source": "DisGeNET",
    "id_in_source": "rs77375493",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2022,
  "fields": {
    "snp_id": "SNP2039",
    "rs_id": "rs77375493",
    "gene": "DISGENE520",
    "drug": "",
    "disease": "DIS279",
    "allele": "",
    "association_with": "Idiopathic Pulmonary Arterial Hypertension",
    "reference": "REF320",
    "p_value": "> 0.07",
    "source": "DisGeNET",
    "id_in_source": "rs77375493",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2023,
  "fields": {
    "snp_id": "SNP2040",
    "rs_id": "rs77375493",
    "gene": "DISGENE520",
    "drug": "",
    "disease": "DIS441",
    "allele": "",
    "association_with": "Polycythemia Vera",
    "reference": "REF320",
    "p_value": "> 0.08",
    "source": "DisGeNET",
    "id_in_source": "rs77375493",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2024,
  "fields": {
    "snp_id": "SNP2041",
    "rs_id": "rs77375493",
    "gene": "DISGENE520",
    "drug": "",
    "disease": "DIS456",
    "allele": "",
    "association_with": "Primary Myelofibrosis",
    "reference": "REF320",
    "p_value": "> 0.06",
    "source": "DisGeNET",
    "id_in_source": "rs77375493",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2025,
  "fields": {
    "snp_id": "SNP2042",
    "rs_id": "rs77375493",
    "gene": "DISGENE520",
    "drug": "",
    "disease": "DIS525",
    "allele": "",
    "association_with": "Thrombocythemia, Essential",
    "reference": "REF320",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs77375493",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2026,
  "fields": {
    "snp_id": "SNP2043",
    "rs_id": "rs773876922",
    "gene": "DISGENE521",
    "drug": "",
    "disease": "DIS507",
    "allele": "",
    "association_with": "Spinocerebellar Ataxia 23",
    "reference": "REF518",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs773876922",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, India, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2027,
  "fields": {
    "snp_id": "SNP2044",
    "rs_id": "rs773876922",
    "gene": "DISGENE522",
    "drug": "",
    "disease": "DIS507",
    "allele": "",
    "association_with": "Spinocerebellar Ataxia 23",
    "reference": "REF518",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs773876922",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, India, Europe",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2028,
  "fields": {
    "snp_id": "SNP2045",
    "rs_id": "rs7748513",
    "gene": "DISGENE523",
    "drug": "",
    "disease": "DIS128",
    "allele": "",
    "association_with": "C-Reactive Protein Measurement",
    "reference": "REF702",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs7748513",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2029,
  "fields": {
    "snp_id": "SNP2046",
    "rs_id": "rs774906736",
    "gene": "DISGENE122",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF354",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs774906736",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2030,
  "fields": {
    "snp_id": "SNP2047",
    "rs_id": "rs775036118",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF466",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs775036118",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2031,
  "fields": {
    "snp_id": "SNP2048",
    "rs_id": "rs775163147",
    "gene": "DISGENE197",
    "drug": "",
    "disease": "DIS106",
    "allele": "",
    "association_with": "Citrullinemia",
    "reference": "REF360",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs775163147",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2032,
  "fields": {
    "snp_id": "SNP2049",
    "rs_id": "rs775274569",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF682",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs775274569",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2033,
  "fields": {
    "snp_id": "SNP2050",
    "rs_id": "rs7755898",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS3",
    "allele": "",
    "association_with": "21-Hydroxylase Deficiency",
    "reference": "REF218",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs7755898",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2034,
  "fields": {
    "snp_id": "SNP2051",
    "rs_id": "rs7755898",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS103",
    "allele": "",
    "association_with": "Chronic Active Hepatitis",
    "reference": "REF218",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs7755898",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2035,
  "fields": {
    "snp_id": "SNP2052",
    "rs_id": "rs7755898",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS121",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency",
    "reference": "REF218",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs7755898",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2036,
  "fields": {
    "snp_id": "SNP2053",
    "rs_id": "rs7755898",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS3",
    "allele": "",
    "association_with": "21-Hydroxylase Deficiency",
    "reference": "REF310",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs7755898",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2037,
  "fields": {
    "snp_id": "SNP2054",
    "rs_id": "rs7755898",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS103",
    "allele": "",
    "association_with": "Chronic Active Hepatitis",
    "reference": "REF310",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs7755898",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2038,
  "fields": {
    "snp_id": "SNP2055",
    "rs_id": "rs7755898",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS121",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency",
    "reference": "REF310",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs7755898",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2039,
  "fields": {
    "snp_id": "SNP2056",
    "rs_id": "rs7755898",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS3",
    "allele": "",
    "association_with": "21-Hydroxylase Deficiency",
    "reference": "REF776",
    "p_value": "0.00000000839",
    "source": "DisGeNET",
    "id_in_source": "rs7755898",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2040,
  "fields": {
    "snp_id": "SNP2057",
    "rs_id": "rs7756992",
    "gene": "DISGENE524",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF622",
    "p_value": "0.25",
    "source": "DisGeNET",
    "id_in_source": "rs7756992",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2041,
  "fields": {
    "snp_id": "SNP2058",
    "rs_id": "rs7756992",
    "gene": "DISGENE524",
    "drug": "",
    "disease": "DIS161",
    "allele": "",
    "association_with": "Diabetes",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs7756992",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2042,
  "fields": {
    "snp_id": "SNP2059",
    "rs_id": "rs7756992",
    "gene": "DISGENE524",
    "drug": "",
    "disease": "DIS162",
    "allele": "",
    "association_with": "Diabetes Mellitus",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs7756992",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2043,
  "fields": {
    "snp_id": "SNP2060",
    "rs_id": "rs7756992",
    "gene": "DISGENE524",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs7756992",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2044,
  "fields": {
    "snp_id": "SNP2061",
    "rs_id": "rs7756992",
    "gene": "DISGENE524",
    "drug": "",
    "disease": "DIS165",
    "allele": "",
    "association_with": "Diabetic Nephropathy",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs7756992",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2045,
  "fields": {
    "snp_id": "SNP2062",
    "rs_id": "rs7756992",
    "gene": "DISGENE524",
    "drug": "",
    "disease": "DIS261",
    "allele": "",
    "association_with": "Hypertensive Disease",
    "reference": "REF560",
    "p_value": "0.0001",
    "source": "DisGeNET",
    "id_in_source": "rs7756992",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2046,
  "fields": {
    "snp_id": "SNP2063",
    "rs_id": "rs7756992",
    "gene": "DISGENE524",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF504",
    "p_value": "0.18",
    "source": "DisGeNET",
    "id_in_source": "rs7756992",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2047,
  "fields": {
    "snp_id": "SNP2064",
    "rs_id": "rs775903553",
    "gene": "DISGENE301",
    "drug": "",
    "disease": "DIS272",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "reference": "REF506",
    "p_value": "0.18",
    "source": "DisGeNET",
    "id_in_source": "rs775903553",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2048,
  "fields": {
    "snp_id": "SNP2065",
    "rs_id": "rs775903553",
    "gene": "DISGENE300",
    "drug": "",
    "disease": "DIS272",
    "allele": "",
    "association_with": "Ichthyosis, Congenital, Autosomal Recessive 6",
    "reference": "REF506",
    "p_value": "0.18",
    "source": "DisGeNET",
    "id_in_source": "rs775903553",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2049,
  "fields": {
    "snp_id": "SNP2066",
    "rs_id": "rs775910328",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF359",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs775910328",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2050,
  "fields": {
    "snp_id": "SNP2067",
    "rs_id": "rs775910328",
    "gene": "DISGENE415",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF359",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs775910328",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2051,
  "fields": {
    "snp_id": "SNP2068",
    "rs_id": "rs7769409",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS121",
    "allele": "",
    "association_with": "Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency",
    "reference": "REF218",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs7769409",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2052,
  "fields": {
    "snp_id": "SNP2069",
    "rs_id": "rs7769409",
    "gene": "DISGENE469",
    "drug": "",
    "disease": "DIS255",
    "allele": "",
    "association_with": "Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency",
    "reference": "REF218",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs7769409",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2053,
  "fields": {
    "snp_id": "SNP2070",
    "rs_id": "rs776977863",
    "gene": "DISGENE331",
    "drug": "",
    "disease": "DIS223",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type Iii",
    "reference": "REF634",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs776977863",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2054,
  "fields": {
    "snp_id": "SNP2071",
    "rs_id": "rs777112652",
    "gene": "DISGENE525",
    "drug": "",
    "disease": "DIS146",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 105",
    "reference": "REF442",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs777112652",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Mauritania, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2055,
  "fields": {
    "snp_id": "SNP2072",
    "rs_id": "rs777305616",
    "gene": "DISGENE266",
    "drug": "",
    "disease": "DIS465",
    "allele": "",
    "association_with": "Psoriasis 2",
    "reference": "REF220",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs777305616",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2056,
  "fields": {
    "snp_id": "SNP2073",
    "rs_id": "rs777640882",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF468",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs777640882",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2057,
  "fields": {
    "snp_id": "SNP2074",
    "rs_id": "rs778210210",
    "gene": "DISGENE237",
    "drug": "",
    "disease": "DIS124",
    "allele": "",
    "association_with": "Congenital Disorder Of Glycosylation, Type Iin",
    "reference": "REF352",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs778210210",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2058,
  "fields": {
    "snp_id": "SNP2075",
    "rs_id": "rs778431173",
    "gene": "DISGENE423",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF177",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs778431173",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Pakistan, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2059,
  "fields": {
    "snp_id": "SNP2076",
    "rs_id": "rs779018464",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS143",
    "allele": "",
    "association_with": "Deafness, Autosomal Dominant 3A (Disorder)",
    "reference": "REF200",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs779018464",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2060,
  "fields": {
    "snp_id": "SNP2077",
    "rs_id": "rs779018464",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF200",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs779018464",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2061,
  "fields": {
    "snp_id": "SNP2078",
    "rs_id": "rs779018464",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS156",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)",
    "reference": "REF200",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs779018464",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2062,
  "fields": {
    "snp_id": "SNP2079",
    "rs_id": "rs779018464",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS157",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "reference": "REF200",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs779018464",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2063,
  "fields": {
    "snp_id": "SNP2080",
    "rs_id": "rs779494870",
    "gene": "DISGENE124",
    "drug": "",
    "disease": "DIS239",
    "allele": "",
    "association_with": "Hepatolenticular Degeneration",
    "reference": "REF337",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs779494870",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2064,
  "fields": {
    "snp_id": "SNP2081",
    "rs_id": "rs780014431",
    "gene": "DISGENE447",
    "drug": "",
    "disease": "DIS488",
    "allele": "",
    "association_with": "Severe Combined Immunodeficiency",
    "reference": "REF444",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs780014431",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Somalia",
    "latitude": "5.1521000",
    "longitude": "46.1996000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2065,
  "fields": {
    "snp_id": "SNP2082",
    "rs_id": "rs7800944",
    "gene": "DISGENE526",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF222",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs7800944",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2066,
  "fields": {
    "snp_id": "SNP2083",
    "rs_id": "rs780520338",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs780520338",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2067,
  "fields": {
    "snp_id": "SNP2084",
    "rs_id": "rs781752990",
    "gene": "DISGENE527",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF243",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs781752990",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2068,
  "fields": {
    "snp_id": "SNP2085",
    "rs_id": "rs781897678",
    "gene": "DISGENE528",
    "drug": "",
    "disease": "DIS133",
    "allele": "",
    "association_with": "Crigler NAjjar Syndrome, Type 1",
    "reference": "REF479",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs781897678",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2069,
  "fields": {
    "snp_id": "SNP2086",
    "rs_id": "rs78289603",
    "gene": "DISGENE529",
    "drug": "",
    "disease": "DIS188",
    "allele": "",
    "association_with": "Factor V And Factor Viii, Combined Deficiency Of, 2",
    "reference": "REF348",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs78289603",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2070,
  "fields": {
    "snp_id": "SNP2087",
    "rs_id": "rs786200944",
    "gene": "DISGENE406",
    "drug": "",
    "disease": "DIS117",
    "allele": "",
    "association_with": "Cone-Rod Dystrophy 18",
    "reference": "REF619",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786200944",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2071,
  "fields": {
    "snp_id": "SNP2088",
    "rs_id": "rs786200944",
    "gene": "DISGENE406",
    "drug": "",
    "disease": "DIS471",
    "allele": "",
    "association_with": "Retinitis Pigmentosa",
    "reference": "REF619",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786200944",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2072,
  "fields": {
    "snp_id": "SNP2089",
    "rs_id": "rs786201006",
    "gene": "DISGENE530",
    "drug": "",
    "disease": "DIS283",
    "allele": "",
    "association_with": "Immunodeficiency 29",
    "reference": "REF814",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786201006",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2073,
  "fields": {
    "snp_id": "SNP2090",
    "rs_id": "rs786203251",
    "gene": "DISGENE531",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF670",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786203251",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2074,
  "fields": {
    "snp_id": "SNP2091",
    "rs_id": "rs786204422",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF540",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204422",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2075,
  "fields": {
    "snp_id": "SNP2092",
    "rs_id": "rs786204433",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS39",
    "allele": "",
    "association_with": "Ataxia Telangiectasia",
    "reference": "REF466",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204433",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2076,
  "fields": {
    "snp_id": "SNP2093",
    "rs_id": "rs786204433",
    "gene": "DISGENE425",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF466",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204433",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2077,
  "fields": {
    "snp_id": "SNP2094",
    "rs_id": "rs786204444",
    "gene": "DISGENE148",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF815",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204444",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2078,
  "fields": {
    "snp_id": "SNP2095",
    "rs_id": "rs786204616",
    "gene": "DISGENE331",
    "drug": "",
    "disease": "DIS223",
    "allele": "",
    "association_with": "Glycogen Storage Disease Type Iii",
    "reference": "REF751",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204616",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2079,
  "fields": {
    "snp_id": "SNP2096",
    "rs_id": "rs786204628",
    "gene": "DISGENE122",
    "drug": "",
    "disease": "DIS496",
    "allele": "",
    "association_with": "Spastic Ataxia, Charlevoix-Saguenay Type",
    "reference": "REF212",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204628",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2080,
  "fields": {
    "snp_id": "SNP2097",
    "rs_id": "rs786204662",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF540",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204662",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2081,
  "fields": {
    "snp_id": "SNP2098",
    "rs_id": "rs786204671",
    "gene": "DISGENE423",
    "drug": "",
    "disease": "DIS48",
    "allele": "",
    "association_with": "Bardet-Biedl Syndrome",
    "reference": "REF800",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204671",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2082,
  "fields": {
    "snp_id": "SNP2099",
    "rs_id": "rs786204786",
    "gene": "DISGENE532",
    "drug": "",
    "disease": "DIS487",
    "allele": "",
    "association_with": "Severe Autosomal Recessive Muscular Dystrophy Of Childhood - North African Type (Disorder)",
    "reference": "REF773",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204786",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2083,
  "fields": {
    "snp_id": "SNP2100",
    "rs_id": "rs786204963",
    "gene": "DISGENE533",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF240",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204963",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2084,
  "fields": {
    "snp_id": "SNP2101",
    "rs_id": "rs786204967",
    "gene": "DISGENE533",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF240",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786204967",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2085,
  "fields": {
    "snp_id": "SNP2102",
    "rs_id": "rs786205051",
    "gene": "DISGENE534",
    "drug": "",
    "disease": "DIS438",
    "allele": "",
    "association_with": "Poikiloderma With Neutropenia",
    "reference": "REF481",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786205051",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2086,
  "fields": {
    "snp_id": "SNP2103",
    "rs_id": "rs786205151",
    "gene": "DISGENE535",
    "drug": "",
    "disease": "DIS119",
    "allele": "",
    "association_with": "Cone-Rod Dystrophy 9",
    "reference": "REF624",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs786205151",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2087,
  "fields": {
    "snp_id": "SNP2104",
    "rs_id": "rs78655421",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF304",
    "p_value": "0.956",
    "source": "DisGeNET",
    "id_in_source": "rs78655421",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Morocco, Tunisia, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2088,
  "fields": {
    "snp_id": "SNP2105",
    "rs_id": "rs7896254",
    "gene": "DISGENE130",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000327",
    "source": "DisGeNET",
    "id_in_source": "rs7896254",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2089,
  "fields": {
    "snp_id": "SNP2106",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF678",
    "p_value": "0.152",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Nigeria, Mexico, Spain",
    "latitude": "40.4637000",
    "longitude": "-3.7492000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2090,
  "fields": {
    "snp_id": "SNP2107",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF769",
    "p_value": "0.0000029",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Austria",
    "latitude": "41.8719000",
    "longitude": "12.5674000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2091,
  "fields": {
    "snp_id": "SNP2108",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF497",
    "p_value": "0.021",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2092,
  "fields": {
    "snp_id": "SNP2109",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF343",
    "p_value": "0.021",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2093,
  "fields": {
    "snp_id": "SNP2110",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF493",
    "p_value": "0.006",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2094,
  "fields": {
    "snp_id": "SNP2111",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF222",
    "p_value": "0.000016",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2095,
  "fields": {
    "snp_id": "SNP2112",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF329",
    "p_value": "0.68",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2096,
  "fields": {
    "snp_id": "SNP2113",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF740",
    "p_value": "0.021",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2097,
  "fields": {
    "snp_id": "SNP2114",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF327",
    "p_value": "0.01",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2098,
  "fields": {
    "snp_id": "SNP2115",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS440",
    "allele": "",
    "association_with": "Polycystic Ovary Syndrome",
    "reference": "REF387",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, UK, China",
    "latitude": "35.8617000",
    "longitude": "104.1954000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2099,
  "fields": {
    "snp_id": "SNP2116",
    "rs_id": "rs7903146",
    "gene": "DISGENE231",
    "drug": "",
    "disease": "DIS396",
    "allele": "",
    "association_with": "Obesity",
    "reference": "REF330",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs7903146",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2100,
  "fields": {
    "snp_id": "SNP2117",
    "rs_id": "rs7918885",
    "gene": "DISGENE130",
    "drug": "",
    "disease": "DIS461",
    "allele": "",
    "association_with": "Prostate Carcinoma",
    "reference": "REF623",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs7918885",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2101,
  "fields": {
    "snp_id": "SNP2118",
    "rs_id": "rs79389353",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS138",
    "allele": "",
    "association_with": "Cystinuria",
    "reference": "REF808",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs79389353",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2102,
  "fields": {
    "snp_id": "SNP2119",
    "rs_id": "rs79389353",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS139",
    "allele": "",
    "association_with": "Cystinuria, Type A",
    "reference": "REF808",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs79389353",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2103,
  "fields": {
    "snp_id": "SNP2120",
    "rs_id": "rs79389353",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS140",
    "allele": "",
    "association_with": "Cystinuria, Type A-B",
    "reference": "REF808",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs79389353",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2104,
  "fields": {
    "snp_id": "SNP2121",
    "rs_id": "rs79389353",
    "gene": "DISGENE194",
    "drug": "",
    "disease": "DIS141",
    "allele": "",
    "association_with": "Cystinuria, Type B",
    "reference": "REF808",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs79389353",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2105,
  "fields": {
    "snp_id": "SNP2122",
    "rs_id": "rs794729665",
    "gene": "DISGENE536",
    "drug": "",
    "disease": "DIS150",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 66",
    "reference": "REF173",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs794729665",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2106,
  "fields": {
    "snp_id": "SNP2123",
    "rs_id": "rs794729665",
    "gene": "DISGENE536",
    "drug": "",
    "disease": "DIS150",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 66",
    "reference": "REF292",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs794729665",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2107,
  "fields": {
    "snp_id": "SNP2124",
    "rs_id": "rs794729665",
    "gene": "DISGENE536",
    "drug": "",
    "disease": "DIS394",
    "allele": "",
    "association_with": "Nonsyndromic Deafness",
    "reference": "REF292",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs794729665",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2108,
  "fields": {
    "snp_id": "SNP2125",
    "rs_id": "rs796052061",
    "gene": "DISGENE195",
    "drug": "",
    "disease": "DIS455",
    "allele": "",
    "association_with": "Primary Hyperoxaluria, Type I",
    "reference": "REF608",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs796052061",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Botswana, South Africa",
    "latitude": "-22.3285000",
    "longitude": "24.6849000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2109,
  "fields": {
    "snp_id": "SNP2126",
    "rs_id": "rs796052130",
    "gene": "DISGENE537",
    "drug": "",
    "disease": "DIS246",
    "allele": "",
    "association_with": "Hip Dysplasia, Beukes Type",
    "reference": "REF630",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs796052130",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2110,
  "fields": {
    "snp_id": "SNP2127",
    "rs_id": "rs796943858",
    "gene": "DISGENE269",
    "drug": "",
    "disease": "DIS531",
    "allele": "",
    "association_with": "Unverricht-Lundborg Syndrome",
    "reference": "REF648",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs796943858",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2111,
  "fields": {
    "snp_id": "SNP2128",
    "rs_id": "rs797044857",
    "gene": "DISGENE538",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF386",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs797044857",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia, Ghana, Nigeria",
    "latitude": "9.1450000",
    "longitude": "40.4897000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2112,
  "fields": {
    "snp_id": "SNP2129",
    "rs_id": "rs797044915",
    "gene": "DISGENE443",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF362",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs797044915",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2113,
  "fields": {
    "snp_id": "SNP2130",
    "rs_id": "rs797044960",
    "gene": "DISGENE539",
    "drug": "",
    "disease": "DIS142",
    "allele": "",
    "association_with": "Deafness, Autosomal Dominant 23",
    "reference": "REF217",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs797044960",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2114,
  "fields": {
    "snp_id": "SNP2131",
    "rs_id": "rs797045023",
    "gene": "DISGENE540",
    "drug": "",
    "disease": "DIS367",
    "allele": "",
    "association_with": "Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 9",
    "reference": "REF413",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs797045023",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2115,
  "fields": {
    "snp_id": "SNP2132",
    "rs_id": "rs797045155",
    "gene": "DISGENE190",
    "drug": "",
    "disease": "DIS477",
    "allele": "",
    "association_with": "Retinitis Pigmentosa 74",
    "reference": "REF349",
    "p_value": "0.000000129",
    "source": "DisGeNET",
    "id_in_source": "rs797045155",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2116,
  "fields": {
    "snp_id": "SNP2133",
    "rs_id": "rs7979473",
    "gene": "DISGENE323",
    "drug": "",
    "disease": "DIS128",
    "allele": "",
    "association_with": "C-Reactive Protein Measurement",
    "reference": "REF702",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs7979473",
    "region": "Mixed Population, African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2117,
  "fields": {
    "snp_id": "SNP2134",
    "rs_id": "rs79850223",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF794",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs79850223",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2118,
  "fields": {
    "snp_id": "SNP2135",
    "rs_id": "rs80034486",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF298",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80034486",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2119,
  "fields": {
    "snp_id": "SNP2136",
    "rs_id": "rs80034486",
    "gene": "DISGENE150",
    "drug": "",
    "disease": "DIS136",
    "allele": "",
    "association_with": "Cystic Fibrosis",
    "reference": "REF794",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80034486",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2120,
  "fields": {
    "snp_id": "SNP2137",
    "rs_id": "rs80338903",
    "gene": "DISGENE373",
    "drug": "",
    "disease": "DIS540",
    "allele": "",
    "association_with": "Usher Syndrome, Type Iia",
    "reference": "REF644",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338903",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, America, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2121,
  "fields": {
    "snp_id": "SNP2138",
    "rs_id": "rs80338933",
    "gene": "DISGENE541",
    "drug": "",
    "disease": "DIS93",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease",
    "reference": "REF780",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338933",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, America, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2122,
  "fields": {
    "snp_id": "SNP2139",
    "rs_id": "rs80338933",
    "gene": "DISGENE541",
    "drug": "",
    "disease": "DIS99",
    "allele": "",
    "association_with": "Charcot-Marie-Tooth Disease, Type 4C",
    "reference": "REF780",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338933",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, America, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2123,
  "fields": {
    "snp_id": "SNP2140",
    "rs_id": "rs80338933",
    "gene": "DISGENE541",
    "drug": "",
    "disease": "DIS358",
    "allele": "",
    "association_with": "Mononeuropathy Of The Median Nerve, Mild",
    "reference": "REF780",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338933",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, America, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2124,
  "fields": {
    "snp_id": "SNP2141",
    "rs_id": "rs80338939",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF491",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338939",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2125,
  "fields": {
    "snp_id": "SNP2142",
    "rs_id": "rs80338939",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS157",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "reference": "REF491",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338939",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2126,
  "fields": {
    "snp_id": "SNP2143",
    "rs_id": "rs80338939",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS143",
    "allele": "",
    "association_with": "Deafness, Autosomal Dominant 3A (Disorder)",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338939",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2127,
  "fields": {
    "snp_id": "SNP2144",
    "rs_id": "rs80338939",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338939",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2128,
  "fields": {
    "snp_id": "SNP2145",
    "rs_id": "rs80338939",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS274",
    "allele": "",
    "association_with": "Ichthyosis, Hystrix-Like, With Deafness",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338939",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2129,
  "fields": {
    "snp_id": "SNP2146",
    "rs_id": "rs80338939",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS297",
    "allele": "",
    "association_with": "Knuckle Pads, Leuconychia And Sensorineural Deafness",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338939",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2130,
  "fields": {
    "snp_id": "SNP2147",
    "rs_id": "rs80338939",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS369",
    "allele": "",
    "association_with": "Mutilating Keratoderma",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338939",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2131,
  "fields": {
    "snp_id": "SNP2148",
    "rs_id": "rs80338939",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS408",
    "allele": "",
    "association_with": "Palmoplantar Keratoderma With Deafness",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338939",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2132,
  "fields": {
    "snp_id": "SNP2149",
    "rs_id": "rs80338948",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF752",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338948",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2133,
  "fields": {
    "snp_id": "SNP2150",
    "rs_id": "rs80338948",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS156",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)",
    "reference": "REF752",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338948",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2134,
  "fields": {
    "snp_id": "SNP2151",
    "rs_id": "rs80338948",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS157",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "reference": "REF752",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338948",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2135,
  "fields": {
    "snp_id": "SNP2152",
    "rs_id": "rs80338948",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF704",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338948",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2136,
  "fields": {
    "snp_id": "SNP2153",
    "rs_id": "rs80338948",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF748",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338948",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2137,
  "fields": {
    "snp_id": "SNP2154",
    "rs_id": "rs80338948",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS156",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)",
    "reference": "REF748",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338948",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2138,
  "fields": {
    "snp_id": "SNP2155",
    "rs_id": "rs80338948",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS157",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "reference": "REF748",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338948",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2139,
  "fields": {
    "snp_id": "SNP2156",
    "rs_id": "rs80338950",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS143",
    "allele": "",
    "association_with": "Deafness, Autosomal Dominant 3A (Disorder)",
    "reference": "REF752",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338950",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2140,
  "fields": {
    "snp_id": "SNP2157",
    "rs_id": "rs80338950",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS147",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 1A (Disorder)",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338950",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2141,
  "fields": {
    "snp_id": "SNP2158",
    "rs_id": "rs80338950",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS156",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb3 (Disorder)",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338950",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2142,
  "fields": {
    "snp_id": "SNP2159",
    "rs_id": "rs80338950",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS157",
    "allele": "",
    "association_with": "Deafness, Digenic, Gjb2/Gjb6 (Disorder)",
    "reference": "REF527",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80338950",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2143,
  "fields": {
    "snp_id": "SNP2160",
    "rs_id": "rs80356769",
    "gene": "DISGENE364",
    "drug": "",
    "disease": "DIS209",
    "allele": "",
    "association_with": "Gaucher Disease, Type 1",
    "reference": "REF376",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356769",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2144,
  "fields": {
    "snp_id": "SNP2161",
    "rs_id": "rs80356936",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF454",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356936",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2145,
  "fields": {
    "snp_id": "SNP2162",
    "rs_id": "rs80356936",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF454",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356936",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2146,
  "fields": {
    "snp_id": "SNP2163",
    "rs_id": "rs80356936",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF365",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356936",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2147,
  "fields": {
    "snp_id": "SNP2164",
    "rs_id": "rs80356936",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF365",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356936",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2148,
  "fields": {
    "snp_id": "SNP2165",
    "rs_id": "rs80356936",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF726",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356936",
    "region": "Mixed Population, Sub-Saharan Africa, African American",
    "country_of_participants": "Nigeria, Barbados, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2149,
  "fields": {
    "snp_id": "SNP2166",
    "rs_id": "rs80356936",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF541",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356936",
    "region": "Mixed Population, Sub-Saharan Africa, North Africa",
    "country_of_participants": "Africa",
    "latitude": "-8.7832000",
    "longitude": "34.5085000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2150,
  "fields": {
    "snp_id": "SNP2167",
    "rs_id": "rs80356936",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF541",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356936",
    "region": "Mixed Population, Sub-Saharan Africa, North Africa",
    "country_of_participants": "Africa",
    "latitude": "-8.7832000",
    "longitude": "34.5085000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2151,
  "fields": {
    "snp_id": "SNP2168",
    "rs_id": "rs80356997",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356997",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2152,
  "fields": {
    "snp_id": "SNP2169",
    "rs_id": "rs80356997",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80356997",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2153,
  "fields": {
    "snp_id": "SNP2170",
    "rs_id": "rs80357064",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF365",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357064",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2154,
  "fields": {
    "snp_id": "SNP2171",
    "rs_id": "rs80357254",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357254",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2155,
  "fields": {
    "snp_id": "SNP2172",
    "rs_id": "rs80357391",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357391",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2156,
  "fields": {
    "snp_id": "SNP2173",
    "rs_id": "rs80357446",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF176",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357446",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Egypt, Morocco, Tunisia, Asia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2157,
  "fields": {
    "snp_id": "SNP2174",
    "rs_id": "rs80357569",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF533",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357569",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2158,
  "fields": {
    "snp_id": "SNP2175",
    "rs_id": "rs80357569",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF533",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357569",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2159,
  "fields": {
    "snp_id": "SNP2176",
    "rs_id": "rs80357590",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF430",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357590",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2160,
  "fields": {
    "snp_id": "SNP2177",
    "rs_id": "rs80357640",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357640",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2161,
  "fields": {
    "snp_id": "SNP2178",
    "rs_id": "rs80357701",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF306",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357701",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2162,
  "fields": {
    "snp_id": "SNP2179",
    "rs_id": "rs80357701",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF306",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357701",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2163,
  "fields": {
    "snp_id": "SNP2180",
    "rs_id": "rs80357701",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF533",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357701",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2164,
  "fields": {
    "snp_id": "SNP2181",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF309",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2165,
  "fields": {
    "snp_id": "SNP2182",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF309",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2166,
  "fields": {
    "snp_id": "SNP2183",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF551",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2167,
  "fields": {
    "snp_id": "SNP2184",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF306",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2168,
  "fields": {
    "snp_id": "SNP2185",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF306",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2169,
  "fields": {
    "snp_id": "SNP2186",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF306",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2170,
  "fields": {
    "snp_id": "SNP2187",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF742",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2171,
  "fields": {
    "snp_id": "SNP2188",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF533",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2172,
  "fields": {
    "snp_id": "SNP2189",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF533",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2173,
  "fields": {
    "snp_id": "SNP2190",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF533",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2174,
  "fields": {
    "snp_id": "SNP2191",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF176",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Egypt, Morocco, Tunisia, Asia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2175,
  "fields": {
    "snp_id": "SNP2192",
    "rs_id": "rs80357724",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF694",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357724",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2176,
  "fields": {
    "snp_id": "SNP2193",
    "rs_id": "rs80357727",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF405",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357727",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2177,
  "fields": {
    "snp_id": "SNP2194",
    "rs_id": "rs80357727",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF350",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357727",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2178,
  "fields": {
    "snp_id": "SNP2195",
    "rs_id": "rs80357727",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF223",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357727",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2179,
  "fields": {
    "snp_id": "SNP2196",
    "rs_id": "rs80357727",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF223",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357727",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2180,
  "fields": {
    "snp_id": "SNP2197",
    "rs_id": "rs80357728",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF309",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357728",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2181,
  "fields": {
    "snp_id": "SNP2198",
    "rs_id": "rs80357728",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF309",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357728",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2182,
  "fields": {
    "snp_id": "SNP2199",
    "rs_id": "rs80357728",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF551",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357728",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2183,
  "fields": {
    "snp_id": "SNP2200",
    "rs_id": "rs80357728",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF551",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357728",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2184,
  "fields": {
    "snp_id": "SNP2201",
    "rs_id": "rs80357783",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF594",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357783",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Iraq, Malaysia, Spain",
    "latitude": "4.2105000",
    "longitude": "101.9758000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2185,
  "fields": {
    "snp_id": "SNP2202",
    "rs_id": "rs80357783",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF594",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357783",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Iraq, Malaysia, Spain",
    "latitude": "4.2105000",
    "longitude": "101.9758000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2186,
  "fields": {
    "snp_id": "SNP2203",
    "rs_id": "rs80357786",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357786",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2187,
  "fields": {
    "snp_id": "SNP2204",
    "rs_id": "rs80357786",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357786",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2188,
  "fields": {
    "snp_id": "SNP2205",
    "rs_id": "rs80357888",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF393",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357888",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2189,
  "fields": {
    "snp_id": "SNP2206",
    "rs_id": "rs80357888",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF397",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357888",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2190,
  "fields": {
    "snp_id": "SNP2207",
    "rs_id": "rs80357888",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF397",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357888",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2191,
  "fields": {
    "snp_id": "SNP2208",
    "rs_id": "rs80357915",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357915",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2192,
  "fields": {
    "snp_id": "SNP2209",
    "rs_id": "rs80357915",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357915",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2193,
  "fields": {
    "snp_id": "SNP2210",
    "rs_id": "rs80357919",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF449",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80357919",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Morocco, Turkey",
    "latitude": "38.9637000",
    "longitude": "35.2433000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2194,
  "fields": {
    "snp_id": "SNP2211",
    "rs_id": "rs80358041",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF703",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358041",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2195,
  "fields": {
    "snp_id": "SNP2212",
    "rs_id": "rs80358086",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF195",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358086",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2196,
  "fields": {
    "snp_id": "SNP2213",
    "rs_id": "rs80358195",
    "gene": "DISGENE542",
    "drug": "",
    "disease": "DIS206",
    "allele": "",
    "association_with": "Fucosidase Deficiency Disease",
    "reference": "REF784",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358195",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, USA",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2197,
  "fields": {
    "snp_id": "SNP2214",
    "rs_id": "rs80358226",
    "gene": "DISGENE543",
    "drug": "",
    "disease": "DIS125",
    "allele": "",
    "association_with": "Corneal Dystrophy, Lattice Type 3",
    "reference": "REF660",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358226",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2198,
  "fields": {
    "snp_id": "SNP2215",
    "rs_id": "rs80358227",
    "gene": "DISGENE543",
    "drug": "",
    "disease": "DIS125",
    "allele": "",
    "association_with": "Corneal Dystrophy, Lattice Type 3",
    "reference": "REF660",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358227",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, USA, Europe",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2199,
  "fields": {
    "snp_id": "SNP2216",
    "rs_id": "rs80358241",
    "gene": "DISGENE123",
    "drug": "",
    "disease": "DIS338",
    "allele": "",
    "association_with": "Megalencephalic Leukoencephalopathy With Subcortical Cysts",
    "reference": "REF290",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358241",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2200,
  "fields": {
    "snp_id": "SNP2217",
    "rs_id": "rs80358242",
    "gene": "DISGENE123",
    "drug": "",
    "disease": "DIS338",
    "allele": "",
    "association_with": "Megalencephalic Leukoencephalopathy With Subcortical Cysts",
    "reference": "REF290",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358242",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Libya, Israel",
    "latitude": "31.0461000",
    "longitude": "34.8516000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2201,
  "fields": {
    "snp_id": "SNP2218",
    "rs_id": "rs80358260",
    "gene": "DISGENE168",
    "drug": "",
    "disease": "DIS390",
    "allele": "",
    "association_with": "Niemann-Pick Disease, Type C",
    "reference": "REF581",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358260",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2202,
  "fields": {
    "snp_id": "SNP2219",
    "rs_id": "rs80358260",
    "gene": "DISGENE168",
    "drug": "",
    "disease": "DIS391",
    "allele": "",
    "association_with": "Niemann-Pick Disease, Type C2",
    "reference": "REF581",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358260",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2203,
  "fields": {
    "snp_id": "SNP2220",
    "rs_id": "rs80358266",
    "gene": "DISGENE168",
    "drug": "",
    "disease": "DIS391",
    "allele": "",
    "association_with": "Niemann-Pick Disease, Type C2",
    "reference": "REF581",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358266",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2204,
  "fields": {
    "snp_id": "SNP2221",
    "rs_id": "rs80358268",
    "gene": "DISGENE168",
    "drug": "",
    "disease": "DIS391",
    "allele": "",
    "association_with": "Niemann-Pick Disease, Type C2",
    "reference": "REF581",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358268",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2205,
  "fields": {
    "snp_id": "SNP2222",
    "rs_id": "rs80358344",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF742",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358344",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2206,
  "fields": {
    "snp_id": "SNP2223",
    "rs_id": "rs80358344",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF176",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358344",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Algeria, Egypt, Morocco, Tunisia, Asia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2207,
  "fields": {
    "snp_id": "SNP2224",
    "rs_id": "rs80358928",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS69",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358928",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2208,
  "fields": {
    "snp_id": "SNP2225",
    "rs_id": "rs80358928",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80358928",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2209,
  "fields": {
    "snp_id": "SNP2226",
    "rs_id": "rs80359180",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF365",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359180",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2210,
  "fields": {
    "snp_id": "SNP2227",
    "rs_id": "rs80359180",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF365",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359180",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2211,
  "fields": {
    "snp_id": "SNP2228",
    "rs_id": "rs80359277",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF551",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359277",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2212,
  "fields": {
    "snp_id": "SNP2229",
    "rs_id": "rs80359277",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF551",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359277",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2213,
  "fields": {
    "snp_id": "SNP2230",
    "rs_id": "rs80359277",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF302",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359277",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2214,
  "fields": {
    "snp_id": "SNP2231",
    "rs_id": "rs80359297",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF795",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359297",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2215,
  "fields": {
    "snp_id": "SNP2232",
    "rs_id": "rs80359375",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF377",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359375",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2216,
  "fields": {
    "snp_id": "SNP2233",
    "rs_id": "rs80359473",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS69",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2",
    "reference": "REF767",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359473",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Asia",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2217,
  "fields": {
    "snp_id": "SNP2234",
    "rs_id": "rs80359473",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF767",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359473",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Asia",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2218,
  "fields": {
    "snp_id": "SNP2235",
    "rs_id": "rs80359473",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF767",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359473",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "North Africa, Asia",
    "latitude": "26.0198000",
    "longitude": "32.2778000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2219,
  "fields": {
    "snp_id": "SNP2236",
    "rs_id": "rs80359527",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF350",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359527",
    "region": "North African",
    "country_of_participants": "Algeria, Morocco, Tunisia",
    "latitude": "33.8869000",
    "longitude": "9.5375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2220,
  "fields": {
    "snp_id": "SNP2237",
    "rs_id": "rs80359530",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF551",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359530",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2221,
  "fields": {
    "snp_id": "SNP2238",
    "rs_id": "rs80359535",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF393",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359535",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2222,
  "fields": {
    "snp_id": "SNP2239",
    "rs_id": "rs80359535",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF288",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359535",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2223,
  "fields": {
    "snp_id": "SNP2240",
    "rs_id": "rs80359624",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF687",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359624",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2224,
  "fields": {
    "snp_id": "SNP2241",
    "rs_id": "rs80359644",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF365",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359644",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2225,
  "fields": {
    "snp_id": "SNP2242",
    "rs_id": "rs80359688",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF393",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359688",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2226,
  "fields": {
    "snp_id": "SNP2243",
    "rs_id": "rs80359688",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF393",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359688",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2227,
  "fields": {
    "snp_id": "SNP2244",
    "rs_id": "rs80359688",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF184",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359688",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2228,
  "fields": {
    "snp_id": "SNP2245",
    "rs_id": "rs80359688",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF288",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359688",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2229,
  "fields": {
    "snp_id": "SNP2246",
    "rs_id": "rs80359688",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF288",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359688",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2230,
  "fields": {
    "snp_id": "SNP2247",
    "rs_id": "rs80359688",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS240",
    "allele": "",
    "association_with": "Hereditary Breast And Ovarian Cancer Syndrome",
    "reference": "REF687",
    "p_value": "0.000000000145",
    "source": "DisGeNET",
    "id_in_source": "rs80359688",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2231,
  "fields": {
    "snp_id": "SNP2248",
    "rs_id": "rs8051542",
    "gene": "DISGENE544",
    "drug": "",
    "disease": "DIS66",
    "allele": "",
    "association_with": "Breast Carcinoma",
    "reference": "REF241",
    "p_value": "0.0004",
    "source": "DisGeNET",
    "id_in_source": "rs8051542",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2232,
  "fields": {
    "snp_id": "SNP2249",
    "rs_id": "rs8051542",
    "gene": "DISGENE544",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF241",
    "p_value": "0.0004",
    "source": "DisGeNET",
    "id_in_source": "rs8051542",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2233,
  "fields": {
    "snp_id": "SNP2250",
    "rs_id": "rs8057044",
    "gene": "DISGENE545",
    "drug": "",
    "disease": "DIS261",
    "allele": "",
    "association_with": "Hypertensive Disease",
    "reference": "REF628",
    "p_value": "0.019",
    "source": "DisGeNET",
    "id_in_source": "rs8057044",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2234,
  "fields": {
    "snp_id": "SNP2251",
    "rs_id": "rs81002823",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF795",
    "p_value": "0.019",
    "source": "DisGeNET",
    "id_in_source": "rs81002823",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2235,
  "fields": {
    "snp_id": "SNP2252",
    "rs_id": "rs81002849",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS69",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2",
    "reference": "REF742",
    "p_value": "0.019",
    "source": "DisGeNET",
    "id_in_source": "rs81002849",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2236,
  "fields": {
    "snp_id": "SNP2253",
    "rs_id": "rs81002849",
    "gene": "DISGENE161",
    "drug": "",
    "disease": "DIS379",
    "allele": "",
    "association_with": "Neoplastic Syndromes, Hereditary",
    "reference": "REF742",
    "p_value": "0.019",
    "source": "DisGeNET",
    "id_in_source": "rs81002849",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2237,
  "fields": {
    "snp_id": "SNP2254",
    "rs_id": "rs8109875",
    "gene": "PHARGENE95",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.000028",
    "source": "DisGeNET",
    "id_in_source": "rs8109875",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2238,
  "fields": {
    "snp_id": "SNP2255",
    "rs_id": "rs8176672",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.000028",
    "source": "DisGeNET",
    "id_in_source": "rs8176672",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2239,
  "fields": {
    "snp_id": "SNP2256",
    "rs_id": "rs8176672",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.000028",
    "source": "DisGeNET",
    "id_in_source": "rs8176672",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2240,
  "fields": {
    "snp_id": "SNP2257",
    "rs_id": "rs8176693",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.000028",
    "source": "DisGeNET",
    "id_in_source": "rs8176693",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2241,
  "fields": {
    "snp_id": "SNP2258",
    "rs_id": "rs8176693",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "0.000028",
    "source": "DisGeNET",
    "id_in_source": "rs8176693",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2242,
  "fields": {
    "snp_id": "SNP2259",
    "rs_id": "rs8176703",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.000000000004",
    "source": "DisGeNET",
    "id_in_source": "rs8176703",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2243,
  "fields": {
    "snp_id": "SNP2260",
    "rs_id": "rs8176703",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "0.000000000004",
    "source": "DisGeNET",
    "id_in_source": "rs8176703",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2244,
  "fields": {
    "snp_id": "SNP2261",
    "rs_id": "rs8176719",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176719",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2245,
  "fields": {
    "snp_id": "SNP2262",
    "rs_id": "rs8176719",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF319",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176719",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ghana",
    "latitude": "7.9465270",
    "longitude": "-1.0231940"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2246,
  "fields": {
    "snp_id": "SNP2263",
    "rs_id": "rs8176722",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176722",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2247,
  "fields": {
    "snp_id": "SNP2264",
    "rs_id": "rs8176722",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176722",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2248,
  "fields": {
    "snp_id": "SNP2265",
    "rs_id": "rs8176743",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176743",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2249,
  "fields": {
    "snp_id": "SNP2266",
    "rs_id": "rs8176743",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176743",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2250,
  "fields": {
    "snp_id": "SNP2267",
    "rs_id": "rs8176746",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176746",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2251,
  "fields": {
    "snp_id": "SNP2268",
    "rs_id": "rs8176746",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176746",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2252,
  "fields": {
    "snp_id": "SNP2269",
    "rs_id": "rs8176749",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176749",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2253,
  "fields": {
    "snp_id": "SNP2270",
    "rs_id": "rs8176749",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176749",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2254,
  "fields": {
    "snp_id": "SNP2271",
    "rs_id": "rs8176751",
    "gene": "DISGENE417",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176751",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2255,
  "fields": {
    "snp_id": "SNP2272",
    "rs_id": "rs8176751",
    "gene": "DISGENE546",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "1.1E-020",
    "source": "DisGeNET",
    "id_in_source": "rs8176751",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2256,
  "fields": {
    "snp_id": "SNP2273",
    "rs_id": "rs822396",
    "gene": "DISGENE128",
    "drug": "",
    "disease": "DIS164",
    "allele": "",
    "association_with": "Diabetes Mellitus, Non-Insulin-Dependent",
    "reference": "REF524",
    "p_value": "0.02",
    "source": "DisGeNET",
    "id_in_source": "rs822396",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2257,
  "fields": {
    "snp_id": "SNP2274",
    "rs_id": "rs854560",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS66",
    "allele": "",
    "association_with": "Breast Carcinoma",
    "reference": "REF674",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs854560",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2258,
  "fields": {
    "snp_id": "SNP2275",
    "rs_id": "rs854560",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS328",
    "allele": "",
    "association_with": "Malignant Neoplasm Of Breast",
    "reference": "REF674",
    "p_value": "0.011",
    "source": "DisGeNET",
    "id_in_source": "rs854560",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2259,
  "fields": {
    "snp_id": "SNP2276",
    "rs_id": "rs854560",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS59",
    "allele": "",
    "association_with": "Bipolar I Disorder",
    "reference": "REF695",
    "p_value": "0.04",
    "source": "DisGeNET",
    "id_in_source": "rs854560",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2260,
  "fields": {
    "snp_id": "SNP2277",
    "rs_id": "rs854560",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS30",
    "allele": "",
    "association_with": "Antiphospholipid Syndrome",
    "reference": "REF375",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs854560",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2261,
  "fields": {
    "snp_id": "SNP2278",
    "rs_id": "rs854560",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS318",
    "allele": "",
    "association_with": "Lupus Erythematosus, Systemic",
    "reference": "REF375",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs854560",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2262,
  "fields": {
    "snp_id": "SNP2279",
    "rs_id": "rs854560",
    "gene": "DISGENE470",
    "drug": "",
    "disease": "DIS442",
    "allele": "",
    "association_with": "Polyendocrinopathies, Autoimmune",
    "reference": "REF375",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs854560",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2263,
  "fields": {
    "snp_id": "SNP2280",
    "rs_id": "rs855791",
    "gene": "DISGENE547",
    "drug": "",
    "disease": "DIS26",
    "allele": "",
    "association_with": "Anemia",
    "reference": "REF232",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs855791",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Rwanda",
    "latitude": "-1.9402780",
    "longitude": "29.8738880"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2264,
  "fields": {
    "snp_id": "SNP2281",
    "rs_id": "rs855791",
    "gene": "DISGENE547",
    "drug": "",
    "disease": "DIS287",
    "allele": "",
    "association_with": "Iron Deficiency",
    "reference": "REF232",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs855791",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Rwanda",
    "latitude": "-1.9402780",
    "longitude": "29.8738880"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2265,
  "fields": {
    "snp_id": "SNP2282",
    "rs_id": "rs855791",
    "gene": "DISGENE547",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF689",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs855791",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2266,
  "fields": {
    "snp_id": "SNP2283",
    "rs_id": "rs855791",
    "gene": "DISGENE547",
    "drug": "",
    "disease": "DIS365",
    "allele": "",
    "association_with": "Multiple Sclerosis",
    "reference": "REF689",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs855791",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Nigeria",
    "latitude": "9.0819990",
    "longitude": "8.6752770"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2267,
  "fields": {
    "snp_id": "SNP2284",
    "rs_id": "rs863223305",
    "gene": "DISGENE222",
    "drug": "",
    "disease": "DIS174",
    "allele": "",
    "association_with": "Elliptocytosis 2 (Disorder)",
    "reference": "REF214",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs863223305",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2268,
  "fields": {
    "snp_id": "SNP2285",
    "rs_id": "rs864309516",
    "gene": "DISGENE548",
    "drug": "",
    "disease": "DIS276",
    "allele": "",
    "association_with": "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis",
    "reference": "REF395",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864309516",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2269,
  "fields": {
    "snp_id": "SNP2286",
    "rs_id": "rs864309516",
    "gene": "DISGENE548",
    "drug": "",
    "disease": "DIS276",
    "allele": "",
    "association_with": "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis",
    "reference": "REF467",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864309516",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2270,
  "fields": {
    "snp_id": "SNP2287",
    "rs_id": "rs864309523",
    "gene": "DISGENE443",
    "drug": "",
    "disease": "DIS149",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 53",
    "reference": "REF603",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864309523",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, Turkey",
    "latitude": "38.9637000",
    "longitude": "35.2433000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2271,
  "fields": {
    "snp_id": "SNP2288",
    "rs_id": "rs864309717",
    "gene": "DISGENE549",
    "drug": "",
    "disease": "DIS494",
    "allele": "",
    "association_with": "Skin Creases, Congenital Symmetric Circumferential, 2",
    "reference": "REF642",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864309717",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2272,
  "fields": {
    "snp_id": "SNP2289",
    "rs_id": "rs864321622",
    "gene": "DISGENE309",
    "drug": "",
    "disease": "DIS176",
    "allele": "",
    "association_with": "Encephalopathy Adverse Event",
    "reference": "REF240",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864321622",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2273,
  "fields": {
    "snp_id": "SNP2290",
    "rs_id": "rs864321622",
    "gene": "DISGENE309",
    "drug": "",
    "disease": "DIS267",
    "allele": "",
    "association_with": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2",
    "reference": "REF240",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864321622",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2274,
  "fields": {
    "snp_id": "SNP2291",
    "rs_id": "rs864321623",
    "gene": "DISGENE309",
    "drug": "",
    "disease": "DIS176",
    "allele": "",
    "association_with": "Encephalopathy Adverse Event",
    "reference": "REF240",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864321623",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2275,
  "fields": {
    "snp_id": "SNP2292",
    "rs_id": "rs864321623",
    "gene": "DISGENE309",
    "drug": "",
    "disease": "DIS267",
    "allele": "",
    "association_with": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2",
    "reference": "REF240",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864321623",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Saudi Arabia",
    "latitude": "26.8206000",
    "longitude": "30.8025000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2276,
  "fields": {
    "snp_id": "SNP2293",
    "rs_id": "rs864622179",
    "gene": "DISGENE550",
    "drug": "",
    "disease": "DIS502",
    "allele": "",
    "association_with": "Spastic Paraplegia 4, Autosomal Dominant",
    "reference": "REF294",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864622179",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2277,
  "fields": {
    "snp_id": "SNP2294",
    "rs_id": "rs864622179",
    "gene": "DISGENE550",
    "drug": "",
    "disease": "DIS502",
    "allele": "",
    "association_with": "Spastic Paraplegia 4, Autosomal Dominant",
    "reference": "REF294",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs864622179",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2278,
  "fields": {
    "snp_id": "SNP2295",
    "rs_id": "rs866266998",
    "gene": "DISGENE254",
    "drug": "",
    "disease": "DIS517",
    "allele": "",
    "association_with": "Stuttering, Familial Persistent 1",
    "reference": "REF714",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs866266998",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "Cameroon, Pakistan, North America",
    "latitude": "54.5260000",
    "longitude": "-105.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2279,
  "fields": {
    "snp_id": "SNP2296",
    "rs_id": "rs869025342",
    "gene": "DISGENE551",
    "drug": "",
    "disease": "DIS266",
    "allele": "",
    "association_with": "Hypotonia, Infantile, With Psychomotor Retardation",
    "reference": "REF661",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs869025342",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2280,
  "fields": {
    "snp_id": "SNP2297",
    "rs_id": "rs869025563",
    "gene": "DISGENE552",
    "drug": "",
    "disease": "DIS311",
    "allele": "",
    "association_with": "Lipoid Proteinosis Of Urbach And Wiethe",
    "reference": "REF701",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs869025563",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2281,
  "fields": {
    "snp_id": "SNP2298",
    "rs_id": "rs869320674",
    "gene": "DISGENE553",
    "drug": "",
    "disease": "DIS148",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 31",
    "reference": "REF789",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs869320674",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2282,
  "fields": {
    "snp_id": "SNP2299",
    "rs_id": "rs869320772",
    "gene": "DISGENE371",
    "drug": "",
    "disease": "DIS346",
    "allele": "",
    "association_with": "Mental Retardation, Autosomal Recessive 53",
    "reference": "REF754",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs869320772",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Pakistan",
    "latitude": "30.3753000",
    "longitude": "69.3451000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2283,
  "fields": {
    "snp_id": "SNP2300",
    "rs_id": "rs869320773",
    "gene": "DISGENE371",
    "drug": "",
    "disease": "DIS346",
    "allele": "",
    "association_with": "Mental Retardation, Autosomal Recessive 53",
    "reference": "REF754",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs869320773",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Egypt, Pakistan",
    "latitude": "30.3753000",
    "longitude": "69.3451000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2284,
  "fields": {
    "snp_id": "SNP2301",
    "rs_id": "rs875989778",
    "gene": "DISGENE406",
    "drug": "",
    "disease": "DIS117",
    "allele": "",
    "association_with": "Cone-Rod Dystrophy 18",
    "reference": "REF619",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs875989778",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2285,
  "fields": {
    "snp_id": "SNP2302",
    "rs_id": "rs875989900",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF697",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs875989900",
    "region": "North African",
    "country_of_participants": "Egypt",
    "latitude": "26.8205530",
    "longitude": "30.8024980"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2286,
  "fields": {
    "snp_id": "SNP2303",
    "rs_id": "rs875989907",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF253",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs875989907",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2287,
  "fields": {
    "snp_id": "SNP2304",
    "rs_id": "rs876657624",
    "gene": "DISGENE554",
    "drug": "",
    "disease": "DIS537",
    "allele": "",
    "association_with": "Usher Syndrome, Type Ic",
    "reference": "REF807",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs876657624",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2288,
  "fields": {
    "snp_id": "SNP2305",
    "rs_id": "rs876661408",
    "gene": "DISGENE525",
    "drug": "",
    "disease": "DIS146",
    "allele": "",
    "association_with": "Deafness, Autosomal Recessive 105",
    "reference": "REF442",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs876661408",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Mauritania, Iran",
    "latitude": "32.4279000",
    "longitude": "53.6880000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2289,
  "fields": {
    "snp_id": "SNP2306",
    "rs_id": "rs878853326",
    "gene": "DISGENE555",
    "drug": "",
    "disease": "DIS211",
    "allele": "",
    "association_with": "Genetic Diseases, Inborn",
    "reference": "REF332",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs878853326",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2290,
  "fields": {
    "snp_id": "SNP2307",
    "rs_id": "rs879254467",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF238",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254467",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2291,
  "fields": {
    "snp_id": "SNP2308",
    "rs_id": "rs879254496",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF595",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254496",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2292,
  "fields": {
    "snp_id": "SNP2309",
    "rs_id": "rs879254526",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF253",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254526",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2293,
  "fields": {
    "snp_id": "SNP2310",
    "rs_id": "rs879254554",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF303",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254554",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2294,
  "fields": {
    "snp_id": "SNP2311",
    "rs_id": "rs879254554",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF238",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254554",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2295,
  "fields": {
    "snp_id": "SNP2312",
    "rs_id": "rs879254594",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF230",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254594",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2296,
  "fields": {
    "snp_id": "SNP2313",
    "rs_id": "rs879254630",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF595",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254630",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2297,
  "fields": {
    "snp_id": "SNP2314",
    "rs_id": "rs879254809",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF595",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254809",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2298,
  "fields": {
    "snp_id": "SNP2315",
    "rs_id": "rs879254867",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF230",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254867",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2299,
  "fields": {
    "snp_id": "SNP2316",
    "rs_id": "rs879254919",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF180",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879254919",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2300,
  "fields": {
    "snp_id": "SNP2317",
    "rs_id": "rs879255003",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF238",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879255003",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2301,
  "fields": {
    "snp_id": "SNP2318",
    "rs_id": "rs879255135",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF230",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879255135",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2302,
  "fields": {
    "snp_id": "SNP2319",
    "rs_id": "rs879255174",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF809",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879255174",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2303,
  "fields": {
    "snp_id": "SNP2320",
    "rs_id": "rs879255213",
    "gene": "PHARGENE54",
    "drug": "",
    "disease": "DIS256",
    "allele": "",
    "association_with": "Hypercholesterolemia, Familial",
    "reference": "REF468",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879255213",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2304,
  "fields": {
    "snp_id": "SNP2321",
    "rs_id": "rs879255281",
    "gene": "DISGENE350",
    "drug": "",
    "disease": "DIS68",
    "allele": "",
    "association_with": "Breast-Ovarian Cancer, Familial, Susceptibility To, 1",
    "reference": "REF795",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879255281",
    "region": "African American",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2305,
  "fields": {
    "snp_id": "SNP2322",
    "rs_id": "rs879255520",
    "gene": "DISGENE556",
    "drug": "",
    "disease": "DIS324",
    "allele": "",
    "association_with": "Macular Degeneration, Age-Related, 1",
    "reference": "REF402",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs879255520",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2306,
  "fields": {
    "snp_id": "SNP2323",
    "rs_id": "rs886037750",
    "gene": "DISGENE557",
    "drug": "",
    "disease": "DIS468",
    "allele": "",
    "association_with": "Rabson-Mendenhall Syndrome",
    "reference": "REF544",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs886037750",
    "region": "North African",
    "country_of_participants": "Libya",
    "latitude": "26.3351000",
    "longitude": "17.2283000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2307,
  "fields": {
    "snp_id": "SNP2324",
    "rs_id": "rs886037762",
    "gene": "DISGENE380",
    "drug": "",
    "disease": "DIS534",
    "allele": "",
    "association_with": "Usher Syndrome, Type I",
    "reference": "REF807",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs886037762",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2308,
  "fields": {
    "snp_id": "SNP2325",
    "rs_id": "rs886037849",
    "gene": "DISGENE111",
    "drug": "",
    "disease": "DIS369",
    "allele": "",
    "association_with": "Mutilating Keratoderma",
    "reference": "REF527",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs886037849",
    "region": "Mixed Population, North Africa",
    "country_of_participants": "Tunisia, New Zealand, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2309,
  "fields": {
    "snp_id": "SNP2326",
    "rs_id": "rs886039789",
    "gene": "DISGENE558",
    "drug": "",
    "disease": "DIS218",
    "allele": "",
    "association_with": "Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency",
    "reference": "REF193",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs886039789",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2310,
  "fields": {
    "snp_id": "SNP2327",
    "rs_id": "rs886039790",
    "gene": "DISGENE558",
    "drug": "",
    "disease": "DIS218",
    "allele": "",
    "association_with": "Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency",
    "reference": "REF193",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs886039790",
    "region": "North African",
    "country_of_participants": "Algeria",
    "latitude": "28.0339000",
    "longitude": "1.6596000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2311,
  "fields": {
    "snp_id": "SNP2328",
    "rs_id": "rs886040963",
    "gene": "DISGENE212",
    "drug": "",
    "disease": "DIS40",
    "allele": "",
    "association_with": "Ataxia With Vitamin E Deficiency",
    "reference": "REF612",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs886040963",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2312,
  "fields": {
    "snp_id": "SNP2329",
    "rs_id": "rs886040964",
    "gene": "DISGENE212",
    "drug": "",
    "disease": "DIS40",
    "allele": "",
    "association_with": "Ataxia With Vitamin E Deficiency",
    "reference": "REF612",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs886040964",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2313,
  "fields": {
    "snp_id": "SNP2330",
    "rs_id": "rs900431442",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS452",
    "allele": "",
    "association_with": "Porphyria, South African Type",
    "reference": "REF590",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs900431442",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2314,
  "fields": {
    "snp_id": "SNP2331",
    "rs_id": "rs900431442",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS541",
    "allele": "",
    "association_with": "Variegate Porphyria",
    "reference": "REF590",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs900431442",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2315,
  "fields": {
    "snp_id": "SNP2332",
    "rs_id": "rs900431442",
    "gene": "DISGENE218",
    "drug": "",
    "disease": "DIS542",
    "allele": "",
    "association_with": "Variegate Porphyria, Homozygous Variant",
    "reference": "REF590",
    "p_value": "< 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs900431442",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "South Africa",
    "latitude": "-30.5594830",
    "longitude": "22.9375060"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2316,
  "fields": {
    "snp_id": "SNP2333",
    "rs_id": "rs9296359",
    "gene": "DISGENE559",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF501",
    "p_value": "0.000000329",
    "source": "DisGeNET",
    "id_in_source": "rs9296359",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2317,
  "fields": {
    "snp_id": "SNP2334",
    "rs_id": "rs946053",
    "gene": "DISGENE233",
    "drug": "",
    "disease": "DIS166",
    "allele": "",
    "association_with": "Disorder Of Achilles Tendon",
    "reference": "REF799",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs946053",
    "region": "Mixed Population, Sub-Saharan Africa",
    "country_of_participants": "South Africa, Australia",
    "latitude": "-30.5595000",
    "longitude": "22.9375000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2318,
  "fields": {
    "snp_id": "SNP2335",
    "rs_id": "rs957176669",
    "gene": "DISGENE560",
    "drug": "",
    "disease": "DIS493",
    "allele": "",
    "association_with": "Sitosterolemia",
    "reference": "REF699",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs957176669",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2319,
  "fields": {
    "snp_id": "SNP2336",
    "rs_id": "rs981454067",
    "gene": "DISGENE120",
    "drug": "",
    "disease": "DIS19",
    "allele": "",
    "association_with": "Alkaptonuria",
    "reference": "REF305",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs981454067",
    "region": "North African",
    "country_of_participants": "Algeria, Europe",
    "latitude": "54.5260000",
    "longitude": "15.2551000"
  }
},
{
  "model": "agmp_app.snp",
  "pk": 2320,
  "fields": {
    "snp_id": "SNP2337",
    "rs_id": "rs9940464",
    "gene": "DISGENE561",
    "drug": "",
    "disease": "DIS325",
    "allele": "",
    "association_with": "Malaria",
    "reference": "REF341",
    "p_value": "> 0.05",
    "source": "DisGeNET",
    "id_in_source": "rs9940464",
    "region": "Sub-Saharan Africa",
    "country_of_participants": "The Gambia, Kenya, Malawi",
    "latitude": "-13.2543000",
    "longitude": "34.3015000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 855,
  "fields": {
    "star_id": "STAR1",
    "star_annotation": "CYP1A2*1K",
    "gene": "PHARGENE19",
    "drug": "DRUG10",
    "allele": "*1K",
    "phenotype": "CYP1A2 *1K is associated with decreased metabolism of caffeine in healthy individuals.",
    "reference": "REF162",
    "p_value": "< 0.02",
    "source": "PharmGKB",
    "id_in_source": "827698390",
    "region": "Sub-Saharan African",
    "country_of_participants": "Ethiopia",
    "latitude": "9.1450000",
    "longitude": "40.4896740"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 856,
  "fields": {
    "star_id": "STAR2",
    "star_annotation": "CYP3A4*1",
    "gene": "PHARGENE27",
    "drug": "DRUG12",
    "allele": "*1/*22 + *22/*22",
    "phenotype": "CYP3A4 *1/*22 + *22/*22 is associated with concentrations of simvastatin as compared to CYP3A4 *1/*1.",
    "reference": "REF152",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1184746928",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 857,
  "fields": {
    "star_id": "STAR3",
    "star_annotation": "CYP3A4*22",
    "gene": "PHARGENE27",
    "drug": "DRUG12",
    "allele": "*1/*22 + *22/*22",
    "phenotype": "CYP3A4 *1/*22 + *22/*22 is associated with concentrations of simvastatin as compared to CYP3A4 *1/*1.",
    "reference": "REF152",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1184746928",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 858,
  "fields": {
    "star_id": "STAR196",
    "star_annotation": "CYP3A4*1",
    "gene": "PHARGENE27",
    "drug": "DRUG55",
    "allele": "*1/*1B",
    "phenotype": "CYP3A4 *1/*1B is associated with increased dose of buprenorphine in people with Opioid-Related Disorders.",
    "reference": "REF160",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449170970",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 859,
  "fields": {
    "star_id": "STAR197",
    "star_annotation": "CYP3A4*1B",
    "gene": "PHARGENE27",
    "drug": "DRUG55",
    "allele": "*1/*1B",
    "phenotype": "CYP3A4 *1/*1B is associated with increased dose of buprenorphine in people with Opioid-Related Disorders.",
    "reference": "REF160",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449170970",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 860,
  "fields": {
    "star_id": "STAR218",
    "star_annotation": "CYP3A4*1",
    "gene": "PHARGENE27",
    "drug": "DRUG11",
    "allele": "*1/*1B",
    "phenotype": "CYP3A4 *1/*1B is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A4 *1/*1.",
    "reference": "REF54",
    "p_value": "< 0.005",
    "source": "PharmGKB",
    "id_in_source": "1447674678",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 861,
  "fields": {
    "star_id": "STAR219",
    "star_annotation": "CYP3A4*1B",
    "gene": "PHARGENE27",
    "drug": "DRUG11",
    "allele": "*1/*1B",
    "phenotype": "CYP3A4 *1/*1B is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A4 *1/*1.",
    "reference": "REF54",
    "p_value": "< 0.005",
    "source": "PharmGKB",
    "id_in_source": "1447674678",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 862,
  "fields": {
    "star_id": "STAR220",
    "star_annotation": "CYP3A5*1A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A.",
    "reference": "REF54",
    "p_value": "< 0.005",
    "source": "PharmGKB",
    "id_in_source": "1447674691",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 863,
  "fields": {
    "star_id": "STAR221",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A.",
    "reference": "REF54",
    "p_value": "< 0.005",
    "source": "PharmGKB",
    "id_in_source": "1447674691",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 864,
  "fields": {
    "star_id": "STAR175",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased clearance of tacrolimus in people with Kidney Transplantation.",
    "reference": "REF39",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448267244",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 865,
  "fields": {
    "star_id": "STAR176",
    "star_annotation": "CYP3A5*6",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased clearance of tacrolimus in people with Kidney Transplantation.",
    "reference": "REF39",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448267244",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 866,
  "fields": {
    "star_id": "STAR177",
    "star_annotation": "CYP3A5*7",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased clearance of tacrolimus in people with Kidney Transplantation.",
    "reference": "REF39",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448267244",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 867,
  "fields": {
    "star_id": "STAR193",
    "star_annotation": "CYP3A5*1A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.",
    "reference": "REF109",
    "p_value": "0,04",
    "source": "PharmGKB",
    "id_in_source": "1449170428",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 868,
  "fields": {
    "star_id": "STAR194",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.",
    "reference": "REF109",
    "p_value": "0,04",
    "source": "PharmGKB",
    "id_in_source": "1449170428",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 869,
  "fields": {
    "star_id": "STAR195",
    "star_annotation": "CYP3A5*6",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.",
    "reference": "REF109",
    "p_value": "0,04",
    "source": "PharmGKB",
    "id_in_source": "1449170428",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 870,
  "fields": {
    "star_id": "STAR206",
    "star_annotation": "CYP3A5*1A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.",
    "reference": "REF109",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1449171185",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 871,
  "fields": {
    "star_id": "STAR207",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.",
    "reference": "REF109",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1449171185",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 872,
  "fields": {
    "star_id": "STAR208",
    "star_annotation": "CYP3A5*6",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.",
    "reference": "REF109",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1449171185",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 873,
  "fields": {
    "star_id": "STAR198",
    "star_annotation": "CYP3A5*1A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6 + *1A/*7",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 + *1A/*7 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *3A/*7 + *6/*6 + *6/*7 + *7/*7.",
    "reference": "REF164",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1449183103",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 874,
  "fields": {
    "star_id": "STAR199",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6 + *1A/*7",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 + *1A/*7 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *3A/*7 + *6/*6 + *6/*7 + *7/*7.",
    "reference": "REF164",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1449183103",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 875,
  "fields": {
    "star_id": "STAR200",
    "star_annotation": "CYP3A5*6",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6 + *1A/*7",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 + *1A/*7 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *3A/*7 + *6/*6 + *6/*7 + *7/*7.",
    "reference": "REF164",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1449183103",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 876,
  "fields": {
    "star_id": "STAR201",
    "star_annotation": "CYP3A5*7",
    "gene": "PHARGENE28",
    "drug": "DRUG11",
    "allele": "*1A/*1A + *1A/*3A + *1A/*6 + *1A/*7",
    "phenotype": "CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 + *1A/*7 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *3A/*7 + *6/*6 + *6/*7 + *7/*7.",
    "reference": "REF164",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1449183103",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 877,
  "fields": {
    "star_id": "STAR4",
    "star_annotation": "CYP2A6*1A",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*1A/*20",
    "phenotype": "CYP2A6 *1A/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.",
    "reference": "REF129",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827827639",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Japan",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 878,
  "fields": {
    "star_id": "STAR5",
    "star_annotation": "CYP2A6*20",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*1A/*20",
    "phenotype": "CYP2A6 *1A/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.",
    "reference": "REF129",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827827639",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Japan",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 879,
  "fields": {
    "star_id": "STAR12",
    "star_annotation": "CYP2A6*17",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*17/*20",
    "phenotype": "CYP2A6 *17/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.",
    "reference": "REF129",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827827648",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Japan",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 880,
  "fields": {
    "star_id": "STAR13",
    "star_annotation": "CYP2A6*1A",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*17/*20",
    "phenotype": "CYP2A6 *17/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.",
    "reference": "REF129",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827827648",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Japan",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 881,
  "fields": {
    "star_id": "STAR14",
    "star_annotation": "CYP2A6*20",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*17/*20",
    "phenotype": "CYP2A6 *17/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.",
    "reference": "REF129",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827827648",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Japan",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 882,
  "fields": {
    "star_id": "STAR6",
    "star_annotation": "CYP2A6*1A",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*1X2B",
    "phenotype": "CYP2A6 *1X2B is associated with increased metabolism of nicotine as compared to CYP2A6 *1A.",
    "reference": "REF58",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827827796",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Japan",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 883,
  "fields": {
    "star_id": "STAR7",
    "star_annotation": "CYP2A6*1X2B",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*1X2B",
    "phenotype": "CYP2A6 *1X2B is associated with increased metabolism of nicotine as compared to CYP2A6 *1A.",
    "reference": "REF58",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "827827796",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA & Japan",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 884,
  "fields": {
    "star_id": "STAR8",
    "star_annotation": "CYP2A6*17",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*4A/*17 + *9/*26",
    "phenotype": "CYP2A6 *4A/*17 + *9/*26 are associated with decreased metabolism of nicotine.",
    "reference": "REF17",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447982613",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 885,
  "fields": {
    "star_id": "STAR9",
    "star_annotation": "CYP2A6*26",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*4A/*17 + *9/*26",
    "phenotype": "CYP2A6 *4A/*17 + *9/*26 are associated with decreased metabolism of nicotine.",
    "reference": "REF17",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447982613",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 886,
  "fields": {
    "star_id": "STAR10",
    "star_annotation": "CYP2A6*4A",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*4A/*17 + *9/*26",
    "phenotype": "CYP2A6 *4A/*17 + *9/*26 are associated with decreased metabolism of nicotine.",
    "reference": "REF17",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447982613",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 887,
  "fields": {
    "star_id": "STAR11",
    "star_annotation": "CYP2A6*9",
    "gene": "PHARGENE20",
    "drug": "DRUG18",
    "allele": "*4A/*17 + *9/*26",
    "phenotype": "CYP2A6 *4A/*17 + *9/*26 are associated with decreased metabolism of nicotine.",
    "reference": "REF17",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447982613",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 888,
  "fields": {
    "star_id": "STAR209",
    "star_annotation": "CYP2A6*2",
    "gene": "PHARGENE20",
    "drug": "DRUG5",
    "allele": "*2",
    "phenotype": "CYP2A6 *2 is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF20",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "827803602",
    "region": "Mixed Population containing african descendant groups",
    "country_of_participants": "Mixed africa",
    "latitude": "37.0902000",
    "longitude": "-95.7129000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 889,
  "fields": {
    "star_id": "STAR63",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with metabolism of efavirenz in people with HIV.",
    "reference": "REF81",
    "p_value": "0,000000234",
    "source": "PharmGKB",
    "id_in_source": "1183944291",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 890,
  "fields": {
    "star_id": "STAR64",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*1/*1",
    "phenotype": "CYP2B6 *1/*1 is associated with increased metabolism of efavirenz in people with HIV as compared to CYP2B6 *6/*6.",
    "reference": "REF81",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183764170",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 891,
  "fields": {
    "star_id": "STAR65",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*1/*1",
    "phenotype": "CYP2B6 *1/*1 is associated with increased metabolism of efavirenz in people with HIV as compared to CYP2B6 *6/*6.",
    "reference": "REF81",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183764170",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 892,
  "fields": {
    "star_id": "STAR66",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*1/*6",
    "phenotype": "CYP2B6 *1/*6 is associated with increased metabolism of efavirenz in people with HIV as compared to CYP2B6 *6/*6.",
    "reference": "REF81",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183771932",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 893,
  "fields": {
    "star_id": "STAR67",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*1/*6",
    "phenotype": "CYP2B6 *1/*6 is associated with increased metabolism of efavirenz in people with HIV as compared to CYP2B6 *6/*6.",
    "reference": "REF81",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183771932",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 894,
  "fields": {
    "star_id": "STAR111",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6/*6",
    "phenotype": "CYP2B6 *6/*6 is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF159",
    "p_value": "0,016",
    "source": "PharmGKB",
    "id_in_source": "1184988338",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Uganda",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 895,
  "fields": {
    "star_id": "STAR112",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*1/*18",
    "phenotype": "CYP2B6 *1/*18 is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF159",
    "p_value": "0,016",
    "source": "PharmGKB",
    "id_in_source": "1184988346",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Uganda",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 896,
  "fields": {
    "star_id": "STAR113",
    "star_annotation": "CYP2B6*18",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*1/*18",
    "phenotype": "CYP2B6 *1/*18 is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF159",
    "p_value": "0,016",
    "source": "PharmGKB",
    "id_in_source": "1184988346",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Uganda",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 897,
  "fields": {
    "star_id": "STAR114",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*1/*9",
    "phenotype": "CYP2B6 *1/*9 is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF159",
    "p_value": "0,016",
    "source": "PharmGKB",
    "id_in_source": "1184988354",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Uganda",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 898,
  "fields": {
    "star_id": "STAR115",
    "star_annotation": "CYP2B6*9",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*1/*9",
    "phenotype": "CYP2B6 *1/*9 is associated with decreased metabolism of efavirenz in people with HIV.",
    "reference": "REF159",
    "p_value": "0,016",
    "source": "PharmGKB",
    "id_in_source": "1184988354",
    "region": "Sub-Saharan African",
    "country_of_participants": "Zimbabwe & Uganda",
    "latitude": "-19.0154380",
    "longitude": "29.1548580"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 899,
  "fields": {
    "star_id": "STAR179",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with increased concentrations of efavirenz in people with HIV as compared to CYP2B6 *1/*1.",
    "reference": "REF110",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448997246",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 900,
  "fields": {
    "star_id": "STAR180",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with increased concentrations of efavirenz in people with HIV as compared to CYP2B6 *1/*1.",
    "reference": "REF110",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448997246",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 901,
  "fields": {
    "star_id": "STAR181",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF26",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995871",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 902,
  "fields": {
    "star_id": "STAR181",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF26",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995871",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 903,
  "fields": {
    "star_id": "STAR181",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF140",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995871",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 904,
  "fields": {
    "star_id": "STAR181",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF140",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995871",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 905,
  "fields": {
    "star_id": "STAR182",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF26",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995871",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 906,
  "fields": {
    "star_id": "STAR182",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF26",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995871",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 907,
  "fields": {
    "star_id": "STAR182",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF140",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995871",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 908,
  "fields": {
    "star_id": "STAR182",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF140",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995871",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 909,
  "fields": {
    "star_id": "STAR189",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*11",
    "phenotype": "CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF26",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995884",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 910,
  "fields": {
    "star_id": "STAR189",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*11",
    "phenotype": "CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF26",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995884",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 911,
  "fields": {
    "star_id": "STAR189",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*11",
    "phenotype": "CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF140",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995884",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 912,
  "fields": {
    "star_id": "STAR189",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*11",
    "phenotype": "CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF140",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995884",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 913,
  "fields": {
    "star_id": "STAR190",
    "star_annotation": "CYP2B6*11",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*11",
    "phenotype": "CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF26",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995884",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 914,
  "fields": {
    "star_id": "STAR190",
    "star_annotation": "CYP2B6*11",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*11",
    "phenotype": "CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF26",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995884",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 915,
  "fields": {
    "star_id": "STAR190",
    "star_annotation": "CYP2B6*11",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*11",
    "phenotype": "CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF140",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995884",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 916,
  "fields": {
    "star_id": "STAR190",
    "star_annotation": "CYP2B6*11",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*11",
    "phenotype": "CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.",
    "reference": "REF140",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1448995884",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 917,
  "fields": {
    "star_id": "STAR191",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6/*6",
    "phenotype": "CYP2B6 *6/*6 is associated with increased concentrations of efavirenz in people with HIV as compared to CYP2B6 *1/*1.",
    "reference": "REF77",
    "p_value": "0,05",
    "source": "PharmGKB",
    "id_in_source": "1448995859",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 918,
  "fields": {
    "star_id": "STAR192",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6/*6",
    "phenotype": "CYP2B6 *6/*6 is associated with increased concentrations of efavirenz in people with HIV as compared to CYP2B6 *1/*1.",
    "reference": "REF77",
    "p_value": "0,05",
    "source": "PharmGKB",
    "id_in_source": "1448995859",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 919,
  "fields": {
    "star_id": "STAR204",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with increased trough concentration of efavirenz in people with HIV and Tuberculosis as compared to CYP2B6 *1.",
    "reference": "REF3",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447984366",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 920,
  "fields": {
    "star_id": "STAR205",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG5",
    "allele": "*6",
    "phenotype": "CYP2B6 *6 is associated with increased trough concentration of efavirenz in people with HIV and Tuberculosis as compared to CYP2B6 *1.",
    "reference": "REF3",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1447984366",
    "region": "Sub-Saharan African",
    "country_of_participants": "Uganda",
    "latitude": "1.3733330",
    "longitude": "32.2902760"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 921,
  "fields": {
    "star_id": "STAR15",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*1/*6 + *1/*18",
    "phenotype": "CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "0,027",
    "source": "PharmGKB",
    "id_in_source": "1445403153",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 922,
  "fields": {
    "star_id": "STAR16",
    "star_annotation": "CYP2B6*18",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*1/*6 + *1/*18",
    "phenotype": "CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "0,027",
    "source": "PharmGKB",
    "id_in_source": "1445403153",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 923,
  "fields": {
    "star_id": "STAR17",
    "star_annotation": "CYP2B6*22",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*1/*6 + *1/*18",
    "phenotype": "CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "0,027",
    "source": "PharmGKB",
    "id_in_source": "1445403153",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 924,
  "fields": {
    "star_id": "STAR18",
    "star_annotation": "CYP2B6*4",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*1/*6 + *1/*18",
    "phenotype": "CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "0,027",
    "source": "PharmGKB",
    "id_in_source": "1445403153",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 925,
  "fields": {
    "star_id": "STAR19",
    "star_annotation": "CYP2B6*5",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*1/*6 + *1/*18",
    "phenotype": "CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "0,027",
    "source": "PharmGKB",
    "id_in_source": "1445403153",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 926,
  "fields": {
    "star_id": "STAR20",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*1/*6 + *1/*18",
    "phenotype": "CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "0,027",
    "source": "PharmGKB",
    "id_in_source": "1445403153",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 927,
  "fields": {
    "star_id": "STAR146",
    "star_annotation": "CYP2B6*1",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*6/*6 + *6/*18",
    "phenotype": "CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445403174",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 928,
  "fields": {
    "star_id": "STAR147",
    "star_annotation": "CYP2B6*18",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*6/*6 + *6/*18",
    "phenotype": "CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445403174",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 929,
  "fields": {
    "star_id": "STAR148",
    "star_annotation": "CYP2B6*22",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*6/*6 + *6/*18",
    "phenotype": "CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445403174",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 930,
  "fields": {
    "star_id": "STAR149",
    "star_annotation": "CYP2B6*4",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*6/*6 + *6/*18",
    "phenotype": "CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445403174",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 931,
  "fields": {
    "star_id": "STAR150",
    "star_annotation": "CYP2B6*5",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*6/*6 + *6/*18",
    "phenotype": "CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445403174",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 932,
  "fields": {
    "star_id": "STAR151",
    "star_annotation": "CYP2B6*6",
    "gene": "PHARGENE21",
    "drug": "DRUG22",
    "allele": "*6/*6 + *6/*18",
    "phenotype": "CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.",
    "reference": "REF22",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445403174",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 933,
  "fields": {
    "star_id": "STAR118",
    "star_annotation": "CYP2C19*1",
    "gene": "PHARGENE23",
    "drug": "DRUG22",
    "allele": "*2 + *17",
    "phenotype": "CYP2C19 *2 + *17 are not associated with response to bupropion in people with Tobacco Use Disorder as compared to CYP2C19 *1.",
    "reference": "REF124",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184985821",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 934,
  "fields": {
    "star_id": "STAR119",
    "star_annotation": "CYP2C19*17",
    "gene": "PHARGENE23",
    "drug": "DRUG22",
    "allele": "*2 + *17",
    "phenotype": "CYP2C19 *2 + *17 are not associated with response to bupropion in people with Tobacco Use Disorder as compared to CYP2C19 *1.",
    "reference": "REF124",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184985821",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 935,
  "fields": {
    "star_id": "STAR120",
    "star_annotation": "CYP2C19*2",
    "gene": "PHARGENE23",
    "drug": "DRUG22",
    "allele": "*2 + *17",
    "phenotype": "CYP2C19 *2 + *17 are not associated with response to bupropion in people with Tobacco Use Disorder as compared to CYP2C19 *1.",
    "reference": "REF124",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184985821",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 936,
  "fields": {
    "star_id": "STAR21",
    "star_annotation": "CYP3A5*1A",
    "gene": "PHARGENE28",
    "drug": "DRUG21",
    "allele": "*3A/*3A",
    "phenotype": "CYP3A5 *3A/*3A is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to CYP3A5 *1A/*1A + *1A/*3A.",
    "reference": "REF117",
    "p_value": "0,037",
    "source": "PharmGKB",
    "id_in_source": "981501747",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 937,
  "fields": {
    "star_id": "STAR22",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG21",
    "allele": "*3A/*3A",
    "phenotype": "CYP3A5 *3A/*3A is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to CYP3A5 *1A/*1A + *1A/*3A.",
    "reference": "REF117",
    "p_value": "0,037",
    "source": "PharmGKB",
    "id_in_source": "981501747",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 938,
  "fields": {
    "star_id": "STAR34",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG29",
    "allele": "*3A/*3A",
    "phenotype": "CYP3A5 *3A/*3A is associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to CYP3A5 *1A/*1A + *1A/*3A.",
    "reference": "REF103",
    "p_value": "0,822",
    "source": "PharmGKB",
    "id_in_source": "982044254",
    "region": "Sub-Saharan African",
    "country_of_participants": "Brazil",
    "latitude": "-14.2350040",
    "longitude": "-51.9252820"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 939,
  "fields": {
    "star_id": "STAR121",
    "star_annotation": "CYP3A5*1A",
    "gene": "PHARGENE28",
    "drug": "DRUG39",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.",
    "reference": "REF57",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184998561",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 940,
  "fields": {
    "star_id": "STAR122",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG39",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.",
    "reference": "REF57",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184998561",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 941,
  "fields": {
    "star_id": "STAR123",
    "star_annotation": "CYP3A5*6",
    "gene": "PHARGENE28",
    "drug": "DRUG39",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.",
    "reference": "REF57",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184998561",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 942,
  "fields": {
    "star_id": "STAR124",
    "star_annotation": "CYP3A5*7",
    "gene": "PHARGENE28",
    "drug": "DRUG39",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.",
    "reference": "REF57",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184998561",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 943,
  "fields": {
    "star_id": "STAR125",
    "star_annotation": "CYP3A5*1A",
    "gene": "PHARGENE28",
    "drug": "DRUG39",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.",
    "reference": "REF57",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184998461",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 944,
  "fields": {
    "star_id": "STAR126",
    "star_annotation": "CYP3A5*3A",
    "gene": "PHARGENE28",
    "drug": "DRUG39",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.",
    "reference": "REF57",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184998461",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 945,
  "fields": {
    "star_id": "STAR127",
    "star_annotation": "CYP3A5*6",
    "gene": "PHARGENE28",
    "drug": "DRUG39",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.",
    "reference": "REF57",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184998461",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 946,
  "fields": {
    "star_id": "STAR128",
    "star_annotation": "CYP3A5*7",
    "gene": "PHARGENE28",
    "drug": "DRUG39",
    "allele": "*3A + *6 + *7",
    "phenotype": "CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.",
    "reference": "REF57",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184998461",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 947,
  "fields": {
    "star_id": "STAR23",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9",
    "phenotype": "CYP2C9 *9 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940156",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 948,
  "fields": {
    "star_id": "STAR23",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9",
    "phenotype": "CYP2C9 *9 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940156",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 949,
  "fields": {
    "star_id": "STAR23",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9",
    "phenotype": "CYP2C9 *9 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940156",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 950,
  "fields": {
    "star_id": "STAR23",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9",
    "phenotype": "CYP2C9 *9 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940156",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 951,
  "fields": {
    "star_id": "STAR24",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*11",
    "phenotype": "CYP2C9 *11 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940175",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 952,
  "fields": {
    "star_id": "STAR24",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*11",
    "phenotype": "CYP2C9 *11 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940175",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 953,
  "fields": {
    "star_id": "STAR24",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*11",
    "phenotype": "CYP2C9 *11 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940175",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 954,
  "fields": {
    "star_id": "STAR24",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*11",
    "phenotype": "CYP2C9 *11 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940175",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 955,
  "fields": {
    "star_id": "STAR25",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*8",
    "phenotype": "CYP2C9 *8 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940163",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 956,
  "fields": {
    "star_id": "STAR25",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*8",
    "phenotype": "CYP2C9 *8 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940163",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 957,
  "fields": {
    "star_id": "STAR25",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*8",
    "phenotype": "CYP2C9 *8 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940163",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 958,
  "fields": {
    "star_id": "STAR25",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*8",
    "phenotype": "CYP2C9 *8 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940163",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 959,
  "fields": {
    "star_id": "STAR26",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*5",
    "phenotype": "CYP2C9 *5 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940181",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 960,
  "fields": {
    "star_id": "STAR26",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*5",
    "phenotype": "CYP2C9 *5 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940181",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 961,
  "fields": {
    "star_id": "STAR26",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*5",
    "phenotype": "CYP2C9 *5 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940181",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 962,
  "fields": {
    "star_id": "STAR26",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*5",
    "phenotype": "CYP2C9 *5 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940181",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 963,
  "fields": {
    "star_id": "STAR27",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*6",
    "phenotype": "CYP2C9 *6 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940169",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 964,
  "fields": {
    "star_id": "STAR27",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*6",
    "phenotype": "CYP2C9 *6 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940169",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 965,
  "fields": {
    "star_id": "STAR27",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*6",
    "phenotype": "CYP2C9 *6 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940169",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 966,
  "fields": {
    "star_id": "STAR27",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*6",
    "phenotype": "CYP2C9 *6 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "981940169",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 967,
  "fields": {
    "star_id": "STAR141",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 968,
  "fields": {
    "star_id": "STAR141",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 969,
  "fields": {
    "star_id": "STAR141",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 970,
  "fields": {
    "star_id": "STAR141",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 971,
  "fields": {
    "star_id": "STAR142",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 972,
  "fields": {
    "star_id": "STAR142",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 973,
  "fields": {
    "star_id": "STAR142",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 974,
  "fields": {
    "star_id": "STAR142",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 975,
  "fields": {
    "star_id": "STAR143",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 976,
  "fields": {
    "star_id": "STAR143",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 977,
  "fields": {
    "star_id": "STAR143",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 978,
  "fields": {
    "star_id": "STAR143",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 979,
  "fields": {
    "star_id": "STAR144",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 980,
  "fields": {
    "star_id": "STAR144",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 981,
  "fields": {
    "star_id": "STAR144",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 982,
  "fields": {
    "star_id": "STAR144",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 983,
  "fields": {
    "star_id": "STAR145",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 984,
  "fields": {
    "star_id": "STAR145",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 985,
  "fields": {
    "star_id": "STAR145",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 986,
  "fields": {
    "star_id": "STAR145",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*9/*11 + *5/*8",
    "phenotype": "CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF155",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444706610",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 987,
  "fields": {
    "star_id": "STAR210",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*2",
    "phenotype": "CYP2C9 *1/*2 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010090",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 988,
  "fields": {
    "star_id": "STAR210",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*2",
    "phenotype": "CYP2C9 *1/*2 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010090",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 989,
  "fields": {
    "star_id": "STAR210",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*2",
    "phenotype": "CYP2C9 *1/*2 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010090",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 990,
  "fields": {
    "star_id": "STAR210",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*2",
    "phenotype": "CYP2C9 *1/*2 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010090",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 991,
  "fields": {
    "star_id": "STAR211",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*2",
    "phenotype": "CYP2C9 *1/*2 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010090",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 992,
  "fields": {
    "star_id": "STAR211",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*2",
    "phenotype": "CYP2C9 *1/*2 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010090",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 993,
  "fields": {
    "star_id": "STAR211",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*2",
    "phenotype": "CYP2C9 *1/*2 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010090",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 994,
  "fields": {
    "star_id": "STAR211",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*2",
    "phenotype": "CYP2C9 *1/*2 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010090",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 995,
  "fields": {
    "star_id": "STAR212",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*1",
    "phenotype": "CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,0011",
    "source": "PharmGKB",
    "id_in_source": "982010010",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 996,
  "fields": {
    "star_id": "STAR212",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*1",
    "phenotype": "CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,0011",
    "source": "PharmGKB",
    "id_in_source": "982010010",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 997,
  "fields": {
    "star_id": "STAR212",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*1",
    "phenotype": "CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,0011",
    "source": "PharmGKB",
    "id_in_source": "982010010",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 998,
  "fields": {
    "star_id": "STAR212",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*1",
    "phenotype": "CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,0011",
    "source": "PharmGKB",
    "id_in_source": "982010010",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 999,
  "fields": {
    "star_id": "STAR213",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*1",
    "phenotype": "CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,0023",
    "source": "PharmGKB",
    "id_in_source": "982010082",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1000,
  "fields": {
    "star_id": "STAR213",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*1",
    "phenotype": "CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,0023",
    "source": "PharmGKB",
    "id_in_source": "982010082",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1001,
  "fields": {
    "star_id": "STAR213",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*1",
    "phenotype": "CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,0023",
    "source": "PharmGKB",
    "id_in_source": "982010082",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1002,
  "fields": {
    "star_id": "STAR213",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*1",
    "phenotype": "CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,0023",
    "source": "PharmGKB",
    "id_in_source": "982010082",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1003,
  "fields": {
    "star_id": "STAR214",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*3",
    "phenotype": "CYP2C9 *1/*3 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010097",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1004,
  "fields": {
    "star_id": "STAR214",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*3",
    "phenotype": "CYP2C9 *1/*3 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010097",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1005,
  "fields": {
    "star_id": "STAR214",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*3",
    "phenotype": "CYP2C9 *1/*3 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010097",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1006,
  "fields": {
    "star_id": "STAR214",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*3",
    "phenotype": "CYP2C9 *1/*3 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010097",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1007,
  "fields": {
    "star_id": "STAR215",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*3",
    "phenotype": "CYP2C9 *1/*3 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010097",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1008,
  "fields": {
    "star_id": "STAR215",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*1/*3",
    "phenotype": "CYP2C9 *1/*3 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010097",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1009,
  "fields": {
    "star_id": "STAR215",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*3",
    "phenotype": "CYP2C9 *1/*3 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010097",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1010,
  "fields": {
    "star_id": "STAR215",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*1/*3",
    "phenotype": "CYP2C9 *1/*3 is not associated with dose of acenocoumarol.",
    "reference": "REF35",
    "p_value": "0,904",
    "source": "PharmGKB",
    "id_in_source": "982010097",
    "region": "North African",
    "country_of_participants": "Morocco",
    "latitude": "31.7917020",
    "longitude": "-7.0926200"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1011,
  "fields": {
    "star_id": "STAR222",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*3",
    "phenotype": "CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1449188274",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1012,
  "fields": {
    "star_id": "STAR222",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*3",
    "phenotype": "CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1449188274",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1013,
  "fields": {
    "star_id": "STAR222",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*3",
    "phenotype": "CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1449188274",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1014,
  "fields": {
    "star_id": "STAR222",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*3",
    "phenotype": "CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1449188274",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1015,
  "fields": {
    "star_id": "STAR223",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*3",
    "phenotype": "CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1449188274",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1016,
  "fields": {
    "star_id": "STAR223",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*3",
    "phenotype": "CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1449188274",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1017,
  "fields": {
    "star_id": "STAR223",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*3",
    "phenotype": "CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1449188274",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1018,
  "fields": {
    "star_id": "STAR223",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*3",
    "phenotype": "CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "< 0.0001",
    "source": "PharmGKB",
    "id_in_source": "1449188274",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1019,
  "fields": {
    "star_id": "STAR224",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*2",
    "phenotype": "CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "0,004",
    "source": "PharmGKB",
    "id_in_source": "1449188252",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1020,
  "fields": {
    "star_id": "STAR224",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*2",
    "phenotype": "CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "0,004",
    "source": "PharmGKB",
    "id_in_source": "1449188252",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1021,
  "fields": {
    "star_id": "STAR224",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*2",
    "phenotype": "CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "0,004",
    "source": "PharmGKB",
    "id_in_source": "1449188252",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1022,
  "fields": {
    "star_id": "STAR224",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*2",
    "phenotype": "CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "0,004",
    "source": "PharmGKB",
    "id_in_source": "1449188252",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1023,
  "fields": {
    "star_id": "STAR225",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*2",
    "phenotype": "CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "0,004",
    "source": "PharmGKB",
    "id_in_source": "1449188252",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1024,
  "fields": {
    "star_id": "STAR225",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG27",
    "allele": "*2",
    "phenotype": "CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "0,004",
    "source": "PharmGKB",
    "id_in_source": "1449188252",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1025,
  "fields": {
    "star_id": "STAR225",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*2",
    "phenotype": "CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "0,004",
    "source": "PharmGKB",
    "id_in_source": "1449188252",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1026,
  "fields": {
    "star_id": "STAR225",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG59",
    "allele": "*2",
    "phenotype": "CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.",
    "reference": "REF13",
    "p_value": "0,004",
    "source": "PharmGKB",
    "id_in_source": "1449188252",
    "region": "North African",
    "country_of_participants": "Tunisia",
    "latitude": "33.8869170",
    "longitude": "9.5374990"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1027,
  "fields": {
    "star_id": "STAR28",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*8",
    "phenotype": "CYP2C9 *1/*8 is not associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1134736215",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1028,
  "fields": {
    "star_id": "STAR29",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*8",
    "phenotype": "CYP2C9 *1/*8 is not associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1134736215",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1029,
  "fields": {
    "star_id": "STAR30",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*6",
    "phenotype": "CYP2C9 *1/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1134049001",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1030,
  "fields": {
    "star_id": "STAR31",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*6",
    "phenotype": "CYP2C9 *1/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1134049001",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1031,
  "fields": {
    "star_id": "STAR32",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*11",
    "phenotype": "CYP2C9 *1/*11 is not associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1134807206",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1032,
  "fields": {
    "star_id": "STAR33",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*11",
    "phenotype": "CYP2C9 *1/*11 is not associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1134807206",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1033,
  "fields": {
    "star_id": "STAR35",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*5 + *5/*6",
    "phenotype": "CYP2C9 *1/*5 + *5/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1133417241",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1034,
  "fields": {
    "star_id": "STAR36",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*5 + *5/*6",
    "phenotype": "CYP2C9 *1/*5 + *5/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1133417241",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1035,
  "fields": {
    "star_id": "STAR37",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG28",
    "allele": "*1/*5 + *5/*6",
    "phenotype": "CYP2C9 *1/*5 + *5/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.",
    "reference": "REF144",
    "p_value": "0,01",
    "source": "PharmGKB",
    "id_in_source": "1133417241",
    "region": "Sub-Saharan African",
    "country_of_participants": "Benin",
    "latitude": "9.3076900",
    "longitude": "2.3158340"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1036,
  "fields": {
    "star_id": "STAR40",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1037,
  "fields": {
    "star_id": "STAR40",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1038,
  "fields": {
    "star_id": "STAR40",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1039,
  "fields": {
    "star_id": "STAR40",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1040,
  "fields": {
    "star_id": "STAR41",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1041,
  "fields": {
    "star_id": "STAR41",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1042,
  "fields": {
    "star_id": "STAR41",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1043,
  "fields": {
    "star_id": "STAR41",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1044,
  "fields": {
    "star_id": "STAR42",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1045,
  "fields": {
    "star_id": "STAR42",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1046,
  "fields": {
    "star_id": "STAR42",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1047,
  "fields": {
    "star_id": "STAR42",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1048,
  "fields": {
    "star_id": "STAR43",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1049,
  "fields": {
    "star_id": "STAR43",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1050,
  "fields": {
    "star_id": "STAR43",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1051,
  "fields": {
    "star_id": "STAR43",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1052,
  "fields": {
    "star_id": "STAR44",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1053,
  "fields": {
    "star_id": "STAR44",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1054,
  "fields": {
    "star_id": "STAR44",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1055,
  "fields": {
    "star_id": "STAR44",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF113",
    "p_value": "0,001",
    "source": "PharmGKB",
    "id_in_source": "1184510263",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1056,
  "fields": {
    "star_id": "STAR68",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1057,
  "fields": {
    "star_id": "STAR68",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1058,
  "fields": {
    "star_id": "STAR68",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1059,
  "fields": {
    "star_id": "STAR68",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1060,
  "fields": {
    "star_id": "STAR69",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1061,
  "fields": {
    "star_id": "STAR69",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1062,
  "fields": {
    "star_id": "STAR69",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1063,
  "fields": {
    "star_id": "STAR69",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1064,
  "fields": {
    "star_id": "STAR70",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1065,
  "fields": {
    "star_id": "STAR70",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1066,
  "fields": {
    "star_id": "STAR70",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1067,
  "fields": {
    "star_id": "STAR70",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1068,
  "fields": {
    "star_id": "STAR71",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1069,
  "fields": {
    "star_id": "STAR71",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1070,
  "fields": {
    "star_id": "STAR71",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1071,
  "fields": {
    "star_id": "STAR71",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1072,
  "fields": {
    "star_id": "STAR72",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1073,
  "fields": {
    "star_id": "STAR72",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1074,
  "fields": {
    "star_id": "STAR72",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1075,
  "fields": {
    "star_id": "STAR72",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1076,
  "fields": {
    "star_id": "STAR73",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1077,
  "fields": {
    "star_id": "STAR73",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1078,
  "fields": {
    "star_id": "STAR73",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1079,
  "fields": {
    "star_id": "STAR73",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1080,
  "fields": {
    "star_id": "STAR74",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1081,
  "fields": {
    "star_id": "STAR74",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1082,
  "fields": {
    "star_id": "STAR74",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1083,
  "fields": {
    "star_id": "STAR74",
    "star_annotation": "CYP2C9*9",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *6 + *5 + *11",
    "phenotype": "CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.",
    "reference": "REF113",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184510278",
    "region": "Sub-Saharan African",
    "country_of_participants": "Sudan",
    "latitude": "12.8628000",
    "longitude": "30.2176000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1084,
  "fields": {
    "star_id": "STAR53",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1085,
  "fields": {
    "star_id": "STAR53",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1086,
  "fields": {
    "star_id": "STAR53",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1087,
  "fields": {
    "star_id": "STAR53",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1088,
  "fields": {
    "star_id": "STAR54",
    "star_annotation": "CYP2C9*10",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1089,
  "fields": {
    "star_id": "STAR54",
    "star_annotation": "CYP2C9*10",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1090,
  "fields": {
    "star_id": "STAR54",
    "star_annotation": "CYP2C9*10",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1091,
  "fields": {
    "star_id": "STAR54",
    "star_annotation": "CYP2C9*10",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1092,
  "fields": {
    "star_id": "STAR55",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1093,
  "fields": {
    "star_id": "STAR55",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1094,
  "fields": {
    "star_id": "STAR55",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1095,
  "fields": {
    "star_id": "STAR55",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1096,
  "fields": {
    "star_id": "STAR56",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1097,
  "fields": {
    "star_id": "STAR56",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1098,
  "fields": {
    "star_id": "STAR56",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1099,
  "fields": {
    "star_id": "STAR56",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1100,
  "fields": {
    "star_id": "STAR57",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1101,
  "fields": {
    "star_id": "STAR57",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1102,
  "fields": {
    "star_id": "STAR57",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1103,
  "fields": {
    "star_id": "STAR57",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1104,
  "fields": {
    "star_id": "STAR58",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1105,
  "fields": {
    "star_id": "STAR58",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1106,
  "fields": {
    "star_id": "STAR58",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1107,
  "fields": {
    "star_id": "STAR58",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1108,
  "fields": {
    "star_id": "STAR59",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1109,
  "fields": {
    "star_id": "STAR59",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1110,
  "fields": {
    "star_id": "STAR59",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1111,
  "fields": {
    "star_id": "STAR59",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*11 + *2 + *3 + *5 + *6",
    "phenotype": "CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.",
    "reference": "REF108",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1183701419",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1112,
  "fields": {
    "star_id": "STAR60",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*6/*6",
    "phenotype": "CYP2C9 *6/*6 is associated with decreased dose of warfarin.",
    "reference": "REF4",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183701586",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1113,
  "fields": {
    "star_id": "STAR60",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*6/*6",
    "phenotype": "CYP2C9 *6/*6 is associated with decreased dose of warfarin.",
    "reference": "REF4",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183701586",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1114,
  "fields": {
    "star_id": "STAR60",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*6/*6",
    "phenotype": "CYP2C9 *6/*6 is associated with decreased dose of warfarin.",
    "reference": "REF4",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183701586",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1115,
  "fields": {
    "star_id": "STAR60",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*6/*6",
    "phenotype": "CYP2C9 *6/*6 is associated with decreased dose of warfarin.",
    "reference": "REF4",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183701586",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1116,
  "fields": {
    "star_id": "STAR61",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*8/*8",
    "phenotype": "CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183700910",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1117,
  "fields": {
    "star_id": "STAR61",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*8/*8",
    "phenotype": "CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183700910",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1118,
  "fields": {
    "star_id": "STAR61",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*8/*8",
    "phenotype": "CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183700910",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1119,
  "fields": {
    "star_id": "STAR61",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*8/*8",
    "phenotype": "CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183700910",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1120,
  "fields": {
    "star_id": "STAR62",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*8/*8",
    "phenotype": "CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183700910",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1121,
  "fields": {
    "star_id": "STAR62",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*8/*8",
    "phenotype": "CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183700910",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1122,
  "fields": {
    "star_id": "STAR62",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*8/*8",
    "phenotype": "CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183700910",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1123,
  "fields": {
    "star_id": "STAR62",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*8/*8",
    "phenotype": "CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF60",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1183700910",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1124,
  "fields": {
    "star_id": "STAR131",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1125,
  "fields": {
    "star_id": "STAR131",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1126,
  "fields": {
    "star_id": "STAR131",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1127,
  "fields": {
    "star_id": "STAR131",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1128,
  "fields": {
    "star_id": "STAR132",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1129,
  "fields": {
    "star_id": "STAR132",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1130,
  "fields": {
    "star_id": "STAR132",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1131,
  "fields": {
    "star_id": "STAR132",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1132,
  "fields": {
    "star_id": "STAR133",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1133,
  "fields": {
    "star_id": "STAR133",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1134,
  "fields": {
    "star_id": "STAR133",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1135,
  "fields": {
    "star_id": "STAR133",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1136,
  "fields": {
    "star_id": "STAR134",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1137,
  "fields": {
    "star_id": "STAR134",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1138,
  "fields": {
    "star_id": "STAR134",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1139,
  "fields": {
    "star_id": "STAR134",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*5 + *6 + *11",
    "phenotype": "CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296737",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1140,
  "fields": {
    "star_id": "STAR137",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*2 + *2/*2",
    "phenotype": "CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296627",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1141,
  "fields": {
    "star_id": "STAR137",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*2 + *2/*2",
    "phenotype": "CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296627",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1142,
  "fields": {
    "star_id": "STAR137",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*2 + *2/*2",
    "phenotype": "CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296627",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1143,
  "fields": {
    "star_id": "STAR137",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*2 + *2/*2",
    "phenotype": "CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296627",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1144,
  "fields": {
    "star_id": "STAR138",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*2 + *2/*2",
    "phenotype": "CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296627",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1145,
  "fields": {
    "star_id": "STAR138",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*2 + *2/*2",
    "phenotype": "CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296627",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1146,
  "fields": {
    "star_id": "STAR138",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*2 + *2/*2",
    "phenotype": "CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296627",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1147,
  "fields": {
    "star_id": "STAR138",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*2 + *2/*2",
    "phenotype": "CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296627",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1148,
  "fields": {
    "star_id": "STAR139",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*3 + *3/*3",
    "phenotype": "CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1149,
  "fields": {
    "star_id": "STAR139",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*3 + *3/*3",
    "phenotype": "CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1150,
  "fields": {
    "star_id": "STAR139",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*3 + *3/*3",
    "phenotype": "CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1151,
  "fields": {
    "star_id": "STAR139",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*3 + *3/*3",
    "phenotype": "CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1152,
  "fields": {
    "star_id": "STAR140",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*3 + *3/*3",
    "phenotype": "CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1153,
  "fields": {
    "star_id": "STAR140",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*3 + *3/*3",
    "phenotype": "CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1154,
  "fields": {
    "star_id": "STAR140",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*3 + *3/*3",
    "phenotype": "CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1155,
  "fields": {
    "star_id": "STAR140",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*3 + *3/*3",
    "phenotype": "CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF128",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1445296671",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1156,
  "fields": {
    "star_id": "STAR135",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*8 + *8/*8",
    "phenotype": "CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF74",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1444695840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1157,
  "fields": {
    "star_id": "STAR135",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*8 + *8/*8",
    "phenotype": "CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF74",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1444695840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1158,
  "fields": {
    "star_id": "STAR135",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*8 + *8/*8",
    "phenotype": "CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF74",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1444695840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1159,
  "fields": {
    "star_id": "STAR135",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*8 + *8/*8",
    "phenotype": "CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF74",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1444695840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1160,
  "fields": {
    "star_id": "STAR136",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*8 + *8/*8",
    "phenotype": "CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF74",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1444695840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1161,
  "fields": {
    "star_id": "STAR136",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*1/*8 + *8/*8",
    "phenotype": "CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF74",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1444695840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1162,
  "fields": {
    "star_id": "STAR136",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*8 + *8/*8",
    "phenotype": "CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF74",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1444695840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1163,
  "fields": {
    "star_id": "STAR136",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*1/*8 + *8/*8",
    "phenotype": "CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF74",
    "p_value": "< 0.01",
    "source": "PharmGKB",
    "id_in_source": "1444695840",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1164,
  "fields": {
    "star_id": "STAR158",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1165,
  "fields": {
    "star_id": "STAR158",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1166,
  "fields": {
    "star_id": "STAR158",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1167,
  "fields": {
    "star_id": "STAR158",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1168,
  "fields": {
    "star_id": "STAR159",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1169,
  "fields": {
    "star_id": "STAR159",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1170,
  "fields": {
    "star_id": "STAR159",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1171,
  "fields": {
    "star_id": "STAR159",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1172,
  "fields": {
    "star_id": "STAR160",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1173,
  "fields": {
    "star_id": "STAR160",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1174,
  "fields": {
    "star_id": "STAR160",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1175,
  "fields": {
    "star_id": "STAR160",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1176,
  "fields": {
    "star_id": "STAR161",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1177,
  "fields": {
    "star_id": "STAR161",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1178,
  "fields": {
    "star_id": "STAR161",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1179,
  "fields": {
    "star_id": "STAR161",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1180,
  "fields": {
    "star_id": "STAR162",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1181,
  "fields": {
    "star_id": "STAR162",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1182,
  "fields": {
    "star_id": "STAR162",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1183,
  "fields": {
    "star_id": "STAR162",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1184,
  "fields": {
    "star_id": "STAR163",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1185,
  "fields": {
    "star_id": "STAR163",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1186,
  "fields": {
    "star_id": "STAR163",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1187,
  "fields": {
    "star_id": "STAR163",
    "star_annotation": "CYP2C9*6",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *6 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF7",
    "p_value": "0,12",
    "source": "PharmGKB",
    "id_in_source": "1447519652",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1188,
  "fields": {
    "star_id": "STAR164",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1189,
  "fields": {
    "star_id": "STAR164",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1190,
  "fields": {
    "star_id": "STAR164",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1191,
  "fields": {
    "star_id": "STAR164",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1192,
  "fields": {
    "star_id": "STAR165",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1193,
  "fields": {
    "star_id": "STAR165",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1194,
  "fields": {
    "star_id": "STAR165",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1195,
  "fields": {
    "star_id": "STAR165",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1196,
  "fields": {
    "star_id": "STAR166",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1197,
  "fields": {
    "star_id": "STAR166",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1198,
  "fields": {
    "star_id": "STAR166",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1199,
  "fields": {
    "star_id": "STAR166",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3",
    "phenotype": "CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF44",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1447520623",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1200,
  "fields": {
    "star_id": "STAR183",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1201,
  "fields": {
    "star_id": "STAR183",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1202,
  "fields": {
    "star_id": "STAR183",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1203,
  "fields": {
    "star_id": "STAR183",
    "star_annotation": "CYP2C9*1",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1204,
  "fields": {
    "star_id": "STAR184",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1205,
  "fields": {
    "star_id": "STAR184",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1206,
  "fields": {
    "star_id": "STAR184",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1207,
  "fields": {
    "star_id": "STAR184",
    "star_annotation": "CYP2C9*11",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1208,
  "fields": {
    "star_id": "STAR185",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1209,
  "fields": {
    "star_id": "STAR185",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1210,
  "fields": {
    "star_id": "STAR185",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1211,
  "fields": {
    "star_id": "STAR185",
    "star_annotation": "CYP2C9*2",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1212,
  "fields": {
    "star_id": "STAR186",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1213,
  "fields": {
    "star_id": "STAR186",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1214,
  "fields": {
    "star_id": "STAR186",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1215,
  "fields": {
    "star_id": "STAR186",
    "star_annotation": "CYP2C9*3",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1216,
  "fields": {
    "star_id": "STAR187",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1217,
  "fields": {
    "star_id": "STAR187",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1218,
  "fields": {
    "star_id": "STAR187",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1219,
  "fields": {
    "star_id": "STAR187",
    "star_annotation": "CYP2C9*5",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1220,
  "fields": {
    "star_id": "STAR188",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1221,
  "fields": {
    "star_id": "STAR188",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG1",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1222,
  "fields": {
    "star_id": "STAR188",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1223,
  "fields": {
    "star_id": "STAR188",
    "star_annotation": "CYP2C9*8",
    "gene": "PHARGENE25",
    "drug": "DRUG60",
    "allele": "*2 + *3 + *5 + *8 + *11",
    "phenotype": "CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.",
    "reference": "REF149",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1448573256",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1224,
  "fields": {
    "star_id": "STAR38",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*6",
    "phenotype": "CYP2D6 *6 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046925",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1225,
  "fields": {
    "star_id": "STAR39",
    "star_annotation": "CYP2D6*6",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*6",
    "phenotype": "CYP2D6 *6 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046925",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1226,
  "fields": {
    "star_id": "STAR45",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*17",
    "phenotype": "CYP2D6 *17 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046931",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1227,
  "fields": {
    "star_id": "STAR46",
    "star_annotation": "CYP2D6*17",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*17",
    "phenotype": "CYP2D6 *17 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046931",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1228,
  "fields": {
    "star_id": "STAR47",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*4",
    "phenotype": "CYP2D6 *4 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046905",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1229,
  "fields": {
    "star_id": "STAR48",
    "star_annotation": "CYP2D6*4",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*4",
    "phenotype": "CYP2D6 *4 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046905",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1230,
  "fields": {
    "star_id": "STAR49",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*40",
    "phenotype": "CYP2D6 *40 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046937",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1231,
  "fields": {
    "star_id": "STAR50",
    "star_annotation": "CYP2D6*40",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*40",
    "phenotype": "CYP2D6 *40 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046937",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1232,
  "fields": {
    "star_id": "STAR51",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*5",
    "phenotype": "CYP2D6 *5 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046919",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1233,
  "fields": {
    "star_id": "STAR52",
    "star_annotation": "CYP2D6*5",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*5",
    "phenotype": "CYP2D6 *5 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",
    "reference": "REF75",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "982046919",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1234,
  "fields": {
    "star_id": "STAR97",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*5/*17",
    "phenotype": "CYP2D6 *5/*17 is associated with decreased metabolism of codeine, debrisoquine, dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *17/*17 + *1/*1.",
    "reference": "REF49",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184756913",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1235,
  "fields": {
    "star_id": "STAR98",
    "star_annotation": "CYP2D6*17",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*5/*17",
    "phenotype": "CYP2D6 *5/*17 is associated with decreased metabolism of codeine, debrisoquine, dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *17/*17 + *1/*1.",
    "reference": "REF49",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184756913",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1236,
  "fields": {
    "star_id": "STAR99",
    "star_annotation": "CYP2D6*5",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*5/*17",
    "phenotype": "CYP2D6 *5/*17 is associated with decreased metabolism of codeine, debrisoquine, dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *17/*17 + *1/*1.",
    "reference": "REF49",
    "p_value": "ambiguous",
    "source": "PharmGKB",
    "id_in_source": "1184756913",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1237,
  "fields": {
    "star_id": "STAR108",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*29/*29",
    "phenotype": "CYP2D6 *29/*29 is associated with decreased metabolism of codeine or debrisoquine in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.",
    "reference": "REF49",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184756952",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1238,
  "fields": {
    "star_id": "STAR109",
    "star_annotation": "CYP2D6*2",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*29/*29",
    "phenotype": "CYP2D6 *29/*29 is associated with decreased metabolism of codeine or debrisoquine in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.",
    "reference": "REF49",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184756952",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1239,
  "fields": {
    "star_id": "STAR110",
    "star_annotation": "CYP2D6*29",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*29/*29",
    "phenotype": "CYP2D6 *29/*29 is associated with decreased metabolism of codeine or debrisoquine in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.",
    "reference": "REF49",
    "p_value": "> 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184756952",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1240,
  "fields": {
    "star_id": "STAR105",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*29/*29",
    "phenotype": "CYP2D6 *29/*29 is associated with decreased metabolism of dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.",
    "reference": "REF49",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184756941",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1241,
  "fields": {
    "star_id": "STAR106",
    "star_annotation": "CYP2D6*2",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*29/*29",
    "phenotype": "CYP2D6 *29/*29 is associated with decreased metabolism of dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.",
    "reference": "REF49",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184756941",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1242,
  "fields": {
    "star_id": "STAR107",
    "star_annotation": "CYP2D6*29",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*29/*29",
    "phenotype": "CYP2D6 *29/*29 is associated with decreased metabolism of dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.",
    "reference": "REF49",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1184756941",
    "region": "Sub-Saharan African",
    "country_of_participants": "Tanzania",
    "latitude": "-6.3690280",
    "longitude": "34.8888210"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1243,
  "fields": {
    "star_id": "STAR178",
    "star_annotation": "CYP2D6*17",
    "gene": "PHARGENE26",
    "drug": "DRUG31",
    "allele": "*17",
    "phenotype": "CYP2D6 *17 is associated with decreased metabolism of codeine in people with Anemia, Sickle Cell.",
    "reference": "REF18",
    "p_value": "< 0.05",
    "source": "PharmGKB",
    "id_in_source": "1447963867",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1244,
  "fields": {
    "star_id": "STAR75",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*17",
    "phenotype": "CYP2D6 *17 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1.",
    "reference": "REF65",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184757110",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1245,
  "fields": {
    "star_id": "STAR76",
    "star_annotation": "CYP2D6*17",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*17",
    "phenotype": "CYP2D6 *17 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1.",
    "reference": "REF65",
    "p_value": "< 0.001",
    "source": "PharmGKB",
    "id_in_source": "1184757110",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1246,
  "fields": {
    "star_id": "STAR77",
    "star_annotation": "CYP2D6*1",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*29",
    "phenotype": "CYP2D6 *29 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1.",
    "reference": "REF65",
    "p_value": "0,21",
    "source": "PharmGKB",
    "id_in_source": "1184757117",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1247,
  "fields": {
    "star_id": "STAR78",
    "star_annotation": "CYP2D6*29",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*29",
    "phenotype": "CYP2D6 *29 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1.",
    "reference": "REF65",
    "p_value": "0,21",
    "source": "PharmGKB",
    "id_in_source": "1184757117",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1248,
  "fields": {
    "star_id": "STAR88",
    "star_annotation": "CYP2D6*4",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*6/*40 + *4/*40",
    "phenotype": "CYP2D6 *6/*40 + *4/*40 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF65",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184757079",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1249,
  "fields": {
    "star_id": "STAR89",
    "star_annotation": "CYP2D6*40",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*6/*40 + *4/*40",
    "phenotype": "CYP2D6 *6/*40 + *4/*40 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF65",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184757079",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1250,
  "fields": {
    "star_id": "STAR90",
    "star_annotation": "CYP2D6*6",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*6/*40 + *4/*40",
    "phenotype": "CYP2D6 *6/*40 + *4/*40 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF65",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184757079",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1251,
  "fields": {
    "star_id": "STAR91",
    "star_annotation": "CYP2D6*3",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*3/*4xN",
    "phenotype": "CYP2D6 *3/*4xN (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF65",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184986056",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1252,
  "fields": {
    "star_id": "STAR92",
    "star_annotation": "CYP2D6*4xN",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*3/*4xN",
    "phenotype": "CYP2D6 *3/*4xN (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF65",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184986056",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1253,
  "fields": {
    "star_id": "STAR83",
    "star_annotation": "CYP2D6*40",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*40/*42",
    "phenotype": "CYP2D6 *40/*42 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF55",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184757143",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1254,
  "fields": {
    "star_id": "STAR84",
    "star_annotation": "CYP2D6*42",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*40/*42",
    "phenotype": "CYP2D6 *40/*42 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF55",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184757143",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1255,
  "fields": {
    "star_id": "STAR93",
    "star_annotation": "CYP2D6*100",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*5/*100",
    "phenotype": "CYP2D6 *5/*100 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF119",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184989053",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Trinidad",
    "latitude": "10.6918000",
    "longitude": "-61.2225000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1256,
  "fields": {
    "star_id": "STAR94",
    "star_annotation": "CYP2D6*5",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*5/*100",
    "phenotype": "CYP2D6 *5/*100 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF119",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184989053",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Trinidad",
    "latitude": "10.6918000",
    "longitude": "-61.2225000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1257,
  "fields": {
    "star_id": "STAR95",
    "star_annotation": "CYP2D6*101",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*2/*101",
    "phenotype": "CYP2D6 *2/*101 is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF119",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184989087",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Trinidad",
    "latitude": "10.6918000",
    "longitude": "-61.2225000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1258,
  "fields": {
    "star_id": "STAR96",
    "star_annotation": "CYP2D6*2",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*2/*101",
    "phenotype": "CYP2D6 *2/*101 is associated with decreased metabolism of dextromethorphan in healthy individuals.",
    "reference": "REF119",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184989087",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "Trinidad",
    "latitude": "10.6918000",
    "longitude": "-61.2225000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1259,
  "fields": {
    "star_id": "STAR116",
    "star_annotation": "CYP2D6*4xN",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*4xN/*56",
    "phenotype": "CYP2D6 *4xN/*56 is associated with decreased metabolism of dextromethorphan.",
    "reference": "REF23",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184986040",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1260,
  "fields": {
    "star_id": "STAR117",
    "star_annotation": "CYP2D6*56",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*4xN/*56",
    "phenotype": "CYP2D6 *4xN/*56 is associated with decreased metabolism of dextromethorphan.",
    "reference": "REF23",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1184986040",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1261,
  "fields": {
    "star_id": "STAR152",
    "star_annotation": "CYP2D6*36",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*4/*36",
    "phenotype": "CYP2D6 *4/*36 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan.",
    "reference": "REF76",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1446897132",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1262,
  "fields": {
    "star_id": "STAR153",
    "star_annotation": "CYP2D6*4",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*4/*36",
    "phenotype": "CYP2D6 *4/*36 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan.",
    "reference": "REF76",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1446897132",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1263,
  "fields": {
    "star_id": "STAR154",
    "star_annotation": "CYP2D6*36",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*4xN/*36",
    "phenotype": "CYP2D6 *4xN/*36 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan.",
    "reference": "REF76",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1446897141",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1264,
  "fields": {
    "star_id": "STAR155",
    "star_annotation": "CYP2D6*4xN",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*4xN/*36",
    "phenotype": "CYP2D6 *4xN/*36 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan.",
    "reference": "REF76",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1446897141",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1265,
  "fields": {
    "star_id": "STAR156",
    "star_annotation": "CYP2D6*2",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*2/*36",
    "phenotype": "CYP2D6 *2/*36 (assigned as extensive metabolizer phenotype) is not associated with decreased metabolism of dextromethorphan.",
    "reference": "REF76",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1446897151",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1266,
  "fields": {
    "star_id": "STAR157",
    "star_annotation": "CYP2D6*36",
    "gene": "PHARGENE26",
    "drug": "DRUG36",
    "allele": "*2/*36",
    "phenotype": "CYP2D6 *2/*36 (assigned as extensive metabolizer phenotype) is not associated with decreased metabolism of dextromethorphan.",
    "reference": "REF76",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1446897151",
    "region": "African American/Afro-Caribbean",
    "country_of_participants": "USA",
    "latitude": "37.0902400",
    "longitude": "-95.7128910"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1267,
  "fields": {
    "star_id": "STAR202",
    "star_annotation": "CYP2D6*2",
    "gene": "PHARGENE26",
    "drug": "DRUG57",
    "allele": "*2/*41",
    "phenotype": "CYP2D6 *2/*41 is associated with increased concentrations of hydrocodone.",
    "reference": "REF59",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449189944",
    "region": "Sub-Saharan African",
    "country_of_participants": "Canada",
    "latitude": "56.1303670",
    "longitude": "-106.3467710"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1268,
  "fields": {
    "star_id": "STAR203",
    "star_annotation": "CYP2D6*41",
    "gene": "PHARGENE26",
    "drug": "DRUG57",
    "allele": "*2/*41",
    "phenotype": "CYP2D6 *2/*41 is associated with increased concentrations of hydrocodone.",
    "reference": "REF59",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1449189944",
    "region": "Sub-Saharan African",
    "country_of_participants": "Canada",
    "latitude": "56.1303670",
    "longitude": "-106.3467710"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1269,
  "fields": {
    "star_id": "STAR129",
    "star_annotation": "CYP2C19*1",
    "gene": "PHARGENE23",
    "drug": "DRUG40",
    "allele": "*1/*17",
    "phenotype": "CYP2C19 *1/*17 is associated with decreased concentrations of voriconazole.",
    "reference": "REF161",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444828163",
    "region": "Sub-Saharan African",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
},
{
  "model": "agmp_app.star_allele",
  "pk": 1270,
  "fields": {
    "star_id": "STAR130",
    "star_annotation": "CYP2C19*17",
    "gene": "PHARGENE23",
    "drug": "DRUG40",
    "allele": "*1/*17",
    "phenotype": "CYP2C19 *1/*17 is associated with decreased concentrations of voriconazole.",
    "reference": "REF161",
    "p_value": "",
    "source": "PharmGKB",
    "id_in_source": "1444828163",
    "region": "Sub-Saharan African",
    "country_of_participants": "Cameroon",
    "latitude": "7.3697000",
    "longitude": "12.3547000"
  }
}
]
